Citrus Sinensis ID: 013126
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 449 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FHD7 | 487 | Probable serine/threonine | no | no | 0.821 | 0.757 | 0.762 | 1e-174 | |
| Q944A7 | 512 | Probable serine/threonine | no | no | 0.732 | 0.642 | 0.685 | 1e-138 | |
| Q7XJT7 | 465 | Probable inactive recepto | no | no | 0.694 | 0.670 | 0.475 | 1e-84 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.608 | 0.665 | 0.328 | 2e-36 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.619 | 0.674 | 0.333 | 2e-36 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.732 | 0.794 | 0.330 | 2e-36 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.659 | 0.749 | 0.323 | 5e-36 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.665 | 0.701 | 0.313 | 9e-36 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.625 | 0.722 | 0.316 | 1e-35 | |
| Q9CAH1 | 450 | Putative receptor-like pr | no | no | 0.685 | 0.684 | 0.3 | 3e-35 |
| >sp|Q9FHD7|Y5126_ARATH Probable serine/threonine-protein kinase At5g41260 OS=Arabidopsis thaliana GN=At5g41260 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 610 bits (1572), Expect = e-174, Method: Compositional matrix adjust.
Identities = 285/374 (76%), Positives = 325/374 (86%), Gaps = 5/374 (1%)
Query: 1 MGIQCSKFTA-CCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGF 59
MG + SK +A CC + ++ PDV + + E + LP FREF++E ++NATSGF
Sbjct: 1 MGCEVSKLSALCCVSESGRSN----PDVTGLDEEGRGESNDLPQFREFSIETIRNATSGF 56
Query: 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT 119
A ENIVSEHGE+APNVVYKGKLENQRRIAVKRFNR +WPD RQFLEEA++VGQLRN+R+
Sbjct: 57 AAENIVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMA 116
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
NLLGCC E +ERLL+AE+MPNETLAKHLFHWE+ PMKWAMRLRV LH+AQALEYCTSKGR
Sbjct: 117 NLLGCCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGR 176
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 239
ALYHDLNAYR+LFD+D NPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY
Sbjct: 177 ALYHDLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 236
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
SFGTLLLDLLSGKHIPPSHALDLIRDRN+QML DS LEGQF+ DDGTEL+RLASRCLQYE
Sbjct: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYE 296
Query: 300 PRERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILE 359
PRERPNPKSLV+A+ PLQK+ E+ SH L+G+P+SA+ + LSPLGEAC R DLTAIHEI+E
Sbjct: 297 PRERPNPKSLVSAMIPLQKDLEIASHQLLGVPNSATTTALSPLGEACLRSDLTAIHEIIE 356
Query: 360 KISYKDDEGVANEV 373
K+ YKDDEG E+
Sbjct: 357 KLGYKDDEGATTEL 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q944A7|Y4523_ARATH Probable serine/threonine-protein kinase At4g35230 OS=Arabidopsis thaliana GN=At4g35230 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 492 bits (1267), Expect = e-138, Method: Compositional matrix adjust.
Identities = 229/334 (68%), Positives = 280/334 (83%), Gaps = 5/334 (1%)
Query: 41 LPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP 100
+PSF EF+ LK AT+ F+ +NIVSE GEKAPN+VYKG+L+N+R IAVK+F +MAWP+P
Sbjct: 55 IPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMAWPEP 114
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160
+QF EEA VG+LR+NRL NL+G CC+GDERLLVAE+MPN+TLAKHLFHWE ++WAMR
Sbjct: 115 KQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIEWAMR 174
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220
LRV ++A+AL+YC+++GR LYHDLNAYR+LFDEDG+PRLS FGLMKNSRDGKSYSTNLA
Sbjct: 175 LRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYSTNLA 234
Query: 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280
+TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +N+ +L DS LEG+F
Sbjct: 235 YTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHLEGKF 294
Query: 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIPH-----SAS 335
+ ++ T +V LAS+CLQYEPRERPN K LV L+PLQ +++VPS+V++GI S
Sbjct: 295 STEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSDVPSYVMLGIKKQEEAPSTP 354
Query: 336 VSPLSPLGEACSRRDLTAIHEILEKISYKDDEGV 369
PLSPLGEACSR DLTAIH+IL Y+DDEG
Sbjct: 355 QRPLSPLGEACSRMDLTAIHQILVMTHYRDDEGT 388
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XJT7|SSP_ARATH Probable inactive receptor-like kinase SSP OS=Arabidopsis thaliana GN=SSP PE=1 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (803), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 158/332 (47%), Positives = 224/332 (67%), Gaps = 20/332 (6%)
Query: 42 PSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPR 101
P +F+ LK AT+ F+ ENIVS+ + +VV+KG+L+N +A+KRFN MAW DP+
Sbjct: 33 PPLTKFSFSALKTATNHFSPENIVSD---QTSDVVFKGRLQNGGFVAIKRFNNMAWSDPK 89
Query: 102 QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRL 161
FLEEA+ VG+LR+ RL NL+G CC+GD+R LVA++M N+TLAK LF + M W++RL
Sbjct: 90 LFLEEAQRVGKLRHKRLVNLIGYCCDGDKRFLVADFMANDTLAKRLFQRKYQTMDWSIRL 149
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF 221
RV +A+AL+YC + G A Y++L+AY++LFDEDG+ LS FGLMK + +
Sbjct: 150 RVAYFVAEALDYCNTAGFASYNNLSAYKVLFDEDGDACLSCFGLMKEINNDQ-------- 201
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
+ TG V PE+VIY FGT+L++LLSGK IPPSHA ++I +N+ L D L+G+F+
Sbjct: 202 -----ITTGSVNPENVIYRFGTVLVNLLSGKQIPPSHAPEMIHRKNVFKLMDPYLKGKFS 256
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIPH----SASVS 337
D+ + +LAS+CL+YE +E PN K +V L LQ TE PS+ ++ + + ++S S
Sbjct: 257 IDEANVVYKLASQCLKYEGQESPNTKEIVATLETLQTRTEAPSYEVVEMTNQEKDASSSS 316
Query: 338 PLSPLGEACSRRDLTAIHEILEKISYKDDEGV 369
LSPLGEAC R DL +IH IL Y DD+ +
Sbjct: 317 NLSPLGEACLRMDLASIHSILVLAGYDDDKDI 348
|
Probable inactive protein kinase that activates the YODA MAP kinase cascade, regulating the asymmetric first division, and thus embryo polarity. Acts as an adapter at the plasma membrane, possibly recruiting an activator. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (388), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 101/307 (32%), Positives = 163/307 (53%), Gaps = 34/307 (11%)
Query: 42 PSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR----------RIAVKR 91
P+ + F+ +LK+AT F ++++ GE V+KG ++ + IAVK+
Sbjct: 51 PNLKSFSFAELKSATRNFRPDSVL---GEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKK 107
Query: 92 FNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWE 151
N+ W +++L E +GQ + L L+G C E + RLLV E+MP +L HLF
Sbjct: 108 LNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 167
Query: 152 TH--PMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208
+ P+ W +RL+V L A+ L + +S+ R +Y D IL D + N +LS FGL K+
Sbjct: 168 LYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKD 227
Query: 209 SRDG-KSY-STNL----AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI----PPSH 258
G KS+ ST + + PEYL TG +T +S +YSFG +LL+LLSG+ PS
Sbjct: 228 GPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSG 287
Query: 259 ALDLIR--------DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
+L+ R + + D+ L+ Q++ ++ ++ L+ RCL E + RPN +V
Sbjct: 288 ERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVV 347
Query: 311 TALSPLQ 317
+ L +Q
Sbjct: 348 SHLEHIQ 354
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 153 bits (387), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 104/312 (33%), Positives = 166/312 (53%), Gaps = 34/312 (10%)
Query: 42 PSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR----------RIAVKR 91
P+ + FT +LK AT F ++++ E G + V+KG ++ Q IAVK+
Sbjct: 52 PNLKSFTFAELKAATRNFRPDSVLGEGGFGS---VFKGWIDEQTLTASKPGTGVVIAVKK 108
Query: 92 FNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWE 151
N+ W +++L E +GQ + L L+G C E + RLLV E+MP +L HLF
Sbjct: 109 LNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 168
Query: 152 TH--PMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208
++ P+ W +RL+V L A+ L + ++ +Y D IL D + N +LS FGL K+
Sbjct: 169 SYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKD 228
Query: 209 SRDG-KSY-STNL----AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-----KHIPPS 257
G KS+ ST + + PEYL TG +T +S +YS+G +LL++LSG K+ PP
Sbjct: 229 GPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPG 288
Query: 258 H------ALDLIRD-RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
A L+ + R L + D+ L+ Q++ ++ ++ LA RCL +E + RPN +V
Sbjct: 289 EQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVV 348
Query: 311 TALSPLQKETEV 322
+ L +Q E
Sbjct: 349 SHLEHIQTLNEA 360
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (387), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 123/372 (33%), Positives = 176/372 (47%), Gaps = 43/372 (11%)
Query: 32 NDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRI-AVK 90
NDE EV + + F+ +L AT F E ++ GE VYKGKLE I AVK
Sbjct: 52 NDEDKEVTNNIAAQTFSFRELATATKNFRQECLI---GEGGFGRVYKGKLEKTGMIVAVK 108
Query: 91 RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHW 150
+ +R ++F+ E + L + L NL+G C +GD+RLLV EYM +L HL
Sbjct: 109 QLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDL 168
Query: 151 --ETHPMKWAMRLRVVLHLAQALEYCTSKGR--ALYHDLNAYRILFDEDGNPRLSTFGLM 206
+ P+ W R+R+ L A LEY K +Y DL A IL D + N +LS FGL
Sbjct: 169 TPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLA 228
Query: 207 KNS--RDGKSYSTNL----AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260
K D + S+ + + PEY RTG++T +S +YSFG +LL+L++G+ + +
Sbjct: 229 KLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRV-----I 283
Query: 261 DLIRDRNLQ-----------------MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
D R ++ Q L D LEG F + + V +A+ CLQ E R
Sbjct: 284 DTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVR 343
Query: 304 PNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEKISY 363
P +VTAL L + + +PH P P E S D A E ++
Sbjct: 344 PLMSDVVTALGFLGTAPDGS----ISVPHYD--DPPQPSDE-TSVEDSVAAEERERAVAE 396
Query: 364 KDDEGVANEVHS 375
+ GVA+ HS
Sbjct: 397 AMEWGVASRAHS 408
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (384), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 107/331 (32%), Positives = 165/331 (49%), Gaps = 35/331 (10%)
Query: 27 VDAAENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR- 85
V AA+ E + P + FT +LK AT F ++++ GE V+KG L+
Sbjct: 36 VAAAQKTEGEILSSTP-VKSFTFNELKLATRNFRPDSVI---GEGGFGCVFKGWLDESTL 91
Query: 86 ---------RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136
IAVK+ N+ + R++L E +GQL + L L+G C E + RLLV E
Sbjct: 92 TPTKPGTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYE 151
Query: 137 YMPNETLAKHLFHWETH--PMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFD 193
+M +L HLF + P+ W +R+ V L A+ L + S + +Y D+ A IL D
Sbjct: 152 FMQKGSLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLD 211
Query: 194 EDGNPRLSTFGLMKNSRDGK-SY-STNL----AFTPPEYLRTGRVTPESVIYSFGTLLLD 247
D N +LS FGL ++ G SY ST + + PEY+ +G + S +YSFG LLL+
Sbjct: 212 ADYNAKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLE 271
Query: 248 LLSGK----HIPPSHALDLI--------RDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
+LSGK H P+ +L+ R + ++ D+ L+ Q+ ++ + +A +C
Sbjct: 272 ILSGKRALDHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQC 331
Query: 296 LQYEPRERPNPKSLVTALSPLQKETEVPSHV 326
L +EP+ RP +V AL LQ PS
Sbjct: 332 LSFEPKSRPTMDQVVRALQQLQDNLGKPSQT 362
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 151 bits (382), Expect = 9e-36, Method: Compositional matrix adjust.
Identities = 108/344 (31%), Positives = 166/344 (48%), Gaps = 45/344 (13%)
Query: 36 SEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR---------- 85
E+ P+ + FT +LKNAT F +N++ E G V+KG ++
Sbjct: 63 GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGF---GCVFKGWIDQTSLTASRPGSGI 119
Query: 86 RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+AVK+ + +++L E +GQL + L L+G C EG+ RLLV E+MP +L
Sbjct: 120 VVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLEN 179
Query: 146 HLFHWETHPMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAYRILFDEDGNPRLSTFG 204
HLF P+ WA+R++V + A+ L + +K + +Y D A IL D D N +LS FG
Sbjct: 180 HLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 205 LMKNSRDGKS--YSTNL----AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258
L K G + ST + + PEY+ TGR+T +S +YSFG +LL+L+SG+
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGR-----R 294
Query: 259 ALD-----------------LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
A+D L R L + D+ L GQ+ LA +CL + +
Sbjct: 295 AMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAK 354
Query: 302 ERPNPKSLVTALSPLQKETEVPS-HVLMGIP--HSASVSPLSPL 342
RP ++ L L+ + + H M P H +SV SP+
Sbjct: 355 LRPKMSEVLVTLEQLESVAKPGTKHTQMESPRFHHSSVMQKSPV 398
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 151 bits (381), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 100/316 (31%), Positives = 159/316 (50%), Gaps = 35/316 (11%)
Query: 43 SFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR----------RIAVKRF 92
+ + F+ +LK AT F +++V GE V++G L+ IAVKR
Sbjct: 45 TVKSFSFNELKLATRNFRSDSVV---GEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRL 101
Query: 93 NRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF---H 149
N + R++L E +GQL + L L+G C E ++RLLV E+M +L HLF +
Sbjct: 102 NPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGN 161
Query: 150 WETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFDEDGNPRLSTFGLMKN 208
+ P+ W +R++V L A+ L + S + +Y D+ A IL D D N +LS FGL ++
Sbjct: 162 KDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARD 221
Query: 209 SRDG-KSYST-----NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK----HIPPSH 258
G +SY + + PEY+ TG + S +YSFG +LL+LL G+ H P+
Sbjct: 222 GPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAK 281
Query: 259 ALDLI--------RDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
+L+ R + ++ D+ L Q+ + L +A +CL +EP+ RP +V
Sbjct: 282 EQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVV 341
Query: 311 TALSPLQKETEVPSHV 326
AL LQ P++V
Sbjct: 342 RALVQLQDSVVKPANV 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAH1|Y1725_ARATH Putative receptor-like protein kinase At1g72540 OS=Arabidopsis thaliana GN=At1g72540 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 149 bits (377), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 102/340 (30%), Positives = 167/340 (49%), Gaps = 32/340 (9%)
Query: 47 FTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRR-------IAVKRFNRMAWPD 99
FT E+LK T GF+ N + GE VYKG +++ + +AVK R
Sbjct: 72 FTYEELKTITQGFSKYNFL---GEGGFGEVYKGFVDDSLKTGLKDQPVAVKALKREGGQG 128
Query: 100 PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAM 159
R++L E +GQL++ L NL+G CCE DERLLV EYM L HLF + W
Sbjct: 129 HREWLAEVIILGQLKHPHLVNLVGYCCEDDERLLVYEYMERGNLEDHLFQKYGGALPWLT 188
Query: 160 RLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFDEDGNPRLSTFGLM------KNSRDG 212
R++++L A+ LE+ + + +Y D IL D + +LS FGL ++S
Sbjct: 189 RVKILLGAAKGLEFLHKQEKPVIYRDFKPSNILLSSDFSSKLSDFGLATDGSEEEDSNFT 248
Query: 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-----------ALD 261
KS + PEY+ G +T S ++SFG +LL++L+ + + A
Sbjct: 249 KSVMGTEGYAAPEYISAGNLTTMSDVFSFGVVLLEMLTARKAVEKYRAQRGRNLVEWARP 308
Query: 262 LIRDRN-LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320
+++D N L+ + D LEG+++ + + LA +CL + P+ RP ++V L P+
Sbjct: 309 MLKDPNKLERIIDPSLEGKYSVEGIRKAAALAYQCLSHNPKSRPTMTTVVKTLEPILDLK 368
Query: 321 EVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
++ + + I V+ +S + E + D+ + E EK
Sbjct: 369 DIQNGPFVYI---VPVAGVSEVHEIKCKDDVKVVKEETEK 405
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 449 | ||||||
| 225454188 | 491 | PREDICTED: probable serine/threonine-pro | 0.824 | 0.753 | 0.892 | 0.0 | |
| 356520418 | 491 | PREDICTED: probable serine/threonine-pro | 0.824 | 0.753 | 0.871 | 0.0 | |
| 224127648 | 491 | predicted protein [Populus trichocarpa] | 0.824 | 0.753 | 0.868 | 0.0 | |
| 255541562 | 493 | receptor protein kinase, putative [Ricin | 0.826 | 0.752 | 0.866 | 0.0 | |
| 356504529 | 491 | PREDICTED: probable serine/threonine-pro | 0.824 | 0.753 | 0.863 | 0.0 | |
| 224064025 | 491 | predicted protein [Populus trichocarpa] | 0.824 | 0.753 | 0.855 | 0.0 | |
| 357507281 | 492 | hypothetical protein MTR_7g077150 [Medic | 0.824 | 0.752 | 0.844 | 0.0 | |
| 297814269 | 490 | kinase family protein [Arabidopsis lyrat | 0.824 | 0.755 | 0.844 | 0.0 | |
| 225426412 | 488 | PREDICTED: probable serine/threonine-pro | 0.824 | 0.758 | 0.833 | 0.0 | |
| 22328189 | 489 | BR-signaling kinase 3 [Arabidopsis thali | 0.821 | 0.754 | 0.847 | 0.0 |
| >gi|225454188|ref|XP_002272416.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297745267|emb|CBI40347.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1795), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/373 (89%), Positives = 346/373 (92%), Gaps = 3/373 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCSK CCW+SQFK +VLEAPDVD N E SEVD LP F E+T EQLKNATSGFA
Sbjct: 1 MGCQCSKLAPCCWDSQFKGSVLEAPDVD---NGEKSEVDYLPVFCEYTFEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNR+AWPD RQF EEAR+VGQLRN+RL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRVAWPDARQFSEEARAVGQLRNHRLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCE +ERLLVAEYMPNETLAKHLFHWET PMKWAMRLRVVLHLAQALEYCT +GRA
Sbjct: 118 LLGCCCEDNERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTGRGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRILFDEDGNPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRILFDEDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT+DDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTNDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERPNPKSLV AL+PLQKETEVPSHVLMGIPHSAS SPLSPLGEACSR DLTAIHEILE
Sbjct: 298 RERPNPKSLVAALTPLQKETEVPSHVLMGIPHSASFSPLSPLGEACSRMDLTAIHEILES 357
Query: 361 ISYKDDEGVANEV 373
+ YKDDEG+ NE+
Sbjct: 358 VGYKDDEGMTNEL 370
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520418|ref|XP_003528859.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/373 (87%), Positives = 344/373 (92%), Gaps = 3/373 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MGIQCS+ CC +SQ KA+V+E PD AE ++ SEV P+FRE+TLEQLKNATSGFA
Sbjct: 1 MGIQCSRLIPCCVDSQVKASVIETPD---AEIEDSSEVSNWPTFREYTLEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGKLENQ RIAVKRFNR AWPD RQFLEEARSVGQLRN RL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKLENQMRIAVKRFNRNAWPDARQFLEEARSVGQLRNQRLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEG+ERLLVAEYMPNETLAKHLFHWET PMKWAMRLRVVLHLAQALEYCTSKGRA
Sbjct: 118 LLGCCCEGEERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDEDGNPRLS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALD+IR RNLQMLTDSCLEGQF+DDDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDVIRGRNLQMLTDSCLEGQFSDDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERPNPKSLV AL+PLQKETEVPSHVLMGI HS + + LSPLGEACSR+DLTAI E+LE
Sbjct: 298 RERPNPKSLVVALAPLQKETEVPSHVLMGIQHSTTFASLSPLGEACSRKDLTAIQEVLES 357
Query: 361 ISYKDDEGVANEV 373
I YKDDEGVANE+
Sbjct: 358 IGYKDDEGVANEL 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127648|ref|XP_002320126.1| predicted protein [Populus trichocarpa] gi|222860899|gb|EEE98441.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/373 (86%), Positives = 345/373 (92%), Gaps = 3/373 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QC+K T CC +SQFKA V+E P V N+E SEV+ LP+FREFT EQLKNATSGFA
Sbjct: 1 MGSQCTKLTPCCLDSQFKAAVVEVPSVG---NEEKSEVNDLPTFREFTFEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD RQFLEEARSVGQLRNNRL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDARQFLEEARSVGQLRNNRLVN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEGDERLLVAE+MPNETLAKHLFHWET P+KWAMRLRVVLHLA+ALEYCTSKGRA
Sbjct: 118 LLGCCCEGDERLLVAEFMPNETLAKHLFHWETQPIKWAMRLRVVLHLAEALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRILFDEDGNP+LS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRILFDEDGNPKLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLD LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF++DDGTELVRLASRCLQYE
Sbjct: 238 FGTLLLDHLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFSNDDGTELVRLASRCLQYEL 297
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERP+ K LV AL+PLQKET+V SH+LMGIPHSAS SPLSP GEAC R+DLTAIHEIL+
Sbjct: 298 RERPSLKFLVAALTPLQKETDVASHILMGIPHSASSSPLSPFGEACLRKDLTAIHEILDN 357
Query: 361 ISYKDDEGVANEV 373
I YKDD+GVANE+
Sbjct: 358 IGYKDDQGVANEL 370
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541562|ref|XP_002511845.1| receptor protein kinase, putative [Ricinus communis] gi|223549025|gb|EEF50514.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/374 (86%), Positives = 345/374 (92%), Gaps = 3/374 (0%)
Query: 1 MGIQCSKFTACCWNSQFKAT-VLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGF 59
MG CSKF CC +SQFKA V+E PD N+ SE+D LP+FREFT EQLKNATSGF
Sbjct: 1 MGSLCSKFIPCCLDSQFKAAAVVEVPDT--VGNEGKSEIDYLPAFREFTFEQLKNATSGF 58
Query: 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT 119
AVENIVSEHGEKAPNVVYKGKLENQRRI VKRFNRMAWPD RQFLEEAR VGQLRN+RL
Sbjct: 59 AVENIVSEHGEKAPNVVYKGKLENQRRIVVKRFNRMAWPDARQFLEEARFVGQLRNHRLA 118
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
NLLGCCCEGDERLLVAEY+PNETLAKHLFHWET PMKWAMRLRV LHLA+ALEYCTSKGR
Sbjct: 119 NLLGCCCEGDERLLVAEYLPNETLAKHLFHWETQPMKWAMRLRVALHLAEALEYCTSKGR 178
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 239
ALYHDLNAYRILFDEDGNPRLS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY
Sbjct: 179 ALYHDLNAYRILFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 238
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
SFGTLL+DLLSGKHIPP+HALDLIRDRNLQMLTDSCLEGQF++DDGTELVRLASRCLQYE
Sbjct: 239 SFGTLLVDLLSGKHIPPNHALDLIRDRNLQMLTDSCLEGQFSNDDGTELVRLASRCLQYE 298
Query: 300 PRERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILE 359
RERP+ KSLV AL+PLQKETEVPSHVLMGIPHSAS+SPLSP+GEACSR+DLTAIHEIL+
Sbjct: 299 LRERPSSKSLVAALTPLQKETEVPSHVLMGIPHSASLSPLSPIGEACSRKDLTAIHEILD 358
Query: 360 KISYKDDEGVANEV 373
+ YKDDEGV NE+
Sbjct: 359 GLGYKDDEGVTNEL 372
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504529|ref|XP_003521048.1| PREDICTED: probable serine/threonine-protein kinase At5g41260-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/373 (86%), Positives = 343/373 (91%), Gaps = 3/373 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MGIQCS+ CC +SQ KA+V+E PD AE ++ SE P+FREFTLEQLKNATSGFA
Sbjct: 1 MGIQCSRLIPCCVDSQVKASVIETPD---AEIEDSSEASNWPTFREFTLEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGKLENQ RIAVKRFNR AWPD RQFLEE+RSVGQLRN RL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKLENQMRIAVKRFNRNAWPDARQFLEESRSVGQLRNQRLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEG+ERLLVAEYMPNETLAKHLFHWET PMKWAMRLRVVLHLAQALEYCTSKGRA
Sbjct: 118 LLGCCCEGEERLLVAEYMPNETLAKHLFHWETQPMKWAMRLRVVLHLAQALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDEDGNPRLS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALD+IR RNLQMLTDSCLEGQF+DDDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDVIRGRNLQMLTDSCLEGQFSDDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERPNPKSLV AL+PLQKETEV SH+LMGI HS + + LSPLGEACSR+DLTAIHE+LE
Sbjct: 298 RERPNPKSLVAALAPLQKETEVLSHILMGIQHSTTFASLSPLGEACSRKDLTAIHEVLES 357
Query: 361 ISYKDDEGVANEV 373
+ YKDDEGVANE+
Sbjct: 358 LGYKDDEGVANEL 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064025|ref|XP_002301354.1| predicted protein [Populus trichocarpa] gi|222843080|gb|EEE80627.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/373 (85%), Positives = 345/373 (92%), Gaps = 3/373 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QC+K T CC +SQFKA V+E PDV N++ SEV+ LP+FREFTLEQLKNATSGFA
Sbjct: 1 MGSQCTKLTRCCVDSQFKAAVVEVPDVG---NEDKSEVNDLPTFREFTLEQLKNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
V+NIVSEHGEKAPNVVYKGKLENQRRIAVKRFN+MAWPD RQFLEEARSVGQLR++RL N
Sbjct: 58 VQNIVSEHGEKAPNVVYKGKLENQRRIAVKRFNKMAWPDARQFLEEARSVGQLRSHRLVN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLG CCEGDER+LVAE+M NETLAKHLFHWET P+KW MRLRVVLHLA+ALEYCTSKGRA
Sbjct: 118 LLGFCCEGDERVLVAEFMLNETLAKHLFHWETQPIKWPMRLRVVLHLAEALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRILFDEDGNP+LS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRILFDEDGNPKLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF+ DDGTELVRLASRCLQYE
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFSSDDGTELVRLASRCLQYEL 297
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERP+ KSLV AL+PLQKE +VPSH+LMGIPH AS SPLSP GEACSRRDLTAI+EIL+
Sbjct: 298 RERPSLKSLVAALTPLQKENDVPSHILMGIPHGASSSPLSPFGEACSRRDLTAINEILDN 357
Query: 361 ISYKDDEGVANEV 373
I YKDD+GVANE+
Sbjct: 358 IGYKDDQGVANEL 370
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507281|ref|XP_003623929.1| hypothetical protein MTR_7g077150 [Medicago truncatula] gi|355498944|gb|AES80147.1| hypothetical protein MTR_7g077150 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 661 bits (1706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 316/374 (84%), Positives = 338/374 (90%), Gaps = 4/374 (1%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MGIQCS CC +SQ KA+V E PD AEN+ E + PSFREFTLEQL NATSGF
Sbjct: 1 MGIQCSSLVPCCVDSQVKASVPEVPD---AENENRIETNDGPSFREFTLEQLNNATSGFN 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VENIVSEHGEKAPNVVYKGK+ENQ RI VKRFNR AWPD RQFLEEARSVGQLR+ RL N
Sbjct: 58 VENIVSEHGEKAPNVVYKGKMENQTRIVVKRFNRSAWPDARQFLEEARSVGQLRSERLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCE DERLLVAEYMPNETLAKHLFHW++ PMKWAMRLRVVLHLA+ALEYCTS GRA
Sbjct: 118 LLGCCCEDDERLLVAEYMPNETLAKHLFHWDSQPMKWAMRLRVVLHLAEALEYCTSNGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDEDGNPRLS+FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS
Sbjct: 178 LYHDLNAYRVLFDEDGNPRLSSFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRN+QMLTDSCLEGQF++DDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSEDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSP-LSPLGEACSRRDLTAIHEILE 359
RERPN KSLV AL+PLQKETEVPSH LMGI HSA++S LSPLG+ACSR+DLTAIHE+LE
Sbjct: 298 RERPNTKSLVAALAPLQKETEVPSHSLMGIQHSATISASLSPLGDACSRKDLTAIHEVLE 357
Query: 360 KISYKDDEGVANEV 373
I YKDD+GVANE+
Sbjct: 358 NIGYKDDDGVANEL 371
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297814269|ref|XP_002875018.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297320855|gb|EFH51277.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/373 (84%), Positives = 338/373 (90%), Gaps = 3/373 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCS + CC NS K VLEAP VD N E SE+ +P+FRE+TLEQLK ATSGFA
Sbjct: 1 MGGQCSSLSQCCRNSSHKTAVLEAPYVD---NGESSEITDVPNFREYTLEQLKAATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VE IVSEHGEKAPNVVYKGKLENQ++IAVKRF RMAWPD RQFLEEARSVGQLR+ R+ N
Sbjct: 58 VEYIVSEHGEKAPNVVYKGKLENQKKIAVKRFTRMAWPDARQFLEEARSVGQLRSERMAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEGDERLLVAE+MPNETLAKHLFHWET PMKW MRLRVVL+LAQALEYCTSKGR
Sbjct: 118 LLGCCCEGDERLLVAEFMPNETLAKHLFHWETQPMKWTMRLRVVLYLAQALEYCTSKGRT 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDE+ NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGR+TPESVIYS
Sbjct: 178 LYHDLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITPESVIYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQ LTDSCL+GQF+D DGTELVRLASRCLQYE
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNLQTLTDSCLDGQFSDSDGTELVRLASRCLQYEA 297
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERPN KSLVTAL+PLQK+TEVPSHVLMG+PHS SVSPLSPLGEACSRRDLTA+ EIL+K
Sbjct: 298 RERPNTKSLVTALTPLQKDTEVPSHVLMGLPHSGSVSPLSPLGEACSRRDLTAMLEILDK 357
Query: 361 ISYKDDEGVANEV 373
+ YKDDEGV NE+
Sbjct: 358 LGYKDDEGVTNEL 370
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225426412|ref|XP_002270065.1| PREDICTED: probable serine/threonine-protein kinase At5g41260 [Vitis vinifera] gi|297742525|emb|CBI34674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 311/373 (83%), Positives = 336/373 (90%), Gaps = 3/373 (0%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCSKF CCW+S+ K V+E P V EN+E SE D LP+F E+T++QL+ ATSGFA
Sbjct: 1 MGCQCSKFWVCCWDSEQKGLVVEPPSV---ENEENSEADDLPAFHEYTIDQLRMATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFN+ AWPD RQFLEEARSVGQLRN+RL N
Sbjct: 58 AENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNKSAWPDARQFLEEARSVGQLRNHRLAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCC EGDERLLVAE+MPN+TLAKHLFHWET PMKWAMRLRV L+LAQALEYCTSKGRA
Sbjct: 118 LLGCCSEGDERLLVAEFMPNDTLAKHLFHWETQPMKWAMRLRVALYLAQALEYCTSKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRI+FD+DG+PRLS FG+MKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV+YS
Sbjct: 178 LYHDLNAYRIVFDDDGDPRLSCFGMMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRN+QMLTDSCLEGQF+ DDGTELVRLASRCLQYEP
Sbjct: 238 FGTLLLDLLSGKHIPPSHALDLIRDRNIQMLTDSCLEGQFSSDDGTELVRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERPNPKSLV AL PLQKETEVPSHVLMG+P S + PLSPLGEAC R DLTAIHEILEK
Sbjct: 298 RERPNPKSLVAALIPLQKETEVPSHVLMGMPQSGATLPLSPLGEACLRMDLTAIHEILEK 357
Query: 361 ISYKDDEGVANEV 373
+ YKDDEG E+
Sbjct: 358 LGYKDDEGATTEL 370
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22328189|ref|NP_191980.2| BR-signaling kinase 3 [Arabidopsis thaliana] gi|17064838|gb|AAL32573.1| Unknown protein [Arabidopsis thaliana] gi|20259854|gb|AAM13274.1| unknown protein [Arabidopsis thaliana] gi|332656524|gb|AEE81924.1| BR-signaling kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 316/373 (84%), Positives = 338/373 (90%), Gaps = 4/373 (1%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCS + CC N+ K VLEAPDVD N E SE+ +P+FRE+TLEQLK ATSGFA
Sbjct: 1 MGGQCSSLS-CCRNTSHKTAVLEAPDVD---NGESSEITDVPNFREYTLEQLKAATSGFA 56
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VE IVSEHGEKAPNVVYKGKLENQ++IAVKRF RMAWPD RQFLEEARSVGQLR+ R+ N
Sbjct: 57 VEYIVSEHGEKAPNVVYKGKLENQKKIAVKRFTRMAWPDSRQFLEEARSVGQLRSERMAN 116
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEGDERLLVAE+MPNETLAKHLFHWET PMKW MRLRVVL+LAQALEYCTSKGR
Sbjct: 117 LLGCCCEGDERLLVAEFMPNETLAKHLFHWETQPMKWTMRLRVVLYLAQALEYCTSKGRT 176
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDE+ NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGR+TPESVIYS
Sbjct: 177 LYHDLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITPESVIYS 236
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQ LTDSCL+GQF+D DGTELVRLASRCLQYE
Sbjct: 237 FGTLLLDLLSGKHIPPSHALDLIRDRNLQTLTDSCLDGQFSDSDGTELVRLASRCLQYEA 296
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERPN KSLVTAL+PLQKETEV SHVLMG+PHS SVSPLSPLGEACSRRDLTA+ EILEK
Sbjct: 297 RERPNTKSLVTALTPLQKETEVLSHVLMGLPHSGSVSPLSPLGEACSRRDLTAMLEILEK 356
Query: 361 ISYKDDEGVANEV 373
+ YKDDEGV NE+
Sbjct: 357 LGYKDDEGVTNEL 369
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 449 | ||||||
| TAIR|locus:2127118 | 489 | BSK3 "brassinosteroid-signalin | 0.821 | 0.754 | 0.847 | 8.2e-170 | |
| TAIR|locus:2031279 | 487 | BSK7 "brassinosteroid-signalin | 0.824 | 0.759 | 0.790 | 1.6e-159 | |
| TAIR|locus:2155115 | 487 | BSK8 "brassinosteroid-signalin | 0.821 | 0.757 | 0.762 | 1.4e-156 | |
| TAIR|locus:2154538 | 489 | BSK5 "brassinosteroid-signalin | 0.812 | 0.746 | 0.748 | 6.7e-152 | |
| TAIR|locus:2198160 | 483 | BSK4 "brassinosteroid-signalin | 0.810 | 0.753 | 0.754 | 1.9e-147 | |
| TAIR|locus:2084475 | 490 | BSK6 "brassinosteroid-signalin | 0.815 | 0.746 | 0.728 | 4e-145 | |
| TAIR|locus:2122058 | 512 | BSK1 "brassinosteroid-signalin | 0.741 | 0.650 | 0.684 | 1.4e-126 | |
| TAIR|locus:2142315 | 489 | BSK2 "brassinosteroid-signalin | 0.777 | 0.713 | 0.616 | 7.4e-121 | |
| TAIR|locus:2083499 | 477 | BSK9 "brassinosteroid-signalin | 0.766 | 0.721 | 0.623 | 2.8e-114 | |
| TAIR|locus:2150074 | 499 | BSK10 "brassinosteroid-signali | 0.819 | 0.737 | 0.565 | 2.6e-111 |
| TAIR|locus:2127118 BSK3 "brassinosteroid-signaling kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1651 (586.2 bits), Expect = 8.2e-170, P = 8.2e-170
Identities = 316/373 (84%), Positives = 338/373 (90%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG QCS + CC N+ K VLEAPDVD N E SE+ +P+FRE+TLEQLK ATSGFA
Sbjct: 1 MGGQCSSLS-CCRNTSHKTAVLEAPDVD---NGESSEITDVPNFREYTLEQLKAATSGFA 56
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
VE IVSEHGEKAPNVVYKGKLENQ++IAVKRF RMAWPD RQFLEEARSVGQLR+ R+ N
Sbjct: 57 VEYIVSEHGEKAPNVVYKGKLENQKKIAVKRFTRMAWPDSRQFLEEARSVGQLRSERMAN 116
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCCCEGDERLLVAE+MPNETLAKHLFHWET PMKW MRLRVVL+LAQALEYCTSKGR
Sbjct: 117 LLGCCCEGDERLLVAEFMPNETLAKHLFHWETQPMKWTMRLRVVLYLAQALEYCTSKGRT 176
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDE+ NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGR+TPESVIYS
Sbjct: 177 LYHDLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITPESVIYS 236
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIRDRNLQ LTDSCL+GQF+D DGTELVRLASRCLQYE
Sbjct: 237 FGTLLLDLLSGKHIPPSHALDLIRDRNLQTLTDSCLDGQFSDSDGTELVRLASRCLQYEA 296
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERPN KSLVTAL+PLQKETEV SHVLMG+PHS SVSPLSPLGEACSRRDLTA+ EILEK
Sbjct: 297 RERPNTKSLVTALTPLQKETEVLSHVLMGLPHSGSVSPLSPLGEACSRRDLTAMLEILEK 356
Query: 361 ISYKDDEGVANEV 373
+ YKDDEGV NE+
Sbjct: 357 LGYKDDEGVTNEL 369
|
|
| TAIR|locus:2031279 BSK7 "brassinosteroid-signaling kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1554 (552.1 bits), Expect = 1.6e-159, P = 1.6e-159
Identities = 295/373 (79%), Positives = 323/373 (86%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG + SK A C S + + V + D E + LP FREF++E L+NATSGFA
Sbjct: 1 MGCEVSKLCAFCCVSDPEGS---NHGVTGLDEDRRGEGNDLPQFREFSIETLRNATSGFA 57
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
ENIVSEHGEKAPNVVYKGKL+NQRRIAVKRFNR AWPD RQFLEEA++VGQLRN R+ N
Sbjct: 58 TENIVSEHGEKAPNVVYKGKLDNQRRIAVKRFNRKAWPDSRQFLEEAKAVGQLRNYRMAN 117
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLGCC EG+ERLLVAE+MPNETLAKHLFHWE+ PMKWAMRLRV LH+AQALEYCT KGRA
Sbjct: 118 LLGCCYEGEERLLVAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTGKGRA 177
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFD+D NPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV+YS
Sbjct: 178 LYHDLNAYRVLFDDDSNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVMYS 237
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
+GTLLLDLLSGKHIPPSHALDLIRDRN+QML DSCLEGQF+ DDGTEL+RLASRCLQYEP
Sbjct: 238 YGTLLLDLLSGKHIPPSHALDLIRDRNIQMLIDSCLEGQFSSDDGTELIRLASRCLQYEP 297
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILEK 360
RERPNPKSLVTA+ PLQK+ E PSH LMGIP SAS +PLSPLGEAC R DLTAIHEILEK
Sbjct: 298 RERPNPKSLVTAMIPLQKDLETPSHQLMGIPSSASTTPLSPLGEACLRTDLTAIHEILEK 357
Query: 361 ISYKDDEGVANEV 373
+SYKDDEG A E+
Sbjct: 358 LSYKDDEGAATEL 370
|
|
| TAIR|locus:2155115 BSK8 "brassinosteroid-signaling kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1526 (542.2 bits), Expect = 1.4e-156, P = 1.4e-156
Identities = 285/374 (76%), Positives = 325/374 (86%)
Query: 1 MGIQCSKFTA-CCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGF 59
MG + SK +A CC + ++ PDV + + E + LP FREF++E ++NATSGF
Sbjct: 1 MGCEVSKLSALCCVSESGRSN----PDVTGLDEEGRGESNDLPQFREFSIETIRNATSGF 56
Query: 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT 119
A ENIVSEHGE+APNVVYKGKLENQRRIAVKRFNR +WPD RQFLEEA++VGQLRN+R+
Sbjct: 57 AAENIVSEHGERAPNVVYKGKLENQRRIAVKRFNRKSWPDSRQFLEEAKAVGQLRNHRMA 116
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
NLLGCC E +ERLL+AE+MPNETLAKHLFHWE+ PMKWAMRLRV LH+AQALEYCTSKGR
Sbjct: 117 NLLGCCYEDEERLLIAEFMPNETLAKHLFHWESQPMKWAMRLRVALHIAQALEYCTSKGR 176
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 239
ALYHDLNAYR+LFD+D NPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY
Sbjct: 177 ALYHDLNAYRVLFDDDANPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 236
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
SFGTLLLDLLSGKHIPPSHALDLIRDRN+QML DS LEGQF+ DDGTEL+RLASRCLQYE
Sbjct: 237 SFGTLLLDLLSGKHIPPSHALDLIRDRNIQMLMDSGLEGQFSSDDGTELIRLASRCLQYE 296
Query: 300 PRERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAIHEILE 359
PRERPNPKSLV+A+ PLQK+ E+ SH L+G+P+SA+ + LSPLGEAC R DLTAIHEI+E
Sbjct: 297 PRERPNPKSLVSAMIPLQKDLEIASHQLLGVPNSATTTALSPLGEACLRSDLTAIHEIIE 356
Query: 360 KISYKDDEGVANEV 373
K+ YKDDEG E+
Sbjct: 357 KLGYKDDEGATTEL 370
|
|
| TAIR|locus:2154538 BSK5 "brassinosteroid-signaling kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1482 (526.7 bits), Expect = 6.7e-152, P = 6.7e-152
Identities = 283/378 (74%), Positives = 324/378 (85%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG +CSK + C W + K+T EA D+D +D LPSF EF+ +QL+ AT GF+
Sbjct: 1 MGPRCSKLSLCWWPTHLKSTHNEASDLDNGTDD-------LPSFTEFSFDQLRAATCGFS 53
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
++IVSEHG KAPNVVYKG+LE+ R IAVKRFNR AWPD RQFLEEA++VGQLRN RL N
Sbjct: 54 TDSIVSEHGVKAPNVVYKGRLEDDRWIAVKRFNRSAWPDTRQFLEEAKAVGQLRNERLAN 113
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
L+G CCEGDERLLVAE+MP ETL+KHLFHW++ PMKW+MRLRV L+LAQALEYC+SKGRA
Sbjct: 114 LIGFCCEGDERLLVAEFMPFETLSKHLFHWDSQPMKWSMRLRVALYLAQALEYCSSKGRA 173
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYRILFD+DGNPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRV PESV+YS
Sbjct: 174 LYHDLNAYRILFDQDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVIPESVVYS 233
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLLSGKHIPPSHALDLIR +N ML DSCL+G F++DDGT+LVRLASRCLQYE
Sbjct: 234 FGTLLLDLLSGKHIPPSHALDLIRGKNFLMLMDSCLDGHFSNDDGTDLVRLASRCLQYEA 293
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSP-----LSPLGEACSRRDLTAIH 355
RERPN KSLV++L+PLQKET++PSHVLMGIPH A+ SP L+PLG+ACSR DLTAIH
Sbjct: 294 RERPNVKSLVSSLAPLQKETDIPSHVLMGIPHGAA-SPKETTSLTPLGDACSRHDLTAIH 352
Query: 356 EILEKISYKDDEGVANEV 373
EILEK+ YKDDEGVANE+
Sbjct: 353 EILEKVGYKDDEGVANEL 370
|
|
| TAIR|locus:2198160 BSK4 "brassinosteroid-signaling kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1440 (512.0 bits), Expect = 1.9e-147, P = 1.9e-147
Identities = 280/371 (75%), Positives = 313/371 (84%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFA 60
MG Q SK CC K T LEAPDV EN E EV+G+ SFRE++LEQLK ATS FA
Sbjct: 1 MGGQSSKIGTCC---SHKTTALEAPDV---ENKENGEVNGVHSFREYSLEQLKIATSCFA 54
Query: 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
+EN+VSEHGE APNVVY+GKLEN +IA+KRF+ AWPDPRQFLEEAR VGQLR+ R+ N
Sbjct: 55 LENVVSEHGETAPNVVYQGKLENHMKIAIKRFSGTAWPDPRQFLEEARLVGQLRSKRMAN 114
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
LLG CCEG ERLLVAE+MPNETLAKHLFHW+T PMKWAMRLRV L++++ALEYC++ G
Sbjct: 115 LLGYCCEGGERLLVAEFMPNETLAKHLFHWDTEPMKWAMRLRVALYISEALEYCSNNGHT 174
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYS 240
LYHDLNAYR+LFDE+ NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGR+T ESVIYS
Sbjct: 175 LYHDLNAYRVLFDEECNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRITAESVIYS 234
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FGTLLLDLL+GKHIPPSHALDLIRDRNLQ LTDSCLEGQF+D DGTELVRL S CLQYE
Sbjct: 235 FGTLLLDLLTGKHIPPSHALDLIRDRNLQTLTDSCLEGQFSDSDGTELVRLTSCCLQYEA 294
Query: 301 RERPNPKSLVTALSPLQKETEVPSHVLMGIPHSAS-VSPLSPLGEACSRRDLTAIHEILE 359
RERPN KSLVTAL LQK+TEV SHVLMG+P S + SP SP EACS +DLT++ EILE
Sbjct: 295 RERPNIKSLVTALISLQKDTEVLSHVLMGLPQSGTFASPPSPFAEACSGKDLTSMVEILE 354
Query: 360 KISYKDDEGVA 370
KI YKDDE ++
Sbjct: 355 KIGYKDDEDLS 365
|
|
| TAIR|locus:2084475 BSK6 "brassinosteroid-signaling kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1418 (504.2 bits), Expect = 4.0e-145, P = 4.0e-145
Identities = 276/379 (72%), Positives = 323/379 (85%)
Query: 1 MGIQCSKFTACCWNSQFK-ATVLEAPDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGF 59
MG +CSKF+ C + S FK A+VLE+PD+ EN +V P+F+EF LEQLK+AT GF
Sbjct: 1 MGARCSKFSFCLFPSHFKSASVLESPDI---ENG--GKV--WPTFKEFKLEQLKSATGGF 53
Query: 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT 119
+ +NIVSEHGEKAPNVVY+G+L++ R IAVKRFNR+AW D RQFL+EA++VG LR++RL
Sbjct: 54 SSDNIVSEHGEKAPNVVYRGRLDDGRLIAVKRFNRLAWADHRQFLDEAKAVGSLRSDRLA 113
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
NL+GCC EG+ERLLVAE+MP+ETLAKHLFHWE +PMKWAMRLRV L LAQALEYC++KGR
Sbjct: 114 NLIGCCFEGEERLLVAEFMPHETLAKHLFHWENNPMKWAMRLRVALCLAQALEYCSNKGR 173
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIY 239
ALYHDLNAYR+LFD+DGNPRLS FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV++
Sbjct: 174 ALYHDLNAYRVLFDKDGNPRLSCFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVVF 233
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
SFGT+LLDL+SGKHIPPSHALDLIR +N ML DS LEG F+++DGTELVRLA+RCLQYE
Sbjct: 234 SFGTVLLDLMSGKHIPPSHALDLIRGKNCAMLMDSALEGHFSNEDGTELVRLATRCLQYE 293
Query: 300 PRERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASV---SPLS--PLGEACSRRDLTAI 354
RERPN KSLVT+L LQKE++V S+VLMGIPH SPLS P G+AC R DLTAI
Sbjct: 294 ARERPNVKSLVTSLVTLQKESDVASYVLMGIPHETEAEEESPLSLTPFGDACLRVDLTAI 353
Query: 355 HEILEKISYKDDEGVANEV 373
EIL KI YKDDEG+ANE+
Sbjct: 354 QEILSKIGYKDDEGIANEL 372
|
|
| TAIR|locus:2122058 BSK1 "brassinosteroid-signaling kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1243 (442.6 bits), Expect = 1.4e-126, P = 1.4e-126
Identities = 232/339 (68%), Positives = 284/339 (83%)
Query: 40 GLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD 99
G+PSF EF+ LK AT+ F+ +NIVSE GEKAPN+VYKG+L+N+R IAVK+F +MAWP+
Sbjct: 54 GIPSFSEFSFADLKAATNNFSSDNIVSESGEKAPNLVYKGRLQNRRWIAVKKFTKMAWPE 113
Query: 100 PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAM 159
P+QF EEA VG+LR+NRL NL+G CC+GDERLLVAE+MPN+TLAKHLFHWE ++WAM
Sbjct: 114 PKQFAEEAWGVGKLRHNRLANLIGYCCDGDERLLVAEFMPNDTLAKHLFHWENQTIEWAM 173
Query: 160 RLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNL 219
RLRV ++A+AL+YC+++GR LYHDLNAYR+LFDEDG+PRLS FGLMKNSRDGKSYSTNL
Sbjct: 174 RLRVGYYIAEALDYCSTEGRPLYHDLNAYRVLFDEDGDPRLSCFGLMKNSRDGKSYSTNL 233
Query: 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279
A+TPPEYLR GRVTPESV YSFGT+LLDLLSGKHIPPSHALD+IR +N+ +L DS LEG+
Sbjct: 234 AYTPPEYLRNGRVTPESVTYSFGTVLLDLLSGKHIPPSHALDMIRGKNIILLMDSHLEGK 293
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIPH-----SA 334
F+ ++ T +V LAS+CLQYEPRERPN K LV L+PLQ +++VPS+V++GI S
Sbjct: 294 FSTEEATVVVELASQCLQYEPRERPNTKDLVATLAPLQTKSDVPSYVMLGIKKQEEAPST 353
Query: 335 SVSPLSPLGEACSRRDLTAIHEILEKISYKDDEGVANEV 373
PLSPLGEACSR DLTAIH+IL Y+DDEG NE+
Sbjct: 354 PQRPLSPLGEACSRMDLTAIHQILVMTHYRDDEGT-NEL 391
|
|
| TAIR|locus:2142315 BSK2 "brassinosteroid-signaling kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1189 (423.6 bits), Expect = 7.4e-121, P = 7.4e-121
Identities = 217/352 (61%), Positives = 283/352 (80%)
Query: 24 APDVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLEN 83
AP+ + N + + + + +F+EF L +L+ AT+GF+ IVSE GEKAPNVVY+GKLE
Sbjct: 19 APNKPESVNGDQVDQE-IQNFKEFELNELRKATNGFSPSCIVSEGGEKAPNVVYRGKLEG 77
Query: 84 QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143
+A+KRF+R +WPD +QF+ EA VG+LRN R+ +L+GCC EGDERLLVAEYMPN+TL
Sbjct: 78 NHLVAIKRFSRQSWPDAQQFVVEATGVGKLRNKRIVSLIGCCAEGDERLLVAEYMPNDTL 137
Query: 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203
+KHLFHWE P+ W MR+R+ ++A+AL+YC + R +YHDLNAYRILFDE+G+PRLSTF
Sbjct: 138 SKHLFHWEKQPLPWDMRVRIADYIAEALDYCNIENRKIYHDLNAYRILFDEEGDPRLSTF 197
Query: 204 GLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI 263
GLMKNSRDGKSYSTNLA+TPPE+LRTGRV PESVI+S+GT+LLDLLSGKHIPPSHALD+I
Sbjct: 198 GLMKNSRDGKSYSTNLAYTPPEFLRTGRVIPESVIFSYGTILLDLLSGKHIPPSHALDII 257
Query: 264 RDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVP 323
R +N +L DS LEGQ+ +DD T+LV LAS+CLQ E ++RP+ K L++A++PLQK+ EV
Sbjct: 258 RGKNALLLMDSSLEGQYANDDATKLVDLASKCLQSEAKDRPDTKFLLSAVAPLQKQEEVA 317
Query: 324 SHVLMGIPHSASVSP--LSPLGEACSRRDLTAIHEILEKISYKDDEGVANEV 373
SHVLMG+P + + P LSPLG+AC++ DL H+IL K Y+D+EG NE+
Sbjct: 318 SHVLMGLPKNTVILPTMLSPLGKACAKMDLATFHDILLKTGYRDEEGAENEL 369
|
|
| TAIR|locus:2083499 BSK9 "brassinosteroid-signaling kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1127 (401.8 bits), Expect = 2.8e-114, P = 2.8e-114
Identities = 220/353 (62%), Positives = 267/353 (75%)
Query: 29 AAENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIA 88
AA+N E E P+F EF+LEQL+ AT GF+ +NIVSEH E+ PN+VYKG+L + R+IA
Sbjct: 11 AADNKEEDEGSTCPNFLEFSLEQLRVATDGFSADNIVSEHNERVPNIVYKGQLNDGRKIA 70
Query: 89 VKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF 148
VKRF R++WPD +F+EEA++VG+ R+ + NL+GCC EG ERLLVAEYMPNETLAKHLF
Sbjct: 71 VKRFQRLSWPDSLEFIEEAQAVGRCRSEHMANLIGCCSEGHERLLVAEYMPNETLAKHLF 130
Query: 149 HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208
HWE PMKW MRLRV LH A ALEYC G LYHDLN YRILFD+ GNPRLS FGLMK
Sbjct: 131 HWEKRPMKWEMRLRVALHTATALEYCNDWGIDLYHDLNTYRILFDKVGNPRLSCFGLMKC 190
Query: 209 SRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268
SR+GKSYSTNLAF PPEYLR G V PESV +SFGTLLLDL+SG+HIPP+HALDL R +N
Sbjct: 191 SREGKSYSTNLAFAPPEYLRLGTVIPESVTFSFGTLLLDLMSGRHIPPNHALDLFRGKNY 250
Query: 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV-PSHVL 327
+L DS L+GQF+D+D TEL+ LASRCL+ EP ERP+ K L++ALS L+K E+ P+
Sbjct: 251 LVLMDSALDGQFSDEDRTELIHLASRCLRPEPDERPSIKFLMSALSRLEKRAELWPNVKE 310
Query: 328 MGIPHSASVSP-------LSPLGEACSRRDLTAIHEILEKISY-KDDEGVANE 372
IP + P L+P GEAC R DL+ +HE+LEK+ Y +DD V NE
Sbjct: 311 ENIPTPSYTEPATKEPLPLTPFGEACWRVDLSGMHELLEKLGYGEDDVVVTNE 363
|
|
| TAIR|locus:2150074 BSK10 "brassinosteroid-signaling kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
Identities = 220/389 (56%), Positives = 278/389 (71%)
Query: 1 MGIQCSKFTACCWNSQFKATVLEAPDVDAAEN--DEMSEVDG--LPS-FREFTLEQLKNA 55
MG C K W + + + +D EN + ++ DG P FREF+LEQL+ A
Sbjct: 1 MGCICFK----SWRRSSSSPSITSTVIDDLENVREYDADDDGGHYPLIFREFSLEQLRIA 56
Query: 56 TSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN 115
T GF+ NIVSEH + PN+VYKGKL + RRIAVKRF R++WPDP +F+ EA++VG+LR+
Sbjct: 57 TDGFSAGNIVSEHNDSVPNIVYKGKLGDGRRIAVKRFQRLSWPDPFEFINEAQAVGRLRS 116
Query: 116 NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT 175
+ NL+GCCC+ +ERLLVAEYMPN TLAKHLFHWE PMKW MRL+V LH A+ALEYC
Sbjct: 117 EHMANLIGCCCDDNERLLVAEYMPNGTLAKHLFHWEKRPMKWEMRLKVALHTARALEYCN 176
Query: 176 SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPE 235
KG LYHDLN YRI+FD+ G P+LS FGLMKNS +GK YSTNLAF PPEYLR G V E
Sbjct: 177 DKGIDLYHDLNPYRIMFDKTGIPKLSCFGLMKNSHEGKIYSTNLAFAPPEYLRLGTVIAE 236
Query: 236 SVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
SV +SFGTLLLDL+SG+HIPP+HALDL R +N +L DS L+GQF+D+D TEL+ +ASRC
Sbjct: 237 SVTFSFGTLLLDLMSGRHIPPNHALDLFRGKNYLVLMDSALDGQFSDEDRTELIHVASRC 296
Query: 296 LQYEPRERPNPKSLVTALSPLQKETEV-PSHVLMGI-PHSASV----SP------LSPLG 343
+ EP ERP+ K L LS LQK ++ P +V + P S ++ P L+P G
Sbjct: 297 FKTEPEERPSIKFLKATLSRLQKRAKLCPINVKRPMSPPSKNLPEKTKPATESLKLTPFG 356
Query: 344 EACSRRDLTAIHEILEKISYKDDEGVANE 372
+ACSR DL++IHE+LEK+ Y++D GV NE
Sbjct: 357 DACSRADLSSIHELLEKLGYEEDNGVGNE 385
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00026835001 | SubName- Full=Chromosome chr15 scaffold_40, whole genome shotgun sequence; (491 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 449 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-21 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-11 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-08 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-05 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-04 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 0.001 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.001 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.001 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.001 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 0.001 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.001 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 0.001 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 0.002 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.004 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.004 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.004 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 0.004 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 60/245 (24%), Positives = 95/245 (38%), Gaps = 49/245 (20%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
VY + + +++A+K + + L E + +L + + L G + +
Sbjct: 8 TVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLY 67
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
LV EY +L L E + LR++L + + LEY S G + H DL IL
Sbjct: 68 LVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENIL 124
Query: 192 FDED-GNPRLSTFGLMKNSRDGKSYST----NLAFTPPEYLR-TGRVTPESVIYSFGTLL 245
D D G +L+ FGL K KS A+ PE L G + +S I+S G +L
Sbjct: 125 LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184
Query: 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
+L DLIR + LQ +P +RP+
Sbjct: 185 YEL--------PELKDLIR-----------------------------KMLQKDPEKRPS 207
Query: 306 PKSLV 310
K ++
Sbjct: 208 AKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 28/256 (10%)
Query: 75 VVYKGKL-----ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L + +AVK A + FL EAR + +L + + LLG C E
Sbjct: 14 EVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ ++V EYMP L +L + + L L +A+ +EY SK H DL A
Sbjct: 74 EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAA 131
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFG 242
L E+ ++S FGL ++ D Y + PE L+ G+ T +S ++SFG
Sbjct: 132 RNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFG 191
Query: 243 TLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
LL ++ + G+ + + L+ ++ +C EL +L +C
Sbjct: 192 VLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP---------ELYKLMLQCWA 242
Query: 298 YEPRERPNPKSLVTAL 313
+P +RP LV L
Sbjct: 243 EDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 1e-21
Identities = 69/256 (26%), Positives = 108/256 (42%), Gaps = 29/256 (11%)
Query: 75 VVYKGKLE-----NQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKGKL+ + +AVK A + FL EAR + +L + + LLG C E
Sbjct: 14 EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEE 73
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ +V EYM L +L + + L L +A+ +EY SK H DL A
Sbjct: 74 EPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESKN--FIHRDLAA 130
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFG 242
L E+ ++S FGL ++ D Y + PE L+ G+ T +S ++SFG
Sbjct: 131 RNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFG 190
Query: 243 TLLLDLLSG-----KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
LL ++ + + L+ +++ +C EL L +C
Sbjct: 191 VLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP---------ELYDLMLQCWA 241
Query: 298 YEPRERPNPKSLVTAL 313
+P +RP LV L
Sbjct: 242 EDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 64/249 (25%), Positives = 102/249 (40%), Gaps = 20/249 (8%)
Query: 75 VVYKGKLEN-QRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VYK K + + +AVK + E R + +L + + L+ + D
Sbjct: 14 TVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHL 73
Query: 132 LLVAEYMPNETLAKHLFHWETH-PMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
LV EY L +L P+ ++ L + + LEY S G + H DL
Sbjct: 74 YLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPEN 128
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGR-VTPESVIYSFGTL 244
IL DE+G +++ FGL K S T TP PE L G P+ ++S G +
Sbjct: 129 ILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 245 LLDLLSGKHI-PPSHALDLIR--DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
L +LL+GK + LD ++ R L + + E L +CL +P
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEF--DEPKWSSGSEEAKDLIKKCLNKDPS 246
Query: 302 ERPNPKSLV 310
+RP + ++
Sbjct: 247 KRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 8e-21
Identities = 73/258 (28%), Positives = 115/258 (44%), Gaps = 32/258 (12%)
Query: 75 VVYKGKL-----ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L + ++AVK A + R+ FLEEA + +L + + LLG C +G
Sbjct: 14 EVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG 73
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ +V EYMP L L + L++ L +A+ +EY SK H DL A
Sbjct: 74 EPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDLAA 130
Query: 188 YRILFDEDGNPRLSTFGLMKN-SRDGKSYSTNLAFTP-----PEYLRTGRVTPESVIYSF 241
L E+ ++S FGL ++ D P PE L+ G+ T +S ++SF
Sbjct: 131 RNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSF 190
Query: 242 GTLLLDLLSG-----KHIPPSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRC 295
G LL ++ + + L+L+ D ++ ++C + EL L +C
Sbjct: 191 GVLLWEIFTLGEQPYPGMSNEEVLELLEDGY-RLPRPENCPD---------ELYELMLQC 240
Query: 296 LQYEPRERPNPKSLVTAL 313
Y+P +RP LV L
Sbjct: 241 WAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 74/262 (28%), Positives = 111/262 (42%), Gaps = 33/262 (12%)
Query: 75 VVYKGKL----ENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGD 129
VYKGKL +AVK A + R FL+EAR + +L + + LLG C E +
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE 69
Query: 130 ERLLVAEYMPNETLAKHL-------FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALY 182
LV EYM L +L E + L + +A+ +EY SK + ++
Sbjct: 70 PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVH 128
Query: 183 HDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPES 236
DL A L ED ++S FGL ++ D Y + + PE L+ G T +S
Sbjct: 129 RDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS 188
Query: 237 VIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291
++SFG LL ++ + G + L+ +R + C + EL L
Sbjct: 189 DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD---------ELYEL 239
Query: 292 ASRCLQYEPRERPNPKSLVTAL 313
C Q +P +RP LV L
Sbjct: 240 MLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 69/244 (28%), Positives = 107/244 (43%), Gaps = 29/244 (11%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VYKG L+ +AVK R P R+FL+EA + Q + + L+G C + +
Sbjct: 11 VYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYI 69
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
V E +P +L L + + + L++ L A +EY SK ++ DL A L
Sbjct: 70 VMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLESKN-CIHRDLAARNCLVG 127
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFGTLLL 246
E+ ++S FG M +G Y+ + + +T PE L GR T ES ++S+G LL
Sbjct: 128 ENNVLKISDFG-MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLW 186
Query: 247 DLLSGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEP 300
+ S P + I + +M C E E+ RL +C Y+P
Sbjct: 187 ETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPE---------EIYRLMLQCWAYDP 236
Query: 301 RERP 304
RP
Sbjct: 237 ENRP 240
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 56/248 (22%), Positives = 93/248 (37%), Gaps = 26/248 (10%)
Query: 75 VVYKGK-LENQRRIAVKRFN-RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
VY + + + +A+K + D + L E + + +L++ + L + D+
Sbjct: 14 KVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLY 73
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL---NAYR 189
LV EY L L A + + ALEY SKG ++ DL N
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLHSKGI-VHRDLKPEN--- 127
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGRVTPESVIYSFGTLLL 246
IL DEDG+ +L+ FGL + G+ +T + PE L I+S G +L
Sbjct: 128 ILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILY 187
Query: 247 DLLSGK-----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+LL+GK I + +L+R + L +P
Sbjct: 188 ELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD----ISPEAKDLIR---KLLVKDPE 240
Query: 302 ERPNPKSL 309
+R +
Sbjct: 241 KRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 68/244 (27%), Positives = 109/244 (44%), Gaps = 16/244 (6%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V G Q+ +AVK + + FL EA + LR+ L LLG +G+ +V
Sbjct: 22 VMLGDYRGQK-VAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L +L + A +L L + + +EY K ++ DL A +L ED
Sbjct: 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSED 138
Query: 196 GNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254
++S FGL K + G S + +T PE LR + + +S ++SFG LL ++ S +
Sbjct: 139 LVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 255 P-PSHALDLIRDR---NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
P P L + +M EG E+ ++ C + +P +RP K L
Sbjct: 199 PYPRIPLKDVVPHVEKGYRM---EAPEGC-----PPEVYKVMKDCWELDPAKRPTFKQLR 250
Query: 311 TALS 314
L+
Sbjct: 251 EQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 14/238 (5%)
Query: 76 VYKGKLE-NQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
V+ G+L + +AVK PD + +FL+EAR + Q + + L+G C + +
Sbjct: 11 VFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
V E + L E +K +++V + A +EY SK ++ DL A L
Sbjct: 71 VMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVT 128
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
E ++S FG+ + DG ST + +T PE L GR + ES ++SFG LL +
Sbjct: 129 EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
S +P ++ + ++ + + + + + RL RC +Y+P +RP+
Sbjct: 189 AFSLGAVPYAN----LSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 23/257 (8%)
Query: 69 GEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
GE V +G+ Q+ +AVK N + FLEE + +L + L LLG
Sbjct: 15 GEGEFGAVLQGEYTGQK-VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH- 70
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
+ +V E M L L + L+ L +A+ +EY SK + ++ DL A
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAAR 129
Query: 189 RILFDEDGNPRLSTFGLMK-NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
IL EDG ++S FGL + S + + +T PE L+ + + +S ++S+G LL +
Sbjct: 130 NILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWE 189
Query: 248 LLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE----LVRLASRCLQYEPRE 302
+ S G+ P +L +++ C+E + + + L + C + EP++
Sbjct: 190 VFSYGRAPYPKMSLKEVKE---------CVEKGYRMEPPEGCPADVYVLMTSCWETEPKK 240
Query: 303 RPNPKSLVTALSPLQKE 319
RP+ L L+KE
Sbjct: 241 RPSFHKLR---EKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 70/251 (27%), Positives = 111/251 (44%), Gaps = 21/251 (8%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
V+KG L+++ +AVK + + +FL EAR + Q + + L+G C + +V
Sbjct: 11 VFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E +P L + +K ++ L A + Y SK ++ DL A L E
Sbjct: 71 MELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKN-CIHRDLAARNCLVGE 128
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ ++S FG+ + DG S+ L +T PE L GR + ES ++S+G LL +
Sbjct: 129 NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF 188
Query: 250 SGKHIP-PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKS 308
S P P R++ + SC Q DD + ++ RC Y+P RP
Sbjct: 189 SLGVCPYPGMTNQQAREQVEKGYRMSC--PQKCPDD---VYKVMQRCWDYKPENRPK--- 240
Query: 309 LVTALSPLQKE 319
S LQKE
Sbjct: 241 ----FSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 74.0 bits (180), Expect = 2e-14
Identities = 73/350 (20%), Positives = 122/350 (34%), Gaps = 35/350 (10%)
Query: 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLR-NNRL 118
I+ + GE + VY + +++ +A+K + +FL E + + L +
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 119 TNLLGCCCEGDERLLVAEYMPNETLAKHL-FHWETHPMKWAMRLRVVLHLAQALEYCTSK 177
L + LV EY+ +L L P+ + L ++ + ALEY SK
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 178 GRALYHDLNAYRILFDEDGN-PRLSTFGLMKNSRDGKSYSTN----------LAFTPPEY 226
G ++ D+ IL D DG +L FGL K D S S+ + PE
Sbjct: 121 G-IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 227 LR---TGRVTPESVIYSFGTLLLDLLSGKH--------IPPSHALDLIRDRNLQMLTDSC 275
L + S I+S G L +LL+G S L +I + L
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA--LSPLQKETEVPSHVLMGIPHS 333
+ L + L +P+ R + S ++ L+ L+ + S +L +
Sbjct: 240 SP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298
Query: 334 ASVSPLSPLGEACSRRDLTAIHEILEKISYKDDEGVANEVHSMFSIIKNY 383
L P EA I DD + E+ +
Sbjct: 299 PLRLSLPPSLEALISS--LNSLAISGSDLKLDDSNFSKELAPNGVSSSPH 346
|
Length = 384 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 26/261 (9%)
Query: 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLL 122
+ E G VV+ GK + +A+K M+ D F+EEA+ + +L + L L
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD---FIEEAKVMMKLSHPNLVQLY 65
Query: 123 GCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRA 180
G C + +V EYM N L +L K L + + +A+EY S G
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG-F 121
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPE 235
++ DL A L ED ++S FGL + D + S+ + + PPE R + +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 236 SVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD---GTELVRLA 292
S ++SFG L+ ++ S +P R N +++ +S G TE+ +
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYE------RFSNSEVV-ESVSAGYRLYRPKLAPTEVYTIM 234
Query: 293 SRCLQYEPRERPNPKSLVTAL 313
C +P +RP K L++ L
Sbjct: 235 YSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 26/241 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++A+K + + P FL EA + QL++ RL L + + ++
Sbjct: 22 VWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIIT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM N +L L E + + + +A+ + + K ++ DL A IL E
Sbjct: 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-YIHRDLRAANILVSET 138
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R+G + + +T PE + G T +S ++SFG LL ++
Sbjct: 139 LCCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSDVWSFGILLTEI 196
Query: 249 LSGKHIP-PSHA-LDLIR--DRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
++ IP P ++I+ +R +M D+C E EL L C + +P ER
Sbjct: 197 VTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE---------ELYELMRLCWKEKPEER 247
Query: 304 P 304
P
Sbjct: 248 P 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 10/181 (5%)
Query: 77 YKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-LVA 135
Y+G ++AVK A + FL EA + QLR++ L LLG E L +V
Sbjct: 27 YRGN-----KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L +L + L+ L + +A+EY + ++ DL A +L ED
Sbjct: 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN-FVHRDLAARNVLVSED 138
Query: 196 GNPRLSTFGLMKNSRDGKSYST-NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254
++S FGL K + + + +T PE LR + + +S ++SFG LL ++ S +
Sbjct: 139 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 255 P 255
P
Sbjct: 199 P 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 21/223 (9%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHL-FHWETHPMKWAMRL 161
F E A + QL + L G C GDE ++V EY+ +L +L + + W +L
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KL 103
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST--- 217
V LA AL + KG L H ++ A +L + + + +K S G S +
Sbjct: 104 EVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK 161
Query: 218 -----NLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML 271
+ + PPE + + ++ + +SFGT L ++ SG P S ALD + LQ
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS-ALD--SQKKLQFY 218
Query: 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
D Q TEL L ++C+ YEP RP+ ++++ L+
Sbjct: 219 ED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 67/266 (25%), Positives = 108/266 (40%), Gaps = 39/266 (14%)
Query: 76 VYKGKLENQR-----RIAVKRFNRMAWPDPRQFLEEARSVGQLRN---NRLTNLLGCCCE 127
V + + ++AVK N R E R + LR + G C +
Sbjct: 20 VELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE--REIEILRTLDHENIVKYKGVCEK 77
Query: 128 GDER--LLVAEYMPNETLAKHL-FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHD 184
R L+ EY+P+ +L +L H + +K L + + ++Y S+ R ++ D
Sbjct: 78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGSQ-RYIHRD 134
Query: 185 LNAYRILFDEDGNPRLSTFGLMK--NSRDGKSYSTNLAFTP-----PEYLRTGRVTPESV 237
L A IL + + ++S FGL K Y +P PE LRT + + S
Sbjct: 135 LAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASD 194
Query: 238 IYSFGTLLLDLLS-GKH--IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR---- 290
++SFG L +L + G PP+ L +I QM+ LE +G L R
Sbjct: 195 VWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE---LLKEGERLPRPPSC 251
Query: 291 ------LASRCLQYEPRERPNPKSLV 310
L C + EP++RP+ L+
Sbjct: 252 PDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 8/186 (4%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV GK Q +A+K + + +F+EEA+ + +L + +L L G C + +V
Sbjct: 19 VVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
EYM N L +L + L + + + + Y SK + ++ DL A L D+
Sbjct: 78 TEYMSNGCLLNYLREHGKRFQP-SQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDD 135
Query: 195 DGNPRLSTFGLMKNSRDGKSYST-----NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G ++S FGL + D + S+ + ++PPE L + + +S +++FG L+ ++
Sbjct: 136 QGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY 195
Query: 250 SGKHIP 255
S +P
Sbjct: 196 SLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGC 124
V E G +V+ G +R++A+K R F+EEA+ + +L + +L L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 125 CCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALY 182
C E LV E+M + L+ +L K++ L + L + + + Y S ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN-VIH 123
Query: 183 HDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESV 237
DL A L E+ ++S FG+ + D + S+ + ++ PE + + +S
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 238 IYSFGTLLLDLLSGKHIP 255
++SFG L+ ++ S P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 63/241 (26%), Positives = 113/241 (46%), Gaps = 25/241 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++AVK + P FL+EA+ + +LR+++L L C E + +V
Sbjct: 22 VWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L L E ++ + + +A+ + Y S+ ++ DL A IL E+
Sbjct: 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGEN 139
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R+G + + +T PE GR T +S ++SFG LL ++
Sbjct: 140 LVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
Query: 249 LSGKHIP-PS-HALDLIR--DRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
++ +P P +++ +R +M +C E EL L +C +P ER
Sbjct: 198 VTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPE---------ELYDLMLQCWDKDPEER 248
Query: 304 P 304
P
Sbjct: 249 P 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 65/273 (23%), Positives = 121/273 (44%), Gaps = 36/273 (13%)
Query: 67 EHGEKAPNVVYKG------KLENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLT 119
E G+ + +VY+G K E + R+A+K N A R +FL EA + + + +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHL----AQAL 171
LLG +G L++ E M L +L E +P++ L+ ++ + A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 172 EYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN------SRDGKSYSTNLAFTPPE 225
Y + + ++ DL A + ED ++ FG+ ++ R G + + PE
Sbjct: 133 AYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191
Query: 226 YLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQF 280
L+ G T S ++SFG +L ++ + P L + + L D+C + F
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLF 251
Query: 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
EL+R+ C QY P+ RP+ +++++
Sbjct: 252 ------ELMRM---CWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 57/249 (22%), Positives = 109/249 (43%), Gaps = 21/249 (8%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V++G +N+ R+A+K + F +E +++ +LR+ L +L C G+ ++
Sbjct: 22 VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
E M +L L E + A + + +A+ + Y + +++ DL A IL ED
Sbjct: 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGED 140
Query: 196 GNPRLSTFGLMKNSRDG--KSYSTNLAF--TPPEYLRTGRVTPESVIYSFGTLLLDLLSG 251
+++ FGL + ++ S + + T PE G + +S ++SFG LL ++ +
Sbjct: 141 LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
Query: 252 KHIP-----PSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
+P D I +M C + E+ ++ C EP +RP+
Sbjct: 201 GQVPYPGMNNHEVYDQI-TAGYRMPCPAKCPQ---------EIYKIMLECWAAEPEDRPS 250
Query: 306 PKSLVTALS 314
K+L L
Sbjct: 251 FKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 62/255 (24%), Positives = 112/255 (43%), Gaps = 32/255 (12%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV+ GK Q ++A+K N A + F+EEA+ + +L + +L L G C + +V
Sbjct: 19 VVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E+M N L +L + K M L + + + +EY + ++ DL A L
Sbjct: 78 TEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGMEY-LERNSFIHRDLAARNCLVSS 135
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G ++S FG+ + D + S++ A ++PPE + + +S ++SFG L+ ++
Sbjct: 136 TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF 195
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR--LAS--------RCLQYE 299
+ +P + N +++ G L R LAS C +
Sbjct: 196 TEGKMP------FEKKSNYEVVEMI--------SRGFRLYRPKLASMTVYEVMYSCWHEK 241
Query: 300 PRERPNPKSLVTALS 314
P RP L+ A++
Sbjct: 242 PEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 8e-11
Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 21/245 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VYK + + +A+K + + + E + + + ++ + G + DE +
Sbjct: 15 EVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74
Query: 134 VAEYMPNETLAKHL-FHWETHPMKW-AMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
V E+ +L L +T A + +L + LEY S G ++ D+ A IL
Sbjct: 75 VMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELL---KGLEYLHSNGI-IHRDIKAANIL 130
Query: 192 FDEDGNPRLSTFGL---MKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
DG +L FGL + +++ + + PE + ++ I+S G ++L
Sbjct: 131 LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIEL 190
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG----TELVRLASRCLQYEPRERP 304
GK PP +L + L + G + E +CLQ P +RP
Sbjct: 191 AEGK--PPYS--ELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243
Query: 305 NPKSL 309
+ L
Sbjct: 244 TAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 24/247 (9%)
Query: 87 IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDER--LLVAEYMPNETL 143
+AVK R + +E + L + + GCC E + L+ EY+P +L
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203
+L H + A L + + + Y S+ ++ DL A +L D D ++ F
Sbjct: 96 RDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDF 151
Query: 204 GLMKNSRDGKSY-------STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS---GKH 253
GL K +G Y + + + E L+ + + S ++SFG L +LL+ K
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211
Query: 254 IPPSHALDLIRDRNLQM----LTDSCLEGQ---FTDDDGTELVRLASRCLQYEPRERPNP 306
PP ++I + QM L + G + E+ L C + E + RP
Sbjct: 212 SPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF 271
Query: 307 KSLVTAL 313
+SL+ L
Sbjct: 272 RSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 37/220 (16%)
Query: 64 IVSEHGEKAPNVVYKGKLENQRR------IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNN 116
+ E GE A V+ G+ + +AVK A D R+ F EA + ++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 117 RLTNLLGCCCEGDERLLVAEYMPNETLAKHL------------FHWETHPMKWAMRLRVV 164
+ G C EGD ++V EYM + L K L + + L++
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------ 218
+ +A + Y S+ ++ DL L D ++ FG+ SRD Y+T+
Sbjct: 129 VQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKIGDFGM---SRD--VYTTDYYRVGG 182
Query: 219 -----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GK 252
+ + PPE + + T ES ++SFG +L ++ + GK
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 36/277 (12%)
Query: 63 NIVSEHGEKAPNVVYKG------KLENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRN 115
++ E G+ + +VY+G K E + R+AVK N A R +FL EA +
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 116 NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHL---- 167
+ + LLG +G L+V E M + L +L E +P + L+ ++ +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 168 AQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN------SRDGKSYSTNLAF 221
A + Y +K + ++ DL A + D ++ FG+ ++ R G + +
Sbjct: 129 ADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCL 276
PE L+ G T S ++SFG +L ++ S P L + D D+C
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP 247
Query: 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
E + L C Q+ P+ RP +V L
Sbjct: 248 E---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 2e-10
Identities = 55/182 (30%), Positives = 77/182 (42%), Gaps = 18/182 (9%)
Query: 129 DERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+E+L LV EY P L HL + A + ALEY S G +Y DL
Sbjct: 65 EEKLYLVLEYAPGGELFSHLSKEGRFSEERA--RFYAAEIVLALEYLHSLG-IIYRDLKP 121
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL D DG+ +L+ FGL K S + TP PE L +S G
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGV 181
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ--FTDDDGTELVRLASRCLQYEPR 301
LL ++L+GK PP +A + + + + L+ F + E L S LQ +P
Sbjct: 182 LLYEMLTGK--PPFYA------EDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT 233
Query: 302 ER 303
+R
Sbjct: 234 KR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 52/284 (18%)
Query: 67 EHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLT 119
E GE A VYKG+L + +A+K A P +Q F +EA + L++ +
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWETH--------------PMKWAMRLRVVL 165
LLG C + ++ EY+ + L + L H + + L + +
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 166 HLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------- 218
+A +EY +S ++ DL A L E ++S FGL SRD YS +
Sbjct: 132 QIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTVKISDFGL---SRDI--YSADYYRVQSK 185
Query: 219 ----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQ 269
+ + PPE + G+ T ES I+SFG +L ++ S P +++IR R L
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL 245
Query: 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
+ C + L C P RP K + T L
Sbjct: 246 PCPEDC---------PARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 26/241 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++A+K + P FL+EA+ + +LR+++L L E + +V
Sbjct: 22 VWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
E+M +L L + +K + + +A + Y + ++ DL A IL ++
Sbjct: 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY-IERMNYIHRDLRAANILVGDN 138
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R G + + +T PE GR T +S ++SFG LL +L
Sbjct: 139 LVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 249 LSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
++ +P L+ + +R +M C +G + EL++L C + +P ER
Sbjct: 197 VTKGRVPYPGMVNREVLEQV-ERGYRM---PCPQG--CPESLHELMKL---CWKKDPDER 247
Query: 304 P 304
P
Sbjct: 248 P 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 18/237 (7%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++AVK + P FLEEA+ + +LR+++L L E + +V
Sbjct: 22 VWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L L E +K + + +A + Y + ++ DL + IL +
Sbjct: 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY-IERMNYIHRDLRSANILVGDG 138
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R G + + +T PE GR T +S ++SFG LL +L
Sbjct: 139 LVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 249 LSGKHIP-PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
++ +P P + +R + + D L L +C + +P ERP
Sbjct: 197 VTKGRVPYPG-----MNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-10
Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 11/187 (5%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V++G N +AVK + DP+ FL EA+ + +LR+ +L L C + +V
Sbjct: 22 VWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
E M +L ++L +K + + +A + Y ++ ++ DL A +L E+
Sbjct: 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGEN 139
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R+G + + +T PE R + +S ++SFG LL ++
Sbjct: 140 NICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIKSDVWSFGILLTEI 197
Query: 249 LSGKHIP 255
++ +P
Sbjct: 198 VTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 28/242 (11%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G R+A+K + P FL+EA+ + +LR+ +L L E + +V
Sbjct: 22 VWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L L ++ + + +A + Y + ++ DL A IL E+
Sbjct: 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-VERMNYVHRDLRAANILVGEN 138
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R G + + +T PE GR T +S ++SFG LL +L
Sbjct: 139 LVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 249 LSGKHIP-----PSHALDLIRDRNLQMLTDS-CLEGQFTDDDGTELVRLASRCLQYEPRE 302
+ +P LD + +R +M C E L L +C + EP E
Sbjct: 197 TTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPE---------SLHDLMCQCWRKEPEE 246
Query: 303 RP 304
RP
Sbjct: 247 RP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 69/278 (24%), Positives = 127/278 (45%), Gaps = 36/278 (12%)
Query: 62 ENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
EN++S + A YKGK ++N + VK N + + + +G+L++ +
Sbjct: 695 ENVISRGKKGAS---YKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVK 747
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY--CTSKG 178
L+G C L+ EY+ + L++ L + W R ++ + +A+AL + C
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 179 RALYHDLNAYRILFDEDGNPRL--STFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPES 236
+ +L+ +I+ D P L S GL+ D K + ++ A+ PE T +T +S
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLRLSLPGLL--CTDTKCFISS-AYVAPETRETKDITEKS 859
Query: 237 VIYSFGTLLLDLLSGKHIPPSHA--------LDLIR----DRNLQMLTDSCLEGQFT--D 282
IY FG +L++LL+GK P+ A ++ R D +L M D + G +
Sbjct: 860 DIYGFGLILIELLTGKS--PADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320
++ E++ LA C +P RP ++ L + +
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 48/284 (16%)
Query: 64 IVSEHGEKAPNVVYKGKLEN------QRRIAVKRFN-RMAWPDPRQFLEEARSVGQLRNN 116
++ E G+ + +VY+G + + R+A+K N + + +FL EA + + +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 117 RLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT- 175
+ LLG G L+V E M L +L P L + ++
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 176 -SKGRALYH-------DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN--------- 218
+ G A DL A + ED ++ FG+ +RD Y T+
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM---TRD--IYETDYYRKGGKGL 182
Query: 219 --LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP---PSH--ALDLIRDRNLQML 271
+ + PE L+ G T +S ++SFG +L ++ + P S+ L + D L
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL 242
Query: 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315
++C + +L+ L C QY P+ RP +V++L
Sbjct: 243 PENCPD---------KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 55/252 (21%), Positives = 108/252 (42%), Gaps = 19/252 (7%)
Query: 69 GEKAPNVVYKGKLENQRRI-AVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC 125
G+ + VV+K + +R+ A+K+ + +M + + ++EAR + +L ++ +
Sbjct: 9 GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF 68
Query: 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL 185
+ + +V EY N L K L P+ R + + L + SK + L+ D+
Sbjct: 69 LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDI 127
Query: 186 NAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSF 241
+ + D N ++ G+ K D +++ + TP PE +S +++
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187
Query: 242 GTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG---TELVRLASRCLQY 298
G +L + +GKH P A N L + G F +L +L +CL
Sbjct: 188 GVVLYECCTGKH--PFDA------NNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239
Query: 299 EPRERPNPKSLV 310
+ R+RP+ L+
Sbjct: 240 DYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 44/160 (27%), Positives = 63/160 (39%), Gaps = 19/160 (11%)
Query: 161 LRVVLHLAQALEYC----TSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS 216
R++ L AL C L+ DL I D + N +L FGL K S++
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 217 TNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272
TP PE L +S I+S G L+ +L + PP A RN L
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS--PPFTA------RNQLQLA 219
Query: 273 DSCLEGQFTDDDG---TELVRLASRCLQYEPRERPNPKSL 309
EG+F +EL + L +P +RP+ + L
Sbjct: 220 SKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 59/275 (21%), Positives = 108/275 (39%), Gaps = 37/275 (13%)
Query: 69 GEKAPNVVYKGKLE----NQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL 122
GE V +G+L +Q ++AVK + + + + +FL EA + + + L+
Sbjct: 8 GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLI 67
Query: 123 GCCCEGDER------LLVAEYMPNETLAKHLFH--WETHPMKWA--MRLRVVLHLAQALE 172
G C E +++ +M + L L + P K L+ ++ +A +E
Sbjct: 68 GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127
Query: 173 YCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPP------EY 226
Y +++ ++ DL A + ED ++ FGL K G Y P E
Sbjct: 128 YLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 227 LRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFT 281
L T +S +++FG + ++ + P D +R N + CL+
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD---- 242
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316
EL L C + +P++RP L L +
Sbjct: 243 -----ELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G N ++AVK + + FLEEA + L++++L L + + ++
Sbjct: 22 VWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
EYM +L L E + + +A+ + Y K ++ DL A +L E
Sbjct: 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY-IHRDLRAANVLVSES 139
Query: 196 GNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+++ FGL + +R+G + + +T PE + G T +S ++SFG LL ++
Sbjct: 140 LMCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIKSDVWSFGILLYEI 197
Query: 249 LSGKHIP 255
++ IP
Sbjct: 198 VTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 66/279 (23%), Positives = 103/279 (36%), Gaps = 53/279 (18%)
Query: 63 NIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTN 120
++ G A VVY L N ++A+KR + + +E +++ Q + +
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRV--------VLH-LAQAL 171
GDE LV Y+ +L MK + VL + + L
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLL--------DIMKSSYPRGGLDEAIIATVLKEVLKGL 115
Query: 172 EYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG----LMKNSRDGKSYSTNLAFTP---- 223
EY S G+ ++ D+ A IL EDG+ +++ FG L + TP
Sbjct: 116 EYLHSNGQ-IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 224 PEYLRTGRVTPESV-IYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLT----DS 274
PE + I+SFG ++L +G PP L MLT
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL---------MLTLQNDPP 225
Query: 275 CLEGQFTDDD----GTELVRLASRCLQYEPRERPNPKSL 309
LE T D ++ S CLQ +P +RP + L
Sbjct: 226 SLE---TGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 62/263 (23%), Positives = 107/263 (40%), Gaps = 42/263 (15%)
Query: 87 IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKH 146
+AVK + + F EA + L++ + G C EGD ++V EYM + L K
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 147 L--------FHWETHP---MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
L E + + + L + +A + Y S+ ++ DL L E+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGEN 156
Query: 196 GNPRLSTFGLMKNSRDGKSYSTN-----------LAFTPPEYLRTGRVTPESVIYSFGTL 244
++ FG+ SRD YST+ + + PPE + + T ES ++S G +
Sbjct: 157 LLVKIGDFGM---SRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 211
Query: 245 LLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
L ++ + GK + + ++ I + +C + E+ L C Q E
Sbjct: 212 LWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK---------EVYDLMLGCWQRE 262
Query: 300 PRERPNPKSLVTALSPLQKETEV 322
P R N K + + L L K + V
Sbjct: 263 PHMRLNIKEIHSLLQNLAKASPV 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 34/261 (13%)
Query: 75 VVYKGKL--ENQRRI--AVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
VY G L + ++I AVK NR+ + QFL+E + + + +LLG C +
Sbjct: 10 CVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE 69
Query: 130 -ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
L+V YM + L ++ ETH + L +A+ +EY SK + ++ DL A
Sbjct: 70 GSPLVVLPYMKHGDL-RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAAR 127
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTN--------LAFTPPEYLRTGRVTPESVIYS 240
+ DE +++ FGL ++ D + YS + + + E L+T + T +S ++S
Sbjct: 128 NCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWS 187
Query: 241 FGTLLLDLLSGKHIPPSHALD-------LIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
FG LL +L++ + PP +D L++ R L L+ ++ D L +
Sbjct: 188 FGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRL-------LQPEYCPD---PLYEVML 236
Query: 294 RCLQYEPRERPNPKSLVTALS 314
C +P RP LV+ +
Sbjct: 237 SCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 53/230 (23%), Positives = 101/230 (43%), Gaps = 11/230 (4%)
Query: 85 RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144
+ +A+K+ N P + E + +L+N + N L GDE +V EY+ +L
Sbjct: 45 QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104
Query: 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204
+ + A R L QALE+ + + ++ D+ + +L DG+ +L+ FG
Sbjct: 105 DVVTETCMDEAQIAAVCRECL---QALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFG 160
Query: 205 LMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260
+S + + TP PE + P+ I+S G + ++++ G+ PP
Sbjct: 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE--PPYLNE 218
Query: 261 DLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
+ +R L + T+ E Q + +RCL+ + +R + K L+
Sbjct: 219 NPLRALYL-IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 26/225 (11%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLR 162
F E A + QL + L L G C DE ++V EY+ L L H E + + +L
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLHWKLD 105
Query: 163 VVLHLAQALEYCTSK--------GRALY---HDLNAYRILFDEDGNPRLSTFGLMKNSRD 211
V LA AL Y K G+ + + LN + F + +P + L + R
Sbjct: 106 VAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV 165
Query: 212 GKSYSTNLAFTPPEYLRTGRVTPESV--IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ 269
+ + PE +R G+ + +SFGT LL++ S P S L +
Sbjct: 166 ERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS---TLSSSEKER 217
Query: 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
D + D EL L ++C Y+P +RP+ ++++ L+
Sbjct: 218 FYQDQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 61/264 (23%), Positives = 115/264 (43%), Gaps = 28/264 (10%)
Query: 67 EHGEKAPNVVYKGKLENQRR----IAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNL 121
E GE V +G+L+ + +A+K + R FL EA +GQ + + L
Sbjct: 16 EFGE-----VCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRAL 181
G + +++ EYM N +L K L + + ++ +A ++Y + +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMN-YV 128
Query: 182 YHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS-YSTN-----LAFTPPEYLRTGRVTPE 235
+ DL A IL + + ++S FGL + D ++ Y+T + +T PE + + T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA 188
Query: 236 SVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG---QFTDDDGTELVRLA 292
S ++SFG ++ +++S P D + Q + + +G D + L +L
Sbjct: 189 SDVWSFGIVMWEVMSYGERP-------YWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLM 241
Query: 293 SRCLQYEPRERPNPKSLVTALSPL 316
C Q + ERP +V+ L +
Sbjct: 242 LDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 50/246 (20%), Positives = 93/246 (37%), Gaps = 27/246 (10%)
Query: 76 VYKGKLENQ-RRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC--EGDE 130
VY ++ +AVK + + + E R + L++ + G E +
Sbjct: 16 VYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNT 75
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLA----QALEYCTSKGRALYH-DL 185
+ EY+ +L+ L + V+ + L Y S G H D+
Sbjct: 76 LNIFLEYVSGGSLSSLL------KKFGKLPEPVIRKYTRQILEGLAYLHSNGIV--HRDI 127
Query: 186 NAYRILFDEDGNPRLSTFGLMK--NSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIY 239
IL D DG +L+ FG K + + ++ TP PE +R + I+
Sbjct: 128 KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIW 187
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
S G ++++ +GK P S + + L + S + + E +CL+ +
Sbjct: 188 SLGCTVIEMATGKP-PWSELGNPM--AALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244
Query: 300 PRERPN 305
P++RP
Sbjct: 245 PKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160
R FL EA ++GQ ++ + L G G+ ++V EYM N L L E + A +
Sbjct: 51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLV--AGQ 108
Query: 161 LRVVLH-LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN- 218
L +L LA ++Y + G ++ L A+++L + D ++S F ++ + Y+T
Sbjct: 109 LMGMLPGLASGMKYLSEMG-YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMS 167
Query: 219 ----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS 250
+ + PE ++ + S ++SFG ++ +++S
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 5e-08
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 12/247 (4%)
Query: 69 GEKAPNVVYKG-KLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
G+ A VY + + +A+++ N P + E + + +N + N L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V EY+ +L + + A R L QALE+ S + ++ D+ +
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSN-QVIHRDIKS 144
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG+ +L+ FG +S + + TP PE + P+ I+S G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ ++++ G+ PP + +R L + T+ E Q + +RCL + +R
Sbjct: 205 MAIEMIEGE--PPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 304 PNPKSLV 310
+ K L+
Sbjct: 262 GSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 65/284 (22%), Positives = 117/284 (41%), Gaps = 48/284 (16%)
Query: 65 VSEHGEKAPNVVYKGKL-----ENQRRIAVKRF----NRMAWPDPRQFLEEARSVGQLRN 115
+ E GE A +YKG L ++ + +A+K N W + F +EA + +L +
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---FQQEASLMAELHH 66
Query: 116 NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHP-----------MKWAMR---- 160
+ LLG + ++ EY+ L + L H +K ++
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-- 218
L + + +A +EY +S ++ DL A IL E + ++S GL + Y
Sbjct: 127 LHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 219 ----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQ 269
+ + PPE + G+ + +S I+SFG +L ++ S P ++++R R L
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL 245
Query: 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
++ C ++ L + C Q P RP K + T L
Sbjct: 246 PCSEDCPPRMYS---------LMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 7e-08
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 12/247 (4%)
Query: 69 GEKAPNVVYKG-KLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
G+ A VY + + +A+K+ N P + E + + +N + N L
Sbjct: 28 GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 87
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V EY+ +L + + A R L QAL++ S + ++ D+ +
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSN-QVIHRDIKS 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG+ +L+ FG +S + + TP PE + P+ I+S G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ ++++ G+ PP + +R L + T+ E Q + +RCL+ + R
Sbjct: 204 MAIEMVEGE--PPYLNENPLRALYL-IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR 260
Query: 304 PNPKSLV 310
+ K L+
Sbjct: 261 GSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 52/223 (23%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLR 162
FL EA + L++++L L + + ++ E+M +L L E +
Sbjct: 48 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106
Query: 163 VVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-------NSRDGKSY 215
+A+ + + + ++ DL A IL +++ FGL + +R+G +
Sbjct: 107 FSAQIAEGMAF-IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 165
Query: 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-PSHA-LDLIR--DRNLQM- 270
+ +T PE + G T +S ++SFG LL+++++ IP P + ++IR +R +M
Sbjct: 166 P--IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
Query: 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
++C E EL + RC + P ERP + + + L
Sbjct: 224 RPENCPE---------ELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 31/228 (13%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDER------LLVAEYMPNETLAKHLFHWETHP-- 154
FL EA + + + + L+G C + E +++ +M + L L +
Sbjct: 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP 106
Query: 155 --MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212
+ M ++ + +A +EY +SK ++ DL A + +E+ N ++ FGL K +G
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165
Query: 213 KSYSTNLAFTPP------EYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALD 261
Y P E L T +S ++SFG + ++ + P S D
Sbjct: 166 DYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225
Query: 262 LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+R N CL+G L L S C P++RP+ ++L
Sbjct: 226 YLRQGNRLKQPPDCLDG---------LYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 52/264 (19%), Positives = 103/264 (39%), Gaps = 44/264 (16%)
Query: 87 IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL-- 143
+AVK A + R L E + Q+ + + L G C + LL+ EY +L
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 144 --------------------AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
+ +L + + + + +++ ++Y ++ + ++
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQY-LAEMKLVHR 151
Query: 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESV 237
DL A +L E ++S FGL ++ + SY + + E L T +S
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211
Query: 238 IYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292
++SFG LL ++++ G + I P +L++ ++C E E+ L
Sbjct: 212 VWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSE---------EMYNLM 262
Query: 293 SRCLQYEPRERPNPKSLVTALSPL 316
C + EP +RP + L +
Sbjct: 263 LTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 51/236 (21%), Positives = 103/236 (43%), Gaps = 13/236 (5%)
Query: 87 IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKH 146
+AVK +FL+EA + ++++ L LLG C ++ E+M L +
Sbjct: 34 VAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 147 LFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206
L + + L + ++ A+EY K ++ DL A L E+ +++ FGL
Sbjct: 93 LRECNRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLS 151
Query: 207 KNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260
+ G +Y+ + + +T PE L + + +S +++FG LL ++ + + P +
Sbjct: 152 RLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGMSPYPGI 209
Query: 261 DLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316
DL + L + + + ++ L C Q+ P +RP+ + A +
Sbjct: 210 DL---SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 61/273 (22%), Positives = 111/273 (40%), Gaps = 39/273 (14%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR--- 160
+E + +G+ +N + NLLG C + ++ EY L ++L M ++
Sbjct: 68 MEMMKMIGKHKN--IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 161 -----------LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209
+ +A+ +EY S+ + ++ DL A +L ED +++ FGL ++
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 210 RDGKSY--STN----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-----KHIPPSH 258
+ Y +TN + + PE L T +S ++SFG LL ++ + IP
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 259 ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318
L+++ + +C EL + C P +RP K LV L +
Sbjct: 245 LFKLLKEGHRMDKPANCTH---------ELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295
Query: 319 ETEVPSHVLMGIPHSASVSPLSP-LGEACSRRD 350
T ++ + +P SP P +CS D
Sbjct: 296 VTSTDEYLDLSVPFE-QYSPGCPDSPSSCSSGD 327
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 23/245 (9%)
Query: 76 VYKGKLENQRR--IAVKRFNRMAWPDPRQFLEEARSV-GQLRNNRLTNLLGCCCEGDERL 132
VYKG ++N+ + +A+K + D + +++ +V Q + +T G +G +
Sbjct: 20 VYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
++ EY+ + L + P++ ++ + + L+Y S+ R ++ D+ A +L
Sbjct: 79 IIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLL 134
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
E G+ +L+ FG+ D + TP PE ++ ++ I+S G ++L
Sbjct: 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
Query: 249 LSGKHIPPSHALDLIRDRNLQML---TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
G+ PP+ DL R L ++ + LEGQ++ CL +PR RP
Sbjct: 195 AKGE--PPNS--DLHPMRVLFLIPKNSPPTLEGQYS----KPFKEFVEACLNKDPRFRPT 246
Query: 306 PKSLV 310
K L+
Sbjct: 247 AKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 64/266 (24%), Positives = 104/266 (39%), Gaps = 45/266 (16%)
Query: 87 IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKH 146
+AVK + F EA + L++ + G C +GD ++V EYM + L K
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 147 LFHWETHPM----------KWAMRLRVVLH----LAQALEYCTSKGRALYHDLNAYRILF 192
L M K + L +LH +A + Y S+ ++ DL L
Sbjct: 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLV 156
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTN-----------LAFTPPEYLRTGRVTPESVIYSF 241
G L G SRD YST+ + + PPE + + T ES ++SF
Sbjct: 157 ---GANLLVKIGDFGMSRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 242 GTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296
G +L ++ + GK + + ++ I + C + E+ + C
Sbjct: 212 GVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK---------EVYDIMLGCW 262
Query: 297 QYEPRERPNPKSLVTALSPLQKETEV 322
Q EP++R N K + L L K T +
Sbjct: 263 QREPQQRLNIKEIYKILHALGKATPI 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 50/225 (22%), Positives = 102/225 (45%), Gaps = 24/225 (10%)
Query: 108 RSVGQLRNNRLTNLL---GCCCEGDER--LLVAEYMPNETLAKHLFHWETHPMKWAMRLR 162
+ + LRN N++ G C E L+ E++P+ +L ++L + + +L+
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLK 113
Query: 163 VVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST----- 217
+ + + ++Y S+ + ++ DL A +L + + ++ FGL K K Y T
Sbjct: 114 YAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 218 --NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS---GKHIPPSHALDLIRDRNLQM-- 270
+ + PE L + S ++SFG L +LL+ + P + L +I + QM
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232
Query: 271 --LTDSCLEGQ---FTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
L EG+ + E+ +L +C +++P +R ++L+
Sbjct: 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 52/242 (21%), Positives = 94/242 (38%), Gaps = 26/242 (10%)
Query: 87 IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+AVK D FL EA + + + + L+G E R ++ E M L
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98
Query: 146 HLFHWE---THPMKWAMR--LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR- 199
L P M+ L +A+ +Y ++ D+ A L G R
Sbjct: 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRV 157
Query: 200 --LSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG 251
++ FG+ ++ Y + + PPE G T ++ ++SFG LL ++ S
Sbjct: 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
Query: 252 KHIP-PSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEPRERPNPKS 308
++P P N +++ G+ G + R+ + C Q+ P +RPN +
Sbjct: 218 GYMPYPGR-------TNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT 270
Query: 309 LV 310
++
Sbjct: 271 IL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 37/235 (15%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHL---------FHWET-- 152
+E + +G+ +N + NLLG C + ++ EY L ++L + ++
Sbjct: 71 MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 153 ---HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-- 207
M + + +A+ +EY S+ + ++ DL A +L E+ +++ FGL +
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 208 NSRDGKSYSTN----LAFTPPEYLRTGRVTPESVIYSFGTLLLDL--LSGK---HIPPSH 258
N+ D +TN + + PE L T +S ++SFG L+ ++ L G IP
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 259 ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
L+++ + +C EL + C P RP K LV L
Sbjct: 248 LFKLLKEGHRMDKPANCT---------NELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 63/259 (24%), Positives = 105/259 (40%), Gaps = 27/259 (10%)
Query: 76 VYKG---KLENQR-RIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY+G EN++ +AVK P R+ FL+EA + Q + + L+G E +
Sbjct: 22 VYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
+V E P L +L + + A + L+ AL Y SK R ++ D+ A +
Sbjct: 81 VWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNV 138
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP-----PEYLRTGRVTPESVIYSFGTLL 245
L +L FGL + D Y + P PE + R T S ++ FG +
Sbjct: 139 LVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 198
Query: 246 LDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
++L G + + + I + + +C L L ++C Y+P
Sbjct: 199 WEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC---------PPTLYSLMTKCWAYDP 249
Query: 301 RERPNPKSLVTALSPLQKE 319
+RP L LS + +E
Sbjct: 250 SKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 32/228 (14%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETH-PMKWAMRL 161
F E A + Q+ + L + G C G E ++V E++ + L L + P+ W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST--- 217
V LA AL Y K L H ++ A IL G T +K S G S++
Sbjct: 121 TVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE-GTSPFIKLSDPGVSFTALSR 177
Query: 218 -----NLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDR 266
+ + PE + G ++ + +SFGT LL++ +P PS + ++
Sbjct: 178 EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFYEK 236
Query: 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
++ SC EL L S+CL YEP +RP+ ++++ L+
Sbjct: 237 KHRLPEPSC----------KELATLISQCLTYEPTQRPSFRTILRDLT 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 12/146 (8%)
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V E++ L + H + + A V L + +AL ++G ++ D+ +
Sbjct: 89 GDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQG-VIHRDIKS 144
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG +LS FG +L TP PE + PE I+S G
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 204
Query: 244 LLLDLLSGK----HIPPSHALDLIRD 265
++++++ G+ + PP A+ +IRD
Sbjct: 205 MVIEMVDGEPPYFNEPPLKAMKMIRD 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 51/257 (19%)
Query: 87 IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+AVK A + R FL+E + + +L++ + LLG C + D ++ EYM N L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 146 HLFH--------------WETHPM---KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
L H + ++ L V L +A ++Y +S ++ DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-FVHRDLATR 167
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPP------EYLRTGRVTPESVIYSFG 242
L E+ +++ FG+ +N G Y P E + G+ T S +++FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 243 TLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL---EGQFTDDDGTE------------ 287
L ++L L +++ LTD + G+F D G +
Sbjct: 228 VTLWEILM-----------LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQG 276
Query: 288 LVRLASRCLQYEPRERP 304
L L +C + RERP
Sbjct: 277 LYELMLQCWSRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 31/250 (12%)
Query: 75 VVYKG-KLENQRRIAVKRFNRMAWPDPRQFLEEARS----VGQLRNNRLTNLLGCCCEGD 129
VVYKG LE +A+K+ + + L+ + L++ + +G D
Sbjct: 15 VVYKGLNLETGDFVAIKQISLEK--IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD 72
Query: 130 ERLLVAEYMPNETLAKHLFHWETHP-MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
++ EY N +L + + + P A+ + VL Q L Y +G ++ D+ A
Sbjct: 73 SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL---QGLAYLHEQG-VIHRDIKAA 128
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTL 244
IL +DG +L+ FG+ D ++ TP PE + + S I+S G
Sbjct: 129 NILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCT 188
Query: 245 LLDLLSGKHIPPSHALDLIRDRN-----LQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+++LL+G PP + D N +++ D + EL +C Q +
Sbjct: 189 VIELLTGN--PPYY------DLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQKD 238
Query: 300 PRERPNPKSL 309
P RP K L
Sbjct: 239 PNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 16/224 (7%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF-------HWETHPM 155
F E +L + + LLG C E + ++ EY L + L + P+
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 156 KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215
++ + +A +++ S R ++ DL A L ++S L K+ + + Y
Sbjct: 115 STKQKVALCTQIALGMDH-LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 216 STN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM 270
L + PE ++ + +S ++SFG L+ ++ + +P L + L
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY---GLSDEEVLNR 230
Query: 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
L LE + + L +L +RC P++RP+ LV+AL
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 43/260 (16%)
Query: 76 VYKGKL-------ENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCE 127
VY+G R+AVK + A + +FL+EA + + + LLG C
Sbjct: 11 VYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL 70
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT-----SKGRALY 182
+ + ++ E M L +L + L + L L+ + ++
Sbjct: 71 NEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLDVAKGCVYLEQMHFIH 129
Query: 183 HDLNAYRILFDEDGNPR-----LSTFGLMKNSRDGKSYST------NLAFTPPEYLRTGR 231
DL A L E G + FGL ++ Y + + PE L G+
Sbjct: 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK 189
Query: 232 VTPESVIYSFGTLLLDLLSGKHIP-PSHALDLIRDRNLQMLTDSCLEGQF------TDDD 284
T +S ++SFG L+ ++L+ P P+ N ++L G+ D
Sbjct: 190 FTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVTAGGRLQKPENCPDK- 241
Query: 285 GTELVRLASRCLQYEPRERP 304
+ +L + C +P ERP
Sbjct: 242 ---IYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 20/212 (9%)
Query: 103 FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF-HWETHPMKWAMRL 161
F E A + Q+ + + L G C E ++V E++ L LF H ++ + +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKF 108
Query: 162 RVVLHLAQALEYCTSK----GRALYHDLNAYRILFDEDGNP--RLSTFGLMKNSRDGKSY 215
+V LA AL Y K G ++ R D + P +LS G+ +
Sbjct: 109 KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC 168
Query: 216 STNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS 274
+ + PE + + + + +SFGT L ++ IP ++D+ L +
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP-------LKDKTLAE-KER 220
Query: 275 CLEGQF--TDDDGTELVRLASRCLQYEPRERP 304
EGQ EL L + C+ Y+P +RP
Sbjct: 221 FYEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 57/248 (22%), Positives = 105/248 (42%), Gaps = 12/248 (4%)
Query: 69 GEKAPNVVYKG-KLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
G+ A VY + + +A+K+ N P + E + + ++ + N L
Sbjct: 28 GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV 87
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V EY+ +L + + A R L QALE+ S ++ D+ +
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ-VIHRDIKS 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG+ +L+ FG +S + + TP PE + P+ I+S G
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ ++++ G+ PP + +R L + T+ E Q + +RCL+ + +R
Sbjct: 204 MAIEMVEGE--PPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 260
Query: 304 PNPKSLVT 311
+ K L+
Sbjct: 261 GSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 37/235 (15%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR--- 160
+E + +G+ +N + NLLG C + ++ EY L ++L M++
Sbjct: 74 MEMMKMIGKHKN--IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 161 -----------LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209
+ +A+ +EY SK + ++ DL A +L ED +++ FGL ++
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 210 RDGKSY--STN----LAFTPPEYLRTGRVTPESVIYSFGTLLLDL--LSGKHIPPSHALD 261
Y +TN + + PE L T +S ++SFG LL ++ L G P +
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 262 LIRDRNLQMLTDSCLEGQFTDDDGT---ELVRLASRCLQYEPRERPNPKSLVTAL 313
L + +L EG D EL + C P +RP K LV L
Sbjct: 251 LFK-----LLK----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 48/200 (24%), Positives = 85/200 (42%), Gaps = 19/200 (9%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLLGCC 125
GE VVYK + +A+K+ + P+ L E + + +L + + LL
Sbjct: 8 GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF 67
Query: 126 CEGDERLLVAEYMPNETLAKHLFHWET----HPMKWAMRLRVVLHLAQALEYCTSKGRAL 181
+ LV E+M + L K + + +K + L Q L +C S G L
Sbjct: 68 RHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYL-----YQLLQGLAFCHSHG-IL 120
Query: 182 YHDLNAYRILFDEDGNPRLSTFGLMKNSR-DGKSYSTNLA---FTPPEYLRTGRVTPESV 237
+ DL +L + +G +L+ FGL ++ + Y+ + + PE L + V
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 238 -IYSFGTLLLDLLSGKHIPP 256
I+S G + +LLS + + P
Sbjct: 181 DIWSVGCIFAELLSRRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 5e-06
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 16/155 (10%)
Query: 163 VVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT 222
++ + LEY S + ++ D+ A IL +E+G +L+ FG+ D + + T
Sbjct: 104 ILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162
Query: 223 P----PEYLRTGRVTPESVIYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLTDS 274
P PE ++ ++ I+S G +++ GK I P A+ +I ++ L+D
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP 222
Query: 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ E +CL +P ERP+ L
Sbjct: 223 -------EKWSPEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 23/198 (11%)
Query: 67 EHGEKAPNVVYKGKLENQRR----IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNL 121
E GE V++G L+ R +A+K RQ FL EA +GQ ++ + L
Sbjct: 17 EFGE-----VFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 122 LGCCCEGDERLLVAEYMPNETLAKHL--FHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
G + +++ EYM N L K+L E + LR +A ++Y S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKY-LSDMN 127
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--SYSTN-----LAFTPPEYLRTGRV 232
++ DL A IL + + ++S FGL + D +Y+T+ + +T PE + +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 233 TPESVIYSFGTLLLDLLS 250
T S ++SFG ++ +++S
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 31/197 (15%)
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V E++ L + H + + A VL +AL + ++G ++ D+ +
Sbjct: 88 GDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVL---KALSFLHAQG-VIHRDIKS 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG +LS FG +L TP PE + E I+S G
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 203
Query: 244 LLLDLLSGK----HIPPSHALDLIRD------RNLQMLTDSCLEGQFTDDDGTELVRLAS 293
++++++ G+ + PP A+ IRD +NL ++ L
Sbjct: 204 MVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVS-------------PRLRSFLD 250
Query: 294 RCLQYEPRERPNPKSLV 310
R L +P +R L+
Sbjct: 251 RMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 25/246 (10%)
Query: 76 VYKGKLEN--QRRIAVKRFNRMAWPDPRQFLEEARSV-GQLRNNRLTNLLGCCCEGDERL 132
V+KG ++N Q+ +A+K + D + +++ +V Q + +T G + +
Sbjct: 20 VFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 78
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
++ EY+ + L E P+ ++ + + L+Y S+ + ++ D+ A +L
Sbjct: 79 IIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLL 134
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
E G +L+ FG+ D + TP PE ++ ++ I+S G ++L
Sbjct: 135 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194
Query: 249 LSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
G+ + P L LI N LEG ++ L CL EP RP
Sbjct: 195 AKGEPPHSELHPMKVLFLIPKNN-----PPTLEGNYS----KPLKEFVEACLNKEPSFRP 245
Query: 305 NPKSLV 310
K L+
Sbjct: 246 TAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 167 LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSYS--TNLAFT 222
LA AL++ S G +Y DL IL DE+G+ +L+ FGL K S D K+YS + +
Sbjct: 107 LALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 165
Query: 223 PPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP 255
PE + T + +SFG L+ ++L+G +P
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG-SLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 35/225 (15%)
Query: 114 RNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHL--------------FHWETHPMKWAM 159
++ + NLLG C + ++ EY L + L + +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 160 RLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--ST 217
+ +A+ +EY S+ R ++ DL A +L ED +++ FGL + D Y ++
Sbjct: 136 LVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 218 N----LAFTPPEYLRTGRVTPESVIYSFGTLLLDL--LSGKH---IPPSHALDLIRDRNL 268
N + + PE L T +S ++SFG L+ ++ L G IP L+R+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR 254
Query: 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
+C EL L C P +RP K LV AL
Sbjct: 255 MDKPSNCTH---------ELYMLMRECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 58/253 (22%), Positives = 105/253 (41%), Gaps = 24/253 (9%)
Query: 79 GKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138
G L N R + F+ P+Q V Q R +R G +L + +
Sbjct: 97 GNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIE------AGQASVLFSRFQ 150
Query: 139 PNETLAKHLFH-----WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
P+ + + + W++ P+ + +A+ +E+ S+ + ++ DL A IL
Sbjct: 151 PSTSGSTNPPQETDDLWKS-PLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLS 208
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
E+ ++ FGL ++ Y L + PE + T +S ++SFG LL +
Sbjct: 209 ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE 268
Query: 248 LLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP 306
+ S G P ++ + Q L D + ++ E+ R+ C Q +P+ERP
Sbjct: 269 IFSLGASPYPGVQIN---EEFCQRLKDGT-RMRAPENATPEIYRIMLACWQGDPKERPTF 324
Query: 307 KSLVTALSPLQKE 319
+LV L L +E
Sbjct: 325 SALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------ 218
+ +A + Y SK R ++ DL A IL D ++ FGLM+ + +
Sbjct: 104 VQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
Query: 219 -LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-----GKHIPPSHALDLIRDRNLQMLT 272
A+ PE LRT + S ++ FG L ++ + + S L I D+ + L
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-DKEGERLE 221
Query: 273 --DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314
++C + ++ + +C + P +RP +L L
Sbjct: 222 RPEACPQ---------DIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 21/240 (8%)
Query: 71 KAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
KA +Y K +++R+ ++ +MA + ++ LE+ S R L E +
Sbjct: 15 KATGKMYACKKLDKKRLKKRKGEQMALNE-KKILEKVSS-------RFIVSLAYAFETKD 66
Query: 131 RL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSKGRALYHDLN 186
L LV M L H+++ A R + + AQ LE+ + R +Y DL
Sbjct: 67 DLCLVMTLMNGGDLKYHIYNVGEPGFPEA---RAIFYAAQIICGLEHLHQR-RIVYRDLK 122
Query: 187 AYRILFDEDGNPRLSTFGL---MKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGT 243
+L D+ GN R+S GL +K + K + + PE L+ ++ G
Sbjct: 123 PENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGC 182
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
L ++++G P + + L+ T + ++ D E L LQ +P +R
Sbjct: 183 TLYEMIAG-RSPFRQRKEKVEKEELKRRTLE-MAVEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 37/235 (15%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM--------------PNETLAKHLFH 149
+E + +G+ +N + NLLG C + +V EY P E +
Sbjct: 66 MEMMKMIGKHKN--IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 150 WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209
+ + +A+ +E+ SK + ++ DL A +L ED +++ FGL ++
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 210 RDGKSY--STN----LAFTPPEYLRTGRVTPESVIYSFGTLLLDL--LSGKHIP--PSHA 259
Y +TN + + PE L T +S ++SFG LL ++ L G P P
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
Query: 260 L-DLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
L L+++ +C + EL L C P +RP K LV L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQ---------ELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 112 QLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQAL 171
+L++ + LG + D + EY+P ++A L ++ + V + + L
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE--TLVRNFVRQILKGL 119
Query: 172 EYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK----NSRDGK------SYSTNLAF 221
Y ++G ++ D+ IL D G ++S FG+ K NS K S ++ +
Sbjct: 120 NYLHNRG-IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH 253
PE ++ T ++ I+S G L++++L+GKH
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 47/276 (17%)
Query: 71 KAPNVVYKGKLENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGD 129
+AP ++ E +AVK A D + F EA + + + + LLG C G
Sbjct: 25 RAPGLL---PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81
Query: 130 ERLLVAEYMPNETLAKHLFHWETH--------------------PMKWAMRLRVVLHLAQ 169
L+ EYM L + L H P+ +L + +A
Sbjct: 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141
Query: 170 ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTP 223
+ Y S+ + ++ DL L E+ +++ FGL +N Y + + + P
Sbjct: 142 GMAY-LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMP 200
Query: 224 PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD------LIRDRNLQMLTDSCLE 277
PE + R T ES ++++G +L ++ S + P + + +RD N+ D+C
Sbjct: 201 PESIFYNRYTTESDVWAYGVVLWEIFS-YGMQPYYGMAHEEVIYYVRDGNVLSCPDNC-- 257
Query: 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
EL L C P +RP+ S+ L
Sbjct: 258 -------PLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VY K + +AVK + ++FL EA + QL + + L+G C +G+ +LV
Sbjct: 15 VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLV 73
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLH-LAQALEYCTSKGRALYHDLNAYRILFD 193
E P L K+L + L+ + H +A + Y SK ++ DL A +L
Sbjct: 74 MELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLV 129
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFGTLLL 246
++S FG+ + G Y L + PE + G+ + +S ++S+G L
Sbjct: 130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW 189
Query: 247 DLLS 250
+ S
Sbjct: 190 EAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 66/286 (23%), Positives = 113/286 (39%), Gaps = 58/286 (20%)
Query: 67 EHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN 120
E GE A V+ + N + +AVK + + F EA + L++ +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETH----------------PMKWAMRLRVV 164
G C EG L+V EYM + L + L +H + L +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFL---RSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------ 218
+A + Y S ++ DL L + ++ FG+ SRD YST+
Sbjct: 129 SQIASGMVYLASL-HFVHRDLATRNCLVGQGLVVKIGDFGM---SRD--IYSTDYYRVGG 182
Query: 219 -----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GK----HIPPSHALDLI-RDRN 267
+ + PPE + + T ES I+SFG +L ++ + GK + + A++ I + R
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE 242
Query: 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
L+ +C E+ + C Q EP++R K + + L
Sbjct: 243 LER-PRTC---------PPEVYAIMQGCWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 76 VYKGK-LENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER- 131
VYK + + +A+K+ P + E + + +LR+ + L +
Sbjct: 15 VYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74
Query: 132 -LLVAEYMPNE---TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+V EYM ++ L + +K M+ L + L+Y S G L+ D+
Sbjct: 75 IYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-----QLLEGLQYLHSNG-ILHRDIKG 128
Query: 188 YRILFDEDGNPRLSTFGLMK--NSRDGKSYSTNLAFT----PPEYLRTG--RVTPESVIY 239
IL + DG +L+ FGL + R+ Y TN T PPE L G R PE ++
Sbjct: 129 SNILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLWYRPPELL-LGATRYGPEVDMW 186
Query: 240 SFGTLLLDLLSGKHIPP----SHALDLI 263
S G +L +L GK I L+ I
Sbjct: 187 SVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 53/250 (21%), Positives = 98/250 (39%), Gaps = 44/250 (17%)
Query: 87 IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145
+AVK R FL+E + + +L+N + LLG C D ++ EYM N L +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 146 HLFHWETHP----------MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195
L E + A L + + +A ++Y S ++ DL L
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-FVHRDLATRNCLVGNH 165
Query: 196 GNPRLSTFGLMKNSRDGKSYSTNLAFTPP------EYLRTGRVTPESVIYSFGTLLLDLL 249
+++ FG+ +N G Y P E + G+ T S +++FG L ++
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCL---EGQFTDDDGTE------------LVRLASR 294
+ L +++ +L+D + G+F + G + + +L R
Sbjct: 226 T-----------LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR 274
Query: 295 CLQYEPRERP 304
C + ++RP
Sbjct: 275 CWSRDIKDRP 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 118 LTNLLGCCCEGDERLL-VAEYMPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCT 175
LT+L C + E L V EY+ L +FH ++ H + L++
Sbjct: 58 LTHLY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 176 SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGR 231
SKG +Y DL IL D DG+ +++ FG+ K + G + + TP PE L +
Sbjct: 114 SKG-IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 232 VTPESVIYSFGTLLLDLLSGKHIPPSHALD 261
+SFG LL ++L G+ P H D
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ--SPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 32/126 (25%), Positives = 57/126 (45%), Gaps = 10/126 (7%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
L+ +Y+ L HL+ E H + +R+ + + AL+ + +Y D+ IL
Sbjct: 82 LILDYVNGGELFTHLYQRE-HFTESEVRV-YIAEIVLALD-HLHQLGIIYRDIKLENILL 138
Query: 193 DEDGNPRLSTFGLMK-----NSRDGKSYSTNLAFTPPEYLRTGRVTPESVI--YSFGTLL 245
D +G+ L+ FGL K S+ + + PE +R G + + +S G L
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 246 LDLLSG 251
+LL+G
Sbjct: 199 FELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 12/146 (8%)
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V E++ L + H + + A V L + +AL Y ++G ++ D+ +
Sbjct: 91 GDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG-VIHRDIKS 146
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG +LS FG +L TP PE + E I+S G
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 244 LLLDLLSGK----HIPPSHALDLIRD 265
++++++ G+ + PP A+ IRD
Sbjct: 207 MVIEMIDGEPPYFNEPPLQAMRRIRD 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET----LAKHLFHWETHPMK 156
R FL EA +GQ + + +L G + ++V EYM N + L KH + +
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV 109
Query: 157 WAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KS 214
+R +A ++Y + G ++ DL A IL + + ++S FGL + D +
Sbjct: 110 GMLR-----GIASGMKYLSDMG-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163
Query: 215 YSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS 250
Y+T + +T PE + + T S ++S+G ++ +++S
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 13/159 (8%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLL-VAEYMPNETLAKHLFHWETHPMKWAMRLR 162
+ E R + RN+ L CC + +RL V E++ L +FH + R R
Sbjct: 43 MTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARAR 99
Query: 163 V-VLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS-RDGKSYSTNLA 220
+ AL + KG +Y DL +L D +G+ +L+ FG+ K +GK+ ST
Sbjct: 100 FYAAEITSALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FC 157
Query: 221 FTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP 255
TP PE L+ P ++ G LL ++L G H P
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 59/281 (20%), Positives = 109/281 (38%), Gaps = 42/281 (14%)
Query: 65 VSEHGEKAPNVVYKGKL------ENQRRIAVKRF-NRMAWPDPRQFLEEARSVGQLRNNR 117
+ E GE VYKG L E + +A+K ++ P +F EA +L++
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 118 LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHP----------MKWAMR----LRV 163
+ LLG + ++ Y + L + L H +K + + +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 164 VLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST------ 217
V +A +E+ +S ++ DL +L + N ++S GL + Y
Sbjct: 130 VTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLT 272
+ + PE + G+ + +S I+S+G +L ++ S P +++IR+R +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248
Query: 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
D C +T L C P RP K + + L
Sbjct: 249 DDCPAWVYT---------LMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 53/243 (21%), Positives = 105/243 (43%), Gaps = 19/243 (7%)
Query: 76 VYKGKLEN--QRRIAVKRFNRMAWPDPRQFLEEARSV-GQLRNNRLTNLLGCCCEGDERL 132
V+KG ++N Q+ +A+K + D + +++ +V Q + +T G +G +
Sbjct: 20 VFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLW 78
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
++ EY+ + L + A L+ +L + L+Y S+ + ++ D+ A +L
Sbjct: 79 IIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-KKIHRDIKAANVLL 134
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
E G+ +L+ FG+ D + TP PE ++ ++ I+S G ++L
Sbjct: 135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIEL 194
Query: 249 LSGKHIPPSHALDLIRDR-NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
G+ PP+ + +R + L G+F+ CL +P RP K
Sbjct: 195 AKGE--PPNSDMHPMRVLFLIPKNNPPTLTGEFSKP----FKEFIDACLNKDPSFRPTAK 248
Query: 308 SLV 310
L+
Sbjct: 249 ELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 25/171 (14%)
Query: 159 MRLRVVLHLAQA----LEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL---MKNSRD 211
+ + ++ +A A L Y + R ++ D+ IL + G +L FG+ + NS
Sbjct: 100 IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159
Query: 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK------------HIPPSHA 259
T+ + PE ++ G+ T +S ++S G +++L GK P
Sbjct: 160 DTFVGTS-TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218
Query: 260 LDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
LDL++ + +Q F +D L CL +P ERP P+ L
Sbjct: 219 LDLLQ-QIVQEPPPRLPSSDFPED----LRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 171 LEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEY 226
L++ SKG +Y DL ++ D DG+ +++ FG+ K + G + ++ TP PE
Sbjct: 109 LQFLHSKG-IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167
Query: 227 LRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD 261
L+ + T +SFG LL ++L G+ P H D
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ--SPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 10/99 (10%)
Query: 162 RVVLHLAQ---ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN 218
R + AQ LE+ + R +Y DL +L D DGN R+S GL +DG+S +
Sbjct: 98 RACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156
Query: 219 LAFTP----PEYLRTGRVTPESVIY-SFGTLLLDLLSGK 252
A TP PE L+ G SV Y + G L ++++ +
Sbjct: 157 YAGTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 28/246 (11%)
Query: 87 IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER--LLVAEYMPNETLA 144
+AVK+ R F E + L+++ + G C R LV EY+P +L
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 145 KHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSKGRALYHDLNAYRILFDEDGNPRLS 201
+L + H + R +++L+ +Q +EY SK R ++ DL IL + + ++
Sbjct: 96 DYL---QKHRERLDHR-KLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIG 150
Query: 202 TFGLMKNSRDGKSYST-------NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254
FGL K K Y + + PE L + + S ++SFG +L +L +
Sbjct: 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210
Query: 255 ---PPSHALDLI-RDRNLQMLTDSCLE-----GQFTDDDG--TELVRLASRCLQYEPRER 303
PP+ + ++ D+ QM+ +E G+ G E+ + C +P +R
Sbjct: 211 SCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQR 270
Query: 304 PNPKSL 309
P+ L
Sbjct: 271 PSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (104), Expect = 9e-05
Identities = 43/156 (27%), Positives = 65/156 (41%), Gaps = 28/156 (17%)
Query: 167 LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF----- 221
L AL+Y S+ + L+ D+ I +G +L FG+ K S+ +
Sbjct: 112 LCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGI------SKVLSSTVDLAKTVV 164
Query: 222 -TP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL 276
TP PE + +S I+S G +L +L + KH P NL L L
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH--PFEG------ENLLELALKIL 216
Query: 277 EGQFTDDD---GTELVRLASRCLQYEPRERPNPKSL 309
+GQ+ +EL L S LQ +P ERP+ +
Sbjct: 217 KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 55/193 (28%), Positives = 82/193 (42%), Gaps = 26/193 (13%)
Query: 71 KAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
K+ VY KL + +F + D F EE R + N+ L C + D+
Sbjct: 65 KSSQKVYAMKL-------LSKFEMIKRSDSAFFWEE-RDIMAFANSPWVVQLFCAFQDDK 116
Query: 131 RL-LVAEYMPNETLAKHLFHWETHPMKWA--MRLRVVLHLAQALEYCTSKGRALYHDLNA 187
L +V EYMP L + +++ P KWA VVL AL+ S G ++ D+
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVVL----ALDAIHSMG-LIHRDVKP 170
Query: 188 YRILFDEDGNPRLSTFGL-MKNSRDGKSYSTNLAFTP----PEYLRT----GRVTPESVI 238
+L D+ G+ +L+ FG MK G TP PE L++ G E
Sbjct: 171 DNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 239 YSFGTLLLDLLSG 251
+S G L ++L G
Sbjct: 231 WSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 15/194 (7%)
Query: 69 GEKAPNVVYKGKLENQRR-----IAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLL 122
G A VYKG + +A+K N P +F++EA + + + L LL
Sbjct: 16 GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 75
Query: 123 GCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALY 182
G C + LV + MP+ L ++ H + + L + +A+ + Y + R ++
Sbjct: 76 GVCLSPTIQ-LVTQLMPHGCLLDYV-HEHKDNIGSQLLLNWCVQIAKGMMYLEER-RLVH 132
Query: 183 HDLNAYRILFDEDGNPRLSTFGLMK-NSRDGKSYSTNLAFTPPEYL-----RTGRVTPES 236
DL A +L + +++ FGL + D K Y+ + P +++ + T +S
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 192
Query: 237 VIYSFGTLLLDLLS 250
++S+G + +L++
Sbjct: 193 DVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 34/135 (25%), Positives = 58/135 (42%), Gaps = 11/135 (8%)
Query: 128 GDERLLVAEYMPN---ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHD 184
D LV EY+ +L K L P WA + + + +E +G ++ D
Sbjct: 69 KDYLYLVMEYLNGGDCASLIKTLGGL---PEDWAKQY--IAEVVLGVEDLHQRG-IIHRD 122
Query: 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTL 244
+ +L D+ G+ +L+ FGL +N + K + + PE + S +S G +
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCV 182
Query: 245 LLDLLSGKHIPPSHA 259
+ + L G PP HA
Sbjct: 183 IFEFLFG--YPPFHA 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 58/253 (22%), Positives = 108/253 (42%), Gaps = 21/253 (8%)
Query: 69 GEKAPNVVYKGKLENQ--RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC 126
GE A VYK + + +A+K+ R+ + + E + ++ + +
Sbjct: 28 GEGASGEVYKAT-DRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLN 186
GDE +V EYM +L + M V + Q LEY S+ ++ D+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFV-RMNEPQIAYVCREVLQGLEYLHSQNV-IHRDIK 143
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFG 242
+ IL +DG+ +L+ FG KS ++ TP PE ++ P+ I+S G
Sbjct: 144 SDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLG 203
Query: 243 TLLLDLLSGK--HI--PPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+ +++ G+ ++ PP AL LI + + L + + E ++CL
Sbjct: 204 IMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP-------EKWSPEFKDFLNKCLVK 256
Query: 299 EPRERPNPKSLVT 311
+P +RP+ + L+
Sbjct: 257 DPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 43/200 (21%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSKGRALYHDLNAYR 189
LV EY+P LA L + + A +++A+ ALEY S G ++ DL
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVA-----RIYIAEIVLALEYLHSNG-IIHRDLKPDN 123
Query: 190 ILFDEDGNPRLSTFGLMK-------NSRDGKSYSTNLAFTPPEYLRTGRVTPESVI---- 238
IL D +G+ +L+ FGL K + + P+Y+ PE ++
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI-----APEVILGQGH 178
Query: 239 ------YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG--QFTDDDGT--EL 288
+S G +L + L G IPP H + + + L G ++ +D E
Sbjct: 179 SKTVDWWSLGCILYEFLVG--IPPFH------GETPEEIFQNILNGKIEWPEDVEVSDEA 230
Query: 289 VRLASRCLQYEPRERPNPKS 308
+ L S+ L +P +R KS
Sbjct: 231 IDLISKLLVPDPEKRLGAKS 250
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHL--FHWETHPMKWA 158
+Q +E + +L++ + LG E D + E +P +LAK L + P+
Sbjct: 47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVI-R 105
Query: 159 MRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS---RDGKSY 215
+ R +L LEY + ++ D+ IL D +G +L+ FG+ K KS+
Sbjct: 106 LYTRQIL---LGLEYLHDRN-TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF 161
Query: 216 STNLAFTPPEYL-RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI-------RDRN 267
+ + PE + + G + I+S G +L++ +GK PP L+ + R +
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAAVFKIGRSKE 219
Query: 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
L + D D+ + + CLQ +P RP L
Sbjct: 220 LPPIPDH------LSDEAKDFILK---CLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSYSTNL 219
+V + + + L Y K + ++ D+ IL + G +L FG+ D S+
Sbjct: 107 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 166
Query: 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH-IPPSHALDLIRDRNLQMLTDSCLEG 278
++ PE L+ + +S I+S G L+++ G++ IPP A + L+++ +EG
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA------KELELMFGCPVEG 220
Query: 279 QFTDDDGTELVRLASRCL-QYEPRERP 304
+ + + R R L Y P RP
Sbjct: 221 DPAESETSPRPRPPGRPLSSYGPDSRP 247
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 54/237 (22%), Positives = 98/237 (41%), Gaps = 15/237 (6%)
Query: 71 KAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
+A +Y K ++RI ++ MA + +Q LE+ N+R L E +
Sbjct: 22 RATGKMYACKKLEKKRIKKRKGESMAL-NEKQILEKV-------NSRFVVSLAYAYETKD 73
Query: 131 RL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
L LV M L H++H + + + LE + R +Y DL
Sbjct: 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED-LHQERIVYRDLKPEN 132
Query: 190 ILFDEDGNPRLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLL 246
IL D+ G+ R+S GL + +G K + + PE ++ R T ++ G LL
Sbjct: 133 ILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 192
Query: 247 DLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
++++G+ P I+ ++ L E ++++ + L L +P+ER
Sbjct: 193 EMIAGQS-PFQQRKKKIKREEVERLVKEVQE-EYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 60/245 (24%), Positives = 103/245 (42%), Gaps = 22/245 (8%)
Query: 75 VVYKG-KLENQRRIAVKRFNRMAWPDPRQFLE-EARSVGQLRNNRLTNLLGCCCEGDERL 132
VYK + +A+K + D + ++ E + + Q R+ +T G +G +
Sbjct: 16 EVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLW 75
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
++ EY + L + A LR VL LEY +G+ ++ D+ A IL
Sbjct: 76 IIMEYCGGGSCLDLLKPGKLDETYIAFILREVLL---GLEYLHEEGK-IHRDIKAANILL 131
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
E+G+ +L+ FG+ S TP PE ++ ++ I+S G ++L
Sbjct: 132 SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIEL 191
Query: 249 LSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
G+ + P L LI N L + +F+ + V L CL +P+ERP
Sbjct: 192 AKGEPPLSDLHPMRVLFLIPKNNPPSLEGN----KFSKP-FKDFVSL---CLNKDPKERP 243
Query: 305 NPKSL 309
+ K L
Sbjct: 244 SAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 22/241 (9%)
Query: 86 RIAVKRFNRMAWPDPRQFL-EEARSVGQLRNN-RLTNLLGCCCEGDERLLVAEYMPNETL 143
++AVK A R+ L E + + L N+ + NLLG C G L++ EY L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 144 AKHLFHWETHPMKWAMRLRVVLH----LAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199
L + + L +L +A+ + + SK ++ DL A +L +
Sbjct: 127 LNFL-RRKRESF---LTLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNVLLTHGKIVK 181
Query: 200 LSTFGLMKNSRDGKSY-STNLAFTP-----PEYLRTGRVTPESVIYSFGTLLLDLLS-GK 252
+ FGL ++ + +Y A P PE + T ES ++S+G LL ++ S G
Sbjct: 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241
Query: 253 HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312
+ P + D L + E+ + C +P +RP K +V
Sbjct: 242 NPYP----GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297
Query: 313 L 313
+
Sbjct: 298 I 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 28/120 (23%)
Query: 170 ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRT 229
ALEY SK +Y DL IL D++G+ +L+ FG K RD ++++ L T PEYL
Sbjct: 113 ALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWT--LCGT-PEYL-- 165
Query: 230 GRVTPESV----------IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279
PE + ++ G L+ ++L G PP D N + + L G+
Sbjct: 166 ---APEVIQSKGHNKAVDWWALGILIYEMLVG--YPP------FFDDNPFGIYEKILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 37/146 (25%), Positives = 61/146 (41%), Gaps = 16/146 (10%)
Query: 118 LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEY 173
LT L C D V EY+ L + E H + +A + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---- 118
Query: 174 CTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-NSRDG---KSYSTNLAFTPPEYLRT 229
SKG +Y DL ++ D +G+ +++ FG+ K N DG K++ + PE +
Sbjct: 119 --SKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 230 GRVTPESVIYSFGTLLLDLLSGKHIP 255
++FG LL ++L+G P
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAG-QAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 170 ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PE 225
L++ KG +Y DL +L D+DG+ +++ FG+ K + +G+ ++ TP PE
Sbjct: 108 GLQFLHKKG-IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPE 166
Query: 226 YLRTGRVTPESV-IYSFGTLLLDLLSGKHIPPSHALD 261
L+ G+ ESV +SFG LL ++L G+ P H D
Sbjct: 167 ILK-GQKYNESVDWWSFGVLLYEMLIGQ--SPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 9e-04
Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 9/92 (9%)
Query: 169 QALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA------FT 222
+ L Y SKG L+ DL A +L D DG ++S FG+ K S D N++ +
Sbjct: 119 EGLAYLHSKG-ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 223 PPEYLRTGR--VTPESVIYSFGTLLLDLLSGK 252
PE + + + + I+S G ++L++ +G+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 7/99 (7%)
Query: 167 LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP--- 223
+A AL Y S +Y DL IL D G+ L+ FGL K + ++ TP
Sbjct: 105 IASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 224 -PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD 261
PE LR + G +L ++L G +PP ++ D
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 15/216 (6%)
Query: 105 EEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVV 164
+E R + +L + + +LG CE L E+M +++ HL + K A+ +
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVS-HLLS-KYGAFKEAVIINYT 109
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP-RLSTFGLM-----KNSRDGK---SY 215
L + L Y + ++ D+ +L D G R++ FG K + G+
Sbjct: 110 EQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC 275
+AF PE LR + ++S G +++++ + K PP +A L S
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK--PPWNAEKHSNHLALIFKIASA 226
Query: 276 LEGQFTDDDGTELVR-LASRCLQYEPRERPNPKSLV 310
+ + +R + RCL+ +P +RP + L+
Sbjct: 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 39/163 (23%), Positives = 75/163 (46%), Gaps = 24/163 (14%)
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL---MKNSRDGKSYSTN 218
R+ + + + L Y S + L+ D+ +L + G +L FG+ + NS K+Y
Sbjct: 99 RIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKTYVGT 156
Query: 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK-----------HIPPSHALDLIRDRN 267
A+ PE + + S ++S G ++L G+ + P L I D +
Sbjct: 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216
Query: 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
+L GQF++ + V ++C++ +P+ERP P++L+
Sbjct: 217 PPVLPV----GQFSE----KFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 17/132 (12%)
Query: 133 LVAEYMPNE---TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
LV EYM ++ L L H+ +K M+ L + L YC K L+ D+
Sbjct: 93 LVFEYMDHDLMGLLESGLVHFSEDHIKSFMK-----QLLEGLNYCHKKN-FLHRDIKCSN 146
Query: 190 ILFDEDGNPRLSTFGLMK--NSRDGKSYSTN----LAFTPPEYLR-TGRVTPESVIYSFG 242
IL + G +L+ FGL + NS + + Y TN L + PPE L R P ++S G
Sbjct: 147 ILLNNKGQIKLADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCG 205
Query: 243 TLLLDLLSGKHI 254
+L +L + K I
Sbjct: 206 CILGELFTKKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 3/104 (2%)
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSYSTNL 219
+V + + + L Y K + ++ D+ IL + G +L FG+ D S+
Sbjct: 107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 166
Query: 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH-IPPSHALDL 262
++ PE L+ + +S I+S G L++L G++ IPP A +L
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 60/250 (24%), Positives = 96/250 (38%), Gaps = 33/250 (13%)
Query: 76 VYKG-KLENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC---CEGD 129
VY L+ +AVK R DP+ E A + L + NL+ +
Sbjct: 16 VYTAVNLDTGELMAVKEIRIQD---NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE 72
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
+ + EY TL + L H + L L + L Y S G ++ D+
Sbjct: 73 KVYIFMEYCSGGTLEELLEHGRILDEH--VIRVYTLQLLEGLAYLHSHG-IVHRDIKPAN 129
Query: 190 ILFDEDGNPRLSTFG----LMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPE--SV-I 238
I D +G +L FG L N+ +LA TP PE + G+ + I
Sbjct: 130 IFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI 189
Query: 239 YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL----VRLASR 294
+S G ++L++ +GK P LD Q++ + D +L R
Sbjct: 190 WSLGCVVLEMATGK--RPWSELD----NEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDR 243
Query: 295 CLQYEPRERP 304
CL+ +P++RP
Sbjct: 244 CLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 40/161 (24%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETH--PMKWA 158
R FL EA +GQ + + +L G + +++ E+M N L L + ++
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV 109
Query: 159 MRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS---Y 215
LR +A ++Y S+ ++ DL A IL + + ++S FGL + D S Y
Sbjct: 110 GMLR---GIAAGMKY-LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165
Query: 216 STNLA------FTPPEYLRTGRVTPESVIYSFGTLLLDLLS 250
+++L +T PE + + T S ++S+G ++ +++S
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 13/149 (8%)
Query: 169 QALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSYSTNLAFTPPEY 226
+ L Y K + ++ D+ IL + G +L FG+ + K++ ++ PE
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPER 170
Query: 227 LRTGRVTPESVIYSFGTLLLDLLSGK------HIPPSHALDLIRDRNLQMLTDSCLEGQF 280
++ + +S I+S G L++L +G+ + PP +L+ + G+F
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-QYIVNEPPPRLPSGKF 229
Query: 281 TDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ D + CL +PRERP+ K L
Sbjct: 230 SPD----FQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 28/250 (11%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDP--RQFLEEARSVGQLRNNRLTNLL--- 122
G A VY+GK + R +A+K N + PD E + QLR ++ N+
Sbjct: 10 GRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 123 GCCCEGDERLLVAEYMPN---ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
G +G ++ EY TL K E + ++ +R VL AL+Y G
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYI---SVIIREVL---VALKYIHKVG- 121
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPE 235
++ D+ A IL GN +L FG+ S + TP PE + G+
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181
Query: 236 SV-IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR-LAS 293
I+S G + ++ +G PP +D R ML + D+ ++L+R +
Sbjct: 182 KADIWSLGITIYEMATGN--PPYSDVDAFR---AMMLIPKSKPPRLEDNGYSKLLREFVA 236
Query: 294 RCLQYEPRER 303
CL EP+ER
Sbjct: 237 ACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 14/160 (8%)
Query: 122 LGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
L C + RL LV EY+ L H+ P + A R + AL + +G
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA-RFYAA-EICIALNFLHERG-I 117
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNS-RDGKSYSTNLA---FTPPEYLRTGRVTPES 236
+Y DL +L D DG+ +L+ +G+ K G + ST + PE LR
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 237 VIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL 276
++ G L+ ++++G+ D+I D N M T+ L
Sbjct: 178 DWWALGVLMFEMMAGR-----SPFDIITD-NPDMNTEDYL 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 15/115 (13%)
Query: 161 LRVVLH-LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL-MKNSRDGKSYSTN 218
+R V + +AL + S + ++ DL A IL DG+ +L+ FG+ KN + T
Sbjct: 105 IRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163
Query: 219 LAFTP----PEYL--RTGRVTP---ESVIYSFGTLLLDLLSGKHIPPSHALDLIR 264
+ TP PE + T + P ++ I+S G L++L + PP H L+ +R
Sbjct: 164 IG-TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME--PPHHELNPMR 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 16/197 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
+VY + L Q RIA+K + EE L++ + LG E +
Sbjct: 23 IVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALE---YCTSKGRALYHDLNAYRI 190
E +P +L+ L + P+K ++ + Q LE Y + ++ D+ +
Sbjct: 83 FMEQVPGGSLSA-LLRSKWGPLK-DNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNV 139
Query: 191 LFDE-DGNPRLSTFGLMKN----SRDGKSYSTNLAFTPPEYLRTGR--VTPESVIYSFGT 243
L + G ++S FG K + ++++ L + PE + G + I+S G
Sbjct: 140 LVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGC 199
Query: 244 LLLDLLSGKHIPPSHAL 260
++++ +GK PP L
Sbjct: 200 TIVEMATGK--PPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 9/154 (5%)
Query: 104 LEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRV 163
L E+R + R+ LT+L D V EY+ L FH + R R
Sbjct: 43 LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRF 99
Query: 164 V-LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK----NSRDGKSYSTN 218
+ AL+Y S G+ +Y DL ++ D+DG+ +++ FGL K ++ K++
Sbjct: 100 YGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158
Query: 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK 252
+ PE L + G ++ +++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 25/156 (16%)
Query: 118 LTNLLGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRL---RVVLHLAQ---A 170
LT L C + +RL V EY+ L +FH ++ + R R + A+
Sbjct: 58 LTQLH-SCFQTKDRLFFVMEYVNGGDL---MFH-----IQRSGRFDEPRARFYAAEIVLG 108
Query: 171 LEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-NSRDGKSYSTNLAFTP----PE 225
L++ +G +Y DL +L D +G+ +++ FG+ K G + ST TP PE
Sbjct: 109 LQFLHERG-IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPE 166
Query: 226 YLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD 261
L P ++ G LL ++L+G+ P D
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ--SPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 34/173 (19%)
Query: 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPP 224
+A+ +E+ S+ + ++ DL A IL E+ ++ FGL +RD + P
Sbjct: 180 FQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGL---ARD--------IYKDP 227
Query: 225 EYLRTGR-------VTPESV----------IYSFGTLLLDLLS-GKHIPPSHALDLIRDR 266
+Y+R G + PES+ ++SFG LL ++ S G P +D R
Sbjct: 228 DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287
Query: 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319
L+ T T E+ + C P +RP LV L L +E
Sbjct: 288 RLKEGTRMRAPEYATP----EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 34/136 (25%), Positives = 59/136 (43%), Gaps = 8/136 (5%)
Query: 122 LGCCCEGDERLL-VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
L C + + RL V EY+ L H+ P + A + LA L Y +G
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHERG-I 117
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPES 236
+Y DL +L D +G+ +L+ +G+ K ++ TP PE LR
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 237 VIYSFGTLLLDLLSGK 252
++ G L+ ++++G+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220
+R ++ +A +EY +SK ++ DL A + +E+ ++ FGL K G Y A
Sbjct: 116 VRFMIDIASGMEYLSSKN-FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 221 FTPP------EYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD------LIRDRNL 268
P E L T S +++FG + ++++ P + + LI+ L
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234
Query: 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
+ D CLE ++ L +C EP+ RP+ + L L
Sbjct: 235 KQPPD-CLE---------DVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 43/208 (20%), Positives = 77/208 (37%), Gaps = 24/208 (11%)
Query: 86 RIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144
R+ VK A PD + FL+E + +L + + LG C E LLV E+ P L
Sbjct: 24 RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83
Query: 145 KHLFHWETHPMKWAMRLRVVLHLAQALE---YCTSKGRALYHDLNAYRILFDEDGNPRLS 201
+L + + V+ +A + + ++ DL D + ++
Sbjct: 84 NYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIG 142
Query: 202 TFGLMKNSRDGKSYSTN------LAFTPPEY-------LRTGRVTPESVIYSFGTLLLDL 248
+GL Y T L + PE L T +S I+S G + +L
Sbjct: 143 DYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
Query: 249 LSGKHIPPSHALDL------IRDRNLQM 270
+ P D +R++++++
Sbjct: 203 FTAADQPYPDLSDEQVLKQVVREQDIKL 230
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 11/207 (5%)
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160
R L E R + +L + L NL + + LV + + L HL + ++
Sbjct: 45 RNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-QVK 103
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---SYST 217
+ + ALEY SKG ++ D+ IL DE G+ ++ F + S S
Sbjct: 104 FWIC-EIVLALEYLHSKG-IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSG 161
Query: 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD-RNLQMLTDSCL 276
+ PE L + +S G + L GK H+ + R Q D
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV-- 219
Query: 277 EGQFTDDDGTELVRLASRCLQYEPRER 303
+ TE + ++ L+ +P++R
Sbjct: 220 --LYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.004
Identities = 39/177 (22%), Positives = 64/177 (36%), Gaps = 44/177 (24%)
Query: 129 DERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSKGRALYH- 183
+E L V EY PN L +++ + + K + A+ ALEY SKG + H
Sbjct: 74 EENLYFVLEYAPNGELLQYIRKYGSLDEKCT-----RFYAAEILLALEYLHSKG--IIHR 126
Query: 184 DLNAYRILFDEDGNPRLSTFG--------LMKNSRDGKSYSTNLA--------------- 220
DL IL D+D + +++ FG S G + + +
Sbjct: 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTA 186
Query: 221 -FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA------LDLIRDRNLQM 270
+ PE L S +++ G ++ +L+GK PP I
Sbjct: 187 EYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK--PPFRGSNEYLTFQKILKLEYSF 241
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 449 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.16 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.9 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.86 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.82 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.44 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.36 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.32 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.25 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.05 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.93 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.77 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.77 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.72 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.58 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.53 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.29 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.26 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.14 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.07 | |
| PLN02236 | 344 | choline kinase | 97.01 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.94 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.92 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.89 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.61 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.38 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.37 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.33 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.16 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.97 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.96 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.92 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.86 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.77 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.61 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.17 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.94 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-52 Score=392.26 Aligned_cols=248 Identities=19% Similarity=0.259 Sum_probs=211.6
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
...+|.+.++||+|+||+||+|+++ ++..||||.+.+.. ....+.+..|+++|+.++|||||.++++++.++.+|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3457888889999999999999954 48999999997763 23356789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC------CCeEEeccCCccc
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED------GNPRLSTFGLMKN 208 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~------~~~kL~DFGla~~ 208 (449)
||||+||+|.++++ ..+.+++..++.++.||+.||++||+++ ||||||||+|||++.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~~-IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHENN-IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999998 5668999999999999999999999999 9999999999999864 4589999999999
Q ss_pred CCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 209 SRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 209 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
..++ .+.+|++.|||||++..+.|+.|+|+||+|+|+|++++|+.||...+...+.......-. .....+...+
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~---~~~~~~~~~s 241 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE---IVPVLPAELS 241 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc---ccCchhhhcc
Confidence 8876 367899999999999999999999999999999999999999987766666543222111 1122233445
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....+++...++.+|.+|.+..+...
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhh
Confidence 56779999999999999987777664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-52 Score=390.19 Aligned_cols=244 Identities=19% Similarity=0.273 Sum_probs=210.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCe-eEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE-RLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~E 136 (449)
++.+.++.||+|+.|+||+++++ +++.+|+|.+....... .+++.+|+++++..+|||||.+||.|..++. +.|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45667889999999999999965 58999999996544333 5789999999999999999999999999994 999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCCC--C
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--K 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~ 213 (449)
||+||||++.+. ..+.+++....+++.+|++||.|||+ ++ ||||||||+|||++..|.+||+|||.++...+. .
T Consensus 159 YMDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~~-IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~ 235 (364)
T KOG0581|consen 159 YMDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEERK-IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIAN 235 (364)
T ss_pred hcCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhccC-eeeccCCHHHeeeccCCCEEeccccccHHhhhhhcc
Confidence 999999999997 45789999999999999999999996 66 999999999999999999999999999875544 5
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch-----hhHHHhhcccccccccccCCCCCch-hHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-----ALDLIRDRNLQMLTDSCLEGQFTDD-DGTE 287 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 287 (449)
++.||..|||||.+.+..|+.++||||||++++|+.+|+.|+... ..-.+...+... . .+..+.. ++++
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~----p-pP~lP~~~fS~e 310 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE----P-PPRLPEGEFSPE 310 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC----C-CCCCCcccCCHH
Confidence 788999999999999999999999999999999999999887664 222222222221 1 1233444 8899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++++..||++||.+|||++++++
T Consensus 311 f~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-51 Score=401.22 Aligned_cols=273 Identities=36% Similarity=0.644 Sum_probs=233.3
Q ss_pred CccccCHHHHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccce
Q 013126 43 SFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL 122 (449)
Q Consensus 43 ~~~~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 122 (449)
..+.|++.++..+|++|+..+++ |+|+||.||+|..++++.||||++.........+|.+|+.++.+++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~i---g~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLI---GEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcce---ecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence 57889999999999999998888 999999999999988899999988765533145699999999999999999999
Q ss_pred eeEeeCC-eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccccCceeeCCCCCeE
Q 013126 123 GCCCEGD-ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG--RALYHDLNAYRILFDEDGNPR 199 (449)
Q Consensus 123 ~~~~~~~-~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~iiHrDlkp~NILl~~~~~~k 199 (449)
|||.+.+ +.+||+||+++|+|.+++......+++|..+.+|+.++|+||+|||... +|+||||||+|||+|+++++|
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999998 5999999999999999998533228999999999999999999999964 499999999999999999999
Q ss_pred EeccCCcccCCC-CCcc----ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch-----------hhHHH
Q 013126 200 LSTFGLMKNSRD-GKSY----STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-----------ALDLI 263 (449)
Q Consensus 200 L~DFGla~~~~~-~~~~----~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~-----------~~~~~ 263 (449)
|+|||+|+.... .... .||.+|+|||++..+..+.|+|||||||++.|++||+.+.... ....+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999977664 3322 7999999999999999999999999999999999999765421 12234
Q ss_pred hhcccccccccccC-CCCCc-hhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 264 RDRNLQMLTDSCLE-GQFTD-DDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 264 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
.+.....+.++... ..++. .....+..+..+|++.+|.+||+|.++++.|+....
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 44566777777655 44443 455678899999999999999999999999855543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=393.29 Aligned_cols=248 Identities=20% Similarity=0.259 Sum_probs=210.9
Q ss_pred CcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCC-------HHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD-------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
++.|.+.+.||+|+||.|-+|. .++|+.||||++++..... .....+|+++|++|+|||||++++++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3457888899999999999999 5569999999997643211 2235799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC---CCeEEeccCCcc
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMK 207 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla~ 207 (449)
.|+||||++||+|.+.+. .++.+.++..+.+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~G-I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQG-IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHcC-cccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999998 6678889999999999999999999999 9999999999999865 779999999999
Q ss_pred cCCCC---CccccCccccccccccCCC---CCCCCceeeHhHHHHHHhcCCCCCCchhhHH-HhhcccccccccccCCCC
Q 013126 208 NSRDG---KSYSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQF 280 (449)
Q Consensus 208 ~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 280 (449)
..... ++.+|||.|.|||++.++. +..++|+||+||+||.+++|.+||.++..+. ..+.+...... ..+..
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~--f~p~~ 405 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA--FGPLQ 405 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc--ccChh
Confidence 88654 5788999999999998765 3348899999999999999999998765444 33333332221 12234
Q ss_pred CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+..++++..+||.+||..||++|||+.|+++
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 5678999999999999999999999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=392.92 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=215.4
Q ss_pred cccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCC-eeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD-ERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~Ey~ 138 (449)
..+.+.+|+|+||+||+|.+++...||||++....... .+.|.+|+.+|++++|||||+++|++.++. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34445589999999999999654449999998754333 458999999999999999999999999987 799999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-CeEEeccCCcccCCC----CC
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRD----GK 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~----~~ 213 (449)
++|+|.+++.......+++..+.+++.||++||.|||++++||||||||+|||++.++ ++||+|||+++.... ..
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~ 202 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMT 202 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccccc
Confidence 9999999998544688999999999999999999999997689999999999999997 999999999986553 23
Q ss_pred ccccCcccccccccc--CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLR--TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
...||+.|||||++. ...|+.|+||||||+++|||+||+.||............... ..+...+..+++.+..+
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~----~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG----GLRPPIPKECPPHLSSL 278 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----CCCCCCCccCCHHHHHH
Confidence 467999999999999 558999999999999999999999999766543333322222 22233445578899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
+.+||+.||+.||++.+++..|+.+....
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 99999999999999999999998876643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=396.00 Aligned_cols=243 Identities=18% Similarity=0.226 Sum_probs=217.6
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
..|...+.||+|||++||.+++ .+|+.||+|++.+.. ....+...+|+++.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4577778889999999999996 789999999998733 234678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
|+|+.++|..+++ .++++++.+++.+++||+.||.|||+++ |+|||||..|++++++.++||+|||+|......
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~-IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG-IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC-ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999997 6789999999999999999999999999 999999999999999999999999999876633
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
.+.+|||.|.|||++.....+..+||||+|||+|.|+.|++||...........+... .-..|..++.++.+|
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------~Y~~P~~ls~~A~dL 248 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------EYSMPSHLSAEAKDL 248 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------CcccccccCHHHHHH
Confidence 4678999999999999888999999999999999999999999988666655544322 123455788899999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
|.++|++||.+|||+++|+.
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=366.29 Aligned_cols=251 Identities=20% Similarity=0.272 Sum_probs=213.8
Q ss_pred CcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCccccee-eEeeCCe-eEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLG-CCCEGDE-RLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~~~~-~~l 133 (449)
..+|+++++||+|+||+||++. ..+|..+|.|.++-+... ..+....|+.+|++|+|||||++++ .+.+++. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3458899999999999999999 567999999999844322 2467899999999999999999999 4555555 899
Q ss_pred EEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 134 VAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTS---KGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~---~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
|||||.+|+|...|+.. ..+.+++..+++++.|++.||..+|+ ++.|+||||||.||+++.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999999753 45779999999999999999999999 23499999999999999999999999999998
Q ss_pred CCCCC----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 209 SRDGK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 209 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
..... +..|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+.+...+..++.+.-..+.+ ..-.
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p----~~~Y 253 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP----DEHY 253 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc----HHHh
Confidence 87663 578999999999999999999999999999999999999999998877777666554222211 2456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
+.++..+|..|+..||+.||+.-.++..+
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 78999999999999999999865555433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=383.38 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=215.8
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
..+++++||+|-||.||.|.+++...||+|.++... ...+.|.+|+++|++|+|+|||+++|++..++.+||||||++.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 356889999999999999999888899999998764 4468899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcc--cc-
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--ST- 217 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~--~g- 217 (449)
|+|.++|+...+..+...+.+.++.|||.|++||++++ +|||||...|||++++..+||+|||+|+...++... .+
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~-~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN-YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC-ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 99999999766788999999999999999999999999 999999999999999999999999999965544321 12
Q ss_pred --CccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 218 --NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 218 --t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
...|+|||.+..+.++.|||||||||+||||+| |+.|++........+...+. .+-..|+.+|+++.+++..
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-----yRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-----YRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-----CcCCCCCCCCHHHHHHHHH
Confidence 367999999999999999999999999999999 55565554433333222221 1223466788999999999
Q ss_pred hcccCCCCCCCHHHHHHHhcccccc
Q 013126 295 CLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
||+.+|++|||++.+...|+.+...
T Consensus 440 CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 440 CWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999999988877543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=369.42 Aligned_cols=239 Identities=22% Similarity=0.283 Sum_probs=211.0
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
+.+++++++.||+|+||.||.++.+ +++.+|+|++++... .+.+...+|..+|.+++||.||+++-.|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4456888999999999999999954 599999999987542 235678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
|+||+.||.|..+|. +.+.+++..++-++.+|+.||.|||++| ||||||||+|||+|.+|+++|+|||+++.....
T Consensus 103 Vld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g-IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG-IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC-eeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999998 6788999999999999999999999999 999999999999999999999999999854332
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
.+.+||+.|||||++.+..|+.++|.||||+++|||++|.+||.......+.+.+..... ...+.-.+.+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-----~~~p~~ls~~ar 254 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-----PLPPGYLSEEAR 254 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-----CCCCccCCHHHH
Confidence 456899999999999999999999999999999999999999998877777666555431 122333778999
Q ss_pred HHHHHhcccCCCCCC
Q 013126 290 RLASRCLQYEPRERP 304 (449)
Q Consensus 290 ~li~~cl~~dP~~Rp 304 (449)
+++.++|++||++|.
T Consensus 255 dll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHHhccCHHHhc
Confidence 999999999999995
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=341.57 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=210.1
Q ss_pred ccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+|..++++|+|.||+||+|+ ..+|+.||||+++.....+ ....+||++.|+.++|+||+.++++|...+.+-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 57778899999999999999 4569999999998765433 45688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
++ .+|...|++ +...++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+++......
T Consensus 83 m~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~-IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 83 MP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW-ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred cc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh-hhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 98 899999986 6678999999999999999999999999 9999999999999999999999999999876542
Q ss_pred ccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-----------------------
Q 013126 214 SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ----------------------- 269 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~----------------------- 269 (449)
....|..|.|||.+.|.. |+..+|+||.|||+.||+-|.+.+++.+.-.-...+..
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 235789999999998865 99999999999999999999987765421111111111
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccCC
Q 013126 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322 (449)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 322 (449)
..+.+.. ...-...+.++.+|+.++|..||.+|+|++++++ +.+....+.
T Consensus 240 ~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~~P~ 289 (318)
T KOG0659|consen 240 QFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKSLPL 289 (318)
T ss_pred cCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhcCCC
Confidence 1111111 1123345677899999999999999999999998 444444333
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=350.86 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=202.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+.|+.++++|+|+||+||+++.+ +|+.||||++....... .+-.+||+++|++++|||+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35788999999999999999955 59999999997654322 4557899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC-CC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-DG--- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~-~~--- 212 (449)
||+. |+.+.+.+ ....++.....++++|++.|+.|+|+++ +|||||||+|||++.+|.+||+|||+|+... ++
T Consensus 82 ~~dh-TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~n-~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKNN-CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhcC-eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9985 55555544 5567899999999999999999999999 9999999999999999999999999999877 33
Q ss_pred CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-HHh-------------------hcccccc
Q 013126 213 KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIR-------------------DRNLQML 271 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~-------------------~~~~~~~ 271 (449)
+.+..|..|.|||.+.+ -+|+..+||||+||++.||++|.+.|++.+.- .+. +.....+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 34667999999999988 56999999999999999999999988765211 110 0111111
Q ss_pred cccccC-----CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 272 TDSCLE-----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 272 ~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.-+.+. ..--+..+.-+.+++.+||+.||++|++.++++.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111 0111345667899999999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=367.90 Aligned_cols=249 Identities=18% Similarity=0.257 Sum_probs=207.8
Q ss_pred cccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCCH-HHHHHHHHHHhccC-CCCcccceeeEeeCC-eeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDP-RQFLEEARSVGQLR-NNRLTNLLGCCCEGD-ERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~~-~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~~lV~ 135 (449)
++|.++++||.|+||.||+|+ ..+|..||||.+++...... -.-+||++.|++++ ||||+++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 579999999999999999999 55699999999987553332 23568999999998 999999999999988 999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
|||+ .+|+++++++ ++.+++..++.|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+||.....
T Consensus 90 E~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G-fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG-FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred Hhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC-cccccCChhheEecccceeEecccccccccccCCCc
Confidence 9998 8999999874 889999999999999999999999999 999999999999999999999999999987655
Q ss_pred CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc------------------------
Q 013126 213 KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN------------------------ 267 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~------------------------ 267 (449)
+.+..|..|+|||++.. +.|+.+.|+|++|||++|+.+-++.|++...-.-..++
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 46778999999999865 45999999999999999999999988764221100000
Q ss_pred -cccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 268 -LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 268 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
..... +..-...-+..+.++.++|.+|+++||++||||.+++++
T Consensus 247 ~~P~~~-~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 247 RFPQVK-PSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCCcCC-CCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00000 111111223478899999999999999999999999984
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=373.98 Aligned_cols=248 Identities=20% Similarity=0.311 Sum_probs=216.7
Q ss_pred CCCcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+.-..|....++|+|+.|.||.|+ ..+++.||||.+........+-+++|+.+|+..+|+|||++++.|..++.+|+||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 344567777899999999999999 4568999999999888777888999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++||+|.|.+ ....+++.++..|.+++++||+|||.+| |+|||||.+|||++.+|.+||+|||++......
T Consensus 350 Eym~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~~g-IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 350 EYMEGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLHARG-IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred eecCCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHHhcc-eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999999999 5566999999999999999999999999 999999999999999999999999998766544
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
.+..|||+|||||++....|++++||||||++++||+-|.+||..+..-. ....-.....+....++.+++.++++
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr---AlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH---HHHHHhhcCCCCcCCccccCHHHHHH
Confidence 45679999999999999999999999999999999999999987532111 11111222333445567889999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+.+||+.|+++|+++.|+|+
T Consensus 503 L~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHhhcchhcCCCHHHHhc
Confidence 99999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=361.65 Aligned_cols=246 Identities=21% Similarity=0.318 Sum_probs=203.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCC--eeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD--ERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~Ey 137 (449)
.+...+.||+|+||+||++... +|+..|||.+........+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3556678899999999999954 48999999997653333667899999999999999999999855444 68999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-CCCeEEeccCCcccCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRD----- 211 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~----- 211 (449)
++||+|.+++..... .+++..++.+++||+.||+|||++| ++||||||+|||++. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g-~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG-IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC-EeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999999985433 8999999999999999999999999 999999999999999 79999999999886552
Q ss_pred --CCccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCch--hhHHHhhcccccccccccCCCCCchhHH
Q 013126 212 --GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSH--ALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 212 --~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
.....||+.|||||++.++. ...++|||||||++.||+||++|+... ............ ..+.++..++.
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----~~P~ip~~ls~ 250 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----SLPEIPDSLSD 250 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----CCCCCCcccCH
Confidence 23467999999999998643 345999999999999999999887652 111111111111 11256777889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
++.+++.+|+++||++||||++++.+.
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 999999999999999999999999854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=367.46 Aligned_cols=246 Identities=20% Similarity=0.261 Sum_probs=215.7
Q ss_pred CCcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCC---CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
.-.++.+.+.||.|+|++|++|+ ..+++.||||++.+.. ....+-..+|-.+|.+| .||.|++++-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34567788888999999999999 4569999999997633 22345577899999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+|+||+++|+|.++|. +-+.+++..++.++.||+.||+|||++| ||||||||+|||+|+|+++||+|||.|+...+.
T Consensus 151 FvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~G-IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSNG-IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhcC-ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999998 5688999999999999999999999999 999999999999999999999999998854321
Q ss_pred -----------------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccc
Q 013126 213 -----------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC 275 (449)
Q Consensus 213 -----------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 275 (449)
.+++||-.|.+||++..+..+..+|+|+||||+|+|+.|.+||.+.+.-.+-++++..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l----- 302 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL----- 302 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-----
Confidence 3467999999999999999999999999999999999999999887766665554432
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.-.+++..++.+.+|+.++|..||.+|+|.++|.++
T Consensus 303 -~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 -DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 234567788999999999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=364.65 Aligned_cols=249 Identities=21% Similarity=0.254 Sum_probs=213.4
Q ss_pred CcccccccccCCccceEEEEEEE-cCCCEEEEEEecCC----CC-CCHHHHHHHHHHHhccC-CCCcccceeeEeeCCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM----AW-PDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 131 (449)
...|++.+.||+|+||.|++|.. .+++.||+|++++. .. ...+.+.+|+.+++.++ ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 45688999999999999999985 45899999987663 11 22456778999999998 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-CCeEEeccCCcccCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSR 210 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~ 210 (449)
++||||+.||+|.+++. +.+++++..++.+++|+++|++|+|++| |+||||||+|||++.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~--~~g~l~E~~ar~~F~Qlisav~y~H~~g-i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIV--NKGRLKEDEARKYFRQLISAVAYCHSRG-IVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHH--HcCCCChHHHHHHHHHHHHHHHHHHhCC-EeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999998 4688999999999999999999999999 9999999999999999 999999999998772
Q ss_pred -C---CCccccCccccccccccCCC-CC-CCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 211 -D---GKSYSTNLAFTPPEYLRTGR-VT-PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 211 -~---~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
. .....||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.......+........ -.++..+
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~------~~~p~~~ 246 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE------FKIPSYL 246 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC------ccCCCCc
Confidence 2 25678999999999999877 86 68999999999999999999998866555554422221 1234445
Q ss_pred -HHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 285 -GTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 285 -~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
++++.+|+.+||..||.+|+|+.+++. ..+.+
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~--h~w~~ 279 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILE--HPWFQ 279 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhh--Chhhc
Confidence 889999999999999999999999994 44444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=366.43 Aligned_cols=241 Identities=19% Similarity=0.264 Sum_probs=212.8
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+|.+.+.||+|+||+||||+. .+.+.||+|.+.+....+ .+.+.+|+++++.++||||+.+++.|+...+.|+|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 345555669999999999994 458899999997754333 56799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
+.| +|..++. .++.++++.++.++.++..||.|||+++ |+|||+||+|||++++|.+|++|||+|+....++
T Consensus 83 a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~r-ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 83 AVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSNR-ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhcC-cccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 985 9999998 6788999999999999999999999998 9999999999999999999999999999877664
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...|||.|||||.+.+++|+..+|+||+|||+||+.+|++||.....-.+-..+..+.+ .++...+..+..++.
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v------~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV------KPPSTASSSFVNFLQ 232 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC------CCcccccHHHHHHHH
Confidence 45799999999999999999999999999999999999999987766555544443322 235578889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
.+|.+||.+|.|..+++.
T Consensus 233 gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHhhcChhhcccHHHHhc
Confidence 999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=341.48 Aligned_cols=236 Identities=18% Similarity=0.228 Sum_probs=210.4
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.++++.++.||.|+||+|.+++.+ +|..+|+|++++...-. .+...+|..+|+.+.||.++++++.+.+.+++|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 345778889999999999999954 58899999998754332 45678999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
|||++||.|..+++ +.+.+++..++.++.||+.||+|||+++ |++|||||+|||+|++|.+||+|||+|+......
T Consensus 123 meyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~-iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLD-IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred EeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcC-eeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 99999999999998 6788999999999999999999999999 9999999999999999999999999999876653
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
+.+|||.|+|||++...+|+.++|.|||||++|||+.|.+||..+....+.+++..... .+|.-.+.++++|+.
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v------~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV------KFPSYFSSDAKDLLK 273 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc------cCCcccCHHHHHHHH
Confidence 57899999999999999999999999999999999999999988876555555544322 346677789999999
Q ss_pred HhcccCCCCC
Q 013126 294 RCLQYEPRER 303 (449)
Q Consensus 294 ~cl~~dP~~R 303 (449)
++|+.|-.+|
T Consensus 274 ~LL~vD~t~R 283 (355)
T KOG0616|consen 274 KLLQVDLTKR 283 (355)
T ss_pred HHHhhhhHhh
Confidence 9999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=357.71 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=204.4
Q ss_pred CcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 133 (449)
-+.|+.+++||+|+||.||+|+ ..+|+.||+|+++.+.. .......+||.+|++|+||||+++.+...+. +.+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568899999999999999999 55699999999987652 3356678999999999999999999998887 68999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
|+|||+ -+|..++.. ..-.+++.++..+++|++.||.|+|++| |+|||||.+|||||.+|.+||+|||+|+......
T Consensus 196 VFeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g-vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG-VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC-eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999998 588888853 3557999999999999999999999999 9999999999999999999999999999655442
Q ss_pred -----ccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc-----------cc--cccc-
Q 013126 214 -----SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------LQ--MLTD- 273 (449)
Q Consensus 214 -----~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-----------~~--~~~~- 273 (449)
....|..|.|||.+.|.. |+.++|+||.||||.||++|++++++...-.-...+ +. .++.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 345689999999999876 999999999999999999999988764322111111 11 1110
Q ss_pred --cccCCCC-------CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 --SCLEGQF-------TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 --~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..+...+ ....++...+|+..+|..||++|.||.+++.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000011 1235678899999999999999999999997
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=349.66 Aligned_cols=254 Identities=19% Similarity=0.247 Sum_probs=211.0
Q ss_pred CCCcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.+-++|++...||.|..++||+|+ ...++.||||++....... .+.+.+|++.++.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 455789999999999999999999 5678999999998765544 58899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|.||.+||+.+.+...-...+++..+..|++++++||.|||.+| .||||||+.||||+++|.+||+|||.+....+.
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G-~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG-HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC-ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999998776778999999999999999999999999 999999999999999999999999976543222
Q ss_pred ------CccccCccccccccccC--CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc----ccCCCC
Q 013126 213 ------KSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS----CLEGQF 280 (449)
Q Consensus 213 ------~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 280 (449)
....||+.|||||++.. ..|+.|+||||||++..||.+|..||.....-.+.-..++..+.. .....-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 34578999999999654 359999999999999999999999986543222222222211110 111111
Q ss_pred CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....+..+++++..||++||.+|||++++++
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 2235678999999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=358.67 Aligned_cols=249 Identities=17% Similarity=0.174 Sum_probs=211.2
Q ss_pred CCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
...+++++++.||+|+||.||+|+.+ +|..+|+|++++... ...+....|-.+|...++|+||+++-.|.+.+++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 45678899999999999999999954 599999999987542 33567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC--
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-- 210 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~-- 210 (449)
|||||++||++..+|. +.+.|++..++.++.+++.|+..+|+.| +|||||||+|+|||..|++||+|||++....
T Consensus 218 LiMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g-yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG-YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC-cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999998 6789999999999999999999999999 9999999999999999999999999975110
Q ss_pred ------------------------C-----C--------------------CccccCccccccccccCCCCCCCCceeeH
Q 013126 211 ------------------------D-----G--------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSF 241 (449)
Q Consensus 211 ------------------------~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 241 (449)
. . .+..|||.|+|||++.+..|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 0 02358999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 013126 242 GTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP---NPKSLVT 311 (449)
Q Consensus 242 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~eil~ 311 (449)
|||+||||.|.+||.++.....-.++..-... +........+.++.+||.+||. ||++|. .++||.+
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRET--LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999999999887666655444332211 1111233456899999999999 999995 5777776
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=365.12 Aligned_cols=245 Identities=18% Similarity=0.253 Sum_probs=220.7
Q ss_pred CcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
...+++.+.||.|+.|.|-+|++ .+|+.+|||++.+... .....+.+|+-+|+-+.||||+++|+++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45688899999999999999994 5699999999987532 2246789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
.||++||.|.+++. ..+++++.++.++++||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|....++
T Consensus 91 lEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~-icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFN-ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhc-ceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999998 6789999999999999999999999998 999999999999999999999999999887666
Q ss_pred -CccccCccccccccccCCCCC-CCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
.+.+|+|.|.|||++.|.+|+ .++||||.|||||.|+||+.||.+++...+..+..+... +.|.+++.++++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------~MPs~Is~eaQd 241 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------EMPSNISSEAQD 241 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc------cCCCcCCHHHHH
Confidence 467899999999999999985 589999999999999999999998887777766555433 346788999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~~ 312 (449)
|+.+||..||++|.|.++|+++
T Consensus 242 LLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 242 LLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHhccCccccccHHHHhhC
Confidence 9999999999999999999984
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=358.82 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=203.4
Q ss_pred cccccccccCCccceEEEEEEE------cCCCEEEEEEecCCCCCC-HHHHHHHHHHHhcc-CCCCcccceeeEeeC-Ce
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEG-DE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~------~~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~ 130 (449)
++|++.+.||+|+||.||+|.+ .+++.||+|+++...... .+.+.+|+.+++.+ +||||+++++++... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 3578889999999999999974 125689999997543222 45789999999999 899999999988764 45
Q ss_pred eEEEEeeCCCCCHHHHHhccC-----------------------------------------------------------
Q 013126 131 RLLVAEYMPNETLAKHLFHWE----------------------------------------------------------- 151 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~----------------------------------------------------------- 151 (449)
.++||||++||+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 899999999999999986421
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC------CccccCcccccc
Q 013126 152 -THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPP 224 (449)
Q Consensus 152 -~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~------~~~~gt~~y~aP 224 (449)
..++++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ....+++.|+||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC-EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 134788889999999999999999999 999999999999999999999999999764322 123346789999
Q ss_pred ccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCC
Q 013126 225 EYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303 (449)
Q Consensus 225 E~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 303 (449)
|++.+..++.++||||||+++|||++ |..||.............. .. .....+...++++.+++.+||+.||++|
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK---DG-TRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh---cC-CCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99998889999999999999999997 8888865332111111110 11 0112244567789999999999999999
Q ss_pred CCHHHHHHHhccccc
Q 013126 304 PNPKSLVTALSPLQK 318 (449)
Q Consensus 304 ps~~eil~~L~~~~~ 318 (449)
||+.++++.|+.+..
T Consensus 322 Ps~~el~~~l~~~~~ 336 (338)
T cd05102 322 PTFSALVEILGDLLQ 336 (338)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999987754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=335.22 Aligned_cols=262 Identities=18% Similarity=0.241 Sum_probs=211.6
Q ss_pred HHhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeC-
Q 013126 53 KNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG- 128 (449)
Q Consensus 53 ~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 128 (449)
....++.++|+.+.+|++|+||.||+|+++ +++.||+|+++...... .-.-++|+.+|.+.+|||||.+..+....
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 344566788999999999999999999954 59999999998755332 34578999999999999999999987654
Q ss_pred -CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 129 -DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 129 -~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
+.+|+|||||+ -+|...+.. -.+++...+++-++.|+++|++|||.+. |+||||||+|+|+++.|.+||+|||+|+
T Consensus 149 ~d~iy~VMe~~E-hDLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~w-ilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 149 MDKIYIVMEYVE-HDLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDNW-ILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred cceeeeeHHHHH-hhHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhce-eEecccchhheeeccCCcEEecccchhh
Confidence 56999999998 689998875 3468999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCC----CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc-----------cccc
Q 013126 208 NSRDG----KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------LQML 271 (449)
Q Consensus 208 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-----------~~~~ 271 (449)
...+. +....|..|.|||.+.+.+ |+.+.|+||+|||+.||+++++.|++...-.-.+.+ +..+
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 87765 3456799999999999865 999999999999999999999988765322211111 1111
Q ss_pred cc--------------cccCCCCCch-hHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 272 TD--------------SCLEGQFTDD-DGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 272 ~~--------------~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.. ..++..+... +++...+|+..+|.+||.+|.||.+.++ +.+..+
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e 366 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRE 366 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--cccccc
Confidence 10 0111111111 4578899999999999999999999998 455544
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=345.19 Aligned_cols=261 Identities=17% Similarity=0.234 Sum_probs=212.7
Q ss_pred CCCccccCHHHHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCC
Q 013126 41 LPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNR 117 (449)
Q Consensus 41 ~p~~~~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~Hpn 117 (449)
+.+.+.++.+++...+ . ..+|+|++|.||+|.+ +|+.||||.++...... .+.+.+|+.++++++|||
T Consensus 9 ~~~~~~i~~~~i~~~~-----~---~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 79 (283)
T PHA02988 9 INDIKCIESDDIDKYT-----S---VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNN 79 (283)
T ss_pred cCcceecCHHHcCCCC-----C---eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCC
Confidence 4455666676663211 1 2469999999999998 68899999998654333 467889999999999999
Q ss_pred cccceeeEee----CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceee
Q 013126 118 LTNLLGCCCE----GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILF 192 (449)
Q Consensus 118 Iv~l~~~~~~----~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl 192 (449)
|++++|++.+ ....++||||++||+|.+++. ....+++.....++.|++.||.|||+. + ++||||||+||++
T Consensus 80 Iv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~Hrdlkp~nill 156 (283)
T PHA02988 80 ILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTN-KPYKNLTSVSFLV 156 (283)
T ss_pred EEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh--hCCCCChhHHHHHHHHHHHHHHHHHhcCC-CCCCcCChhhEEE
Confidence 9999999877 356899999999999999997 456789999999999999999999985 6 8999999999999
Q ss_pred CCCCCeEEeccCCcccCCCC-CccccCccccccccccC--CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc
Q 013126 193 DEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ 269 (449)
Q Consensus 193 ~~~~~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 269 (449)
++++.+||+|||+++..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.......+......
T Consensus 157 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~ 236 (283)
T PHA02988 157 TENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN 236 (283)
T ss_pred CCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 99999999999998865443 23457899999999976 6799999999999999999999999976544433332211
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
.. .....+...++++.+++.+||+.||++|||++++++.|+.++
T Consensus 237 ~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 237 KN----NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cC----CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11 112234456789999999999999999999999999998765
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=341.71 Aligned_cols=246 Identities=20% Similarity=0.290 Sum_probs=200.6
Q ss_pred cccccccCCccceEEEEEEE-cCCCEEEEEEecC--CCCCCHHHHHHHHHHHhccCCCCcccceeeEee-----CCeeEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE-----GDERLL 133 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~~~~~l 133 (449)
|..++.||+|+||.|..+.+ .+|+.||||++.. ......++..+|+++|+.++|+||+.+++++.. -+.+|+
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 44478899999999999995 4599999999974 334457889999999999999999999999876 246899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
|+|+|+ .+|...++ .++.++.+.+..+++|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|+.....
T Consensus 104 V~elMe-tDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAn-ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 104 VFELME-TDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSAN-VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred ehhHHh-hHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhccc-ccccccchhheeeccCCCEEeccccceeeccccC
Confidence 999995 89999996 5556999999999999999999999999 999999999999999999999999999987431
Q ss_pred -----CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-------------------HHhhcc
Q 013126 213 -----KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-------------------LIRDRN 267 (449)
Q Consensus 213 -----~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-------------------~~~~~~ 267 (449)
+.+..|..|.|||.+.. ..||.+.||||+|||+.||++|++.|++...- .+....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 45677999999999865 45999999999999999999999988764111 111111
Q ss_pred ccccccc------ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 268 LQMLTDS------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 268 ~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....... .+....-++.++.+.+|+.+||..||.+|+|++|+++
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111110 0001122366789999999999999999999999998
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=359.27 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=212.0
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.+++..+..+||+|.||+||+|+|.+ .||||+++...... .+.|.+|+.++++-+|.||+-+.|++..+.. .||+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 34556778899999999999999865 59999998766544 5789999999999999999999999998877 9999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
-+|+|.+|+.+++. ....+...+.+.|++||++|+.|||.++ |||||||..||++.++++|||+|||++......
T Consensus 467 qwCeGsSLY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK~-IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAKN-IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hhccCchhhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhhh-hhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999999999976 3467888999999999999999999999 999999999999999999999999998653322
Q ss_pred ---CccccCccccccccccCC---CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTG---RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
....|...|||||+++.+ +|+..+||||||+++|||+||..|+.....+.+.-..-+....+ .......+++.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p-d~s~~~s~~pk 623 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP-DLSKIRSNCPK 623 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc-cchhhhccCHH
Confidence 234567889999999754 59999999999999999999999987544333322221111111 11223456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++.+|+..||.+++++||.+.+++..|+.+.+.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 999999999999999999999999988887653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=354.09 Aligned_cols=245 Identities=17% Similarity=0.191 Sum_probs=207.8
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
+++|++++.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467889999999999999999965 48999999997532 22346789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-C
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-K 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~ 213 (449)
|||++||+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 97 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 97 LEFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSKD-IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred EcCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999999999997 4567899999999999999999999999 999999999999999999999999999876543 3
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ...+...+..+.+++.
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR------LKFPNWFDGRARDLVK 247 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------cCCCCCCCHHHHHHHH
Confidence 4568999999999998889999999999999999999999987654333322221111 1223446678999999
Q ss_pred HhcccCCCCCCC-----HHHHHHH
Q 013126 294 RCLQYEPRERPN-----PKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps-----~~eil~~ 312 (449)
+||+.||.+||+ +++++.+
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999986 6777763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=346.14 Aligned_cols=247 Identities=16% Similarity=0.228 Sum_probs=203.8
Q ss_pred cccccccCCccceEEEEEEE-cCCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
|++++.||+|+||+||+|.. .+++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 45677889999999999995 4699999999865332 2234688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---Cc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KS 214 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~ 214 (449)
+++|+|.+++.......+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++...... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER-IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99999998886544557899999999999999999999999 999999999999999999999999999875433 23
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.................. ....++...++++.+++.+
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHHHHHH
Confidence 46899999999999889999999999999999999999998754322111111111111 1123445677899999999
Q ss_pred hcccCCCCCCC-----HHHHHH
Q 013126 295 CLQYEPRERPN-----PKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps-----~~eil~ 311 (449)
||+.||++||+ ++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhc
Confidence 99999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=321.23 Aligned_cols=256 Identities=21% Similarity=0.266 Sum_probs=220.6
Q ss_pred CCCCCccccCHHHHHHhhCCCcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCC---CCHHHHHHHHHHHhccC
Q 013126 39 DGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLR 114 (449)
Q Consensus 39 ~~~p~~~~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~ 114 (449)
.+.+..+.+++++ +++.+.||+|-||.||+|+ .+++..||+|++.+... .-..++.+|+++-+.|+
T Consensus 11 ~~~~~~~~~~l~d----------feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~ 80 (281)
T KOG0580|consen 11 FGSRATKTWTLDD----------FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR 80 (281)
T ss_pred cccccccccchhh----------ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC
Confidence 3444456666655 5566778999999999999 55688999999976432 22567999999999999
Q ss_pred CCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC
Q 013126 115 NNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (449)
Q Consensus 115 HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~ 194 (449)
||||+++|++|.+...+||++||.++|+|...+.+.....+++..+..+++|++.||.|+|.++ |+||||||+|+|++.
T Consensus 81 hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~-VIhRdiKpenlLlg~ 159 (281)
T KOG0580|consen 81 HPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR-VIHRDIKPENLLLGS 159 (281)
T ss_pred CccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC-cccCCCCHHHhccCC
Confidence 9999999999999999999999999999999998767788999999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCCcccCCCC--CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc
Q 013126 195 DGNPRLSTFGLMKNSRDG--KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272 (449)
Q Consensus 195 ~~~~kL~DFGla~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 272 (449)
.+.+|++|||.+.....+ .+.+||..|.|||...+..++..+|+|++|++.||++.|.+||.....+....++...
T Consensus 160 ~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-- 237 (281)
T KOG0580|consen 160 AGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-- 237 (281)
T ss_pred CCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--
Confidence 999999999998765433 4678999999999999999999999999999999999999999877654444433221
Q ss_pred ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.-.++..++.++.++|.+|+.++|.+|.+..++++
T Consensus 238 ----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 ----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 12345678889999999999999999999999988
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=341.51 Aligned_cols=245 Identities=17% Similarity=0.238 Sum_probs=215.1
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHH---HHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPR---QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~---~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
-+|++.+.||+|.||.|-+|.. ..|+.||||.++++...+.+ .+.+|+++|..|+||||+.+|.+|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4588999999999999999994 56999999999987766644 5789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||..+|.|+|++. ..+.+++.+++.+++||.+|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+.+.
T Consensus 133 EYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr-VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR-VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc-ceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 9999999999998 6788999999999999999999999998 999999999999999999999999999887766
Q ss_pred CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
.+++|++.|.+||++.|.+| ++.+|.|||||+||.|+.|..||.+.....+-.++..... . .+.-+..+.-|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY----r---EP~~PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY----R---EPETPSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc----c---CCCCCchHHHH
Confidence 46889999999999999887 5689999999999999999999998765544433322211 1 12334568899
Q ss_pred HHHhcccCCCCCCCHHHHHHHhc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~ 314 (449)
|+.||..||++|.|..+|..+-+
T Consensus 283 IRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhhe
Confidence 99999999999999999987643
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=348.92 Aligned_cols=243 Identities=18% Similarity=0.186 Sum_probs=206.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||+||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778899999999999999965 589999999965321 224568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-Ccc
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~ 215 (449)
|+++++|.+++. ..+.+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++..... ...
T Consensus 82 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 82 YVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 999999999997 4567899999999999999999999999 999999999999999999999999999865543 345
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (449)
.||+.|+|||++.+..++.++||||||+++|+|++|+.||................ ..++...+..+.+++.+|
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK------LEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------cCCCccCCHHHHHHHHHH
Confidence 68999999999998889999999999999999999999987654433333222111 123445567899999999
Q ss_pred cccCCCCCCC-----HHHHHHH
Q 013126 296 LQYEPRERPN-----PKSLVTA 312 (449)
Q Consensus 296 l~~dP~~Rps-----~~eil~~ 312 (449)
|+.||.+||+ +++++++
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcC
Confidence 9999999995 8888864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=351.64 Aligned_cols=236 Identities=20% Similarity=0.249 Sum_probs=201.4
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
.||+|+||.||+++.. +|+.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||++|++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 5799999999999964 589999999975321 224568899999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----CccccC
Q 013126 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTN 218 (449)
Q Consensus 143 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~gt 218 (449)
|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....||
T Consensus 82 L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~-ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 82 LFFHLS--RERVFSEDRARFYGAEIVSALGYLHSCD-VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 999987 4567899999999999999999999999 999999999999999999999999998753222 235689
Q ss_pred ccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhccc
Q 013126 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (449)
Q Consensus 219 ~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (449)
+.|+|||++.+..++.++||||+||++|||++|+.||............... ...++...++++.+++.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999888999999999999999999999998765544433322211 1123456778899999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 013126 299 EPRERP-----NPKSLVT 311 (449)
Q Consensus 299 dP~~Rp-----s~~eil~ 311 (449)
||++|| ++.++++
T Consensus 233 dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 233 DPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHcCCCCCCCHHHHHc
Confidence 999999 7999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.22 Aligned_cols=248 Identities=19% Similarity=0.311 Sum_probs=213.5
Q ss_pred hCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 56 TSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 56 ~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.-.|+...-++.||+|+.|-||+|+++ ++.||||+++.-. ..+|+-|++|+||||+.+.|+|....-+||||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 345666666788999999999999984 6899999986432 46788999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
|||..|-|...|+ .+++++......|..+||.|+.|||.+. |||||||.-||||+.+..+||+|||.++...+.
T Consensus 192 EfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hK-IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 192 EFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHK-IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK 268 (904)
T ss_pred eccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhh-HhhhccCCCceEeeccceEEeccccchHhhhhhhhh
Confidence 9999999999998 6788999999999999999999999998 999999999999999999999999999876544
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
..+.||..|||||++++.+.++|+||||||||||||+||..|+.+-... .++-.+-...+....+..+++.+.-|+
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLL 344 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHH
Confidence 3578999999999999999999999999999999999999887654222 222233333334455678889999999
Q ss_pred HHhcccCCCCCCCHHHHHHHhccccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
++||+..|..||++++++.+|+-..+
T Consensus 345 Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred HHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 99999999999999999999876544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=349.23 Aligned_cols=243 Identities=19% Similarity=0.292 Sum_probs=207.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.|+.+..||+|+||.||+|.+. +++.||+|++......+ .++..+|+.+|.+++++||.++|+.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 3556678899999999999954 59999999998755444 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
.||++.+.+. ....+.+....-++++++.||.|+|+++ .+|||||+.|||+..+|.+||+|||.+...... .+
T Consensus 94 ~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~-kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 94 GGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK-KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred cCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc-eecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 9999999996 4455588888899999999999999999 999999999999999999999999998765443 56
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
+.||+.|||||++.+..|+.|+||||||++.+||++|.+|+...-. .+.+..++.. .++.+....++.+++++..
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----mrvlflIpk~-~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----MRVLFLIPKS-APPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----ceEEEeccCC-CCCccccccCHHHHHHHHH
Confidence 7899999999999988899999999999999999999988754321 1222222222 2233444778899999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||++||+.||+|.++++
T Consensus 246 CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLK 262 (467)
T ss_pred HhhcCcccCcCHHHHhh
Confidence 99999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=343.72 Aligned_cols=252 Identities=18% Similarity=0.193 Sum_probs=209.0
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--------------CHHHHHHHHHHHhccCCCCcccce
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--------------DPRQFLEEARSVGQLRNNRLTNLL 122 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--------------~~~~~~~E~~~l~~l~HpnIv~l~ 122 (449)
..+.|++++.||+|.||.|-+|+.. +++.||||++.+.... ..+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3567899999999999999999954 5999999999753211 135789999999999999999999
Q ss_pred eeEeeC--CeeEEEEeeCCCCCHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeE
Q 013126 123 GCCCEG--DERLLVAEYMPNETLAKHLFHWETHP-MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (449)
Q Consensus 123 ~~~~~~--~~~~lV~Ey~~ggsL~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~k 199 (449)
.+..+. +.+|||+|||..|.+...= ...+ +++.+++++++++..||.|||.+| ||||||||+|+|++++|++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg-iiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG-IIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC-eeccccchhheEEcCCCcEE
Confidence 998765 5799999999988775432 4455 999999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCC---------CccccCccccccccccCCC----CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhc
Q 013126 200 LSTFGLMKNSRDG---------KSYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR 266 (449)
Q Consensus 200 L~DFGla~~~~~~---------~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 266 (449)
|+|||.+.....+ ....|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.+.....+.++
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998755222 2357999999999998733 35689999999999999999999998877666665
Q ss_pred ccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
+...... ....+++.+.+++||.++|.+||++|.+..+|..+.+-..
T Consensus 331 Ivn~pL~----fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 331 IVNDPLE----FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HhcCccc----CCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 5443222 1222356789999999999999999999999988665443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=348.88 Aligned_cols=251 Identities=20% Similarity=0.230 Sum_probs=204.9
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|++++.||+|+||.||+++.. ++..+|+|.+...... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 56889999999999999999965 5889999999764322 245799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--Ccc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSY 215 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~~~ 215 (449)
++|++|.+++. ....+++..+..++.|++.||.|||+++.|+||||||+||++++++.+||+|||++...... ...
T Consensus 85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 85 MDGGSLDQVLK--EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 99999999997 44578999999999999999999998633999999999999999999999999998765432 345
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc------------------------
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML------------------------ 271 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------------------------ 271 (449)
.||+.|+|||++.+..++.++||||||+++|||++|+.||.......+........
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 242 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence 68999999999998889999999999999999999999986433222211000000
Q ss_pred ------------------cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 272 ------------------TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 272 ------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.............++++.+++.+||++||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000001112356789999999999999999999999984
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=351.41 Aligned_cols=246 Identities=17% Similarity=0.209 Sum_probs=207.9
Q ss_pred CCcccccccccCCccceEEEEEEEcC--CCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN--QRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~--~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
.+++|++++.||+|+||.||+|.+++ +..||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 44568899999999999999998543 3689999986432 223567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||++||+|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 108 lv~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQSLN-IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999997 4567999999999999999999999999 999999999999999999999999999865443
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....||+.|+|||++.+..++.++|||||||++|||++|+.||................ ...+...++.+.++
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~l 258 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI------IYFPKFLDNNCKHL 258 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC------CCCCCCCCHHHHHH
Confidence 34568999999999998889999999999999999999999997654433332222211 12344566789999
Q ss_pred HHHhcccCCCCCC-----CHHHHHHH
Q 013126 292 ASRCLQYEPRERP-----NPKSLVTA 312 (449)
Q Consensus 292 i~~cl~~dP~~Rp-----s~~eil~~ 312 (449)
+.+||+.||++|+ ++++++++
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 9999999999995 88888874
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.96 Aligned_cols=249 Identities=17% Similarity=0.175 Sum_probs=207.2
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||.||+|++. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788999999999999999965 48999999997532 1234578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-Ccc
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~ 215 (449)
|++|++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++..... ...
T Consensus 82 ~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 82 YVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELG-YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 999999999996 4567899999999999999999999999 999999999999999999999999999865442 345
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc--cccccccCCCCCchhHHHHHHHHH
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ--MLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
.||+.|+|||++.+..++.++|||||||++|||++|..||.............. ...............+.++.+++.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 689999999999988999999999999999999999999876544332221111 101100001111245788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~ 312 (449)
+||..+|++||++++++++
T Consensus 239 ~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 239 KLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHhhChhhhcCCHHHHHhC
Confidence 9999999999999999984
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=350.24 Aligned_cols=247 Identities=18% Similarity=0.203 Sum_probs=221.9
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCe-eEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE-RLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~ 135 (449)
+.|..++++|+|+||.+++.+.+ +++.+++|.+....... .+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999999954 48899999998655444 4468899999999999999999999999888 99999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
+||+||+|.+.|.+.++..++++.+..|+.|++.|+.|||+++ |+|||||++||++++++.+||+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~-iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR-VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh-hhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999999999999877788999999999999999999999887 999999999999999999999999999987765
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
.+..||+.||.||.+.+.+|+.|+|||||||++|||++-+++|.......+..++...... ..+...+.++..+
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~-----Plp~~ys~el~~l 237 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS-----PLPSMYSSELRSL 237 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-----CCCccccHHHHHH
Confidence 3578999999999999999999999999999999999999999988877777776666533 3455677899999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~ 312 (449)
+..||+.+|..||++.+++..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=345.68 Aligned_cols=235 Identities=20% Similarity=0.231 Sum_probs=198.9
Q ss_pred cCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
||+|+||+||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++.+++..++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 599999999999965 48899999997532 22346788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----CccccCc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTNL 219 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~gt~ 219 (449)
.+++. ..+.+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ....||+
T Consensus 81 ~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQ--REGRFDLSRARFYTAELLCALENLHKFN-VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99997 4567999999999999999999999999 999999999999999999999999998753322 2346899
Q ss_pred cccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccC
Q 013126 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (449)
Q Consensus 220 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (449)
.|+|||++.+..++.++||||+||++|+|++|+.||............... ....+...++++.+++.+||+.|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE------PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC------CCCCCCcCCHHHHHHHHHHcCCC
Confidence 999999999888999999999999999999999998765544433322221 12334567788999999999999
Q ss_pred CCCCCC---HHHHHH
Q 013126 300 PRERPN---PKSLVT 311 (449)
Q Consensus 300 P~~Rps---~~eil~ 311 (449)
|++||+ +.+++.
T Consensus 232 p~~R~~~~~~~e~l~ 246 (312)
T cd05585 232 PTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHcCCCCCHHHHHc
Confidence 999985 566665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=326.56 Aligned_cols=246 Identities=21% Similarity=0.239 Sum_probs=214.4
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|.+-+.||+|+|+.||++.. .+|+.+|+|+++... ..+.+++.+|+++-+.|+||||+++.+.+.+....|+|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 466777889999999999984 469999999986432 33578899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---CCCeEEeccCCcccCCCCC-
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~- 213 (449)
++|++|..-|. .+-.+++..+-..++||+.+|.|+|.++ |+|||+||+|+++.+ .--+||+|||+|....++.
T Consensus 92 m~G~dl~~eIV--~R~~ySEa~aSH~~rQiLeal~yCH~n~-IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 92 VTGGELFEDIV--AREFYSEADASHCIQQILEALAYCHSNG-IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred ccchHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHhcC-ceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99999987776 3356788899999999999999999999 999999999999963 3449999999999887553
Q ss_pred --ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 214 --SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 214 --~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
...|||.|||||++...+|+..+|||+-|||||-|+.|.+||.++....+.+++.....+- .+...+.+++++++|
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~--~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY--PSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC--CCcccCcCCHHHHHH
Confidence 4578999999999999999999999999999999999999999977777777666654443 233466788999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+++||..||.+|.|+.|+++
T Consensus 247 vrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHhccChhhhccHHHHhC
Confidence 99999999999999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=354.46 Aligned_cols=241 Identities=20% Similarity=0.307 Sum_probs=211.6
Q ss_pred hCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCe
Q 013126 56 TSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 56 ~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 130 (449)
.-+..++++++.||+|.||+|+++..+ +++.+|||.++++.. .+.+..+.|.+++... +||.+++++..|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345667889999999999999999965 488999999998653 3366788899988888 59999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
+|+||||+.||++..+. ..+.+++..++.++..|+.||+|||++| |||||||.+|||+|.+|.+||+|||+++...
T Consensus 444 l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~-IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG-IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC-ceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999955444 5678999999999999999999999999 9999999999999999999999999998644
Q ss_pred ----CCCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 211 ----DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 211 ----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...+.+|||.|||||++.+..|+.++|.|||||+||||+.|..||+++..+.+-+.+... ...+|..++.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------~~~yP~~ls~ 593 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSK 593 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------CCCCCCcccH
Confidence 235678999999999999999999999999999999999999999988877777655543 2245677889
Q ss_pred HHHHHHHHhcccCCCCCCCH
Q 013126 287 ELVRLASRCLQYEPRERPNP 306 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~ 306 (449)
+..++++++|.+||++|.-+
T Consensus 594 ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHhccCcccccCC
Confidence 99999999999999999744
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=345.79 Aligned_cols=237 Identities=19% Similarity=0.245 Sum_probs=201.2
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
.||+|+||.||++... +++.||+|+++... ......+.+|+++++.++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5799999999999964 58999999997542 2234578899999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----CccccC
Q 013126 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTN 218 (449)
Q Consensus 143 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~gt 218 (449)
|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ....||
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 82 LFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSGK-IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 999886 4567999999999999999999999999 999999999999999999999999998753221 234689
Q ss_pred ccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhccc
Q 013126 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (449)
Q Consensus 219 ~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (449)
+.|+|||++.+..++.++|||||||++|+|++|+.||............... ...++...++++.+++.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------DIKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC------CccCCCCCCHHHHHHHHHHcCC
Confidence 9999999999888999999999999999999999998765444333222211 1123456778899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 013126 299 EPRERP-----NPKSLVTA 312 (449)
Q Consensus 299 dP~~Rp-----s~~eil~~ 312 (449)
||++|+ ++.+++++
T Consensus 233 dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 999997 88998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=368.35 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=214.7
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
++.+.+++||+|+||+||+|+.. +...||||.++..... ..++|.+|+++++.++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34567789999999999999943 2467999999987765 4678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC--------C----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEE
Q 013126 133 LVAEYMPNETLAKHLFHWE--------T----HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~--------~----~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL 200 (449)
+|+|||..|+|.++|+... . .+++..+.+.|+.|||.|+.||-++. .|||||-..|.||.++..|||
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-FVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-ccccchhhhhceeccceEEEe
Confidence 9999999999999998532 2 23888999999999999999999997 999999999999999999999
Q ss_pred eccCCcccCCCCCcc------ccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccc
Q 013126 201 STFGLMKNSRDGKSY------STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTD 273 (449)
Q Consensus 201 ~DFGla~~~~~~~~~------~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 273 (449)
+|||+++..-...-+ .-..+|||||.+..+++|.+||||||||+|||++| |+.|+.+-+.+..-+... .
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~----~ 720 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR----A 720 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH----c
Confidence 999999875544322 22478999999999999999999999999999998 666765543333222211 1
Q ss_pred cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
... -..++++|.++++|+..||+.+|.+||+++||-..|+.+....+
T Consensus 721 g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 721 GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 111 24467889999999999999999999999999999988865543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=338.37 Aligned_cols=248 Identities=18% Similarity=0.235 Sum_probs=200.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+|++++.||+|+||+||+|++. +++.||+|+++.... ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5788899999999999999975 488999999975432 2246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----- 212 (449)
++++++..+.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99877765543 3467899999999999999999999999 999999999999999999999999999865432
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc---c-----------------cccc
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---L-----------------QMLT 272 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~---~-----------------~~~~ 272 (449)
....+++.|+|||++.+..++.++||||+||++|||++|+.||............ . ....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 2345789999999999888999999999999999999999988754221110000 0 0000
Q ss_pred ccccC------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 DSCLE------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+... .......+.++.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0111235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=331.49 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=211.0
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.++|+++++||+|++|.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+..++..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45788999999999999999998778899999987543 23578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----- 213 (449)
++++|.+++.......+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||+++......
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 9999999997545567889999999999999999999998 9999999999999999999999999998654432
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...++..|+|||++.+..++.++||||||+++|+|+| |+.|+................. .......+.++.+++
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li 237 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-----MPRMENCPDELYDIM 237 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----CCCCCCCCHHHHHHH
Confidence 2234567999999988889999999999999999998 8888765433333222221111 112234667899999
Q ss_pred HHhcccCCCCCCCHHHHHHHhccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.+||+.+|++||+++++.+.|+++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=333.96 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=206.5
Q ss_pred CcccccccccCCccceEEEEEEEc----CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
...|++.+.||+|+||.||+|.+. .+..||+|.++...... ...+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 346788899999999999999853 36789999998653222 4578999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.++++|||.+.......
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~~-iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 84 VTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMG-YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999874 3457899999999999999999999999 9999999999999999999999999876543221
Q ss_pred -----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 214 -----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 214 -----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...++..|+|||++.+..++.++||||||+++||+++ |..||................ ....+...+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 236 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-----RLPAPRNCPNL 236 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-----CCCCCCCCCHH
Confidence 1234578999999998899999999999999999775 988886554333222211111 11224456788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
+.+++.+||+.+|++||+++++.+.|+++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=339.38 Aligned_cols=251 Identities=19% Similarity=0.271 Sum_probs=201.5
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
..++|+++++||+|+||+||+|... +++.||+|.++..... ....+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3567899999999999999999965 5899999999754322 3457889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLD-SDLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKRK-ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCC-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9998 599998864 3446789999999999999999999999 999999999999999999999999998764322
Q ss_pred -CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc-----------c--------
Q 013126 213 -KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM-----------L-------- 271 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-----------~-------- 271 (449)
....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||............... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 23457899999999876 45899999999999999999999998654332211111000 0
Q ss_pred -cccccC----CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 272 -TDSCLE----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 272 -~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..+... ....+..+.++.+++.+||+.||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 0011235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=339.76 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=200.1
Q ss_pred cccccccccCCccceEEEEEEEcC-----------------CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccc
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-----------------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNL 121 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-----------------~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l 121 (449)
.+|++.++||+|+||.||+|.+++ +..||+|.+....... ..+|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999998532 3469999997643222 4579999999999999999999
Q ss_pred eeeEeeCCeeEEEEeeCCCCCHHHHHhccC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccc
Q 013126 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWE-----------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHD 184 (449)
Q Consensus 122 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrD 184 (449)
++++.+.+..++||||+++++|.+++.... ...+++...+.++.||+.||+|||+++ ++|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-ivH~d 163 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-FVHRD 163 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-ccccC
Confidence 999999999999999999999999986421 124678889999999999999999999 99999
Q ss_pred cccCceeeCCCCCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcC--CCCCC
Q 013126 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG--KHIPP 256 (449)
Q Consensus 185 lkp~NILl~~~~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg--~~p~~ 256 (449)
|||+|||+++++.+||+|||+++...... ...++..|+|||++.++.++.++||||||+++|||+++ ..|+.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999997654322 22346789999999888899999999999999999874 45554
Q ss_pred chhhHHHhhcccccccc--cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 257 SHALDLIRDRNLQMLTD--SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 257 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
................. .......++..+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 33222211111000000 00011123456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=344.79 Aligned_cols=237 Identities=19% Similarity=0.246 Sum_probs=200.0
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
.||+|+||.||+++.. +|+.||+|.++... ......+.+|+++++.++||||+++++.+...+..++||||++||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 5799999999999954 58999999997532 1234567889999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----CccccC
Q 013126 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTN 218 (449)
Q Consensus 143 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~gt 218 (449)
|..++. ....+++..++.++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++..... ....||
T Consensus 82 L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 82 LFFHLS--RERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 999886 4567899999999999999999999999 999999999999999999999999998753221 235689
Q ss_pred ccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhccc
Q 013126 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (449)
Q Consensus 219 ~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (449)
+.|+|||++.+..++.++|||||||++|||++|+.||................ ..++...++++.+++.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~------~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------IRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------CCCCCCCCHHHHHHHHHHccC
Confidence 99999999998899999999999999999999999987654433332221111 123456678899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 013126 299 EPRERP-----NPKSLVTA 312 (449)
Q Consensus 299 dP~~Rp-----s~~eil~~ 312 (449)
||++|| ++.+++++
T Consensus 233 dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHhCCCCCCCHHHHHcC
Confidence 999998 88888863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=328.47 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=205.2
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.+++++++.||+|+||.||++.++++..+|+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 35678889999999999999998777899999986443 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----- 213 (449)
+||+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||.++......
T Consensus 82 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 82 ENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERNS-FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999864 2346899999999999999999999999 9999999999999999999999999987653322
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...++..|+|||++.+..++.++||||||+++|+|++ |+.|+................. ...+...+.++.+++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~~~li 234 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-----LYRPKLASMTVYEVM 234 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-----CCCCCCCCHHHHHHH
Confidence 1234567999999988889999999999999999999 8888765443333222221111 111233456899999
Q ss_pred HHhcccCCCCCCCHHHHHHHh
Q 013126 293 SRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L 313 (449)
.+||+.||++||+++++++.|
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=346.81 Aligned_cols=246 Identities=21% Similarity=0.229 Sum_probs=205.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||+||+|... +++.||+|+++... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5788899999999999999965 58999999997532 1335678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--- 213 (449)
|++|++|.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g-iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKLG-FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999973 468999999999999999999999999 9999999999999999999999999987644322
Q ss_pred ------------------------------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHH
Q 013126 214 ------------------------------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI 263 (449)
Q Consensus 214 ------------------------------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~ 263 (449)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 34588999999999999999999999999999999999999876543333
Q ss_pred hhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 013126 264 RDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN-PKSLVTA 312 (449)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~eil~~ 312 (449)
.......... .........++++.+++.+||. ||.+||+ +++++++
T Consensus 239 ~~~i~~~~~~--~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWKES--LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccCCc--ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2222210000 0111122357889999999997 9999999 9999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=349.93 Aligned_cols=247 Identities=18% Similarity=0.164 Sum_probs=199.9
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.|++++.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4778899999999999999954 589999999975332 224568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~----- 211 (449)
|++||+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~g-ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKMG-FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999997 4567899999999999999999999999 99999999999999999999999998753210
Q ss_pred ----------------------------------------------CCccccCccccccccccCCCCCCCCceeeHhHHH
Q 013126 212 ----------------------------------------------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLL 245 (449)
Q Consensus 212 ----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil 245 (449)
.....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0124589999999999988899999999999999
Q ss_pred HHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHh--cccCCCCCCCHHHHHHH
Q 013126 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC--LQYEPRERPNPKSLVTA 312 (449)
Q Consensus 246 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~dP~~Rps~~eil~~ 312 (449)
|||++|..||.................. .........++++.+++.++ +..+|..||++.+++.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENT--LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccc--cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999998765433222211110000 01111224567899999984 45566669999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.36 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=208.0
Q ss_pred CcccccccccCCccceEEEEEEEcC-C-----CEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN-Q-----RRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~-~-----~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
+.++++++.||+|+||.||+|...+ + ..||+|.++...... .+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3467889999999999999998543 2 579999987543222 45689999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWET--------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~ 197 (449)
+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccccceEEEcCCCc
Confidence 999999999999999974321 46788999999999999999999999 999999999999999999
Q ss_pred eEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccccc
Q 013126 198 PRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (449)
Q Consensus 198 ~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (449)
++|+|||+++..... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||.......+.......
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998764322 12345678999999988889999999999999999998 98888765443333222111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
. ....+...+.++.+++.+||+.||++||++++++++|+.+
T Consensus 243 ~-----~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 243 Q-----LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred C-----cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 1123456778999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=351.33 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=203.4
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhcc-CCCCcccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 131 (449)
++|++.+.||+|+||.||+|.+. ++..||+|.++.....+ .+.+.+|+++++.+ +||||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 35778899999999999999842 24579999997644332 45688999999999 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccC------------------------------------------------------------
Q 013126 132 LLVAEYMPNETLAKHLFHWE------------------------------------------------------------ 151 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~------------------------------------------------------------ 151 (449)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999986321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC------cccc
Q 013126 152 --------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------SYST 217 (449)
Q Consensus 152 --------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~------~~~g 217 (449)
..++++..+++++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++...... ...+
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN-CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 124788899999999999999999999 9999999999999999999999999987644322 1224
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (449)
++.|+|||++.+..++.++||||||+++|||++ |+.||............. ........+...++++.+++.+||
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----HcccCccCCCCCCHHHHHHHHHHc
Confidence 567999999988889999999999999999997 998886543221111111 111111223345688999999999
Q ss_pred ccCCCCCCCHHHHHHHhccc
Q 013126 297 QYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 297 ~~dP~~Rps~~eil~~L~~~ 316 (449)
+.||++|||+.++++.|+++
T Consensus 353 ~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 353 NLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCChhhCcCHHHHHHHHHHH
Confidence 99999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=349.37 Aligned_cols=246 Identities=16% Similarity=0.145 Sum_probs=201.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||+||+|+.. +++.||||+++... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 5778899999999999999965 58999999997532 1224567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++||+|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKLG-YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999997 4567999999999999999999999999 999999999999999999999999998643211
Q ss_pred --------------------------------------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCC
Q 013126 213 --------------------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254 (449)
Q Consensus 213 --------------------------------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p 254 (449)
....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 013589999999999988899999999999999999999999
Q ss_pred CCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 013126 255 PPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN---PKSLVTA 312 (449)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~eil~~ 312 (449)
|.................. .........++++.+++.+|+. +|.+|++ +++++++
T Consensus 239 f~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQETYRKIINWKET--LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHHHHHHHcCCCc--cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 8765433222221111000 0011112456789999999997 9999987 8888873
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.19 Aligned_cols=239 Identities=20% Similarity=0.275 Sum_probs=199.9
Q ss_pred ccccCCccceEEEEEEE----cCCCEEEEEEecCCC----CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 65 VSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMA----WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~----~~~~~vAiK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++.||+|+||.||+++. .+++.||+|.++... ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 35789999999999985 247899999997532 1224567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++|++|.+++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 999999999997 4567889999999999999999999999 999999999999999999999999998753322
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
....||+.|+|||++.+..++.++||||||+++|||++|+.||............... ....+...++++.+++
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li 231 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG------KLNLPPYLTPEARDLL 231 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHH
Confidence 2346899999999999888999999999999999999999998765433322222111 1123455678899999
Q ss_pred HHhcccCCCCCC-----CHHHHHHH
Q 013126 293 SRCLQYEPRERP-----NPKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rp-----s~~eil~~ 312 (449)
.+||+.||++|| ++++++++
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcC
Confidence 999999999999 78888773
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=341.82 Aligned_cols=247 Identities=20% Similarity=0.213 Sum_probs=215.1
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCC---CHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP---DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 134 (449)
..|++.+.||+|.||+||+++.+. |+.+|+|.+++.... +.+...+|+.+|++++ |||||.+++++++.+.+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 357788899999999999999655 999999999875543 3468999999999998 99999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC----CCCeEEeccCCcccCC
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE----DGNPRLSTFGLMKNSR 210 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~----~~~~kL~DFGla~~~~ 210 (449)
||++.||.|.+.+... .+++..+..+++|++.+++|||+.| |+||||||+|+|+.. ++.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g-vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG-VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999854 3999999999999999999999999 999999999999973 2579999999999877
Q ss_pred CC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 211 DG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 211 ~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
.. ....||+.|+|||++...+|+..+||||+|+++|.|++|.+||................. .......+..+..
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--DFTSEPWDDISES 268 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--CCCCCCccccCHH
Confidence 63 356799999999999989999999999999999999999999988765554443333222 2233456678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+.+++.+++..||..|+|+.+++++
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999999999999999999993
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=329.08 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=210.0
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.++.+.+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|+++++.++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778888999999999999965 48899999987543 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc----
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS---- 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~---- 214 (449)
++++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 9999999997545567899999999999999999999999 99999999999999999999999999876554321
Q ss_pred -cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 215 -YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 215 -~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...+..|+|||.+.+..++.++||||||+++|||++ |..|++.............. .....+...+.++.+++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li 238 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-----YRMERPEGCPPKVYELM 238 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----CCCCCCCCCCHHHHHHH
Confidence 223567999999988889999999999999999998 88887665443332222111 11233456678999999
Q ss_pred HHhcccCCCCCCCHHHHHHHhccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.+||+.||++|||+.++++.|+.+
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.26 Aligned_cols=250 Identities=20% Similarity=0.249 Sum_probs=202.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|+++++||+|+||.||++.+. ++..+|+|.++..... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 46888999999999999999965 4889999998764322 245789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--Ccc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSY 215 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~~~ 215 (449)
++|++|.+++. ..+.+++..+..++.|++.||.|||++++++||||||+|||+++++.+||+|||++...... ...
T Consensus 85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 85 MDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 99999999997 45678999999999999999999998533999999999999999999999999998754332 345
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc---c-----------------------
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL---Q----------------------- 269 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~---~----------------------- 269 (449)
.++..|+|||++.+..++.++|||||||++|+|++|+.|+............. .
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (333)
T cd06650 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242 (333)
T ss_pred CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence 68899999999998889999999999999999999999886543222111000 0
Q ss_pred --------------cccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 --------------MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 --------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+.............+.++.+++.+||++||++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000000000001124578999999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.73 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=212.4
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.+|++++.||.|+||.||+|...+++.+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 35788899999999999999987799999999987665556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----cc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----SY 215 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----~~ 215 (449)
+++|.+++.+.....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||.+....... ..
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~ 164 (261)
T cd05148 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK 164 (261)
T ss_pred cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccCcceEEEcCCceEEEccccchhhcCCccccccCC
Confidence 999999998655667899999999999999999999999 9999999999999999999999999987654332 22
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
.++..|+|||++.+..++.++||||||+++|+|++ |+.|+............... .....+...++.+.+++.+
T Consensus 165 ~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-----YRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred CCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-----CcCCCCCCCCHHHHHHHHH
Confidence 34578999999988889999999999999999998 78887654333222222111 1112244667889999999
Q ss_pred hcccCCCCCCCHHHHHHHhcc
Q 013126 295 CLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~L~~ 315 (449)
||+.||++|||++++++.|+.
T Consensus 240 ~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 240 CWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HcCCCchhCcCHHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=349.55 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=201.0
Q ss_pred ccccccccCCccceEEEEEEE------cCCCEEEEEEecCCCC-CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~------~~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
+|++.+.||+|+||+||+|++ +++..||+|+++.... ...+.+.+|+++++.+ +||||+++++++..++..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 577889999999999999973 2366899999975432 2346789999999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC-------------------------------------------------------------
Q 013126 133 LVAEYMPNETLAKHLFHWE------------------------------------------------------------- 151 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~------------------------------------------------------------- 151 (449)
+||||++||+|.+++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999999986421
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC------
Q 013126 152 ------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------ 213 (449)
Q Consensus 152 ------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~------ 213 (449)
...+++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++......
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 124788899999999999999999999 9999999999999999999999999987654332
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...++..|+|||++.+..++.++||||||+++|||++ |..|+............... ......+...+.++.+++
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYRMLSPECAPSEMYDIM 350 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----CccCCCCCCCCHHHHHHH
Confidence 1233567999999998899999999999999999998 77776543221111111110 001112234467899999
Q ss_pred HHhcccCCCCCCCHHHHHHHhcc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~ 315 (449)
.+||+.||++|||+.++++.|++
T Consensus 351 ~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHccCChhHCcCHHHHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.02 Aligned_cols=249 Identities=19% Similarity=0.234 Sum_probs=197.4
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|++++.||+|+||+||+|+.. +++.||+|+++..... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 56889999999999999999965 5899999999754322 245678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
++ ++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 85 VH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRY-ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred CC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 96 688888764 3467899999999999999999999999 999999999999999999999999998754322 2
Q ss_pred ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhh--HHHhhcc----------cc---c---cccc
Q 013126 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHAL--DLIRDRN----------LQ---M---LTDS 274 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~--~~~~~~~----------~~---~---~~~~ 274 (449)
...+|+.|+|||++.+. .++.++||||+||++|+|++|..||..... ..+.... .. . ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 34578999999998764 488899999999999999999999865311 1110000 00 0 0000
Q ss_pred ccCCCCC---------chhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 CLEGQFT---------DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 ~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
......+ ...+.++.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 112357889999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=348.58 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=214.5
Q ss_pred ccccccccCCccceEEEEEEEcC--C---CEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN--Q---RRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~--~---~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
+..+.++||+|+||.||+|++.. + ..||||..+... .....+|++|++++++++|||||++||+......++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34455899999999999999543 2 238999998533 223578999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+|||+|+||+|.++|+.. ...++..+...++.+.+.||+|||+++ ++||||-.+|+|++.++.+||+|||+++.....
T Consensus 238 ivmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k~-~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSKN-CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EEEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHCC-CcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 999999999999999852 336999999999999999999999999 999999999999999999999999998765422
Q ss_pred C----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 213 K----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 213 ~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
. ...-...|+|||.+..+.|+.++|||||||++||+.+ |..|+++.....+.......- .+...+...+.+
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~----~r~~~~~~~p~~ 391 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG----YRMPIPSKTPKE 391 (474)
T ss_pred eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC----ccCCCCCCCHHH
Confidence 1 1123578999999999999999999999999999999 778888776555554442211 122334567789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhcccccccCCC
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVP 323 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~ 323 (449)
+..++.+||..||++||+|.++.+.|+.+......+
T Consensus 392 ~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 392 LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred HHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 999999999999999999999999999988776654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=333.98 Aligned_cols=249 Identities=20% Similarity=0.250 Sum_probs=196.7
Q ss_pred ccccccccCCccceEEEEEEEc--CCCEEEEEEecCCCCC--CHHHHHHHHHHHhcc---CCCCcccceeeEee-----C
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE--NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQL---RNNRLTNLLGCCCE-----G 128 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~--~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-----~ 128 (449)
.|++++.||+|+||+||+|+.. +++.||+|.++..... ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5788899999999999999863 3688999998754322 234677788877766 69999999999853 4
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
...++||||++ ++|.+++.......+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~-iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 56899999997 69999987545567899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc--------------
Q 013126 209 SRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML-------------- 271 (449)
Q Consensus 209 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------------- 271 (449)
.... ....+|+.|+|||++.+..++.++|||||||++|||++|++||................
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 5433 23457899999999988889999999999999999999999886543221111110000
Q ss_pred ccccc-------CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 272 TDSCL-------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 272 ~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..... .....+..++.+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 00111345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=346.59 Aligned_cols=251 Identities=16% Similarity=0.154 Sum_probs=206.1
Q ss_pred hCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 56 TSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 56 ~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
.-+.++|++++.||+|+||.||+++.. +++.||+|.+++.. ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345667899999999999999999965 58999999996532 22345678999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||++||+|.+++. +..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~---~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999999985 346889999999999999999999999 99999999999999999999999999876543
Q ss_pred C-----CccccCccccccccccCC----CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCc
Q 013126 212 G-----KSYSTNLAFTPPEYLRTG----RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 212 ~-----~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||................... ......
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~ 272 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL--TFPDDI 272 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC--CCCCcC
Confidence 2 234689999999998653 37889999999999999999999997765433332222111111 001122
Q ss_pred hhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013126 283 DDGTELVRLASRCLQYEPRE--RPNPKSLVTA 312 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~--Rps~~eil~~ 312 (449)
..+.++.+++.+||+.+|++ |+++.+++++
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 46788999999999999988 9999999884
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=342.98 Aligned_cols=237 Identities=22% Similarity=0.261 Sum_probs=199.9
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
.||+|+||.||++... +++.||+|+++... ......+.+|+++++.++||||+++++++..++..++||||++||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5799999999999954 58999999997532 1224567889999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccccc
Q 013126 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (449)
Q Consensus 143 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~g 217 (449)
|.+++. ....+++..+..++.||+.||+|||+ ++ |+||||||+|||+++++.+||+|||+++..... ....|
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~~-ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 82 LFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCC-EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 999886 45679999999999999999999997 68 999999999999999999999999998753221 23468
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
|+.|+|||++.+..++.++|||||||++|+|++|+.||............... ...++...++++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHhh
Confidence 99999999999888999999999999999999999998765444333322211 112344567889999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 013126 298 YEPRERP-----NPKSLVTA 312 (449)
Q Consensus 298 ~dP~~Rp-----s~~eil~~ 312 (449)
.||++|+ ++.+++++
T Consensus 233 ~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcC
Confidence 9999996 89999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=326.64 Aligned_cols=252 Identities=20% Similarity=0.251 Sum_probs=202.8
Q ss_pred CcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCC-cccceeeEeeCC-----
Q 013126 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNR-LTNLLGCCCEGD----- 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~----- 129 (449)
...|..++++|+|+||+||+|+ ..+|+.||+|+++..... -.....+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4457778889999999999999 456999999999865442 3567899999999999999 999999999877
Q ss_pred -eeEEEEeeCCCCCHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 130 -ERLLVAEYMPNETLAKHLFHWET--HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 130 -~~~lV~Ey~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
..++|+||++ .+|..++..... ..++...++.+++||+.||+|||+++ |+||||||+|||++++|.+||+|||+|
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~-IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG-ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-eecccCCcceEEECCCCcEeeeccchH
Confidence 7899999997 899999975332 46778899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCC----CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-----------c
Q 013126 207 KNSRDG----KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-----------M 270 (449)
Q Consensus 207 ~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------~ 270 (449)
+...-. ....+|..|.|||++.+. .|+...||||+|||++||+++++.|++.........+.. .
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 866522 344678999999999987 599999999999999999999998876533221111111 1
Q ss_pred cc---ccc-cCCCC--C-------chhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 271 LT---DSC-LEGQF--T-------DDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 271 ~~---~~~-~~~~~--~-------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.. +.. ..... + +...++..+++.+||+.+|.+|.|++.++.+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 10 000 00000 1 1122578999999999999999999999984
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.42 Aligned_cols=241 Identities=20% Similarity=0.279 Sum_probs=199.1
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHH---hccCCCCcccceeeEeeCCeeEEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSV---GQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
|++++.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++ +.++||||+++++++..++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999964 58999999997532 12245566776655 567899999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||++|++|...+. ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENK-IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999998884 457999999999999999999999999 999999999999999999999999998753222
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||............... ....+...+..+.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~ 230 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSREAIS 230 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHH
Confidence 2356899999999999888999999999999999999999998765444333222111 11234456788999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHHH
Q 013126 291 LASRCLQYEPRERP-----NPKSLVTA 312 (449)
Q Consensus 291 li~~cl~~dP~~Rp-----s~~eil~~ 312 (449)
++.+||+.||++|| ++.+++++
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 99999999999999 56777663
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=346.12 Aligned_cols=246 Identities=16% Similarity=0.135 Sum_probs=199.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||+||++... +++.||||++.+.. ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 5778899999999999999954 58999999986532 1224568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++||+|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKLG-FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999997 4567899999999999999999999999 999999999999999999999999998532110
Q ss_pred -----------------------------------------------CccccCccccccccccCCCCCCCCceeeHhHHH
Q 013126 213 -----------------------------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLL 245 (449)
Q Consensus 213 -----------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil 245 (449)
....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 013588999999999988899999999999999
Q ss_pred HHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 013126 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER---PNPKSLVTA 312 (449)
Q Consensus 246 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~eil~~ 312 (449)
|||++|..||................ .. .........+.++.+++.+||. +|.+| +++.+++.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~-~~-~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWR-ET-LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccC-Cc-cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999986544332222111100 00 0000112356789999999998 67665 599999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.27 Aligned_cols=247 Identities=17% Similarity=0.194 Sum_probs=198.3
Q ss_pred CCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.++++++.++.||+|+||+||+|++. +++.||||++....... .+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 34667888899999999999999964 58999999996543222 46789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||+++++|.+. ...++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 151 ~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRH-IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999999998653 23567788899999999999999999 999999999999999999999999998765432
Q ss_pred --CccccCccccccccccC-----CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 213 --KSYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
....||..|+|||++.. ...+.++|||||||++|||++|+.||.......+...... .. .......+...+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~ 301 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA-IC-MSQPPEAPATAS 301 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-Hh-ccCCCCCCCccC
Confidence 34568999999998843 2245689999999999999999999863321111110000 00 001112344567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.++.+++.+||+.||++|||+.+++++
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 889999999999999999999999983
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.23 Aligned_cols=247 Identities=13% Similarity=0.110 Sum_probs=199.4
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||+||++... +++.||+|++++... .....+.+|+.++.+++||||+++++.+.+++..|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 5778899999999999999954 589999999975321 223568889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++||+|.+++. +.+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~g-ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQLG-FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999997 4568999999999999999999999999 999999999999999999999999998643211
Q ss_pred -----------------------------------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCc
Q 013126 213 -----------------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPS 257 (449)
Q Consensus 213 -----------------------------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~ 257 (449)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 124689999999999988999999999999999999999999976
Q ss_pred hhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 013126 258 HALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ--YEPRERPNPKSLVTA 312 (449)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rps~~eil~~ 312 (449)
...................+. ....++++.+++.+++. .++..||++++++++
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 544333322221100100111 12356788999998664 233356899999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=340.58 Aligned_cols=242 Identities=19% Similarity=0.254 Sum_probs=201.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCC-CcccceeeEeeCCeeEEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNN-RLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~ 135 (449)
+|++++.||+|+||.||+|+.. +++.||+|+++... ....+.+..|++++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4678899999999999999965 47899999997532 23356788999999999765 5888999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~---- 211 (449)
||++||+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999999999987 4567899999999999999999999999 99999999999999999999999999875321
Q ss_pred CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 212 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
.....||+.|+|||++.+..++.++||||+||++|+|++|+.||............... ...++...++++.++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~l 231 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------NVSYPKSLSKEAVSI 231 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHH
Confidence 12346899999999999988999999999999999999999998765443333222211 122345567889999
Q ss_pred HHHhcccCCCCCCCH-----HHHHH
Q 013126 292 ASRCLQYEPRERPNP-----KSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~-----~eil~ 311 (449)
+.+||+.||++|++. +++++
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 999999999999976 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.17 Aligned_cols=247 Identities=18% Similarity=0.176 Sum_probs=201.8
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+.|++++.||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|++++++++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 35889999999999999999954 58999999996532 123466889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~---- 211 (449)
||++||+|.+++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999997 4567899999999999999999999999 99999999999999999999999999742210
Q ss_pred -------------------------------------------CCccccCccccccccccCCCCCCCCceeeHhHHHHHH
Q 013126 212 -------------------------------------------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248 (449)
Q Consensus 212 -------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el 248 (449)
.....||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0123589999999999988899999999999999999
Q ss_pred hcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 013126 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP---NPKSLVTA 312 (449)
Q Consensus 249 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~eil~~ 312 (449)
++|+.||................. ..........++++.+++.+|+ .+|.+|+ ++.+++++
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWET--TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCc--cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999876543332222111100 0111112356778999999976 5999999 89999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=338.66 Aligned_cols=237 Identities=19% Similarity=0.248 Sum_probs=199.0
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++..++..|+||||++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5799999999999965 48899999997532 22345678899999876 7999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~g 217 (449)
+|.+.+. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++..... ....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 82 DLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRHG-VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 9999987 4567899999999999999999999999 999999999999999999999999998753322 23458
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
|+.|+|||++.+..++.++||||||+++|+|++|+.||................ ...+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD------VLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHHHHHHHhc
Confidence 999999999998889999999999999999999999997665444333322211 12234466789999999999
Q ss_pred cCCCCCC-------CHHHHHHH
Q 013126 298 YEPRERP-------NPKSLVTA 312 (449)
Q Consensus 298 ~dP~~Rp-------s~~eil~~ 312 (449)
.||++|| ++++++++
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcC
Confidence 9999999 78888864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=348.19 Aligned_cols=245 Identities=18% Similarity=0.180 Sum_probs=198.7
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.|++++.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4778899999999999999954 588999999975321 224568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----- 211 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~----- 211 (449)
|++||+|.+++. +.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~al~~lH~~~-ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLI--RMGIFPEDLARFYIAELTCAVESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999997 4467899999999999999999999999 99999999999999999999999999742210
Q ss_pred ----------------------------------------------CCccccCccccccccccCCCCCCCCceeeHhHHH
Q 013126 212 ----------------------------------------------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLL 245 (449)
Q Consensus 212 ----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil 245 (449)
.....||+.|+|||++.+..++.++||||+||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0123588999999999988999999999999999
Q ss_pred HHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 013126 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN---PKSLVT 311 (449)
Q Consensus 246 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~eil~ 311 (449)
|||++|+.||.................. .........++++.+++.+++ .+|++|++ +++++.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTS--LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCC--cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999765432222211111000 111112346778999999976 59999987 888776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.03 Aligned_cols=248 Identities=16% Similarity=0.215 Sum_probs=204.6
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
|++++.||+|+||+||++... +++.||+|.+...... ....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 567788899999999999964 5899999999753322 234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---c
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---S 214 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---~ 214 (449)
+++|+|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER-IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999886544567999999999999999999999999 9999999999999999999999999988754332 3
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..|++.|+|||++.+..++.++||||+|+++|+|++|+.||...............+.. .....+...+..+.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHHHHHHH
Confidence 46789999999999888999999999999999999999998764332221111111111 1122344567889999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 013126 295 CLQYEPRERP-----NPKSLVTA 312 (449)
Q Consensus 295 cl~~dP~~Rp-----s~~eil~~ 312 (449)
||+.||++|| ++++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999 88888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=330.28 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=206.4
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
..|.+++.||+|+||.||+|... +++.||+|.++..... ..+.+.+|+++++.++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45778889999999999999853 2478999999765443 3568999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEE
Q 013126 133 LVAEYMPNETLAKHLFHWE------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL 200 (449)
+||||++|++|.+++.... ...+++..+..++.|++.|++|||+++ ++||||||+||+++.++.+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-FVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-eeccccccceEEEcCCCeEEE
Confidence 9999999999999997432 245788999999999999999999999 999999999999999999999
Q ss_pred eccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccc
Q 013126 201 STFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTD 273 (449)
Q Consensus 201 ~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 273 (449)
+|||+++..... ....+++.|+|||++.+..++.++||||||+++|||++ |..|+.................
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~- 242 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL- 242 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc-
Confidence 999998754322 22334678999999999999999999999999999998 9988765443333222221111
Q ss_pred cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
...+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 243 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 243 ----LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=328.56 Aligned_cols=250 Identities=19% Similarity=0.189 Sum_probs=211.7
Q ss_pred CCCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
-+++.+++++.||.|.-|+||+++..+ +..+|+|++.+.... ...+...|-+||+.++||.++.+|+.++.+...|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 357788999999999999999999755 789999999875433 2456788999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC--
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-- 210 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~-- 210 (449)
++||||+||+|....++...+.+++..++.++.+|+-||+|||..| ||+|||||+|||+.++|++.|+||.++....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG-ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG-IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc-eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999998777888999999999999999999999999 9999999999999999999999998853100
Q ss_pred --------------------------------C-C-------------------------CccccCccccccccccCCCC
Q 013126 211 --------------------------------D-G-------------------------KSYSTNLAFTPPEYLRTGRV 232 (449)
Q Consensus 211 --------------------------------~-~-------------------------~~~~gt~~y~aPE~~~~~~~ 232 (449)
. . .+.+||-.|.|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 12357888999999999999
Q ss_pred CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCC----HHH
Q 013126 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN----PKS 308 (449)
Q Consensus 233 ~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~e 308 (449)
+.++|.|+|||.+|||+.|..||.+.........+...-.. -.-.+..+..+++||+++|.+||.+|.. |.|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~----Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK----FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc----CCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 99999999999999999999999887555444333332111 1112366789999999999999999987 788
Q ss_pred HHH
Q 013126 309 LVT 311 (449)
Q Consensus 309 il~ 311 (449)
|.+
T Consensus 389 IK~ 391 (459)
T KOG0610|consen 389 IKR 391 (459)
T ss_pred hhc
Confidence 875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=356.45 Aligned_cols=309 Identities=21% Similarity=0.264 Sum_probs=244.9
Q ss_pred ccCHHHHHHhhCCCcc------cccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCCC-HHHHHHHHHHHhccC
Q 013126 46 EFTLEQLKNATSGFAV------ENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLR 114 (449)
Q Consensus 46 ~~~~~~l~~~~~~f~~------~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~ 114 (449)
.+++++--++.+.|.. ..+-+.||.|.||.|++|+++- ...||||.++....+. ..+|+.|+.||.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 3566666555555432 3556678999999999999642 4579999999876444 568999999999999
Q ss_pred CCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC
Q 013126 115 NNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (449)
Q Consensus 115 HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~ 194 (449)
||||+++.|+......++||+|||++|+|+.+|+. +.+.+++.+...++++|+.|++||-+.+ +|||||...|||++.
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~-~DGqftviQLVgMLrGIAsGMkYLsdm~-YVHRDLAARNILVNs 766 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIASGMKYLSDMN-YVHRDLAARNILVNS 766 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh-cCCceEeehHHHHHHHHHHHhHHHhhcC-chhhhhhhhheeecc
Confidence 99999999999999999999999999999999987 4466999999999999999999999999 999999999999999
Q ss_pred CCCeEEeccCCcccCCCCC-cccc------CccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhc
Q 013126 195 DGNPRLSTFGLMKNSRDGK-SYST------NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDR 266 (449)
Q Consensus 195 ~~~~kL~DFGla~~~~~~~-~~~g------t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 266 (449)
+-..|++|||+++...++. .... ..+|+|||.+...++|.+|||||+|+++||.++ |..|+.+...+.....
T Consensus 767 nLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka 846 (996)
T KOG0196|consen 767 NLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA 846 (996)
T ss_pred ceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH
Confidence 9999999999999876654 2211 368999999999999999999999999999877 7788877655554443
Q ss_pred ccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccCCCCccccCCCCCCCCCCCCCCCccc
Q 013126 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEAC 346 (449)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (449)
+.+.. +...|.++|..+.+|+..||++|..+||.+.+|+..|+++......-... ......++...+....+
T Consensus 847 Ie~gy-----RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~---~~~~~r~s~~lld~~~~ 918 (996)
T KOG0196|consen 847 IEQGY-----RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTI---APESPRPSQPLLDRSGS 918 (996)
T ss_pred HHhcc-----CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhccc---CCCCCCCcccccCCCCC
Confidence 33322 22345688999999999999999999999999999999998764332211 11112222222222334
Q ss_pred CCCCchhHHHHHHhcCCC
Q 013126 347 SRRDLTAIHEILEKISYK 364 (449)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~ 364 (449)
......++.+|++.++..
T Consensus 919 ~~~~f~sv~~WL~aIkm~ 936 (996)
T KOG0196|consen 919 DFTPFRSVGDWLEAIKMG 936 (996)
T ss_pred CCcccCCHHHHHHHhhhh
Confidence 455677889999887644
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.95 Aligned_cols=236 Identities=20% Similarity=0.273 Sum_probs=198.0
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||+||+|+.+ +++.||+|++++.. ....+.+.+|..++..+ +||||+++++++...+..++||||++||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5799999999999965 58999999997532 22346678899998877 6999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~g 217 (449)
+|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++..... ....|
T Consensus 82 ~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~~-ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 82 DLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred hHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 9999887 4567999999999999999999999999 999999999999999999999999998753221 23468
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
|+.|+|||++.+..++.++|||||||++|+|++|+.||................ ...+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE------VVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------CCCCCCCCHHHHHHHHHHcc
Confidence 999999999998889999999999999999999999997665444333322211 12234567789999999999
Q ss_pred cCCCCCCCH------HHHHH
Q 013126 298 YEPRERPNP------KSLVT 311 (449)
Q Consensus 298 ~dP~~Rps~------~eil~ 311 (449)
.||++||++ ++++.
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHc
Confidence 999999998 56654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=324.72 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=208.9
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
+.+++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 3577889999999999999998777899999997644 346789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC--ccc-
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--SYS- 216 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--~~~- 216 (449)
+++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++...... ...
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN-YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 999999997544457899999999999999999999999 9999999999999999999999999988655321 112
Q ss_pred --cCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 217 --TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 217 --gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
.+..|+|||++.+..++.++||||||+++|+|++ |+.|+................. ...+...+..+.+++.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~ 238 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-----MPCPPGCPKELYDIML 238 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----CCCCCcCCHHHHHHHH
Confidence 2357999999998889999999999999999999 8888766443332222211111 1223456678999999
Q ss_pred HhcccCCCCCCCHHHHHHHhccc
Q 013126 294 RCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
+||+.+|++||++.++.+.|+.+
T Consensus 239 ~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 239 DCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=331.17 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=197.9
Q ss_pred ccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCC-----eeEEEEe
Q 013126 63 NIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ERLLVAE 136 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E 136 (449)
+-.+.+|.|+||.||+|... +++.||||+.-.+. +--.+|+++|+.++|||||++.-+|.... ...+|||
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 33455699999999999954 48999999985433 23358999999999999999998886532 3468999
Q ss_pred eCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-CCeEEeccCCcccCCCC-
Q 013126 137 YMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~- 212 (449)
|++ .||.+.++.. .+..++.-.++-++.||.+||+|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+....+
T Consensus 103 ymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~-IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 103 YMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG-ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC-cccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 998 8999999742 3567888888999999999999999999 9999999999999954 99999999999976554
Q ss_pred --CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh----------------cc------
Q 013126 213 --KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD----------------RN------ 267 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~----------------~~------ 267 (449)
.++..|..|+|||.+.|.. |+.+.||||.|||+.||+-|++.|+++....... .+
T Consensus 181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~ 260 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF 260 (364)
T ss_pred CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence 3566799999999999865 9999999999999999999999987753222111 11
Q ss_pred -cccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 268 -LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 268 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
...+....+........++++.+|+.++|+++|.+|.++.+++. ++..++..
T Consensus 261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~--h~fFdelr 313 (364)
T KOG0658|consen 261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA--HPFFDELR 313 (364)
T ss_pred cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc--chhhHHhh
Confidence 11111111111234567789999999999999999999999997 34444433
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.02 Aligned_cols=234 Identities=20% Similarity=0.225 Sum_probs=197.0
Q ss_pred cccCCccceEEEEEEE----cCCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 66 SEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~----~~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5689999999999984 3578999999975332 224567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSY 215 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~ 215 (449)
+|+|.+++. +...+++..++.++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++..... ...
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 999999996 4567999999999999999999999999 999999999999999999999999998765433 234
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (449)
.||+.|+|||++.+..++.++||||||+++|||++|+.||................ ...+...++++.+++.+|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK------LGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHHHHHHH
Confidence 68999999999998889999999999999999999999987654333332221111 123445678899999999
Q ss_pred cccCCCCCCCHHH
Q 013126 296 LQYEPRERPNPKS 308 (449)
Q Consensus 296 l~~dP~~Rps~~e 308 (449)
|+.||++||++.+
T Consensus 233 l~~~P~~R~~a~~ 245 (318)
T cd05582 233 FKRNPANRLGAGP 245 (318)
T ss_pred hhcCHhHcCCCCC
Confidence 9999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=340.94 Aligned_cols=243 Identities=19% Similarity=0.248 Sum_probs=199.6
Q ss_pred ccccccccCCccceEEEEEEE----cCCCEEEEEEecCCC----CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCee
Q 013126 61 VENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMA----WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~----~~~~~vAiK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 131 (449)
+|++++.||+|+||+||+++. .+++.||+|++++.. ....+.+.+|+++++.+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 377889999999999999985 258899999996532 12245688999999999 589999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||++||+|.+++. ....+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKLG-IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999997 4567999999999999999999999999 99999999999999999999999999875432
Q ss_pred C-----CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhh----HHHhhcccccccccccCCCCC
Q 013126 212 G-----KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 212 ~-----~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 281 (449)
. ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ..+...... .....+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~~~~~ 231 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CDPPFP 231 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CCCCCC
Confidence 2 2346899999999998654 78899999999999999999999853211 111111111 112234
Q ss_pred chhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013126 282 DDDGTELVRLASRCLQYEPRERP-----NPKSLVTA 312 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~~ 312 (449)
...+..+.+++.+||+.||++|| ++++++++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 45678899999999999999999 67788763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=356.27 Aligned_cols=247 Identities=17% Similarity=0.194 Sum_probs=206.5
Q ss_pred CcccccccccCCccceEEEEEEEc-C-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-N-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+..|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 445889999999999999999843 3 67899998765443334568889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 137 YMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|++||+|.+++... ...++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK-MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC-EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999988532 3457899999999999999999999999 999999999999999999999999999865432
Q ss_pred ----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......+......... ...+...+.++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~ 299 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-----DPFPCPVSSGM 299 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCccCCHHH
Confidence 234589999999999988899999999999999999999999876544333332222111 12234566789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 013126 289 VRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+++.+||+.||++||++.+++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHh
Confidence 99999999999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=338.74 Aligned_cols=247 Identities=19% Similarity=0.300 Sum_probs=195.7
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeC-----CeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 132 (449)
.|++.+.||+|+||.||+|... +++.||||.++... .....++.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3778899999999999999954 58999999987532 22345788999999999999999999988643 2479
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+. ++|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999996 78999886 4567999999999999999999999999 999999999999999999999999998754321
Q ss_pred -------CccccCccccccccccC--CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh-------------------
Q 013126 213 -------KSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR------------------- 264 (449)
Q Consensus 213 -------~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~------------------- 264 (449)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 23468899999999876 56899999999999999999999988654221100
Q ss_pred hccc----ccccc--cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 265 DRNL----QMLTD--SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 265 ~~~~----~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... ..... +.......+..++++.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 00000 00000111234577899999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=340.87 Aligned_cols=252 Identities=17% Similarity=0.163 Sum_probs=203.7
Q ss_pred hhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 55 ATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 55 ~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
....-..|++++.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3334467889999999999999999965 48899999986422 2234568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||++||+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~---~~~~~~~~~~~~~~qil~aL~~LH~~~-IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSMG-LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999985 346899999999999999999999999 9999999999999999999999999998654
Q ss_pred CC-----CccccCccccccccccCCC----CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCC
Q 013126 211 DG-----KSYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 211 ~~-----~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
.. ....||+.|+|||++.+.. ++.++||||+||++|+|++|+.||................... .....
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~ 271 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL--NFPED 271 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc--CCCCc
Confidence 32 2446899999999997543 7889999999999999999999997664433332222111111 00111
Q ss_pred chhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013126 282 DDDGTELVRLASRCLQYEPRE--RPNPKSLVTA 312 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~--Rps~~eil~~ 312 (449)
...+..+.+++.+||..++.+ |+++.+++++
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 245778999999999865544 8899999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=324.57 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=205.4
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.+|++++.||+|+||+||+|...++..+|+|.++... ...+.+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999998777789999987543 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----c
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----~ 214 (449)
+++|.+++... ...+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||.++...... .
T Consensus 83 ~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 83 NGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQ-FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 99999999742 347899999999999999999999999 9999999999999999999999999987654332 1
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..++..|+|||++.+..++.++||||||+++|+|++ |..|+.................. ..+...+..+.+++.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~ 235 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-----YRPHLASEKVYAIMY 235 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----CCCCCCCHHHHHHHH
Confidence 234567999999988889999999999999999999 88887654333222222221111 112334678999999
Q ss_pred HhcccCCCCCCCHHHHHHHhc
Q 013126 294 RCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~ 314 (449)
+||+.||++||++.++++.|+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=330.00 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=206.6
Q ss_pred CCcccccccccCCccceEEEEEEEcC------CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~------~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
+++.|+++++||+|+||.||+|...+ +..||+|+++...... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 34568899999999999999998532 4789999997544222 3568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC
Q 013126 131 RLLVAEYMPNETLAKHLFHW--------------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~ 196 (449)
.++++||+++++|.+++... ....+++..+..++.|++.||+|+|+++ ++||||||+||++++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-VVHKDLATRNVLVFDKL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-ccccccchhheEecCCC
Confidence 99999999999999998521 1235788899999999999999999999 99999999999999999
Q ss_pred CeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccc
Q 013126 197 NPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQ 269 (449)
Q Consensus 197 ~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 269 (449)
.+||+|||+++...... ...+++.|+|||++.++.++.++||||||+++|||++ |..|+.......+......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987643321 2234678999999988889999999999999999998 7667655433333322221
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.. ....+...+..+.+++.+||+.+|++||++++++..|+.+
T Consensus 242 ~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 242 RQ-----VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred CC-----cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 11 1123456778899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=337.24 Aligned_cols=237 Identities=19% Similarity=0.242 Sum_probs=197.1
Q ss_pred cccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
+.||+|+||.||+|++. +|+.||+|.++... ....+.+..|..++... +||||+++++++.+++..|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 35799999999999965 58999999997532 22345677888888765 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----CCccc
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYS 216 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~----~~~~~ 216 (449)
|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 g~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHSKG-IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 99999987 4567899999999999999999999999 99999999999999999999999999875321 13456
Q ss_pred cCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhc
Q 013126 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (449)
Q Consensus 217 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (449)
||+.|+|||++.+..++.++||||+||++|||++|+.||............... ....+...+.++.+++.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------TPHYPRWITKESKDILEKLF 231 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHHHHHHHc
Confidence 899999999999889999999999999999999999998766544333322111 11233456778999999999
Q ss_pred ccCCCCCCCHH-HHHH
Q 013126 297 QYEPRERPNPK-SLVT 311 (449)
Q Consensus 297 ~~dP~~Rps~~-eil~ 311 (449)
+.||++||++. ++++
T Consensus 232 ~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 232 ERDPTRRLGVVGNIRG 247 (316)
T ss_pred cCCHHHcCCChHHHHc
Confidence 99999999984 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=343.08 Aligned_cols=244 Identities=17% Similarity=0.168 Sum_probs=196.2
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.-..|++++.||+|+||.||++.+. +++.||+|... .+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3456999999999999999999964 58999999753 2457899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
++. ++|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~~~-IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 164 RYK-TDLYCYLA--AKRNIAICDILAIERSVLRAIQYLHENR-IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred cCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 996 78988886 4467899999999999999999999999 999999999999999999999999998753221
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh--------HH---Hhhc--------------
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL--------DL---IRDR-------------- 266 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~--------~~---~~~~-------------- 266 (449)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .. +...
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 234689999999999988899999999999999999999977643210 00 0000
Q ss_pred ----ccccccc-c-ccCCCC-----CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 267 ----NLQMLTD-S-CLEGQF-----TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 267 ----~~~~~~~-~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....... . ...... ....+.++.+++.+||+.||++|||++++++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0 000000 0134678999999999999999999999997
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=323.35 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=206.3
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
++|+++++||+|+||.||+|...++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 35788899999999999999987888899999976443 4578999999999999999999999875 456899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----c
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----~ 214 (449)
+++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 999999997544566899999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||............... .....+...+..+.+++.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-----YRMPCPQDCPISLHELML 237 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCcCCHHHHHHHH
Confidence 234567999999988889999999999999999999 77777654333322222111 111234456788999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcc
Q 013126 294 RCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~ 315 (449)
+||+.||++|||++++.+.|+.
T Consensus 238 ~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 238 QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=335.22 Aligned_cols=236 Identities=21% Similarity=0.292 Sum_probs=195.3
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||+||+|+.. +++.||+|.++... ....+.+..|..++... +||||+++++++..++..++||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5799999999999964 48899999997532 22345566777777654 8999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~g 217 (449)
+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ....|
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~-ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 82 DLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKKG-IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 9999987 4567999999999999999999999999 999999999999999999999999998754322 23468
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
|+.|+|||++.+..++.++|||||||++|||++|+.||............... ....+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND------RPHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 99999999999888999999999999999999999998765444333222111 112344567789999999999
Q ss_pred cCCCCCCCHH-HHHH
Q 013126 298 YEPRERPNPK-SLVT 311 (449)
Q Consensus 298 ~dP~~Rps~~-eil~ 311 (449)
.||++||++. ++++
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05592 233 RDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHcCCChHHHHc
Confidence 9999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=328.78 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=205.5
Q ss_pred CcccccccccCCccceEEEEEEE-----cCCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-----~~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
++++++++.||+|+||+||+|.. .++..||+|.++..... ....+.+|+++++.++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 45688899999999999999984 23578999999753322 2357889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWE---------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~ 197 (449)
+||||+++++|.+++.... ...+++.....++.|++.||+|||+++ ++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-eehhccccceEEEcCCCc
Confidence 9999999999999985321 234788899999999999999999999 999999999999999999
Q ss_pred eEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccccc
Q 013126 198 PRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (449)
Q Consensus 198 ~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (449)
+||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++ |..|+.......+.......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 242 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999999764332 22334567999999988889999999999999999999 88787654333222222111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
. ....+...++.+.+++.+||+.||++||++.++++.|..+
T Consensus 243 ~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 243 Q-----LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred C-----cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 1 1123345678899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=323.22 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=207.3
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
+.|+++++||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++||||+++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 3578899999999999999998788999999997544 34678999999999999999999999874 567899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----c
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----~ 214 (449)
+++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN-YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 999999987555567899999999999999999999999 9999999999999999999999999987655221 2
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..++..|+|||++.+..++.++||||||+++||+++ |+.|+................ ....+...+.++.+++.
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-----RMPRPDNCPEELYELMR 237 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-----CCCCCCCCCHHHHHHHH
Confidence 234578999999988889999999999999999999 888886544333222211111 11223445678999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcc
Q 013126 294 RCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~ 315 (449)
+||+.+|++||++++++..|+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 238 LCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHccCChhhCCCHHHHHHHhhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=337.24 Aligned_cols=237 Identities=19% Similarity=0.248 Sum_probs=198.7
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+|++++.||+|+||.||+|... +++.||+|++++... ...+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3678889999999999999965 478999999976432 2234577888888877 5899999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~---- 211 (449)
||++||+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999999999986 4467899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 212 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||................ ..++...+.++.++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~l 231 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------VAYPKSMSKEAVAI 231 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CCCCCcCCHHHHHH
Confidence 124568999999999999899999999999999999999999987654443333222211 12345667889999
Q ss_pred HHHhcccCCCCCCCH
Q 013126 292 ASRCLQYEPRERPNP 306 (449)
Q Consensus 292 i~~cl~~dP~~Rps~ 306 (449)
+.+||+.||++|++.
T Consensus 232 i~~~l~~~p~~R~~~ 246 (323)
T cd05616 232 CKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHcccCHHhcCCC
Confidence 999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=339.76 Aligned_cols=246 Identities=17% Similarity=0.164 Sum_probs=202.5
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||+||++... +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5778899999999999999964 589999999976432 234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--- 213 (449)
|++||+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~-i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 82 YQPGGDLLSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQMG-YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999974 2367999999999999999999999999 9999999999999999999999999997654432
Q ss_pred --ccccCcccccccccc------CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 214 --SYSTNLAFTPPEYLR------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 214 --~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
...||+.|+|||++. +..++.++|||||||++|+|++|+.||................. ..........+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 237 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR--FLKFPEDPKVS 237 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC--ccCCCCCCCCC
Confidence 235889999999986 45578999999999999999999999876543332222111100 00011122467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.++.+++.+||+ ||++|||+.+++.
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 789999999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=323.36 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=205.9
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.+|++.++||+|+||.||+|++.++..||+|.++... ...+.+.+|+++++.++||||+++++.+. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3588999999999999999997666789999997533 34568999999999999999999999874 456899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----c
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----~ 214 (449)
+++|.+++.......+++..+..++.|++.||+|+|+++ ++||||||+||++++++.++|+|||.++...... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 999999997544456899999999999999999999999 9999999999999999999999999987654332 2
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..++..|+|||+..+..++.++||||||+++|+|+| |..|+................ ....+...+..+.+++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----RMPCPPECPESLHDLMC 237 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-----CCCCccccCHHHHHHHH
Confidence 234567999999988889999999999999999999 676775543333222211111 11223456778999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcccc
Q 013126 294 RCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
+||+.||++||++.++++.|+.+.
T Consensus 238 ~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 238 QCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHccCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=336.28 Aligned_cols=232 Identities=21% Similarity=0.247 Sum_probs=192.9
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHH-HHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEAR-SVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||+||+|... +|+.||+|++..... .....+.+|.. +++.++||||+++++.+.+++..++||||++||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 5799999999999965 589999999975321 22344556655 567899999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~g 217 (449)
+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g-ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 9999987 4567899999999999999999999999 999999999999999999999999998753221 23468
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
|+.|+|||++.+..++.++|||||||++|+|++|+.||................ ...++..+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------LRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHHHHHHHhh
Confidence 999999999998889999999999999999999999987654444333222211 12234567889999999999
Q ss_pred cCCCCCCCHH
Q 013126 298 YEPRERPNPK 307 (449)
Q Consensus 298 ~dP~~Rps~~ 307 (449)
.||++||++.
T Consensus 233 ~~p~~R~~~~ 242 (323)
T cd05575 233 KDRTKRLGAK 242 (323)
T ss_pred cCHHhCCCCC
Confidence 9999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=329.82 Aligned_cols=241 Identities=19% Similarity=0.258 Sum_probs=196.6
Q ss_pred cCCccceEEEEEEEc-CCCEEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
||+|+||+||++.+. +++.||+|.+...... ..+.+..|+++++.++||||+++.+++..++..++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 599999999999964 5899999999753322 235678899999999999999999999999999999999999999
Q ss_pred HHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccccc
Q 013126 144 AKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (449)
Q Consensus 144 ~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~g 217 (449)
.+++... ....+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++...... ....|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 9887532 3456899999999999999999999999 999999999999999999999999998765433 23468
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
|+.|+|||++.+..++.++||||||+++|+|++|+.||................... ....+...++++.+++.+||+
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhc
Confidence 899999999999999999999999999999999999986532211111111111111 112345577889999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 013126 298 YEPRERP-----NPKSLVT 311 (449)
Q Consensus 298 ~dP~~Rp-----s~~eil~ 311 (449)
.||++|| +++++++
T Consensus 238 ~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHhcCCCCCCHHHHhc
Confidence 9999999 6777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.84 Aligned_cols=245 Identities=27% Similarity=0.468 Sum_probs=196.4
Q ss_pred ccccccCCccceEEEEEEEc-----CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 63 NIVSEHGEKAPNVVYKGKLE-----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~-----~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++.+.||.|+||.||+|.+. .+..|+||.++..... ..+.|.+|++.+++++||||++++|++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678899999999999976 2678999999653322 25789999999999999999999999998888999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|+++|+|.+++.......+++..+..|+.|++.||+|||+++ ++|+||+++||++++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN-IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT-EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence 999999999998654678999999999999999999999998 999999999999999999999999999876322
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
........|+|||.+.+..++.++||||||+++||+++ |+.|+.......+........ ....+...+..+.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-----RLPIPDNCPKDIY 235 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-----ETTSBTTSBHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cceeccchhHHHH
Confidence 22345678999999998889999999999999999999 667766543333322221111 1123445678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHh
Q 013126 290 RLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~L 313 (449)
+++.+||+.||++|||++++++.|
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=335.17 Aligned_cols=237 Identities=20% Similarity=0.262 Sum_probs=196.3
Q ss_pred cccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
+.||+|+||+||+|... +++.||+|.++... ....+.+..|..+++.. +||||+++++++.+.+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 35799999999999965 48899999997642 22345677788888764 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----CCccc
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYS 216 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~----~~~~~ 216 (449)
|+|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~~~-ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSKG-IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 99999997 4467899999999999999999999999 99999999999999999999999999875322 12456
Q ss_pred cCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhc
Q 013126 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (449)
Q Consensus 217 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (449)
||+.|+|||++.+..++.++||||+||++|||++|+.||............... ....+...+.++.+++.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------NPCYPRWLTREAKDILVKLF 231 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHHHHHHHHHh
Confidence 899999999999888999999999999999999999998765443332221111 11223446678999999999
Q ss_pred ccCCCCCCCHH-HHHH
Q 013126 297 QYEPRERPNPK-SLVT 311 (449)
Q Consensus 297 ~~dP~~Rps~~-eil~ 311 (449)
+.||++||++. +++.
T Consensus 232 ~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 232 VREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCHhhcCCChHHHHc
Confidence 99999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=308.31 Aligned_cols=257 Identities=19% Similarity=0.209 Sum_probs=209.7
Q ss_pred CCcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCC-----ee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ER 131 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~ 131 (449)
|=++|++.+++|+|||+-||+++ ..+++.||+|++.-....+.+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 33679999999999999999999 6678999999998777677889999999999999999999998876543 48
Q ss_pred EEEEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccccCceeeCCCCCeEEeccCCccc
Q 013126 132 LLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
||+++|...|||.+.+... ++..+++.+.+.|+.+|++||++||+.. +.+||||||.|||+++++.+++.|||.+..
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999999754 3457999999999999999999999975 499999999999999999999999998865
Q ss_pred CCCC-------------CccccCcccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-cc
Q 013126 209 SRDG-------------KSYSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-ML 271 (449)
Q Consensus 209 ~~~~-------------~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-~~ 271 (449)
..-. .....|..|+|||.+. +...++++|||||||+||+|+.|..||..... ..+... .+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---~GgSlaLAv 255 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---QGGSLALAV 255 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---cCCeEEEee
Confidence 4321 1234589999999985 34578999999999999999999999864321 111111 11
Q ss_pred cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
..+...-......++.+.+++..||+.||.+||++.+++..++.+.
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111111112347889999999999999999999999999887653
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.27 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=204.0
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.++++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4577888999999999999998777889999986543 235678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc-----
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS----- 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~----- 214 (449)
|++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...+...
T Consensus 83 ~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 83 NGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESNG-FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999974 2347899999999999999999999999 99999999999999999999999999876543321
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..++..|+|||.+.+..++.++||||||+++|++++ |+.|+................ ....+...+.++.+++.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-----RLYRPKLAPTEVYTIMY 235 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-----cCCCCCCCCHHHHHHHH
Confidence 122357999999998889999999999999999999 677775443322222211111 11223456788999999
Q ss_pred HhcccCCCCCCCHHHHHHHh
Q 013126 294 RCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L 313 (449)
+||..+|++|||+.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=327.79 Aligned_cols=243 Identities=16% Similarity=0.221 Sum_probs=196.2
Q ss_pred cCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
||+|+||.||++... +|+.||+|.+..... .....+..|++++++++||||+++++++..+...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 599999999999954 589999999965321 1234566799999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---ccccCcc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---SYSTNLA 220 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---~~~gt~~ 220 (449)
.+++.......+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||++....... ...++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC-EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 99887545567899999999999999999999999 9999999999999999999999999987654432 3457899
Q ss_pred ccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCC
Q 013126 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (449)
Q Consensus 221 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (449)
|+|||++.+..++.++||||+||++|||++|+.|+...................... ......+.++.+++.+||+.||
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHhccCH
Confidence 999999998889999999999999999999999986432211111111111111110 1123467789999999999999
Q ss_pred CCCCCHHHHHHH
Q 013126 301 RERPNPKSLVTA 312 (449)
Q Consensus 301 ~~Rps~~eil~~ 312 (449)
++||+++++++.
T Consensus 239 ~~R~~~~~~~~~ 250 (277)
T cd05607 239 EDRLGSREKNDD 250 (277)
T ss_pred hhCCCCccchhh
Confidence 999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.09 Aligned_cols=253 Identities=17% Similarity=0.249 Sum_probs=204.7
Q ss_pred cccccccccCCccceEEEEEEEc-CCC----EEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~----~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.+|++++.||+|+||+||+|.+. +++ .||+|.++.... ...+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45788899999999999999853 333 489999975432 2356799999999999999999999998764 5789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
++||+++|+|.+++.. ....+++.....++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 86 v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~-iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 86 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEERR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhcC-eeccccchhheEecCCCcEEEccccccccccCCC
Confidence 9999999999999974 3456889999999999999999999999 9999999999999999999999999998654332
Q ss_pred c------cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 S------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ~------~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
. ..++..|+|||++.+..++.++||||||+++|||++ |..|+.......+....... .....+...+.
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 238 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----ERLPQPPICTI 238 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-----CCCCCCCCCCH
Confidence 1 223567999999998899999999999999999998 88887654433322211111 01112334567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
++.+++.+||+.||++||++.+++..+..+.+..
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 8999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=324.30 Aligned_cols=250 Identities=18% Similarity=0.180 Sum_probs=203.9
Q ss_pred CcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
..+|++++.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45788999999999999999995 45889999999765544556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
+++++|.+++. ...++++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++..... .
T Consensus 88 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 88 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSKG-KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999986 4567899999999999999999999999 999999999999999999999999998765322 2
Q ss_pred ccccCcccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc-cccccccccCCCCCchhHHHHH
Q 013126 214 SYSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-LQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
...+++.|+|||.+. ...++.++|+||+|+++|||++|+.|+............ ......+. .......+..+.
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 242 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK--LKDKTKWSSTFH 242 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCC--CccccccCHHHH
Confidence 345788999999984 344788999999999999999999887543211111000 00111110 111234567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHh
Q 013126 290 RLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~L 313 (449)
+++.+||+.||++|||++++++.|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 999999999999999999998854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=322.66 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=206.1
Q ss_pred cccccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
++|++.+.||+|+||+||+|.+.. ...||+|.++...... ..+|.+|+.++++++||||+++++.+.+++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 346677888999999999999642 4579999987644332 46789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~-i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 84 TEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN-YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEcCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999999974 3457899999999999999999999999 9999999999999999999999999998764211
Q ss_pred -----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 214 -----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 214 -----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...++..|+|||.+.+..++.++||||||+++|+|++ |..|+................. ...+...++.
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 236 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR-----LPPPMDCPSA 236 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----CCCCCCCCHH
Confidence 1223568999999998889999999999999999998 8888765443333322221111 1123456778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
+.+++.+||+.+|++||++.++++.|+.+
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=335.11 Aligned_cols=236 Identities=20% Similarity=0.284 Sum_probs=198.5
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||+||+|... +++.||+|++++.. ....+.+.+|.++++.+ +||||+++++++...+..++||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5799999999999965 48899999997532 22345678899999888 7999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~g 217 (449)
+|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++..... ....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 82 DLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHERG-IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 9999886 4457999999999999999999999999 999999999999999999999999998653221 23458
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
|+.|+|||++.+..++.++|||||||++|+|++|+.||............... ....+...+.++.+++.+||+
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------EVRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------CCCCCCcCCHHHHHHHHHHcc
Confidence 89999999999989999999999999999999999998765443333222111 112344567889999999999
Q ss_pred cCCCCCCCH-----HHHHH
Q 013126 298 YEPRERPNP-----KSLVT 311 (449)
Q Consensus 298 ~dP~~Rps~-----~eil~ 311 (449)
.||++||++ .++++
T Consensus 233 ~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHcCCCCCCCHHHHhc
Confidence 999999999 88876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=335.52 Aligned_cols=240 Identities=17% Similarity=0.258 Sum_probs=195.2
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||.||+++.. +++.||+|+++.... ...+.+.+|..+++.+ +||||+++++++.+.+..++||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5799999999999965 589999999976432 2245688999999998 7999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----CCcccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~----~~~~~g 217 (449)
+|.+++. ..+.+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 9999886 4567999999999999999999999999 99999999999999999999999999875221 123568
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-----HhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
|+.|+|||++.+..++.++|+|||||++|+|++|+.||....... ........+... ....+...+.++.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li 236 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKASSVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 999999999998889999999999999999999999985321100 000000011111 1123455678899999
Q ss_pred HHhcccCCCCCCC------HHHHHH
Q 013126 293 SRCLQYEPRERPN------PKSLVT 311 (449)
Q Consensus 293 ~~cl~~dP~~Rps------~~eil~ 311 (449)
.+||+.||.+|++ ++++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhc
Confidence 9999999999997 567765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=320.82 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=206.0
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEe-eCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC-EGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~Ey 137 (449)
..+|++.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++++++|+|++++++++. .++..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 45688889999999999999986 47889999986533 3567999999999999999999999765 45678999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-ccc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-SYS 216 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-~~~ 216 (449)
+++++|.+++.......+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 160 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeccccchheEEEcCCCcEEecCCccceeccccCCCCc
Confidence 99999999997544456889999999999999999999999 9999999999999999999999999987654332 334
Q ss_pred cCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 013126 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (449)
Q Consensus 217 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (449)
++..|+|||++.+..++.++||||||+++|+|++ |+.|+................ ....++..++.+.+++.+|
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----KMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCCCHHHHHHHHHH
Confidence 4568999999988889999999999999999997 888876554433322221111 1123445678899999999
Q ss_pred cccCCCCCCCHHHHHHHhcc
Q 013126 296 LQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 296 l~~dP~~Rps~~eil~~L~~ 315 (449)
|+.||++|||+.++++.|+.
T Consensus 236 l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 236 WHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred hcCChhhCcCHHHHHHHHhc
Confidence 99999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.96 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=207.9
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
..+.+.+.+|+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 34677888999999999999842 245689999876554446679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEec
Q 013126 134 VAEYMPNETLAKHLFHWE-----------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLST 202 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~D 202 (449)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccCcceEEEccCCcEEecc
Confidence 999999999999996321 235899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccc
Q 013126 203 FGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSC 275 (449)
Q Consensus 203 FGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (449)
||+++...... ...++..|+|||++.+..++.++||||||+++|+|++ |..|+.................
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~--- 240 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV--- 240 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc---
Confidence 99987543321 2234678999999998889999999999999999998 8887765443332222222111
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
...+...+.++.+++.+||+.||.+|||++++++.|+.+.+.
T Consensus 241 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 241 --LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 112334567899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=341.69 Aligned_cols=245 Identities=13% Similarity=0.126 Sum_probs=199.8
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||+||++... +++.||+|+++... ......+.+|+.++..++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5778889999999999999964 58999999997532 2234578889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++||+|.+++. +...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~g-ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQLG-FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999997 4567999999999999999999999999 999999999999999999999999998643211
Q ss_pred -----------------------------------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCc
Q 013126 213 -----------------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPS 257 (449)
Q Consensus 213 -----------------------------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~ 257 (449)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 123589999999999998999999999999999999999999876
Q ss_pred hhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 013126 258 HALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN---PKSLVT 311 (449)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~eil~ 311 (449)
.................... .....++++.+++.+++. ||.+|++ ++++++
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p--~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFP--PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCHHHHHHHHHcCCCceecC--CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 55443332222110000000 112356789999999774 9999985 667765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.32 Aligned_cols=252 Identities=17% Similarity=0.227 Sum_probs=207.0
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
++|++.+.||+|+||.||+|+.. +++.||||.++.....+ ...+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46788899999999999999954 68999999886533222 356889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 136 EYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||+++++|.+++... ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999888532 2356889999999999999999999999 9999999999999999999999999987654432
Q ss_pred ----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH--HHhhcccccccccccCCCCCchhHHH
Q 013126 214 ----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD--LIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 214 ----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|+.|+...... ...... . ............+..
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~ 236 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-E---QCDYPPLPTEHYSEK 236 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-h---cCCCCCCChhhcCHH
Confidence 345788999999998888999999999999999999999998654221 111111 1 111111122345678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
+.+++.+||+.+|++||++.++++.++.+
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=318.75 Aligned_cols=244 Identities=19% Similarity=0.281 Sum_probs=206.4
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|.+.+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 567788899999999999964 589999999865432 23567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----c
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----~ 214 (449)
+|++|.+++.......+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||+++...... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~-i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999998654578999999999999999999999999 9999999999999999999999999987654432 2
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..+++.|+|||++.+..++.++|+||||+++|+|++|+.|+................. ...+...+.++.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-----PPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----CCCccccCHHHHHHHHH
Confidence 3578899999999988899999999999999999999999876543333222222111 12233566789999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||+.+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 236 CLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HccCCcccCcCHHHHhh
Confidence 99999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=319.92 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=197.4
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHH
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 144 (449)
.||+|+||.||+|.+. +++.||+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5799999999999964 6899999998654322 2467999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc------cccC
Q 013126 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS------YSTN 218 (449)
Q Consensus 145 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~------~~gt 218 (449)
+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++........ ...+
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 82 TFLRT-EGPRLKVKELIQMVENAAAGMEYLESKH-CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99864 3446899999999999999999999999 99999999999999999999999999876443211 1223
Q ss_pred ccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 219 ~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
..|+|||.+.++.++.++||||||+++|+|++ |..|+............... .....+...+..+.+++.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-----VRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----CCCCCcccCCHHHHHHHHHHcC
Confidence 56999999988889999999999999999998 77766543322222211111 1112344567789999999999
Q ss_pred cCCCCCCCHHHHHHHhc
Q 013126 298 YEPRERPNPKSLVTALS 314 (449)
Q Consensus 298 ~dP~~Rps~~eil~~L~ 314 (449)
.||++|||+.++++.|.
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=334.15 Aligned_cols=240 Identities=18% Similarity=0.258 Sum_probs=194.3
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||.||+|... +++.||+|++++... ...+.+.+|+.++.++ +||||+++++++..++..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 5799999999999964 588999999976432 2245677899988877 8999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----CCcccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~----~~~~~g 217 (449)
+|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 9999886 4567999999999999999999999999 99999999999999999999999999875322 123568
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-----HhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
|+.|+|||++.+..++.++||||||+++|+|++|+.||....... ........+... ....+...+.++.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll 236 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence 999999999999899999999999999999999999984211000 000000001111 1124556678899999
Q ss_pred HHhcccCCCCCCCH------HHHHH
Q 013126 293 SRCLQYEPRERPNP------KSLVT 311 (449)
Q Consensus 293 ~~cl~~dP~~Rps~------~eil~ 311 (449)
.+||+.||++||++ .++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 99999999999984 57665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=343.24 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=204.4
Q ss_pred cccccccccCCccceEEEEEEEcC------CCEEEEEEecCCCCC-CHHHHHHHHHHHhccC-CCCcccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~------~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 131 (449)
+.+++.+.||+|+||.||+|++.. +..||||+++..... ..+.+.+|++++++++ ||||+++++++.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 467788999999999999998521 346999999754332 2467999999999996 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccC------------------------------------------------------------
Q 013126 132 LLVAEYMPNETLAKHLFHWE------------------------------------------------------------ 151 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~------------------------------------------------------------ 151 (449)
++||||+++|+|.+++....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 99999999999999886421
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC
Q 013126 152 ----------------------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 152 ----------------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~ 197 (449)
...+++..+..++.|++.||+|||+++ ++||||||+|||+++++.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-CVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChHhEEEeCCCE
Confidence 124778888999999999999999999 999999999999999999
Q ss_pred eEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccccc
Q 013126 198 PRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (449)
Q Consensus 198 ~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (449)
+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..|+.....+.........
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~ 355 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc
Confidence 9999999987643321 2235678999999998889999999999999999997 88887654322111111111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
. .....+...+.++.+++.+||+.||++|||+.++.+.|+.+.+
T Consensus 356 ---~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 356 ---G-YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---C-CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 1112234567889999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=328.40 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=208.9
Q ss_pred CcccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
+.++.+.+.||+|+||.||+|+.. ++..+++|.++.......+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 345778889999999999999842 34568999987655444567999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCe
Q 013126 133 LVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP 198 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~ 198 (449)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccCcceEEEccCCcE
Confidence 9999999999999996421 234789999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccc
Q 013126 199 RLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQML 271 (449)
Q Consensus 199 kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 271 (449)
+|+|||++...... ....++..|+|||++.+..++.++||||||+++|||+| |+.|+.........+......
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 242 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence 99999998754332 22345678999999998889999999999999999999 888875543332222111111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
. ...+...+..+.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 243 ~-----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 243 V-----LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred C-----CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 112334567899999999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=322.10 Aligned_cols=255 Identities=18% Similarity=0.235 Sum_probs=208.4
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
++|++.+.||+|++|.||+|.. .+++.+|||.+......+ .+++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677888999999999999995 468999999886533222 357889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 136 EYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||+++++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999988632 2456899999999999999999999999 9999999999999999999999999987654332
Q ss_pred ----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 214 ----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 214 ----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
...++..|+|||++.+..++.++|+||||+++|+|++|..|+.....+.... ...+.........+...++++.
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH--hhhhhcCCCCCCCcccccHHHH
Confidence 3457889999999988889999999999999999999999886443221110 0011111111112234678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 290 RLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
+++.+||+.||++|||+.++++.++++.
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999999887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=335.12 Aligned_cols=235 Identities=20% Similarity=0.230 Sum_probs=193.1
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHH-HHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEAR-SVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||+||+|++. +++.||+|++..... .....+.+|.. +++.++||||+++++++..++..++||||++|+
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5799999999999965 478999999975321 12334555544 567889999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----CCcccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~----~~~~~g 217 (449)
+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~g-iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 82 ELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 9999997 4567888999999999999999999999 99999999999999999999999999875322 234568
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
|+.|+|||++.+..++.++|||||||++|+|++|+.||............... ....++..+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC------CcCCCCCCCHHHHHHHHHHcc
Confidence 99999999999888999999999999999999999998765444333222211 112344567889999999999
Q ss_pred cCCCCCCCHHHHH
Q 013126 298 YEPRERPNPKSLV 310 (449)
Q Consensus 298 ~dP~~Rps~~eil 310 (449)
.||.+||++.+.+
T Consensus 233 ~~p~~R~~~~~~~ 245 (325)
T cd05602 233 KDRTKRLGAKDDF 245 (325)
T ss_pred cCHHHCCCCCCCH
Confidence 9999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=361.88 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=210.5
Q ss_pred cccccccccCCccceEEEEEEEcC--CC----EEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN--QR----RIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~--~~----~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
....+...||+|+||.||.|...+ +. .||||.+++... ....+|++|+.+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345667788999999999999543 33 499999987643 33678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 133 LVAEYMPNETLAKHLFHWE-----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
|++|||+||+|..+|++.+ ...++..+.+.++.|||+|+.||++++ .|||||..+|+|++....+||+|||+|+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-FVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-CcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999998631 456889999999999999999999998 9999999999999999999999999999
Q ss_pred cCCCCCcc------ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCC-CCCCchhhHHHhhcccccccccccCCCC
Q 013126 208 NSRDGKSY------STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK-HIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (449)
Q Consensus 208 ~~~~~~~~------~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (449)
.......+ .-...|||||.+..+.+|.|+|||||||++||++|.. .|++......+..... ... +-..
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~----~gg-RL~~ 925 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL----EGG-RLDP 925 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH----hCC-ccCC
Confidence 54433211 1236799999999999999999999999999999955 5555443322222111 111 2344
Q ss_pred CchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
|..++..+.++|.+||+.+|++||++..+++.+..+.....
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 67788999999999999999999999999998887766543
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=319.90 Aligned_cols=246 Identities=16% Similarity=0.202 Sum_probs=207.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+|++++.||+|+||.||++... +++.+|+|.++... ....+.+.+|+.+++.++||||+++++.+.+++.++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3678899999999999999965 58999999986533 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
++++|.+++.......+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++++|||.+...... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR-VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 9999999987545567899999999999999999999999 999999999999999999999999998765433 23
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..+++.|+|||++.+..++.++|+||||+++|+|++|..||................. ...+...+..+.+++.+
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-----KPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-----CCCCcccCHHHHHHHHH
Confidence 4578899999999888899999999999999999999999876544333222211111 12234566789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~ 312 (449)
||+.||++|||+.+++..
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=328.11 Aligned_cols=252 Identities=19% Similarity=0.248 Sum_probs=210.2
Q ss_pred HHhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 53 KNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 53 ~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
...++....|++++.+|+|++|.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 344455567889999999999999999954 5899999999876655667899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||++|++|.+++. ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~g-i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 93 WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred EEeecccCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999999999984 356899999999999999999999999 99999999999999999999999999876443
Q ss_pred C----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 212 G----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 212 ~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
. ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||............. .........+...+..
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 245 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAI 245 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh---cCCCCCCCCccccCHH
Confidence 2 23467889999999988889999999999999999999999986543221111111 1111111223456678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.+++.+||..||++||++.+++.
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhh
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=338.92 Aligned_cols=256 Identities=17% Similarity=0.173 Sum_probs=205.3
Q ss_pred HHHhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEee
Q 013126 52 LKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127 (449)
Q Consensus 52 l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 127 (449)
+....-...+|++++.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344445577889999999999999999965 48899999986422 1224567899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 128 ~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
++..++||||++||+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999999985 346889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCC-----CccccCccccccccccCCC----CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCC
Q 013126 208 NSRDG-----KSYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 208 ~~~~~-----~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (449)
..... ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||................... ..
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~~ 268 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--TF 268 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc--cC
Confidence 65432 2456899999999997543 7889999999999999999999997655433333222211111 11
Q ss_pred CCCchhHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRE--RPNPKSLVTAL 313 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~--Rps~~eil~~L 313 (449)
......+..+.+++.+||..++.+ |+++.+++++.
T Consensus 269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 112356788999999999844433 67999998854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=319.59 Aligned_cols=241 Identities=21% Similarity=0.261 Sum_probs=198.3
Q ss_pred ccCCccceEEEEEEEc---CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
+||+|+||.||+|.++ ++..+|+|+++..... ..+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5799999999999743 4789999998754322 2467899999999999999999999875 45679999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc-------
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS------- 214 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~------- 214 (449)
+|.+++. ....+++..+..++.|++.||+|+|+++ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEETN-FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999996 4457899999999999999999999999 99999999999999999999999999876543321
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..+++.|+|||.+.+..++.++|+||||+++|||++ |..||.......+....... .....+...++++.+++.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-----ERMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-----CCCCCCCCCCHHHHHHHH
Confidence 123478999999988889999999999999999998 88888654333322222111 112234567788999999
Q ss_pred HhcccCCCCCCCHHHHHHHhccc
Q 013126 294 RCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
+||+.||++||++++|.+.|+..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 233 LCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHhccCchhCcCHHHHHHHHhcc
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.48 Aligned_cols=252 Identities=19% Similarity=0.204 Sum_probs=210.0
Q ss_pred hCCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCC----C----HHHHHHHHHHHhcc-CCCCcccceeeE
Q 013126 56 TSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP----D----PRQFLEEARSVGQL-RNNRLTNLLGCC 125 (449)
Q Consensus 56 ~~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~----~----~~~~~~E~~~l~~l-~HpnIv~l~~~~ 125 (449)
..-|..|.-.+.+|+|..++|-++.. .++..+|+|++...... . .+.-.+|+.+|+++ .||||+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34455666667779999999999884 46899999999643221 1 24567899999999 699999999999
Q ss_pred eeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 126 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
+.+...++|+|.|+.|.|.|++. +.-.++++..++|++|+..|+.|||.++ |+||||||+|||++++.++||+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~~-IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHARN-IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHhh-hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999999997 5678999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCC---ccccCccccccccccC------CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccccc
Q 013126 206 MKNSRDGK---SYSTNLAFTPPEYLRT------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL 276 (449)
Q Consensus 206 a~~~~~~~---~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (449)
+.....+. ..+|||+|.|||.+.- ..|+..+|+|+.|||+|.++.|.+||.-...-.+...++..... .
T Consensus 170 a~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq--F 247 (411)
T KOG0599|consen 170 ACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ--F 247 (411)
T ss_pred eeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc--c
Confidence 99888774 5689999999998843 34888999999999999999999998755433333333222211 1
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.+.-+.+.+..+++||.+||+.||.+|.|++|++++
T Consensus 248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 223356778899999999999999999999999973
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=325.68 Aligned_cols=250 Identities=22% Similarity=0.273 Sum_probs=204.5
Q ss_pred CcccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
++++.+.++||+|+||.||++... ++..+|+|.++.......+.+.+|+++++.++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 456788899999999999999732 35689999987655444678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeE
Q 013126 133 LVAEYMPNETLAKHLFHWET-------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~k 199 (449)
++|||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-eecccccHhhEEEcCCCCEE
Confidence 99999999999999974321 35789999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccccccc
Q 013126 200 LSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLT 272 (449)
Q Consensus 200 L~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 272 (449)
|+|||+++..... ....+++.|+|||++.+..++.++||||||+++|||++ |..|+................
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 241 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR- 241 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-
Confidence 9999998754322 12234678999999998889999999999999999998 787775433222221111110
Q ss_pred ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
....+...++.+.+++.+||+.||++||+++++.+.|+
T Consensus 242 ----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 ----ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11223456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=319.09 Aligned_cols=248 Identities=26% Similarity=0.379 Sum_probs=209.4
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.++++.+.+|+|++|.||+|.. .|+.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4577888999999999999987 478999999976543 46789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc-cccC
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS-YSTN 218 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~gt 218 (449)
+++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||.++....... ...+
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN-FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 999999997544457999999999999999999999999 99999999999999999999999999987643322 2345
Q ss_pred ccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 219 ~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
..|+|||++.+..++.++||||||+++|++++ |..|+................ ....+...++++.+++.+||.
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-----RMEAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-----CCCCccCCCHHHHHHHHHHhc
Confidence 67999999988889999999999999999997 888876654443332222111 112234567889999999999
Q ss_pred cCCCCCCCHHHHHHHhcc
Q 013126 298 YEPRERPNPKSLVTALSP 315 (449)
Q Consensus 298 ~dP~~Rps~~eil~~L~~ 315 (449)
.+|++|||+.++++.|+.
T Consensus 238 ~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 238 LDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cChhhCcCHHHHHHHHhc
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=325.70 Aligned_cols=257 Identities=17% Similarity=0.204 Sum_probs=209.4
Q ss_pred HHHHHhhCCCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC
Q 013126 50 EQLKNATSGFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128 (449)
Q Consensus 50 ~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 128 (449)
+++.+.....+.|+++++||.|+||.||+|+... ++.+|+|.+........+.+.+|+++++.++||||+++++.+..+
T Consensus 2 ~~~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 2 EHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 3455555666789999999999999999999654 899999999765544467789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
+..++||||++|++|..++.+ ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSMK-IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcCC-eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999888764 3467899999999999999999999999 99999999999999999999999998865
Q ss_pred CCCC----CccccCccccccccccC-----CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCC
Q 013126 209 SRDG----KSYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 209 ~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (449)
.... ....+++.|+|||++.+ ..++.++|+||||+++|+|++|..|+................ .....
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~ 236 (292)
T cd06644 160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLS 236 (292)
T ss_pred ccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC---CccCC
Confidence 3322 23457889999999853 347889999999999999999998876543222111111110 01112
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+...+.++.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 23456678999999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=335.51 Aligned_cols=235 Identities=18% Similarity=0.214 Sum_probs=194.0
Q ss_pred cccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHH-HHhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEAR-SVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
+.||+|+||+||+|+.. +|+.||+|++..... .....+.+|.. +++.++||||+++++++..++..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35799999999999954 589999999965321 22345566655 46778999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----CCccc
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYS 216 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~----~~~~~ 216 (449)
|+|..++. ....+++..+..++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~g-ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSIN-IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 99999886 5567999999999999999999999999 99999999999999999999999999875322 12456
Q ss_pred cCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhc
Q 013126 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (449)
Q Consensus 217 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (449)
||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ...++..+..+.+++.+||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------LVLRPGASLTAWSILEELL 231 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------ccCCCCCCHHHHHHHHHHh
Confidence 8999999999998899999999999999999999999987665444333222211 1223356678999999999
Q ss_pred ccCCCCCCCHHHH
Q 013126 297 QYEPRERPNPKSL 309 (449)
Q Consensus 297 ~~dP~~Rps~~ei 309 (449)
+.||.+||++++.
T Consensus 232 ~~~p~~R~~~~~~ 244 (325)
T cd05604 232 EKDRQRRLGAKED 244 (325)
T ss_pred ccCHHhcCCCCCC
Confidence 9999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=331.58 Aligned_cols=232 Identities=21% Similarity=0.244 Sum_probs=192.0
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHH-HHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEAR-SVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||.||+|+.. +++.||+|++.+... .....+.+|.. +++.++||||+++++++.+.+..++||||++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5799999999999965 589999999965321 12344556654 678899999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~g 217 (449)
+|...+. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 82 ELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 9998886 4567889999999999999999999999 999999999999999999999999998753221 23468
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
|+.|+|||++.+..++.++|||||||++|||++|..||................ ...+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP------LQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC------CCCCCCCCHHHHHHHHHHcc
Confidence 899999999998889999999999999999999999987665444333322211 12344566789999999999
Q ss_pred cCCCCCCCHH
Q 013126 298 YEPRERPNPK 307 (449)
Q Consensus 298 ~dP~~Rps~~ 307 (449)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (321)
T cd05603 233 KDQRRRLGAK 242 (321)
T ss_pred CCHhhcCCCC
Confidence 9999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=323.78 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=200.6
Q ss_pred ccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
+|++.+.||+|+||.||+|.+. +++.||+|.++.... ....++.+|+.+++.++||||+++++++.++...++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 4778888999999999999753 256799999865332 224568899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 134 VAEYMPNETLAKHLFHWE--------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||+
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCcchheEEEcCCCCEEECCCCC
Confidence 999999999999986422 124577889999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCC
Q 013126 206 MKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 206 a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (449)
++...... ...+++.|+|||++.++.++.++||||||+++|||++ |..|+................ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-----~~ 240 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-----LL 240 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-----cC
Confidence 87543321 2234678999999998889999999999999999999 677776544333222111111 01
Q ss_pred CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
..+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 223456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=327.66 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=205.7
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCC--EEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQR--RIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~--~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
.+++|++.+.||+|+||.||+|.+. ++. .+|+|.++..... ....+.+|++++.++ +||||+++++++..++.++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 4567888899999999999999964 344 4588887653322 245788999999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCe
Q 013126 133 LVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP 198 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~ 198 (449)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchheEEecCCCcE
Confidence 9999999999999996422 135789999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccccccccc
Q 013126 199 RLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDS 274 (449)
Q Consensus 199 kL~DFGla~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 274 (449)
||+|||+++..... .....+..|+|||++.+..++.++||||||+++|||+| |..||...............
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---- 239 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---- 239 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC----
Confidence 99999998643221 11223567999999988889999999999999999998 88887654333322211111
Q ss_pred ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.....+...++++.+++.+||+.+|++||++++++..|+.+....
T Consensus 240 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 240 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111223345678999999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=318.08 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=209.1
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
++|++.+.||+|++|.||+|..++++.||+|.+.... ...+++.+|+.++++++||||+++++++..+...++||||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4678889999999999999998778899999997544 346789999999999999999999999999899999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----c
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----~ 214 (449)
+++|.+++.......+++..+..++.|++.|++|||+++ ++|+||||+||++++++.+||+|||+++...... .
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~-i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN-YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 999999997644567899999999999999999999999 9999999999999999999999999987654321 1
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...+..|+|||.+.+..++.++|+||+|+++|++++ |+.|+................ ....+...+.++.+++.
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-----RMPRPPNCPEELYDLML 238 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCCHHHHHHHH
Confidence 223567999999998889999999999999999999 888876543333222221111 11223345678999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcc
Q 013126 294 RCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~ 315 (449)
+||+.+|++||+++++.+.|+.
T Consensus 239 ~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 239 QCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=334.84 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=201.8
Q ss_pred ccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhcc-CCCCcccceeeEeeC-Cee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEG-DER 131 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~~ 131 (449)
+|++++.||+|+||.||+|... +++.||+|+++...... .+.+.+|+.++.++ +|+||+++++++... ..+
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 6889999999999999999732 24789999997543222 35688899999999 899999999988654 568
Q ss_pred EEEEeeCCCCCHHHHHhccC-----------------------------------------------------------C
Q 013126 132 LLVAEYMPNETLAKHLFHWE-----------------------------------------------------------T 152 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~-----------------------------------------------------------~ 152 (449)
+++|||+++++|.+++.... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999999986321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC------CccccCcccccccc
Q 013126 153 HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEY 226 (449)
Q Consensus 153 ~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~ 226 (449)
.++++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++..... ....++..|+|||+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~~-ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 26889999999999999999999999 999999999999999999999999999865332 12344678999999
Q ss_pred ccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCC
Q 013126 227 LRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305 (449)
Q Consensus 227 ~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (449)
+.+..++.++|||||||++|||++ |..||................ .....+...++++.+++.+||+.+|++||+
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG----TRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc----CCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999999999999998 888875432111111111110 011223445678999999999999999999
Q ss_pred HHHHHHHhccccc
Q 013126 306 PKSLVTALSPLQK 318 (449)
Q Consensus 306 ~~eil~~L~~~~~ 318 (449)
+.++++.|+.+.+
T Consensus 323 ~~ell~~l~~~~~ 335 (337)
T cd05054 323 FSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHHHh
Confidence 9999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=329.92 Aligned_cols=251 Identities=19% Similarity=0.295 Sum_probs=200.8
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
..+.|+++++||+|+||+||+|+.. +++.||+|.++..... ....+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 3456899999999999999999965 5889999999754322 2456889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++ ++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 84 e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLD-KDLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9998 588888764 3456889999999999999999999999 999999999999999999999999998754322
Q ss_pred -CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc-------------------
Q 013126 213 -KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML------------------- 271 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------------------- 271 (449)
....+++.|+|||++.+ ..++.++||||||+++|+|+||+.||................
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 23456889999999865 458999999999999999999999986543322111110000
Q ss_pred -cccccC----CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 272 -TDSCLE----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 272 -~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..+... .......++++.+++.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 0011245678999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=318.48 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=204.7
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
..|++.++||+|++|.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3477888999999999999998777789999986543 34567999999999999999999999875 466899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----c
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----~ 214 (449)
+++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN-YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 999999997544456899999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..++..|+|||...+..++.++||||||+++|+|++ |+.|+................ ....+...+..+.+++.
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-----RMPCPQGCPESLHELMK 237 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----CCCCCcccCHHHHHHHH
Confidence 234578999999988889999999999999999999 787776543333222211111 11223456788999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcc
Q 013126 294 RCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~ 315 (449)
+||++||++||+++++++.|+.
T Consensus 238 ~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 238 LCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=331.96 Aligned_cols=236 Identities=17% Similarity=0.254 Sum_probs=196.9
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEe
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++.++.||+|+||+||+|... +|+.||+|++++.. ....+.+..|..+++.+. |++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456778899999999999964 58999999997532 223456888999998886 5778889999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++||+|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~~-ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 82 YVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRRG-IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 999999999986 4567999999999999999999999999 999999999999999999999999998754322
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
....||+.|+|||++.+..++.++||||+|+++|+|++|+.||............... ....+...+.++.+++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li 232 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------NVSYPKSLSKEAVSIC 232 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCccCCHHHHHHH
Confidence 2345899999999999888999999999999999999999998765443333322211 1123445677899999
Q ss_pred HHhcccCCCCCCCH
Q 013126 293 SRCLQYEPRERPNP 306 (449)
Q Consensus 293 ~~cl~~dP~~Rps~ 306 (449)
.+||+.||.+|++.
T Consensus 233 ~~~l~~~p~~R~~~ 246 (323)
T cd05615 233 KGLMTKHPSKRLGC 246 (323)
T ss_pred HHHcccCHhhCCCC
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=325.42 Aligned_cols=249 Identities=16% Similarity=0.196 Sum_probs=195.8
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhcc---CCCCcccceeeEeeC-----C
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQL---RNNRLTNLLGCCCEG-----D 129 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~-----~ 129 (449)
.|++++.||+|+||+||+|... +++.||+|.++..... ....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3778899999999999999965 5899999999754322 234566788777766 699999999988642 4
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
..+++|||++ ++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++..
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC-IVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECccCccccc
Confidence 5899999998 58999887544556899999999999999999999999 999999999999999999999999998865
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc--------cc------
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--------LT------ 272 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~------ 272 (449)
... ....+|..|+|||++.+..++.++||||+||++|+|++|++||..........+.... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 433 2345788999999999888999999999999999999999888544222111110000 00
Q ss_pred cccc-------CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 DSCL-------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .....+..+.++.+++.+||+.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00112345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=324.46 Aligned_cols=250 Identities=23% Similarity=0.310 Sum_probs=204.9
Q ss_pred ccccccccCCccceEEEEEEEcC------CCEEEEEEecCCCC-CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~------~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
+|++++.||+|+||.||++...+ ...+|+|.+..... ....++.+|+++++++ +||||+++++++..++..+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 47788899999999999998532 36899999875432 2235688999999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCe
Q 013126 133 LVAEYMPNETLAKHLFHW--------------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP 198 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~ 198 (449)
++|||+++|+|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-CIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-ccccccceeeEEEcCCCeE
Confidence 999999999999998642 2356889999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccc
Q 013126 199 RLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQML 271 (449)
Q Consensus 199 kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 271 (449)
||+|||+++...... ...++..|+|||++.+..++.++||||||+++||+++ |..|+................
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 251 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY 251 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998654321 1234567999999988889999999999999999998 888876554333322211111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 252 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 252 -----RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1122345567899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=331.30 Aligned_cols=249 Identities=19% Similarity=0.179 Sum_probs=199.5
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||+||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++|+||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 5788999999999999999964 48999999996421 1234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--- 213 (449)
|++||+|.+++.+ ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLG-YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred cCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 9999999999964 3457899999999999999999999999 9999999999999999999999999987654332
Q ss_pred --ccccCccccccccccC-----CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 --SYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 --~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..................... .......++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 238 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF-PPDVTDVSE 238 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC-CCccCCCCH
Confidence 2358999999999863 34788999999999999999999998765433322222111100000 111234677
Q ss_pred HHHHHHHHhcccCCC--CCCCHHHHHHH
Q 013126 287 ELVRLASRCLQYEPR--ERPNPKSLVTA 312 (449)
Q Consensus 287 ~l~~li~~cl~~dP~--~Rps~~eil~~ 312 (449)
++.+++.+||..+++ .|+++++++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 899999998865443 37899999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=325.76 Aligned_cols=256 Identities=21% Similarity=0.273 Sum_probs=206.7
Q ss_pred CcccccccccCCccceEEEEEEEcC-C--CEEEEEEecCCCC-CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN-Q--RRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~-~--~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 133 (449)
+++|++.+.||+|+||.||+|...+ + ..+++|.++.... ...+.+.+|+++++++ +||||+++++++...+..++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 3567888899999999999998643 3 3578998875332 2246789999999999 79999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeE
Q 013126 134 VAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~k 199 (449)
+|||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-FIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCcCCcceEEECCCCeEE
Confidence 999999999999996421 135888999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccc
Q 013126 200 LSTFGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSC 275 (449)
Q Consensus 200 L~DFGla~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (449)
|+|||++...... .....+..|+|||++.+..++.++||||||+++|||++ |..||................
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~---- 235 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---- 235 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC----
Confidence 9999998643321 11223457999999988889999999999999999998 888886654443333222111
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
....+..++.++.+++.+||+.||.+|||++++++.|+.+....
T Consensus 236 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 236 -RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11223456778999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.65 Aligned_cols=247 Identities=17% Similarity=0.206 Sum_probs=205.0
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCC-------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------- 129 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------- 129 (449)
..|++.+.||+|+||+||+|+. .+++.||||.+...... ....+.+|+.++..++|+||+++++.+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 4688889999999999999995 46899999999754322 2456889999999999999999988765432
Q ss_pred -eeEEEEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 130 -ERLLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 130 -~~~lV~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
.+++||||+++|+|.+++... ....+++..+..++.|++.||+|+|+++ |+||||||+|||+++++.+||+|||++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~-IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEeCCCCEEEEecccC
Confidence 368999999999999998642 2457899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCC
Q 013126 207 KNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (449)
Q Consensus 207 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (449)
+..... ....||+.|+|||++.+..++.++||||||+++|||++|+.||................. ...
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-----~~~ 265 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-----DPL 265 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-----CCC
Confidence 764321 345689999999999988899999999999999999999999976654443333222211 123
Q ss_pred CchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+...++++.+++.+||+.||++||++.++++.
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 45677899999999999999999999999863
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=319.41 Aligned_cols=238 Identities=19% Similarity=0.339 Sum_probs=193.4
Q ss_pred ccCCccceEEEEEEEcC-------------CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 67 EHGEKAPNVVYKGKLEN-------------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~-------------~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.||+|+||.||+|+..+ ...||+|.+..........+.+|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 57999999999998432 23589999876554445678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC-------eEEeccCCc
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN-------PRLSTFGLM 206 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~-------~kL~DFGla 206 (449)
||||+++++|..++.. ....+++..++.++.||+.||+|||+++ ++||||||+|||++.++. ++++|||++
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKD-LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCC-eECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999999988864 3456899999999999999999999999 999999999999987664 899999998
Q ss_pred ccCCCCCccccCcccccccccc-CCCCCCCCceeeHhHHHHHHh-cCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 207 KNSRDGKSYSTNLAFTPPEYLR-TGRVTPESVIYSFGTLLLDLL-SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 207 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
..........++..|+|||++. +..++.++||||||+++|||+ +|..|+............ . .. .......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~----~~--~~~~~~~ 232 (262)
T cd05077 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-E----GQ--CMLVTPS 232 (262)
T ss_pred ccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-h----cC--ccCCCCC
Confidence 8766555667888999999987 456899999999999999998 477666543322211100 0 00 0112234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
+.++.+++.+||+.||++||++.++++.+
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 56899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=323.32 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=201.2
Q ss_pred ccccccccCCccceEEEEEEEc-----CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-----NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-----~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 133 (449)
.+++++.||+|+||+||++..+ +++.||+|.++.......+.+.+|++++++++||||+++++++... ...++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 5788899999999999999742 4789999999765544456889999999999999999999987543 46899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 85 v~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~~-i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 85 VMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999964 3356899999999999999999999999 9999999999999999999999999998654332
Q ss_pred c-------cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh---ccc--------ccccccc
Q 013126 214 S-------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD---RNL--------QMLTDSC 275 (449)
Q Consensus 214 ~-------~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~---~~~--------~~~~~~~ 275 (449)
. ..++..|+|||++.+..++.++||||||+++|||++|..++.......... ... .......
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 1 122346999999988889999999999999999999876643322111100 000 0000001
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.....+...+.++.+++.+||+.+|++|||++++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11122345677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=326.82 Aligned_cols=255 Identities=19% Similarity=0.258 Sum_probs=212.1
Q ss_pred HHHHHhhCCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC
Q 013126 50 EQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128 (449)
Q Consensus 50 ~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 128 (449)
+++....+....|++++.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..+
T Consensus 9 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 9 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred HhhcccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 34444455567899999999999999999995 46899999999876655567889999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
+..++||||++|++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~-i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred CEEEEeecccCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEECcCccceE
Confidence 99999999999999999984 356899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCC----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 209 SRDGK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 209 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
..... ...+++.|+|||.+.+..++.++|+||||+++|++++|..||.......... ............+...
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNGTPELQNPERL 241 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---eeccCCCCCCCCcccc
Confidence 54332 3457889999999998889999999999999999999999886543211110 0111111111233456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+..+.+++.+||+.||++||++.++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 678999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=323.48 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=199.4
Q ss_pred ccccccCCccceEEEEEEE-----cCCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEEE
Q 013126 63 NIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLLV 134 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~-----~~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 134 (449)
++++.||+|+||+||++.. .+++.||+|.++.... ...+.+.+|+++++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7888999999999988652 3478899999976432 2356788999999999999999999987654 458999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
|||+++++|.+++. ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~---~~~l~~~~~~~i~~~l~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHSQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHH---HcCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 99999999999995 346999999999999999999999999 9999999999999999999999999987654322
Q ss_pred ------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH--HHhhccc--------ccccccccC
Q 013126 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD--LIRDRNL--------QMLTDSCLE 277 (449)
Q Consensus 214 ------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~--~~~~~~~--------~~~~~~~~~ 277 (449)
...++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ....... .........
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 123456799999998888999999999999999999999886432111 0000000 000011111
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
...+...+.++.+++.+||+.||++|||++++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 122445678999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=321.82 Aligned_cols=245 Identities=16% Similarity=0.201 Sum_probs=201.7
Q ss_pred cccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
|++++.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 6788999999999999999654 788999998765544466789999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cccc
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYS 216 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~ 216 (449)
++|..++.. ...++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ....
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~-i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 999988754 3467999999999999999999999999 999999999999999999999999998754332 2345
Q ss_pred cCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 217 TNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 217 gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
++..|+|||++. +..++.++||||+||++|+|++|+.|+.................. ....+...+.++.++
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l 241 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP---TLAQPSRWSSEFKDF 241 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC---CCCCccccCHHHHHH
Confidence 789999999984 345788999999999999999999888654322211111111110 111233466789999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+.+||+.||++||++.++++
T Consensus 242 i~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHccCChhhCcCHHHHhc
Confidence 99999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=337.75 Aligned_cols=247 Identities=18% Similarity=0.235 Sum_probs=197.4
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCC-----eeEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ERLL 133 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~l 133 (449)
+++++.||+|+||+||++... +++.||+|++..... ...+++.+|+++++.++||||+++++++...+ ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 567888999999999999964 589999999865322 23467889999999999999999999998776 7899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+. ++|.+.+. ....+++..++.++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 82 v~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 82 VTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAG-ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred Eeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 999997 68888886 4567999999999999999999999999 999999999999999999999999999764432
Q ss_pred ----CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc------------------
Q 013126 213 ----KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------ 269 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------------ 269 (449)
....+++.|+|||++.+.. ++.++||||+||++|||++|+.||..............
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 2235688999999998754 79999999999999999999999865432211110000
Q ss_pred -----cccc-ccc--CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 270 -----MLTD-SCL--EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 270 -----~~~~-~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.... +.. ........++++.+++.+||+.||++|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000 001223446789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=314.44 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=200.6
Q ss_pred ccCCccceEEEEEEEcCCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHH
Q 013126 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ 145 (449)
.||+|+||.||+|...+++.+|+|.++...... ...+.+|+++++.++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 569999999999998788999999987654222 3468899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----ccccCcc
Q 013126 146 HLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----SYSTNLA 220 (449)
Q Consensus 146 ~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----~~~gt~~ 220 (449)
++.. ....+++..+..++.|++.||.|+|+++ ++||||||+||++++++.+||+|||++....... ...++..
T Consensus 82 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 82 FLRK-KKDELKTKQLVKFALDAAAGMAYLESKN-CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 9864 3456889999999999999999999999 9999999999999999999999999987543321 1233567
Q ss_pred ccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccC
Q 013126 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (449)
Q Consensus 221 y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (449)
|+|||++.+..++.++||||||+++|++++ |..|+............... .....+...+..+.+++.+||+.+
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-----YRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHHHHHcccC
Confidence 999999988889999999999999999998 88887654433332222111 112234456788999999999999
Q ss_pred CCCCCCHHHHHHHhc
Q 013126 300 PRERPNPKSLVTALS 314 (449)
Q Consensus 300 P~~Rps~~eil~~L~ 314 (449)
|++||++.++++.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=320.86 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=204.1
Q ss_pred cccccccccCCccceEEEEEEEcC------CCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~------~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
++|++.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++||||+++++++..++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 457788999999999999998642 37899999865432 22457889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccC
Q 013126 133 LVAEYMPNETLAKHLFHWE--------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFG 204 (449)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-FVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccChheEEEcCCCCEEECCcc
Confidence 9999999999999986422 234688899999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccC
Q 013126 205 LMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 205 la~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
+++..... ....++..|+|||.+.++.++.++||||||+++||+++ |+.|+............... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-----~~ 239 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-----GH 239 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-----CC
Confidence 98754332 22345678999999988889999999999999999998 88887654433332222111 01
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
...+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1234455788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.55 Aligned_cols=252 Identities=18% Similarity=0.164 Sum_probs=209.5
Q ss_pred cccccccccCCccceEEEEEEEcCC-CEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeE-eeC------Ce
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQ-RRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCC-CEG------DE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~-~~~------~~ 130 (449)
...++.+.|.+|||+.||+|.+..+ ..||+|++-..+..+.+...+|+++|++|+ |+|||.++|.. ... -.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3577888899999999999997664 999999998776667788999999999996 99999999932 211 24
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
++|.||||+||.|-|++..+....|++.++++|+.++++|+++||... +|||||||-+||||+.+|..||||||.+...
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 789999999999999998766677999999999999999999999975 4999999999999999999999999988643
Q ss_pred CCCC-------------ccccCccccccccc---cCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc
Q 013126 210 RDGK-------------SYSTNLAFTPPEYL---RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273 (449)
Q Consensus 210 ~~~~-------------~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 273 (449)
.... ...+|+-|+|||++ .+.+.++|+|||+|||+||-|+....||.....-.+....+.
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~---- 272 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYS---- 272 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecccc----
Confidence 2211 12468999999987 466799999999999999999999999976533223222222
Q ss_pred cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
-...+..+..+.+||..||+.||++||++-+++..+..+...
T Consensus 273 ----~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 273 ----FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 122357888999999999999999999999999988766543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=321.78 Aligned_cols=240 Identities=24% Similarity=0.367 Sum_probs=194.4
Q ss_pred ccCCccceEEEEEEEcC-C-------CEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 67 EHGEKAPNVVYKGKLEN-Q-------RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~-~-------~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.||+|+||.||+|.... + ..+|+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 57999999999998532 2 348888886554444567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC--------eEEeccCCcccCC
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--------PRLSTFGLMKNSR 210 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~--------~kL~DFGla~~~~ 210 (449)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ ++||||||+||+++.++. ++++|||++....
T Consensus 82 ~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 82 KFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDKG-LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99999999974 2346899999999999999999999999 999999999999987665 6999999987766
Q ss_pred CCCccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 211 DGKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 211 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
......+++.|+|||++.+. .++.++||||||+++|+|++|..++............... ....+...+.++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 233 (258)
T cd05078 160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------RHQLPAPKWTELA 233 (258)
T ss_pred CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------cccCCCCCcHHHH
Confidence 66666788999999999864 4899999999999999999996444322111111100000 1123344557899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 290 RLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
+++.+||+.||++|||++++++.|+
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHhcC
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=319.45 Aligned_cols=247 Identities=17% Similarity=0.177 Sum_probs=201.8
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.+|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46788889999999999999954 58999999997655444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
++++|.+++. ..+.+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...... ..
T Consensus 89 ~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 89 GGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSKG-KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 9999999986 4567999999999999999999999999 999999999999999999999999998654322 34
Q ss_pred cccCcccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc-cccccccccCCCCCchhHHHHHH
Q 013126 215 YSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-LQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 215 ~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
..|+..|+|||++. ...++.++|+|||||++|+|++|..|+............ ......+.. ......+..+.+
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 243 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL--KDKMKWSNSFHH 243 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcc--cccCCCCHHHHH
Confidence 56889999999974 455889999999999999999999887543211111000 011111100 111235678999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||+.||++||+++++++
T Consensus 244 li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHccCCchhCcCHHHHhc
Confidence 999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.64 Aligned_cols=243 Identities=30% Similarity=0.420 Sum_probs=204.7
Q ss_pred cccCCccceEEEEEEEcC----CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
+.||+|+||.||+|.... +..||+|.++...... .+.+.+|++.++.++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 357999999999999643 7899999998755433 67899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 141 ETLAKHLFHWE-------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 141 gsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-cccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999997531 377899999999999999999999999 999999999999999999999999999876543
Q ss_pred -----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 213 -----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
....++..|+|||.+.+..++.++||||+|+++|+|++ |..|+............... .....+...+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 234 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-----YRLPKPEYCPD 234 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCccCCh
Confidence 23456788999999988889999999999999999999 58887665433333222211 11223455678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
++.+++.+||+.||++|||+.++++.|+
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=333.38 Aligned_cols=248 Identities=16% Similarity=0.196 Sum_probs=195.4
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCC------
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 129 (449)
...|++++.||+|+||.||++... +|+.||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 356889999999999999999964 589999999975432 23567889999999999999999999986543
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
..|+||||++ ++|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 4799999997 56766663 34888999999999999999999999 999999999999999999999999999764
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc----------------
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM---------------- 270 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---------------- 270 (449)
... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 332 2356789999999999889999999999999999999999998643211100000000
Q ss_pred --ccc--ccc----------------CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 271 --LTD--SCL----------------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 271 --~~~--~~~----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
... +.. ........++++.+++.+||+.||++|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000 000111235678999999999999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=343.19 Aligned_cols=247 Identities=21% Similarity=0.274 Sum_probs=193.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC--------Ce
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--------DE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~~ 130 (449)
..|++++.||+|+||+||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 46889999999999999999964 58999999985432 3456799999999999999999887532 24
Q ss_pred eEEEEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-CeEEeccCCcc
Q 013126 131 RLLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMK 207 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~ 207 (449)
+++||||++ ++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 142 l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~-IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCcCHHHEEEcCCCCceeeeccccch
Confidence 679999998 5787776531 3567899999999999999999999999 99999999999999654 79999999998
Q ss_pred cCCCC---CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc-------------
Q 013126 208 NSRDG---KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM------------- 270 (449)
Q Consensus 208 ~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~------------- 270 (449)
..... ....+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+.............
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 65433 245678999999998764 5899999999999999999999998764322111111000
Q ss_pred ----------ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 271 ----------LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 271 ----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.........++...++++.+|+.+||++||.+|||+.+++++
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000001111233456789999999999999999999999973
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=339.17 Aligned_cols=240 Identities=20% Similarity=0.297 Sum_probs=203.7
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHH
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ 145 (449)
.||+|.||+||.|++. +..++|||.+........+-+..|+.+-++++|.|||+++|.+.+++.+-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 3799999999999954 578899999988776677789999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-CCCCeEEeccCCcccCCC----CCccccC
Q 013126 146 HLFHWETHPM--KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRD----GKSYSTN 218 (449)
Q Consensus 146 ~l~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~----~~~~~gt 218 (449)
+++. +=+++ ++.+.-.+.+||+.||.|||++. |+|||||-+|+|++ -.|.+||+|||-++.... ..++.||
T Consensus 662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~-IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENK-IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcc-eeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 9985 34566 78888999999999999999998 99999999999998 679999999998876432 3567899
Q ss_pred ccccccccccCCC--CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhc
Q 013126 219 LAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (449)
Q Consensus 219 ~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (449)
..|||||++..++ |+.++|||||||++.||.||++||..-.......-.... -...+..|.+++.+++.+|.+|+
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm---yKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM---YKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc---eecCCCCcHHHHHHHHHHHHHHc
Confidence 9999999998765 899999999999999999999998543211111111111 11224567789999999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 013126 297 QYEPRERPNPKSLVT 311 (449)
Q Consensus 297 ~~dP~~Rps~~eil~ 311 (449)
..||.+||++.+++.
T Consensus 817 epd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcccCccHHHhcc
Confidence 999999999999996
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=322.56 Aligned_cols=239 Identities=23% Similarity=0.373 Sum_probs=191.9
Q ss_pred ccCCccceEEEEEEEcC-------------------------CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccc
Q 013126 67 EHGEKAPNVVYKGKLEN-------------------------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNL 121 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~-------------------------~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 121 (449)
.||+|+||.||+|.... ...||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 57999999999997421 24589999865443334678899999999999999999
Q ss_pred eeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-----
Q 013126 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----- 196 (449)
Q Consensus 122 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~----- 196 (449)
++++.+++..++||||+++|+|..++.. ..+.+++..+..++.|++.||+|||+++ ++||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKN-LVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCC-ccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999999998864 3467899999999999999999999998 99999999999998644
Q ss_pred --CeEEeccCCcccCCCCCccccCccccccccccC-CCCCCCCceeeHhHHHHHHh-cCCCCCCchhhHHHhhccccccc
Q 013126 197 --NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLL-SGKHIPPSHALDLIRDRNLQMLT 272 (449)
Q Consensus 197 --~~kL~DFGla~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~ 272 (449)
.+|++|||++..........++..|+|||.+.+ ..++.++||||||+++||++ +|+.|+........... ...
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~-- 236 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-YEK-- 236 (274)
T ss_pred cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-HHh--
Confidence 389999999876554445567888999999875 45899999999999999995 68877754432221111 000
Q ss_pred ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
....+...++.+.+++.+||+.+|++|||+.++++.|.
T Consensus 237 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 237 ----KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ----ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 01122233467999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=324.21 Aligned_cols=247 Identities=17% Similarity=0.270 Sum_probs=201.6
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
|++.+.||+|+||+||++... +++.||+|.+....... ...+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 445566799999999999965 58999999987543222 34578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---c
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---S 214 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---~ 214 (449)
++|++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++....... .
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 99999999986544557999999999999999999999999 9999999999999999999999999987654332 3
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..|+..|+|||++.+..++.++||||+|+++|+|++|+.||.......... ........ .....+...++++.+++.+
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE-VQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhhh-hhhhcCccCCHHHHHHHHH
Confidence 467899999999998889999999999999999999999987532111000 00111110 0112344566789999999
Q ss_pred hcccCCCCCCC-----HHHHHH
Q 013126 295 CLQYEPRERPN-----PKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps-----~~eil~ 311 (449)
||+.||++||| ++++++
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHc
Confidence 99999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.56 Aligned_cols=252 Identities=17% Similarity=0.234 Sum_probs=200.9
Q ss_pred cccccccccCCccceEEEEEEEc-CCC----EEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~----~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.++++++.||+|+||+||+|.+. +++ .+++|.+...... ...++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35778889999999999999963 344 4788887543222 2356788888999999999999999875 456789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
++||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 86 i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHR-MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999974 3467899999999999999999999999 9999999999999999999999999997643321
Q ss_pred ------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...++..|+|||++.++.++.++||||||+++||+++ |..|+.........+..... .....+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 238 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-----ERLAQPQICTI 238 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----CcCCCCCCCCH
Confidence 2335678999999998889999999999999999998 88887654333222111110 01111223456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++.+++.+||..||++|||+.++++.|..+.+.
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 789999999999999999999999998886643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=326.88 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=206.2
Q ss_pred cccccccccCCccceEEEEEEEc--------CCCEEEEEEecCCCC-CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~--------~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 129 (449)
.+|.+.+.||+|+||.||+|+.. ++..||+|.++.... ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 45778889999999999999741 245799999875432 2356789999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~ 195 (449)
..+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||+++++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-ivH~dlkp~Nili~~~ 173 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-CIHRDLAARNVLVTEN 173 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-eeecccccceEEEcCC
Confidence 9999999999999999997532 135788889999999999999999999 9999999999999999
Q ss_pred CCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccc
Q 013126 196 GNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNL 268 (449)
Q Consensus 196 ~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 268 (449)
+.+||+|||+++...... ...+++.|+|||++.+..++.++||||||+++|+|++ |..|+.......+.....
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 253 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 999999999998654321 2234578999999988889999999999999999998 677776544443333221
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
... ....+...+.++.+++.+||+.+|++|||+.++++.|+++..
T Consensus 254 ~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 254 EGH-----RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred cCC-----cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111 112234567889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=322.84 Aligned_cols=247 Identities=18% Similarity=0.240 Sum_probs=201.7
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
|+..+.||+|+||+||+|.+. +++.||+|.+...... ..+.+.+|+++++.++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 445566799999999999964 5899999999654322 234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---Cc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KS 214 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~ 214 (449)
+++++|.+++.......+++..+..++.|++.||.|||+++ |+||||||+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN-TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 99999999887544557999999999999999999999999 999999999999999999999999998765432 23
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..|+..|+|||++.+..++.++|+||+|+++|+|++|..||................... ....+...+.++.+++.+
T Consensus 161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKSICKM 238 (285)
T ss_pred CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHHHHHH
Confidence 467899999999988889999999999999999999999987543322211111111111 112344567789999999
Q ss_pred hcccCCCCCCC-----HHHHHH
Q 013126 295 CLQYEPRERPN-----PKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps-----~~eil~ 311 (449)
||+.||++||+ +.+++.
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HccCCHhHcCCCcccChHHHHc
Confidence 99999999999 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.60 Aligned_cols=248 Identities=15% Similarity=0.210 Sum_probs=196.8
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeC------C
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------D 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 129 (449)
..+|++++.||+|+||.||++... +++.||||++..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 356888999999999999999964 488999999975432 2346788999999999999999999987643 3
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
..|+||||++ ++|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC-eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 5799999997 57777774 34788999999999999999999999 999999999999999999999999999865
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc------------
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS------------ 274 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------------ 274 (449)
... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||..................+
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 443 23467899999999999899999999999999999999999986543221111111000000
Q ss_pred ---------------------c---cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 275 ---------------------C---LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 275 ---------------------~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
. .........+.++.+++.+||+.||++|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0000111234578999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.95 Aligned_cols=255 Identities=19% Similarity=0.257 Sum_probs=211.1
Q ss_pred HHHHHhhCCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC
Q 013126 50 EQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128 (449)
Q Consensus 50 ~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 128 (449)
+.+...++.-..|++++.||.|++|+||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..+
T Consensus 9 ~~~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 9 RTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred HHHHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 33444454456688999999999999999995 45899999999766555567889999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
+..++|+||+++++|.+++. ...+++.++..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++..
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~~-i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred ceEEEEEEecCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 99999999999999999884 456899999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCC----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 209 SRDGK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 209 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
..... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||.............. ........+...
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~ 241 (296)
T cd06655 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPEKL 241 (296)
T ss_pred cccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCcccCCcccC
Confidence 54332 34578899999999888899999999999999999999999865432211111100 001111224456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+.+++.+||..||++||++.+++.
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 778999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.16 Aligned_cols=242 Identities=20% Similarity=0.270 Sum_probs=197.2
Q ss_pred ccCCccceEEEEEEEc---CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCC
Q 013126 67 EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
+||+|+||.||+|.+. ++..||+|.+....... .+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4799999999999853 35679999997654322 467999999999999999999999875 457899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc-------c
Q 013126 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS-------Y 215 (449)
Q Consensus 143 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-------~ 215 (449)
|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++....... .
T Consensus 81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKN-FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcC-eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999864 3457899999999999999999999999 99999999999999999999999999875433211 1
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
.++..|+|||++.+..++.++||||||+++|++++ |..|+............... .....+...++++.+++.+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-----KRLDCPAECPPEMYALMKD 233 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-----CCCCCCCCCCHHHHHHHHH
Confidence 22468999999988889999999999999999996 88887654333222211111 1122344567899999999
Q ss_pred hcccCCCCCCCHHHHHHHhccc
Q 013126 295 CLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~L~~~ 316 (449)
||..||++||++.++.+.|+.+
T Consensus 234 c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 234 CWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=356.09 Aligned_cols=255 Identities=21% Similarity=0.248 Sum_probs=205.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.+|++++.||+|+||.||+|.+. +++.||+|+++...... .+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46889999999999999999965 48999999997643222 457999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 136 EYMPNETLAKHLFHWE---------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
||++|++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-IIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-VLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999886311 234566788899999999999999999 999999999999999999999999998
Q ss_pred ccCCCC----------------------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh
Q 013126 207 KNSRDG----------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR 264 (449)
Q Consensus 207 ~~~~~~----------------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~ 264 (449)
+..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 754110 1235899999999999989999999999999999999999998654322221
Q ss_pred hcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCC-CHHHHHHHhccccc
Q 013126 265 DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP-NPKSLVTALSPLQK 318 (449)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~eil~~L~~~~~ 318 (449)
... ....+. ........++.+.+++.+||+.||++|| +++++.+.|+.+..
T Consensus 241 ~~~--~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 241 YRD--VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh--hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111 111110 0011235667899999999999999995 67778888877644
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.99 Aligned_cols=245 Identities=18% Similarity=0.208 Sum_probs=202.1
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-----CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-----DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.|++.+.||+|++|.||+|... +++.||+|.++..... ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 3556677799999999999954 5899999998654321 134688999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
+||++|++|.+.+. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.....
T Consensus 83 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999987 4467899999999999999999999999 999999999999999999999999998754322
Q ss_pred -----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 213 -----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
....++..|+|||++.+..++.++||||+|+++|+|++|+.||............. ........+...+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 235 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA----TQPTNPQLPSHVSPD 235 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh----ccCCCCCCCccCCHH
Confidence 22456788999999998889999999999999999999999886532221111111 111112344566788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+.+++.+||..+|++|||+.++++.
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhC
Confidence 9999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.03 Aligned_cols=252 Identities=19% Similarity=0.252 Sum_probs=202.8
Q ss_pred cccccccccCCccceEEEEEEEc-CCC----EEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~----~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
+++++++.||+|+||+||+|++. +++ .||+|.++..... ..+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 35778889999999999999853 444 4899998754322 24678899999999999999999999875 45789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
++||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 86 ~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~-iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 86 VTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999999999974 3456899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...+++.|+|||...+..++.++||||||+++|||++ |..|+................ ....+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 238 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-----RLPQPPICTI 238 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----cCCCCccCCH
Confidence 1234568999999988889999999999999999998 777775543322222111110 1112334667
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++.+++.+||+.||++||++.++++.|+.+...
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 899999999999999999999999988777544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.97 Aligned_cols=248 Identities=20% Similarity=0.305 Sum_probs=205.6
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
..+++.++||+|+||.||++.+.++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.+ ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 4578889999999999999997777889999987543 235679999999999999999999999887 77899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----c
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-----S 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----~ 214 (449)
+++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||.+....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC-ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 999999997544566888999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..++..|+|||++.+..++.++|+||||+++|++++ |+.|+................ ....+...+.++.+++.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-----RMPRPENCPEELYNIMM 237 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-----CCCCcccCCHHHHHHHH
Confidence 234567999999988889999999999999999999 888876543333222211111 11223456678999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcc
Q 013126 294 RCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~ 315 (449)
+||+.||++||++.++++.|+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 238 RCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.09 Aligned_cols=254 Identities=18% Similarity=0.265 Sum_probs=202.0
Q ss_pred cccccccccCCccceEEEEEEEcC-----------------CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccc
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-----------------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNL 121 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-----------------~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l 121 (449)
.+|+++++||+|+||.||+|.... +..||+|.+...... ..+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 368899999999999999998542 245899998765432 35678999999999999999999
Q ss_pred eeeEeeCCeeEEEEeeCCCCCHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee
Q 013126 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWE---------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (449)
Q Consensus 122 ~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl 192 (449)
++++..++..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-i~H~dlkp~Nili 163 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-FVHRDLATRNCLV 163 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccccchhceee
Confidence 999999999999999999999999997432 126899999999999999999999999 9999999999999
Q ss_pred CCCCCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc--CCCCCCchhhHHHh
Q 013126 193 DEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS--GKHIPPSHALDLIR 264 (449)
Q Consensus 193 ~~~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~~ 264 (449)
++++.++|+|||+++..... ....+++.|+|||++.+..++.++||||||+++|||++ |..|+.........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 99999999999998764332 12335678999999988889999999999999999998 55565443222221
Q ss_pred hccccccc--ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 265 DRNLQMLT--DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 265 ~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
........ ........+...+.++.+++.+||+.||++|||+.++++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111100 001111123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=329.47 Aligned_cols=236 Identities=19% Similarity=0.259 Sum_probs=192.0
Q ss_pred ccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++...+.+++||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 5799999999999964 588999999976432 2245688999999888 6999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----CCcccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD----GKSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~----~~~~~g 217 (449)
+|.+++. ..+.+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 82 DLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHERG-IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 9999886 4567999999999999999999999999 99999999999999999999999999875321 123568
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH---HhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL---IRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
|+.|+|||++.+..++.++||||||+++|+|++|+.||....... ............ ....+...+..+.+++.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence 999999999998899999999999999999999999985321100 000000011111 112345567889999999
Q ss_pred hcccCCCCCCCHH
Q 013126 295 CLQYEPRERPNPK 307 (449)
Q Consensus 295 cl~~dP~~Rps~~ 307 (449)
||+.||++|++++
T Consensus 237 ~L~~dP~~R~~~~ 249 (327)
T cd05617 237 FLNKDPKERLGCQ 249 (327)
T ss_pred HhccCHHHcCCCC
Confidence 9999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=316.44 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=201.0
Q ss_pred cccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCe-----
Q 013126 62 ENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE----- 130 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 130 (449)
|++.+.||+|+||.||+|.... +..||+|.++...... .+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 3567888999999999998532 3789999997543222 4578999999999999999999998876554
Q ss_pred -eEEEEeeCCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 131 -RLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 131 -~~lV~Ey~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
.+++|||+++++|..++... ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-FIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-eeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988532 2246899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCC
Q 013126 206 MKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 206 a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (449)
++...... ....+..|+|||++.+..++.++||||||+++|||++ |..|+................ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~ 234 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-----RL 234 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----CC
Confidence 88654332 1234568999999988889999999999999999999 777775543322222111111 11
Q ss_pred CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
..+...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 23445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.04 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=207.8
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
..|++.+.||+|++|.||+|... +|+.||+|.++.... ...+.+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 35778888999999999999965 689999999864322 22567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 136 EYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC-EecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999998642 2456899999999999999999999999 999999999999999999999999998764432
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH--HHhhcccccccccccCCCCCchhHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD--LIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
....+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ...+...... .........+..
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 236 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD----YPPLPADHYSEE 236 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC----CCCCChhhcCHH
Confidence 2345788999999998888999999999999999999999988544221 1111111111 111112255678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
+.+++.+||..+|++|||+.++++.|+.+.
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=333.61 Aligned_cols=248 Identities=16% Similarity=0.229 Sum_probs=196.5
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeC------C
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG------D 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 129 (449)
.++|++++.||+|+||.||++... +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 457888999999999999999954 4899999999754322 246788999999999999999999988654 3
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
..++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~-~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhc-ccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 5799999997 56777664 35888999999999999999999999 999999999999999999999999999865
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc---------------
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML--------------- 271 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------------- 271 (449)
... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 443 23568899999999998889999999999999999999999986542211100000000
Q ss_pred ---c----------------cccc--CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 272 ---T----------------DSCL--EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 272 ---~----------------~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
. +... ........+.++.+++.+||+.||++|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 0000 001112235678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=329.50 Aligned_cols=250 Identities=18% Similarity=0.171 Sum_probs=200.4
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
++|++++.||+|+||+||+++.. +++.||+|.+.+.. ......+.+|..++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35788999999999999999965 58899999996522 122345888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC--
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-- 213 (449)
||++||+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~~-iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQLH-YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999999999974 2457899999999999999999999999 9999999999999999999999999987654332
Q ss_pred ---ccccCccccccccccC-----CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 214 ---SYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 214 ---~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
...||+.|+|||++.+ +.++.++||||||+++|+|++|+.||..................... .......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~~~~~ 237 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF-PSHITDVS 237 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC-CCccccCC
Confidence 2458999999999875 45788999999999999999999998765433322222111111101 11123457
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013126 286 TELVRLASRCLQYEPRE--RPNPKSLVTA 312 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~--Rps~~eil~~ 312 (449)
+++.+++.+||..++++ |+++++++++
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 88999999999876654 4688888864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=321.76 Aligned_cols=250 Identities=17% Similarity=0.217 Sum_probs=205.9
Q ss_pred CCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+..+.|+++++||.|++|.||++... ++..+|+|.+........+.+.+|++++++++||||+++++.+..++..++||
T Consensus 2 ~~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred CchhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 34567899999999999999999964 58999999997655444667999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSHK-VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999999864 3457999999999999999999999999 999999999999999999999999987654332
Q ss_pred -CccccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 213 -KSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
....+++.|+|||++. +..++.++|+||||+++|+|++|+.|+................ ......+...+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 236 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQPSKWSS 236 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC---CCCcCCcccCCH
Confidence 2345788999999975 3447789999999999999999999886543222111111110 011112345667
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+++.+||+.||++||++.++++
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhc
Confidence 8999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=325.12 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=206.9
Q ss_pred cccccccccCCccceEEEEEEEcC--------CCEEEEEEecCCCC-CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~--------~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 129 (449)
++|.+.+.||+|+||.||++...+ ...+|+|.++.... ....++.+|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 458889999999999999998521 34699999976432 2345788999999999 7999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~ 195 (449)
..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+++ ++||||||+||+++++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-i~H~dlkp~Nill~~~ 176 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTED 176 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-cccccccHHheEEcCC
Confidence 9999999999999999997532 135888999999999999999999999 9999999999999999
Q ss_pred CCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccc
Q 013126 196 GNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNL 268 (449)
Q Consensus 196 ~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 268 (449)
+.+||+|||.++...... ...+++.|+|||++.+..++.++||||||+++|+|++ |+.|+.............
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 999999999987654321 1223468999999988889999999999999999998 777776544433332211
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.. .....+...+.++.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 257 ~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 257 EG-----HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred cC-----CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11 11123445678899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.53 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=204.7
Q ss_pred CcccccccccCCccceEEEEEEEcC-C---CEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN-Q---RRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~-~---~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
..++++.+.||+|+||.||+|.... + ..||+|.++.... ...++|.+|+.+++.++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 3467888999999999999999643 3 3699999876432 225679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||+++++|.+++.. ..+.+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~g-~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999874 3456899999999999999999999999 9999999999999999999999999987543321
Q ss_pred c-------cc--cCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCch
Q 013126 214 S-------YS--TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 214 ~-------~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (449)
. .. .+..|+|||++.+..++.++||||||+++||+++ |..|+................ ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-----~~~~~~~ 235 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-----RLPPPMD 235 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----cCCCccc
Confidence 1 11 1347999999998889999999999999999886 888886544333322221111 1112345
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.+..+.+++.+||+.+|++||++++++..|+.+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 667899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.70 Aligned_cols=252 Identities=19% Similarity=0.330 Sum_probs=200.2
Q ss_pred cccccccCCccceEEEEEEE-----cCCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~-----~~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 133 (449)
|++++.||+|+||.||+++. .+++.||+|.++.... ...+.+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 67888999999999999984 2478999999875432 2246799999999999999999999998775 56899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||++|++|.+++.+ ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||+++......
T Consensus 86 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~g-i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 86 IMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999864 2346899999999999999999999999 9999999999999999999999999987654321
Q ss_pred -------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh-----------hcccccccccc
Q 013126 214 -------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR-----------DRNLQMLTDSC 275 (449)
Q Consensus 214 -------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-----------~~~~~~~~~~~ 275 (449)
...++..|+|||++.+..++.++||||||+++|+|++++.|.......... ..........
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG- 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC-
Confidence 234567799999998888999999999999999999987654221100000 0000000000
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 01122345678899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.49 Aligned_cols=242 Identities=21% Similarity=0.288 Sum_probs=199.3
Q ss_pred ccCCccceEEEEEEEcC--C--CEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLEN--Q--RRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~--~--~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|++|+||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 57999999999999643 3 3699999987654 345689999999999999999999999988 8899999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-------Cc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-------KS 214 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-------~~ 214 (449)
+|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC-ccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 9999997533357899999999999999999999999 999999999999999999999999998765432 12
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..++..|+|||++.+..++.++||||||+++|+|++ |+.|+............... ......+...+..+.+++.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE----GERLERPEACPQDIYNVML 235 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----CCcCCCCccCCHHHHHHHH
Confidence 345678999999988889999999999999999999 99887543322222111110 0111123455678999999
Q ss_pred HhcccCCCCCCCHHHHHHHhc
Q 013126 294 RCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~ 314 (449)
+||+.+|++|||+.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=313.43 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=204.5
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.+++++.+.||+|+||.||+|.+.+++.+|+|.++... .....+.+|++++++++|||++++++++......++||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 34678889999999999999998778899999987543 34568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----- 213 (449)
++++|.+++.. ....++++.++.++.|++.|++|||+++ ++||||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 82 EHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESSN-VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999864 3456889999999999999999999999 9999999999999999999999999987543321
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...++..|+|||++.++.++.++||||||+++|||++ |..|+................ ....+...+..+.+++
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-----RLYKPRLASQSVYELM 234 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-----CCCCCCCCCHHHHHHH
Confidence 1234568999999988889999999999999999998 888876544333222211110 0111223467899999
Q ss_pred HHhcccCCCCCCCHHHHHHHh
Q 013126 293 SRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L 313 (449)
.+||+.+|++|||+.++++.|
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.04 Aligned_cols=249 Identities=18% Similarity=0.224 Sum_probs=201.5
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+|++++.||+|+||.||++... ++..+|+|.++...... ..++.+|++++++++||||+++++.+..++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 5778899999999999999954 58889999987543222 356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCCC--Ccc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSY 215 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~~~ 215 (449)
+|++|.+++. ....+++..+..++.|++.||.|||+ .+ ++||||||+||++++++.+||+|||++...... ...
T Consensus 82 ~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (308)
T cd06615 82 DGGSLDQVLK--KAGRIPENILGKISIAVLRGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158 (308)
T ss_pred CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC-EEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence 9999999997 44678999999999999999999998 47 999999999999999999999999998764332 345
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc---cccc--------------------
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL---QMLT-------------------- 272 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~---~~~~-------------------- 272 (449)
.++..|+|||++.+..++.++|+||||+++|+|++|+.|+............. ....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence 67899999999988889999999999999999999999875433222111000 0000
Q ss_pred ---------ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 273 ---------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 273 ---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
............+.++.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000011246689999999999999999999999984
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=316.05 Aligned_cols=247 Identities=21% Similarity=0.246 Sum_probs=192.0
Q ss_pred cccCCccceEEEEEEEcC---CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 66 SEHGEKAPNVVYKGKLEN---QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~---~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
+.||+|+||.||+|.+.+ +..+|+|.++..... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 357999999999998543 467999998765432 2357889999999999999999999999999999999999999
Q ss_pred CHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----
Q 013126 142 TLAKHLFHWE---THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (449)
Q Consensus 142 sL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----- 213 (449)
+|.+++.... ....++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-EeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 9999996422 234567788899999999999999999 9999999999999999999999999987543321
Q ss_pred -ccccCccccccccccCC-------CCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 214 -SYSTNLAFTPPEYLRTG-------RVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
...++..|+|||++.+. .++.++|+||||+++|||++ |+.||.............................
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 23456789999998642 35789999999999999996 9888865432222111111111111111222345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
++.+.+++.+|| .+|++|||+++++..|+
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 677899999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=325.16 Aligned_cols=252 Identities=20% Similarity=0.296 Sum_probs=204.1
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhcc-CCCCcccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 131 (449)
+++.+.+.||+|+||.||++... .+..||+|.++...... .+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 34777888899999999999742 24579999987643222 45789999999999 799999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
+++|||+++|+|.+++.......+++.+...++.|++.||+|||+++ ++|+||||+||++++++.++|+|||+++....
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999997544445899999999999999999999999 99999999999999999999999999876543
Q ss_pred CC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 212 GK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 212 ~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
.. ...++..|+|||.+.+..++.++||||+|+++|+|++ |..|+............... ......+...
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~ 269 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQPEHA 269 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc----CCcCCCCCCC
Confidence 22 2234678999999998889999999999999999998 88887654322111111110 0111123345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
++++.+++.+||+.+|++|||+.++++.|.++
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 67899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=313.74 Aligned_cols=246 Identities=18% Similarity=0.209 Sum_probs=206.5
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|++++.||.|+||.||.++. .+++.+++|.+.... .....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 367888899999999999994 458999999986543 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
+++++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999997544567899999999999999999999999 9999999999999999999999999987654432
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...+++.|+|||.+.+..++.++||||||+++|+|++|..|+................. ...+...+.++.+++.
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~ 234 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY-----TPVVSVYSSELISLVH 234 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----CCCccccCHHHHHHHH
Confidence 35578999999999888899999999999999999999998866443332222221111 1122456678999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~ 312 (449)
+||+.+|++||++.++++.
T Consensus 235 ~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 235 SLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHcccCcccCCCHHHHhhC
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.70 Aligned_cols=254 Identities=20% Similarity=0.276 Sum_probs=199.7
Q ss_pred cccccccccCCccceEEEEEEEcC---------------CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCccccee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN---------------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLG 123 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~---------------~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~ 123 (449)
.+|++.++||+|+||.||++...+ ...||+|.++...... .+.+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468899999999999999987532 2358999997643222 457999999999999999999999
Q ss_pred eEeeCCeeEEEEeeCCCCCHHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC
Q 013126 124 CCCEGDERLLVAEYMPNETLAKHLFHWE----------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193 (449)
Q Consensus 124 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~ 193 (449)
++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||+++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~Nill~ 163 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-FVHRDLATRNCLVG 163 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-eeccccChhhEEEc
Confidence 9999999999999999999999986421 124678899999999999999999999 99999999999999
Q ss_pred CCCCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc--CCCCCCchhhHHHhh
Q 013126 194 EDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS--GKHIPPSHALDLIRD 265 (449)
Q Consensus 194 ~~~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~~~ 265 (449)
+++.+||+|||++....... ...++..|+|||++.++.++.++||||||+++|+|++ |..|+..........
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 99999999999987643321 1234578999999988889999999999999999998 445554432222211
Q ss_pred ccccccc--ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 266 RNLQMLT--DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 266 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
....... ........++..++.+.+++.+||+.||++|||+.++++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 244 NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1100000 000011123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.99 Aligned_cols=247 Identities=19% Similarity=0.263 Sum_probs=190.3
Q ss_pred cccCCccceEEEEEEEcC---CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 66 SEHGEKAPNVVYKGKLEN---QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~---~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
++||+|+||.||+|...+ ...+|+|.+...... ....+.+|+.+++.++||||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 357999999999997433 457888887654322 2456889999999999999999999999999999999999999
Q ss_pred CHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC------
Q 013126 142 TLAKHLFHWE---THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------ 212 (449)
Q Consensus 142 sL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~------ 212 (449)
+|.+++.... ....++.....++.||+.||+|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-EecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 9999997532 233467888999999999999999999 999999999999999999999999998653322
Q ss_pred CccccCccccccccccC-------CCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 213 KSYSTNLAFTPPEYLRT-------GRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
....+++.|+|||++.. ..++.++||||||+++|||++ |..|+.........................+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 12234677999998743 346889999999999999999 6666654332222111111111111122334456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
++.+.+++..|| .||++|||++++++.|.
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 778889999999 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.20 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=202.1
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
..+.+++.||+|++|.||+|.+. .+..||+|.++...... ...|.+|+.+++.++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 34677888899999999999964 35789999887543222 456999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC---CeEEeccC
Q 013126 133 LVAEYMPNETLAKHLFHWET-----HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG---NPRLSTFG 204 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~---~~kL~DFG 204 (449)
+||||++|++|.+++..... ..+++..+..++.||+.||+|||+++ ++||||||+||+++.++ .+||+|||
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-FIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999999975321 25889999999999999999999999 99999999999998654 59999999
Q ss_pred CcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccC
Q 013126 205 LMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 205 la~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||............... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----~~ 239 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-----GR 239 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-----Cc
Confidence 998653221 1122467999999988889999999999999999997 88887665433332221111 11
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
...+...+..+.+++.+||+.||++|||+.++++.|.
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2234556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=314.03 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=204.8
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+.+|++.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++|||++++++++..+ ..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 45688899999999999999975 67889999986532 356789999999999999999999998664 579999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-Ccccc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSYST 217 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~~g 217 (449)
++++|.+++.......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK-LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCC
Confidence 9999999997544556899999999999999999999999 999999999999999999999999998765433 22334
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (449)
+..|+|||.+.+..++.++|+||||+++|+|++ |+.|+................ ....+...+..+.+++.+||
T Consensus 160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-----RMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-----CCCCCCcCCHHHHHHHHHHc
Confidence 567999999988889999999999999999998 888876654433332221111 11223456788999999999
Q ss_pred ccCCCCCCCHHHHHHHhcc
Q 013126 297 QYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 297 ~~dP~~Rps~~eil~~L~~ 315 (449)
+.+|++||+++++++.|+.
T Consensus 235 ~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 235 ETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCChhhCcCHHHHHHHHcc
Confidence 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=327.72 Aligned_cols=249 Identities=18% Similarity=0.172 Sum_probs=200.0
Q ss_pred ccccccccCCccceEEEEEEEcC-CCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||+||+++.+. ++.+|+|++.+.. ......+.+|+.++..++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 57888999999999999999654 8899999986421 1223458889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++||+|.+++.+ ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 82 y~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~-iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999999974 2457899999999999999999999999 999999999999999999999999998754322
Q ss_pred -CccccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 213 -KSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.................... .......+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~~~s~ 238 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-FPAQVTDVSE 238 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc-CCCccccCCH
Confidence 1246899999999986 24588999999999999999999999876543333322221111110 1111235678
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013126 287 ELVRLASRCLQYEPRE--RPNPKSLVTA 312 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~--Rps~~eil~~ 312 (449)
++.+++.+|+..++++ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 8999999999765544 6899999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=315.57 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=196.9
Q ss_pred cccccCCccceEEEEEEEcC-CC--EEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeC------CeeE
Q 013126 64 IVSEHGEKAPNVVYKGKLEN-QR--RIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DERL 132 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~-~~--~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~ 132 (449)
+.+.||+|+||.||+|.+.+ +. .+|+|.++.... ...+.+.+|+++++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45778999999999999654 33 689999876432 2246789999999999999999999987532 2468
Q ss_pred EEEeeCCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 133 LVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
++|||+++|+|.+++... ....+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++.
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-FIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhheEEcCCCCEEECCCCcccc
Confidence 999999999999987421 2345889999999999999999999998 99999999999999999999999999886
Q ss_pred CCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCC
Q 013126 209 SRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 209 ~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
..... ...+++.|+|||+..+..++.++||||||+++|||++ |+.|+............... .....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~ 236 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-----NRLKQP 236 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-----CCCCCC
Confidence 54322 2234678999999998889999999999999999999 77777654332222211111 011223
Q ss_pred chhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
...+..+.+++.+||+.||++|||++++++.|+.+
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 45667899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=331.43 Aligned_cols=243 Identities=21% Similarity=0.252 Sum_probs=205.2
Q ss_pred cccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
|.-++.||.|+||-||-|++ .+++.||||++.-..... -+++++|+..|++++|||++.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 33456789999999999994 568899999997654333 35789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcccc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~g 217 (449)
|- ||-.|.+.- ...++.+.++..|..+.+.||+|||+++ .||||||..|||+++.|.|||+|||.|....+..++.|
T Consensus 108 Cl-GSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~-~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvG 184 (948)
T KOG0577|consen 108 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN-RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVG 184 (948)
T ss_pred Hh-ccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhh-HHhhhccccceEecCCCeeeeccccchhhcCchhcccC
Confidence 97 788887754 5678999999999999999999999999 99999999999999999999999999999999999999
Q ss_pred Ccccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 218 NLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 218 t~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
||.|||||++. .+.|+.++||||||++..||...++|...-+.-...-.+.+. -.+. ...++.+..+.+++..
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPt---Lqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPT---LQSNEWSDYFRNFVDS 260 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCC---CCCchhHHHHHHHHHH
Confidence 99999999985 367999999999999999999999886543222111111111 0111 1245778899999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||++-|.+|||.++++.
T Consensus 261 CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLK 277 (948)
T ss_pred HHhhCcccCCcHHHHhh
Confidence 99999999999999886
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.86 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=204.6
Q ss_pred cccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
+++.+.||+|+||.||+|... +...+|+|.+...... ..+++.+|+.+++.++||||+++++.+..++..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 567788999999999999853 2357899988754322 245789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee
Q 013126 135 AEYMPNETLAKHLFHWE----------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl 192 (449)
+||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-ivH~dikp~nill 160 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-LVHRDLAARNVLV 160 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-eehhhhhhheEEE
Confidence 99999999999986321 135788999999999999999999999 9999999999999
Q ss_pred CCCCCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhh
Q 013126 193 DEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRD 265 (449)
Q Consensus 193 ~~~~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~ 265 (449)
++++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..|+.......+..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999987643321 2234678999999988889999999999999999998 888876554333322
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
...... ....+...+.++.+++.+||+.||++||+++++++.|+++..
T Consensus 241 ~~~~~~-----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 241 LLKTGY-----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHhCCC-----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 211111 112234566789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=316.96 Aligned_cols=245 Identities=13% Similarity=0.191 Sum_probs=198.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeC------CeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEG------DERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------~~~~ 132 (449)
.|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++ +||||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 4566778899999999999964 48899999997543 3456788999999999 799999999998753 4589
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
++|||+++++|.+++.......+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 9999999999999997644567899999999999999999999999 999999999999999999999999998764322
Q ss_pred ----CccccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCch
Q 013126 213 ----KSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (449)
....|++.|+|||++. +..++.++||||+||++|||++|+.|+.............. ..........
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~ 240 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----NPAPRLKSKK 240 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc----CCCCCCCCCC
Confidence 2356788999999986 33588899999999999999999998854322211111111 1111112334
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+.++.+++.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 5678999999999999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=312.93 Aligned_cols=248 Identities=17% Similarity=0.199 Sum_probs=205.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
++|++.+.+|.|++|.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 35778889999999999999964 58899999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
++++|.+++.. ....+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++...... ..
T Consensus 83 ~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 83 GGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHETG-KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999998864 2367999999999999999999999999 999999999999999999999999998764432 23
Q ss_pred cccCccccccccccCC---CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc-cccccccccCCCCCchhHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTG---RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-LQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.|+............ ....... ........+.++.+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 238 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP--KLKDKEKWSPVFHD 238 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc--cccchhhhhHHHHH
Confidence 4578889999999776 7899999999999999999999988654322111111 1101111 11123345678999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||..||.+|||+++++.
T Consensus 239 li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=328.32 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=195.9
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeC------C
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG------D 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 129 (449)
.+.|++++.||+|+||+||+|... +++.||||.+...... ..+.+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 356888899999999999999954 5889999999754322 245678999999999999999999987643 3
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
..++++|++ +++|.+++ ....+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIV---KCQKLSDEHVQFLIYQLLRGLKYIHSAG-IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999998 68998887 4467999999999999999999999999 999999999999999999999999999875
Q ss_pred CCC-CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc------------------
Q 013126 210 RDG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------ 269 (449)
Q Consensus 210 ~~~-~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------------ 269 (449)
... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence 543 34568999999999977 4589999999999999999999998865322111100000
Q ss_pred -ccccc---ccC---CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 -MLTDS---CLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 -~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..... ... .......++.+.+++.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000 0001123456889999999999999999999997
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=324.70 Aligned_cols=242 Identities=17% Similarity=0.244 Sum_probs=209.3
Q ss_pred cccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|.+-+.||+|-|++|-+|++ -+|+.||||++.+..... ...+.+|++.|+.++|||||++|.+...+..+|||+|.=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 55667889999999999993 479999999998755333 467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-CCCCeEEeccCCcccCCCCC---c
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRDGK---S 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~---~ 214 (449)
++|+|.++|.+ ....+.++.+.+++.||+.|+.|+|+.. ++||||||+|+.+. +-|-+||+|||++..+.+++ +
T Consensus 100 D~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqLH-VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 100 DGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQLH-VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred CCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhhh-hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 99999999986 4567999999999999999999999997 99999999998775 67999999999998877764 5
Q ss_pred cccCccccccccccCCCCCC-CCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTP-ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
.+|+..|.|||++.|..|+. ++||||||||||.|++|++||...+.......++.- .-..|..++.+.++||.
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC------KYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC------KYTVPSHVSKECRDLIQ 251 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc------cccCchhhhHHHHHHHH
Confidence 67899999999999999865 899999999999999999999765433332222221 12346778899999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
.||..||.+|.+.++|..
T Consensus 252 sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHHhcCchhhccHHHHhc
Confidence 999999999999999987
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=337.35 Aligned_cols=258 Identities=17% Similarity=0.203 Sum_probs=212.2
Q ss_pred HHHHHhhCCCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC
Q 013126 50 EQLKNATSGFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128 (449)
Q Consensus 50 ~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 128 (449)
+-+....+.-+.+++++.||.|+||.||+|..++ +-.-|.|++........++|+-|++||...+||+||++++.|..+
T Consensus 22 ehv~rdlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e 101 (1187)
T KOG0579|consen 22 EHVYRDLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE 101 (1187)
T ss_pred HHHhccCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence 3333444444567899999999999999999544 556688998877766788999999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
+.+|++.|||.||.....+.+ -++++++.++..+.+|++.||.|||+++ |||||||..|||++-+|.++|+|||.+..
T Consensus 102 nkLwiliEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~-iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN-IIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred CceEEEEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc-hhhhhccccceEEEecCcEeeeccccccc
Confidence 999999999999999888875 5678999999999999999999999998 99999999999999999999999998754
Q ss_pred CCC----CCccccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCC
Q 013126 209 SRD----GKSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 209 ~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (449)
... ..++.|||+|||||+.. ..+|+.++||||||++|.||..+.+|-..-....+.-++...-++ ...
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP---TLl 256 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP---TLL 256 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC---ccc
Confidence 332 35788999999999874 457999999999999999999999775443222222111111111 112
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
-|...+..+.+++.+||.+||..||++.+++++
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 255678899999999999999999999999863
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=311.68 Aligned_cols=242 Identities=28% Similarity=0.419 Sum_probs=200.8
Q ss_pred cccCCccceEEEEEEEcCCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHH
Q 013126 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 144 (449)
+.||+|++|.||++.+.+++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..++||||++|++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 357999999999999766999999998765433 3567999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC------ccccC
Q 013126 145 KHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------SYSTN 218 (449)
Q Consensus 145 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~------~~~gt 218 (449)
+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...... ....+
T Consensus 81 ~~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~~-i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 81 TFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKN-CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 99964 3456889999999999999999999999 9999999999999999999999999987654321 12234
Q ss_pred ccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 219 ~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
..|+|||.+.++.++.++|+||||+++|+|+| |..|+............... .....+...+.++.+++.+||.
T Consensus 159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-----YRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-----CCCCCCccCCHHHHHHHHHHhc
Confidence 67999999988889999999999999999999 67776554333322221111 1112244567889999999999
Q ss_pred cCCCCCCCHHHHHHHhc
Q 013126 298 YEPRERPNPKSLVTALS 314 (449)
Q Consensus 298 ~dP~~Rps~~eil~~L~ 314 (449)
.+|++|||+.++++.|+
T Consensus 234 ~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 234 YDPENRPSFSEIYNELQ 250 (251)
T ss_pred cChhhCcCHHHHHHHhh
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.78 Aligned_cols=245 Identities=19% Similarity=0.258 Sum_probs=198.3
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
++++++.||+|+||.||+|.+ .+++.||+|.+...... ..+.+.+|++++++++||||+++++.+..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 467888999999999999995 45899999998754322 2456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--Cccc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSYS 216 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~~~~ 216 (449)
++++|..+. .+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++...... ....
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK-ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC-EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 999996542 4688899999999999999999999 999999999999999999999999998765433 3456
Q ss_pred cCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH---HhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL---IRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 217 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
++..|+|||++.+..++.++|+||||+++|+|++|+.||....... ......................++++.+++.
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 8899999999998889999999999999999999999885421100 0000001111111111112345678999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~ 312 (449)
+||+.||++||+++++++.
T Consensus 235 ~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 235 QCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHhhCChhhCCCHHHHhcC
Confidence 9999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=312.62 Aligned_cols=246 Identities=15% Similarity=0.198 Sum_probs=204.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEee-CCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 136 (449)
.|++++.+|+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|+|++++++.+.. ++..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3778899999999999999954 478999999965432 234578899999999999999999998764 446899999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|+++++|.+++.......+++.++..++.|++.|+++||+++ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~-i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 999999999997644567899999999999999999999999 999999999999999999999999998765432
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
....+++.|+|||++.+..++.++|+||+|+++|+|++|+.|+................. ...+...++++.+++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li 234 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-----PPMPKDYSPELGELI 234 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----CCCccccCHHHHHHH
Confidence 234578899999999988899999999999999999999998865443332222211111 123345678899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~ 312 (449)
.+||+.||++||++.+++++
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHhccCcccCCCHHHHhcC
Confidence 99999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=315.88 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=204.0
Q ss_pred cccccccccCCccceEEEEEEEc-C---CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-N---QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~---~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.+|++.+.||+|+||.||+|.+. + +..+|+|.++..... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45778889999999999999853 2 337999998754322 245789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS 214 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 214 (449)
|||+++++|.+++.. ....+++.++..++.|++.||+|||+++ ++||||||+||++++++.++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 84 TEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMG-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999974 3456899999999999999999999999 99999999999999999999999999886543321
Q ss_pred -------cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 215 -------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 215 -------~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
..++..|+|||++.+..++.++|+||||+++|++++ |..|+................ ....+...++
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 236 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-----RLPAPMDCPA 236 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-----cCCCCCCCCH
Confidence 112457999999998889999999999999999886 998876543322222211111 1112335667
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.+.+++.+||+.+|++||++.++++.|.++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.89 Aligned_cols=251 Identities=18% Similarity=0.286 Sum_probs=201.9
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.++.|+++++||+|+||.||+|+.. +++.||+|.++..... ....+.+|+.+++.++||||+++++++..++..++||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4677999999999999999999965 5889999999754322 3457889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++ ++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 84 e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9997 689888864 3456889999999999999999999999 999999999999999999999999998764322
Q ss_pred -CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc-----------ccccc------
Q 013126 213 -KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL-----------QMLTD------ 273 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~-----------~~~~~------ 273 (449)
....+++.|+|||++.+. .++.++||||||+++|+|++|+.||............. .....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 233468899999998764 47889999999999999999999886543321111000 00000
Q ss_pred ---cccC----CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 ---SCLE----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ---~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+... .......++.+.+++.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 0112345678999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.49 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=204.9
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.++|++++.||+|+||+||++... +++.||+|++..... ...+.+.+|+++++.++||||+++++.+...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356889999999999999999954 588999999875432 235679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCCC--C
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--K 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~ 213 (449)
|+++++|.+++. ..+.+++..+..++.|++.||.|||+ ++ ++||||||+||++++++.++|+|||++...... .
T Consensus 84 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 84 FMDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred cCCCCCHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHhcC-eeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 999999999986 44678999999999999999999997 56 999999999999999999999999998654322 3
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH--------HHhhcccccccccccCCCCCchhH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD--------LIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
...++..|+|||++.+..++.++|+|||||++|++++|+.||...... .+.. ..................+
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH-HHHHHhhccCCCCCchhcC
Confidence 346889999999998888999999999999999999999998653321 0000 0111111111111112356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
.++.+++.+||+.||++|||+.++++..
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 7899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=315.30 Aligned_cols=245 Identities=18% Similarity=0.239 Sum_probs=210.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.+.++++||+|+||.||+|.++ +|..+|||.+... .+.+++.+|+.++++.+.|++|++||.+.....+|+|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3568899999999999999965 5999999998754 468899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSY 215 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~ 215 (449)
.|+..+.++. ++.+++++++..+++..++||+|||... -+|||||..|||++-+|.+||+|||.+....+. .+.
T Consensus 112 AGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~-KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 112 AGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLK-KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHH-HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 9999999876 6789999999999999999999999987 899999999999999999999999998765543 466
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (449)
.||+.|||||++..-.|+.++||||||++..||..|++|+...- ..+.+..-...+.+.-.-++..+.++-+++++|
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH---PMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH---PMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc---ccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 79999999999998999999999999999999999998875421 111122222222222334567789999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 013126 296 LQYEPRERPNPKSLVTA 312 (449)
Q Consensus 296 l~~dP~~Rps~~eil~~ 312 (449)
|-++|++|-|+.+++++
T Consensus 267 LiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEH 283 (502)
T ss_pred hcCCHHHHHHHHHHhhh
Confidence 99999999999988863
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=313.09 Aligned_cols=242 Identities=19% Similarity=0.297 Sum_probs=200.7
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---------HHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
|.+.+.||+|++|.||+|... +++.+|+|.+....... .+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456678899999999999964 58899999987543322 14688999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
+++|||+++++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||.++....
T Consensus 82 ~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~-ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHNRG-IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHH--hccCccHHHHHHHHHHHHHHHHHHHhcC-cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999997 4467899999999999999999999999 99999999999999999999999999876542
Q ss_pred C----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCC
Q 013126 212 G----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 212 ~----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
. ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.............. ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~ 233 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-----NASPEIP 233 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-----cCCCcCC
Confidence 1 123467899999999888899999999999999999999999865422111111001 1112234
Q ss_pred chhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 282 DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...+..+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 456788999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=322.75 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=204.9
Q ss_pred ccccccccCCccceEEEEEEEc--------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeCCe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~--------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 130 (449)
++.+.++||+|+||.||+++.. .+..+|+|.++..... ....+.+|+++++++ +||||+++++++..++.
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 4678889999999999999742 2457999998754322 245788999999999 69999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~ 196 (449)
.+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-i~H~dlkp~Nill~~~~ 171 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-CIHRDLAARNVLVTEDN 171 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-eeeccccceeEEEcCCC
Confidence 999999999999999996432 235889999999999999999999999 99999999999999999
Q ss_pred CeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccc
Q 013126 197 NPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQ 269 (449)
Q Consensus 197 ~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 269 (449)
.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|+|++ |..|+..............
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 251 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999998654321 1123467999999988889999999999999999999 7777765433332222111
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
. .....+...+.++.+++.+||+.||++|||+.++++.|..+...
T Consensus 252 ~-----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 252 G-----HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred C-----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1 11122445667899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=325.32 Aligned_cols=247 Identities=18% Similarity=0.198 Sum_probs=193.7
Q ss_pred cccccCCc--cceEEEEEEE-cCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 64 IVSEHGEK--APNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 64 ~l~~lG~G--~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+++.||+| +|++||++.. .+|+.||+|.++...... .+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56778999 7889999995 468999999997643222 346778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC------
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------ 212 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~------ 212 (449)
++|+|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG-YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999997544566899999999999999999999999 999999999999999999999999864432111
Q ss_pred -----CccccCccccccccccC--CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc----cc--------
Q 013126 213 -----KSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML----TD-------- 273 (449)
Q Consensus 213 -----~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~-------- 273 (449)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||................ .+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 12235677999999976 358999999999999999999999986432111110000000 00
Q ss_pred ----------------c------------ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 ----------------S------------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ----------------~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
. ..........++++.+++.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 0000011234578999999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=318.91 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=201.8
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
.+|++++.||+|+||.||+|..+ .+..||+|.++..... ....+.+|+.+++.++||||+++++++.+++..+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 46788899999999999999743 2458999998654322 2346889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccC
Q 013126 133 LVAEYMPNETLAKHLFHWE--------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFG 204 (449)
+||||+++|+|.+++.... ....++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcCCCCChheEEEcCCCcEEECcCC
Confidence 9999999999999997422 134567788999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccC
Q 013126 205 LMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 205 la~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
+++..... ....++..|+|||.+.++.++.++||||||+++|||++ |..|+................ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-----~ 239 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-----Y 239 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----C
Confidence 98754322 12234567999999998889999999999999999999 677775543333322211110 0
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
...+...++.+.+++.+||+.||++|||+.++++.|.+.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 122334567899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=314.83 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=203.0
Q ss_pred ccccccccCCccceEEEEEEEcC-C---CEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-Q---RRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~---~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+++..+.||+|+||.||+|.... + ..+|+|.++.... ...+.+.+|++++++++||||+++.+++...+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 34566778999999999999642 3 3799999876432 22467899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc-
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS- 214 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~- 214 (449)
||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 86 EYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDMN-YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999999864 3467899999999999999999999999 99999999999999999999999999876543211
Q ss_pred ------cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 215 ------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 215 ------~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...+..|+|||++.+..++.++||||||+++||+++ |+.|+................ ....+...+.+
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-----~~~~~~~~~~~ 238 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-----RLPAPMDCPSA 238 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-----CCCCCCCCCHH
Confidence 112357999999988889999999999999999997 998886543333322221111 11223356678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
+.+++.+||+.+|++||++.++++.|+++
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=329.42 Aligned_cols=236 Identities=19% Similarity=0.196 Sum_probs=190.9
Q ss_pred cCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhcc---CCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL---RNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
||+|+||+||+|+.. +++.||+|++..... .....+..|..++... +||||+++++.+.+++..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 599999999999964 589999999964321 1233456677777665 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cccc
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYS 216 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~ 216 (449)
|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~~-ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKYD-IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99999987 4567999999999999999999999999 999999999999999999999999998753222 2456
Q ss_pred cCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 013126 217 TNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (449)
Q Consensus 217 gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (449)
||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.................. ......++++.+++.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~~~li~~~ 232 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-----FPKNVLSDEGRQFVKGL 232 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-----CCCccCCHHHHHHHHHH
Confidence 899999999997654 899999999999999999999998765444333222111110 01123567899999999
Q ss_pred cccCCCCCC----CHHHHHH
Q 013126 296 LQYEPRERP----NPKSLVT 311 (449)
Q Consensus 296 l~~dP~~Rp----s~~eil~ 311 (449)
|+.||++|| ++.++++
T Consensus 233 L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhc
Confidence 999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.09 Aligned_cols=195 Identities=17% Similarity=0.198 Sum_probs=173.6
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-C-----CCcccceeeEeeCCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-N-----NRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~~~~~l 133 (449)
+|.+++.||+|+||.|-+|.+ ++++.||||+++... .-..+-..|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 578899999999999999995 459999999997543 22456678999999997 4 479999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC--CCeEEeccCCcccCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED--GNPRLSTFGLMKNSRD 211 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~--~~~kL~DFGla~~~~~ 211 (449)
|+|.+. .+|+++++.++-.+++...++.++.||+.||.+||+.+ |||+||||+|||+.+. ..+||+|||.+.....
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~-IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG-IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 999996 89999999888889999999999999999999999999 9999999999999744 4699999999987665
Q ss_pred C-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch
Q 013126 212 G-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258 (449)
Q Consensus 212 ~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 258 (449)
. -.+..+..|+|||++.|.+|+.+.||||||||++||++|.+.|+++
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 4 3566789999999999999999999999999999999998887654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=312.40 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=204.4
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+|++.+.+|.|++|+||+|... ++..+|+|++..... ...+.+.+|+++++.++|+||+++++.+..++..++|||++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 5778889999999999999954 588999999975432 24577999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 139 PNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
+|++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~-i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG-QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999999975332 56899999999999999999999999 9999999999999999999999999987554332
Q ss_pred ----ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 214 ----SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 214 ----~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
...++..|+|||++... .++.++|+||||+++|+|++|+.|+.............................++.+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 23578899999999877 6899999999999999999999998654322222111111111111111113567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 013126 289 VRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+++.+||+.||++||++.+++.
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhh
Confidence 99999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=326.07 Aligned_cols=242 Identities=12% Similarity=0.128 Sum_probs=191.2
Q ss_pred ccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.|++++.||+|+||.||+|+... ++.||+|..... ....|+.++++++||||+++++++..++..++||||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 58899999999999999999654 789999985432 34579999999999999999999999999999999996
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---Cccc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYS 216 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~~~ 216 (449)
++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 141 -~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 141 -SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR-IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred -CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 688888864 4567999999999999999999999999 999999999999999999999999998754322 2356
Q ss_pred cCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh-----------HHHhhccc-ccccccccC-------
Q 013126 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-----------DLIRDRNL-QMLTDSCLE------- 277 (449)
Q Consensus 217 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~-----------~~~~~~~~-~~~~~~~~~------- 277 (449)
||+.|+|||++.+..++.++|||||||++|||+++..++..... ..+..... .........
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 297 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL 297 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHH
Confidence 89999999999988999999999999999999987655422100 00000000 000000000
Q ss_pred ------------C-------CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 278 ------------G-------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 278 ------------~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
. ......+.++.++|.+||+.||++|||+.++++
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 298 VRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 0 001133456778999999999999999999997
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=314.87 Aligned_cols=242 Identities=18% Similarity=0.269 Sum_probs=203.4
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+|++++.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5778889999999999999965 58999999997543 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
++++|.+++. ..++++..+..++.|++.||.|||+++ ++||||+|+||++++++.++|+|||+++..... ..
T Consensus 82 ~~~~L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 82 GGGSCLDLLK---PGKLDETYIAFILREVLLGLEYLHEEG-KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred CCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 9999999995 348899999999999999999999999 999999999999999999999999998765533 23
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCch-hHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD-DGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~ 293 (449)
..+++.|+|||++.+..++.++||||||+++|+|+||+.|+................ ....... .+.++.+++.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-----CCCCcccccCHHHHHHHH
Confidence 457888999999998889999999999999999999999886543222211111111 1111222 6678999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
+||..||++|||++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 233 LCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHhhCChhhCcCHHHHhh
Confidence 999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=311.36 Aligned_cols=243 Identities=22% Similarity=0.303 Sum_probs=198.3
Q ss_pred cccCCccceEEEEEEEcC-C---CEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLEN-Q---RRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~-~---~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
++||+|+||.||+|.+.. + ..+|+|.+...... ..+++.+|+++++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 467999999999998432 2 78999999765532 3567999999999999999999999875 4568999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc------
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS------ 214 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~------ 214 (449)
++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLESKH-FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHhhcC-eeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999997 3447899999999999999999999999 99999999999999999999999999886543321
Q ss_pred -cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 215 -YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 215 -~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
..++..|+|||.+.+..++.++||||||+++|+|++ |..|+............... .....+...+..+.+++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li 231 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-----ERLPRPEECPQEIYSIM 231 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----CcCCCCCCCCHHHHHHH
Confidence 112457999999988889999999999999999998 88887654332222211111 11123445667899999
Q ss_pred HHhcccCCCCCCCHHHHHHHhcccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
.+||..||++||++.++++.|+...
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=316.53 Aligned_cols=253 Identities=18% Similarity=0.235 Sum_probs=206.0
Q ss_pred cccccccccCCccceEEEEEEEcC-----CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEee-CCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-----~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~ 132 (449)
+.|++.+.||+|+||.||+|.+.+ +..|++|.+...... ..+.+.+|+.++++++||||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 456777888999999999999655 688999998754322 24668899999999999999999998776 46789
Q ss_pred EEEeeCCCCCHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 133 LVAEYMPNETLAKHLFHWET------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
+++||+++++|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-VIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccCHhhEEEcCCCcEEECCCCCc
Confidence 99999999999999864322 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCC
Q 013126 207 KNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 207 ~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (449)
+...... ...++..|+|||++.+..++.++||||||+++||+++ |+.|+.......+........ ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~~ 239 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-----RLA 239 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-----CCC
Confidence 8653321 2335677999999988889999999999999999999 888886543333322211111 111
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
.+...++++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 233456789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=318.20 Aligned_cols=256 Identities=22% Similarity=0.323 Sum_probs=204.6
Q ss_pred CcccccccccCCccceEEEEEEEc-----CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEee--CCe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDE 130 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-----~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~ 130 (449)
...+++++.||+|+||.||+|.+. +++.+|+|.++..... ..+.|.+|+++++.++||||+++++++.. +..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 346788899999999999999853 3689999999865543 35689999999999999999999999877 557
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.+++|||+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQR-YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHh-CccccCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999964 2335899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCC-------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh----------hcccccccc
Q 013126 211 DGK-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNLQMLTD 273 (449)
Q Consensus 211 ~~~-------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~----------~~~~~~~~~ 273 (449)
... ...++..|+|||.+.+..++.++||||||+++|||++|..|+......... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 321 122345699999998888999999999999999999999886543221110 000000000
Q ss_pred cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.......+...+.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111112334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=318.32 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=202.5
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
++|++++.||+|+||.||+|... ++..||+|.+....... .+++.+|+.++++++||||+++++++.+++..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 45788899999999999999853 46789999987543222 456899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee
Q 013126 133 LVAEYMPNETLAKHLFHWE--------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl 192 (449)
++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-i~H~dl~p~nil~ 163 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-FVHRDLATRNCLV 163 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-eecccccHhheEe
Confidence 9999999999999996421 124778889999999999999999999 9999999999999
Q ss_pred CCCCCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhh
Q 013126 193 DEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRD 265 (449)
Q Consensus 193 ~~~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~ 265 (449)
++++.++|+|||+++..... .....+..|+|||.+.+..++.++||||||+++|||++ |..|+..........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~ 243 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998754322 12234567999999988889999999999999999998 777775433322221
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 013126 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 315 (449)
..... .. ...+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 244 ~~~~~----~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 244 YVRDG----NV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHhcC----CC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 00 11234566789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=318.69 Aligned_cols=253 Identities=19% Similarity=0.280 Sum_probs=198.9
Q ss_pred ccccccccCCccceEEEEEEEc-----------------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccce
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-----------------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLL 122 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-----------------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~ 122 (449)
+|++.++||+|+||.||++... ++..||+|.++..... ..+++.+|+++++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5788899999999999998632 2346899999764322 246799999999999999999999
Q ss_pred eeEeeCCeeEEEEeeCCCCCHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC
Q 013126 123 GCCCEGDERLLVAEYMPNETLAKHLFHWE---------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193 (449)
Q Consensus 123 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~ 193 (449)
+++..++..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||+++
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dlkp~Nili~ 164 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-FVHRDLATRNCLVG 164 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-eecccCChheEEEc
Confidence 99999999999999999999999987422 124678889999999999999999999 99999999999999
Q ss_pred CCCCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc--CCCCCCchhhHHHhh
Q 013126 194 EDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS--GKHIPPSHALDLIRD 265 (449)
Q Consensus 194 ~~~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~~~ 265 (449)
+++.++|+|||+++...... ...+++.|+|||+..++.++.++||||||+++|||++ |..|+..........
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 99999999999987653322 1223568999999888889999999999999999998 556664432222111
Q ss_pred cccccccc--cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 266 RNLQMLTD--SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 266 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
........ .......+..+++.+.+++.+||+.||++||++.++.+.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11000000 00001123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=314.93 Aligned_cols=252 Identities=17% Similarity=0.233 Sum_probs=201.7
Q ss_pred HHHhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 52 LKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 52 l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
++.+++++....+ ||+|+||.||+|.+. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~~---lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 3 YEYEYDENGERVV---LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred cccccccCCceEE---EecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 3445666665554 599999999999954 588999999876655556789999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-CCCeEEeccCCcc
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPM--KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMK 207 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~ 207 (449)
.++|+||+++++|.+++... ...+ ++..+..++.|++.||+|||+++ ++||||||+||+++. ++.++|+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999999742 2345 78888999999999999999999 999999999999986 6799999999987
Q ss_pred cCCCC----CccccCccccccccccCCC--CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCC
Q 013126 208 NSRDG----KSYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 208 ~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
..... ....+++.|+|||++.+.. ++.++||||||+++|+|++|+.|+............ ..........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~ 234 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VGMFKIHPEIP 234 (268)
T ss_pred ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---hhhhccCCCCC
Confidence 54322 2345788999999987644 788999999999999999999887543211110000 00000112234
Q ss_pred chhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 282 DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...++++.+++.+||+.+|++|||+.+++.
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 556788999999999999999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=313.58 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=196.5
Q ss_pred ccCCccceEEEEEEEcC-CC--EEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEKAPNVVYKGKLEN-QR--RIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~-~~--~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+|+||.||+|.+.+ +. .+|+|.++..... ..+.+.+|++++.++ +||||+++++++...+..++||||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 46999999999999643 44 5688988754322 346788999999999 8999999999999999999999999999
Q ss_pred CHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 142 TLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 142 sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
+|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccccceEEEcCCCeEEECCCCCcc
Confidence 9999996422 124789999999999999999999999 9999999999999999999999999986
Q ss_pred cCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCch
Q 013126 208 NSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 208 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (449)
..... .....+..|+|||++.+..++.++||||||+++|||++ |..||............... .....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~ 235 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-----YRLEKPLN 235 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----CCCCCCCc
Confidence 43221 11223567999999988889999999999999999997 88888654333222221111 01112334
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.+.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 567899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=332.81 Aligned_cols=252 Identities=20% Similarity=0.293 Sum_probs=202.6
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccC-CCCcccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLR-NNRLTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 131 (449)
+++.+.+.||+|+||.||+|++. .++.||+|+++...... .+.+.+|++++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 35667789999999999999853 24689999997643322 457889999999997 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCC-----------------------------------------------------------
Q 013126 132 LLVAEYMPNETLAKHLFHWET----------------------------------------------------------- 152 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~----------------------------------------------------------- 152 (449)
++||||+++|+|.+++.....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999964211
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC
Q 013126 153 -------------------------------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (449)
Q Consensus 153 -------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~ 195 (449)
..+++...+.++.|++.||+|||+++ ++||||||+|||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-CVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-cCcccCCcceEEEeCC
Confidence 23677788999999999999999998 9999999999999999
Q ss_pred CCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccc
Q 013126 196 GNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNL 268 (449)
Q Consensus 196 ~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 268 (449)
+.+||+|||+++..... ....++..|+|||.+.+..++.++||||||+++|||++ |..|+.............
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~ 355 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence 99999999998754322 12345678999999988889999999999999999998 777775432221111111
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
. .......+...+.++.+++.+||+.+|++||+++++++.|+.+
T Consensus 356 ~----~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 356 K----RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H----cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 0011123445678899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=322.39 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=206.2
Q ss_pred ccccccccCCccceEEEEEEEcC--------CCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeCCe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~--------~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 130 (449)
.|++.+.||+|+||.||+|...+ +..||+|.++..... ..+++.+|+++++++ +||||+++++++..++.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 47889999999999999997421 236899998754322 246789999999999 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~ 196 (449)
.+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||++++++
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-ivH~dlkp~Nill~~~~ 171 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-CIHRDLAARNVLVTEDN 171 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-eeccccccceEEEcCCC
Confidence 999999999999999997422 234788899999999999999999999 99999999999999999
Q ss_pred CeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccc
Q 013126 197 NPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQ 269 (449)
Q Consensus 197 ~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 269 (449)
.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..|+..............
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 251 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999987654321 1223467999999998889999999999999999998 7777765544433322211
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.. ....+...+.++.+++.+||+.+|++|||+.++++.|+.+....
T Consensus 252 ~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 252 GH-----RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CC-----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 11223455678999999999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=310.66 Aligned_cols=245 Identities=16% Similarity=0.209 Sum_probs=206.1
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|++++.||+|+||.||++... +++.||+|.+..... ...+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 3678889999999999999954 589999999865322 2345789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
+++++|.+++.......+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 99999999997544456899999999999999999999999 9999999999999999999999999987654432
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...+++.|+|||++.+..++.++|+||||+++|+|++|+.|+................. ...+...+.++.+++.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~ 234 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-----PPVSSHYSYDLRNLVS 234 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-----CCCcccCCHHHHHHHH
Confidence 23578889999999888899999999999999999999998865543333222222111 1223456778999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
+||+.+|++||++.++++
T Consensus 235 ~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 235 QLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHhhCChhhCcCHHHHhh
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=311.06 Aligned_cols=237 Identities=26% Similarity=0.392 Sum_probs=191.8
Q ss_pred ccCCccceEEEEEEEcC-C----------CEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 67 EHGEKAPNVVYKGKLEN-Q----------RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~-~----------~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.||+|+||.||+|.+.+ + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. +..++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 57999999999999754 3 25788887654433 6789999999999999999999999988 7789999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-------CeEEeccCCccc
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-------NPRLSTFGLMKN 208 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-------~~kL~DFGla~~ 208 (449)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++ .+||+|||++..
T Consensus 80 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 80 EYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDKK-LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EcCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhhCC-eecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 99999999999974 2237899999999999999999999999 99999999999999887 799999999987
Q ss_pred CCCCCccccCccccccccccCC--CCCCCCceeeHhHHHHHHhcC-CCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 209 SRDGKSYSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSG-KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 209 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
........++..|+|||++.+. .++.++||||||+++|+|++| ..|+........... .. . ....+....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-~~---~---~~~~~~~~~ 230 (259)
T cd05037 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQ---D---QHRLPMPDC 230 (259)
T ss_pred cccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-Hh---c---CCCCCCCCc
Confidence 6655555677889999999876 689999999999999999995 555433321111110 00 0 011111223
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
..+.+++.+||..+|++|||+.++++.|+
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 231 AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 68999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=317.36 Aligned_cols=249 Identities=18% Similarity=0.252 Sum_probs=202.7
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|++++.||+|+||.||++... +++.||+|.++.... .....+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35789999999999999999965 589999999875422 2246789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCCC--C
Q 013126 138 MPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~ 213 (449)
++|++|..++.... ...+++..+..++.|++.||.|||+ .+ ++||||||+||++++++.+||+|||++...... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC-EeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 99999999886321 2478999999999999999999997 47 999999999999999999999999998765332 3
Q ss_pred ccccCccccccccccCCC------CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 214 SYSTNLAFTPPEYLRTGR------VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||............ ...... .....+...+.+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~ 237 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL-SAIVDG-DPPTLPSGYSDD 237 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH-HHHhhc-CCCCCCcccCHH
Confidence 345778999999986543 588999999999999999999998654332222111 111111 112334457788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.+++.+||+.+|++||++++++.
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhc
Confidence 999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=317.95 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=200.4
Q ss_pred cccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCH--HHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDP--RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~--~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|++++.||+|+||+||+++..+ ++.||+|.+........ ....+|+.++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999765 77899999987543222 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC----CCCc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR----DGKS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~----~~~~ 214 (449)
++++|.+++. ....+++..+..++.|++.||++||+++ ++|+||||+||++++++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~-i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG-IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT-EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccc--cccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999997 4577899999999999999999999999 9999999999999999999999999987521 1234
Q ss_pred cccCcccccccccc-CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH----HHhhcccccccccccCCCCCchhHHHHH
Q 013126 215 YSTNLAFTPPEYLR-TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD----LIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 215 ~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
..++..|+|||++. +..++.++||||+|+++|+|++|..|+...... ............. .......++++.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 234 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---SQQSREKSEELR 234 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---TTSHTTSHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---ccccchhHHHHH
Confidence 56789999999998 778999999999999999999999988765111 1111111111111 111112247899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+||+.||++|||+.++++
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=326.73 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=199.8
Q ss_pred ccccccccCCccceEEEEEEE------cCCCEEEEEEecCCCCCC-HHHHHHHHHHHhcc-CCCCcccceeeEeeC-Cee
Q 013126 61 VENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEG-DER 131 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~------~~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~~ 131 (449)
+|++.+.||+|+||+||+|.+ .+++.||||.++...... ...+.+|+.++.++ +||||+++++++... ...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 688999999999999999973 246889999997644222 45688999999999 689999999988654 467
Q ss_pred EEEEeeCCCCCHHHHHhccC------------------------------------------------------------
Q 013126 132 LLVAEYMPNETLAKHLFHWE------------------------------------------------------------ 151 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~------------------------------------------------------------ 151 (449)
+++|||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 89999999999999986421
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC------ccccCcc
Q 013126 152 -----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------SYSTNLA 220 (449)
Q Consensus 152 -----~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~------~~~gt~~ 220 (449)
...+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++....... ...++..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 123678888999999999999999999 9999999999999999999999999987643221 2234567
Q ss_pred ccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccC
Q 013126 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (449)
Q Consensus 221 y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (449)
|+|||++.+..++.++||||||+++|+|++ |..|+.............. .. .....+...++++.+++.+||+.|
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---EG-TRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh---cc-CCCCCCCCCCHHHHHHHHHHccCC
Confidence 999999988889999999999999999997 7777754321111111000 00 011122334568999999999999
Q ss_pred CCCCCCHHHHHHHhccccc
Q 013126 300 PRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 300 P~~Rps~~eil~~L~~~~~ 318 (449)
|++|||+.++++.|+.+.+
T Consensus 323 p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 323 PSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=319.44 Aligned_cols=246 Identities=20% Similarity=0.204 Sum_probs=203.4
Q ss_pred ccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++.+.||+|++|+||+|...+ ++.||+|.+...... ..+.+.+|+++++.++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 57788889999999999999654 899999999765432 34568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|+.|++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC-eeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999987544567999999999999999999999999 999999999999999999999999987653221
Q ss_pred -----------------------------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHH
Q 013126 213 -----------------------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI 263 (449)
Q Consensus 213 -----------------------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~ 263 (449)
....|+..|+|||++.+..++.++||||||+++|+|++|+.|+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 123467889999999988899999999999999999999999865543322
Q ss_pred hhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 013126 264 RDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN----PKSLVT 311 (449)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 311 (449)
....... ..........+..+.+++.+||+.||++||| +++++.
T Consensus 241 ~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 FSNILKK----EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHhcC----CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2211111 1111112225788999999999999999999 777777
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=310.14 Aligned_cols=245 Identities=18% Similarity=0.230 Sum_probs=204.3
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
++|++.+.+|+|++|.||+|...+ ++.+|+|.++.... .+++.+|++++++++||||+++++.+..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 357788889999999999999755 88999999975432 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----c
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----~ 214 (449)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~-i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNK-KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99999999864 3567899999999999999999999999 9999999999999999999999999987654332 3
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..++..|+|||++.+..++.++||||||+++|+|++|+.|+.............. ........+...+.++.+++.+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCCCCCchhhcCHHHHHHHHH
Confidence 3478899999999888899999999999999999999998865322211111100 0001111233456789999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||+.||++|||+.++++
T Consensus 236 ~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 236 CLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHhcChhhCcCHHHHhc
Confidence 99999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=316.83 Aligned_cols=248 Identities=20% Similarity=0.263 Sum_probs=197.7
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+|++++.||+|++|.||+|+.. +++.||+|.++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3678889999999999999965 589999999875432 2246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 138 MPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
++ ++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 98 68988886432 367899999999999999999999999 999999999999999999999999998754332
Q ss_pred CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc----------------------
Q 013126 213 KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ---------------------- 269 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------------------- 269 (449)
....+++.|+|||++.+. .++.++||||||+++|+|+||+.|+..............
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 223457889999998764 478899999999999999999988864322111000000
Q ss_pred --cccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 --MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 --~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....... .......++++.+++.+||+.||++|||+.+++.
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 239 FPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0112235678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=330.41 Aligned_cols=243 Identities=16% Similarity=0.197 Sum_probs=196.2
Q ss_pred ccccccccCCccceEEEEEEEc---CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|++++.||+|+||.||++... .++.||+|.+... ....+|++++++++||||+++++++...+..+++||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 5889999999999999999743 3678999998643 3456899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----- 212 (449)
+. ++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 168 ~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g-ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 168 YK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG-IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred cC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 96 78888885 5578999999999999999999999999 999999999999999999999999998754432
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH----Hhh---c----cc------------
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL----IRD---R----NL------------ 268 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~----~~~---~----~~------------ 268 (449)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. . ..
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 13468999999999998889999999999999999999999986532110 000 0 00
Q ss_pred --cccccc-ccCCCC-----CchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 269 --QMLTDS-CLEGQF-----TDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 269 --~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
...... ...... ....+.++.++|.+||..||++|||+.+++.+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000000 11345678899999999999999999999984
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=311.30 Aligned_cols=244 Identities=18% Similarity=0.231 Sum_probs=201.1
Q ss_pred cccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC------HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
|++.+.||+|+||+||+|...+++.+|+|.++...... .+.+.+|+++++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 56778889999999999998788999999987533211 245889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~---- 211 (449)
||++|++|.+++. +..++++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLHNNC-VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999997 4457899999999999999999999999 99999999999999999999999999875321
Q ss_pred ------CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 212 ------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 212 ------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
.....++..|+|||++.+..++.++||||||+++|+|++|..||.............. ........+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 235 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---HRGLMPRLPDSFS 235 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh---ccCCCCCCCCCCC
Confidence 1234578899999999888899999999999999999999998864321111100000 0001122344567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.++.+++.+||+.+|++||++.+++.
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 88999999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=313.84 Aligned_cols=252 Identities=19% Similarity=0.253 Sum_probs=206.4
Q ss_pred cccccccccCCccceEEEEEEEcC-CC----EEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QR----RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~----~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.+|++++.||+|+||+||+|.++. ++ .+|+|.++..... ....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 357788999999999999999543 33 6899998765432 24678899999999999999999999887 78899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 86 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~-i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 86 ITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEKR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999974 3456899999999999999999999998 9999999999999999999999999998654332
Q ss_pred c------cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 S------YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ~------~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
. ..++..|+|||.+.+..++.++|+||||+++||+++ |+.|+.......+......... ...+...+.
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 238 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-----LPQPPICTI 238 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-----CCCCCCCCH
Confidence 1 113467999999988889999999999999999998 9988876544443332221111 112334557
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.+.+++.+||..||++||++.++++.|..+.+.
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=314.88 Aligned_cols=243 Identities=18% Similarity=0.293 Sum_probs=201.9
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.|+.++.||+|+||.||+|.+. +++.||+|.++.... ...+.+.+|++++++++||||+++++.+..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667788899999999999864 488999999875432 22457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----c
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----~ 214 (449)
++++|.+++. .+.+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLHSER-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC-eeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9999999884 467899999999999999999999999 9999999999999999999999999987654332 2
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..++..|+|||++.+..++.++||||||+++|||++|+.|+........... .... .........+.++.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL----IPKN-SPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh----hhcC-CCCCCCcccCHHHHHHHHH
Confidence 3578899999999988899999999999999999999988754322211111 1111 1112334566789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~ 312 (449)
||+.+|++||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 236 CLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HccCCcccCcCHHHHHHh
Confidence 999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=319.80 Aligned_cols=240 Identities=19% Similarity=0.273 Sum_probs=198.9
Q ss_pred ccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 65 VSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
...||+|+||.||++... ++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456799999999999954 5889999998765544466789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----CccccCc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTNL 219 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~gt~ 219 (449)
.+++. .+.+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||++...... ....++.
T Consensus 107 ~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 182 (292)
T cd06658 107 TDIVT---HTRMNEEQIATVCLSVLRALSYLHNQG-VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTP 182 (292)
T ss_pred HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCc
Confidence 99884 456899999999999999999999999 999999999999999999999999998754322 2345788
Q ss_pred cccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccC
Q 013126 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (449)
Q Consensus 220 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (449)
.|+|||.+.+..++.++||||||+++|||++|+.|+................ .... ......+..+.+++.+||..|
T Consensus 183 ~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRV--KDSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCcc--ccccccCHHHHHHHHHHccCC
Confidence 9999999988889999999999999999999999986543222111111111 1111 112245678999999999999
Q ss_pred CCCCCCHHHHHH
Q 013126 300 PRERPNPKSLVT 311 (449)
Q Consensus 300 P~~Rps~~eil~ 311 (449)
|++|||++++++
T Consensus 260 P~~Rpt~~~il~ 271 (292)
T cd06658 260 PSQRATAQELLQ 271 (292)
T ss_pred hhHCcCHHHHhh
Confidence 999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.17 Aligned_cols=246 Identities=17% Similarity=0.215 Sum_probs=188.6
Q ss_pred ccCCccceEEEEEEEcCC---CEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCC
Q 013126 67 EHGEKAPNVVYKGKLENQ---RRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~~---~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
+||+|+||.||+|...++ ..+++|.++.... ...+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 579999999999985433 3567777765432 235689999999999999999999999999999999999999999
Q ss_pred HHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC------CCc
Q 013126 143 LAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD------GKS 214 (449)
Q Consensus 143 L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~------~~~ 214 (449)
|.+++.+.. ....++.....++.||+.||+|||+++ ++||||||+|||+++++.+||+|||++..... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-eeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999997432 234667788899999999999999998 99999999999999999999999999764221 123
Q ss_pred cccCccccccccccC-------CCCCCCCceeeHhHHHHHHhcC-CCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 215 YSTNLAFTPPEYLRT-------GRVTPESVIYSFGTLLLDLLSG-KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
..++..|+|||++.+ ..++.++||||||+++|||+++ ..|+.............................++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 456789999999853 2357899999999999999975 44554332222221111111111112233344667
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
.+.+++..|| .+|++||+++++++.|.
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 8999999999 67999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=307.83 Aligned_cols=245 Identities=18% Similarity=0.221 Sum_probs=204.8
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|++++.||+|++|.||++... +++.+|+|.+...... ..+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 3678888999999999999954 5889999999754322 256789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-CCeEEeccCCcccCCCCC---
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~--- 213 (449)
+++++|.+++.......+++..+..++.|++.||+|||+++ ++|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999997644566899999999999999999999999 9999999999999855 468999999988655432
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...++..|+|||.+.+..++.++||||||+++|+|++|+.|+................. ...+...+.++.+++.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~ 234 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-----APISDRYSPDLRQLIL 234 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-----CCCCCCcCHHHHHHHH
Confidence 34578899999999888899999999999999999999998866543333322221111 1233456778999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
+||+.||++|||+.++++
T Consensus 235 ~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 235 SMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHccCChhhCCCHHHHhh
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.08 Aligned_cols=244 Identities=18% Similarity=0.268 Sum_probs=204.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
..|+.++.||.|+||.||+|.+. +++.||+|.++.... ...+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677888999999999999965 588999999875432 2356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
++|++|.+++. .+++++..+..++.|++.||+|+|+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~~-ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 84 LGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSEK-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 99999999985 457899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...++..|+|||++.+..++.++|+||||+++|||++|..|+............ ............+..+.+++.
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-----PKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-----hcCCCCCCchhhhHHHHHHHH
Confidence 235678899999998888999999999999999999999888654322221111 111112334467788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~ 312 (449)
+||+.+|++||++.+++..
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHcccCcccCcCHHHHHhC
Confidence 9999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=329.79 Aligned_cols=255 Identities=20% Similarity=0.322 Sum_probs=218.0
Q ss_pred ccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
+..+..+||.|.||.||.|.|+. .-.||||.++.+. ...++|+.|+.+|+.++|||+|+++|+|..+..+|||+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 34566789999999999999865 7789999998765 457899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc--ccc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS--YST 217 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~--~~g 217 (449)
+|+|.++|++.++..++.-..+.++.||.+|+.||..++ .|||||-..|.|+.++..+|++|||+++.+..+.. ..|
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn-FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence 999999999877788888899999999999999999998 99999999999999999999999999998776532 233
Q ss_pred ---CccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 218 ---NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 218 ---t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
.+.|.|||.+....++.|+|||+|||+|||+.| |-.|+++.....+. .+.....+..-+..+++.+.+|++
T Consensus 426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-----~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----GLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-----HHHhccccccCCCCCCHHHHHHHH
Confidence 467999999999999999999999999999988 44566654322222 122222223446788899999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcccccccCC
Q 013126 294 RCLQYEPRERPNPKSLVTALSPLQKETEV 322 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 322 (449)
.||+++|.+||++.|+-+.++.+......
T Consensus 501 aCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred HHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 99999999999999999999988766544
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=319.51 Aligned_cols=242 Identities=16% Similarity=0.253 Sum_probs=185.0
Q ss_pred cccCCccceEEEEEEEc---CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEee--CCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~g 140 (449)
++||+|+||+||+|+.. +++.||+|.++... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 57899999999999954 46889999986543 23567899999999999999999999854 456899999996
Q ss_pred CCHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee----CCCCCeEEeccCCcccC
Q 013126 141 ETLAKHLFHW-------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 141 gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla~~~ 209 (449)
++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-EEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 6888887532 1235889999999999999999999999 9999999999999 45678999999999765
Q ss_pred CCC-------CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhH----------HHh---h---
Q 013126 210 RDG-------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALD----------LIR---D--- 265 (449)
Q Consensus 210 ~~~-------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~----------~~~---~--- 265 (449)
... ....+|+.|+|||++.+. .++.++||||+||++|+|++|++||.....+ ... .
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 432 234678999999999874 4899999999999999999999988532110 000 0
Q ss_pred -------cccccccc----------cccC--------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 266 -------RNLQMLTD----------SCLE--------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 266 -------~~~~~~~~----------~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
........ .... .......+.++.+++.+||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000 0000112356889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.89 Aligned_cols=244 Identities=26% Similarity=0.322 Sum_probs=192.5
Q ss_pred ccCCccceEEEEEEEcC----CCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEe-eCCeeEEEEeeCCC
Q 013126 67 EHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCC-EGDERLLVAEYMPN 140 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~Ey~~g 140 (449)
.||+|+||.||+|.+.+ +..+|+|.+..... ...+.+.+|+.+++.++||||+++++++. .++..+++|||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 56999999999998532 45799999864322 23567889999999999999999999775 45568999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--------
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-------- 212 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-------- 212 (449)
++|.+++.. .....++.....++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 82 GDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASKK-FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999964 2345677888999999999999999998 999999999999999999999999998754322
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCC-CCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI-PPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....++..|+|||.+.+..++.++||||||+++|||++|+.| +................ ....+...+..+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l 234 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-----RLLQPEYCPDPLYEV 234 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-----CCCCCCcCCHHHHHH
Confidence 122346789999999888899999999999999999996544 44332222221111110 111123456789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
+.+||+.+|++||++.++++.|+.+.
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 99999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=314.46 Aligned_cols=248 Identities=21% Similarity=0.279 Sum_probs=199.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|++++.||+|++|.||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5778889999999999999965 489999999865432 2245688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
+++++|..++. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 82 CDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHN-CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred cCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 99988888775 4457899999999999999999999999 9999999999999999999999999998655432
Q ss_pred ccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc---c-----------------cccc
Q 013126 214 SYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---L-----------------QMLT 272 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~---~-----------------~~~~ 272 (449)
...++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.......... . ....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3456789999999876 45789999999999999999999888643221110000 0 0000
Q ss_pred ccccCC-----CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 DSCLEG-----QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+.... ...+..+..+.+++.+||+.||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 001234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=336.06 Aligned_cols=243 Identities=19% Similarity=0.228 Sum_probs=192.9
Q ss_pred ccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.|.+.+.||+|+||.||+|.+.. ++.||||... ...+.+|++++++++|+||+++++++..++..++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 47888999999999999999654 8899999642 2346789999999999999999999999999999999996
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC------C
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------K 213 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~------~ 213 (449)
++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 244 -~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~g-IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 -SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEG-IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred -CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 789888864 3457999999999999999999999999 999999999999999999999999998764332 1
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh------------hHHHhhcccc--cccc------
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA------------LDLIRDRNLQ--MLTD------ 273 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~------------~~~~~~~~~~--~~~~------ 273 (449)
...||+.|+|||++.+..++.++|||||||++|||++|..++.... ...+...... ....
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 2458999999999999899999999999999999999876543211 1111111000 0000
Q ss_pred -------------cccCC-CC--CchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 274 -------------SCLEG-QF--TDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 274 -------------~~~~~-~~--~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+.... .+ ....+.++.+|+.+||+.||++|||+.|++++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00 01234578999999999999999999999983
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.91 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=209.5
Q ss_pred cccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
..+.++||+|-||.|.++...++..||+|.++..+... ..+|.+|+++|.+++||||++++|+|..++.+++|+||+++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 56789999999999999998778999999999877555 47899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCccc----
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS---- 216 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~---- 216 (449)
|+|.+++..+....+.-....+|+.||++|++||.+-+ ++||||.+.|+|+++++++||+|||+++..-.+..+.
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n-fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN-FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc-hhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 99999998643333445566779999999999999998 9999999999999999999999999999766554333
Q ss_pred --cCccccccccccCCCCCCCCceeeHhHHHHHHhc--CCCCCCchhhHHHhhcccccccccc--cCCCCCchhHHHHHH
Q 013126 217 --TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS--GKHIPPSHALDLIRDRNLQMLTDSC--LEGQFTDDDGTELVR 290 (449)
Q Consensus 217 --gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~ 290 (449)
-...|||||.+..+++|.++|||+||+++||+++ ...|+..-..+.+-+..-....++. .....|.-++.++.+
T Consensus 699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lye 778 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYE 778 (807)
T ss_pred eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHH
Confidence 2489999999999999999999999999999865 5567655433333322211111111 112235567889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHhcc
Q 013126 291 LASRCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~~L~~ 315 (449)
++.+||..|-++|||++++...|.+
T Consensus 779 lml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 779 LMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred HHHHHhchhhhcCCCHHHHHHHHHH
Confidence 9999999999999999999987754
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=312.30 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=203.9
Q ss_pred cccccccccCCccceEEEEEEEcC----CCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.++.+.+.||+|+||.||+|.+.+ ...||+|....... ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 446777889999999999998543 34789999875442 235679999999999999999999998875 567899
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 85 MELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKR-FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEcCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999999964 2346899999999999999999999999 9999999999999999999999999987654332
Q ss_pred ----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 214 ----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 214 ----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
...++..|+|||.+.+..++.++||||||+++||+++ |..||................ ....+...+.++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 237 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-----RLPMPPNCPPTL 237 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----cCCCCCCCCHHH
Confidence 1223467999999988889999999999999999986 998886554332222111110 112344567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.+++.+||..+|++|||+.++++.|+.+..+
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.40 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=202.4
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
+++++++.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45778889999999999999953 2467999998654433 2467999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 133 LVAEYMPNETLAKHLFHWET-------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
+||||+++++|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||++++++.++++|||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-FVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-cccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999974331 26899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCC-----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCC
Q 013126 206 MKNSRDG-----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 206 a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (449)
++..... ....++..|+|||.+.+..++.++||||||+++|++++ |..|+.............. ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~----~~~~~~ 239 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA----GKLELP 239 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc----CCcCCC
Confidence 8654322 22345677999999988888999999999999999999 6666654322222211111 111112
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
.+...+..+.+++.+||+.||++|||+.++++.|.
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 23456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=318.30 Aligned_cols=249 Identities=18% Similarity=0.160 Sum_probs=202.2
Q ss_pred ccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|+||.||++.... ++.||+|.+..... ...+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788899999999999999654 88999999876432 224578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++|++|.+++. ..+.+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~g~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLK--NIGALPVDMARMYFAETVLALEYLHNYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999997 4467899999999999999999999999 999999999999999999999999988631100
Q ss_pred ---------------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccC
Q 013126 213 ---------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 213 ---------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
....++..|+|||.+.+..++.++|+||||+++||+++|..||.+.....+.......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~---~ 235 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---W 235 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---C
Confidence 1134678899999998888999999999999999999999998765444333322211111 0
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 315 (449)
.......+.++.+++.+||+.||++||++.++.+.|+.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11122456789999999999999999986555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=316.97 Aligned_cols=243 Identities=19% Similarity=0.251 Sum_probs=201.2
Q ss_pred ccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 63 NIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..+++|||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 34456799999999999964 58999999997655555677899999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccccc
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYST 217 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~g 217 (449)
+|.+++. ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...... ....+
T Consensus 104 ~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 104 ALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred CHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 9999874 456899999999999999999999999 999999999999999999999999998754332 23457
Q ss_pred CccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 218 NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 218 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
+..|+|||++.+..++.++||||||+++|||++|+.|+............. ..... ........+..+.+++.+||+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-DSPPP--KLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-ccCCC--CccccCCCCHHHHHHHHHHhc
Confidence 899999999988889999999999999999999999886443222111111 10111 111233456789999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013126 298 YEPRERPNPKSLVTA 312 (449)
Q Consensus 298 ~dP~~Rps~~eil~~ 312 (449)
.+|++||++.++++.
T Consensus 257 ~~P~~Rps~~~ll~~ 271 (297)
T cd06659 257 REPQERATAQELLDH 271 (297)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.67 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=200.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+|++.+.||+|++|.||+|.+. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3778899999999999999964 589999999976542 2356799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
+ +++|.+++.. ...++++..++.++.|++.||+|||+++ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 9999999864 3467999999999999999999999999 9999999999999999999999999988655432
Q ss_pred -ccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc--------------------c
Q 013126 214 -SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--------------------L 271 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------------------~ 271 (449)
...++..|+|||.+.+.. ++.++||||+|+++|+|++|.+++............... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345788999999987544 689999999999999999997776543211111000000 0
Q ss_pred cccc----cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 272 TDSC----LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 272 ~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.... ......++.+.++.+++.+||+.||++|||+++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0001123456889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=314.14 Aligned_cols=242 Identities=20% Similarity=0.255 Sum_probs=204.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+|++++.||+|++|.||++... +++.||+|.++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5788899999999999999965 589999999875332 234678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-Ccc
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~ 215 (449)
|+++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||+|+||++++++.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~-i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 82 YVPGGELFSHLR--KSGRFPEPVARFYAAQVVLALEYLHSLD-IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred cCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence 999999999997 4467999999999999999999999999 999999999999999999999999998875544 334
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (449)
.+++.|+|||.+.+...+.++||||||+++|+|++|+.|+............... ....+...+..+.+++.+|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG------KVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------CccCCccCCHHHHHHHHHH
Confidence 5789999999998888899999999999999999999998655432222221111 1123445578899999999
Q ss_pred cccCCCCCC-----CHHHHHH
Q 013126 296 LQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 296 l~~dP~~Rp-----s~~eil~ 311 (449)
|+.||.+|+ ++++++.
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCHHHccCcccCCHHHHHc
Confidence 999999998 7777775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=310.85 Aligned_cols=248 Identities=19% Similarity=0.233 Sum_probs=199.2
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-----C-----HHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-----D-----PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-----~-----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
|.+.+.||+|++|.||+|... +++.||+|.++..... . .+.+.+|+.+++.++|||++++++++..++.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 566778899999999999854 5899999998642111 0 2457889999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||++|++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||+++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVLEGLAYLHSKG-ILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhhCC-eeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999997 3467899999999999999999999999 9999999999999999999999999987644
Q ss_pred CC------CccccCccccccccccCCC--CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCc
Q 013126 211 DG------KSYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 211 ~~------~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
.. ....++..|+|||.+.... ++.++|+||||+++|++++|..|+...........................
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 32 2235788999999987654 789999999999999999999988543222111111111111111122233
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.++.++.+++.+||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 457889999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=311.62 Aligned_cols=248 Identities=15% Similarity=0.175 Sum_probs=196.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEe-----eCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCC-----EGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-----~~~~~~ 132 (449)
++|++++.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++. .++..+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 34678888899999999999964 48899999986532 2246788999999999 6999999999874 345689
Q ss_pred EEEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 133 LVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
+||||++|++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC-ccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999999987532 3456889999999999999999999998 9999999999999999999999999987654
Q ss_pred CC----CccccCccccccccccC-----CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCC
Q 013126 211 DG----KSYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 211 ~~----~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
.. ....+++.|+|||++.. ..++.++||||+||++|+|++|+.|+............... .. .....+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~ 252 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-PP--PTLHQP 252 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc-CC--CcccCC
Confidence 32 23457899999999853 44788999999999999999999987654221111111110 00 011122
Q ss_pred chhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
...+.++.+++.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 3345689999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=324.51 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=219.4
Q ss_pred hCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 56 TSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 56 ~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
.+.+..|.+++.||+|.|++|.+|++. ++..||||.+.+..... .+.+.+|+++|+.++|||||+++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 345667899999999999999999954 59999999998765433 356899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+.+|.+.+++. +.+.+.+..++.++.|+.+|++|||+++ |+|||||.+|||++.+.++||+|||++.....+
T Consensus 132 lV~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k~-ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSKN-IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhcc-eeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999998 5567777999999999999999999999 999999999999999999999999999877654
Q ss_pred ---CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
.+.+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||.+.....++.+.+.... .++..++.+.
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~------rIp~~ms~dc 282 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY------RIPFYMSCDC 282 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee------cccceeechh
Confidence 56789999999999999886 6799999999999999999999998877777665554432 2344566789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 289 VRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
.++|+++|..+|.+|++.+++...-
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhhc
Confidence 9999999999999999999998743
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=316.18 Aligned_cols=247 Identities=19% Similarity=0.230 Sum_probs=196.0
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|++++.||+|++|.||+|... +|+.||+|.++..... ....+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 677888999999999999965 5899999999753322 2356888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
+ ++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++..... ..
T Consensus 82 ~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 82 D-QDLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSHN-VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred C-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 7 588887754 3467999999999999999999999999 999999999999999999999999998765432 22
Q ss_pred cccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCch-hhHHHhhccc--------------ccccccccC-
Q 013126 215 YSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNL--------------QMLTDSCLE- 277 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~--------------~~~~~~~~~- 277 (449)
..++..|+|||++.+.. ++.++||||||+++|+|+||+.|+... .......... ....+....
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 35678999999987654 789999999999999999999885322 1111000000 000000000
Q ss_pred --------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 278 --------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 278 --------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....+..++++.+++.+||+.||.+|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0112345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.57 Aligned_cols=242 Identities=23% Similarity=0.352 Sum_probs=197.1
Q ss_pred ccCCccceEEEEEEEcC-------CCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 67 EHGEKAPNVVYKGKLEN-------QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~-------~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.||+|+||.||+|+..+ ++.+|+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 57999999999998542 26799999865432 33567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-----CeEEeccCCccc
Q 013126 139 PNETLAKHLFHWE-----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-----NPRLSTFGLMKN 208 (449)
Q Consensus 139 ~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-----~~kL~DFGla~~ 208 (449)
++++|.+++.... ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++ .++|+|||+++.
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-cccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999997432 234788999999999999999999998 99999999999999877 899999999875
Q ss_pred CCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCC
Q 013126 209 SRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 209 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
.... ....++..|+|||++.++.++.++||||||+++|+|++ |+.|+.............. ......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-----~~~~~~~ 235 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-----GGRLQKP 235 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-----CCccCCc
Confidence 4322 12234678999999998889999999999999999998 8888765432222211111 0111234
Q ss_pred chhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
...+..+.+++.+||+.+|++||+++++++.|+
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 456788999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.50 Aligned_cols=255 Identities=14% Similarity=0.211 Sum_probs=201.9
Q ss_pred CHHHHHHhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeE
Q 013126 48 TLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCC 125 (449)
Q Consensus 48 ~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 125 (449)
++.++.... ..|++.+.+|.|+||.||+|... +++.+|+|.+.... .....+..|+.+++++ +||||+++++++
T Consensus 7 ~~~~~~~~~---~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 7 DLSALRDPA---GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhcChh---hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 444444433 35667788899999999999964 58899999986543 2345788999999999 799999999998
Q ss_pred ee------CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeE
Q 013126 126 CE------GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (449)
Q Consensus 126 ~~------~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~k 199 (449)
.. .+..+++|||+++|+|.+++.......+++..+..++.|++.||+|||+++ ++||||||+||++++++.++
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK-VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEE
Confidence 53 457899999999999999997655567889999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCC----CCccccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc
Q 013126 200 LSTFGLMKNSRD----GKSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM 270 (449)
Q Consensus 200 L~DFGla~~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 270 (449)
|+|||++..... .....+++.|+|||++. +..++.++|+||||+++|+|++|+.||.......... .
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~----~ 237 (282)
T cd06636 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF----L 237 (282)
T ss_pred EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----h
Confidence 999999875432 23355788999999986 3458889999999999999999999885432111111 0
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..............+.++.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11111111122346778999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=315.49 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=206.4
Q ss_pred hCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 56 TSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 56 ~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.+....|++++.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 334467888999999999999999854 5889999998765545567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
+||+++++|.+++. ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~g-i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 MEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EecCCCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhCC-EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999999985 346889999999999999999999999 9999999999999999999999999886544332
Q ss_pred ---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 214 ---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
...+++.|+|||.+.+..++.++|+||||+++|++++|+.||............ ..........+...+..+.+
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHH
Confidence 335778899999998888999999999999999999999998654322111100 00111111123345678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~~ 312 (449)
++.+||+.+|++||++.+++.+
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=305.97 Aligned_cols=245 Identities=28% Similarity=0.415 Sum_probs=201.6
Q ss_pred ccccccCCccceEEEEEEEcC-C----CEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 63 NIVSEHGEKAPNVVYKGKLEN-Q----RRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~~-~----~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++++.||.|+||.||++...+ + ..||+|.++..... ..+.+.+|++.++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456788999999999999654 3 88999999765543 46789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc--
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS-- 214 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-- 214 (449)
|+++++|.+++.......+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~-~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC-eeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999999997433333899999999999999999999999 99999999999999999999999999876554311
Q ss_pred ---cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 215 ---YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 215 ---~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
..+++.|+|||.+.+..++.++||||+|+++|+|++ |..|+................. ...+...+.++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 235 (258)
T smart00219 161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-----LPKPENCPPEIYK 235 (258)
T ss_pred cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----CCCCCcCCHHHHH
Confidence 235688999999988889999999999999999998 6776654433332222111111 1223346788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHh
Q 013126 291 LASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~~L 313 (449)
++.+||..||++|||+.++++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=347.16 Aligned_cols=248 Identities=17% Similarity=0.226 Sum_probs=197.5
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 132 (449)
.+.+|++++.||+|+||+||+|.+. ++..||+|.+...... ....+..|+.++++++|||||++++++... ..+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3467899999999999999999965 4789999998754322 246789999999999999999999988653 5689
Q ss_pred EEEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC------CccccccccCceeeCC----------
Q 013126 133 LVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKG------RALYHDLNAYRILFDE---------- 194 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~------~iiHrDlkp~NILl~~---------- 194 (449)
+||||+++++|.++|... ....+++..++.|+.||+.||+|||+.+ +|+||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999998642 2357999999999999999999999832 2999999999999964
Q ss_pred -------CCCeEEeccCCcccCCCC---CccccCccccccccccC--CCCCCCCceeeHhHHHHHHhcCCCCCCchhh-H
Q 013126 195 -------DGNPRLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-D 261 (449)
Q Consensus 195 -------~~~~kL~DFGla~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~-~ 261 (449)
.+.+||+|||++...... ....||+.|+|||++.+ ..++.++||||||||+|+|+||..||..... .
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 345899999999865433 23468999999999864 3488999999999999999999999864321 1
Q ss_pred HHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 262 LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+... ....+ .......+.++.+||.+||+.+|.+||++.+++.
T Consensus 251 qli~~-lk~~p-----~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 251 QLISE-LKRGP-----DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHH-HhcCC-----CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11111 11100 0111234678999999999999999999999985
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=309.08 Aligned_cols=241 Identities=22% Similarity=0.272 Sum_probs=204.2
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
|++.+.||.|+||.||+|.+. +++.||+|.+..... ...+.+.+|++++++++||||+++++.+.+++..++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 678889999999999999965 589999999975432 2356899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---Cc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KS 214 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~ 214 (449)
++|++|.+++.. ..++++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 82 LLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSKG-IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 999999999963 368999999999999999999999999 999999999999999999999999998765543 33
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh---HHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL---DLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
..++..|+|||.+.+..++.++|+||||+++|+|++|..|+..... ......... .....+...+..+.++
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------ADVLYPATWSTEAIDA 232 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------ccccCcccCcHHHHHH
Confidence 4578899999999888899999999999999999999999876542 222111110 1123445667899999
Q ss_pred HHHhcccCCCCCCCH--HHHHH
Q 013126 292 ASRCLQYEPRERPNP--KSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~--~eil~ 311 (449)
+.+||+.||.+||++ +++++
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHccCChhHcCCccHHHHhc
Confidence 999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=322.46 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=208.1
Q ss_pred cccccCCccceEEEEEEEcC-----CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 64 IVSEHGEKAPNVVYKGKLEN-----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~-----~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+-+.||.|-||.||+|...+ +-.||||..+.+...+ .+.|+.|+-+|++++||||++++|+|.+ ...|||||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEec
Confidence 44678999999999999422 3368999998865444 7789999999999999999999999976 578999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcccc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~g 217 (449)
++.|.|..++.. +...++......+..||+.||+|||++. .+||||-..|||+.+...+||+|||+++...+..-+..
T Consensus 472 ~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSkr-fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 472 APLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESKR-FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred ccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhhc-hhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence 999999999986 4567888999999999999999999998 99999999999999999999999999999887654332
Q ss_pred -----CccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 218 -----NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 218 -----t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
...|||||.+.-..+|.++|||-|||.+||+++ |..||.+- .+...-......-+...|+++|+.+..|
T Consensus 550 S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv-----kNsDVI~~iEnGeRlP~P~nCPp~LYsl 624 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV-----KNSDVIGHIENGERLPCPPNCPPALYSL 624 (974)
T ss_pred cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc-----cccceEEEecCCCCCCCCCCCChHHHHH
Confidence 367999999998999999999999999999977 77787653 2222222222333345678899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+.+||++||.+||.+.++...|+.+..
T Consensus 625 mskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 625 MSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999988876654
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=314.89 Aligned_cols=251 Identities=20% Similarity=0.289 Sum_probs=200.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCC----EEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~----~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
+++.++.||+|+||.||+|.+. +++ .||+|.+....... ...+.+|+.+++.++||||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 4567788999999999999853 344 57999887543322 34688999999999999999999998754 56799
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
+||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 87 TQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred ehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhcC-eeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999999864 3446889999999999999999999999 9999999999999999999999999998654321
Q ss_pred -----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 214 -----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 214 -----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...++..|+|||++.+..++.++||||||+++||+++ |+.|+............... .....+...+..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 239 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-----ERLPQPPICTID 239 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-----CCCCCCCCCCHH
Confidence 1234578999999988889999999999999999997 88887654333222111111 001112345578
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
+.+++.+||..+|++||++.++++.|+.+...
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=313.13 Aligned_cols=246 Identities=20% Similarity=0.235 Sum_probs=201.7
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
..|++++.||+|+||+||+|... +++.||+|.+....... .+++.+|+++++.++||||+++.+++..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778888999999999999964 58999999986543322 356889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcc
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 215 (449)
||++ |+|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.........
T Consensus 95 e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~~-i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~ 171 (307)
T cd06607 95 EYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHE-RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF 171 (307)
T ss_pred HhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcccEEECCCCCEEEeecCcceecCCCCCc
Confidence 9997 677777653 3457899999999999999999999999 999999999999999999999999999877666667
Q ss_pred ccCcccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 216 STNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 216 ~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
.+++.|+|||++. ...++.++||||||+++|||++|+.|+............... ..........+..+.+++
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC----CCCCCCchhhCHHHHHHH
Confidence 7889999999884 355889999999999999999999887654322211111110 001111234567899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~ 312 (449)
.+||+.||++||++.+++.+
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=312.08 Aligned_cols=244 Identities=19% Similarity=0.263 Sum_probs=201.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.+...+.||+|++|.||++... +++.+++|.++.......+.+.+|+.+++.++||||+++++++..++..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3444467799999999999954 589999999876554445678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSY 215 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~ 215 (449)
|++|.+++.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||.+...... ...
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG-VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 9999999853 57899999999999999999999999 999999999999999999999999987654332 234
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHh
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (449)
.+++.|+|||.+.+..++.++||||||+++|+|++|+.|+............... ..+ ....+...+..+.+++.+|
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPP--KLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCC--CCcccccCCHHHHHHHHHH
Confidence 5788999999998888999999999999999999999988654322222211111 111 1111233667899999999
Q ss_pred cccCCCCCCCHHHHHH
Q 013126 296 LQYEPRERPNPKSLVT 311 (449)
Q Consensus 296 l~~dP~~Rps~~eil~ 311 (449)
|+.||++||++.++++
T Consensus 253 l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 253 LVRDPAQRATAAELLN 268 (285)
T ss_pred cccChhhCcCHHHHcc
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.90 Aligned_cols=248 Identities=19% Similarity=0.277 Sum_probs=198.5
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|++++.||+|+||.||+|.++ +++.||+|.+...... ..+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5778899999999999999975 4899999998654322 246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
+++++|.++.. ....+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 82 VDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred CCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 99999888775 3456899999999999999999999999 999999999999999999999999998764432 2
Q ss_pred ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc----------------cc----cc
Q 013126 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL----------------QM----LT 272 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~----------------~~----~~ 272 (449)
...++..|+|||++.+. .++.++||||||+++|||++|++|+............. .. ..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 24567899999998753 47889999999999999999998875432211000000 00 00
Q ss_pred ccc-----cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 DSC-----LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+. ......+..+..+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 000112345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=306.55 Aligned_cols=243 Identities=21% Similarity=0.227 Sum_probs=201.3
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-----CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-----DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
|+..+.||+|++|.||+|... +++.|++|.+...... ..+.+.+|+++++.++|+||+++++++..++..++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 455677899999999999965 6899999998654321 2457899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||+++++|.+++. +...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 82 ELVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLEYLHDRN-TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EecCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 9999999999997 4456899999999999999999999999 999999999999999999999999998765433
Q ss_pred CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....++..|+|||.+.... ++.++|+||||+++|+|++|+.|+............. ........+...++.+.++
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG----RSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH----hcccCCCcCCCcCHHHHHH
Confidence 3455788999999997766 8999999999999999999999986543211111111 1001122344567889999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+.+||+.+|++||++.+++.
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHhhcCcccCcCHHHHhc
Confidence 99999999999999999987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=307.32 Aligned_cols=243 Identities=18% Similarity=0.181 Sum_probs=196.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-----CHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-----DPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 132 (449)
+|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 4667788899999999999964 4899999998643211 134688899999999999999999988764 4688
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~- 211 (449)
++|||++|++|.+++. ....+++.....++.|++.||+|||+++ ++|+||||+||++++++.++|+|||+++....
T Consensus 83 ~v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYLHSNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 9999999999999986 3456889999999999999999999999 99999999999999999999999999875432
Q ss_pred ------CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 212 ------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 212 ------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
.....++..|+|||++.+..++.++||||||+++|+|++|+.|+............... ......+...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 235 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ----PTNPVLPPHVS 235 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC----CCCCCCchhhC
Confidence 12345788999999998888999999999999999999999998643222111111111 11122344566
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..+.+++.+||. +|++||+++++++
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 789999999995 9999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.08 Aligned_cols=247 Identities=17% Similarity=0.207 Sum_probs=189.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC------CCcccceeeEeeC-Cee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN------NRLTNLLGCCCEG-DER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H------pnIv~l~~~~~~~-~~~ 131 (449)
..|++++.||+|+||+||+|.+. +++.||||+++... .....+..|+++++.++| ++++++++++..+ ++.
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 45888899999999999999964 58899999996532 223456677777777755 4588888888764 578
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeCCCC--------------
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDG-------------- 196 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~~~~-------------- 196 (449)
++|||++ |++|.+++. +.+.+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~g-IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEEecc-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCC-eecCCCCHHHEEEecCCcccccccccccCCC
Confidence 9999998 688999887 456799999999999999999999984 8 99999999999998765
Q ss_pred --CeEEeccCCcccCCCC-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhc---cccc
Q 013126 197 --NPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR---NLQM 270 (449)
Q Consensus 197 --~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~---~~~~ 270 (449)
.+||+|||.+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....
T Consensus 284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 363 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363 (467)
T ss_pred CceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence 4999999987654332 356789999999999999999999999999999999999999865432111000 0000
Q ss_pred c----------------cc------cccCC---------C-C-CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 L----------------TD------SCLEG---------Q-F-TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 ~----------------~~------~~~~~---------~-~-~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+ .. +.... . . .....+.+.+||.+||++||++|||++|+++
T Consensus 364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0 00 00000 0 0 0011356789999999999999999999998
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=307.02 Aligned_cols=247 Identities=15% Similarity=0.194 Sum_probs=199.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCC------ee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD------ER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~------~~ 131 (449)
++|++++.||+|++|.||+|... +++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 46778889999999999999965 478999999876542 356799999999999 7999999999997644 48
Q ss_pred EEEEeeCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 132 LLVAEYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
++||||+++++|.+++.... +..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHHHEEEccCCeEEECCCccceec
Confidence 99999999999999886433 567899999999999999999999999 999999999999999999999999998754
Q ss_pred CCC----CccccCccccccccccC-----CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCC
Q 013126 210 RDG----KSYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (449)
Q Consensus 210 ~~~----~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (449)
... ....++..|+|||++.. ..++.++||||||+++|+|++|+.|+................ ......
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~ 240 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PPTLKS 240 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CCCCCc
Confidence 332 23457889999998853 247889999999999999999999986432211111111111 111111
Q ss_pred CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+...+.++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2335678999999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=309.04 Aligned_cols=244 Identities=19% Similarity=0.279 Sum_probs=202.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+|++++.||+|++|.||++... +++.+|+|.+...... ..+++.+|++++++++||||+++++.+..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4677888999999999999965 5899999999765432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCCC--Ccc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSY 215 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~~~ 215 (449)
++++|.+++... ...+++.....++.|++.||+|+|+ .+ ++|+||||+||++++++.++|+|||.+...... ...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~-i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 82 DGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred CCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHcCCCC-eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 999999999742 2688999999999999999999999 88 999999999999999999999999998754322 225
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh-----hHHHhhcccccccccccCCCCCch-hHHHHH
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-----LDLIRDRNLQMLTDSCLEGQFTDD-DGTELV 289 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~ 289 (449)
.++..|+|||.+.+..++.++||||||+++|+|++|+.|+.... .......... ... ...+.. .+.++.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~ 234 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN----EPP-PRLPSGKFSPDFQ 234 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc----CCC-CCCChhhcCHHHH
Confidence 67889999999988889999999999999999999999886431 1111111111 111 111222 677899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
++|.+||..||++|||+.+++.
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhh
Confidence 9999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=311.08 Aligned_cols=250 Identities=19% Similarity=0.286 Sum_probs=196.5
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.+.|++++.||+|++|+||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 457889999999999999999965 5899999999754322 23567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++ ++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~-~~L~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLD-TDLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQRR-VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCC-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 998 599998864 3357899999999999999999999999 999999999999999999999999998754321
Q ss_pred CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhh--HHHh---h-------cccccccc------
Q 013126 213 KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL--DLIR---D-------RNLQMLTD------ 273 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~--~~~~---~-------~~~~~~~~------ 273 (449)
....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||..... +... + ........
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 12345788999999876 4488999999999999999999988854321 1100 0 00000000
Q ss_pred -------cccCCCCCchhH--HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 -------SCLEGQFTDDDG--TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 -------~~~~~~~~~~~~--~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
............ .++.+++.+||+.||++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000001122 67889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=311.79 Aligned_cols=247 Identities=19% Similarity=0.252 Sum_probs=195.9
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+++.++.||+|+||.||++... +++.||+|.+...... ....+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678899999999999964 4899999999754322 3457889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHH---hccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 138 MPNETLAKHL---FHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 138 ~~ggsL~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
+. +++.++. .......+++..+..++.|++.||+|||+. + ++||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-eeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 86 5655543 222346799999999999999999999985 7 999999999999999999999999998754332
Q ss_pred --CccccCccccccccccCC---CCCCCCceeeHhHHHHHHhcCCCCCCchhh--HHHhhcccccccccccCCCCCchhH
Q 013126 213 --KSYSTNLAFTPPEYLRTG---RVTPESVIYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
....++..|+|||++.+. .++.++||||+|+++|+|++|+.||..... ...... ... ..+......+...+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~ 240 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV-VKG-DPPILSNSEEREFS 240 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh-cCC-CCCcCCCcCCCccC
Confidence 234578899999999776 589999999999999999999999865421 111111 110 11111112223567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.++.+++.+||+.||++|||+++++.
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 88999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=304.79 Aligned_cols=245 Identities=19% Similarity=0.254 Sum_probs=203.9
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEee--CCeeEEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVA 135 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 135 (449)
+|++++.||.|+||.||++... +++.+|+|.++...... .+++.+|+++++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3678889999999999999954 58899999987543322 4568899999999999999999998754 45689999
Q ss_pred eeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 136 EYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCT-----SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH-----~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
||+++++|.+++... ...++++..++.++.|++.||+||| +.+ ++|+||||+||++++++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc-ceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998642 2467899999999999999999999 888 99999999999999999999999999887
Q ss_pred CCCCC----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 209 SRDGK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 209 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
..... ...+++.|+|||++.+..++.++|+||||+++|+|++|+.|+................ ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~ 234 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-----FRRIPYRY 234 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC-----CCCCcccc
Confidence 65433 3467899999999988889999999999999999999999987654333332221111 12334566
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+..+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=310.71 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=198.2
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|++++.||.|++|.||+|+.. +++.||||.++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 677888999999999999965 5899999998754322 2457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
. ++|.+++.......+++..+..++.|++.||+|||+++ ++||||+|+||++++++.+||+|||++...... ..
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 6 68999887545677899999999999999999999999 999999999999999999999999998765432 22
Q ss_pred cccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc-----------------c--
Q 013126 215 YSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD-----------------S-- 274 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------------~-- 274 (449)
..+++.|+|||++.+.. ++.++||||||+++|+|+||+.||.................. .
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 34578899999987654 688999999999999999999988654322111100000000 0
Q ss_pred -ccC---CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 -CLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 -~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
... ....+..++++.+++.+||+.||++|||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 0011235577899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=310.85 Aligned_cols=251 Identities=18% Similarity=0.244 Sum_probs=199.8
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeC--CeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 132 (449)
+.+.|++++.||+|+||.||+|... +++.+|+|.++...... ...+.+|+.++++++||||+++++++... +..+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 4457888899999999999999975 48899999997544222 34678899999999999999999998877 8899
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||++ ++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 83 lv~e~~~-~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 83 MVMEYVE-HDLKSLMET-MKQPFLQSEVKCLMLQLLSGVAHLHDNW-ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEehhcC-cCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999998 599998864 2346899999999999999999999999 999999999999999999999999998865443
Q ss_pred ----CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc-------------------
Q 013126 213 ----KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL------------------- 268 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~------------------- 268 (449)
....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..|+.............
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 2234678899999987654 6889999999999999999998886432211111100
Q ss_pred ------ccccccccCCCCCch-hHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 ------QMLTDSCLEGQFTDD-DGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 ------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...........++.. .++.+.+++.+||+.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000111112222 4678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=303.77 Aligned_cols=243 Identities=20% Similarity=0.280 Sum_probs=200.8
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+|++.+.||+|++|.||+|... +++.||+|.++..... ..+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3677788999999999999964 5899999999765543 456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
+++++|.+++. ....+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~-i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHG-IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHh--hcCCCChHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999997 4456889999999999999999999999 9999999999999999999999999987654321
Q ss_pred ----ccccCccccccccccCCC---CCCCCceeeHhHHHHHHhcCCCCCCchhhH-HHhhcccccccccccCCCCCc--h
Q 013126 214 ----SYSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTD--D 283 (449)
Q Consensus 214 ----~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~--~ 283 (449)
...+++.|+|||++.+.. ++.++||||||+++|++++|+.||...... ........ .. ....+. .
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~--~~~~~~~~~ 232 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GH--KPPIPDSLQ 232 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CC--CCCCCcccc
Confidence 234678999999998766 889999999999999999999998543111 11111111 00 111222 3
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+..+.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 233 LSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 4678999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=307.56 Aligned_cols=246 Identities=19% Similarity=0.280 Sum_probs=199.6
Q ss_pred cccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCC------CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
|+..+.||+|++|.||++.. .+++.||+|.++..... ..+.+.+|++++++++|+||+++++++.+++..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 45556779999999999995 56899999999753321 135788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-CeEEeccCCcccCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~- 212 (449)
|||++|++|.+++. ...++++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .+||+|||.+......
T Consensus 82 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~~~-i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 82 VEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHENQ-IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EeccCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999997 4467899999999999999999999999 99999999999998776 5999999998764432
Q ss_pred -------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 -------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
....++..|+|||.+.+..++.++|+||+|+++|+|++|..|+............ ............+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-HHHhccCCCCCCchhhC
Confidence 1235678999999998888999999999999999999999988543211111110 01111111123445567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 88999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=305.36 Aligned_cols=241 Identities=18% Similarity=0.196 Sum_probs=194.4
Q ss_pred cccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHH-HhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARS-VGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
+.||+|+||.||+|... +++.||+|.++...... ...+..|..+ ....+|+|++++++++..++..++|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999964 58999999997543211 2234455544 4455899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCccccCcc
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~gt~~ 220 (449)
++|.+++. ...++++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.........++..
T Consensus 82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQRG-IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD 158 (260)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcC
Confidence 99999997 4467899999999999999999999999 99999999999999999999999999987665556678899
Q ss_pred ccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCC
Q 013126 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (449)
Q Consensus 221 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (449)
|+|||.+.+..++.++||||+|+++|+|++|..|+.................. ........+++++.+++.+||+.||
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCCcccccCCHHHHHHHHHHccCCH
Confidence 99999998888999999999999999999999998655433332221111111 1112233567889999999999999
Q ss_pred CCCCCHHHHHH
Q 013126 301 RERPNPKSLVT 311 (449)
Q Consensus 301 ~~Rps~~eil~ 311 (449)
++||++.++.+
T Consensus 237 ~~R~~~~~~~~ 247 (260)
T cd05611 237 AKRLGANGYQE 247 (260)
T ss_pred HHccCCCcHHH
Confidence 99997754444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=308.35 Aligned_cols=247 Identities=19% Similarity=0.255 Sum_probs=204.4
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
-..|++.+.+|+|++|.||+|.++ +++.||+|.+..... ..+.+.+|++.++.++|+||+++++.+..++..++++||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 344667788899999999999976 588999999976543 467889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
++|++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 97 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 97 MDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN-VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 99999999997422 37999999999999999999999999 999999999999999999999999987654433 2
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...++..|+|||++.+..++.++|+||||+++|+|++|+.|+................. .........+..+.+++.
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI---PPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---CCCcchhhCCHHHHHHHH
Confidence 33467899999999888899999999999999999999998765432221111111111 111112235678999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
+||+.+|.+|||+.+++.
T Consensus 252 ~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHhccChhhCcCHHHHhh
Confidence 999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=308.48 Aligned_cols=244 Identities=18% Similarity=0.270 Sum_probs=194.9
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHH-HhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARS-VGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+|++++.||+|+||.||++... +|+.||+|.++..... ...++..|+.+ ++.++||||+++++++..++..+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 5778899999999999999965 5999999999765322 23456667765 6667899999999999999999999999
Q ss_pred CCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 138 MPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
++ ++|.+++... ....+++..++.++.|++.||+|||++ + ++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-eecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 97 7888887642 235789999999999999999999997 7 9999999999999999999999999987654332
Q ss_pred --ccccCccccccccccC----CCCCCCCceeeHhHHHHHHhcCCCCCCchh--hHHHhhcccccccccccCCCCCchhH
Q 013126 214 --SYSTNLAFTPPEYLRT----GRVTPESVIYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 214 --~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
...++..|+|||++.+ ..++.++|+||||+++|+|++|+.|+.... .+..... .............+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 234 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-----VEEPSPQLPAEKFS 234 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH-----HhcCCCCCCccccC
Confidence 2457889999998865 446889999999999999999999885421 1111111 11111111123456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.++.+++.+||+.+|++||++.++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 78999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=306.93 Aligned_cols=243 Identities=18% Similarity=0.268 Sum_probs=202.7
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.|+++++||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667888999999999999864 588999999865432 22457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
++++|.+++. ...+++..+..++.|++.|+.|||+++ ++|+||||+||++++++.++|+|||++...... ..
T Consensus 85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccCC-eecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 9999999984 457899999999999999999999999 999999999999999999999999998765433 22
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..++..|+|||.+.+..++.++|+||||+++|+|++|..|+............... .........+.++.+++.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-----NPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-----CCCCCCcccCHHHHHHHHH
Confidence 45788899999998888899999999999999999999888654322222111111 1122334567889999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~ 312 (449)
||+.+|++||++.+++.+
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=306.13 Aligned_cols=243 Identities=18% Similarity=0.213 Sum_probs=195.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-----CHHHHHHHHHHHhccCCCCcccceeeEee--CCeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-----DPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~ 132 (449)
.|+..+.+|+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+ +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 3556677899999999999964 5899999998653221 13468899999999999999999998875 35789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+++||+++++|.+++. ....+++...+.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 83 l~~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~-i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999997 4456899999999999999999999998 999999999999999999999999998754321
Q ss_pred -------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 -------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
....++..|+|||++.+..++.++||||+|+++|+|++|+.||............. ........+...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~ 235 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA----TQPTNPQLPSHIS 235 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh----cCCCCCCCchhcC
Confidence 12347889999999998889999999999999999999999886432111111111 1111123344556
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.+.+++ +||..+|++||++++++.
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 7788888 688899999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=314.56 Aligned_cols=242 Identities=16% Similarity=0.241 Sum_probs=184.4
Q ss_pred cccCCccceEEEEEEEc---CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEee--CCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~g 140 (449)
++||+|+||+||+|+.. +++.||+|.+.... ....+.+|+++++.++||||+++++++.. +...++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 46899999999999954 35789999987543 23568899999999999999999998854 467899999997
Q ss_pred CCHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee----CCCCCeEEeccCCcccC
Q 013126 141 ETLAKHLFHW-------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 141 gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla~~~ 209 (449)
++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||++ ++++.+||+|||+++..
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-EEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 5788877421 1235889999999999999999999999 9999999999999 46678999999999865
Q ss_pred CCC-------CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh-------------h---
Q 013126 210 RDG-------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR-------------D--- 265 (449)
Q Consensus 210 ~~~-------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-------------~--- 265 (449)
... ....+|+.|+|||++.+. .++.++||||||+++|||+||++||.....+... .
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 432 234578999999999764 4899999999999999999999887532111000 0
Q ss_pred ----ccccc---------cccccc------------CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 266 ----RNLQM---------LTDSCL------------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 266 ----~~~~~---------~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..... ...... ........+..+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000000 00001122456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=303.45 Aligned_cols=245 Identities=17% Similarity=0.268 Sum_probs=203.4
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|.+.+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+++++.++|+||+++++.+..++..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 567788899999999999965 488999999965422 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC-eEEeccCCcccCCCCC----
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN-PRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~-~kL~DFGla~~~~~~~---- 213 (449)
++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 9999999997544456899999999999999999999999 999999999999998764 6999999987655432
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...+++.|+|||++.+..++.++|+||||+++|+|++|..|+................. ....+..+.++.+++.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-----APISPNFSRDLRSLIS 235 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-----CCCCCCCCHHHHHHHH
Confidence 23578899999999888899999999999999999999999865433332222221111 1223455678999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~ 312 (449)
+||+.+|++|||+.++++.
T Consensus 236 ~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 236 QLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHhccChhhCcCHHHHhhC
Confidence 9999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=306.13 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=200.1
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCC-CCHHHHHHHHHHHhccC---CCCcccceeeEeeCCeeEEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.|++++.||+|+||.||+|.+ .+++.||+|.++.... ...+++.+|+.++++++ |||++++++++..++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366778899999999999996 4589999999875432 33567889999999996 999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++|++|.+++. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 82 EYAEGGSVRTLMK---AGPIAEKYISVIIREVLVALKYIHKVG-VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred ecCCCCcHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 9999999999985 347899999999999999999999999 999999999999999999999999998765443
Q ss_pred -CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCc-hhHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD-DDGTELV 289 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 289 (449)
....++..|+|||.+.++ .++.++|+||||+++|+|++|..|+............... .. ...+. ..+.++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~ 232 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS----KP-PRLEDNGYSKLLR 232 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC----CC-CCCCcccCCHHHH
Confidence 234578899999998754 4789999999999999999999998654332222111111 01 11112 2567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+||+.||++||++.+++.
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhh
Confidence 9999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.48 Aligned_cols=249 Identities=17% Similarity=0.236 Sum_probs=199.5
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 136 (449)
.++.+++||.|++|.||++... +++.+|+|.+...... ...++.+|++++++++||||+++++++... +.+++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 4667788899999999999964 5899999999754332 356799999999999999999999988654 46899999
Q ss_pred eCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 137 YMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|++|++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK-IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999887532 3456889999999999999999999999 999999999999999999999999998754432
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh-----HHHhhcccccccccccCCCC--CchhH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-----DLIRDRNLQMLTDSCLEGQF--TDDDG 285 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~--~~~~~ 285 (449)
....++..|+|||.+.+..++.++||||+|+++|+|++|+.|+..... ......... ...+...... ....+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGNGIKWS 239 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCCCCchH
Confidence 234568899999999888899999999999999999999998865411 111111000 0111111111 12356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 240 EEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 78999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=305.26 Aligned_cols=248 Identities=17% Similarity=0.276 Sum_probs=201.9
Q ss_pred cccccccCCccceEEEEEEEcC--CCEEEEEEecCCCC----------CCHHHHHHHHHHHhc-cCCCCcccceeeEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLEN--QRRIAVKRFNRMAW----------PDPRQFLEEARSVGQ-LRNNRLTNLLGCCCEG 128 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~--~~~vAiK~l~~~~~----------~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~ 128 (449)
|++.+.||+|+||.||+|.... ++.+|+|.+..... ....++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5677889999999999999654 78899999864221 123457788888875 7999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCC
Q 013126 129 DERLLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
+..+++|||++|++|.+++... ....+++..++.++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|||.
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc-eeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999987531 34568999999999999999999996 66 99999999999999999999999999
Q ss_pred cccCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCc
Q 013126 206 MKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 206 a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
+...... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+..................+ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~ 236 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP----LPEG 236 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc----CCcc
Confidence 8865544 23457889999999998889999999999999999999999886554333332222211111 1122
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
..++++.+++.+||+.||++||++.++.+++.
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 45678999999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=306.91 Aligned_cols=251 Identities=16% Similarity=0.168 Sum_probs=196.8
Q ss_pred HHHHHhhCCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEee
Q 013126 50 EQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCE 127 (449)
Q Consensus 50 ~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 127 (449)
.+..+..+++..++.++ +|+|+||.||++.. .+++.+|+|.+........ |+.....+ +||||+++++.+..
T Consensus 7 ~~~~~~~~~~~~~~~~~-lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLK-LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhcccccee-ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34444444444444443 59999999999995 4588999999875432211 22222222 79999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-CeEEeccCCc
Q 013126 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLM 206 (449)
Q Consensus 128 ~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla 206 (449)
++..++||||+++++|.+++. ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVEALNDLHKHN-IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 999999999999999999997 3358999999999999999999999999 99999999999999888 9999999999
Q ss_pred ccCCCCCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 207 KNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 207 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
+.........++..|+|||++.+..++.++||||+|+++|+|++|+.|+................... ........++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (267)
T PHA03390 158 KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK--KLPFIKNVSK 235 (267)
T ss_pred eecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--cCCcccccCH
Confidence 87776666778999999999998889999999999999999999999986432221111111111111 1122335778
Q ss_pred HHHHHHHHhcccCCCCCCC-HHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPN-PKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps-~~eil~ 311 (449)
.+.+++.+||+.||.+||+ ++++++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 8999999999999999995 699886
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=310.26 Aligned_cols=247 Identities=21% Similarity=0.221 Sum_probs=196.6
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-----CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-----DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
|++++.||+|++|.||+|... +++.||+|.++..... ....+.+|++++++++|+||+++++++.+++..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 567788899999999999965 5899999999765432 2345778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC--
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-- 213 (449)
||+ +++|.+++... ...+++..+..++.||++||+|||+++ ++||||||+||+++.++.++|+|||+++......
T Consensus 82 e~~-~~~L~~~i~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 82 EFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSNW-ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred ccc-CCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 999 89999999642 237999999999999999999999999 9999999999999999999999999997654432
Q ss_pred --ccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc--------------cc---
Q 013126 214 --SYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML--------------TD--- 273 (449)
Q Consensus 214 --~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------------~~--- 273 (449)
...+++.|+|||.+.+ ..++.++||||||+++|+|++|.+++................ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 2345778999999865 457899999999999999999977665432111110000000 00
Q ss_pred -----cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 -----SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 -----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...........+..+.+++.+||+.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000112345678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=308.75 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=199.4
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|++++.||+|++|.||+|... +++.||+|.++.... ...+.+.+|++++++++|+||+++++++..++..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778889999999999999965 488999999875332 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
++++.+..+.. +...+++..+..++.|++.||+|||+++ ++||||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHN-IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99877766554 4466899999999999999999999999 9999999999999999999999999987654432
Q ss_pred -ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhc--------------------ccc--
Q 013126 214 -SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR--------------------NLQ-- 269 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~--------------------~~~-- 269 (449)
...++..|+|||++.+. .++.++||||||+++|+|++|+.|+........... ...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34567889999999888 789999999999999999999988764321110000 000
Q ss_pred ccccc----ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 MLTDS----CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 ~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..... ......+...+.++.+++.+||..||++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0001122334788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.13 Aligned_cols=257 Identities=16% Similarity=0.162 Sum_probs=201.5
Q ss_pred cCHHHHHHhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceee
Q 013126 47 FTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGC 124 (449)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 124 (449)
++++++..+++ +|.+++.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.+++++ +|||+++++++
T Consensus 12 ~~~~~~~~~~~---~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 12 LGLESLGDPTD---TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred hhcccCCCCCC---CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 34445444444 4667788899999999999964 58999999986533 2346788999999999 89999999999
Q ss_pred EeeC-----CeeEEEEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC
Q 013126 125 CCEG-----DERLLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 125 ~~~~-----~~~~lV~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~ 197 (449)
+... +..++||||++|++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEEcCCCC
Confidence 8754 3589999999999999988531 3457899999999999999999999999 999999999999999999
Q ss_pred eEEeccCCcccCCCC----CccccCccccccccccCC-----CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc
Q 013126 198 PRLSTFGLMKNSRDG----KSYSTNLAFTPPEYLRTG-----RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268 (449)
Q Consensus 198 ~kL~DFGla~~~~~~----~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 268 (449)
+||+|||++...... ....++..|+|||++... .++.++||||||+++|+|++|+.|+.............
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 999999998764432 234578899999998643 26889999999999999999999886543211111111
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .....+...+..+.+++.+||+.||++||++.++++
T Consensus 247 ~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNPP---PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCCC---CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1100 111123345568999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=307.35 Aligned_cols=241 Identities=17% Similarity=0.254 Sum_probs=196.1
Q ss_pred cCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
||+|+||+||++... +|+.||+|.+..... ...+.+.+|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 599999999999854 589999999965321 2245678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---CccccCcc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYSTNLA 220 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~~~gt~~ 220 (449)
.+++.......+++..+..++.|++.||.|||+++ ++||||+|+||++++++.++|+|||++...... ....++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR-IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 99997544457999999999999999999999999 999999999999999999999999998765432 23456789
Q ss_pred ccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCC
Q 013126 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (449)
Q Consensus 221 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (449)
|+|||++.+..++.++||||+|+++|+|++|+.||.................. .....+...++.+.+++.+||+.||
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHHccCCh
Confidence 99999998888999999999999999999999998654321111111111111 1122344567889999999999999
Q ss_pred CCCC-----CHHHHHH
Q 013126 301 RERP-----NPKSLVT 311 (449)
Q Consensus 301 ~~Rp-----s~~eil~ 311 (449)
++|| ++.+++.
T Consensus 238 ~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 238 EKRLGCRGGSADEVRE 253 (277)
T ss_pred hHccCCCcccHHHHHh
Confidence 9999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.08 Aligned_cols=243 Identities=19% Similarity=0.278 Sum_probs=205.0
Q ss_pred ccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+|++++.||+|++|.||+|...+ ++.||+|++..... ...+.+.+|++.+++++|+||+++++++..++..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 46778888999999999999664 99999999976543 23578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
++++|.+++. ....+++..+..++.|++.|++|||+ .+ ++||||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~~-~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 82 DGGSLADLLK--KVGKIPEPVLAYIARQILKGLDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred CCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhccCC-CccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 9999999997 34789999999999999999999999 98 9999999999999999999999999987654432
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh---hHHHhhcccccccccccCCCCCch-hHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNLQMLTDSCLEGQFTDD-DGTELV 289 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~ 289 (449)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.... ........... .. ...+.. .+..+.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~l~ 233 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG----PP-PSLPAEEFSPEFR 233 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC----CC-CCCCcccCCHHHH
Confidence 3356789999999988889999999999999999999999875542 11111111111 11 122333 678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+||+.+|++||++.++++
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHh
Confidence 9999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=310.93 Aligned_cols=249 Identities=18% Similarity=0.229 Sum_probs=203.3
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
|..++.||+|+||.||+++.. ++..||+|.+....... .+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556778899999999999954 58999999987543222 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcccc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~g 217 (449)
++ |+|.+.+.. ...++++..+..++.|++.||.|||+++ ++||||+|+||++++++.+||+|||++..........+
T Consensus 107 ~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~-i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (317)
T cd06635 107 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN-MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG 183 (317)
T ss_pred CC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcccEEECCCCCEEEecCCCccccCCcccccC
Confidence 97 578777653 3567899999999999999999999999 99999999999999999999999999887766666778
Q ss_pred Ccccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 218 NLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 218 t~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
++.|+|||++. ++.++.++||||||+++|+|++|+.|+............... ..........++.+.+++.+
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~ 259 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTLQSNEWSDYFRNFVDS 259 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc----cCCCCCCccccHHHHHHHHH
Confidence 99999999974 356899999999999999999999987654222111111111 01111123456789999999
Q ss_pred hcccCCCCCCCHHHHHHHhcccc
Q 013126 295 CLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
||+.+|.+||++.++++.+....
T Consensus 260 ~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 260 CLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HccCCcccCcCHHHHHhChhhhc
Confidence 99999999999999998665544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=316.14 Aligned_cols=246 Identities=19% Similarity=0.248 Sum_probs=197.6
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCC--CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
=..|+++++||+||.+.||++...+.+.||+|++.... .....-|.+|+..|.+| .|.+|+++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 35799999999999999999998777889999886432 22356799999999999 5999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC--
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-- 213 (449)
||=+ -+|...|..+......| .++.+..|++.++.++|.+| |||.||||.|+|+- .|.+||+|||+|.......
T Consensus 440 E~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g-IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG-IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred eccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc-eeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 9976 79999998644333334 77889999999999999999 99999999999987 5789999999998776653
Q ss_pred ----ccccCccccccccccCCC-----------CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCC
Q 013126 214 ----SYSTNLAFTPPEYLRTGR-----------VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 214 ----~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (449)
+..||+.||+||.+.... .+.++||||+|||||+|+.|+.||....... ..+..+.++...-
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~---aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI---AKLHAITDPNHEI 592 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH---HHHHhhcCCCccc
Confidence 467999999999985322 5679999999999999999999885432111 1223333332222
Q ss_pred CCCchh-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 279 QFTDDD-GTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 279 ~~~~~~-~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.-- ..++.+++..||++||++|||..++|+
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 222211 123999999999999999999999998
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=298.26 Aligned_cols=246 Identities=20% Similarity=0.278 Sum_probs=205.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
+|.+.+.||+|++|.||++... +++.+++|+++.......+.+.+|++.++.++|||++++++.+..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667788999999999999975 588999999987655456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---Cccc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYS 216 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~~~ 216 (449)
|++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||+|+||++++++.++|+|||.+...... ....
T Consensus 81 ~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSNG-IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCC-EecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 9999999864 2257899999999999999999999998 999999999999999999999999998776554 3456
Q ss_pred cCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhc
Q 013126 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296 (449)
Q Consensus 217 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (449)
++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.................. ........+..+.+++.+||
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l 235 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP---GLRNPEKWSDEFKDFLKKCL 235 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCC---CcCcccccCHHHHHHHHHHc
Confidence 788999999998888999999999999999999999988654222111111111000 01111223678999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 013126 297 QYEPRERPNPKSLVT 311 (449)
Q Consensus 297 ~~dP~~Rps~~eil~ 311 (449)
+.||++|||+.+++.
T Consensus 236 ~~~p~~R~t~~~~l~ 250 (253)
T cd05122 236 QKNPEKRPTAEQLLK 250 (253)
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.32 Aligned_cols=249 Identities=20% Similarity=0.296 Sum_probs=197.3
Q ss_pred cccccccCCccceEEEEEEEc----CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCC------
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ 129 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 129 (449)
|++.+.||+|+||.||+|.+. +++.||||.++..... ..+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678899999999999853 3688999999764322 2457889999999999999999999886542
Q ss_pred eeEEEEeeCCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 130 ERLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
..++++||+++|+|.+++... ....+++...+.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-FIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999999887531 1235788999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCC
Q 013126 206 MKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 206 a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (449)
++...... ...+++.|++||.+.+..++.++||||||+++|+|++ |+.|+................ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----~~ 234 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-----RL 234 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-----cC
Confidence 88654321 2234578999999988889999999999999999999 777765443322222111110 11
Q ss_pred CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 12334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=301.88 Aligned_cols=237 Identities=19% Similarity=0.228 Sum_probs=198.0
Q ss_pred cCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
||.|++|.||+++.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+.+++..+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 599999999999965 489999999975432 2246799999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---CccccCcc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYSTNLA 220 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~~~gt~~ 220 (449)
.+++. +...+++..+..++.|++.||+|||+++ ++|+||||+||++++++.++|+|||+++..... ....++..
T Consensus 81 ~~~l~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~-~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILR--DRGLFDEYTARFYIACVVLAFEYLHNRG-IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 99997 4456899999999999999999999999 999999999999999999999999998876543 23457889
Q ss_pred ccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh--hHHHhhcccccccccccCCCCCchhHHHHHHHHHHhccc
Q 013126 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298 (449)
Q Consensus 221 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (449)
|+|||.+.+..++.++|+||+|+++|+|++|..|+.... ......... ........+...+.++.+++.+||+.
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL----KGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh----ccCCCCCCCcccCHHHHHHHHHHccC
Confidence 999999988889999999999999999999999986554 111111111 11111233444578899999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 013126 299 EPRERPN-----PKSLVT 311 (449)
Q Consensus 299 dP~~Rps-----~~eil~ 311 (449)
||++||+ ++++++
T Consensus 234 ~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 234 NPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ChhhCcCCcccCHHHHhc
Confidence 9999999 778776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=307.08 Aligned_cols=240 Identities=19% Similarity=0.262 Sum_probs=198.4
Q ss_pred ccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 65 VSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
...||+|+||.||++... +++.||+|++........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 356799999999999964 5899999998654444456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----CccccCc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTNL 219 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~gt~ 219 (449)
.+++. ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||++...... ....+++
T Consensus 105 ~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~g-ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 105 TDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred HHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 99874 456899999999999999999999999 999999999999999999999999987654332 2345788
Q ss_pred cccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccC
Q 013126 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (449)
Q Consensus 220 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (449)
.|+|||.+.+..++.++|+||+|+++|+|++|..|+................... .......+..+.+++.+||+.|
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK---LKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc---cCCcccCCHHHHHHHHHHHhCC
Confidence 9999999988889999999999999999999999886543222211111111111 0112345678999999999999
Q ss_pred CCCCCCHHHHHH
Q 013126 300 PRERPNPKSLVT 311 (449)
Q Consensus 300 P~~Rps~~eil~ 311 (449)
|.+||++.+++.
T Consensus 258 P~~R~~~~~ll~ 269 (292)
T cd06657 258 PAQRATAAELLK 269 (292)
T ss_pred cccCcCHHHHhc
Confidence 999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.75 Aligned_cols=244 Identities=20% Similarity=0.241 Sum_probs=209.3
Q ss_pred CcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.+++..++.||+|.||.|-+++ ..+++.+|||++++...-. ...-+.|-++|+..+||.+..+.-.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4456678888999999999999 4569999999998754333 34567899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC----
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR---- 210 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~---- 210 (449)
|||+.||.|.-++. +.+.++++..+.+-.+|..||.|||+++ |++||||.+|.|+|++|++||+|||+++..-
T Consensus 247 MeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~-ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN-IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC-eeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999999887 5678999999999999999999999998 9999999999999999999999999998532
Q ss_pred CCCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 211 DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 211 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
..+.++|||.|.|||++....|+.++|.|.+||++|||++|+.||....-+.+-+-+... .-.+|..+++++..
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------d~kFPr~ls~eAkt 397 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------DLKFPRTLSPEAKT 397 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------hccCCccCCHHHHH
Confidence 235789999999999999999999999999999999999999999876544444333222 12456778899999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHH
Q 013126 291 LASRCLQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rp-----s~~eil~ 311 (449)
|+..+|.+||.+|. .+.||.+
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHh
Confidence 99999999999995 3555554
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.98 Aligned_cols=239 Identities=18% Similarity=0.197 Sum_probs=189.6
Q ss_pred cCCccceEEEEEEEc-CCCEEEEEEecCCCCC---CHHHHHHHHHHHhc---cCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQ---LRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~---l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
||+|+||.||++... +++.+|+|.+...... ....+.+|..+++. .+||||+.+++++..++..++||||++|
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 699999999999964 5899999998654322 12334555544443 4799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--CccccC
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSYSTN 218 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~~~~gt 218 (449)
++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||++...... ....++
T Consensus 82 ~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~~-ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (279)
T cd05633 82 GDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (279)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence 99999987 4567999999999999999999999999 999999999999999999999999998754432 234588
Q ss_pred ccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 219 LAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 219 ~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
..|+|||.+.+ ..++.++||||+|+++|+|++|..||.......... ..... .......++..+.++.+++.+||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT-LTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHh-hcCCcCCccccCHHHHHHHHHHhc
Confidence 99999999864 458999999999999999999999986432111110 00000 011123345667889999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 013126 298 YEPRERP-----NPKSLVTA 312 (449)
Q Consensus 298 ~dP~~Rp-----s~~eil~~ 312 (449)
.||++|| |+++++++
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhC
Confidence 9999999 69999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=306.04 Aligned_cols=250 Identities=20% Similarity=0.253 Sum_probs=196.9
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++|++.+.||+|++|+||+|... +|+.||+|.+...... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999965 5899999998654322 24578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-CCCeEEeccCCcccCCCC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~--- 212 (449)
|++ ++|.+++.......+++..+..++.||+.||+|||+++ ++||||||+||++++ ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 996 68888886444445688889999999999999999999 999999999999985 567999999998754322
Q ss_pred -CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc--------------cc---
Q 013126 213 -KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML--------------TD--- 273 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------------~~--- 273 (449)
....+++.|+|||++.+. .++.++||||+|+++|+|+||+.|+................ .+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 233567899999998764 47899999999999999999998886432211111000000 00
Q ss_pred c------ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 S------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
. .......+..++++.+++.+||+.||++||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000012345678999999999999999999999997
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.11 Aligned_cols=248 Identities=20% Similarity=0.263 Sum_probs=197.3
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|++++.||.|++|.||+|... +|+.||+|++..... ...+.+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 467788999999999999964 599999999975432 22467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
+ ++|.+++.......+++..+..++.|++.||+|||+++ ++||||+|+||++++++.++|+|||+++..... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~-~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 6 79999987433347899999999999999999999998 999999999999999999999999998754322 22
Q ss_pred cccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-----------------c----cc
Q 013126 215 YSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-----------------M----LT 272 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------------~----~~ 272 (449)
..++..|+|||++.+. .++.++|+||||+++|+|++|+.||.............. . ..
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 3457889999988764 478899999999999999999988864322111000000 0 00
Q ss_pred cc--ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 DS--CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.. .......+..+..+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0001112345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=305.35 Aligned_cols=249 Identities=20% Similarity=0.247 Sum_probs=194.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
..|++++.||+|+||.||+|... +++.||+|.+....... ...+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 45788899999999999999954 58999999997544322 34678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
+. ++|.+.+.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++..... .
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 85 MH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQH-ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred cc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 96 677777653 3456788889999999999999999999 999999999999999999999999998754322 2
Q ss_pred ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhH--HHhhc----------------ccc----c
Q 013126 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALD--LIRDR----------------NLQ----M 270 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~--~~~~~----------------~~~----~ 270 (449)
...+++.|+|||++.+. .++.++||||||+++|+|++|..||...... .+... ... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 23468899999998764 4788999999999999999999988643211 00000 000 0
Q ss_pred ccccccCCCC-----CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 LTDSCLEGQF-----TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 ~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.......... ....+.++.+++.+|++.||++|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0012467899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=297.16 Aligned_cols=245 Identities=20% Similarity=0.262 Sum_probs=207.8
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+|++++.||+|++|.||++... +++.+|+|++..... ...+.+.+|+++++.++|||++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3677888999999999999965 589999999976543 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC--
Q 013126 138 MPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-- 213 (449)
+++++|.+++.... ...+++..+..++.+++.||.|||+++ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC-EecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999997532 477999999999999999999999998 9999999999999999999999999987654432
Q ss_pred --ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 214 --SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 214 --~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
...+++.|+|||...+..++.++|+||+|+++|+|++|+.|+................. ...+...+.++.++
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 234 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY-----PPIPSQYSSELRNL 234 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC-----CCCCCCCCHHHHHH
Confidence 34578889999999888899999999999999999999999866543333332222211 22344567889999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+.+||..+|++|||+.++++
T Consensus 235 i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 235 VSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=310.22 Aligned_cols=244 Identities=19% Similarity=0.235 Sum_probs=190.7
Q ss_pred ccCCc--cceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 67 EHGEK--APNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 67 ~lG~G--~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
.||+| +||+||++++. +|+.||+|++....... .+.+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 44555 99999999964 69999999987543222 467889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---------
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--------- 212 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--------- 212 (449)
+|.+++.......+++..+..++.|++.||+|||+++ ++||||||+||++++++.++++|||.+......
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG-YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9999987544556899999999999999999999999 999999999999999999999999854322111
Q ss_pred --CccccCccccccccccCC--CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc------------------
Q 013126 213 --KSYSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM------------------ 270 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~------------------ 270 (449)
....++..|+|||++.+. .++.++||||+|+++|+|++|+.|+...............
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 011245679999999764 4789999999999999999999998654221111000000
Q ss_pred -----------------------ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 -----------------------LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 -----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..............+..+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000011112345678999999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=313.48 Aligned_cols=249 Identities=18% Similarity=0.253 Sum_probs=210.7
Q ss_pred CCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
+.|..|+++ |+|+||.||-+.. .+|+-+|.|++.+... ......++|-.+|.+++.+.||.+--.|.+.+.++
T Consensus 185 n~F~~~Rvl---GkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 185 NTFRVYRVL---GKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cceeeeEEE---ecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 457888877 9999999999995 4699999999965332 22456789999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+|+..|+||+|.-+|....+..+++..++.++.+|+-||++||+.+ ||+||+||+|||+|+.|+++|+|+|+|.....+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~-iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR-IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc-eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 9999999999999998766678999999999999999999999998 999999999999999999999999999987776
Q ss_pred C---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 K---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
. ...||.+|||||++.++.|+...|.||+||++|||+.|+.||.......-.++..+..... ...+++..+++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--~~ey~~kFS~eak 418 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--PEEYSDKFSEEAK 418 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--hhhcccccCHHHH
Confidence 4 3478999999999999999999999999999999999999997653322222222222211 2356788899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHH
Q 013126 290 RLASRCLQYEPRERPN-----PKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps-----~~eil~ 311 (449)
++.+.+|++||++|.. ++++.+
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhh
Confidence 9999999999999964 445554
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=302.95 Aligned_cols=246 Identities=19% Similarity=0.239 Sum_probs=193.2
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccC-CCCcccceeeEeeC--CeeEEEEe
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLR-NNRLTNLLGCCCEG--DERLLVAE 136 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E 136 (449)
|++++.+|+|+||.||+|... +++.||+|.++.... .......+|+.+++++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999954 589999999876432 22334568999999985 99999999999987 88999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---C
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---K 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~ 213 (449)
|++ ++|.+.+.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++ +.+||+|||+++..... .
T Consensus 81 ~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMD-MNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRNG-IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCC-ccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 997 588888764 2357899999999999999999999999 999999999999999 99999999998765433 2
Q ss_pred ccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc----------------ccccccc
Q 013126 214 SYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ----------------MLTDSCL 276 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~----------------~~~~~~~ 276 (449)
...++..|+|||++.+ +.++.++||||+||++|||++|..||.............. .......
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 3457889999998754 4578899999999999999999998865422111000000 0000000
Q ss_pred CC-------CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 277 EG-------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 277 ~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.. ......+.++.+++.+||++||++||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 011245789999999999999999999999987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=311.64 Aligned_cols=247 Identities=20% Similarity=0.313 Sum_probs=200.8
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCC-----eeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 132 (449)
.|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++.+++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3678888999999999999965 48999999997644 233567999999999999999999999988775 789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
++|||++ ++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~g-i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSAN-VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999998 68999886 4458999999999999999999999999 999999999999999999999999998865543
Q ss_pred C-------ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc----------
Q 013126 213 K-------SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS---------- 274 (449)
Q Consensus 213 ~-------~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 274 (449)
. ...++..|+|||++.+. .++.++|+||+|+++|+|++|+.||..................+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 34567889999999887 78999999999999999999999986554322111111100000
Q ss_pred ---------------ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 ---------------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 ---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.......+..+.++.+++.+||+.||++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000112335678999999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=313.55 Aligned_cols=248 Identities=17% Similarity=0.255 Sum_probs=194.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCC-----eeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 132 (449)
++|++++.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.++++++||||+++++++.... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 35778889999999999999954 589999999964322 23466889999999999999999999876543 579
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+++||++ ++|.+.+ ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~-ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 85 IVQELME-TDLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEehhcc-cCHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 9999997 6888887 4567999999999999999999999999 999999999999999999999999998764432
Q ss_pred -------CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc-----------cc----
Q 013126 213 -------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------LQ---- 269 (449)
Q Consensus 213 -------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-----------~~---- 269 (449)
....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||............ ..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 12356889999998765 45899999999999999999999988653221100000 00
Q ss_pred ----cccccccC------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 270 ----MLTDSCLE------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 270 ----~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
........ ....+..++++.+++.+||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00112345779999999999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=331.25 Aligned_cols=250 Identities=16% Similarity=0.179 Sum_probs=185.2
Q ss_pred cccccccccCCccceEEEEEEEcC--CCEEEEEEec--------------C---CCCCCHHHHHHHHHHHhccCCCCccc
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN--QRRIAVKRFN--------------R---MAWPDPRQFLEEARSVGQLRNNRLTN 120 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~--~~~vAiK~l~--------------~---~~~~~~~~~~~E~~~l~~l~HpnIv~ 120 (449)
..|+++++||+|+||+||++..+. +...+.|.+. + ........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 568999999999999999987532 2223333111 0 01112356889999999999999999
Q ss_pred ceeeEeeCCeeEEEEeeCCCCCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC
Q 013126 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWE---THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 121 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~ 197 (449)
+++++...+..|+|+|++. ++|.+++.... ........++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-IiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-LIHRDIKLENIFLNCDGK 305 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCC
Confidence 9999999999999999996 67877775321 122345677889999999999999999 999999999999999999
Q ss_pred eEEeccCCcccCCCCC-----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh----HHHhhcc-
Q 013126 198 PRLSTFGLMKNSRDGK-----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----DLIRDRN- 267 (449)
Q Consensus 198 ~kL~DFGla~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~----~~~~~~~- 267 (449)
+||+|||+++...... ...||+.|+|||++.+..++.++|||||||++|||++|..++..... ..+....
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 9999999998654332 34689999999999998999999999999999999999865432110 1110000
Q ss_pred -----ccccccc-----------cc---CCC-----CCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 268 -----LQMLTDS-----------CL---EGQ-----FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 268 -----~~~~~~~-----------~~---~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...+++. .. ... .....+.++.+++.+||+.||++|||+.|++.
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 00 000 01123456788899999999999999999997
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=304.90 Aligned_cols=249 Identities=19% Similarity=0.232 Sum_probs=194.4
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccC-CCCcccceeeEeeCCe-----e
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDE-----R 131 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~-----~ 131 (449)
+|++.+.||+|+||.||+|.+. +++.||+|.++..... ....+.+|+.+++.++ ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 4677888899999999999965 5899999998654322 2467889999999995 6999999999887665 8
Q ss_pred EEEEeeCCCCCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-CCCeEEeccCCcc
Q 013126 132 LLVAEYMPNETLAKHLFHWE---THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMK 207 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~ 207 (449)
|+||||+++ +|.+++.... ...+++..++.++.||+.||+|||+++ ++||||||+||+++. ++.+||+|||+++
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChHHEEEecCCCeEEEeecccce
Confidence 999999985 8988886432 346899999999999999999999999 999999999999998 8999999999987
Q ss_pred cCCCC----CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc---------
Q 013126 208 NSRDG----KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD--------- 273 (449)
Q Consensus 208 ~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 273 (449)
..... ....+++.|+|||++.+. .++.++|+||||+++|+|++|..||..................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54322 223457889999988654 4799999999999999999999888654221111100000000
Q ss_pred -------------cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 -------------SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 -------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.......+..+.++.++|.+||+.||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000111346678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=306.16 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=197.5
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeC--CeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 132 (449)
+.+.|++++.||+|+||.||+|... +|+.||+|.++...... ...+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4567889999999999999999964 58999999997543222 34567899999999999999999998765 5689
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCE-QDLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHENF-IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999997 588888864 3467899999999999999999999999 999999999999999999999999998865533
Q ss_pred ----CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc--------------
Q 013126 213 ----KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD-------------- 273 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------------- 273 (449)
....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 12234678999999876 45789999999999999999999988654322211111000000
Q ss_pred ---cccCCC-------CCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 ---SCLEGQ-------FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ---~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...... .....++++.++|.+||+.||++|||+++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 00124678899999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=295.40 Aligned_cols=242 Identities=22% Similarity=0.302 Sum_probs=204.2
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|++.+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|||++++++++.+++..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 667888999999999999865 488999999987654 23567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----c
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----~ 214 (449)
++++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~L~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 82 ENGSLRQIIK--KFGPFPESLVAVYVYQVLQGLAYLHEQG-VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCcHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 9999999997 3468999999999999999999999999 9999999999999999999999999988765443 2
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..++..|+|||...+..++.++||||+|+++|+|++|..|+.............. ......+...+..+.+++.+
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-----DDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-----cCCCCCCCCCCHHHHHHHHH
Confidence 4578899999999887789999999999999999999988764332111111111 11123345567889999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||..+|++|||+.+++.
T Consensus 234 ~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 234 CFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhCChhhCcCHHHHhc
Confidence 99999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.89 Aligned_cols=241 Identities=15% Similarity=0.150 Sum_probs=197.2
Q ss_pred cccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeC----CeeEEEEeeCC
Q 013126 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEG----DERLLVAEYMP 139 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~~~~lV~Ey~~ 139 (449)
..||-|-.|.|-.+..+ +++.+|+|++.. .....+|++.--.. .|||||++++++.+. ..+.+|||.++
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 46799999999999854 599999999853 34667888876665 699999999998753 45789999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC---CCCCeEEeccCCcccCCCC---C
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG---K 213 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~---~ 213 (449)
||.|.+.+.++..+.+++.++..|++||+.|+.|||+.+ |.||||||+|+|.. .|..+||+|||+|+..... .
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n-IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~ 221 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN-IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLM 221 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc-hhhccCChhheeeecCCCCcceEecccccccccCCCcccc
Confidence 999999999878888999999999999999999999999 99999999999997 4556999999999986643 3
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc--ccCCCCCchhHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS--CLEGQFTDDDGTELVRL 291 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l 291 (449)
+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||...--..+..+....+... ..+..-+..+++..+++
T Consensus 222 TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdl 301 (400)
T KOG0604|consen 222 TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDL 301 (400)
T ss_pred CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHH
Confidence 4456899999999988889999999999999999999999987542221111111111111 11122245678999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~ 312 (449)
|+++|..+|.+|.|..+++++
T Consensus 302 IR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 302 IRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHHHhcCCchhheeHHHhhcC
Confidence 999999999999999999983
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=312.22 Aligned_cols=246 Identities=15% Similarity=0.202 Sum_probs=194.9
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeC------Ce
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 130 (449)
..|++++.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45778889999999999999954 58999999986532 22345688999999999999999999988644 35
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 96 ~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 799999997 688888752 2889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCC---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc------------------
Q 013126 211 DGK---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------ 269 (449)
Q Consensus 211 ~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------------ 269 (449)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..............
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 432 34578899999999988899999999999999999999998864321110000000
Q ss_pred ---------------cccccc----cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 ---------------MLTDSC----LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 ---------------~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...... .........++++.+++.+||+.||++|||+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 000001234667899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=295.94 Aligned_cols=244 Identities=19% Similarity=0.243 Sum_probs=203.7
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEEEEe
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLLVAE 136 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 136 (449)
|++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.+++++||||+++++.+... +..++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 556677899999999999965 589999999976543 2357799999999999999999999999988 88999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--- 213 (449)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~-~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG-IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999999974 348999999999999999999999999 9999999999999999999999999987655432
Q ss_pred ---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 214 ---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
...++..|+|||.+.+...+.++||||||+++|+|++|..|+.......... ............+...+..+.+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL---YKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HhccccCCCcCCCcccCHHHHH
Confidence 3457889999999988889999999999999999999999886543111000 0111111112344556789999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||+.||++||++.+++.
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhh
Confidence 999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=302.22 Aligned_cols=247 Identities=22% Similarity=0.293 Sum_probs=197.1
Q ss_pred cccccccCCccceEEEEEEEcC-CCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEEEEe
Q 013126 62 ENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLLVAE 136 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 136 (449)
|+++++||+|++|.||+|...+ ++.+|+|.++... ......+.+|+++++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 4678889999999999999654 8999999998753 22346788999999999999999999999988 88999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--- 213 (449)
|++ ++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~-~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMD-HDLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSNG-ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-ccHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 998 589888864 2357899999999999999999999999 9999999999999999999999999987655432
Q ss_pred --ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc----------------
Q 013126 214 --SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS---------------- 274 (449)
Q Consensus 214 --~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------- 274 (449)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.|+..................+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23457789999987654 47899999999999999999998886543322111110000000
Q ss_pred ---------ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 ---------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..........+.++.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000011112678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=303.63 Aligned_cols=249 Identities=18% Similarity=0.265 Sum_probs=198.2
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+|+++++||.|++|.||+|+.. +|+.||||.++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 3678889999999999999965 5899999999765432 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 139 PNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
+ ++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||++...... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 8 58888886422 356899999999999999999999999 999999999999999999999999998754332 2
Q ss_pred ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-----------------cccccc
Q 013126 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-----------------MLTDSC 275 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------------~~~~~~ 275 (449)
...++..|++||++.+. .++.++||||||+++|+|++|+.|+.............. ......
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 34467889999998664 478899999999999999999988865432211111100 000000
Q ss_pred cC------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 276 LE------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 276 ~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+. ....+..+..+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0011234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=304.63 Aligned_cols=254 Identities=18% Similarity=0.286 Sum_probs=197.7
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhc--cCCCCcccceeeEeeCC----eeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQ--LRNNRLTNLLGCCCEGD----ERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~----~~~lV 134 (449)
..++++.+|+|.||.||+|.++ ++.||||+++. .+.+.|.+|-+|.+. ++|+||++++++-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3445566799999999999984 58999999975 335778888877665 58999999999877665 78999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccccccccCceeeCCCCCeEEeccCCc
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK--------GRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
+||.+.|+|.++| +...++|....+++..+++||+|||+. .+|+|||||.+|||+.+|++..|+|||+|
T Consensus 287 t~fh~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 287 TEFHPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeeccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999999 567899999999999999999999973 13999999999999999999999999999
Q ss_pred ccCCCCC------ccccCccccccccccCCC-CC-----CCCceeeHhHHHHHHhcCCCCC------------Cc-----
Q 013126 207 KNSRDGK------SYSTNLAFTPPEYLRTGR-VT-----PESVIYSFGTLLLDLLSGKHIP------------PS----- 257 (449)
Q Consensus 207 ~~~~~~~------~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvil~elltg~~p~------------~~----- 257 (449)
.....+. ...||.+|||||++.+.. .. .+.||||+|.|||||+++..-. ..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8766542 357999999999997643 22 3699999999999999864211 10
Q ss_pred hhhHHHhhcccccccccccCCCCC-chhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 258 HALDLIRDRNLQMLTDSCLEGQFT-DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
...+.++.-..+....+..+..+. ......+.+.+..||+.||+.|.|+.-+.+++..+....+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 022223322222222222222211 1234678999999999999999999999998887765543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=310.33 Aligned_cols=247 Identities=17% Similarity=0.268 Sum_probs=195.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEee----CCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~l 133 (449)
.|++.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 4667788899999999999954 599999999976432 235678899999999999999999998763 356899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+. ++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 86 VMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 999996 68999886 4566999999999999999999999999 999999999999999999999999998754322
Q ss_pred -------CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh-------------------
Q 013126 213 -------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD------------------- 265 (449)
Q Consensus 213 -------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~------------------- 265 (449)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 12357888999999865 458999999999999999999999986542211000
Q ss_pred ccccccccccc-C-----CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 266 RNLQMLTDSCL-E-----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 266 ~~~~~~~~~~~-~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
........... . ....+..++++.+++.+||+.||++||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000000000 0 0111345788999999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=298.53 Aligned_cols=239 Identities=22% Similarity=0.236 Sum_probs=196.2
Q ss_pred cCCccceEEEEEEEcC-CCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 68 HGEKAPNVVYKGKLEN-QRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
||.|+||.||++.+.+ ++.+|+|.+..... ...+.+.+|++++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999999764 89999999976543 2356789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----------
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----------- 212 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----------- 212 (449)
.+++.+ ...+++..+..++.|++.||+|||+++ ++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNG-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcC-eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999973 347899999999999999999999999 999999999999999999999999998754332
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....++..|+|||...+...+.++||||||+++|++++|..|+.................. .......+..+.++
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 233 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE----WPEDVEVSDEAIDL 233 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC----CCccccCCHHHHHH
Confidence 1234678899999998888999999999999999999999998655443333222111111 00111236789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHh
Q 013126 292 ASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L 313 (449)
+.+||+.+|++|||+.++.+.|
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHh
Confidence 9999999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.77 Aligned_cols=243 Identities=20% Similarity=0.232 Sum_probs=198.4
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+..+++||+|+||+||+|+.. +++.||+|.+....... .+.+.+|+++++.++|||++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445567899999999999964 58999999997543222 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcccc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~g 217 (449)
+. ++|.+.+.. ...++++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||++..........+
T Consensus 103 ~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~g-i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~ 179 (313)
T cd06633 103 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN-MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVG 179 (313)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccc
Confidence 97 678777753 3467899999999999999999999999 99999999999999999999999999877665566678
Q ss_pred Ccccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 218 NLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 218 t~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
+..|+|||++. ...++.++||||||+++|+|++|..|+................ .........+..+.+++.+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND----SPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----CCCCCccccCHHHHHHHHH
Confidence 89999999984 3558889999999999999999999876543222111111110 1111223455679999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||+.+|.+||++.+++.
T Consensus 256 ~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 256 CLQKIPQERPASAELLR 272 (313)
T ss_pred HccCChhhCcCHHHHhc
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=304.52 Aligned_cols=245 Identities=20% Similarity=0.224 Sum_probs=199.8
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.|..++.||+|++|.||+|+.. +++.+|+|.+...... ..+++.+|+++++.++|+|++++.+++..++..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3566788899999999999964 5889999998643222 23568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCccc
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS 216 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 216 (449)
|+. |+|.+.+.. ...++++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++..........
T Consensus 96 ~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (308)
T cd06634 96 YCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV 172 (308)
T ss_pred ccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHhEEECCCCcEEECCcccceeecCccccc
Confidence 997 688877753 3456899999999999999999999998 9999999999999999999999999998776666677
Q ss_pred cCcccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 217 TNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 217 gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
+++.|+|||++. ...++.++||||||+++|+|++|..|+................ .........+..+.+++.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~ 248 (308)
T cd06634 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPALQSGHWSEYFRNFVD 248 (308)
T ss_pred CCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC----CCCcCcccccHHHHHHHH
Confidence 889999999975 3457889999999999999999998875532221111111110 111113356678999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~ 312 (449)
+||+.+|++||++.+++..
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHhhCCcccCCCHHHHhhC
Confidence 9999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=298.16 Aligned_cols=243 Identities=19% Similarity=0.214 Sum_probs=198.5
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC-----CCCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-----WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 132 (449)
.|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+. +..+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 4677888899999999999954 58999999985421 11235788999999999999999999998764 4688
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+++||+++++|.+++. ....+++.....++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999986 4456889999999999999999999999 999999999999999999999999998754321
Q ss_pred -------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 -------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
....++..|+|||++.+..++.++|+||||+++|++++|+.||........... ..........+...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~p~~~~ 235 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK----IATQPTKPMLPDGVS 235 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH----HHcCCCCCCCCcccC
Confidence 234578899999999888899999999999999999999999865422111111 111112234466777
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+++.+||+ +|..||++.+++.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhc
Confidence 899999999999 5799999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=296.26 Aligned_cols=244 Identities=18% Similarity=0.235 Sum_probs=205.1
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|++.+.+|+|++|.||++... +++.+|+|.+...... ....+.+|+++++.++|+||+++.+++.+....++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 677888999999999999854 5889999999764322 2457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--Cc
Q 013126 139 PNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~~ 214 (449)
++++|.+++.+. ....+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.+||+|||++...... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~-i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK-ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 999999998642 2357899999999999999999999999 999999999999999999999999998765543 23
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|+.|+................. ...+...+.++.+++.+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY-----PPIPPIYSQDLQNFIRS 235 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----CCCchhhCHHHHHHHHH
Confidence 4578899999999988899999999999999999999999876544333332222111 12234567889999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||+.+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 236 MLQVKPKLRPNCDKILA 252 (256)
T ss_pred HcCCCcccCCCHHHHhc
Confidence 99999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=303.51 Aligned_cols=247 Identities=12% Similarity=0.084 Sum_probs=185.2
Q ss_pred cccccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCCCH-----------HHHHHHHHHHhccCCCCcccceee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPDP-----------RQFLEEARSVGQLRNNRLTNLLGC 124 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~l~~~ 124 (449)
..|++.+.||+|+||+||+|...+ +..+|+|+......... .....+...+..++|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 468899999999999999999643 45667776433221110 112334455667799999999997
Q ss_pred EeeCC----eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEE
Q 013126 125 CCEGD----ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (449)
Q Consensus 125 ~~~~~----~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL 200 (449)
+.... ..++++|++. .++.+.+. .....++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFK--RIKCKNKKLIKNIMKDMLTTLEYIHEHG-ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHH--hhccCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCcEEE
Confidence 66543 3478888875 57777665 2334678889999999999999999999 999999999999999999999
Q ss_pred eccCCcccCCCC-----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh-HHHhh---
Q 013126 201 STFGLMKNSRDG-----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRD--- 265 (449)
Q Consensus 201 ~DFGla~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~-~~~~~--- 265 (449)
+|||+++..... ....||+.|+|||+..+..++.++|||||||++|||++|+.||..... .....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999998754211 224589999999999988899999999999999999999999865421 11110
Q ss_pred -cccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 266 -RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
.....+.... ......++++.+++..||+.+|++||+++++++.+
T Consensus 248 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111111111 11234568899999999999999999999999865
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=295.16 Aligned_cols=251 Identities=17% Similarity=0.263 Sum_probs=196.1
Q ss_pred CcccccccccCCccceEEEEEE-EcC----CCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEee-CCe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGK-LEN----QRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCE-GDE 130 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~-~~~----~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 130 (449)
...|++++.||+|+||.||+|. .++ ++.+|||+++...... .....+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4468999999999999999996 222 2379999998653322 4568899999999999999999999987 788
Q ss_pred eEEEEeeCCCCCHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC----CCeEEecc
Q 013126 131 RLLVAEYMPNETLAKHLFHW---ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED----GNPRLSTF 203 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~----~~~kL~DF 203 (449)
+++++||.+ -+|+..|+.+ +.+.++...++.|+.||+.|+.|||++- |+||||||+|||+..+ |.+||+||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh-eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999998 5899988743 2357889999999999999999999998 9999999999999877 99999999
Q ss_pred CCcccCCCC-------CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHH-------------
Q 013126 204 GLMKNSRDG-------KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDL------------- 262 (449)
Q Consensus 204 Gla~~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~------------- 262 (449)
|+++...+. .....|..|.|||.+.|.. ||.+.|||+.|||+.||+|-.+.|.+...+.
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999976643 2345689999999999866 9999999999999999999887664321110
Q ss_pred Hh-------hccccccc---c------cccCCCCCch------------hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 263 IR-------DRNLQMLT---D------SCLEGQFTDD------------DGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 263 ~~-------~~~~~~~~---~------~~~~~~~~~~------------~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+. ++.+..+. + .... ....+ -++...+|+.++|+.||-+|.|++++++.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~-~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRR-HYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHH-hhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 00 00000000 0 0000 00011 12347899999999999999999999983
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=309.55 Aligned_cols=248 Identities=17% Similarity=0.251 Sum_probs=196.7
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeC-----CeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 132 (449)
.|.+++.||+|+||+||+|... +++.||||.++... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 4778888999999999999954 58999999987532 22345678999999999999999999988654 3479
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+|+||+. ++|.+++. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 86 lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999996 78998886 4567999999999999999999999999 999999999999999999999999998865433
Q ss_pred ----CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh-------------------ccc
Q 013126 213 ----KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD-------------------RNL 268 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-------------------~~~ 268 (449)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 23457889999998865 458899999999999999999999886432111000 000
Q ss_pred c----ccccc--ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 269 Q----MLTDS--CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 269 ~----~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
. ..... .......+..++++.+++.+||+.||++|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 00000 00001123467889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=270.95 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=201.3
Q ss_pred ccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|...++||+|.||+||+|+ +++++.||+|.++.+... -....++|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35567889999999999999 556999999999765432 257789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
|. .+|..+... -++.++.+.++.++.|+++||.++|+++ +.|||+||+|.||+.+|.+|++|||+++...-. .
T Consensus 83 cd-qdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn-vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CD-QDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN-VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hh-HHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh-hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 97 789888865 5678999999999999999999999998 999999999999999999999999999876644 2
Q ss_pred ccccCccccccccccCCC-CCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccc--------------cccccccC
Q 013126 214 SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQ--------------MLTDSCLE 277 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~--------------~~~~~~~~ 277 (449)
....|..|.+|.++.+.. |+...|+||.|||+.|+.. |++.|++...+....++.. .+++-.+.
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 345689999999999876 8999999999999999987 4555665544332222211 11111111
Q ss_pred CCCC---------chhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 278 GQFT---------DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 278 ~~~~---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.++ +.....-+++++++|.-+|.+|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111 223455689999999999999999999987
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=291.14 Aligned_cols=237 Identities=19% Similarity=0.221 Sum_probs=197.5
Q ss_pred cccCCccceEEEEEE-EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 66 SEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
+.||+|+|+.|--+. ..+|..||||++.+.......+..+|++++.+. .|+||++++++|+++...|||||-+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 356999999999998 778999999999887666788999999999999 599999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC---eEEeccCCcccCCCC--------
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKNSRDG-------- 212 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~---~kL~DFGla~~~~~~-------- 212 (449)
..+|. ++..+++.++.+++++|+.||.+||.+| |.||||||+|||-.+... +||+||.+.......
T Consensus 164 LshI~--~~~~F~E~EAs~vvkdia~aLdFlH~kg-IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 164 LSHIQ--KRKHFNEREASRVVKDIASALDFLHTKG-IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred HHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhcC-cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 99998 6678999999999999999999999999 999999999999975544 899999886532211
Q ss_pred ---CccccCcccccccccc---C--CCCCCCCceeeHhHHHHHHhcCCCCCCch-------------------hhHHHhh
Q 013126 213 ---KSYSTNLAFTPPEYLR---T--GRVTPESVIYSFGTLLLDLLSGKHIPPSH-------------------ALDLIRD 265 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~---~--~~~~~~sDvwSlGvil~elltg~~p~~~~-------------------~~~~~~~ 265 (449)
.+..|+..|||||+.. + ..|+.+.|.||||||+|-|++|.+||.+. ..+.+.+
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE 320 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE 320 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence 1345677899999873 2 23899999999999999999999999653 1111222
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.. .++ ..-+..++.+..+++..+|..|+.+|.++.+++.
T Consensus 321 GkY-eFP-----dkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 321 GKY-EFP-----DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCC-cCC-----hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111 111 1223457889999999999999999999999887
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=288.97 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=199.1
Q ss_pred CCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCC-CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 134 (449)
+.++.+.++.||.|+.|+||+++... |...|||.+.+.. .+..++++..++++..- +.|+||+.+|+|..+..+++-
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 34556778899999999999999654 8999999997654 23356788888877665 479999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
||.|. ..+..+++ +-.+++++..+-++...+.+||.||..+..|+|||+||+|||+|+.|++||+|||++...-+..
T Consensus 170 MelMs-~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 170 MELMS-TCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHH-HHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 99994 44444444 3567899999999999999999999876559999999999999999999999999987765543
Q ss_pred --ccccCccccccccccC---CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-HhhcccccccccccCCCCCchhHHH
Q 013126 214 --SYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 214 --~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...|-+.|||||.+.- ..|+.++||||||++++||.||+.|+.....+. .........+ +.++. ....++.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~--~~gFSp~ 324 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPG--HMGFSPD 324 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCc--ccCcCHH
Confidence 3457899999999954 349999999999999999999999987743221 2222222222 22221 2237889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.+++..||++|+.+||...++++
T Consensus 325 F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 325 FQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHHHhhcCcccCcchHHHhc
Confidence 999999999999999999999998
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=306.68 Aligned_cols=248 Identities=17% Similarity=0.244 Sum_probs=193.5
Q ss_pred cccccccCCccceEEEEEEEc---CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE---NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 133 (449)
|++++.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 677888999999999999954 47899999998643 23346788999999999999999999999988 78999
Q ss_pred EEeeCCCCCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC----CCCeEEeccCCc
Q 013126 134 VAEYMPNETLAKHLFHWE---THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE----DGNPRLSTFGLM 206 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~----~~~~kL~DFGla 206 (449)
||||++ ++|.+.+.... ...+++..++.++.|++.||+|||+++ ++||||||+||+++. ++.+||+|||++
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-EeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 999997 57777664321 237899999999999999999999999 999999999999999 899999999998
Q ss_pred ccCCCC-------CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHH----------Hh---h
Q 013126 207 KNSRDG-------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDL----------IR---D 265 (449)
Q Consensus 207 ~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~----------~~---~ 265 (449)
...... ....+++.|+|||++.+. .++.++||||||+++|+|++|+.|+....... +. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 764332 223567889999988764 47899999999999999999998875432211 00 0
Q ss_pred ----------------cccccccccccCCCCC-----------chhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 266 ----------------RNLQMLTDSCLEGQFT-----------DDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 266 ----------------~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.......+.......+ ...+.++.+++.+||+.||++|||+.+++.
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000000011 134567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=301.82 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=199.3
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|++++.||+|++|.||+|... +++.+++|.++..... ....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999964 5899999998764433 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----c
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----~ 214 (449)
+ ++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||.+....... .
T Consensus 81 ~-~~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 D-TDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSHG-ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred C-CCHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHCC-eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 7 588888864 3368999999999999999999999999 9999999999999999999999999987655432 3
Q ss_pred cccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-----------cccc---------
Q 013126 215 YSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-----------MLTD--------- 273 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------~~~~--------- 273 (449)
..++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.............. ....
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4567889999999876 689999999999999999999988865432111100000 0000
Q ss_pred ----cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 ----SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
........+..+.++.+++.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000112345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.67 Aligned_cols=251 Identities=20% Similarity=0.256 Sum_probs=193.0
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCC-----
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD----- 129 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 129 (449)
..+.|+++++||+|+||.||+|... +++.||||.+...... ....+.+|++++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3456889999999999999999965 5899999998654322 2345678999999999999999999987654
Q ss_pred ---eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 130 ---ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 130 ---~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
..++||||+. ++|.+.+.. ....+++.+++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNK-ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3599999997 588888753 3347899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCC--------ccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc---ccccccc
Q 013126 207 KNSRDGK--------SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---LQMLTDS 274 (449)
Q Consensus 207 ~~~~~~~--------~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~---~~~~~~~ 274 (449)
....... ...++..|+|||.+.+.. ++.++||||||+++|+|++|+.|+............ .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 7543221 234578899999987654 788999999999999999999887654322111000 0000000
Q ss_pred c--------------cCC--------CC-CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 C--------------LEG--------QF-TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 ~--------------~~~--------~~-~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
. ... .. ....+..+.+++.+||..||++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000 00 0012356789999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=298.38 Aligned_cols=248 Identities=21% Similarity=0.252 Sum_probs=196.0
Q ss_pred cccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCC--HHHHHHHHHHHhcc---CCCCcccceeeEeeCCe-----
Q 013126 62 ENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPD--PRQFLEEARSVGQL---RNNRLTNLLGCCCEGDE----- 130 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~----- 130 (449)
|++++.||+|++|.||+|+.++ ++.||+|.++.....+ ...+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4677888999999999999764 8999999997543222 34566788777666 59999999999988776
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.+++|||++ ++|.+++.......+++..++.++.|++.||+|||+++ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~-i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999997 58999887534456899999999999999999999999 9999999999999999999999999987754
Q ss_pred CCC---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc---------------
Q 013126 211 DGK---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT--------------- 272 (449)
Q Consensus 211 ~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 272 (449)
... ...++..|+|||++.+..++.++|+||||+++|+|++|++|+.................
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 332 23467889999999988899999999999999999999888765432221111110000
Q ss_pred ---cccc---CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 ---DSCL---EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ---~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .....+..+..+.+++.+||+.||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 00111234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.28 Aligned_cols=242 Identities=21% Similarity=0.236 Sum_probs=187.7
Q ss_pred cCCccceEEEEEEEcCCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHH
Q 013126 68 HGEKAPNVVYKGKLENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ 145 (449)
+|.|+++.||++.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+++..+++|||+++++|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 34444444444443 68999999997642 2335689999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----------Cc
Q 013126 146 HLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----------KS 214 (449)
Q Consensus 146 ~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-----------~~ 214 (449)
++.......+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+...... ..
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~-ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG-FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence 997655567899999999999999999999999 999999999999999999999999987643221 12
Q ss_pred cccCccccccccccCC--CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh-hcc---ccccc----------------
Q 013126 215 YSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR-DRN---LQMLT---------------- 272 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~---~~~~~---------------- 272 (449)
..++..|+|||++.+. .++.++|+||+|+++|||++|+.||......... ... .....
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence 3456789999999763 4889999999999999999999998643211111 000 00000
Q ss_pred ----c----cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 ----D----SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ----~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
. ...........+.++.+++.+||+.||++|||++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 00001112234578899999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.23 Aligned_cols=235 Identities=20% Similarity=0.218 Sum_probs=189.3
Q ss_pred cCCccceEEEEEEEc-CCCEEEEEEecCCCCC---CHHHHHHHHH---HHhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEAR---SVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~~E~~---~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
||+|+||.||+|... +++.||+|.+...... ....+..|.. .++...||||+++++++...+..++||||++|
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 699999999999954 5899999998754322 1223444544 34445799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--CccccC
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--KSYSTN 218 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~~~~gt 218 (449)
++|.+++. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...... ....|+
T Consensus 82 ~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (278)
T cd05606 82 GDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (278)
T ss_pred CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCC
Confidence 99999886 4567999999999999999999999999 999999999999999999999999998754332 245688
Q ss_pred ccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhh---HHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 219 LAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHAL---DLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 219 ~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..|+|||++.++ .++.++||||+|+++|+|++|+.||..... ........ ......+...+.++.+++.+
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------TMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh------ccCCCCCCcCCHHHHHHHHH
Confidence 999999999754 589999999999999999999999865421 11111110 01122344557889999999
Q ss_pred hcccCCCCCC-----CHHHHHH
Q 013126 295 CLQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rp-----s~~eil~ 311 (449)
||..||.+|| ++.++++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHh
Confidence 9999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=299.48 Aligned_cols=242 Identities=21% Similarity=0.259 Sum_probs=202.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+|.+.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5778889999999999999965 589999999976322 22456889999999998 999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC--
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-- 213 (449)
||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~--~~~~l~~~~~~~i~~ql~~~l~~Lh~~~-~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIR--KYGSLDEKCTRFYAAEILLALEYLHSKG-IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999997 4457999999999999999999999999 9999999999999999999999999987543321
Q ss_pred ----------------------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc
Q 013126 214 ----------------------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML 271 (449)
Q Consensus 214 ----------------------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 271 (449)
...++..|+|||+..+..++.++|+||||++++++++|+.|+..............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 236 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-- 236 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--
Confidence 12457889999999888899999999999999999999998875532222111111
Q ss_pred cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 013126 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP----KSLVT 311 (449)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~eil~ 311 (449)
.....+...++.+.+++.+||+.||++||++ +++++
T Consensus 237 ----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 237 ----LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1123345567889999999999999999999 78776
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=298.60 Aligned_cols=248 Identities=18% Similarity=0.302 Sum_probs=196.2
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|++++.||+|++|+||+|... +++.||||.+...... +.....+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 457788999999999999975 4889999998764322 2335667999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---Ccc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSY 215 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~~ 215 (449)
+++|.+++.......+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++...... ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~-i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG-FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 789999887544457899999999999999999999999 999999999999999999999999998765543 234
Q ss_pred ccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc---------------------cccccc
Q 013126 216 STNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---------------------LQMLTD 273 (449)
Q Consensus 216 ~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~---------------------~~~~~~ 273 (449)
.++..|+|||++.+ ..++.++|+||||+++|+|++|++|++........... ......
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 57889999998854 44789999999999999999999887544221111000 000000
Q ss_pred cccC---CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 SCLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... ....+..+.++.+++++||+.||++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 0011122578999999999999999999999987
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=301.11 Aligned_cols=245 Identities=18% Similarity=0.259 Sum_probs=196.7
Q ss_pred cccccccCCccceEEEEEEE----cCCCEEEEEEecCCCC----CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 62 ENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMAW----PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~----~~~~~vAiK~l~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
|++.+.||+|+||.||++.. .+|+.||+|.++.... ...+.+.+|+++++++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 67788899999999999985 3688999999975321 2246788999999999 5899999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLS--QRERFKEQEVQIYSGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999997 4467889999999999999999999999 999999999999999999999999998765432
Q ss_pred C-----ccccCccccccccccCC--CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 213 K-----SYSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 ~-----~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
. ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+................... ....+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--CCCCCccCC
Confidence 1 34578899999998753 47889999999999999999998875321111101111111111 112344567
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rp-----s~~eil~ 311 (449)
+.+.+++.+||+.||++|| ++.+++.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 7899999999999999997 6677766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=315.85 Aligned_cols=242 Identities=19% Similarity=0.272 Sum_probs=204.3
Q ss_pred ccccccCCccceEEEEEEEcC--CC--EEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 63 NIVSEHGEKAPNVVYKGKLEN--QR--RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~~--~~--~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++.++||+|.||+|++|.|.. |+ .||||+++.+... ...+|++|+.+|.+|+|||++++||+..+ ....+|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 455677999999999999753 43 6799999877655 46789999999999999999999999987 678999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcc--
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY-- 215 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-- 215 (449)
++.|+|.+.|++.....+.......++.||+.|+.||.+++ .|||||-..|+|+.....+||+|||+.+....+...
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr-lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR-LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh-hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 99999999998766778888899999999999999999998 999999999999999999999999999987665432
Q ss_pred -----ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCC-CCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 216 -----STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK-HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 216 -----~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
.....|.|||.+....++.++|||+|||++|||+|+. .|+.+.....+.... +...+...++.++++++
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i-----D~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI-----DAGERLPRPKYCSEDIY 345 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc-----cccccCCCCCCChHHHH
Confidence 2346799999999999999999999999999999964 566554333333222 11122234678899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++..||..+|++|||+..|.+
T Consensus 346 ~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred HHHHHhccCCccccccHHHHHH
Confidence 9999999999999999999974
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=342.21 Aligned_cols=241 Identities=18% Similarity=0.233 Sum_probs=200.4
Q ss_pred ccccCCccceEEEEEE-EcCCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 65 VSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
-..||.|.||.||.|. .++|+-.|+|-++.... ...+.+.+|..++..++|||+|+++|+-.+.+..+|.||||+||
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 3467999999999999 56699999999875432 22467889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--------C
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--------K 213 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--------~ 213 (449)
+|.+.+. .++..++...+.+..|++.|++|||++| ||||||||+||+++.+|.+|++|||.|...... +
T Consensus 1320 sLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~g-IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEHG-IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred cHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhcC-ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 9999997 5566788888889999999999999999 999999999999999999999999999865543 2
Q ss_pred ccccCccccccccccCCC---CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
...||+.|||||++.+.. ...++||||+|||+.||+||+.|+..-..+. .++..+. ..-.+++|..++.+-.+
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~-~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVA-AGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHh-ccCCCCCchhhhHhHHH
Confidence 457999999999997643 5679999999999999999999985321111 0111111 11123456678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~~ 312 (449)
++.+||+.||++|.++.++++.
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHh
Confidence 9999999999999999999884
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=317.90 Aligned_cols=238 Identities=17% Similarity=0.228 Sum_probs=195.7
Q ss_pred cccCCccceEEEEEEEc-CCCEEEEEEec---CC-CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCe--eEEEEeeC
Q 013126 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFN---RM-AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE--RLLVAEYM 138 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~---~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--~~lV~Ey~ 138 (449)
..||+|+|-+||+|.+. +|-.||=-.++ .. .....++|..|+.+|+.|+||||+++|+++.+... +-+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 45799999999999964 37777632222 11 12235789999999999999999999999988765 78999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccccCceeeCC-CCCeEEeccCCcccCCCC--Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRDG--KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~--~~ 214 (449)
..|||..|++ +.+.++.+..+.|++||++||.|||++. ||||||||.+||+|+. .|.|||+|+|+|...... +.
T Consensus 126 TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks 203 (632)
T KOG0584|consen 126 TSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS 203 (632)
T ss_pred cCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccce
Confidence 9999999998 5677889999999999999999999975 4999999999999984 589999999999876654 45
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch-hhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..|||.|||||+.. ..|+..+||||||+.++||+|+..|+..- ....+..+....+.+..+. .--.++++++|.
T Consensus 204 vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~----kV~dPevr~fIe 278 (632)
T KOG0584|consen 204 VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS----KVKDPEVREFIE 278 (632)
T ss_pred eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh----ccCCHHHHHHHH
Confidence 68999999999997 78999999999999999999999988643 3334444444444433322 222468999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
+||.. .++|||+.|+|+
T Consensus 279 kCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHhcC-chhccCHHHHhh
Confidence 99999 999999999997
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=305.41 Aligned_cols=247 Identities=21% Similarity=0.290 Sum_probs=193.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeC--CeeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEG--DERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~--~~~~lV 134 (449)
.|++.+.||+|+||.||+|.+. +++.+|+|++.... ......+.+|+.+++++ +||||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 5777888899999999999965 58899999986432 22345678899999999 999999999998654 368999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
|||++ ++|.+++.. ..+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 88 ~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~-i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 88 FEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGN-VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred ecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99997 699998852 37889999999999999999999999 9999999999999999999999999987543321
Q ss_pred --------ccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc-----------------
Q 013126 214 --------SYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN----------------- 267 (449)
Q Consensus 214 --------~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~----------------- 267 (449)
...++..|+|||++.+ ..++.++||||||+++|+|++|+.||............
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 2357889999998865 45788999999999999999999888543211110000
Q ss_pred ------ccccccc--ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 268 ------LQMLTDS--CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 268 ------~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
....... .......+..+.++.+++.+||+.||++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 00011122356789999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=299.47 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=196.5
Q ss_pred CCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 134 (449)
++++|++++.||+|++|.||+|.+++ ++.||||.++..... ....+.+|+.++.+. +||||+++++++.++...+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 45668889999999999999999765 899999999764322 245677788777666 499999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
|||+. ++|.+.+.. ....+++..+..++.|++.||+|||+ .+ ++||||+|+||++++++.+||+|||++.......
T Consensus 93 ~e~~~-~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMS-TCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHG-VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccC-cCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCC-EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99986 577777654 34578999999999999999999997 57 9999999999999999999999999987654322
Q ss_pred ---ccccCccccccccccCCC----CCCCCceeeHhHHHHHHhcCCCCCCchhhH-HHhhcccccccccccCCCCCchhH
Q 013126 214 ---SYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 214 ---~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
...++..|+|||.+.+.. ++.++||||||+++|+|++|+.|+...... ........... .........+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 246 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP---PSLPPNEGFS 246 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC---CCCCCCCCCC
Confidence 234678899999997553 788999999999999999999998652111 11111111100 0011112356
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.++.+++.+||+.||++||++.+++..
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 789999999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.51 Aligned_cols=249 Identities=18% Similarity=0.244 Sum_probs=198.8
Q ss_pred cccccccCCccceEEEEEEEc----CCCEEEEEEecCCCC----CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAW----PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
|++.+.||+|++|.||+++.. +++.||||.++.... ...+.+.+|++++.++ +||||+++++.+..++..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 677888999999999999842 478899999875321 2245688999999999 5999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~-~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQLG-IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHh--hcCCcCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999986 4467899999999999999999999998 999999999999999999999999998764332
Q ss_pred C-----ccccCccccccccccCCC--CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 213 K-----SYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 ~-----~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
. ...++..|+|||.+.+.. .+.++|+||||+++|+|++|..|+................... ....+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--KPPFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--CCCCCcccC
Confidence 1 235788999999987655 7889999999999999999999875321111000000111111 112234466
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 315 (449)
..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 789999999999999999998888776544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=329.56 Aligned_cols=257 Identities=18% Similarity=0.162 Sum_probs=215.5
Q ss_pred HHHHHhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeE
Q 013126 50 EQLKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCC 125 (449)
Q Consensus 50 ~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 125 (449)
..+++..-+-++|++++.||+|+||.|.+++++ +++.||+|++++. ...+..-|..|-++|..-+.+.|++++-.|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 455555566778999999999999999999965 4899999999872 233456789999999999999999999999
Q ss_pred eeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 126 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
.+++++|+||||++||+|-.++.+ ...++++.++.++..|.-||.-+|+.| +|||||||+|||+|.+|++||+|||.
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~mg-yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSMG-YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhcc-ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999999973 337999999999999999999999999 99999999999999999999999998
Q ss_pred cccCCCCC-----ccccCccccccccccC-----CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccc
Q 013126 206 MKNSRDGK-----SYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC 275 (449)
Q Consensus 206 a~~~~~~~-----~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 275 (449)
+-....++ ..+|||.|.+||++.. +.|+..+|.||+||++|||+.|..||..++......+++.-...-.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS 301 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence 87666432 4579999999999852 4589999999999999999999999998876666655544321111
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPN---PKSLVTA 312 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~eil~~ 312 (449)
.+ ....+++++.+||.+.+. +|+.|.. ++++..+
T Consensus 302 FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 302 FP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 11 123578999999999886 5888877 8888874
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=300.63 Aligned_cols=249 Identities=21% Similarity=0.247 Sum_probs=194.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCC-------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------- 129 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------- 129 (449)
+.|++.+.+|+|++|.||+|... +++.||+|.++.... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 45778888899999999999975 489999999975432 22456789999999999999999999987655
Q ss_pred ---eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 130 ---ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 130 ---~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
..++|+||+++ ++.+.+.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKKN-FLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999985 77777753 2457899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCC-----ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc----------
Q 013126 207 KNSRDGK-----SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM---------- 270 (449)
Q Consensus 207 ~~~~~~~-----~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---------- 270 (449)
....... ...++..|+|||.+.+. .++.++||||||+++|+|++|++|+...............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 7654332 12346789999988654 4789999999999999999999888643221111000000
Q ss_pred -cccccc-------------CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 -LTDSCL-------------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 -~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+..... ........+..+.+++.+||+.||++||++.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 00011235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=306.56 Aligned_cols=247 Identities=16% Similarity=0.218 Sum_probs=196.0
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCC------e
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 130 (449)
+.|++++.||+|+||.||++... +++.||+|.+....... .+.+.+|++++++++||||+++++++..+. .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 45788899999999999999954 58999999986533222 356889999999999999999999987654 3
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||+ |++|.+++. ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~g-i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999999 689998884 457999999999999999999999999 9999999999999999999999999998655
Q ss_pred CC-CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-------------------
Q 013126 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------- 269 (449)
Q Consensus 211 ~~-~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------------- 269 (449)
.. ....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||..............
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 43 23467889999999876 3588899999999999999999998864422111100000
Q ss_pred ccccccc------CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 MLTDSCL------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 ~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....... ........+..+.+++.+||+.||++|||+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00112345677999999999999999999999996
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.75 Aligned_cols=247 Identities=17% Similarity=0.244 Sum_probs=193.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCC------e
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 130 (449)
..|.+.+.||+|+||.||+|... +|+.||+|++...... ....+.+|+++++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 46778889999999999999954 5899999998753222 2456889999999999999999999987543 4
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++|+||+. .+|.+.. ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 95 ~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG-IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 699999997 5777665 246899999999999999999999999 9999999999999999999999999987654
Q ss_pred CC-CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-------------------
Q 013126 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------- 269 (449)
Q Consensus 211 ~~-~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------------- 269 (449)
.. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 33 23457888999999876 4588999999999999999999999875432211110000
Q ss_pred ccc---ccccCC---CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 270 MLT---DSCLEG---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 270 ~~~---~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
... ...... ...+..+.++.+++.+||+.||++||++++++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000000 0012345678999999999999999999999963
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=306.43 Aligned_cols=247 Identities=17% Similarity=0.223 Sum_probs=193.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC----------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG---------- 128 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---------- 128 (449)
..|++++.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 45788889999999999999964 5899999999766555567789999999999999999999876543
Q ss_pred ----CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-CCCCeEEecc
Q 013126 129 ----DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTF 203 (449)
Q Consensus 129 ----~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-~~~~~kL~DF 203 (449)
...++||||++ ++|.+++. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ +++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSAN-VLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999997 68988884 457899999999999999999999999 99999999999998 5567899999
Q ss_pred CCcccCCCC-------CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc-----
Q 013126 204 GLMKNSRDG-------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM----- 270 (449)
Q Consensus 204 Gla~~~~~~-------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----- 270 (449)
|+++..... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 998754322 12346788999998754 45888999999999999999999998643211111000000
Q ss_pred ----------ccc----cccC-----CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 ----------LTD----SCLE-----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 ----------~~~----~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
... .... ....+..+.++.+++.+||+.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0000 0111245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=303.70 Aligned_cols=246 Identities=18% Similarity=0.272 Sum_probs=194.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEee-CCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 136 (449)
.|++++.||.|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++.+++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 4677888899999999999954 68999999986432 2234678899999999999999999999876 467899999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-Ccc
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~ 215 (449)
|+ +++|.+++. ..++++..+..++.|++.||+|||+++ ++||||||+||++++++.++|+|||.+...... ...
T Consensus 91 ~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~-iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 165 (328)
T cd07856 91 LL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAG-VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY 165 (328)
T ss_pred hh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence 98 478988884 456888899999999999999999999 999999999999999999999999998765433 234
Q ss_pred ccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHH---------------hhcc--------cccc
Q 013126 216 STNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI---------------RDRN--------LQML 271 (449)
Q Consensus 216 ~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~---------------~~~~--------~~~~ 271 (449)
.++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .... ....
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence 56888999999866 4689999999999999999999988864322110 0000 0000
Q ss_pred cc--cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 272 TD--SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 272 ~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.. ..+.....+..+.++.+++.+||+.+|++|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000111245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=304.25 Aligned_cols=260 Identities=17% Similarity=0.225 Sum_probs=200.5
Q ss_pred cccCHHHHHHhhCCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccc
Q 013126 45 REFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNL 121 (449)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l 121 (449)
+.....++...+++ |.+++.||+|+||.||+|.. .+++.||+|+++..... ..+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~~~~~~---y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 5 RQELNKTIWEVPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred hhhHHHHHhhccCc---eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence 44455666666655 55777889999999999985 46899999999754322 24578899999999999999999
Q ss_pred eeeEeeC------CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC
Q 013126 122 LGCCCEG------DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (449)
Q Consensus 122 ~~~~~~~------~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~ 195 (449)
++++... ...+++++++ |++|.+.+. ...+++..+..++.|++.||+|||+++ ++||||||+||+++++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~ 156 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNED 156 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChHHEEEcCC
Confidence 9988643 3468888887 789988874 356899999999999999999999999 9999999999999999
Q ss_pred CCeEEeccCCcccCCCC-CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc----
Q 013126 196 GNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ---- 269 (449)
Q Consensus 196 ~~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~---- 269 (449)
+.+||+|||+++..... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+..............
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 157 CELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred CCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999998865443 23467889999999876 4588999999999999999999998864322111000000
Q ss_pred -------ccc-----------ccccC---CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 270 -------MLT-----------DSCLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 270 -------~~~-----------~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.+. ..... .......++++.+++.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00000 00011346678999999999999999999999973
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=328.64 Aligned_cols=245 Identities=19% Similarity=0.217 Sum_probs=185.1
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEee----------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCE---------- 127 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---------- 127 (449)
++++.++.||+||||.||+++. -+|+.||||+++... ........+|+..+++|+|||||+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4455666679999999999994 379999999998654 1224568899999999999999988743320
Q ss_pred -------------------------------------------------------C------------------------
Q 013126 128 -------------------------------------------------------G------------------------ 128 (449)
Q Consensus 128 -------------------------------------------------------~------------------------ 128 (449)
+
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ------------------------------CeeEEEEeeCCCCCHHHHHhccCCCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 013126 129 ------------------------------DERLLVAEYMPNETLAKHLFHWETHPM-KWAMRLRVVLHLAQALEYCTSK 177 (449)
Q Consensus 129 ------------------------------~~~~lV~Ey~~ggsL~~~l~~~~~~~l-~~~~~~~i~~qi~~aL~yLH~~ 177 (449)
..+||-||||+..+|.++++++ ... .....++++++|+.||+|+|+.
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 1247899999988888887632 222 4678899999999999999999
Q ss_pred CCccccccccCceeeCCCCCeEEeccCCcccCC----------------------CCCccccCccccccccccCCC---C
Q 013126 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR----------------------DGKSYSTNLAFTPPEYLRTGR---V 232 (449)
Q Consensus 178 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~----------------------~~~~~~gt~~y~aPE~~~~~~---~ 232 (449)
| +|||||||.||++++++.+||+|||+|.... ..+...||..|+|||++.+.. |
T Consensus 717 g-iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 717 G-IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred c-eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9 9999999999999999999999999997511 112346889999999997654 9
Q ss_pred CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 233 ~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.|+|+||||||++||+. ||.........-..++...-+.. ..+..+.-+.-..+|++++++||++||||.|++.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999986 35443222211111111111111 1223333456678999999999999999999998
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=299.67 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=192.7
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCC------
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 129 (449)
.++|++++.||+|++|.||+|... +++.+|+|.+......+ ...+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 457889999999999999999965 58999999986543222 346789999999999999999999875443
Q ss_pred --eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 130 --ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 130 --~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
..++||||+. ++|.+.+.. ....+++..+..++.|+++||+|||+++ ++||||||+||++++++.++|+|||+++
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENH-ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECcCccch
Confidence 4699999997 577777653 3457999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCC---------------ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc--
Q 013126 208 NSRDGK---------------SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-- 269 (449)
Q Consensus 208 ~~~~~~---------------~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-- 269 (449)
...... ...+++.|+|||.+.+. .++.++||||||+++|+|++|++|+..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 543221 12346789999988654 488999999999999999999988764432211111000
Q ss_pred ---------------cccccccCCCC-------CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 ---------------MLTDSCLEGQF-------TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 ---------------~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
........... .....+.+.+++.+||+.||++|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 1123367889999999999999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=303.77 Aligned_cols=248 Identities=19% Similarity=0.211 Sum_probs=194.5
Q ss_pred cccccc-cccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--------------HHHHHHHHHHHhccCCCCccccee
Q 013126 60 AVENIV-SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--------------PRQFLEEARSVGQLRNNRLTNLLG 123 (449)
Q Consensus 60 ~~~~~l-~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~ 123 (449)
.+|..+ +.||+|+||+||+|.+. +++.||+|.++...... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 345444 55899999999999965 58999999986543221 125789999999999999999999
Q ss_pred eEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEecc
Q 013126 124 CCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (449)
Q Consensus 124 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DF 203 (449)
++..++..++||||++ ++|.+++. ....+++.....++.|++.||+|||+++ ++||||||+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~~-i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 69999886 4567899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCC------------------CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh
Q 013126 204 GLMKNSRDG------------------KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR 264 (449)
Q Consensus 204 Gla~~~~~~------------------~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~ 264 (449)
|+++..... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.|+.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998754410 1223577899999997644 789999999999999999999888654322111
Q ss_pred hccccccccc----------------------ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 265 DRNLQMLTDS----------------------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 265 ~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.........+ ..........+.++.+++.+||+.||++|||+++++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1110000000 0000011234678899999999999999999999997
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=288.54 Aligned_cols=235 Identities=23% Similarity=0.278 Sum_probs=197.7
Q ss_pred cCCccceEEEEEEEc-CCCEEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 68 HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
||+|+||.||++... +++.+|+|.++..... ..+.+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 599999999999965 4899999999765432 245789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----CccccCc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSYSTNL 219 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~~gt~ 219 (449)
.+++. ....+++..+..++.|++.||.|+|+.+ ++|+||||+||++++++.++|+|||++...... ....++.
T Consensus 81 ~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lh~~~-~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLS--KEGRFSEERARFYAAEIVLALEYLHSLG-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99997 3457899999999999999999999998 999999999999999999999999998765442 2345788
Q ss_pred cccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccC
Q 013126 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (449)
Q Consensus 220 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (449)
.|+|||...+...+.++|+||||+++|++++|..|+.............. .....+...+..+.+++.+||..|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK------DPLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------CCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999999888889999999999999999999999865543322222221 112234455788999999999999
Q ss_pred CCCCCCH---HHHHH
Q 013126 300 PRERPNP---KSLVT 311 (449)
Q Consensus 300 P~~Rps~---~eil~ 311 (449)
|++||++ .++++
T Consensus 232 p~~R~~~~~~~~l~~ 246 (250)
T cd05123 232 PTKRLGSGGAEEIKA 246 (250)
T ss_pred HhhCCCcccHHHHHh
Confidence 9999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.17 Aligned_cols=248 Identities=19% Similarity=0.256 Sum_probs=196.8
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCe-----
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE----- 130 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 130 (449)
.+.|++++.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 345788899999999999999965 48899999986532 2234567889999999999999999998876654
Q ss_pred -eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 131 -RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 131 -~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
.++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~g-i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSAG-IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 579999884 467999999999999999999999999 999999999999999999999999998865
Q ss_pred CCC-CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc---------------
Q 013126 210 RDG-KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT--------------- 272 (449)
Q Consensus 210 ~~~-~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 272 (449)
... ....++..|+|||.+.+. .++.++||||||+++|++++|+.||.................
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 433 345678889999998653 578899999999999999999998865432211111000000
Q ss_pred ----ccccC---C---CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 ----DSCLE---G---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ----~~~~~---~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..... . ......++++.+++.+||+.||++|||+.+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 0 001234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=340.89 Aligned_cols=244 Identities=24% Similarity=0.406 Sum_probs=194.1
Q ss_pred ccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 65 VSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
.+.||+|+||.||+|+. .+++.||+|.++..... ...|++.+++++|||||+++|++.+++..++||||+++|+|
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L 770 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence 34569999999999996 46899999998754321 23568899999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCccccCcc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCT---SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~gt~~ 220 (449)
.++++ .++|..+.+++.|++.||+||| +.+ ++||||||+||+++.++..++. ||............+|+.
T Consensus 771 ~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~ 843 (968)
T PLN00113 771 SEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPA-VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA 843 (968)
T ss_pred HHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCC-eecCCCCHHhEEECCCCceEEE-eccccccccCCCcccccc
Confidence 99994 3889999999999999999999 556 9999999999999999888875 666654444444568899
Q ss_pred ccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh-----HHHh-----hcccccccccccCC--CCCchhHHHH
Q 013126 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-----DLIR-----DRNLQMLTDSCLEG--QFTDDDGTEL 288 (449)
Q Consensus 221 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~-----~~~~-----~~~~~~~~~~~~~~--~~~~~~~~~l 288 (449)
|+|||++.+..++.++|||||||++|||+||+.|+..... ..+. ........++.... ........++
T Consensus 844 y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (968)
T PLN00113 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEV 923 (968)
T ss_pred ccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHH
Confidence 9999999988999999999999999999999998743210 0111 11111122222211 1223345578
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 924 ~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 924 MNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 8999999999999999999999999887543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=293.71 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=198.0
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
|++++.||+|++|.||+|+.. +++.||+|.++... ....+.+.+|+.+++.++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678899999999999965 48999999998653 223567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----c
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----S 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----~ 214 (449)
+ ++|.+++... ...+++..+..++.|++.||+|||+++ ++||||+|+||++++++.++|+|||.++...... .
T Consensus 81 ~-~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHR-ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 8 6999999742 257999999999999999999999999 9999999999999999999999999987654332 2
Q ss_pred cccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc--------------------cccc
Q 013126 215 YSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ--------------------MLTD 273 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~--------------------~~~~ 273 (449)
..++..|+|||.+.+. .++.++||||||+++||+++|+.|+.............. ....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 3456789999999776 689999999999999999999988865432211110000 0000
Q ss_pred c---ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 S---CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
. .......+..+..+.+++.+||+.||++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000111234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=290.91 Aligned_cols=244 Identities=16% Similarity=0.208 Sum_probs=198.0
Q ss_pred ccccccccCCccceEEEEEEEcC-CCEEEEEEecCCC-----CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA-----WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.|.+.+.||+|+||.||++++.. +..+++|.++... .....++.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36778899999999999999644 5566677765422 12234677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 135 AEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
|||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||||+||++++ +.++|+|||+++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR-ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC-ccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999999988642 3467899999999999999999999999 999999999999975 56999999998765432
Q ss_pred ----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..|+............... .....+...+.++
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 233 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-----PTPSLPETYSRQL 233 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-----CCCCCcchhcHHH
Confidence 2345788999999998888999999999999999999999988654333222221111 1112344667889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 013126 289 VRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+++.+||+.||++||++.++++
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhh
Confidence 99999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=301.15 Aligned_cols=246 Identities=18% Similarity=0.246 Sum_probs=191.5
Q ss_pred cccccccCCccceEEEEEEEc-C--CCEEEEEEecCCCCC--CHHHHHHHHHHHhcc-CCCCcccceeeEeeC----Cee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-N--QRRIAVKRFNRMAWP--DPRQFLEEARSVGQL-RNNRLTNLLGCCCEG----DER 131 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~--~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~~~ 131 (449)
|++.+.||+|+||.||++... + +..||+|.+...... ..+.+.+|+++++++ +||||+++++..... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 667888999999999999954 3 779999998753222 246788999999999 599999999875432 457
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++++||+. ++|.+.+. ....+++..++.++.||+.||.|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSAN-VLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 89999986 78999886 4567999999999999999999999999 99999999999999999999999999875432
Q ss_pred C--------CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-----------cc
Q 013126 212 G--------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-----------ML 271 (449)
Q Consensus 212 ~--------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------~~ 271 (449)
. ....++..|+|||++.+ ..++.++|+||+|+++|+|++|++|+.............. .+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2 12357889999998865 4589999999999999999999988764321111100000 00
Q ss_pred --------------cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 272 --------------TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 272 --------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..........+..+..+.+++.+||+.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000112234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.13 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=194.4
Q ss_pred ccccccCCccceEEEEEE-EcCCCEEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCC------eeEEE
Q 013126 63 NIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ERLLV 134 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~lV 134 (449)
..-+.||+||||.||+|+ ..+|+.||||.++... ....+...+|+++|++++|||||+++++-.+.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 344667999999999999 5569999999998744 334678999999999999999999999865543 57899
Q ss_pred EeeCCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC--CCCC--eEEeccCCcccC
Q 013126 135 AEYMPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDGN--PRLSTFGLMKNS 209 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~--~~~~--~kL~DFGla~~~ 209 (449)
||||.||||...+.+.+ ...+++.+.+.++..++.||.|||++| |+||||||.||++- .+|+ .||+|||.|+..
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~-IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG-IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999998654 367999999999999999999999999 99999999999985 3344 799999999998
Q ss_pred CCCC---ccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH----H----hhcccccccc----
Q 013126 210 RDGK---SYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL----I----RDRNLQMLTD---- 273 (449)
Q Consensus 210 ~~~~---~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~----~----~~~~~~~~~~---- 273 (449)
.++. +..||..|.+||.+.. +.|+..+|.|||||++|+++||..||....... + ..+....+..
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 8774 5679999999999984 779999999999999999999999985331110 0 0000000000
Q ss_pred ----cc-c------CCCCCchhHHHHHHHHHHhcccCCCCCC--CHHHHHHHh
Q 013126 274 ----SC-L------EGQFTDDDGTELVRLASRCLQYEPRERP--NPKSLVTAL 313 (449)
Q Consensus 274 ----~~-~------~~~~~~~~~~~l~~li~~cl~~dP~~Rp--s~~eil~~L 313 (449)
+. . +..........+..++..+|..+|.+|. ...+..+.+
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV 307 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence 00 0 0011122335566788889999999998 555555444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=308.25 Aligned_cols=239 Identities=21% Similarity=0.243 Sum_probs=200.1
Q ss_pred CCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.+..|++...+|.|+|+.|-.+.. .+++..++|++.+.. .+-.+|+.++... +||||+++.+++.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 367799999999999999999984 458999999997652 2334677666665 7999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee-CCCCCeEEeccCCcccCCCCC-
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF-DEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl-~~~~~~kL~DFGla~~~~~~~- 213 (449)
|.+.|+-|.+.+.. ..... ..+..|+.+|+.|+.|||++| ++||||||+|||+ ++.|+++|+|||.++......
T Consensus 396 e~l~g~ell~ri~~--~~~~~-~e~~~w~~~lv~Av~~LH~~g-vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~ 471 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS--KPEFC-SEASQWAAELVSAVDYLHEQG-VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD 471 (612)
T ss_pred hhccccHHHHHHHh--cchhH-HHHHHHHHHHHHHHHHHHhcC-eeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence 99999999888862 23333 778889999999999999999 9999999999999 589999999999998877662
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-HHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
..+-|..|.|||++....||+++|+||||++||+|++|+.|+.....+ .+.... ..+.+...++.++++|+
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i--------~~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI--------QMPKFSECVSDEAKDLL 543 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh--------cCCccccccCHHHHHHH
Confidence 235578899999999889999999999999999999999998766544 121111 11233467889999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~ 312 (449)
++||+.||.+||++.++...
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHhccCChhhCcChhhhccC
Confidence 99999999999999999883
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=284.98 Aligned_cols=218 Identities=20% Similarity=0.231 Sum_probs=179.4
Q ss_pred ccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhc
Q 013126 71 KAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFH 149 (449)
Q Consensus 71 G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~ 149 (449)
|.+|.||++.+. +++.||+|.++... .+.+|...+....||||+++++++.+.+..++||||++||+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~- 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS- 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH-
Confidence 889999999964 58999999997643 23455566666789999999999999999999999999999999987
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-CccccCcccccccccc
Q 013126 150 WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLR 228 (449)
Q Consensus 150 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~ 228 (449)
....+++..+..++.|++.||+|||+++ ++||||||+||++++++.++++|||.+...... ....++..|+|||...
T Consensus 78 -~~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 78 -KFLNIPEECVKRWAAEMVVALDALHREG-IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG 155 (237)
T ss_pred -HhcCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence 3456899999999999999999999999 999999999999999999999999987655433 2334567899999998
Q ss_pred CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCH
Q 013126 229 TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP 306 (449)
Q Consensus 229 ~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (449)
+..++.++|+||+|+++|||++|..|+...... . . .......+...++.+.+++.+||+.||++||++
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----N----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----c----cccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 888999999999999999999999775432111 0 0 000112334566789999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.39 Aligned_cols=146 Identities=23% Similarity=0.284 Sum_probs=131.9
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
+..|+++++||+|+||+||+|.+. +++.||||+++...... ...+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467889999999999999999965 58999999997643222 36788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
|||++|++|.+++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~--~~~~l~~~~~~~i~~qil~aL~yLH~~g-IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLH--IYGYFDEEMAVKYISEVALALDYLHRHG-IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999996 4457889999999999999999999998 9999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=288.32 Aligned_cols=251 Identities=18% Similarity=0.265 Sum_probs=197.3
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc--CCCCcccceeeEeeCC----eeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL--RNNRLTNLLGCCCEGD----ERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~~~~~~~~----~~~lV 134 (449)
...+++.+|+|.||.||+|.+ .|+.||||++.. .+.+.+.+|.++.+.+ +|+||+.+++.-..++ ++|||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 467889999999999999999 578999999965 3456788888887765 9999999998755443 58999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----C--CccccccccCceeeCCCCCeEEeccCCcc
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-----G--RALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----~--~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
++|.++|||+|+| .+..++....++++..++.||++||.. | .|.|||||..|||+.++|...|+|+|+|.
T Consensus 288 TdYHe~GSL~DyL---~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 288 TDYHEHGSLYDYL---NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eecccCCcHHHHH---hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999999 557899999999999999999999962 2 29999999999999999999999999997
Q ss_pred cCCCC--------CccccCccccccccccCCC----CC--CCCceeeHhHHHHHHhcCC----------CCCCc-----h
Q 013126 208 NSRDG--------KSYSTNLAFTPPEYLRTGR----VT--PESVIYSFGTLLLDLLSGK----------HIPPS-----H 258 (449)
Q Consensus 208 ~~~~~--------~~~~gt~~y~aPE~~~~~~----~~--~~sDvwSlGvil~elltg~----------~p~~~-----~ 258 (449)
..... +...||.+|||||++...- +. ..+||||||.|+||++.+. .||.+ .
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 65443 3467999999999996431 22 2699999999999997632 34322 2
Q ss_pred hhHHHhhcccccccccccCCCC-CchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 259 ALDLIRDRNLQMLTDSCLEGQF-TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
..+.+++-.-.....+..+..+ ..+.-..+.++++.||..||..|.|+-.+.+.|.++..
T Consensus 445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 3333333222222222222222 23456788899999999999999999999999888764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=298.40 Aligned_cols=238 Identities=20% Similarity=0.252 Sum_probs=201.7
Q ss_pred cccCCccceEEEEEEE-cCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCC
Q 013126 66 SEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
+.||+|.||+||-|++ ++|+.||||++.+.... ...++.+|+.||.++.||.||.+.-.|+..+.+++|||-+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 4679999999999995 46999999999875433 35678999999999999999999999999999999999997 56
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC---CCeEEeccCCcccCCCC---Cccc
Q 013126 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMKNSRDG---KSYS 216 (449)
Q Consensus 143 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~---~~~~ 216 (449)
..+.|...+.+.+++.....++.||+-||.|||.++ |+|.||||+|||+.+. ..+||+|||+|+..... .+..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn-IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN-IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc-eeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 666666657789999999999999999999999999 9999999999999744 46999999999987765 4678
Q ss_pred cCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh--hHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 217 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
|||.|.|||+++++.|...-|+||+|||+|.-++|..||..+. .+.+.+.... .+...+.++++++.+||..
T Consensus 728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM------yPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM------YPPNPWSEISPEAIDLINN 801 (888)
T ss_pred CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc------cCCCchhhcCHHHHHHHHH
Confidence 9999999999999999999999999999999999999987541 1222222111 1123355778899999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
+|+..-.+|-|.+..+.
T Consensus 802 LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHHhcchHhhcc
Confidence 99999999999988775
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=282.73 Aligned_cols=246 Identities=18% Similarity=0.238 Sum_probs=194.5
Q ss_pred ccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 63 NIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
+-++.||.|+||+|+|-.++ .|+..|||.++.... .+.++++.|.+...+- +.||||++||....++..|+-||.|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 34578899999999999954 599999999987654 3467899999876666 67999999999999999999999997
Q ss_pred CCCHHHHH---hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---C
Q 013126 140 NETLAKHL---FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---K 213 (449)
Q Consensus 140 ggsL~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~ 213 (449)
-||..+- .......+++...-.|......||.||...-+|||||+||+|||++..|.+||+|||++....+. .
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 6765543 23356678998888999999999999988656999999999999999999999999998655443 2
Q ss_pred ccccCccccccccccC--CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccccc---CCCCCchhHHHH
Q 013126 214 SYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL---EGQFTDDDGTEL 288 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 288 (449)
.-.|-..|||||.+.. ..|+.+|||||||++|||+.||+.|+..+.. +.++..+-.....+ ...-.-+.+..+
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDKECVHYSFSM 303 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCcccccccCHHH
Confidence 3457789999999954 3489999999999999999999988766532 22222111111111 111122367889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 013126 289 VRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+++..||.+|.+.||.+.++++
T Consensus 304 ~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHhhcccccCcchhhhhc
Confidence 99999999999999999999987
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=286.78 Aligned_cols=237 Identities=19% Similarity=0.261 Sum_probs=204.5
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCC---CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 134 (449)
.+++.+..||+|+||.|.+|..++ .+.+|||+++++.. .+.+--+.|-++|..- +-|.++++...++.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 457788899999999999999554 78999999987542 2234456777888777 468899999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC---
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--- 211 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~--- 211 (449)
|||+.||+|--+|+ +-+.+.+..+..++.+|+-||-+||++| ||+||||.+||++|.+|++||+|||+++..--
T Consensus 429 MEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~kg-IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcCC-eeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 99999999999997 5678999999999999999999999999 99999999999999999999999999985332
Q ss_pred -CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 212 -GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 212 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
.++.+|||.|+|||++..++|+.++|.||+||+||||+.|++||.++..+.+-..+...- -.++..++.++.+
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn------vsyPKslSkEAv~ 579 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN------VSYPKSLSKEAVA 579 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc------CcCcccccHHHHH
Confidence 246789999999999999999999999999999999999999999887766655443321 2467788999999
Q ss_pred HHHHhcccCCCCCCC
Q 013126 291 LASRCLQYEPRERPN 305 (449)
Q Consensus 291 li~~cl~~dP~~Rps 305 (449)
++...|.++|.+|..
T Consensus 580 ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHhhcCCccccC
Confidence 999999999999953
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=283.10 Aligned_cols=249 Identities=15% Similarity=0.166 Sum_probs=198.9
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccC-C-CC----cccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-N-NR----LTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-H-pn----Iv~l~~~~~~~~~~~ 132 (449)
..|.+++.+|+|.||.|-.+.+.. +..||||+++... .-.+..+-|+++|.++. + |+ +|++.++|...++.|
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 468889999999999999999654 7899999997533 22456678999999993 3 33 888899999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC------------------
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE------------------ 194 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~------------------ 194 (449)
||+|.+ |.|+.+++..++-.+++...++.+++|++.++++||+.+ ++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k-l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK-LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc-eeecCCChheEEEeccceEEEeccCCccceecc
Confidence 999999 579999999877788999999999999999999999998 999999999999832
Q ss_pred --CCCeEEeccCCcccCCCC-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH---Hhhccc
Q 013126 195 --DGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL---IRDRNL 268 (449)
Q Consensus 195 --~~~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~---~~~~~~ 268 (449)
+..++|+|||.|...... .....|..|.|||++.+-+++..+||||+||||+|+.||...|+.+.... +.+.+.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIl 325 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERIL 325 (415)
T ss_pred CCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhh
Confidence 234899999999876655 45578999999999999999999999999999999999998776542111 111111
Q ss_pred ccccccccC-------------------------------------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 QMLTDSCLE-------------------------------------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 ~~~~~~~~~-------------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..++..... ....+....++.+|+++||..||.+|+|+.|++.
T Consensus 326 Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 326 GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 111100000 0111234467999999999999999999999987
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.11 Aligned_cols=246 Identities=15% Similarity=0.233 Sum_probs=204.3
Q ss_pred cccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEee-----CCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCE-----GDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-----~~~~~ 132 (449)
+.++++..+|.|.+|.||+++ .++++..|+|+....... .++...|.++++.. .|||++.++|++.. ++++|
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 345566777999999999999 567899999998765533 46788899999998 68999999999874 46899
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
||||||.|||..|+++...+..+.|..+..|++.++.|+.+||.+. ++|||||-.|||++.++.+||.|||.+......
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk-viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc-eeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 9999999999999998777888999999999999999999999998 999999999999999999999999998765543
Q ss_pred ----CccccCccccccccccCC-----CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc-cccccCCCCCc
Q 013126 213 ----KSYSTNLAFTPPEYLRTG-----RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML-TDSCLEGQFTD 282 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 282 (449)
.+..||+.|||||++.-. .|+.++|+||||++..||.-|.+|+..--. .+.+-.+ ..+.+....+.
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----mraLF~IpRNPPPkLkrp~ 252 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----MRALFLIPRNPPPKLKRPK 252 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----hhhhccCCCCCCccccchh
Confidence 466799999999999542 378899999999999999999987643211 1111111 12222233466
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..+.++.++|..||.+|.++||++.++++
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 78899999999999999999999999885
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=294.62 Aligned_cols=248 Identities=17% Similarity=0.196 Sum_probs=213.1
Q ss_pred CCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.+++.+.+..||-|+||.|=+++.++ ...+|+|++++.... ..+....|-.+|...+.|.||++|-.|.++.++|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 45667888999999999999999755 334899999875433 35668899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
.||-|-||.|+..++ .++.++..+++.++..++.|++|||+++ ||+|||||+|.+++.+|-+||.|||+|+....+.
T Consensus 498 LmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~-iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKG-IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcC-ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999999998 6788999999999999999999999999 9999999999999999999999999999877664
Q ss_pred ---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 214 ---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
+++|||.|.|||++.++..+.++|.||||+++|||++|.+||.+...-...+.++..+- .-.+|..++....+
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid----~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID----KIEFPRRITKTATD 650 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh----hhhcccccchhHHH
Confidence 57899999999999999999999999999999999999999987644444433333322 22445677788999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHHH
Q 013126 291 LASRCLQYEPRERPN-----PKSLVTA 312 (449)
Q Consensus 291 li~~cl~~dP~~Rps-----~~eil~~ 312 (449)
+++++...+|.+|.. ..+|.++
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhh
Confidence 999999999999975 5566553
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=304.49 Aligned_cols=249 Identities=20% Similarity=0.266 Sum_probs=208.4
Q ss_pred cccccccCCccceEEEEEEE-cC----CCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKL-EN----QRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~-~~----~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.+..++||+|+||+||+|.+ .. +-+||||++..... +...+++.|+-+|.+++|||+++++|++.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45668899999999999995 33 45789999976543 34678999999999999999999999998765 88999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcc
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 215 (449)
+|+++|+|.++++. ++.++..+..+.|..||++||.|||.+. ++||||-..|||+.+-..+|+.|||+++........
T Consensus 777 q~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qr-lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQR-LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcc-hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999987 5678888999999999999999999998 999999999999999999999999999987655322
Q ss_pred ------ccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 216 ------STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 216 ------~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
...+.|||-|.+....|+.++|||||||++||++| |..|+.+...+.+.+-. ....+..-|+.++-++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-----e~geRLsqPpiCtiDV 929 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-----EKGERLSQPPICTIDV 929 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-----hccccCCCCCCccHHH
Confidence 22467999999999999999999999999999998 66777766555444321 1111223466788899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 289 VRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
..++.+||..|++.||+++++...+..+.+
T Consensus 930 y~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 930 YMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 999999999999999999999987765543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.53 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=192.9
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeC--------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-------- 128 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------- 128 (449)
+.|+.+.++|+|.||.||+|+.+ +|+.||+|++-... ..-....++|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34666778899999999999954 58889998874322 22256788999999999999999999887643
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
..+|+|+.+|+ -+|...+.. ....++..++.+++.++..||.|+|... |+|||+||+|+||+.+|.+||+|||+++.
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k-ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK-ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh-HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 34799999998 588888853 3467899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCC--------ccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh-----------ccc
Q 013126 209 SRDGK--------SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD-----------RNL 268 (449)
Q Consensus 209 ~~~~~--------~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-----------~~~ 268 (449)
..... ....|..|.+||.+.|.. |+++.|||+.|||+.||+||.+.+.+........ +.+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 54332 233489999999998865 9999999999999999999998775542221100 000
Q ss_pred cccc----------ccccCCCC--------CchhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 269 QMLT----------DSCLEGQF--------TDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 269 ~~~~----------~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
.... .+.+.+.. +-.-.++..+|+.++|..||.+|+++++++.+-
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0000 00000000 001124788999999999999999999999843
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=279.65 Aligned_cols=247 Identities=22% Similarity=0.274 Sum_probs=196.3
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC-CCC------HHHHHHHHHHHhccCCCCcccceeeEeeC-Cee
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA-WPD------PRQFLEEARSVGQLRNNRLTNLLGCCCEG-DER 131 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~-~~~------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~ 131 (449)
+|-++..||+|+|+.||+|.+ ..++.||+|+-..+. |.+ .+...+|.+|-+.|+||.||++|+++.-+ +.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 467788999999999999994 458899999875422 222 23467899999999999999999998754 668
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeCC---CCCeEEeccCCcc
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDE---DGNPRLSTFGLMK 207 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~~---~~~~kL~DFGla~ 207 (449)
|-|+|||+|.+|.-++. ..+.+++.+++.|+.||+.||.||... .+|||-||||.|||+-+ .|.+||+|||+++
T Consensus 544 CTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 99999999999999997 567899999999999999999999875 35999999999999963 4789999999999
Q ss_pred cCCCCC-----------ccccCccccccccccCC----CCCCCCceeeHhHHHHHHhcCCCCCCchh-hHHHhhcc-ccc
Q 013126 208 NSRDGK-----------SYSTNLAFTPPEYLRTG----RVTPESVIYSFGTLLLDLLSGKHIPPSHA-LDLIRDRN-LQM 270 (449)
Q Consensus 208 ~~~~~~-----------~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~p~~~~~-~~~~~~~~-~~~ 270 (449)
.+.+.. ...||..|.+||.+.-+ ..+.|+||||+|||+|.++.|+.||.... ...+...+ +..
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 876542 24689999999988543 37889999999999999999999996542 22222211 111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
... ......+.++.++.++|++||++.-++|....++..
T Consensus 702 AtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 702 ATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred cee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111 111223456789999999999999999998888765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.73 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=201.5
Q ss_pred cccccCCccceEEEEEEEcC--------CCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEE
Q 013126 64 IVSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~--------~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 133 (449)
+.+.+|+|+||.|++|.... ...||||.++..... +.+.+..|+++|+.+ +||||+.++|++...+..++
T Consensus 300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~ 379 (609)
T KOG0200|consen 300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV 379 (609)
T ss_pred ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence 34578999999999998431 457999999875543 367899999999999 69999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeE
Q 013126 134 VAEYMPNETLAKHLFHWE------T--------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~------~--------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~k 199 (449)
|+||+.+|+|.++++..+ . ..++..+.+.++.||+.|++||++.+ ++||||-..|||+.++..+|
T Consensus 380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-~vHRDLAaRNVLi~~~~~~k 458 (609)
T KOG0200|consen 380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-CVHRDLAARNVLITKNKVIK 458 (609)
T ss_pred EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-ccchhhhhhhEEecCCCEEE
Confidence 999999999999998643 0 13888999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcc-----cc--CccccccccccCCCCCCCCceeeHhHHHHHHhcCC-CCCCchh-hHHHhhccccc
Q 013126 200 LSTFGLMKNSRDGKSY-----ST--NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK-HIPPSHA-LDLIRDRNLQM 270 (449)
Q Consensus 200 L~DFGla~~~~~~~~~-----~g--t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~p~~~~~-~~~~~~~~~~~ 270 (449)
|+|||+++.......+ .+ ...|||||.+....|+.++|||||||+|||++|.. .|+++.. ...+.+
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~----- 533 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE----- 533 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-----
Confidence 9999999965544322 11 24599999999988999999999999999999955 4444321 111111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
......+...|..++.++.++++.||+.+|++||++.++.+.++...
T Consensus 534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 11111223345667889999999999999999999999999998853
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=266.00 Aligned_cols=234 Identities=22% Similarity=0.276 Sum_probs=194.9
Q ss_pred cceEEEEEEEcC-CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhc
Q 013126 72 APNVVYKGKLEN-QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFH 149 (449)
Q Consensus 72 ~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~ 149 (449)
+||.||+|...+ ++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 578999999754 8999999998765544 68899999999999999999999999999999999999999999999863
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---CccccCcccccccc
Q 013126 150 WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYSTNLAFTPPEY 226 (449)
Q Consensus 150 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~~~gt~~y~aPE~ 226 (449)
...+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+...... ....++..|++||.
T Consensus 81 --~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 81 --RGRLSEDEARFYARQILSALEYLHSNG-IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV 157 (244)
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHHcC-eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence 333899999999999999999999998 999999999999999999999999998876553 34567889999999
Q ss_pred ccCCCCCCCCceeeHhHHHHHHhcCCCCCCc-hhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCC
Q 013126 227 LRTGRVTPESVIYSFGTLLLDLLSGKHIPPS-HALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305 (449)
Q Consensus 227 ~~~~~~~~~sDvwSlGvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (449)
+.+..++.++||||+|+++|++++|..|+.. ................. .......+.++.+++.+||..+|++||+
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---PPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---ccccccCCHHHHHHHHHHccCCchhccC
Confidence 9888899999999999999999999988865 32222222111111110 0011116678999999999999999999
Q ss_pred HHHHHH
Q 013126 306 PKSLVT 311 (449)
Q Consensus 306 ~~eil~ 311 (449)
+.++++
T Consensus 235 ~~~~~~ 240 (244)
T smart00220 235 AEEALQ 240 (244)
T ss_pred HHHHhh
Confidence 999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=258.78 Aligned_cols=257 Identities=20% Similarity=0.271 Sum_probs=205.3
Q ss_pred ccCHHHHHHhhCCCcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCccccee
Q 013126 46 EFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLG 123 (449)
Q Consensus 46 ~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~ 123 (449)
-+.++.....+.+-++|++++++|+|.|+.||.|. ..+++.++||+++... .+.+.+|+.+|..|. ||||+++++
T Consensus 24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhh
Confidence 46777777777788899999999999999999999 5578999999998643 577899999999996 999999999
Q ss_pred eEeeC--CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-CCCCeEE
Q 013126 124 CCCEG--DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRL 200 (449)
Q Consensus 124 ~~~~~--~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-~~~~~kL 200 (449)
+..++ ..+.||+||+++.+....- ..++...++.++.+++.||.|+|+.| |+|||+||.|++|| +...++|
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G-ImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG-IMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC-cccccCCcceeeechhhceeee
Confidence 98875 4578999999988776654 45778889999999999999999999 99999999999999 4567999
Q ss_pred eccCCcccCCCCCcc---ccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCch--hhHH------------
Q 013126 201 STFGLMKNSRDGKSY---STNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSH--ALDL------------ 262 (449)
Q Consensus 201 ~DFGla~~~~~~~~~---~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~--~~~~------------ 262 (449)
+|+|+|....++..+ ..+..|..||.+-.-+ |+..-|+|||||++..|+..+.||... +.+.
T Consensus 175 IDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred eecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 999999988877543 4578899999997654 899999999999999999999998532 0110
Q ss_pred ----Hhh------ccccccccc----cc----CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 263 ----IRD------RNLQMLTDS----CL----EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 263 ----~~~------~~~~~~~~~----~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.. .....+... .+ ......-.++++.+++.++|..|..+|+|++|++.
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000 000000000 00 00111123588999999999999999999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=286.97 Aligned_cols=252 Identities=19% Similarity=0.222 Sum_probs=202.2
Q ss_pred cccCHHHHHHhhCCCcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCccc
Q 013126 45 REFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTN 120 (449)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~ 120 (449)
++..+-.++.+.-+-+-+-.|+.||-|+||.|-++. .+++..||+|.+++.+.- .......|-+||..-+++.||+
T Consensus 614 KESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVr 693 (1034)
T KOG0608|consen 614 KESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVR 693 (1034)
T ss_pred hhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEE
Confidence 334555666666666677789999999999999998 456889999999775422 2345778999999999999999
Q ss_pred ceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEE
Q 013126 121 LLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (449)
Q Consensus 121 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL 200 (449)
+|-.|.+.+.+|+||||++||++-.+|. +.+-+.+..++.++.++..|+++.|..| .|||||||+|||||.+|++||
T Consensus 694 LyySFQDkdnLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkmG-FIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 694 LYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKMG-FIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred EEEEeccCCceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhcc-ceecccCccceEEccCCceee
Confidence 9999999999999999999999999887 5678999999999999999999999999 999999999999999999999
Q ss_pred eccCCcccCC---------CC-------------------------------------CccccCccccccccccCCCCCC
Q 013126 201 STFGLMKNSR---------DG-------------------------------------KSYSTNLAFTPPEYLRTGRVTP 234 (449)
Q Consensus 201 ~DFGla~~~~---------~~-------------------------------------~~~~gt~~y~aPE~~~~~~~~~ 234 (449)
+|||++.-+. .+ ....||+.|+|||++....|+.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 9999975211 00 0235789999999999999999
Q ss_pred CCceeeHhHHHHHHhcCCCCCCchhhHHHhhc--ccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCC
Q 013126 235 ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR--NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304 (449)
Q Consensus 235 ~sDvwSlGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (449)
.+|.||.|||||||+.|++||-.........+ +++...+ -.+..++++++.++|.++.. +++.|.
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~----~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLH----IPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccc----cccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99999999999999999999865533322221 1222221 22334677888888887654 466664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.22 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=168.3
Q ss_pred CCcccccccccCCccceEEEEEEEc-C----CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceee------Ee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-N----QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGC------CC 126 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~----~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~------~~ 126 (449)
..++|++.+.||+|+||.||+|++. + +..||+|++.... ..+.+..| .++...+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4567889999999999999999964 4 6899999986432 11222222 1222223333332222 23
Q ss_pred eCCeeEEEEeeCCCCCHHHHHhccCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccC
Q 013126 127 EGDERLLVAEYMPNETLAKHLFHWETH------------------PMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188 (449)
Q Consensus 127 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~ 188 (449)
.+...++||||+++++|.+++...... ......+..++.|++.||+|||+++ |+||||||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-IiHRDLKP~ 284 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-IVHRDVKPQ 284 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-EEeCcCCHH
Confidence 556789999999999999998642110 0112345679999999999999999 999999999
Q ss_pred ceeeCC-CCCeEEeccCCcccCCCC-----CccccCccccccccccCCC----------------------CCCCCceee
Q 013126 189 RILFDE-DGNPRLSTFGLMKNSRDG-----KSYSTNLAFTPPEYLRTGR----------------------VTPESVIYS 240 (449)
Q Consensus 189 NILl~~-~~~~kL~DFGla~~~~~~-----~~~~gt~~y~aPE~~~~~~----------------------~~~~sDvwS 240 (449)
|||+++ ++.+||+|||+++..... ....+++.|+|||.+.... ++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999995 689999999999765432 3456789999999764322 344679999
Q ss_pred HhHHHHHHhcCCCCCCchhhHHHh---hcc-----cccccccccCC------CCCchhHHHHHHHHHHhcccCCCCCCCH
Q 013126 241 FGTLLLDLLSGKHIPPSHALDLIR---DRN-----LQMLTDSCLEG------QFTDDDGTELVRLASRCLQYEPRERPNP 306 (449)
Q Consensus 241 lGvil~elltg~~p~~~~~~~~~~---~~~-----~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (449)
+||++|||+++..+.......... ... +.......... ...+.......+|+.+||++||++|||+
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999999987654433211110 000 00000000000 0011122345689999999999999999
Q ss_pred HHHHHH
Q 013126 307 KSLVTA 312 (449)
Q Consensus 307 ~eil~~ 312 (449)
.+++++
T Consensus 445 ~e~L~H 450 (566)
T PLN03225 445 KAALAH 450 (566)
T ss_pred HHHhCC
Confidence 999983
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.35 Aligned_cols=253 Identities=17% Similarity=0.193 Sum_probs=179.9
Q ss_pred CcccccccccCCccceEEEEEEE-----------------cCCCEEEEEEecCCCCCCHHH--------------HHHHH
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-----------------ENQRRIAVKRFNRMAWPDPRQ--------------FLEEA 107 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-----------------~~~~~vAiK~l~~~~~~~~~~--------------~~~E~ 107 (449)
.++|++.++||+|+||+||+|.+ ..++.||||+++.......++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45677888889999999999963 235689999997543322233 34467
Q ss_pred HHHhccCCCCc-----ccceeeEee--------CCeeEEEEeeCCCCCHHHHHhccC----------------------C
Q 013126 108 RSVGQLRNNRL-----TNLLGCCCE--------GDERLLVAEYMPNETLAKHLFHWE----------------------T 152 (449)
Q Consensus 108 ~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~ggsL~~~l~~~~----------------------~ 152 (449)
..+.+++|.++ +++++++.. .+..++||||+++++|.+++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 667777653 356899999999999999986321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc-----cccCccccccccc
Q 013126 153 HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS-----YSTNLAFTPPEYL 227 (449)
Q Consensus 153 ~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~gt~~y~aPE~~ 227 (449)
..+++..++.++.|++.||.|+|+++ |+||||||+||+++.++.+||+|||+++....... ..+|+.|+|||.+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~-ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 13456788999999999999999999 99999999999999999999999999876443221 2347899999998
Q ss_pred cCCC--------------------C--CCCCceeeHhHHHHHHhcCCC-CCCchhh-H-HHhh--cc---cccccccccC
Q 013126 228 RTGR--------------------V--TPESVIYSFGTLLLDLLSGKH-IPPSHAL-D-LIRD--RN---LQMLTDSCLE 277 (449)
Q Consensus 228 ~~~~--------------------~--~~~sDvwSlGvil~elltg~~-p~~~~~~-~-~~~~--~~---~~~~~~~~~~ 277 (449)
.... + ..+.||||+||++|+|++|.. |+..... . .... .. +.........
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 5432 1 124799999999999999985 4322100 0 0000 00 0011111111
Q ss_pred CCCCchhHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 013126 278 GQFTDDDGTELVRLASRCLQYEP---RERPNPKSLVTA 312 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~eil~~ 312 (449)
-...+..++...+++.++|..+| .+|+|+++++++
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 12234567889999999999876 689999999983
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.29 Aligned_cols=245 Identities=18% Similarity=0.269 Sum_probs=190.6
Q ss_pred ccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCC-----eeEEEEe
Q 013126 65 VSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-----ERLLVAE 136 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E 136 (449)
-+.||-|+||+||.+++. +|+.||+|++..... ...+++.+|+++|..++|.|++..++...-.. .+|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 356799999999999965 599999999975332 23578999999999999999999998876443 4688999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc--
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS-- 214 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-- 214 (449)
.+. .+|...|. ..+.++.+.++-+++||++||+|||+.+ |+||||||.|.|++++..+||+|||+++.......
T Consensus 138 LmQ-SDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~-ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LMQ-SDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN-ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHH-hhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc-hhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 996 78988887 6788999999999999999999999999 99999999999999999999999999997665432
Q ss_pred ---cccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhh----H------------HHh---hcccccc
Q 013126 215 ---YSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHAL----D------------LIR---DRNLQML 271 (449)
Q Consensus 215 ---~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~----~------------~~~---~~~~~~~ 271 (449)
...|..|.|||.+.|.. |+.+.||||+|||+.|++-++..|..... + .++ ++....+
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 34578999999999865 99999999999999999988866643210 0 000 0000000
Q ss_pred cccccC-C--------CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 272 TDSCLE-G--------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 272 ~~~~~~-~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
...... . ..+.....+...++.+++..||+.|.+..+.+..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000000 0 01112335677889999999999999999988754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=262.15 Aligned_cols=242 Identities=18% Similarity=0.274 Sum_probs=197.7
Q ss_pred CCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC---CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
+..+++++..||+|+|+.|.++++ ++.+.+|+|++++.- .++..-...|-.+..+- +||.+|-+...|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 466788899999999999999994 458899999998743 33445566777777776 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC--
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-- 210 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~-- 210 (449)
+|.||++||+|--+++ +.+.++++.++.+..+|+.||.|||++| ||+||||.+|+|+|..|.+||+|+|+++..-
T Consensus 328 fvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rg-iiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcC-eeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999987776 6678999999999999999999999999 9999999999999999999999999987532
Q ss_pred --CCCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH----HhhcccccccccccCCCCCchh
Q 013126 211 --DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL----IRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 211 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
...+++|||.|.|||++++..|...+|.|+|||+++||+.|+.||.--..+. ..+-..+-+... .-.+|...
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--qiriprsl 482 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--QIRIPRSL 482 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--ccccccee
Confidence 2246789999999999999999999999999999999999999985321110 011111111111 11235566
Q ss_pred HHHHHHHHHHhcccCCCCCC
Q 013126 285 GTELVRLASRCLQYEPRERP 304 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rp 304 (449)
+-.+..++...|.+||.+|.
T Consensus 483 svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhc
Confidence 67788899999999999995
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=242.50 Aligned_cols=198 Identities=18% Similarity=0.204 Sum_probs=166.7
Q ss_pred cccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC-HHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeC
Q 013126 62 ENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
...+.+||+|+||.|-+-++ .+|...|+|.++..-... .++.++|+.+..+. ..|.+|.+||.......+++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34567889999999999884 569999999997644322 45688899876665 7899999999999999999999999
Q ss_pred CCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---
Q 013126 139 PNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 139 ~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--- 213 (449)
+ .||..+-++ ..++.+++...-+|+..+.+||.|||++-.++|||+||+|||++.+|++|++|||++-...+.-
T Consensus 128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence 7 788766543 2567899999999999999999999998669999999999999999999999999987766542
Q ss_pred ccccCccccccccccC----CCCCCCCceeeHhHHHHHHhcCCCCCCchhh
Q 013126 214 SYSTNLAFTPPEYLRT----GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~elltg~~p~~~~~~ 260 (449)
...|-..|||||.+.. ..|+.++||||||+++.||.+++.|++.+..
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 2457788999998853 3599999999999999999999999876543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=286.16 Aligned_cols=237 Identities=22% Similarity=0.251 Sum_probs=182.2
Q ss_pred CcccccccccCCccceE-EEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEe
Q 013126 59 FAVENIVSEHGEKAPNV-VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~-Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
|...+++ |.|+.|+ ||+|.. +|+.||||++-... .....+|++.|+.- +|||||++++.-.++...||..|
T Consensus 511 ~~~~eil---G~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEIL---GYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHc---ccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3444444 7777765 799998 57899999985432 34567999999998 69999999999999999999999
Q ss_pred eCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---C--CCeEEeccCCcccC
Q 013126 137 YMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---D--GNPRLSTFGLMKNS 209 (449)
Q Consensus 137 y~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~--~~~kL~DFGla~~~ 209 (449)
.|. .+|.+++... ......--..+.++.|+++||++||+.+ |+||||||+||||+. + .+++|+|||+++..
T Consensus 584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK-IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc-cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 997 8999999752 1111111345778999999999999998 999999999999985 3 46999999999876
Q ss_pred CCCC-------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcC-CCCCCchhhHH--HhhcccccccccccCCC
Q 013126 210 RDGK-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-KHIPPSHALDL--IRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 210 ~~~~-------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 279 (449)
..++ ...||-+|+|||++....-+.++||||+||++|+.++| .+||....... +...+... . .
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L---~----~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL---V----H 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce---e----e
Confidence 6543 34689999999999988888899999999999999998 56765432211 11111100 0 0
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..+....++.+||.+|+++||..||+|.+++.
T Consensus 735 L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 LEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111128999999999999999999999996
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-33 Score=277.74 Aligned_cols=250 Identities=17% Similarity=0.193 Sum_probs=206.6
Q ss_pred CCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+.-++|+++.++|+|+||.|||+++ .+++..|+|+++.....+..-..+|+-+++..+|||||.++|.+...+..|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3446788999999999999999995 459999999999877667777889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC----C
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR----D 211 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~----~ 211 (449)
|||.||+|.+.-+ -.+++++.+...+.++.++||+|||+.+ -+|||||-.|||+++.|.+|++|||.+.... .
T Consensus 92 EycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g-k~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG-KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC-cccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 9999999999765 6789999999999999999999999999 9999999999999999999999999876543 3
Q ss_pred CCccccCcccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCch-hhHHHhhcccccccccccCCCCCchhHHH
Q 013126 212 GKSYSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 212 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
.+++.||+.|||||+.. .+.|...+|||++|++..|+-.-++|-... ....+.-........+. ..-+...++.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~--lkDk~kws~~ 246 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT--LKDKTKWSEF 246 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc--ccCCccchHH
Confidence 46788999999999873 456999999999999999998777664322 11111111111111111 1223456788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.++++.+|.++|++||+++.++.
T Consensus 247 fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhee
Confidence 999999999999999999998875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=269.91 Aligned_cols=201 Identities=15% Similarity=0.187 Sum_probs=175.9
Q ss_pred HHhhCCCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCC--------CCHHHHHHHHHHHhccC---CCCccc
Q 013126 53 KNATSGFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAW--------PDPRQFLEEARSVGQLR---NNRLTN 120 (449)
Q Consensus 53 ~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~--------~~~~~~~~E~~~l~~l~---HpnIv~ 120 (449)
+....+|++|..++.+|+|+||.|++|.++. +..|+||.+.+... .+.-..-.|++||..++ |+||++
T Consensus 554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 3445689999999999999999999999654 77899999976431 11123456999999997 999999
Q ss_pred ceeeEeeCCeeEEEEeeC-CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeE
Q 013126 121 LLGCCCEGDERLLVAEYM-PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPR 199 (449)
Q Consensus 121 l~~~~~~~~~~~lV~Ey~-~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~k 199 (449)
++++|++++++||+||-. +|-+|.++|. ....+++.++..|++||+.|+++||+.+ |+|||||-+|+.++.+|.+|
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~~-ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQG-IVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccccC-ceecccccccEEEecCCeEE
Confidence 999999999999999976 5668999997 5677999999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCC--CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCC
Q 013126 200 LSTFGLMKNSRDG--KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPP 256 (449)
Q Consensus 200 L~DFGla~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~ 256 (449)
|+|||.+....++ ..+.||..|.|||++.|.+| +..-|||++|++||.++....|+.
T Consensus 711 lidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999998876655 57889999999999999887 557999999999999999888875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=249.54 Aligned_cols=244 Identities=17% Similarity=0.228 Sum_probs=189.8
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCC--CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCC------ee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM--AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD------ER 131 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~ 131 (449)
+|.-++.+|.|+- .|-.+-+. .+++||+|++... .....++..+|...+..++|+||++++.++.-.. ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 3555667788887 55555532 4899999998543 2334677889999999999999999999987543 47
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
|+|||++. .+|...+. -.++-.+...++.|++.|++|||+.+ |+||||||+||++..++.+||.|||+++....
T Consensus 97 y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~-IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG-IIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc-eeecccCcccceecchhheeeccchhhcccCc
Confidence 99999997 79988885 34667788999999999999999999 99999999999999999999999999987654
Q ss_pred C---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-HH------------------------
Q 013126 212 G---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LI------------------------ 263 (449)
Q Consensus 212 ~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~------------------------ 263 (449)
. +.+..|..|.|||++.+..+.+.+||||+||++.||++|+..|++...- .+
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 4 4567889999999999988999999999999999999999777543100 00
Q ss_pred --hh-------cccccccccccCC--CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 264 --RD-------RNLQMLTDSCLEG--QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 264 --~~-------~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.. .....+++..... +.+...+..+++++.+||..||++|.|+++++.
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 0000111111111 111123467899999999999999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=237.72 Aligned_cols=206 Identities=27% Similarity=0.413 Sum_probs=183.6
Q ss_pred cCCccceEEEEEEEcC-CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHH
Q 013126 68 HGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAK 145 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ 145 (449)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||++|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 5899999999999754 899999999865432 34689999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-CCCeEEeccCCcccCCCC----CccccCcc
Q 013126 146 HLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRDG----KSYSTNLA 220 (449)
Q Consensus 146 ~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~----~~~~gt~~ 220 (449)
++... ...+++..+..++.++++++++||+++ ++|+||+|.||+++. ++.++|+|||.+...... ....+...
T Consensus 81 ~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~-~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKEN-EGKLSEDEILRILLQILEGLEYLHSNG-IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 98632 147899999999999999999999998 999999999999999 899999999998866543 33456788
Q ss_pred ccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccC
Q 013126 221 FTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299 (449)
Q Consensus 221 y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (449)
|++||..... .++.++|+|++|++++++ ..+.+++.+|++.|
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence 9999999877 788999999999999999 46899999999999
Q ss_pred CCCCCCHHHHHHH
Q 013126 300 PRERPNPKSLVTA 312 (449)
Q Consensus 300 P~~Rps~~eil~~ 312 (449)
|++||++.++++.
T Consensus 202 p~~R~~~~~l~~~ 214 (215)
T cd00180 202 PEKRPSAKEILEH 214 (215)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=260.05 Aligned_cols=249 Identities=17% Similarity=0.186 Sum_probs=198.3
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccC------CCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLR------NNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~~~~~~~~~ 132 (449)
..|++.+..|+|-|++|.+|.+.. |..||||++..+. .-.+.=++|+++|++|+ --|+++++..|...+++|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 357888899999999999999655 8899999997643 22455678999999995 358999999999999999
Q ss_pred EEEeeCCCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-CCeEEeccCCcccCC
Q 013126 133 LVAEYMPNETLAKHLFHW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSR 210 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~ 210 (449)
||+|-+. .+|.+.|... .+-.|....++.++.|+.-||..|-..| |+|.||||+|||+++. ..+||||||.|....
T Consensus 511 lVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~-vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 511 LVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG-VLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred EEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC-eeecccCccceEeccCcceeeeccCccccccc
Confidence 9999985 8999999753 3456888999999999999999999999 9999999999999954 568999999988766
Q ss_pred CC--CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh-----------------------
Q 013126 211 DG--KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD----------------------- 265 (449)
Q Consensus 211 ~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~----------------------- 265 (449)
.+ ..+..+..|.|||++.|.+|+...|+||+||+||||.||+..|++...+.+..
T Consensus 589 eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqH 668 (752)
T KOG0670|consen 589 ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQH 668 (752)
T ss_pred cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhh
Confidence 55 34556788999999999999999999999999999999998887653322111
Q ss_pred -----------------cccccc---ccc-------cc-CCCCCc---hhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 266 -----------------RNLQML---TDS-------CL-EGQFTD---DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 266 -----------------~~~~~~---~~~-------~~-~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.....+ ..+ .. ...++. ..-..+.+|+.+||..||++|.|..++|+
T Consensus 669 FD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 669 FDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred cccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 000000 000 00 001111 13357889999999999999999999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=234.25 Aligned_cols=193 Identities=25% Similarity=0.304 Sum_probs=171.1
Q ss_pred cccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
|++.+.+|.|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.++.++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 3456778999999999999765 899999999876544 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----C
Q 013126 140 NETLAKHLFHWETHP-MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (449)
Q Consensus 140 ggsL~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-----~ 213 (449)
+++|.+++.. ... +++.....++.+++.++.+||+++ ++|+|++|+||+++.++.++|+|||.+...... .
T Consensus 81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRK--KGGKLSEEEARFYLRQILEALEYLHSLG-IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999973 233 889999999999999999999998 999999999999999999999999998876554 3
Q ss_pred ccccCccccccccc-cCCCCCCCCceeeHhHHHHHHhcCCCCCCc
Q 013126 214 SYSTNLAFTPPEYL-RTGRVTPESVIYSFGTLLLDLLSGKHIPPS 257 (449)
Q Consensus 214 ~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltg~~p~~~ 257 (449)
...++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 45677889999998 556688899999999999999999999866
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=232.71 Aligned_cols=238 Identities=21% Similarity=0.241 Sum_probs=187.5
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceee-EeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGC-CCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~-~~~~~~~~lV~Ey 137 (449)
.|.+.+.+|+|.||.+-+++++ +++.+++|-++... ....+|.+|..---.| .|.||+.-|++ |+..+.+++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 5788899999999999999965 48899999997654 4467899999876667 58999998876 6777888999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC--CCCCeEEeccCCcccCCCCCc-
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDGNPRLSTFGLMKNSRDGKS- 214 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~~- 214 (449)
++.|+|.+-+ ....+-+....+++.|+++|+.|+|+++ ++|||||.+||||- +..++||+|||+.+..+..-.
T Consensus 104 aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHskn-lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 104 APRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSKN-LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred Cccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhccc-hhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 9999999988 5567888899999999999999999999 99999999999995 456899999999877654432
Q ss_pred cccCccccccccccCC---C--CCCCCceeeHhHHHHHHhcCCCCCCch--------hhHHHhhcccccccccccCCCCC
Q 013126 215 YSTNLAFTPPEYLRTG---R--VTPESVIYSFGTLLLDLLSGKHIPPSH--------ALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~---~--~~~~sDvwSlGvil~elltg~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
..-+..|.+||..... . ..+.+|+|.||+++|.++||+.|+... .+..+..+... ..+ ..-
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-----~~P-~~F 253 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-----ALP-KKF 253 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-----cCc-hhh
Confidence 2345779999987532 2 678899999999999999999998633 12222222222 111 112
Q ss_pred chhHHHHHHHHHHhcccCCCCCCCHHHH
Q 013126 282 DDDGTELVRLASRCLQYEPRERPNPKSL 309 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~ei 309 (449)
...++.+.++.++-|..+|++|-...++
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHH
Confidence 3456788999999999999999433333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=247.63 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=192.0
Q ss_pred cccccccccCCccceEEEEEEEc----CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 134 (449)
..|.++.++|+|.|++||++.+. .++.||+|.+.... ...+..+|++.|..+ .+.||+++.+.+..+++..+|
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 45788899999999999999943 47899999997644 456899999999999 589999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-CCCCeEEeccCCcccC----
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLMKNS---- 209 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~---- 209 (449)
+||+++.+..++.. .++..+++.+++.++.||+++|.+| ||||||||+|+|.+ ..+.-.|.|||+|...
T Consensus 114 lp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G-IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG-IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC-ccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999988884 4668899999999999999999999 99999999999998 5678899999998610
Q ss_pred -------------CC--C-----------------------------CccccCccccccccccCCC-CCCCCceeeHhHH
Q 013126 210 -------------RD--G-----------------------------KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTL 244 (449)
Q Consensus 210 -------------~~--~-----------------------------~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvi 244 (449)
.. + ....||++|.|||++...+ .++++||||.|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00 0 0124789999999997655 7889999999999
Q ss_pred HHHHhcCCCCCCchhhH--------------HH------hhc-------c----------cccc-ccccc--------CC
Q 013126 245 LLDLLSGKHIPPSHALD--------------LI------RDR-------N----------LQML-TDSCL--------EG 278 (449)
Q Consensus 245 l~elltg~~p~~~~~~~--------------~~------~~~-------~----------~~~~-~~~~~--------~~ 278 (449)
+..+++++.||.....+ .+ ... + ...+ ..... ..
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999997432000 00 000 0 0000 00000 01
Q ss_pred CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...+..+..+.+++.+||+.||.+|.|++++|+
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 111223458999999999999999999999998
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=245.75 Aligned_cols=135 Identities=17% Similarity=0.191 Sum_probs=115.7
Q ss_pred hCCCc--ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-----C---CCcccceee
Q 013126 56 TSGFA--VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-----N---NRLTNLLGC 124 (449)
Q Consensus 56 ~~~f~--~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv~l~~~ 124 (449)
.+-|. +|-++++||-|-|++||++.+ .+.+.||+|+.+... .-.+..+.||++|++++ | .+||++++.
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 34454 799999999999999999995 458899999987432 33567889999999993 3 359999999
Q ss_pred Eee----CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee
Q 013126 125 CCE----GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (449)
Q Consensus 125 ~~~----~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl 192 (449)
|.. +.++|+|+|++ |.+|..+|....-+.++...++.|++||+.||.|||.+..|||-||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 875 45799999999 78999999887788999999999999999999999997559999999999997
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=238.82 Aligned_cols=251 Identities=19% Similarity=0.206 Sum_probs=198.0
Q ss_pred ccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeC-CeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG-DERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~ 132 (449)
+.++...+-+|.||.||.|.+. +.+.|-+|.++....+ ....++.|.-.+..+.|||+.++.+++.++ ..++
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 3556667789999999999653 2455778887654422 256789999999999999999999998664 5688
Q ss_pred EEEeeCCCCCHHHHHh-----cc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 133 LVAEYMPNETLAKHLF-----HW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~-----~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
.++.+..-|+|..++. +. ..+.++-.+...++.|++.|++|||+++ +||.||...|.+||+.-.+||+|=.++
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-VIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-cccchhhhhcceehhheeEEeccchhc
Confidence 9999999999999997 21 2345667778889999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCC
Q 013126 207 KNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 207 ~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (449)
+...+.. .......||+||.+.+..|+.++|||||||++|||+| |+.|+..-....+..- .....+-.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-----lkdGyRla 518 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-----LKDGYRLA 518 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH-----Hhccceec
Confidence 8755442 2223568999999999999999999999999999998 5556543222222111 11111123
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
-|-++|.++..++.-||+.+|++||+++++..-|.+..
T Consensus 519 QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 519 QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 35688999999999999999999999999998876653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=269.86 Aligned_cols=190 Identities=16% Similarity=0.171 Sum_probs=140.5
Q ss_pred ccCC-CCcccceeeE-------eeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q 013126 112 QLRN-NRLTNLLGCC-------CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183 (449)
Q Consensus 112 ~l~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHr 183 (449)
.++| +||+++++++ .+.+.++.++||+. ++|.+++.. ....+++.+++.+++||+.||+|||+++ |+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g-IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQG-IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCC-eeec
Confidence 4556 6888888877 23346788899885 799999964 3466999999999999999999999999 9999
Q ss_pred ccccCceeeCC-------------------CCCeEEeccCCcccCCCC--------------------CccccCcccccc
Q 013126 184 DLNAYRILFDE-------------------DGNPRLSTFGLMKNSRDG--------------------KSYSTNLAFTPP 224 (449)
Q Consensus 184 Dlkp~NILl~~-------------------~~~~kL~DFGla~~~~~~--------------------~~~~gt~~y~aP 224 (449)
||||+|||++. ++.+|++|||+++..... ....||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 455677777776532110 012468889999
Q ss_pred ccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCC
Q 013126 225 EYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304 (449)
Q Consensus 225 E~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (449)
|++.+..++.++|||||||+||||++|.+|+..... .... .......+ ... ...+...+++.+||++||.+||
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~~-~~~~~~~~----~~~-~~~~~~~~~~~~~L~~~P~~Rp 257 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-TMSS-LRHRVLPP----QIL-LNWPKEASFCLWLLHPEPSCRP 257 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-HHHH-HHHhhcCh----hhh-hcCHHHHHHHHHhCCCChhhCc
Confidence 999999999999999999999999999876543211 1110 00111111 111 1123467889999999999999
Q ss_pred CHHHHHH
Q 013126 305 NPKSLVT 311 (449)
Q Consensus 305 s~~eil~ 311 (449)
++.++++
T Consensus 258 s~~eil~ 264 (793)
T PLN00181 258 SMSELLQ 264 (793)
T ss_pred ChHHHhh
Confidence 9999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=214.48 Aligned_cols=166 Identities=18% Similarity=0.149 Sum_probs=127.7
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCccccCcc
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~gt~~ 220 (449)
|||.+++.. .+.++++.+++.++.|++.||+|||+++ ||+|||++.++.+|+ ||+++...... ..||+.
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~-------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~g~~~ 69 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA-------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SRVDPY 69 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CcccEeEcCccceee--ccceEeecccc-CCCccc
Confidence 689999974 3567999999999999999999999986 999999999999999 99988755433 368899
Q ss_pred ccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-HHhhcccccccccccC-CCCCchhHH--HHHHHHHHhc
Q 013126 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLE-GQFTDDDGT--ELVRLASRCL 296 (449)
Q Consensus 221 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~--~l~~li~~cl 296 (449)
|+|||++.+..++.++|||||||++|||+||+.|+...... ................ .......+. ++.+++.+||
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 149 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCA 149 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHH
Confidence 99999999999999999999999999999999988543211 1111111111111000 011222333 6999999999
Q ss_pred ccCCCCCCCHHHHHHHhcccc
Q 013126 297 QYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 297 ~~dP~~Rps~~eil~~L~~~~ 317 (449)
+.||++||++.++++++....
T Consensus 150 ~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 150 SRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred hcccccccCHHHHHHHHHHHH
Confidence 999999999999999876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=214.81 Aligned_cols=254 Identities=19% Similarity=0.269 Sum_probs=205.2
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+++..+++.+|.+.-.|..|+|+++. ..+++|+++...... ..+|..|.-.|+.+.||||+.++|.|..+.++.++.
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 46667788899999999999999964 467778886544333 467999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc-ccccCceeeCCCCCeEEeccCCcccCCCCCc
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKS 214 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHr-Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 214 (449)
.|++.|+|+..+++..+-..+..++.+++.++++|++|||+..+++-| -|....+++|++-+++|+ .+-.+.......
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfqe~g 345 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVG 345 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeeeccc
Confidence 999999999999865555677889999999999999999998777777 899999999999888875 233333333333
Q ss_pred cccCccccccccccCCCCC---CCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVT---PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
..-.|.||+||.+...+.+ .++|+|||++++||+.|...||.....-....+. .-..++..+++..+..+.+|
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----aleglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----ALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----hhccccccCCCCccHHHHHH
Confidence 4456899999999876633 4799999999999999999998765433322221 11223446678889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
+.-|+..||.+||.++.++-.|++++
T Consensus 422 m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999888764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=215.58 Aligned_cols=257 Identities=16% Similarity=0.164 Sum_probs=198.9
Q ss_pred ccccccccCCccceEEEEEEEcC--CCEEEEEEecCCCCCCHHHHHHHHHHHhccCC----CCcccceeeE-eeCCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN--QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN----NRLTNLLGCC-CEGDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~--~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~~~~~~~l 133 (449)
.|.+.++||+|+||.||++.... ...+|+|.-..........+..|..++..+.+ +++..+++.+ ..++..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 78999999999999999999655 35889998876543333378889999999973 6899999999 47788999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-----CCeEEeccCCcc-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-----GNPRLSTFGLMK- 207 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-----~~~kL~DFGla~- 207 (449)
||+.+ |.+|.++......+.++..++..++.|++.+|.++|+.| ++||||||+|+++... ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G-~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG-FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC-cccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 99998 799999886545578999999999999999999999999 9999999999999854 359999999998
Q ss_pred -cCC-C-----------CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc
Q 013126 208 -NSR-D-----------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS 274 (449)
Q Consensus 208 -~~~-~-----------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 274 (449)
... . .....||..|+++.+..+...+.+.|+||++.++.++..|..|+............ ......
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~-~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF-EKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH-HHHhhh
Confidence 311 1 11245899999999999999999999999999999999999887443211111110 010110
Q ss_pred ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
..........+.++.++...+-..+..++|....+...+.......
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 0000022334567788888887899999999999999887765543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=218.26 Aligned_cols=166 Identities=17% Similarity=0.081 Sum_probs=128.0
Q ss_pred cccccccccCCccceEEEEEEEc--CCCEEEEEEecCCCC-----CCHHHHHHHHHHHhccCCCCccc-ceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE--NQRRIAVKRFNRMAW-----PDPRQFLEEARSVGQLRNNRLTN-LLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~--~~~~vAiK~l~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~ 131 (449)
..|.+.+.||+|+||+||+|.++ +++.||||++..... ...+.+.+|++++++++|+|++. +++ .+..
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~ 93 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKD 93 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCc
Confidence 34778888899999999999854 477789998753311 12456899999999999999985 443 2457
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccc-ccCceeeCCCCCeEEeccCCcccCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL-NAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDl-kp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
++||||++|++|.. +. ... ...++.|++.||.|||++| |+|||| ||+|||++.++.+||+|||+++...
T Consensus 94 ~LVmE~~~G~~L~~-~~--~~~------~~~~~~~i~~aL~~lH~~g-IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHL-AR--PHG------DPAWFRSAHRALRDLHRAG-ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHH-hC--ccc------hHHHHHHHHHHHHHHHHCC-CeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 99999999999963 21 111 1467899999999999999 999999 9999999999999999999998654
Q ss_pred CCC------------ccccCccccccccccCCC------CCCCCcee
Q 013126 211 DGK------------SYSTNLAFTPPEYLRTGR------VTPESVIY 239 (449)
Q Consensus 211 ~~~------------~~~gt~~y~aPE~~~~~~------~~~~sDvw 239 (449)
... ...+++.|+|||.+.-.. .+..+|-|
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 332 234577899999985432 33446766
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=198.89 Aligned_cols=262 Identities=16% Similarity=0.153 Sum_probs=205.4
Q ss_pred CHHHHHHhhCCCcccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC-CCcccceeeE
Q 013126 48 TLEQLKNATSGFAVENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN-NRLTNLLGCC 125 (449)
Q Consensus 48 ~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~ 125 (449)
+.+++..++ .|+++++||+|+||.+|.|. ..+|+.||||+=.... ...++..|.++.+.|++ ..|..+..+.
T Consensus 7 s~~~~iv~g----ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 7 SLEELIVGG----KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred chhhheecc----ceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhc
Confidence 444544443 58999999999999999999 6679999999965433 23578899999999987 7899999999
Q ss_pred eeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC---CCCCeEEec
Q 013126 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLST 202 (449)
Q Consensus 126 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~---~~~~~kL~D 202 (449)
.+..+-.+||+.. |.||.++..- -.+.++..+++-++-|++.-++|+|.++ .+||||||+|+|+. ....+.++|
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~-fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRN-FIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred cccccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhc-cccccCCccceeeccccccceEEEEe
Confidence 9999999999999 7999998754 4567999999999999999999999999 99999999999997 345699999
Q ss_pred cCCcccCCCC-----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh--cccc
Q 013126 203 FGLMKNSRDG-----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD--RNLQ 269 (449)
Q Consensus 203 FGla~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--~~~~ 269 (449)
||+++...+. ....||..|.+--...+...+.+.|+=|+|.+|..+--|..||.+-....-.+ +.+.
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 9999865432 45578999998877777778889999999999999999999987642221111 1111
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+..-..+........|.++.-.+.-|-..--++-|...-+.+.+.-+..
T Consensus 238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 1111112223345677889999999999988999998877776654443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=206.48 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=194.9
Q ss_pred cccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCC-CcccceeeEeeCCeeEEEEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNN-RLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~Ey 137 (449)
|++.+.+|.|+||.||++... ..+++|.+....... ...+.+|+.+++.+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788899999999999975 789999997755433 67799999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-CeEEeccCCcccCCCC---
Q 013126 138 MPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~--- 212 (449)
+.++++.+.+..... ..++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~-~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG-IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999977753111 27899999999999999999999999 99999999999999888 7999999998754332
Q ss_pred -------CccccCccccccccccC---CCCCCCCceeeHhHHHHHHhcCCCCCCchhh----HHHhhcccccccccccCC
Q 013126 213 -------KSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 213 -------~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 278 (449)
....+|..|+|||.+.+ ..++...|+||+|++++++++|..|+..... ............. ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 237 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLAS 237 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cccc
Confidence 34568999999999987 5788899999999999999999988655432 1111111111110 0000
Q ss_pred CCC----chhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 279 QFT----DDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 279 ~~~----~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
... ......+.+++.+++..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111 1123578899999999999999988877653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=200.93 Aligned_cols=254 Identities=17% Similarity=0.190 Sum_probs=204.3
Q ss_pred ccccccccCCccceEEEEEE-EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.|++.++||+|+||+.+.|+ +-+|+.||||.=...+ +..++..|.+..+.|. .++|..+|-+..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 37788999999999999999 6689999999865433 3567888999999885 599999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-----CCeEEeccCCcccCCCC-
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-----GNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-----~~~kL~DFGla~~~~~~- 212 (449)
|.||.|+.. +-++.++.+++..++.|++.-++|+|++. +|+|||||+|+||... ..+.++|||+|+...+.
T Consensus 107 -GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~-LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 -GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD-LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred -CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc-eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 799998763 46788999999999999999999999998 9999999999999743 34899999999876543
Q ss_pred ----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhc--ccccccccccCCCC
Q 013126 213 ----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR--NLQMLTDSCLEGQF 280 (449)
Q Consensus 213 ----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~ 280 (449)
++..||..||+--...|...+.+.|+=|||-++++.+-|..||.+-..+..+.+ .+.+.....+...+
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L 263 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL 263 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence 456799999999988888899999999999999999999999876433222221 11111222222233
Q ss_pred CchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
..+.|.++..-+.-.-..+-++-|..+-+...+..+...
T Consensus 264 c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 264 CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 456788888888888888899999988877766655443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=191.04 Aligned_cols=140 Identities=15% Similarity=0.162 Sum_probs=111.5
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC---------HHH-----------------HHHHHHHHhccCCCCc
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD---------PRQ-----------------FLEEARSVGQLRNNRL 118 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~---------~~~-----------------~~~E~~~l~~l~HpnI 118 (449)
.+.||+|++|.||+|...+|+.||||+++...... ..+ ..+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46789999999999997789999999997643211 112 2349999999998887
Q ss_pred ccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccccccccCceeeCCCCC
Q 013126 119 TNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 119 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~iiHrDlkp~NILl~~~~~ 197 (449)
.....+... ..++||||++|+++..... ...++++..+..++.|++.+|.++ |+.| |+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g-iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR-LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEE-CCc
Confidence 554433222 2389999999887765533 346789999999999999999999 6888 99999999999998 578
Q ss_pred eEEeccCCcccCC
Q 013126 198 PRLSTFGLMKNSR 210 (449)
Q Consensus 198 ~kL~DFGla~~~~ 210 (449)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-25 Score=229.52 Aligned_cols=244 Identities=17% Similarity=0.117 Sum_probs=184.4
Q ss_pred cccccCCccceEEEEEEEc-CCCEEEEEEecCC--CCCCH----HHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 64 IVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM--AWPDP----RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~--~~~~~----~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
....+|.|++|.|+..... ..+..+.|..... ..... ..+..|..+-..++|||++.......+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3456699999988877743 3455555544311 11111 225668888888999999988888777766666699
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
||++ +|...+. ....++..++..++.|++.|++|+|+.| +.|||+||+|++++.+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~--~~~~~~~~e~~c~fKqL~~Gv~y~h~~G-iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVM--SNGKLTPLEADCFFKQLLRGVKYLHSMG-LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHh--cccccchhhhhHHHHHHHHHHHHHHhcC-ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9998 9999996 4457888999999999999999999999 999999999999999999999999988754322
Q ss_pred ----CccccCccccccccccCCCCCC-CCceeeHhHHHHHHhcCCCCCCchhhHHH---hhcccccccccccCCCCCchh
Q 013126 213 ----KSYSTNLAFTPPEYLRTGRVTP-ESVIYSFGTLLLDLLSGKHIPPSHALDLI---RDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvil~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 284 (449)
....|+..|+|||++.+..|++ ..||||.|+++..|++|+.||........ ....................+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 2356889999999999999877 69999999999999999988754322111 011111111111112233456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.+.+.+|.++|+.||.+|.|+++|++
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhh
Confidence 788999999999999999999999998
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=194.20 Aligned_cols=169 Identities=12% Similarity=0.078 Sum_probs=133.2
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHH---------HHHHHHHHhccCCCCcccceeeEeeC--
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQ---------FLEEARSVGQLRNNRLTNLLGCCCEG-- 128 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~---------~~~E~~~l~~l~HpnIv~l~~~~~~~-- 128 (449)
..|++++.+|.|+||.||+... ++..+|+|.+.......... +.+|++.+.+++||+|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred CceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 3588889999999999999766 57789999997654333322 68999999999999999999886643
Q ss_pred ------CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEec
Q 013126 129 ------DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLST 202 (449)
Q Consensus 129 ------~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~D 202 (449)
+..+++|||++|.+|.+... +++ ....+++.++..+|+.| ++|||+||+||+++++| ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g-i~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG-MVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC-CccCCCChHHEEEeCCC-EEEEE
Confidence 35799999999999988642 232 24569999999999999 99999999999999988 99999
Q ss_pred cCCcccCCCCCccccCccccccccccCCCCCCCCceeeHhHHHHHHh
Q 013126 203 FGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249 (449)
Q Consensus 203 FGla~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell 249 (449)
||........... ..++....++.++|+||||+++....
T Consensus 178 fg~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 9987655332211 11334455778999999999887653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=184.02 Aligned_cols=141 Identities=15% Similarity=0.193 Sum_probs=113.8
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCC---------------------C-----HHHHHHHHHHHhccCCCCc
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP---------------------D-----PRQFLEEARSVGQLRNNRL 118 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~HpnI 118 (449)
.+.||+|++|.||+|...+|+.||||+++..... . ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4678999999999999778999999999765311 0 1124578999999999998
Q ss_pred ccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCC
Q 013126 119 TNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 119 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~ 197 (449)
.....+... ..++||||++|+++..... ....++......++.|++.++.++|+ +| ++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g-ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG-LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC-EecCCCChhhEEEE-CCC
Confidence 665554433 2489999999886544322 34567888999999999999999999 88 99999999999999 889
Q ss_pred eEEeccCCcccCCC
Q 013126 198 PRLSTFGLMKNSRD 211 (449)
Q Consensus 198 ~kL~DFGla~~~~~ 211 (449)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-24 Score=211.30 Aligned_cols=224 Identities=18% Similarity=0.213 Sum_probs=189.0
Q ss_pred cCCccceEEEEEEE----cCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 68 HGEKAPNVVYKGKL----ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 68 lG~G~~g~Vy~~~~----~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
+|+|+||.|++++. +.|.-+|+|++++.... .......|..++...+ ||.+|++.-.+..+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 59999999998762 34788999999764322 2235667888999996 99999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCccccCcc
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA 220 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~gt~~ 220 (449)
|.|...+. +...+++.....+...++-+++++|+.+ ++|||+|++||+++.+|++++.|||+++..-..+..+||..
T Consensus 82 g~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~-iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~e 158 (612)
T KOG0603|consen 82 GDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLG-IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYE 158 (612)
T ss_pred chhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhH-HHHhcccccceeecccCccccCCchhhhHhHhhhhcccchh
Confidence 99988886 5667788888889999999999999999 99999999999999999999999999998777766699999
Q ss_pred ccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCC
Q 013126 221 FTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300 (449)
Q Consensus 221 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (449)
|||||++. ....++|.||||++.+||+||..||..+....+... ....+...+..+.+++..++..+|
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~----------~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKA----------ELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhh----------ccCCchhhhHHHHHHHHHHHhhCH
Confidence 99999997 677899999999999999999999987322222211 123456778899999999999999
Q ss_pred CCCCCH
Q 013126 301 RERPNP 306 (449)
Q Consensus 301 ~~Rps~ 306 (449)
..|.-.
T Consensus 227 ~nrLg~ 232 (612)
T KOG0603|consen 227 ENRLGA 232 (612)
T ss_pred HHHhcc
Confidence 999644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-22 Score=188.68 Aligned_cols=230 Identities=20% Similarity=0.181 Sum_probs=149.8
Q ss_pred cccccccCCccceEEEEEEEcC-CCEEEEEEecCCCC---CCHHHHHHHHHHHhccCC----------CCcccceeeEee
Q 013126 62 ENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRN----------NRLTNLLGCCCE 127 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~H----------pnIv~l~~~~~~ 127 (449)
....+.||.|+++.||.+++.. |+.+|+|++..... ...+++.+|.-....+.+ -.++-.++...-
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3445677999999999999764 99999999854332 224667777766655432 123332332221
Q ss_pred ---------CC--------eeEEEEeeCCCCCHHHHHhc---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccc
Q 013126 128 ---------GD--------ERLLVAEYMPNETLAKHLFH---WETH--PMKWAMRLRVVLHLAQALEYCTSKGRALYHDL 185 (449)
Q Consensus 128 ---------~~--------~~~lV~Ey~~ggsL~~~l~~---~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDl 185 (449)
.. +.+++|+-+. ++|.+.+.. .... .+....++.+..|+++.+++||+.| ++|+||
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-lVHgdi 171 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG-LVHGDI 171 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-EEEST-
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-eEeccc
Confidence 11 2367888886 788887642 1121 2334455677799999999999999 999999
Q ss_pred ccCceeeCCCCCeEEeccCCcccCCCCCc-cccCccccccccccCC--------CCCCCCceeeHhHHHHHHhcCCCCCC
Q 013126 186 NAYRILFDEDGNPRLSTFGLMKNSRDGKS-YSTNLAFTPPEYLRTG--------RVTPESVIYSFGTLLLDLLSGKHIPP 256 (449)
Q Consensus 186 kp~NILl~~~~~~kL~DFGla~~~~~~~~-~~gt~~y~aPE~~~~~--------~~~~~sDvwSlGvil~elltg~~p~~ 256 (449)
||+|++++.+|.++|+||+.....+.... ...+..|.|||..... .++.+.|.|+||+++|.|++|..|+.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 99999999999999999998766554433 3455789999977432 47889999999999999999999987
Q ss_pred chhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCC
Q 013126 257 SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303 (449)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 303 (449)
.......... .-.... +.|+.++.||..+|++||++|
T Consensus 252 ~~~~~~~~~~---------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEADPEW---------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGSTSGG---------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCccccccc---------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 5432211111 112233 788899999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=209.61 Aligned_cols=242 Identities=18% Similarity=0.213 Sum_probs=178.8
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCC-CCCHHHHHHHHHH--HhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA-WPDPRQFLEEARS--VGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++...+.||++.|=.|.+|+++.|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-+...+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788899999999999987775 9999986544 3344555544433 4445899999998888888888999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC---CCCc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR---DGKS 214 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~---~~~~ 214 (449)
.. -+|+|.+. .+.-+...+.+-|+.|++.||.-+|..| |+|||||.+|||++.-+.+.|+||...+..- ++..
T Consensus 103 vk-hnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~g-VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VK-HNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLG-VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hh-hhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcC-ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 97 69999995 3444667788889999999999999999 9999999999999999999999998765421 1111
Q ss_pred --------cccCccccccccccCC----------C-CCCCCceeeHhHHHHHHhcC-CCCCCchhhHHHhhccccccccc
Q 013126 215 --------YSTNLAFTPPEYLRTG----------R-VTPESVIYSFGTLLLDLLSG-KHIPPSHALDLIRDRNLQMLTDS 274 (449)
Q Consensus 215 --------~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~ 274 (449)
...-..|.|||.+-.. . .+++.||||+||++.|+++- ++||.-...-..+.+. ......
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~-~~~~e~ 257 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN-ADDPEQ 257 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC-ccCHHH
Confidence 1122469999987431 2 67899999999999999885 5555433222222221 111111
Q ss_pred ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.+. .+. ...+++++..|++.||++|.++++.++.
T Consensus 258 ~Le-~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLE-KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHH-hCc---CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111 111 1368999999999999999999999975
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-21 Score=172.41 Aligned_cols=180 Identities=17% Similarity=0.142 Sum_probs=138.6
Q ss_pred cccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC----HHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEeeC
Q 013126 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD----PRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~----~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+...|++|+||+||.+.. .+.+++.+.+....+-. ...+.+|+++|++++ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 345679999999998776 67889988887654321 125889999999995 5889999886 3469999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccc-ccCceeeCCCCCeEEeccCCcccCCCCCc---
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL-NAYRILFDEDGNPRLSTFGLMKNSRDGKS--- 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDl-kp~NILl~~~~~~kL~DFGla~~~~~~~~--- 214 (449)
+|.+|.+.+. .. ...++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~---~~------~~~~~~qi~~~L~~lH~~G-IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPP---RG------DLAYFRAARRLLQQLHRCG-VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhh---hh------hHHHHHHHHHHHHHHHHCc-CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9999976442 11 1357889999999999999 999999 79999999999999999999986554321
Q ss_pred --------------cccCccccccccccCC-CCC-CCCceeeHhHHHHHHhcCCCCCCch
Q 013126 215 --------------YSTNLAFTPPEYLRTG-RVT-PESVIYSFGTLLLDLLSGKHIPPSH 258 (449)
Q Consensus 215 --------------~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvil~elltg~~p~~~~ 258 (449)
...++.|++|+..... ..+ .+.+.++.|.-+|.++|++.+..++
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0135677777655332 233 4678889999999999999876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=173.93 Aligned_cols=133 Identities=14% Similarity=0.110 Sum_probs=105.3
Q ss_pred cccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-----CCCCcccceeeEeeCC---eeE-EEEe
Q 013126 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-----RNNRLTNLLGCCCEGD---ERL-LVAE 136 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~~~-lV~E 136 (449)
..||+|++|.||. +......+||++........+.+.+|+++++.+ +||||++++|++.++. .++ +|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4569999999996 333233479998765545567899999999999 5799999999998874 434 7899
Q ss_pred e--CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCccccccccCceeeCC----CCCeEEeccCCc
Q 013126 137 Y--MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQAL-EYCTSKGRALYHDLNAYRILFDE----DGNPRLSTFGLM 206 (449)
Q Consensus 137 y--~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~~iiHrDlkp~NILl~~----~~~~kL~DFGla 206 (449)
| ++++||.+++.+ ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~-IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNR-IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 567999999953 346655 35678888888 9999999 999999999999974 347999995433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-21 Score=189.83 Aligned_cols=208 Identities=22% Similarity=0.340 Sum_probs=162.4
Q ss_pred HhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc-cccccccC
Q 013126 110 VGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA-LYHDLNAY 188 (449)
Q Consensus 110 l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~i-iHrDlkp~ 188 (449)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.-...++++++.||+|+|+.. | .|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccc
Confidence 4678999999999999999999999999999999999975 4677888888999999999999999986 5 99999999
Q ss_pred ceeeCCCCCeEEeccCCcccCCCC------CccccCccccccccccCCC-------CCCCCceeeHhHHHHHHhcCCCCC
Q 013126 189 RILFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGR-------VTPESVIYSFGTLLLDLLSGKHIP 255 (449)
Q Consensus 189 NILl~~~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlGvil~elltg~~p~ 255 (449)
|.++|....+||+|||+....... ........|.|||.+.+.. .+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998766421 1222346799999997641 466899999999999999999998
Q ss_pred CchhhHHHhhcccccccc---cccCCCC--CchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 256 PSHALDLIRDRNLQMLTD---SCLEGQF--TDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
..........+....+.+ ...++.. ....++++..++.+||..+|++||+++++...++.+.+.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 653221111111111111 1111111 114455799999999999999999999999988777654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=176.28 Aligned_cols=191 Identities=16% Similarity=0.204 Sum_probs=145.0
Q ss_pred CCCCcccceeeEee---------------------------CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHH
Q 013126 114 RNNRLTNLLGCCCE---------------------------GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLH 166 (449)
Q Consensus 114 ~HpnIv~l~~~~~~---------------------------~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~q 166 (449)
+|||||++.++|.+ +...|+||...+ .||..++- .+..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~---~~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW---TRHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh---cCCCchHHHHHHHHH
Confidence 59999999887764 234689999887 79999994 456677788889999
Q ss_pred HHHHHHHHHhCCCccccccccCceeeC--CCC--CeEEeccCCcccCCC----------CCccccCccccccccccCCC-
Q 013126 167 LAQALEYCTSKGRALYHDLNAYRILFD--EDG--NPRLSTFGLMKNSRD----------GKSYSTNLAFTPPEYLRTGR- 231 (449)
Q Consensus 167 i~~aL~yLH~~~~iiHrDlkp~NILl~--~~~--~~kL~DFGla~~~~~----------~~~~~gt~~y~aPE~~~~~~- 231 (449)
+++|+.|||.+| |.|||+|.+|||+. +|+ .+.|+|||.+---.. .-...|.-.-||||+....+
T Consensus 350 lLEav~hL~~hg-vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 350 LLEAVTHLHKHG-VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHcc-chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999 99999999999994 444 478999997532221 12334677789999986432
Q ss_pred ----C-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCH
Q 013126 232 ----V-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP 306 (449)
Q Consensus 232 ----~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (449)
. -.|+|.|+.|.+.||+++...||.......+.....++-. -+..++.+++.+++++...|+.||++|++.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q----LPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ----LPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh----CCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 2 2489999999999999999999987544333333332211 123466778899999999999999999987
Q ss_pred HHHHHHh
Q 013126 307 KSLVTAL 313 (449)
Q Consensus 307 ~eil~~L 313 (449)
.-....|
T Consensus 505 ~iAANvl 511 (598)
T KOG4158|consen 505 NIAANVL 511 (598)
T ss_pred cHHHhHH
Confidence 6555544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=170.55 Aligned_cols=158 Identities=15% Similarity=0.110 Sum_probs=120.2
Q ss_pred ccCHHHHHHhhCCCcccccccccCCccceEEEEEE--EcCCCEEEEEEecCCCCC-------------------C-----
Q 013126 46 EFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGK--LENQRRIAVKRFNRMAWP-------------------D----- 99 (449)
Q Consensus 46 ~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~--~~~~~~vAiK~l~~~~~~-------------------~----- 99 (449)
.++..++....+.=..|.+.+.||+|++|.||+|. ..+|+.||+|+++..... .
T Consensus 14 ~~~~~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (237)
T smart00090 14 GRTRLALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLV 93 (237)
T ss_pred hHHHHHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHH
Confidence 34444555555554567888999999999999998 457999999999754211 0
Q ss_pred HHHHHHHHHHHhccCCCC--cccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 013126 100 PRQFLEEARSVGQLRNNR--LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK 177 (449)
Q Consensus 100 ~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 177 (449)
...+.+|+++++++.+.+ ++++++. ...++||||++|++|..... ....+.......++.|++.++++||++
T Consensus 94 ~~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~ 167 (237)
T smart00090 94 RLWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE 167 (237)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc
Confidence 123568999999997633 3344432 23589999999988876543 334566667789999999999999998
Q ss_pred CCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 178 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
++++||||||+||+++ ++.++|+|||.+....
T Consensus 168 g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 168 GELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 6699999999999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=163.96 Aligned_cols=134 Identities=17% Similarity=0.208 Sum_probs=114.3
Q ss_pred cccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--------HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+.||+|++|.||+|.+ +|..+++|......... ...+.+|++++..++|+|+.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5679999999999987 67789999876433221 23578899999999999998888888778889999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
++|++|.+.+.. .. . ....++.+++.+|.++|+.+ ++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~--~~---~-~~~~i~~~i~~~l~~lH~~~-i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS--NG---M-EELELSREIGRLVGKLHSAG-IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh--cc---H-HHHHHHHHHHHHHHHHHhCC-cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999852 11 2 78889999999999999999 99999999999999 78899999998765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=195.75 Aligned_cols=206 Identities=19% Similarity=0.197 Sum_probs=151.5
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
++++.|+.+..|+||-||..+++. .+++|+| +++.. .+.+. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-------------------
Confidence 455677777999999999999654 7889994 43322 11111 33333333333
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC--------
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR-------- 210 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~-------- 210 (449)
|+-...+. ..++++.+. +.+++|+|+.+ |+|||+||+|.+|+.-|++|++|||+++..-
T Consensus 136 --gDc~tllk--~~g~lPvdm--------vla~Eylh~yg-ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 --GDCATLLK--NIGPLPVDM--------VLAVEYLHSYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred --chhhhhcc--cCCCCcchh--------hHHhHhhccCC-eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 44444453 334454433 67899999999 9999999999999999999999999986321
Q ss_pred -----------CCCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCC
Q 013126 211 -----------DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 211 -----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (449)
..+..+||+.|.|||++..+.|+..+|.|++|+|+||.+-|..||.++..+.+....+...+.. .+
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w---pE 279 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW---PE 279 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc---cc
Confidence 1134578999999999999999999999999999999999999999987666655544433221 12
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCC-CHHH
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERP-NPKS 308 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rp-s~~e 308 (449)
-.+..++++++++.++|+.+|..|. |..+
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 2455678999999999999999994 4433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=192.11 Aligned_cols=241 Identities=18% Similarity=0.173 Sum_probs=177.0
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC---CCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E 136 (449)
..|.|-+.+|+|+||.||+|...+|+.||+|+=+... .-+|.--.+++.+|+ -+.|..+...+.-.+.-++|+|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 3467778899999999999998779999999976533 122333334445554 3456666666667777899999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-------CCCCeEEeccCCcccC
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-------EDGNPRLSTFGLMKNS 209 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-------~~~~~kL~DFGla~~~ 209 (449)
|.+.|||.+++. ..+.+++..+..++.|+++-+..||..+ |||+||||+|.||. +...++|+|||-+..+
T Consensus 775 y~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~-IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 775 YSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG-IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred ccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc-eecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 999999999997 6788999999999999999999999999 99999999999995 2345999999987643
Q ss_pred ---CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCch
Q 013126 210 ---RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 210 ---~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (449)
.++ ....+|-.+-.+|+..|.+++..+|.|+++.+++.|+.|+..- ..++....+... ++.-
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------~~~g~~~~~~~~-----~~Ry 919 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------VKNGSSWMVKTN-----FPRY 919 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------hcCCcceecccc-----chhh
Confidence 333 2345688899999999999999999999999999999998421 111111111110 1111
Q ss_pred hH-HHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 284 DG-TELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 284 ~~-~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
.- .-..++...+|..|-..=|...++...++.+..
T Consensus 920 ~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 920 WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 11 223467777777444444788888877766543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=159.07 Aligned_cols=129 Identities=18% Similarity=0.258 Sum_probs=107.7
Q ss_pred cCCccceEEEEEEEcCCCEEEEEEecCCCCCC--------HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 68 HGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
||+|++|.||+|.+ ++..+++|......... .+++.+|+++++.++|+++.....++...+..++||||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 69999999999995 56889999965432111 2557789999999999887766666667777899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
|++|.+.+.. ... .++.+++.+|.++|+.+ ++|||++|.||+++ ++.++++|||+++.
T Consensus 81 g~~l~~~~~~--~~~-------~~~~~i~~~l~~lH~~g-i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEE--GND-------ELLREIGRLVGKLHKAG-IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhh--cHH-------HHHHHHHHHHHHHHHCC-eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998752 111 78999999999999999 99999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.5e-20 Score=180.58 Aligned_cols=166 Identities=25% Similarity=0.378 Sum_probs=126.2
Q ss_pred eeEEEEeeCCCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 130 ERLLVAEYMPNETLAKHLFHW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
++||.|++|+..+|.++|..+ .....++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~-~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG-LIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc-chhhhccccccccccchhhhhhhhhheee
Confidence 578999999999999999732 23456778889999999999999 77 99999999999999999999999999765
Q ss_pred CCCCC----------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcC-CCCCC-chhhHHHhhccccccccccc
Q 013126 209 SRDGK----------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSG-KHIPP-SHALDLIRDRNLQMLTDSCL 276 (449)
Q Consensus 209 ~~~~~----------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~p~~-~~~~~~~~~~~~~~~~~~~~ 276 (449)
..... ...||..||+||.+.+..|+.++||||||++|+|++.- ...+. ..+...++++.+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip------- 478 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIP------- 478 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCC-------
Confidence 44332 34689999999999999999999999999999999982 11111 1112222222211
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHH
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKS 308 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (449)
+.+..+. ++-..|+.+++...|.+||++.+
T Consensus 479 -~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 479 -PEFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -hHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 1111112 34568999999999999994443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=156.47 Aligned_cols=137 Identities=15% Similarity=0.153 Sum_probs=109.1
Q ss_pred cccccccCCccceEEEEEEEcCCCEEEEEEecCCCCC----------------------CHHHHHHHHHHHhccCCCC--
Q 013126 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP----------------------DPRQFLEEARSVGQLRNNR-- 117 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~----------------------~~~~~~~E~~~l~~l~Hpn-- 117 (449)
|.+.+.||+|+||.||++...+|+.||||+++..... ....+.+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 6667888999999999999878999999997643210 0123678899999998874
Q ss_pred cccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC
Q 013126 118 LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 118 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~ 197 (449)
++..++ ....++||||++|++|.+... . .....++.+++.++.++|+.+ ++||||||+||++++++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~---~-----~~~~~~~~~i~~~l~~lh~~g-i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV---L-----EDPEEVLDEILEEIVKAYKHG-IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc---c-----ccHHHHHHHHHHHHHHHHHCC-CCcCCCCcccEEEcCCCc
Confidence 444443 245689999999999876542 0 345678899999999999999 999999999999999999
Q ss_pred eEEeccCCcccCCC
Q 013126 198 PRLSTFGLMKNSRD 211 (449)
Q Consensus 198 ~kL~DFGla~~~~~ 211 (449)
++|+|||++.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-18 Score=179.74 Aligned_cols=134 Identities=19% Similarity=0.182 Sum_probs=109.6
Q ss_pred ccccccCCccceEEEEEEEcCCCEEEEEEe-cCCCCC-------CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRF-NRMAWP-------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l-~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
...+.||+|+||+||+|.+.++ .+++|+. .+.... ..+++.+|+++++.++|++++....+.......++|
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 3456789999999999987543 3444433 221111 124688999999999999999888888777788999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
|||++|++|.+++. ....++.|++.+|.+||+.+ ++||||||+||++ +++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g-iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG-IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC-CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999884 35678999999999999999 9999999999999 6789999999998763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-17 Score=144.43 Aligned_cols=135 Identities=15% Similarity=0.040 Sum_probs=114.3
Q ss_pred cccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC--CCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN--NRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
+++.+|+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++++++++...++..+++|||++|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35678999999999999754 7899999865443 5678999999999976 58999999888888899999999987
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK---GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++..+ +......++.+++.+++++|.. + ++|+|++|+||++++.+.++++|||.+.....
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~-i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~ 141 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLV-LCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceE-EEecCCCcceEEEECCcEEEEEecccccCCCh
Confidence 66543 5566778899999999999984 6 99999999999999989999999999875443
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=147.09 Aligned_cols=138 Identities=15% Similarity=0.162 Sum_probs=99.2
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHH----------------------HHHHHHHHhccCCCC--c
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQ----------------------FLEEARSVGQLRNNR--L 118 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~----------------------~~~E~~~l~~l~Hpn--I 118 (449)
.+.||+|+||+||+|.+.+++.||||+++...... ... ...|.+.+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46789999999999998789999999987543211 111 135666666664433 4
Q ss_pred ccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCC
Q 013126 119 TNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 119 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~ 197 (449)
.+.++. ...++||||++|+++..... ...... ..+..++.+++.++.++|. .+ ++||||||+||+++ ++.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l--~~~~~~-~~~~~~~~~~~~~l~~lh~~~~-ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRL--KDVRLL-EDPEELYDQILELMRKLYREAG-LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhh--hhhhhc-ccHHHHHHHHHHHHHHHhhccC-cCcCCCChhhEEEE-CCc
Confidence 444443 24589999999854322111 000111 5678899999999999999 88 99999999999999 899
Q ss_pred eEEeccCCcccCCC
Q 013126 198 PRLSTFGLMKNSRD 211 (449)
Q Consensus 198 ~kL~DFGla~~~~~ 211 (449)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-18 Score=182.83 Aligned_cols=251 Identities=16% Similarity=0.148 Sum_probs=193.3
Q ss_pred CcccccccccCCccceEEEEEEEc--CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE--NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~--~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 133 (449)
...|++++.+|+|+|+.|-..... ....+|.|.+.... ....++...|..+-+.+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345778888999999999888743 35567777775543 112344556888888886 9999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccccccccCceeeCCCC-CeEEeccCCcccCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT-SKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRD 211 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~ 211 (449)
+++|..|+++.+-+........+...+..++.|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~-~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG-VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc-cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999883222226677788889999999999999 888 99999999999999999 999999999987665
Q ss_pred -CC------cccc-CccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCc
Q 013126 212 -GK------SYST-NLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 212 -~~------~~~g-t~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
.+ ...| ++.|+|||...+.. ..+..|+||.|+++..+++|..|+............+.... .........
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 256 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPWN 256 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCccc
Confidence 22 3457 99999999998754 57789999999999999999988754432221111111111 011122345
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..+....+++.+++..+|+.|.+.+++..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccc
Confidence 56678899999999999999999988865
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.3e-17 Score=150.32 Aligned_cols=133 Identities=19% Similarity=0.179 Sum_probs=103.8
Q ss_pred cC-CccceEEEEEEEcCCCEEEEEEecCCC-------------CCCHHHHHHHHHHHhccCCCCc--ccceeeEeeCCe-
Q 013126 68 HG-EKAPNVVYKGKLENQRRIAVKRFNRMA-------------WPDPRQFLEEARSVGQLRNNRL--TNLLGCCCEGDE- 130 (449)
Q Consensus 68 lG-~G~~g~Vy~~~~~~~~~vAiK~l~~~~-------------~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~~~- 130 (449)
+| .|+.|+||.+... +..+++|.+.... ......+.+|++++..++|++| ++.+++......
T Consensus 39 lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~ 117 (239)
T PRK01723 39 VGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL 117 (239)
T ss_pred eecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence 46 7788889998874 6789999885321 0123568899999999998875 667766443322
Q ss_pred ---eEEEEeeCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 131 ---RLLVAEYMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 131 ---~~lV~Ey~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
.++|||+++| .+|.+++. ..+++... +.+++.+|.+||++| |+||||||.|||++.++.++|+|||.+
T Consensus 118 ~~~~~lV~e~l~G~~~L~~~l~---~~~l~~~~----~~~i~~~l~~lH~~G-I~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 118 FYRADILIERIEGARDLVALLQ---EAPLSEEQ----WQAIGQLIARFHDAG-VYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ceeeeEEEEecCCCCCHHHHHh---cCCCCHHH----HHHHHHHHHHHHHCC-CCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 3599999997 69998884 34555443 578999999999999 999999999999999899999999988
Q ss_pred ccC
Q 013126 207 KNS 209 (449)
Q Consensus 207 ~~~ 209 (449)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.1e-15 Score=149.78 Aligned_cols=140 Identities=19% Similarity=0.186 Sum_probs=100.2
Q ss_pred cccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--------------------------H--------------HHHHH
Q 013126 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--------------------------P--------------RQFLE 105 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--------------------------~--------------~~~~~ 105 (449)
+.+|.|++|.||+|++++|+.||||+.+.+.... . -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4689999999999999899999999987542110 0 02556
Q ss_pred HHHHHhccC----CCCcccceeeEe-eCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 013126 106 EARSVGQLR----NNRLTNLLGCCC-EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ-ALEYCTSKGR 179 (449)
Q Consensus 106 E~~~l~~l~----HpnIv~l~~~~~-~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~-aL~yLH~~~~ 179 (449)
|++.+.+++ |.+-+.+-.++. ..+..++||||++|++|.+..... .... ....++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~-~~~~---~~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD-EAGL---DRKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH-hcCC---CHHHHHHHHHHHHHHHHHhCC-
Confidence 777666663 222223222332 234579999999999998876421 1122 23456666665 468889999
Q ss_pred ccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 180 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
++|+|+||.||++++++.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999986643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.7e-14 Score=145.11 Aligned_cols=240 Identities=21% Similarity=0.258 Sum_probs=184.0
Q ss_pred ccccccCC--ccceEEEEEEE---cCCCEEEEEEecCCCC--CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEE
Q 013126 63 NIVSEHGE--KAPNVVYKGKL---ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 63 ~~l~~lG~--G~~g~Vy~~~~---~~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 134 (449)
.+.+.+|. |.+|.||.+.. .++..+|+|.-+.... .....=.+|+...+++ .|+|.++.+..+...+..++-
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence 45577899 99999999986 2478899998543222 2334456777777777 599999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCccccccccCceeeCCC-CCeEEeccCCcccC
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ----ALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNS 209 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~ 209 (449)
+|++. .+|.++... ....++....+..+.+... ||.++|+.+ ++|-|+||+||+..++ ...+++|||+....
T Consensus 197 tE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~-~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN-IVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred ecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCc-ccccccchhheecccccceeecCCcceeEEc
Confidence 99995 888888864 2334777888888888888 999999998 9999999999999998 88999999998876
Q ss_pred CCCC---------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCC
Q 013126 210 RDGK---------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (449)
Q Consensus 210 ~~~~---------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (449)
.+.. ...+...|++||... +.++.+.|+||+|.+..+..++..++...-...|.. +.......++
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-----~r~~~ip~e~ 347 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-----LRQGYIPLEF 347 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-----cccccCchhh
Confidence 6543 114567899999985 678899999999999999999887654331111111 1111122233
Q ss_pred CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....+.++...+..+++.+|-.|++++.+.+
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 4445566777999999999999999988875
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-13 Score=120.67 Aligned_cols=128 Identities=16% Similarity=0.107 Sum_probs=97.0
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcc-cceeeEeeCCeeEEEEeeCCCCCH
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT-NLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
++.++.|..+.||+++.. ++.|++|....... ....+.+|+.+++.+.+.+++ +++... ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356789999999999874 77899999865432 234568899999999765544 455443 3345899999999887
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc-----cccccccCceeeCCCCCeEEeccCCccc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA-----LYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~i-----iHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
.+. .. ....++.+++++|+.||+.+ + +|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~-------~~---~~~~~~~~l~~~l~~LH~~~-~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE-------DF---SDPENLEKIAKLLKKLHSSP-LPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-------cc---cCHHHHHHHHHHHHHHhCCC-CCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 542 01 12345689999999999987 5 9999999999999 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.5e-14 Score=145.25 Aligned_cols=144 Identities=17% Similarity=0.166 Sum_probs=97.5
Q ss_pred CcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCC--------------------------CH-----------
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWP--------------------------DP----------- 100 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~--------------------------~~----------- 100 (449)
|..++. +.+|+|++|.||+|++++ |+.||||+.+.+... +.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 555555 678999999999999877 999999999754210 00
Q ss_pred ---HHHHHHHHHHhccC----CCCcccceeeEee-CCeeEEEEeeCCCCCHHHHHhccCCC----CCCHHHHHHHHHHHH
Q 013126 101 ---RQFLEEARSVGQLR----NNRLTNLLGCCCE-GDERLLVAEYMPNETLAKHLFHWETH----PMKWAMRLRVVLHLA 168 (449)
Q Consensus 101 ---~~~~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~Ey~~ggsL~~~l~~~~~~----~l~~~~~~~i~~qi~ 168 (449)
-++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.-...+ .+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 12455666666553 3444444444433 34568999999999998742211111 23333334444444
Q ss_pred HHHHHHHhCCCccccccccCceeeCCCC----CeEEeccCCcccCCC
Q 013126 169 QALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNSRD 211 (449)
Q Consensus 169 ~aL~yLH~~~~iiHrDlkp~NILl~~~~----~~kL~DFGla~~~~~ 211 (449)
+..| ++|+|+||.||+++.+| .+++.|||++.....
T Consensus 277 ------f~~G-ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDG-FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCC-eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4578 99999999999999888 999999999876544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-13 Score=128.90 Aligned_cols=199 Identities=18% Similarity=0.213 Sum_probs=141.4
Q ss_pred HHHHHhccCCCCcccceeeEeeCC-----eeEEEEeeCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013126 106 EARSVGQLRNNRLTNLLGCCCEGD-----ERLLVAEYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKG 178 (449)
Q Consensus 106 E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~Ey~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~ 178 (449)
-...|-++.|.|||+++.++.+.. ...++.||+..|+|..+|++.+ ...+....-.+|..||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 345677778999999999987654 4689999999999999998533 456778888999999999999999965
Q ss_pred C-ccccccccCceeeCCCCCeEEeccCCcccCC--------CCCccccCccccccccccCCCCCCCCceeeHhHHHHHHh
Q 013126 179 R-ALYHDLNAYRILFDEDGNPRLSTFGLMKNSR--------DGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249 (449)
Q Consensus 179 ~-iiHrDlkp~NILl~~~~~~kL~DFGla~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell 249 (449)
| |+|+++..+.|++..+|-+|+.---...... ......+-++|.+||.=..-..+.++|||+||....+|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 4 8999999999999999988875321111000 001223568899999877667888999999999999998
Q ss_pred cCCCCCC-chhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 250 SGKHIPP-SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 250 tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
-+..-+. ......... ........ -....-+.++.+|++-.|+.||+|++++-+.
T Consensus 277 ilEiq~tnseS~~~~ee-~ia~~i~~--------len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEE-NIANVIIG--------LENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceeehhh-hhhhheee--------ccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 8764322 111111111 11111000 0011234688999999999999999988643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=3e-12 Score=115.11 Aligned_cols=136 Identities=11% Similarity=0.158 Sum_probs=101.1
Q ss_pred cccCCccceEEEEEEEcC-------CCEEEEEEecCCCC---------------------CC-HHHH----HHHHHHHhc
Q 013126 66 SEHGEKAPNVVYKGKLEN-------QRRIAVKRFNRMAW---------------------PD-PRQF----LEEARSVGQ 112 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~-------~~~vAiK~l~~~~~---------------------~~-~~~~----~~E~~~l~~ 112 (449)
+.||.|--+.||.|...+ +..+|||+.+.... .+ .+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 567999999999998542 47999999863210 01 1223 389999999
Q ss_pred cCC--CCcccceeeEeeCCeeEEEEeeCCCCCHHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccccccccC
Q 013126 113 LRN--NRLTNLLGCCCEGDERLLVAEYMPNETLAK-HLFHWETHPMKWAMRLRVVLHLAQALEYC-TSKGRALYHDLNAY 188 (449)
Q Consensus 113 l~H--pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~iiHrDlkp~ 188 (449)
+.. -++++++++ ..-++||||+.++.+.. .+ +...++......+..+++.+|..+ |..+ ++|+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g-lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN-LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHH
Confidence 954 567777765 45589999997654422 23 223455566778889999999999 8888 999999999
Q ss_pred ceeeCCCCCeEEeccCCcccCC
Q 013126 189 RILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 189 NILl~~~~~~kL~DFGla~~~~ 210 (449)
||+++ ++.+.++|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.5e-13 Score=135.69 Aligned_cols=243 Identities=14% Similarity=0.070 Sum_probs=180.9
Q ss_pred cccccccccCCccceEEEEEEEc--CCCEEEEEEecCCCCCCHHH--HHHHHHHHhcc-CCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE--NQRRIAVKRFNRMAWPDPRQ--FLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~--~~~~vAiK~l~~~~~~~~~~--~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 134 (449)
.++..+..||.|.|+.|+....+ ++..|++|.+.+.......+ -..|+.+...+ .|.+++.....+...++.|+-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 44667888999999999998843 58899999987755444332 34567676666 599999999999888899999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-CCeEEeccCCcccCCCCC
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~ 213 (449)
-|||+++++...+. -...+++...+++..|++.++.++|+.. .+|+|+||+||++..+ +..+++|||......-..
T Consensus 345 ~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~-~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKL-FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred hhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchh-hhcccccccceeeccchhhhhccccccccccceec
Confidence 99999998877663 4567888889999999999999999998 9999999999999976 788999999886432221
Q ss_pred -c-cccCccc-cccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 214 -S-YSTNLAF-TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 214 -~-~~gt~~y-~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
. ..++..| .+|+......+..+.|++|||..+.+.++|......... + ..+.... ....+....++..
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--~-----~~i~~~~--~p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--S-----LTIRSGD--TPNLPGLKLQLQV 492 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--c-----eeeeccc--ccCCCchHHhhhh
Confidence 1 2233344 355555666788899999999999999999864432210 1 1111110 0112233467888
Q ss_pred HHHHhcccCCCCCCCHHHHHHHhc
Q 013126 291 LASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
+...+...++..||.+.++..+.+
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hhhhhcCCccccchhhhhhcccch
Confidence 889999999999999988876443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.6e-11 Score=124.94 Aligned_cols=163 Identities=15% Similarity=0.170 Sum_probs=128.0
Q ss_pred EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHH
Q 013126 81 LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160 (449)
Q Consensus 81 ~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~ 160 (449)
..++.+|.|...+.......+...+-++.|+.++||||+++++.++..+..|||+|-+. .|..++.+ +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence 44688999999876654345667888999999999999999999999999999999984 77777753 224556
Q ss_pred HHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCc----cccCccccccccccCCCCCCCC
Q 013126 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKS----YSTNLAFTPPEYLRTGRVTPES 236 (449)
Q Consensus 161 ~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~s 236 (449)
..-+.||+.||.+||+.++++|++|.-+-|+++..|..||++|-++........ ...-..|..|+.+.... -..
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence 667899999999999776699999999999999999999999988755433221 11223466666543211 356
Q ss_pred ceeeHhHHHHHHhcCC
Q 013126 237 VIYSFGTLLLDLLSGK 252 (449)
Q Consensus 237 DvwSlGvil~elltg~ 252 (449)
|.|.||++++|++.|.
T Consensus 185 D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhHHHHHHHHhCcc
Confidence 9999999999999994
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=3e-13 Score=142.91 Aligned_cols=244 Identities=17% Similarity=0.134 Sum_probs=180.2
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.++...+++.+-+|+++.++.++-. .|...++|+..... ..+.+....+-.++-...||-++...--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4556677788889999999988843 35445555543321 1222333334344444455666665555556678899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC---
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR--- 210 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~--- 210 (449)
+++|..|++|...++ ..+..+..-++..+..+..+++|||+.. +.|||++|.|+++..+|..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~~-r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSSL-RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccch-hhcccccccchhhcccCCcccCcccccccccccc
Confidence 999999999999987 4556777777888889999999999997 9999999999999999999999998432110
Q ss_pred ---------------------------C-----CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch
Q 013126 211 ---------------------------D-----GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH 258 (449)
Q Consensus 211 ---------------------------~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 258 (449)
. .....+|+.|.+||...+......+|.|+.|++++|.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 01234689999999999999999999999999999999999999877
Q ss_pred hhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHH
Q 013126 259 ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307 (449)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 307 (449)
..+.+-+........ ...-+...+.++.+++.+.+..+|.+|..+.
T Consensus 1039 tpq~~f~ni~~~~~~---~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIP---WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhhhccccCCCC---CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 665555444333222 1223445677899999999999999997655
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.5e-11 Score=105.79 Aligned_cols=131 Identities=19% Similarity=0.191 Sum_probs=101.6
Q ss_pred ccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--------HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.+++|+-+.+|.+.+. |..+++|.-.+..... .++-.+|++++.+++--.|.-..=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4589999999999864 4456666543222111 245778999999998767666666666778889999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
+|..|.+.+... ...+++.+-.-+.-||..| |+|+||.++||++++++ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g-ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAG-IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC-eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888632 2556778888888999999 99999999999998765 999999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.3e-11 Score=113.91 Aligned_cols=140 Identities=17% Similarity=0.160 Sum_probs=108.6
Q ss_pred cccCCccceEEEEEEEcCCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCC--CCcccceeeEeeCC---eeEEEEeeCC
Q 013126 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRN--NRLTNLLGCCCEGD---ERLLVAEYMP 139 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~---~~~lV~Ey~~ 139 (449)
+.+|.|..+.||++...+|+.+++|........ ....+.+|+++++.+.+ .++.+++.+....+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 456999999999999766689999998654321 34678999999999976 44677777766543 6689999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK------------------------------------------ 177 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~------------------------------------------ 177 (449)
|.++.+.+. ...+++.....++.+++++|..||+.
T Consensus 84 G~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998877552 14567777778888888888888741
Q ss_pred -------------CCccccccccCceeeCC--CCCeEEeccCCccc
Q 013126 178 -------------GRALYHDLNAYRILFDE--DGNPRLSTFGLMKN 208 (449)
Q Consensus 178 -------------~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~ 208 (449)
..++|+|++|.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 01699999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.5e-11 Score=103.19 Aligned_cols=143 Identities=16% Similarity=0.160 Sum_probs=108.9
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCC--------CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP--------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+..+-+|+-+.|+++.+ .|+...||.-...... ...+..+|++.|.++.--.|.-..-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 44557899999999998 5677777764322211 13567899999999987777666667777777789999
Q ss_pred eCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC---eEEeccCCcccC
Q 013126 137 YMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKNS 209 (449)
Q Consensus 137 y~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~---~kL~DFGla~~~ 209 (449)
|++| .++.+++...-...........+++.|-..+.-||.++ ++|+||..+||++..++. +.++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd-iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND-IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC-eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9986 48888887544444444444788999999999999999 999999999999975543 589999998653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.3e-10 Score=111.42 Aligned_cols=215 Identities=19% Similarity=0.177 Sum_probs=153.7
Q ss_pred cceEEEEEE-EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEee----CCeeEEEEeeCCC-CCHHH
Q 013126 72 APNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLLVAEYMPN-ETLAK 145 (449)
Q Consensus 72 ~~g~Vy~~~-~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~~g-gsL~~ 145 (449)
...+.|++. ..+|..|++|+++.+.......-..-++.++++.|+|+|++.+++.. +..+++|++|.++ +||.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 446789998 44699999999965443333334456789999999999999999873 3468999999986 57777
Q ss_pred HHhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 146 HLFHW-------------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 146 ~l~~~-------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
.-... .+...++...|.++.|+..||.++|+.| +..+-|.|.+||++.+.+++|+..|+......+
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 65421 1234678999999999999999999999 999999999999999999999988887655444
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
. . |-+.+ -.+-|.=.||.++..|.||..-.... +...... ...+....+.++++++
T Consensus 447 ~--------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~--d~~~~s~---------~~~I~~~yS~D~rn~v 502 (655)
T KOG3741|consen 447 P--------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRT--DSTQSSH---------LTRITTTYSTDLRNVV 502 (655)
T ss_pred C--------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccc--cchHHHH---------HHHhhhhhhHHHHHHH
Confidence 3 0 11111 12567778999999999996321100 0000000 0122345667888888
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~ 312 (449)
.-....++++ -+..+++..
T Consensus 503 ~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhcCccc-ccHHHHHHH
Confidence 8888888886 567777653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.8e-10 Score=105.79 Aligned_cols=132 Identities=12% Similarity=0.116 Sum_probs=99.3
Q ss_pred EEEEEEEcCCCEEEEEEecCCCCC-----------CHHHHHHHHHHHhccCCCCc--ccceeeEee-----CCeeEEEEe
Q 013126 75 VVYKGKLENQRRIAVKRFNRMAWP-----------DPRQFLEEARSVGQLRNNRL--TNLLGCCCE-----GDERLLVAE 136 (449)
Q Consensus 75 ~Vy~~~~~~~~~vAiK~l~~~~~~-----------~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~-----~~~~~lV~E 136 (449)
.|.+..+ +|+.|.||......+. ....+.+|...+.++..-+| +.++++... ...-++|||
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3667666 5778999977543311 11247899999999954443 445556543 234689999
Q ss_pred eCCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-------CCCeEEeccCCccc
Q 013126 137 YMPNE-TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-------DGNPRLSTFGLMKN 208 (449)
Q Consensus 137 y~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-------~~~~kL~DFGla~~ 208 (449)
++++. +|.+++......+.+......++.+++..+.-||.+| |+|+|+++.|||++. ++.+.++||+.++.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G-i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG-INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc-CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99975 8999886433455667788899999999999999999 999999999999975 46799999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.6e-10 Score=100.56 Aligned_cols=127 Identities=17% Similarity=0.181 Sum_probs=85.4
Q ss_pred EEEEEEEcCCCEEEEEEecCCCCC----------------------C----HHHHHHHHHHHhccCCC--CcccceeeEe
Q 013126 75 VVYKGKLENQRRIAVKRFNRMAWP----------------------D----PRQFLEEARSVGQLRNN--RLTNLLGCCC 126 (449)
Q Consensus 75 ~Vy~~~~~~~~~vAiK~l~~~~~~----------------------~----~~~~~~E~~~l~~l~Hp--nIv~l~~~~~ 126 (449)
.||.|...+|..+|+|+.+..... . .....+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999888999999998642110 0 13467899999999765 567776553
Q ss_pred eCCeeEEEEeeCC--CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCccccccccCceeeCCCCCeEEecc
Q 013126 127 EGDERLLVAEYMP--NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY-CTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (449)
Q Consensus 127 ~~~~~~lV~Ey~~--ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~~iiHrDlkp~NILl~~~~~~kL~DF 203 (449)
...|||||++ |..+..+.. ..++......++.+++..+.. +|..| ++|+||.+.||+++++ .+.++||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~----~~~~~~~~~~~~~~il~~~~~~~~~~g-ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD----VDLSPEEPKELLEEILEEIIKMLHKAG-IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH----CGGGGSTHHHHHHHHHHHHHHHHHCTT-EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHh----ccccchhHHHHHHHHHHHHHHHHHhcC-ceecCCChhhEEeecc-eEEEEec
Confidence 3479999998 655554332 112234556677888886666 47888 9999999999999987 9999999
Q ss_pred CCcccCCC
Q 013126 204 GLMKNSRD 211 (449)
Q Consensus 204 Gla~~~~~ 211 (449)
|.+.....
T Consensus 151 ~qav~~~~ 158 (188)
T PF01163_consen 151 GQAVDSSH 158 (188)
T ss_dssp TTEEETTS
T ss_pred CcceecCC
Confidence 98876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-09 Score=102.73 Aligned_cols=249 Identities=18% Similarity=0.173 Sum_probs=157.3
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCccc--------ceeeEeeCCeeEEEE
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTN--------LLGCCCEGDERLLVA 135 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~--------l~~~~~~~~~~~lV~ 135 (449)
...||+|+-+.+|-.- .-+..+.|+..........+ -+..|... .||-+-. ++|- ..+..+.+.|
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEec
Confidence 3567999999998653 11224557776543222222 22233333 4554332 1111 1122367888
Q ss_pred eeCCCCCH-HHHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 136 EYMPNETL-AKHLFH----WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 136 Ey~~ggsL-~~~l~~----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
..++|..- .++..- .+-....|+-.++.++.++.+.+.||..| .+-+|+.++|+|+++++.+.|.|=.......
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-CcccccCccceeeecCceEEEEcccceeecc
Confidence 88876522 222211 01234679999999999999999999999 8889999999999999999999855433333
Q ss_pred CCC---ccccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcC-CCCCCchh--------hH-HHhhccccccc
Q 013126 211 DGK---SYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSG-KHIPPSHA--------LD-LIRDRNLQMLT 272 (449)
Q Consensus 211 ~~~---~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg-~~p~~~~~--------~~-~~~~~~~~~~~ 272 (449)
++. ...|...|++||... +..-+..+|.|.||+++++++.| ++|+.+.. .+ .+.......-.
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 332 235778999999765 33467789999999999999998 77764321 00 11111110000
Q ss_pred ------ccccCCCCCchhHHHHHHHHHHhcccC--CCCCCCHHHHHHHhccccccc
Q 013126 273 ------DSCLEGQFTDDDGTELVRLASRCLQYE--PRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 273 ------~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~Rps~~eil~~L~~~~~~~ 320 (449)
.+.+......-+++.+..+..+|+... +.-|||++..+.+|..+..+.
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 111111112345688999999999753 568999999999887766554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.1e-08 Score=94.71 Aligned_cols=150 Identities=17% Similarity=0.160 Sum_probs=107.6
Q ss_pred CHHHHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCC----------------------CHHHHHH
Q 013126 48 TLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP----------------------DPRQFLE 105 (449)
Q Consensus 48 ~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~----------------------~~~~~~~ 105 (449)
+.=.+.....+=..+.+..+||-|--+.||.|..+.|.++|||.=+..... ......+
T Consensus 79 D~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~r 158 (304)
T COG0478 79 DALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAER 158 (304)
T ss_pred hHHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHH
Confidence 333444444444456677889999999999999988999999986532111 0124678
Q ss_pred HHHHHhccCCC--CcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q 013126 106 EARSVGQLRNN--RLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183 (449)
Q Consensus 106 E~~~l~~l~Hp--nIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHr 183 (449)
|.++|.+|.-. .+++.+++ +...+||||++|-.|... +++......++..|+.-+.-+-..| ++|+
T Consensus 159 Ef~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~G-iVHG 226 (304)
T COG0478 159 EFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRG-IVHG 226 (304)
T ss_pred HHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcC-cccc
Confidence 99999999655 77777765 445899999998666432 1233344445555555555555778 9999
Q ss_pred ccccCceeeCCCCCeEEeccCCcccC
Q 013126 184 DLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 184 Dlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
|+.+-||+++++|.+.++||.-+...
T Consensus 227 DlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 227 DLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred CCchheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999999766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-08 Score=92.44 Aligned_cols=123 Identities=22% Similarity=0.235 Sum_probs=92.9
Q ss_pred CCEEEEEEecCCC-------CCCHHHHHHHHHHHhccCCC--CcccceeeEeeCC----eeEEEEeeCCC-CCHHHHHhc
Q 013126 84 QRRIAVKRFNRMA-------WPDPRQFLEEARSVGQLRNN--RLTNLLGCCCEGD----ERLLVAEYMPN-ETLAKHLFH 149 (449)
Q Consensus 84 ~~~vAiK~l~~~~-------~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~~----~~~lV~Ey~~g-gsL~~~l~~ 149 (449)
++.+-+|...... .-......+|...+..+..- .+++.+++..... ..++|+|+++| .+|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 5666666543211 11245688899998888543 4566677766532 34899999997 479998863
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC---CeEEeccCCcccC
Q 013126 150 WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG---NPRLSTFGLMKNS 209 (449)
Q Consensus 150 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~---~~kL~DFGla~~~ 209 (449)
. ...+......++.+++..++-||.+| ++|+|+++.|||++.++ .+.++||+-++..
T Consensus 112 ~--~~~~~~~~~~ll~~l~~~i~~lH~~g-i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 112 W--EQLDPSQRRELLRALARLIAKLHDAG-IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred h--cccchhhHHHHHHHHHHHHHHHHHCc-CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 2 22666778899999999999999999 99999999999999877 7999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=6.1e-10 Score=114.08 Aligned_cols=145 Identities=21% Similarity=0.307 Sum_probs=105.3
Q ss_pred HHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcc-------------ccCccccccccccCCC
Q 013126 165 LHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY-------------STNLAFTPPEYLRTGR 231 (449)
Q Consensus 165 ~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-------------~gt~~y~aPE~~~~~~ 231 (449)
.+++.|+.|+|...++||++|.|++|.++.++..||+.|+++........+ .....|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 345599999999877999999999999999999999999987655442111 1246799999999878
Q ss_pred CCCCCceeeHhHHHHHHhcC-CCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 013126 232 VTPESVIYSFGTLLLDLLSG-KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (449)
Q Consensus 232 ~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil 310 (449)
.+.++|+||+|+.+|.+..| +..+............ .............+++.++.+-+.+++..++.-||++.++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--RNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--hcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 89999999999999999844 4333222111111110 11111111234467889999999999999999999777765
Q ss_pred H
Q 013126 311 T 311 (449)
Q Consensus 311 ~ 311 (449)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 4
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.2e-08 Score=87.54 Aligned_cols=137 Identities=14% Similarity=0.088 Sum_probs=103.6
Q ss_pred CCccceEEEEEEEcCCCEEEEEEecCCC------CCCHHHHHHHHHHHhccCCC--CcccceeeEe-eC----CeeEEEE
Q 013126 69 GEKAPNVVYKGKLENQRRIAVKRFNRMA------WPDPRQFLEEARSVGQLRNN--RLTNLLGCCC-EG----DERLLVA 135 (449)
Q Consensus 69 G~G~~g~Vy~~~~~~~~~vAiK~l~~~~------~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~-~~----~~~~lV~ 135 (449)
|+||.+.|+.-..+ |..+-+|.-.... ......|.+|...+.++..- +++++. ++. .. -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67899999998874 4468888875211 12357899999999999543 355554 332 11 1358999
Q ss_pred eeCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC--eEEeccCCccc
Q 013126 136 EYMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--PRLSTFGLMKN 208 (449)
Q Consensus 136 Ey~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~--~kL~DFGla~~ 208 (449)
|-++| .||.+++.+....+.+......++.+++..++-||+.| +.|+|+.+.||+++.+|. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G-v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN-RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 58988886443456678888899999999999999999 999999999999986677 99999976553
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.3e-08 Score=89.23 Aligned_cols=158 Identities=21% Similarity=0.265 Sum_probs=116.5
Q ss_pred ccccCHHHHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCC-------------------CHH---
Q 013126 44 FREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP-------------------DPR--- 101 (449)
Q Consensus 44 ~~~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~-------------------~~~--- 101 (449)
+...+.+.+....+.-..-.+.+.|+.|--+.||+|...++..+|+|+++..... +..
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 3456788888888888778888899999999999999878999999999653211 111
Q ss_pred --HHHHHHHHHhccC--CCCcccceeeEeeCCeeEEEEeeCCCCCH-HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 013126 102 --QFLEEARSVGQLR--NNRLTNLLGCCCEGDERLLVAEYMPNETL-AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS 176 (449)
Q Consensus 102 --~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL-~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~ 176 (449)
...+|...|+++. +-.+.+.+++.. ..|||||+..... .=.| +.-++...++..+..++++.+.-|-.
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 2356888888884 455666666543 3799999954311 1111 22334444677888899999988877
Q ss_pred -CCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 177 -KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 177 -~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.+ ++|+||+.-|||+. ++.+.++|+|-+....
T Consensus 185 ~a~-LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAG-LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcC-cccccchhhheEEE-CCeEEEEECccccccC
Confidence 66 99999999999999 8899999999876544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1e-07 Score=97.94 Aligned_cols=141 Identities=16% Similarity=0.153 Sum_probs=95.6
Q ss_pred cccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--------------------------H--------------HHHHH
Q 013126 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--------------------------P--------------RQFLE 105 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--------------------------~--------------~~~~~ 105 (449)
..++.++-|.||+|++++|+.||||+.+.+-... . -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 4668999999999999999999999997542111 0 02556
Q ss_pred HHHHHhccC-----CCCcccceeeEe-eCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 013126 106 EARSVGQLR-----NNRLTNLLGCCC-EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQA-LEYCTSKG 178 (449)
Q Consensus 106 E~~~l~~l~-----HpnIv~l~~~~~-~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~a-L~yLH~~~ 178 (449)
|+..+.+++ .|++ ++=.+++ -.+...|+|||++|-.+.+...- +....+.+. ++..++.+ +.-+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAAL-KSAGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHH-HhcCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 777766663 2332 2223333 34566899999999888887432 224455332 33333332 23333467
Q ss_pred CccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 179 RALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 179 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
..|.|..|.||+++.+|++.+.|||+.....+.
T Consensus 286 -ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 -FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999998765543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.2e-06 Score=81.41 Aligned_cols=137 Identities=11% Similarity=0.135 Sum_probs=85.6
Q ss_pred cccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC--cccceeeEeeCCeeEEEEeeCCCCC-
Q 013126 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNLLGCCCEGDERLLVAEYMPNET- 142 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~ggs- 142 (449)
..+|+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 35699999999984 24567889886533 3456789999999996433 5778888877788899999999863
Q ss_pred HHHHHh--------------c----cCC---CCCCHHHHH-HHHH----------HHHH-HHHHHHh---CCCccccccc
Q 013126 143 LAKHLF--------------H----WET---HPMKWAMRL-RVVL----------HLAQ-ALEYCTS---KGRALYHDLN 186 (449)
Q Consensus 143 L~~~l~--------------~----~~~---~~l~~~~~~-~i~~----------qi~~-aL~yLH~---~~~iiHrDlk 186 (449)
+...+. + -.. ...+..... .+-. .+.. ...+|.. ...++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 001 011111100 0100 0111 1122221 1127899999
Q ss_pred cCceeeCCCCCeEEeccCCccc
Q 013126 187 AYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 187 p~NILl~~~~~~kL~DFGla~~ 208 (449)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2e-06 Score=80.76 Aligned_cols=74 Identities=14% Similarity=0.119 Sum_probs=54.7
Q ss_pred CCccc-eEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEeeCCCCCHHHH
Q 013126 69 GEKAP-NVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPNETLAKH 146 (449)
Q Consensus 69 G~G~~-g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~ 146 (449)
..|.. +.||+.... +..+.+|...... .....+|+++++.+. +--+.+++++...++..++|||+++|.+|...
T Consensus 7 ~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 7 TEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 44444 789999764 4788889876543 345778999998884 45567788887776778999999998877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.2e-06 Score=77.91 Aligned_cols=134 Identities=13% Similarity=0.120 Sum_probs=84.8
Q ss_pred cccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHH---------HHHHHHHHHhccCCC---CcccceeeEee--
Q 013126 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPR---------QFLEEARSVGQLRNN---RLTNLLGCCCE-- 127 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~---------~~~~E~~~l~~l~Hp---nIv~l~~~~~~-- 127 (449)
|+.++.+-......|.+-.. +|+.+.+|..+.......+ ...+++..+..++.. ....++.+...
T Consensus 33 ~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~ 111 (229)
T PF06176_consen 33 YKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI 111 (229)
T ss_pred ceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence 44444445555555665555 5689999998754322111 123444444455332 23333333222
Q ss_pred ---CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccC
Q 013126 128 ---GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (449)
Q Consensus 128 ---~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFG 204 (449)
....+++|||++|..|.+... +++ .+...+..++.-+|..| +.|+|..|.|+++++++ ++++||+
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G-~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG-FYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred ccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC-CccCCCCcCcEEEECCc-EEEEECc
Confidence 134568999999988866532 222 24456777899999999 99999999999999655 9999998
Q ss_pred Cccc
Q 013126 205 LMKN 208 (449)
Q Consensus 205 la~~ 208 (449)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.3e-06 Score=78.19 Aligned_cols=78 Identities=19% Similarity=0.282 Sum_probs=57.5
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCC--CcccceeeEee---CCeeEEEEeeCC
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN--RLTNLLGCCCE---GDERLLVAEYMP 139 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~---~~~~~lV~Ey~~ 139 (449)
++.++.|..+.||+....+ +.+++|..... .......+|..+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3567899999999999866 69999997654 2356788999999988543 35666664432 235789999999
Q ss_pred CCCHHH
Q 013126 140 NETLAK 145 (449)
Q Consensus 140 ggsL~~ 145 (449)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.2e-07 Score=96.68 Aligned_cols=178 Identities=10% Similarity=-0.010 Sum_probs=128.9
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC-cccceeeEeeCCeeEEEEeeCCCC-C
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLVAEYMPNE-T 142 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~~gg-s 142 (449)
...+++|+++.++|.+.--.+....+.+.. .....-++++|.+++||| .+..++-+..++..+++++++.++ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 345688999999988732233333555432 245567899999999999 777788888888999999999876 2
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---CccccCc
Q 013126 143 LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---KSYSTNL 219 (449)
Q Consensus 143 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~~~~gt~ 219 (449)
-...... ....+..-+...+.+.-+++++++|+.. -+||| ||+..+ +..+..||+........ ....+++
T Consensus 322 ~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~-~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~ 394 (829)
T KOG0576|consen 322 SALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY-KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTP 394 (829)
T ss_pred ccccCCh-hhHhhhhhhhhhhhhhhccccccccccc-ccCcc----cccccc-cccccccccCCcccCcccccccCCCCC
Confidence 2111100 1112233344555667778999999975 68999 777765 67899999987765544 4567899
Q ss_pred cccccccccCCCCCCCCceeeHhHHHHHHhcCCCC
Q 013126 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI 254 (449)
Q Consensus 220 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p 254 (449)
.++|||+.....+..+.|+|++|+-..++.-|-+|
T Consensus 395 ~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 395 EPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 99999999999999999999999877777777654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.2e-06 Score=72.29 Aligned_cols=130 Identities=17% Similarity=0.187 Sum_probs=92.6
Q ss_pred ccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCccc-ceeeEeeCCeeEEEEeeCCCC
Q 013126 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN-LLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lV~Ey~~gg 141 (449)
+..+.||+|.+|.||++.+. |..+|+|+-+.++ ....+..|+++|..++-.++.+ ++.+..+ ++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 45577899999999999984 5689999976544 3578999999999998766644 4554433 4569999988
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccc-cCceeeCCCCCeEEeccCCcccC
Q 013126 142 TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLN-AYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 142 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlk-p~NILl~~~~~~kL~DFGla~~~ 209 (449)
.|.+.-.. .+... +..++..---|-..| |-|+.|. |...++.+++.+.|+||.-|+..
T Consensus 98 ~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~G-I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIG-----GDRKH----LLRVLEKAYKLDRLG-IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhc-----ccHHH----HHHHHHHHHHHHHhc-cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 88776531 12222 334444433445567 9999886 66666666679999999988743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.8e-06 Score=90.15 Aligned_cols=80 Identities=14% Similarity=0.258 Sum_probs=59.5
Q ss_pred cccccCCccceEEEEEEEcCC---CEEEEEEecCCCC-CCHHHHHHHHHHHhccC-CCCc--ccceeeEeeC---CeeEE
Q 013126 64 IVSEHGEKAPNVVYKGKLENQ---RRIAVKRFNRMAW-PDPRQFLEEARSVGQLR-NNRL--TNLLGCCCEG---DERLL 133 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~~---~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~---~~~~l 133 (449)
-+.+++.|.++.+|+....++ ..+++|+...... .....+.+|+++++.+. |+++ ++++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 367789999999999886543 4788888654332 23457889999999995 6665 7777777654 46799
Q ss_pred EEeeCCCCCH
Q 013126 134 VAEYMPNETL 143 (449)
Q Consensus 134 V~Ey~~ggsL 143 (449)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999997643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.5e-05 Score=72.16 Aligned_cols=126 Identities=17% Similarity=0.125 Sum_probs=92.0
Q ss_pred ccCCccceEEEEEEEcCCCEEEEEEecCCC----------------CCCHHHHHHHHHHHhccC------CCCcccceee
Q 013126 67 EHGEKAPNVVYKGKLENQRRIAVKRFNRMA----------------WPDPRQFLEEARSVGQLR------NNRLTNLLGC 124 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~----------------~~~~~~~~~E~~~l~~l~------HpnIv~l~~~ 124 (449)
.||+|+.-.||.-- ++....||+..... .....+..+|+.-...+. +.+|.+++|+
T Consensus 8 ~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 8 LIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred ccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 45999999998654 45568889987655 222456777777666665 7899999999
Q ss_pred EeeCCeeEEEEeeCCC------CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC--C
Q 013126 125 CCEGDERLLVAEYMPN------ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED--G 196 (449)
Q Consensus 125 ~~~~~~~~lV~Ey~~g------gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~--~ 196 (449)
.+++....+|+|.+.. .||.+++. ...++. .....+ -.-..||-+++ |+.+|++|+||++..+ +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~L---~~f~~~l~~~~-Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQAL---DEFKRYLLDHH-IVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHHH---HHHHHHHHHcC-CeecCCCcccEEEEecCCC
Confidence 9999999999998743 47888884 445665 333333 34456777887 9999999999999632 2
Q ss_pred --CeEEec
Q 013126 197 --NPRLST 202 (449)
Q Consensus 197 --~~kL~D 202 (449)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 477787
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.6e-06 Score=85.68 Aligned_cols=142 Identities=16% Similarity=0.108 Sum_probs=93.0
Q ss_pred cccCCccceEEEEEEEcCCCEEEEEEecCCCCCC-------------------------------------HHHHHHHHH
Q 013126 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD-------------------------------------PRQFLEEAR 108 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~-------------------------------------~~~~~~E~~ 108 (449)
+.||.-+.|.||+|+.++|+.||||+-+.+-... .=+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 3568899999999999999999999986532211 013667777
Q ss_pred HHhcc----CCCC---cccceeeEee-CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHH-HHHhCCC
Q 013126 109 SVGQL----RNNR---LTNLLGCCCE-GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALE-YCTSKGR 179 (449)
Q Consensus 109 ~l~~l----~Hpn---Iv~l~~~~~~-~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~-yLH~~~~ 179 (449)
...+. .|-+ =|.+=.++++ .....|+|||++|..+.|.-.- ....++.... +..+.++.. -+-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i---~~~l~~~~~~qIf~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDI---LNKLVEAYLEQIFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHH---HHHHHHHHHHHHHhcC-
Confidence 66555 3545 1112233332 2456899999999877654221 3345555433 333333322 223457
Q ss_pred ccccccccCceeeCC----CCCeEEeccCCcccCCCC
Q 013126 180 ALYHDLNAYRILFDE----DGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 180 iiHrDlkp~NILl~~----~~~~kL~DFGla~~~~~~ 212 (449)
.+|.|=.|-||+++. ++.+.+-|||+.......
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 999999999999994 677999999998765543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.1e-05 Score=69.67 Aligned_cols=137 Identities=19% Similarity=0.260 Sum_probs=97.4
Q ss_pred CCCCccccCHHHHHHhhCCCcccccccccCCccc-eEEEEEEEcCCCEEEEEEecC---CCC------------------
Q 013126 40 GLPSFREFTLEQLKNATSGFAVENIVSEHGEKAP-NVVYKGKLENQRRIAVKRFNR---MAW------------------ 97 (449)
Q Consensus 40 ~~p~~~~~~~~~l~~~~~~f~~~~~l~~lG~G~~-g~Vy~~~~~~~~~vAiK~l~~---~~~------------------ 97 (449)
..|..+.|+... .+.+.++.||.|.- |.||+++. +|+.+|+|+++. ...
T Consensus 25 ~gPKL~~F~~h~--------~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (207)
T PF13095_consen 25 PGPKLEPFTHHG--------DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPA 95 (207)
T ss_pred CCCCcCCcCCCC--------CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhh
Confidence 456677777611 56778888999999 99999998 567999999432 000
Q ss_pred CCHHHHHHHHHHHhccC---CCCc--ccceeeEeeC------------------CeeEEEEeeCCCCCHHHHHhccCCCC
Q 013126 98 PDPRQFLEEARSVGQLR---NNRL--TNLLGCCCEG------------------DERLLVAEYMPNETLAKHLFHWETHP 154 (449)
Q Consensus 98 ~~~~~~~~E~~~l~~l~---HpnI--v~l~~~~~~~------------------~~~~lV~Ey~~ggsL~~~l~~~~~~~ 154 (449)
.-...|..|.+...+|+ +.++ |+.+|+..-. ....||.||++... .
T Consensus 96 ~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~ 164 (207)
T PF13095_consen 96 HYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------P 164 (207)
T ss_pred hhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------c
Confidence 01135888988888875 4556 8999987432 12367888877432 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 155 MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 155 l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
++... +.+|.+-+..+|..| |+-+|+++.|.. .-||+|||.+
T Consensus 165 ~~~~~----~~~~~~dl~~~~k~g-I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQIRD----IPQMLRDLKILHKLG-IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cchhH----HHHHHHHHHHHHHCC-eeeccCcccccc-----CCEEEecccC
Confidence 22222 567777889999999 999999999987 3489999854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.05 E-value=4e-05 Score=71.57 Aligned_cols=73 Identities=15% Similarity=0.119 Sum_probs=46.3
Q ss_pred cccCCccce-EEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCC---CcccceeeEeeC---CeeEEEEeeC
Q 013126 66 SEHGEKAPN-VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN---RLTNLLGCCCEG---DERLLVAEYM 138 (449)
Q Consensus 66 ~~lG~G~~g-~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~---~~~~lV~Ey~ 138 (449)
..++.|+.. .||+. +..+++|..+.. .....+.+|+++++.+... .+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 345655555 58875 235778876542 2345789999999988532 345555444332 2358999999
Q ss_pred CCCCHH
Q 013126 139 PNETLA 144 (449)
Q Consensus 139 ~ggsL~ 144 (449)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.03 E-value=9.8e-05 Score=71.54 Aligned_cols=77 Identities=13% Similarity=0.091 Sum_probs=57.8
Q ss_pred cccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC---CCcccceeeEeeC---CeeEEEEee
Q 013126 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN---NRLTNLLGCCCEG---DERLLVAEY 137 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~~---~~~~lV~Ey 137 (449)
-++.||.|..+.||+....++ .+.+|..+.. .....+.+|++.|+.+.- ..++++++++..+ +..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 345789999999999986555 4677775431 134689999999999953 4688888877543 568999999
Q ss_pred CCCCCH
Q 013126 138 MPNETL 143 (449)
Q Consensus 138 ~~ggsL 143 (449)
++|+++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.4e-05 Score=70.42 Aligned_cols=99 Identities=22% Similarity=0.307 Sum_probs=78.7
Q ss_pred HHHHHHHhccCC-CCcccceeeEeeCCeeEEEEeeCCCCCHHHH---HhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 013126 104 LEEARSVGQLRN-NRLTNLLGCCCEGDERLLVAEYMPNETLAKH---LFHWETHPMKWAMRLRVVLHLAQALEYCTSK-- 177 (449)
Q Consensus 104 ~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~---l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-- 177 (449)
..|.-+++.+++ +++++++|+|-. ++|.||...+++... +. .-...+|..+.+|+.++++.+.+++..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~--~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLS--QFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccc--cccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357888888876 799999999933 779999987766421 11 123468999999999999999999873
Q ss_pred CCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 178 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
+.+.-.|++|+|+-++++|++|++|...+..
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 3356669999999999999999999986644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.9e-05 Score=82.32 Aligned_cols=193 Identities=20% Similarity=0.169 Sum_probs=141.1
Q ss_pred HHHHHHHHhccCCCCcccceeeEeeCCee----EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013126 103 FLEEARSVGQLRNNRLTNLLGCCCEGDER----LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG 178 (449)
Q Consensus 103 ~~~E~~~l~~l~HpnIv~l~~~~~~~~~~----~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 178 (449)
...|...+.+..|+|++.++.+..+.... .+..|++.+-++...+. .-+..+....+.+..+...||+|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 44577778888999999999987765332 34568888888888887 5677888999999999999999999986
Q ss_pred CccccccccC---ceeeCCCCCeEEe--ccCCcccCCCCCc---cccCccccccccccCCCCCC--CCceeeHhHHHHHH
Q 013126 179 RALYHDLNAY---RILFDEDGNPRLS--TFGLMKNSRDGKS---YSTNLAFTPPEYLRTGRVTP--ESVIYSFGTLLLDL 248 (449)
Q Consensus 179 ~iiHrDlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~---~~gt~~y~aPE~~~~~~~~~--~sDvwSlGvil~el 248 (449)
..|.-+..+ +--.+..+....+ ||+..+...+... ...+..+.+||......++. ..|+|.+|.....+
T Consensus 307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred -cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 777655555 5555667777777 9988877665432 23356688888887666555 47999999999999
Q ss_pred hcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 013126 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313 (449)
Q Consensus 249 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 313 (449)
..|..+..... .+... .+........+...+|+..++++|+++.+++...
T Consensus 386 ~~~~~i~~~~~-----------~~~~~----l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 386 SQGEDISEKSA-----------VPVSL----LDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhcCccccccc-----------chhhh----hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99876532211 00000 0111112577888999999999999999999854
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.92 E-value=9.2e-05 Score=69.00 Aligned_cols=73 Identities=18% Similarity=0.122 Sum_probs=49.0
Q ss_pred cccCCccceEEEEEEEcC--CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC-cccceeeEeeCCeeEEEEeeCCCCC
Q 013126 66 SEHGEKAPNVVYKGKLEN--QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~--~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
+.|..|-.+.+|+....+ ++.|++|+...... ..-...+|+.+++.+...+ .+++++... -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 456788889999998654 67899998754322 1123357888999885433 444544332 248999999876
Q ss_pred H
Q 013126 143 L 143 (449)
Q Consensus 143 L 143 (449)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00015 Score=70.13 Aligned_cols=138 Identities=16% Similarity=0.192 Sum_probs=84.7
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC--cccceee------EeeCCeeEEEEe
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNLLGC------CCEGDERLLVAE 136 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lV~E 136 (449)
++.+..|....+|+....+ ..+++|+... ...+....|++++..+.+.+ +++++.. ...++..+.+++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 5567888889999987644 4788998764 23456778888888885432 4444432 223456789999
Q ss_pred eCCCCCHHH----HH----------hcc-CC--------CCCCHHHHH----------HHHHHHHHHHHHHHh-------
Q 013126 137 YMPNETLAK----HL----------FHW-ET--------HPMKWAMRL----------RVVLHLAQALEYCTS------- 176 (449)
Q Consensus 137 y~~ggsL~~----~l----------~~~-~~--------~~l~~~~~~----------~i~~qi~~aL~yLH~------- 176 (449)
|++|.++.. .. +.. .. ....|.... .....+..++.++..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876432 00 000 00 001111110 011122334444443
Q ss_pred CCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 177 KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 177 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
.+ ++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~-l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RG-VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred Cc-CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 34 9999999999999998778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00031 Score=66.43 Aligned_cols=134 Identities=13% Similarity=0.112 Sum_probs=78.5
Q ss_pred cCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCc-ccceeeEeeCCeeEEEEeeCCCCCHHHH
Q 013126 68 HGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYMPNETLAKH 146 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~ggsL~~~ 146 (449)
+..|-.+.+|+... +++.+++|........-.-+..+|.++++.+...++ .+++.... -++||||++|.++...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 46688889999874 567888998654322111245789999999865433 44444432 3689999998765421
Q ss_pred --------------HhccC-----CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCccccccccCc
Q 013126 147 --------------LFHWE-----THPMKWA-MRLRVVLHL---------AQALEYCTS--------KGRALYHDLNAYR 189 (449)
Q Consensus 147 --------------l~~~~-----~~~l~~~-~~~~i~~qi---------~~aL~yLH~--------~~~iiHrDlkp~N 189 (449)
+.+-. ..+++.. ....+..++ ...+..+-. .. ++|+|+.|.|
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~H~Dl~~~N 157 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA-PLHMDVHAYN 157 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe-eecCCCCcCc
Confidence 11101 1112211 111111111 111222211 13 8999999999
Q ss_pred eeeCCCCCeEEeccCCccc
Q 013126 190 ILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 190 ILl~~~~~~kL~DFGla~~ 208 (449)
|++++++ +.++||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00056 Score=66.59 Aligned_cols=157 Identities=13% Similarity=0.186 Sum_probs=90.8
Q ss_pred cCHHHHHHhhCCCcc--cccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC--cccce
Q 013126 47 FTLEQLKNATSGFAV--ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNLL 122 (449)
Q Consensus 47 ~~~~~l~~~~~~f~~--~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~ 122 (449)
.+.+++...-..|+. ...++.++.|....+|+....++ .+++|+..... ..+....|.+++..|...+ +++++
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 345566555444432 33466778888889999876444 67789875422 2445667777777774322 44444
Q ss_pred ee------EeeCCeeEEEEeeCCCCCHH-----------HHH---hcc-CC--CC----C---CHHHHH-----------
Q 013126 123 GC------CCEGDERLLVAEYMPNETLA-----------KHL---FHW-ET--HP----M---KWAMRL----------- 161 (449)
Q Consensus 123 ~~------~~~~~~~~lV~Ey~~ggsL~-----------~~l---~~~-~~--~~----l---~~~~~~----------- 161 (449)
.. ....+..++++||++|.++. ..+ +.. .. .+ . .|....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 32 12245678999999985432 111 100 00 00 0 011000
Q ss_pred -HHHHHHHHHHHHHHh-------CCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 162 -RVVLHLAQALEYCTS-------KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 162 -~i~~qi~~aL~yLH~-------~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
.....+...++++.. .+ ++|+|+.+.||++++++...|+||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~-l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRG-VIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCc-cCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011223344555532 45 9999999999999988877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00071 Score=67.83 Aligned_cols=76 Identities=13% Similarity=0.079 Sum_probs=55.8
Q ss_pred ccccCCccceEEEEEEEcCC-CEEEEEEecC------CC-CCCHHHHHHHHHHHhccC---CCCcccceeeEeeCCeeEE
Q 013126 65 VSEHGEKAPNVVYKGKLENQ-RRIAVKRFNR------MA-WPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~-~~vAiK~l~~------~~-~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~l 133 (449)
++.+|.|..+.||++...+| +.|.||.-.. .. ....+++..|.+.|+.+. -.++++++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 45789999999999998766 5899998542 11 124567888999988873 24677777773 455789
Q ss_pred EEeeCCCCC
Q 013126 134 VAEYMPNET 142 (449)
Q Consensus 134 V~Ey~~ggs 142 (449)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00079 Score=65.85 Aligned_cols=158 Identities=12% Similarity=0.114 Sum_probs=87.0
Q ss_pred ccCHHHHHHhhCCCcc--cccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC--cccc
Q 013126 46 EFTLEQLKNATSGFAV--ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNL 121 (449)
Q Consensus 46 ~~~~~~l~~~~~~f~~--~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l 121 (449)
..+.+++......|.. ..-++.++.|....+|+....+| .+++|+... ...+....|+..++.|...+ +.+.
T Consensus 6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 3455666555555533 12245567788889999886555 688998762 22344455666666663222 3343
Q ss_pred ee------eEeeCCeeEEEEeeCCCCCHH-----------HHHh---cc-CC--------CCCCH-HHHH----------
Q 013126 122 LG------CCCEGDERLLVAEYMPNETLA-----------KHLF---HW-ET--------HPMKW-AMRL---------- 161 (449)
Q Consensus 122 ~~------~~~~~~~~~lV~Ey~~ggsL~-----------~~l~---~~-~~--------~~l~~-~~~~---------- 161 (449)
+. +....+..++++||++|..+. +.+. .. .. ..+.+ ....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 122345679999999986431 1111 00 00 01111 1110
Q ss_pred --HHHHH-HHHHHHHHH-------hCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 162 --RVVLH-LAQALEYCT-------SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 162 --~i~~q-i~~aL~yLH-------~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
..+.+ +...++.+. ..+ ++|+|+.|.||+++++...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~-liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRG-VIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcc-cCCCCCCCCcEEEECCceEEEEecccccC
Confidence 01111 111222322 135 99999999999999776668999997643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00052 Score=66.62 Aligned_cols=74 Identities=20% Similarity=0.255 Sum_probs=50.5
Q ss_pred cccCCccceEEEEEEEcC-------CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC-cccceeeEeeCCeeEEEEee
Q 013126 66 SEHGEKAPNVVYKGKLEN-------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~-------~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey 137 (449)
+.+..|-...+|+....+ ++.+++|+..... ....+..+|.++++.+...+ ..++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 455678888999998654 5789999976543 22345678888888885433 3455555532 368999
Q ss_pred CCCCCHH
Q 013126 138 MPNETLA 144 (449)
Q Consensus 138 ~~ggsL~ 144 (449)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9987664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00057 Score=66.36 Aligned_cols=143 Identities=16% Similarity=0.201 Sum_probs=102.0
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCC---------------------CCCH-----HHHHHHHHHHhccC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA---------------------WPDP-----RQFLEEARSVGQLR 114 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~---------------------~~~~-----~~~~~E~~~l~~l~ 114 (449)
.-++-+.|..|--+.||.|.-.+|..+|||+++... .... -....|++.|+++.
T Consensus 145 i~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 145 IVEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred eeecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 345567788899999999998889999999986421 0011 12457889999998
Q ss_pred CCCcccceeeEeeCCeeEEEEeeCCCCC-HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC
Q 013126 115 NNRLTNLLGCCCEGDERLLVAEYMPNET-LAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193 (449)
Q Consensus 115 HpnIv~l~~~~~~~~~~~lV~Ey~~ggs-L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~ 193 (449)
...|.-.--... ....|||+|+-+.. -.-.| +...++...+..+-.|++.-+.-|-...++||.||.--|+|+.
T Consensus 225 ~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 225 NAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred hcCCCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 777654332222 23479999994221 11122 4556777888888899999999887765699999999999987
Q ss_pred CCCCeEEeccCCcccC
Q 013126 194 EDGNPRLSTFGLMKNS 209 (449)
Q Consensus 194 ~~~~~kL~DFGla~~~ 209 (449)
+|.+.++|-+-+...
T Consensus 300 -dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEH 314 (520)
T ss_pred -CCEEEEEEccccccC
Confidence 568999998866543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00035 Score=66.72 Aligned_cols=151 Identities=15% Similarity=0.116 Sum_probs=106.4
Q ss_pred cccCHHHHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCC--------------------CCC--HHH
Q 013126 45 REFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA--------------------WPD--PRQ 102 (449)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~--------------------~~~--~~~ 102 (449)
..+.+=.++...+.=..+.+..+||=|--+.||.+.+.+|++.++|.-+... |.- .-.
T Consensus 77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla 156 (465)
T KOG2268|consen 77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA 156 (465)
T ss_pred ccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence 4455666677776666777888999999999999999889999999753211 000 112
Q ss_pred HHHHHHHHhccC-C-CCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 013126 103 FLEEARSVGQLR-N-NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180 (449)
Q Consensus 103 ~~~E~~~l~~l~-H-pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~i 180 (449)
..+|...|+.|. | --+++.+++. ..++|||++.|-.|...-. ..+..+ +...+..-+--|-.+| +
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~-----v~d~~~---ly~~lm~~Iv~la~~G-l 223 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRH-----VEDPPT---LYDDLMGLIVRLANHG-L 223 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeee-----cCChHH---HHHHHHHHHHHHHHcC-c
Confidence 457888888884 3 3456666553 4589999999887765321 122222 3334444455667888 9
Q ss_pred cccccccCceeeCCCCCeEEeccCCccc
Q 013126 181 LYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 181 iHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
||+|..-=||++++++.++++||.-...
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhhc
Confidence 9999999999999999999999985443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.004 Score=60.38 Aligned_cols=154 Identities=14% Similarity=0.110 Sum_probs=90.0
Q ss_pred CCCcccccccccCCccceEEEEEEEcCCCEEEEEEecC--CCCCCHHHHHHHHHHHhccCC--CCcccceeeEeeCC--e
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRN--NRLTNLLGCCCEGD--E 130 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~--~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~--~ 130 (449)
..+....+++.+..|....+|..... ++.++++ .+. ..........+|..+++.+.- .-+...++.+.++. .
T Consensus 22 p~~~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~ 99 (321)
T COG3173 22 PGYAGLLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGT 99 (321)
T ss_pred cCcCCCceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCC
Confidence 34455556666655655556666543 7888888 332 222334566778888888743 34555666676665 6
Q ss_pred eEEEEeeCCCCCHHH------------------HHhccC------------CCCCCHHHHHHHHH--------------H
Q 013126 131 RLLVAEYMPNETLAK------------------HLFHWE------------THPMKWAMRLRVVL--------------H 166 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~------------------~l~~~~------------~~~l~~~~~~~i~~--------------q 166 (449)
.+.||+|++|..+.+ .|..-+ .......+...+.. .
T Consensus 100 pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 100 PFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 799999999732222 111100 00000111111111 1
Q ss_pred HHHHHHHHHhCC-------CccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 167 LAQALEYCTSKG-------RALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 167 i~~aL~yLH~~~-------~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
...-..+++.+. .++|+|+.+.|++++.++-+=+.||+++..-.+.
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 122344554432 2899999999999998888999999998765443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00011 Score=82.17 Aligned_cols=170 Identities=10% Similarity=-0.070 Sum_probs=121.5
Q ss_pred EEEEEecCCCCCC-----HHHHHHHHHHHhccCCCCcccceeeEee--CCeeEEEEeeCCCCCHHHHHhccC--CCCCCH
Q 013126 87 IAVKRFNRMAWPD-----PRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVAEYMPNETLAKHLFHWE--THPMKW 157 (449)
Q Consensus 87 vAiK~l~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ggsL~~~l~~~~--~~~l~~ 157 (449)
+-+|+.+..+.+. .+....|...++...|+++.....-... ...-+.+++|+.+|.+.+.|.+.. ..++..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 3556655433222 2334556666777789998877665543 234689999999999999987532 233444
Q ss_pred HHHHHHHHHHHHHHHHHHhCCC----ccccccccCceeeCCCCCeEEeccCCcccCCCCC----ccccCccccccccccC
Q 013126 158 AMRLRVVLHLAQALEYCTSKGR----ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----SYSTNLAFTPPEYLRT 229 (449)
Q Consensus 158 ~~~~~i~~qi~~aL~yLH~~~~----iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----~~~gt~~y~aPE~~~~ 229 (449)
.-+.....+...+..-+|+... .+|+++|+.|.+|..+..+|++++|+.+...+.. ...+++.|+.|+....
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH
Confidence 3444444444666666665321 6899999999999999999999999999544443 3445778999999887
Q ss_pred CCCCCCCceeeHhHHHHHHhcCCCCCC
Q 013126 230 GRVTPESVIYSFGTLLLDLLSGKHIPP 256 (449)
Q Consensus 230 ~~~~~~sDvwSlGvil~elltg~~p~~ 256 (449)
-.++.++|+|..|+-+|+.--|..++-
T Consensus 1415 ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1415 IKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 788989999999999999988886653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0033 Score=60.17 Aligned_cols=45 Identities=13% Similarity=-0.006 Sum_probs=31.2
Q ss_pred cCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC
Q 013126 68 HGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR 114 (449)
Q Consensus 68 lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~ 114 (449)
.++|-...|+.....+|+.+++|.-+... ......+|+++++.+.
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~~--~~~~l~rE~~vL~~L~ 63 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRRPD--VSERAAAEKRVLALVR 63 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCCHH--HHHHHHHHHHHHHHHH
Confidence 35555566676655568899999875322 2456889999999995
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0099 Score=59.57 Aligned_cols=74 Identities=15% Similarity=0.169 Sum_probs=52.2
Q ss_pred cccccCCccceEEEEEEEcCCCEEEEEEecCCC------C-CCHHHHHHHHHHHhccC---CCCcccceeeEeeCCeeEE
Q 013126 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA------W-PDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~------~-~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~l 133 (449)
-.+.+|.|....||+.... ++.++||.-.... + .+..+-..|++.|+.+. ..++++++.++. +.-++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3567899999999998864 5579999875211 1 13445556677777664 257888888876 44578
Q ss_pred EEeeCCC
Q 013126 134 VAEYMPN 140 (449)
Q Consensus 134 V~Ey~~g 140 (449)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0044 Score=61.33 Aligned_cols=138 Identities=17% Similarity=0.184 Sum_probs=82.0
Q ss_pred ccccCCccceEEEEEEEcC-----CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCc-ccceeeEeeCCeeEEEEeeC
Q 013126 65 VSEHGEKAPNVVYKGKLEN-----QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~-----~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~ 138 (449)
+..+-.|-...+|+....+ ++.|++|+......... +-.+|..+++.+..-++ .++++.+..+ .|.||+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 4455668889999987532 36899998865432222 23678999998864444 3556655332 589999
Q ss_pred CCCCHHHH--------------HhccCCC-------CCCHHHHHHHHHHH-----------------HHHHHHH----Hh
Q 013126 139 PNETLAKH--------------LFHWETH-------PMKWAMRLRVVLHL-----------------AQALEYC----TS 176 (449)
Q Consensus 139 ~ggsL~~~--------------l~~~~~~-------~l~~~~~~~i~~qi-----------------~~aL~yL----H~ 176 (449)
+|.+|... +.+-... ...+.+..++..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 88776421 0000000 11123333333222 1111112 11
Q ss_pred ----CCCccccccccCceeeCC-CCCeEEeccCCccc
Q 013126 177 ----KGRALYHDLNAYRILFDE-DGNPRLSTFGLMKN 208 (449)
Q Consensus 177 ----~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~ 208 (449)
.. ++|+|+++.||++++ ++.+.++||..+..
T Consensus 196 ~~~~~~-~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIG-FCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCce-EEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 23 899999999999986 57899999987643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.013 Score=57.03 Aligned_cols=64 Identities=19% Similarity=0.303 Sum_probs=40.2
Q ss_pred EEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCC--Ccccceee------EeeCCeeEEEEeeCCCCCH
Q 013126 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN--RLTNLLGC------CCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 75 ~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~------~~~~~~~~lV~Ey~~ggsL 143 (449)
.||+....+| .+++|+... ..+....|...+..|... .+++++.. ...++..+.++||++|.++
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 3898886444 688998752 234556677777777433 33444322 2235668999999998544
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.004 Score=59.84 Aligned_cols=75 Identities=16% Similarity=0.168 Sum_probs=49.7
Q ss_pred ccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC---CCCcccceeeEeeCCeeEEEEeeCC
Q 013126 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
+-++.++.|.-+.+|+.. .+++.+.+|.-.. .....|..|++-|+.|. --.+++++++...++..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 334566889999999988 4678999999762 22457889999999883 3558889999888888899999998
Q ss_pred CC
Q 013126 140 NE 141 (449)
Q Consensus 140 gg 141 (449)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 65
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.013 Score=57.77 Aligned_cols=72 Identities=14% Similarity=0.064 Sum_probs=49.0
Q ss_pred ccCCccceEEEEEEEcCC-CEEEEEEecC------CC-CCCHHHHHHHHHHHhccC--CC-CcccceeeEeeCCeeEEEE
Q 013126 67 EHGEKAPNVVYKGKLENQ-RRIAVKRFNR------MA-WPDPRQFLEEARSVGQLR--NN-RLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~~~~~-~~vAiK~l~~------~~-~~~~~~~~~E~~~l~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 135 (449)
++|.|....||++..++| +.|+||.-.. .. .-..++..-|.+.|+... -| .+++++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 6899997532 11 223566677888887763 24 45555544 445667999
Q ss_pred eeCCC
Q 013126 136 EYMPN 140 (449)
Q Consensus 136 Ey~~g 140 (449)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.014 Score=57.54 Aligned_cols=138 Identities=15% Similarity=0.173 Sum_probs=79.4
Q ss_pred cccCCccceEEEEEEEcC----CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCc-ccceeeEeeCCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~g 140 (449)
+.+..|-...+|+....+ +..|++|+...... ..-+-.+|..+++.+..-++ +++++++.. + +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 445568788899987533 24899998765432 22234578899998865555 455665532 2 58999987
Q ss_pred CCHHH--------------HHhccCCCC------C-CHHHHHHHHHHH----------------------HH---HHHHH
Q 013126 141 ETLAK--------------HLFHWETHP------M-KWAMRLRVVLHL----------------------AQ---ALEYC 174 (449)
Q Consensus 141 gsL~~--------------~l~~~~~~~------l-~~~~~~~i~~qi----------------------~~---aL~yL 174 (449)
.+|.. .+++-...+ . .+....++..++ .. .+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76532 111101111 1 123333322221 11 11111
Q ss_pred H-hCC-C--ccccccccCceeeCC-CCCeEEeccCCccc
Q 013126 175 T-SKG-R--ALYHDLNAYRILFDE-DGNPRLSTFGLMKN 208 (449)
Q Consensus 175 H-~~~-~--iiHrDlkp~NILl~~-~~~~kL~DFGla~~ 208 (449)
. ..+ + .+|.|+.+.||++++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 111 1 699999999999974 57899999987643
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.026 Score=51.74 Aligned_cols=75 Identities=21% Similarity=0.251 Sum_probs=53.0
Q ss_pred cccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC---CCCcccceeeEeeCCeeEEEEeeCCCCC
Q 013126 66 SEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
+++..|.-...|...+ +..++-+|+=.. +....|..|+.-|..+. .-++.+++.+..+.++.|+||||.+-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3445555555555554 456788888432 33467889998888884 3568888888889999999999998755
Q ss_pred HH
Q 013126 143 LA 144 (449)
Q Consensus 143 L~ 144 (449)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 44
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.021 Score=56.97 Aligned_cols=74 Identities=14% Similarity=0.052 Sum_probs=51.3
Q ss_pred ccccCCccceEEEEEEEcC-CCEEEEEEecC-----CC-CCCHHHHHHHHHHHhccC--CC-CcccceeeEeeCCeeEEE
Q 013126 65 VSEHGEKAPNVVYKGKLEN-QRRIAVKRFNR-----MA-WPDPRQFLEEARSVGQLR--NN-RLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~-----~~-~~~~~~~~~E~~~l~~l~--Hp-nIv~l~~~~~~~~~~~lV 134 (449)
++.||.|.-..||++...+ ++.|+||.-.. .. .-..++..-|.+.|+... -| ++++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6788999999999999743 67899987532 12 223567778888888773 24 45556654 44556788
Q ss_pred EeeCCC
Q 013126 135 AEYMPN 140 (449)
Q Consensus 135 ~Ey~~g 140 (449)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.017 Score=52.53 Aligned_cols=113 Identities=13% Similarity=0.071 Sum_probs=71.2
Q ss_pred cceEEEEEEEcCCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhcc
Q 013126 72 APNVVYKGKLENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHW 150 (449)
Q Consensus 72 ~~g~Vy~~~~~~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~ 150 (449)
+.++.-.++.+-| +..+|+++..... ....|.++.++++++. .|+++..- .+-.+.++.|+|-...
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------- 140 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------- 140 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc--------
Confidence 3444444443222 4566776654433 4566788888888774 46666521 3334678999985221
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccC
Q 013126 151 ETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFG 204 (449)
Q Consensus 151 ~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFG 204 (449)
-.+ .- ++..=+.+|.-.|+ +++.+|+|-.|+||+-|+.|-+||.|-+
T Consensus 141 ---i~~---~N-~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 141 ---INF---SN-FITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred ---cch---hH-HHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 111 11 12222467788894 4459999999999999999999999865
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.015 Score=56.64 Aligned_cols=75 Identities=19% Similarity=0.103 Sum_probs=59.5
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
.+.|++|++. |+++.. + ..-.++++..++.+-+.-++-+..+-+.-|||+.-.||||+ +|++.|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4567788876 454432 2 23457889999999999888888876799999999999999 99999999999985
Q ss_pred CCC
Q 013126 209 SRD 211 (449)
Q Consensus 209 ~~~ 211 (449)
...
T Consensus 371 ~~~ 373 (488)
T COG5072 371 SYS 373 (488)
T ss_pred ccC
Confidence 433
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.11 Score=58.71 Aligned_cols=159 Identities=16% Similarity=0.248 Sum_probs=86.9
Q ss_pred ccCHHHHHHhh-CCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC--CCC--ccc
Q 013126 46 EFTLEQLKNAT-SGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR--NNR--LTN 120 (449)
Q Consensus 46 ~~~~~~l~~~~-~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~--Hpn--Iv~ 120 (449)
.++.+++.... ..|....-++.|+ |..-.+|+....+|+.+++|+.+... .......|.+.+..|. ++. +.+
T Consensus 10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~ 86 (1013)
T PRK06148 10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPR 86 (1013)
T ss_pred CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCe
Confidence 34554443332 3333323345665 45688999987778899999997643 2334445556666552 122 222
Q ss_pred ce----ee----Eee-CC--eeEEEEeeCCCCCHHHHH-------hc--------------cC----CCCCCHH------
Q 013126 121 LL----GC----CCE-GD--ERLLVAEYMPNETLAKHL-------FH--------------WE----THPMKWA------ 158 (449)
Q Consensus 121 l~----~~----~~~-~~--~~~lV~Ey~~ggsL~~~l-------~~--------------~~----~~~l~~~------ 158 (449)
++ |- ... ++ ..+-+++|++|..+.+.. .. .. ...+.|.
T Consensus 87 ~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~ 166 (1013)
T PRK06148 87 LIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGR 166 (1013)
T ss_pred eeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchh
Confidence 22 11 111 12 467789999998776511 00 00 1112221
Q ss_pred -----------HHHHHHHHHHHHHHH-----HHh--CCCccccccccCceeeCCCC--CeE-EeccCCccc
Q 013126 159 -----------MRLRVVLHLAQALEY-----CTS--KGRALYHDLNAYRILFDEDG--NPR-LSTFGLMKN 208 (449)
Q Consensus 159 -----------~~~~i~~qi~~aL~y-----LH~--~~~iiHrDlkp~NILl~~~~--~~k-L~DFGla~~ 208 (449)
..+.++.++.....- +.. .+ +||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 167 l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~-vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 167 ARDRLHFIDDPEDRALVERFLARFERNVAPRLAALPAQ-VIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred hhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcCCcc-eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 112223333332221 111 35 99999999999999775 454 999998754
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.02 Score=56.62 Aligned_cols=60 Identities=17% Similarity=0.053 Sum_probs=44.6
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDE 194 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~ 194 (449)
..++-+|.+|.++..++. ....++....+++.-.++|+--+-- .+ .+|.|+.|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~---~~~~pe~l~kkva~lg~~AllkMl~vDN-FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVK---WKSQPEALVKKVAKLGVNALLKMLIVDN-FVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhh---cccChHHHHHHHHHHHHHHHHHHHHhhc-ceecccCCCcEEEEe
Confidence 357778999999999984 3445556677777766777655443 44 999999999999963
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.47 Score=46.54 Aligned_cols=97 Identities=19% Similarity=0.153 Sum_probs=57.8
Q ss_pred ccccCHHHHHHhhCCCccc--ccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCC--Ccc
Q 013126 44 FREFTLEQLKNATSGFAVE--NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN--RLT 119 (449)
Q Consensus 44 ~~~~~~~~l~~~~~~f~~~--~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv 119 (449)
+..++.+.+..+.....-. .-+..|+ +.-..||+....++..+++|+.+... ........|++.+..+... .++
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~-s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~ 85 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALN-SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV 85 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeec-cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 3456666666665443211 1122333 34567999988778889999986433 2456777888888777422 122
Q ss_pred cce---e--eEeeCCeeEEEEeeCCCCC
Q 013126 120 NLL---G--CCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 120 ~l~---~--~~~~~~~~~lV~Ey~~ggs 142 (449)
... | ....++..+.++++++|..
T Consensus 86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 86 APLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 221 2 2233456788999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.1 Score=50.82 Aligned_cols=29 Identities=17% Similarity=0.179 Sum_probs=26.6
Q ss_pred ccccccccCceeeCCCCCeEEeccCCccc
Q 013126 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 180 iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
++|+|+.+.|+++++++.+.++||..+..
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 99999999999999999999999987654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.033 Score=50.93 Aligned_cols=119 Identities=18% Similarity=0.178 Sum_probs=61.3
Q ss_pred CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCc-ccceeeEeeCCeeEEEEeeCCCCCHHHH-Hhc------------
Q 013126 84 QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYMPNETLAKH-LFH------------ 149 (449)
Q Consensus 84 ~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~ggsL~~~-l~~------------ 149 (449)
++.|++|+..... ...-.-.+|..+++.+...++ .++++.+.. ..|.||++|.+|... +..
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678999986653 344566789999998865444 556665533 267799987765321 100
Q ss_pred ------c---CCCCCCHHHHHHH----------------------HHHHHHHHHHHHh--------CCCccccccccCce
Q 013126 150 ------W---ETHPMKWAMRLRV----------------------VLHLAQALEYCTS--------KGRALYHDLNAYRI 190 (449)
Q Consensus 150 ------~---~~~~l~~~~~~~i----------------------~~qi~~aL~yLH~--------~~~iiHrDlkp~NI 190 (449)
. ....--+.....+ ...+..-+..+.. .. +.|+|+.|.||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v-~cHnDl~~~Ni 155 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLV-FCHNDLNPGNI 155 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEE-EE-S--SGGGE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCce-EeeccCccccE
Confidence 0 0000011222222 1112222222221 23 79999999999
Q ss_pred ee-CCCCCeEEeccCCccc
Q 013126 191 LF-DEDGNPRLSTFGLMKN 208 (449)
Q Consensus 191 Ll-~~~~~~kL~DFGla~~ 208 (449)
++ +.++.++++||..+..
T Consensus 156 l~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 156 LINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EETSSSSCEEE--GTT-EE
T ss_pred EeccCCCeEEEecHHHHhh
Confidence 99 7899999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.15 Score=50.05 Aligned_cols=139 Identities=17% Similarity=0.210 Sum_probs=82.4
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCc------ccceee--EeeCC--eeEEE
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL------TNLLGC--CCEGD--ERLLV 134 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI------v~l~~~--~~~~~--~~~lV 134 (449)
...|.+ .-..+|+....+|+. ++|+.+.. ....+..-|...+..+.-.+| ...=|- ..-.+ ..+-+
T Consensus 31 ~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 31 LRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred cccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 334444 456799999866665 89998765 345667778888887732221 111111 11123 77889
Q ss_pred EeeCCCCCHHH-H----Hh----------cc-CC---------CCCCHHH-------------HHHHHHHHHHHHHHHHh
Q 013126 135 AEYMPNETLAK-H----LF----------HW-ET---------HPMKWAM-------------RLRVVLHLAQALEYCTS 176 (449)
Q Consensus 135 ~Ey~~ggsL~~-~----l~----------~~-~~---------~~l~~~~-------------~~~i~~qi~~aL~yLH~ 176 (449)
++|++|..+.. . +. .. ++ ....|.. ......++...+..+.+
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 99999887762 1 10 00 00 0112220 01123344444555443
Q ss_pred C-------CC--ccccccccCceeeCCCCC-eEEeccCCcc
Q 013126 177 K-------GR--ALYHDLNAYRILFDEDGN-PRLSTFGLMK 207 (449)
Q Consensus 177 ~-------~~--iiHrDlkp~NILl~~~~~-~kL~DFGla~ 207 (449)
. +. +||+|+.|.||+++.+.. ..++|||-+.
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 12 899999999999998874 8999999764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.024 Score=57.65 Aligned_cols=49 Identities=18% Similarity=0.193 Sum_probs=39.5
Q ss_pred HHHHHHHHHHHhccCCCCcccceeeEeeC-CeeEEEEeeCCCCCHHHHHhc
Q 013126 100 PRQFLEEARSVGQLRNNRLTNLLGCCCEG-DERLLVAEYMPNETLAKHLFH 149 (449)
Q Consensus 100 ~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~Ey~~ggsL~~~l~~ 149 (449)
..+.+-..+.++.+.|+|....+++.... ....+|||++. .||.+.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHh
Confidence 45677778899999999999998887654 34688999995 899998863
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.2 Score=50.24 Aligned_cols=76 Identities=14% Similarity=0.236 Sum_probs=47.0
Q ss_pred cccccCCccceEEEEEEEcCC--CE-----EEEEEecCCCCCCHHHHHHHHHHHhccCCCCc-ccceeeEeeCCeeEEEE
Q 013126 64 IVSEHGEKAPNVVYKGKLENQ--RR-----IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVA 135 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~~--~~-----vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~ 135 (449)
-++.+..|-.+.+|++...++ .. |.++...... .-.-+-.+|+++++.+...++ .++++.+.. +++.
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ 128 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ 128 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence 345666788899999975432 22 4444432111 111233578999999965544 456666543 6999
Q ss_pred eeCCCCCHH
Q 013126 136 EYMPNETLA 144 (449)
Q Consensus 136 Ey~~ggsL~ 144 (449)
||++|.+|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 449 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-24 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 449 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 6e-62 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-61 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-58 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-26 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-24 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-24 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-23 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-21 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-21 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-21 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 9e-21 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-20 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-20 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-20 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-18 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-18 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-18 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-18 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-17 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-17 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-17 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-17 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-17 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-16 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 8e-16 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-15 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-15 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-15 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-15 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-15 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-14 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-14 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-14 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-14 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 8e-14 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 9e-14 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-13 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-13 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-13 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-13 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-13 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 6e-13 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-13 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-13 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-13 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 7e-13 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-12 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-12 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-12 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-12 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-12 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-12 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-12 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-12 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-12 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 6e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-12 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-12 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-12 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-11 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-11 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-11 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-11 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-10 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-10 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-10 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 9e-10 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-09 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-09 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-09 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-09 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-09 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-09 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 9e-09 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-08 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-08 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-08 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-08 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 7e-08 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-08 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 8e-08 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-07 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-07 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-07 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-07 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-07 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-07 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-07 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-07 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 7e-07 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-07 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-06 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-06 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-06 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-06 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-06 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-06 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-06 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-06 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 8e-06 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 8e-06 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 9e-06 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 9e-06 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 9e-06 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-05 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-05 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-05 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-05 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-05 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-05 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-05 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-05 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-05 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-05 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-05 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-05 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-05 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-04 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-04 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-04 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-04 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-04 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-04 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-04 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-04 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-04 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-04 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-04 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-04 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-04 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-04 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-62
Identities = 88/311 (28%), Positives = 144/311 (46%), Gaps = 30/311 (9%)
Query: 26 DVDAAENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQR 85
DV A E+ E+ L + F+L +L+ A+ F+ +NI+ G VYKG+L +
Sbjct: 3 DVPAEEDPEVH----LGQLKRFSLRELQVASDNFSNKNIL---GRGGFGKVYKGRLADGT 55
Query: 86 RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLA 144
+AVKR QF E + + L L G C ERLLV YM N ++A
Sbjct: 56 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115
Query: 145 KHLF--HWETHPMKWAMRLRVVLHLAQALEY--CTSKGRALYHDLNAYRILFDEDGNPRL 200
L P+ W R R+ L A+ L Y + ++ D+ A IL DE+ +
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 201 STFGLMKNSRDGKSY-STNLAFT----PPEYLRTGRVTPESVIYSFGTLLLDLLSGK--- 252
FGL K ++ +T + T PEYL TG+ + ++ ++ +G +LL+L++G+
Sbjct: 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
Query: 253 --HIPP--------SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
L++++ L+ L D L+G + D++ +L+++A C Q P E
Sbjct: 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPME 295
Query: 303 RPNPKSLVTAL 313
RP +V L
Sbjct: 296 RPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-61
Identities = 85/317 (26%), Positives = 142/317 (44%), Gaps = 42/317 (13%)
Query: 31 ENDEMSEVDGLPSFREFTLEQLKNATSGFAVENIVSEH---GEKAPNVVYKGKLENQRRI 87
EN + D F F+ +LKN T+ F I GE VVYKG + N +
Sbjct: 1 ENKSLEVSDT--RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-V 57
Query: 88 AVKRFNRMAWPDP----RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETL 143
AVK+ M +QF +E + + + ++ L LLG +GD+ LV YMPN +L
Sbjct: 58 AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 144 AKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR------ILFDEDG 196
L + T P+ W MR ++ A + + L+ + + +R IL DE
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINF-------LHENHHIHRDIKSANILLDEAF 170
Query: 197 NPRLSTFGLMK-NSRDGKSY-STNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLS 250
++S FGL + + + ++ ++ + T PE L G +TP+S IYSFG +LL++++
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT 229
Query: 251 GK-----HIPPSHALD-----LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
G H P LD ++ ++ D + + +AS+CL +
Sbjct: 230 GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKK 288
Query: 301 RERPNPKSLVTALSPLQ 317
+RP+ K + L +
Sbjct: 289 NKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 2e-58
Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 23/288 (7%)
Query: 45 REFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFL 104
L L+ AT+ F + ++ G VYKG L + ++A+KR + +F
Sbjct: 27 YRVPLVDLEEATNNFDHKFLI---GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 105 EEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLF--HWETHPMKWAMRLR 162
E ++ R+ L +L+G C E +E +L+ +YM N L +HL+ T M W RL
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 163 VVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-NSRDGKSY-STNLA 220
+ + A+ L Y ++ D+ + IL DE+ P+++ FG+ K + +++ ST +
Sbjct: 144 ICIGAARGLHY-LHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 221 FTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGK----HIPPSH-------ALDLIRD 265
T PEY GR+T +S +YSFG +L ++L + P A++ +
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
L+ + D L + + + A +CL +RP+ ++ L
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 51/325 (15%), Positives = 104/325 (32%), Gaps = 57/325 (17%)
Query: 43 SFREFTLEQLKNATSGFAVENIVSE--HGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDP 100
S + E L + + + + G V+K +L N+ +AVK F D
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGC-----VWKAQLLNEY-VAVKIFP---IQDK 60
Query: 101 RQFLEEA--RSVGQLRNNRLTNLLGCCCEGD----ERLLVAEYMPNETLAKHLFHWETHP 154
+ + E S+ +++ + +G G + L+ + +L+ L +
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NV 117
Query: 155 MKWAMRLRVVLHLAQALEYCTSKGRALY--------H-DLNAYRILFDEDGNPRLSTFGL 205
+ W + +A+ L Y L H D+ + +L + ++ FGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 206 MKNSRDGKSYSTNLAFT------PPEYLRTGRVTPESV-----IYSFGTLLLDLLSGK-- 252
GKS PE L +Y+ G +L +L S
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 253 --------------HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT-ELVRLASRCLQ 297
I +L+ +++ + L + G L C
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297
Query: 298 YEPRERPNPKSLVTALSPLQKETEV 322
++ R + + ++ +Q+ T +
Sbjct: 298 HDAEARLSAGCVGERITQMQRLTNI 322
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 46/258 (17%), Positives = 92/258 (35%), Gaps = 24/258 (9%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
++KG+ + I VK W R F EE + + + +LG C
Sbjct: 25 ELWKGRWQGND-IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 133 L--VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+ +MP +L L + + ++ L +A+ + + + + LN+
Sbjct: 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV---IYSFGTLLL 246
++ DED R+S + K S A+ PE L+ ++SF LL
Sbjct: 144 VMIDEDMTARISMADV-KFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 247 DLLSGK----HIPPSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+L++ + + + L+ + + +L C+ +P
Sbjct: 203 ELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP---------HVSKLMKICMNEDPA 253
Query: 302 ERPNPKSLVTALSPLQKE 319
+RP +V L +Q +
Sbjct: 254 KRPKFDMIVPILEKMQDK 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 52/264 (19%), Positives = 109/264 (41%), Gaps = 23/264 (8%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDP--RQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
V++ + +AVK + +FL E + +LR+ + +G +
Sbjct: 52 TVHRAEWHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 133 LVAEYMPNETLAKHLFHWETH-PMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRI 190
+V EY+ +L + L + RL + +A+ + Y ++ + H +L + +
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLL 246
L D+ ++ FGL + S + A TP PE LR +S +YSFG +L
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 247 DLLSGK----HIPPSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+L + + ++ P+ + + + ++ + + ++ + C EP
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP---------QVAAIIEGCWTNEPW 281
Query: 302 ERPNPKSLVTALSPLQKETEVPSH 325
+RP+ +++ L PL K P +
Sbjct: 282 KRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 57/261 (21%), Positives = 105/261 (40%), Gaps = 28/261 (10%)
Query: 76 VYKGKLENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL- 132
VYKGK +AVK N + F E + + R+ + +G +L
Sbjct: 40 VYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLA 95
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
+V ++ +L HL H + + + A+ ++Y +K + H DL + I
Sbjct: 96 IVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIF 152
Query: 192 FDEDGNPRLSTFGL--MKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESV---IYSFG 242
ED ++ FGL K+ G L+ + PE +R P S +Y+FG
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 243 TLLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+L +L++G+ +I + + R S + + + RL + CL+
Sbjct: 213 IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS----KVRSNCPKRMKRLMAECLKK 268
Query: 299 EPRERPNPKSLVTALSPLQKE 319
+ ERP+ ++ + L +E
Sbjct: 269 KRDERPSFPRILAEIEELARE 289
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 51/259 (19%), Positives = 105/259 (40%), Gaps = 31/259 (11%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV K K + +A+K+ + + F+ E R + ++ + + L G C + LV
Sbjct: 23 VVCKAKWRAKD-VAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77
Query: 135 AEYMPNETLAKHLFHWETHP-MKWAMRLRVVLHLAQALEYC-TSKGRALYH-DLNAYRIL 191
EY +L L E P A + L +Q + Y + + +AL H DL +L
Sbjct: 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137
Query: 192 FDEDGN-PRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLL 246
G ++ FG + D +++ TN + PE + + ++S+G +L
Sbjct: 138 LVAGGTVLKICDFGT---ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194
Query: 247 DLLSGK------HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
++++ + P + + + L + + + L +RC +P
Sbjct: 195 EVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK---------PIESLMTRCWSKDP 245
Query: 301 RERPNPKSLVTALSPLQKE 319
+RP+ + +V ++ L +
Sbjct: 246 SQRPSMEEIVKIMTHLMRY 264
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 58/343 (16%), Positives = 103/343 (30%), Gaps = 68/343 (19%)
Query: 46 EFTLEQLKNATSGFAVENIVSE--HGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQF 103
E + + ++ +G VYKG L+ + +AVK F+ + + + F
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGA-----VYKGSLDERP-VAVKVFS---FANRQNF 52
Query: 104 LEEAR--SVGQLRNNRLTNLLGCCCEGD-----ERLLVAEYMPNETLAKHLFHWETHPMK 156
+ E V + ++ + + E LLV EY PN +L K+L H
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSD 109
Query: 157 WAMRLRVVLHLAQALEY-------CTSKGRALYH-DLNAYRILFDEDGNPRLSTFGL--- 205
W R+ + + L Y A+ H DLN+ +L DG +S FGL
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 206 -----MKNSRDGKSYSTNLAFTP----PEYLR-------TGRVTPESVIYSFGTLLLDLL 249
+ + + + + T PE L + +Y+ G + ++
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 250 SGKHI-----------PPSHALDLIRDRNLQMLTDSCLEGQ-------FTDDDGT--ELV 289
M E Q + ++ L
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 290 RLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIPH 332
C + R + ++ L E V H
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 47/272 (17%), Positives = 88/272 (32%), Gaps = 38/272 (13%)
Query: 76 VYKGKLENQRR-IAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
K + +K R R FL+E + + L + + +G + +
Sbjct: 26 AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
EY+ TL + W+ R+ +A + Y S + H DLN++ L
Sbjct: 86 TEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR 142
Query: 194 EDGNPRLSTFGL--------------MKNSRDGKSYSTNLAFTP----PEYLRTGRVTPE 235
E+ N ++ FGL + + + P PE + +
Sbjct: 143 ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK 202
Query: 236 SVIYSFGTLLLDLLSGKHIPP-----SHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELV 289
++SFG +L +++ + P + L L +C
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP---------SFF 253
Query: 290 RLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
+ RC +P +RP+ L L L+
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 49/263 (18%), Positives = 95/263 (36%), Gaps = 40/263 (15%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDP----RQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY+ +AVK D +EA+ L++ + L G C +
Sbjct: 22 KVYRAFWIGDE-VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA--LYHDLNAY 188
LV E+ L + L + + + + +A+ + Y + ++ DL +
Sbjct: 81 LCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 189 RILFDEDGNPRLST--------FGLMKNSRD-GKSYSTNLAFTP----PEYLRTGRVTPE 235
IL + + FGL +R+ ++ + A PE +R +
Sbjct: 138 NILILQKVENGDLSNKILKITDFGL---AREWHRTTKMSAAGAYAWMAPEVIRASMFSKG 194
Query: 236 SVIYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVR 290
S ++S+G LL +LL+G+ I + L + + +C E +
Sbjct: 195 SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE---------PFAK 245
Query: 291 LASRCLQYEPRERPNPKSLVTAL 313
L C +P RP+ +++ L
Sbjct: 246 LMEDCWNPDPHSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 56/269 (20%), Positives = 108/269 (40%), Gaps = 42/269 (15%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP-------RQFLEEARSVGQLRNNRLTNLLGCCC 126
+V+KG+ ++++ +A+K ++F E + L + + L G
Sbjct: 34 LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93
Query: 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DL 185
+V E++P L L + HP+KW+++LR++L +A +EY ++ + H DL
Sbjct: 94 NPP--RMVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150
Query: 186 NAYRILFDEDGNPRLST-----FGLMKNSRDGKSYSTNLAFTP----PEYL--RTGRVTP 234
+ I FGL S+ + L PE + T
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGL---SQQSVHSVSGLLGNFQWMAPETIGAEEESYTE 207
Query: 235 ESVIYSFGTLLLDLLSGK----HIPPSHA--LDLIRDRNLQM-LTDSCLEGQFTDDDGTE 287
++ YSF +L +L+G+ +++IR+ L+ + + C
Sbjct: 208 KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPP---------R 258
Query: 288 LVRLASRCLQYEPRERPNPKSLVTALSPL 316
L + C +P++RP+ +V LS L
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 46/279 (16%), Positives = 90/279 (32%), Gaps = 45/279 (16%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDP-----RQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
VY G+ + +A++ + + F E + Q R+ + +G C
Sbjct: 48 QVYHGRWHGE--VAIRLID---IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
++ TL + + ++ + + + Y +KG + H DL +
Sbjct: 103 HLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSK 159
Query: 189 RILFDEDGNPRLSTFGL--MKNSRDGKSYSTNLAFTP-------PEYLRTGRVTPESV-- 237
+ +D +G ++ FGL + L PE +R E
Sbjct: 160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218
Query: 238 -------IYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286
+++ GT+ +L + + P + + L+ G
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI--------GMGK 270
Query: 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSH 325
E+ + C +E ERP L+ L L K SH
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 67/258 (25%), Positives = 105/258 (40%), Gaps = 26/258 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G R+A+K P FL+EA+ + +LR+ +L L E + +V
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDE 194
EYM +L L ++ + + +A + Y H DL A IL E
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 315
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + A +T PE GR T +S ++SFG LL +L
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ +P LD + +R +M C E L L +C + EP ER
Sbjct: 376 TKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPE---------SLHDLMCQCWRKEPEER 425
Query: 304 PNPKSLVTALSPLQKETE 321
P + L L TE
Sbjct: 426 PTFEYLQAFLEDYFTSTE 443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 56/260 (21%), Positives = 112/260 (43%), Gaps = 26/260 (10%)
Query: 76 VYKGKLENQR-RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VY+G + +AVK + + +FL+EA + ++++ L LLG C ++
Sbjct: 236 VYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
E+M L +L + + L + ++ A+EY K H +L A L
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG 352
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDL 248
E+ +++ FGL + + A +T PE L + + +S +++FG LL ++
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 249 LSGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
+ P S +L+ +++ +M + C E ++ L C Q+ P +
Sbjct: 413 ATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPE---------KVYELMRACWQWNPSD 462
Query: 303 RPNPKSLVTALSPLQKETEV 322
RP+ + A + +E+ +
Sbjct: 463 RPSFAEIHQAFETMFQESSI 482
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 67/258 (25%), Positives = 105/258 (40%), Gaps = 26/258 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G R+A+K P FL+EA+ + +LR+ +L L E + +V
Sbjct: 283 VWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDE 194
EYM +L L ++ + + +A + Y H DL A IL E
Sbjct: 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE 398
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + A +T PE GR T +S ++SFG LL +L
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ +P LD + +R +M C E L L +C + EP ER
Sbjct: 459 TKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPE---------SLHDLMCQCWRKEPEER 508
Query: 304 PNPKSLVTALSPLQKETE 321
P + L L TE
Sbjct: 509 PTFEYLQAFLEDYFTSTE 526
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 56/258 (21%), Positives = 104/258 (40%), Gaps = 26/258 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ ++AVK + FL EA + L++++L L + + ++
Sbjct: 204 VWMATYNKHTKVAVKT-MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 261
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDE 194
E+M +L L E + +A+ + + + H DL A IL
Sbjct: 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSA 319
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+++ FGL + D + + A +T PE + G T +S ++SFG LL++++
Sbjct: 320 SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ IP + + +R +M ++C E EL + RC + P ER
Sbjct: 380 TYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPE---------ELYNIMMRCWKNRPEER 429
Query: 304 PNPKSLVTALSPLQKETE 321
P + + + L TE
Sbjct: 430 PTFEYIQSVLDDFYTATE 447
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 56/260 (21%), Positives = 106/260 (40%), Gaps = 24/260 (9%)
Query: 75 VVYKGKLENQR-RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VY+G + +AVK + +FL+EA + ++++ L LLG C +
Sbjct: 28 EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILF 192
+ E+M L +L + + L + ++ A+EY K H DL A L
Sbjct: 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV 144
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLD 247
E+ +++ FGL + + A +T PE L + + +S +++FG LL +
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 248 LLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
+ + P S +L+ + C E ++ L C Q+ P +
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE---------KVYELMRACWQWNPSD 255
Query: 303 RPNPKSLVTALSPLQKETEV 322
RP+ + A + +E+ +
Sbjct: 256 RPSFAEIHQAFETMFQESSI 275
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 51/257 (19%), Positives = 110/257 (42%), Gaps = 26/257 (10%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV GK + Q +AVK + +F +EA+++ +L + +L G C + +V
Sbjct: 23 VVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
EY+ N L +L ++ + L + + + + + S H DL A L D
Sbjct: 82 TEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD 138
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDL 248
D ++S FG+ + D + S+ ++ PE + + +S +++FG L+ ++
Sbjct: 139 RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198
Query: 249 LSGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
S +P S + + + ++ + + ++ C P +
Sbjct: 199 FSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASD---------TIYQIMYSCWHELPEK 248
Query: 303 RPNPKSLVTALSPLQKE 319
RP + L++++ PL+++
Sbjct: 249 RPTFQQLLSSIEPLREK 265
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 65/256 (25%), Positives = 103/256 (40%), Gaps = 30/256 (11%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-LV 134
V G + +AVK A + FL EA + QLR++ L LLG E L +V
Sbjct: 209 VMLGDYRGNK-VAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
EYM +L +L + L+ L + +A+EY H DL A +L
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS 323
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLAF----TPPEYLRTGRVTPESVIYSFGTLLLDLL 249
ED ++S FGL +++ S T PE LR + + +S ++SFG LL ++
Sbjct: 324 EDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 250 S-GKH----IPPSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
S G+ IP + + ++ +M D C + + C + R
Sbjct: 381 SFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPP---------AVYDVMKNCWHLDAATR 430
Query: 304 PNPKSLVTALSPLQKE 319
P L L ++
Sbjct: 431 PTFLQLREQLEHIRTH 446
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 65/257 (25%), Positives = 104/257 (40%), Gaps = 30/257 (11%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-L 133
V G + +AVK A + FL EA + QLR++ L LLG E L +
Sbjct: 36 DVMLGDYRGNK-VAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILF 192
V EYM +L +L + L+ L + +A+EY H DL A +L
Sbjct: 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV 150
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAF----TPPEYLRTGRVTPESVIYSFGTLLLDL 248
ED ++S FGL +++ S T PE LR + + +S ++SFG LL ++
Sbjct: 151 SEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 249 LS-GKH----IPPSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
S G+ IP + + ++ +M D C + + C +
Sbjct: 208 YSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAM 257
Query: 303 RPNPKSLVTALSPLQKE 319
RP+ L L ++
Sbjct: 258 RPSFLQLREQLEHIKTH 274
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 63/259 (24%), Positives = 107/259 (41%), Gaps = 28/259 (10%)
Query: 76 VYKGKLENQR-RIAVKRFNR-MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
V+ G+L +AVK + +FL+EAR + Q + + L+G C + +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILF 192
V E + L E ++ L++V A +EY SK H DL A L
Sbjct: 190 VMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV 246
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAF------TPPEYLRTGRVTPESVIYSFGTLLL 246
E ++S FG+ + DG ++ T PE L GR + ES ++SFG LL
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 247 DLLSGKHIP-----PSHALDLIRDRNLQM-LTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
+ S P + + ++ ++ + C + + RL +C YEP
Sbjct: 307 ETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPD---------AVFRLMEQCWAYEP 356
Query: 301 RERPNPKSLVTALSPLQKE 319
+RP+ ++ L ++K
Sbjct: 357 GQRPSFSTIYQELQSIRKR 375
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 26/258 (10%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135
V+ G ++AVK + + P FL EA + QL++ RL L + + ++
Sbjct: 29 VWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86
Query: 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDE 194
EYM N +L L + L + +A+ + + + H DL A IL +
Sbjct: 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSD 144
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + A +T PE + G T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+ IP + + +R +M+ D+C E EL +L C + P +R
Sbjct: 205 THGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDR 254
Query: 304 PNPKSLVTALSPLQKETE 321
P L + L TE
Sbjct: 255 PTFDYLRSVLEDFFTATE 272
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 7e-16
Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 26/257 (10%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV GK Q +A+K + +F+EEA+ + L + +L L G C + ++
Sbjct: 39 VVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
EYM N L +L H + L + + +A+EY SK H DL A L +
Sbjct: 98 TEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN 154
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+ G ++S FGL + D + S+ + ++PPE L + + +S I++FG L+ ++
Sbjct: 155 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214
Query: 249 LSGKHIP-P----SHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
S +P S + I + L++ E ++ + C + E
Sbjct: 215 YSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASE---------KVYTIMYSCWHEKADE 264
Query: 303 RPNPKSLVTALSPLQKE 319
RP K L++ + + E
Sbjct: 265 RPTFKILLSNILDVMDE 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 8e-16
Identities = 55/256 (21%), Positives = 105/256 (41%), Gaps = 26/256 (10%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
+V+ G N+ ++A+K A F+EEA + +L + +L L G C E LV
Sbjct: 23 LVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD 193
E+M + L+ +L + L + L + + + Y + H DL A L
Sbjct: 82 TEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG 138
Query: 194 EDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTLLLDL 248
E+ ++S FG+ + D + S+ + PE R + +S ++SFG L+ ++
Sbjct: 139 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 198
Query: 249 LSGKHIP-P----SHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
S IP S ++ I ++ + ++ + C + P +
Sbjct: 199 FSEGKIPYENRSNSEVVEDI-STGFRLYKPRLAST---------HVYQIMNHCWRERPED 248
Query: 303 RPNPKSLVTALSPLQK 318
RP L+ L+ + +
Sbjct: 249 RPAFSRLLRQLAEIAE 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 60/280 (21%), Positives = 103/280 (36%), Gaps = 37/280 (13%)
Query: 76 VYKGKL--------ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
++KG ++ + +K ++ F E A + +L + L G C
Sbjct: 24 IFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
GDE +LV E++ +L +L + + +L V LA A+ + L H ++
Sbjct: 84 GDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVC 140
Query: 187 AYRILFDEDGNPR--------LSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRV-TPESV 237
A IL + + + LS G+ + + PPE + + +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATD 200
Query: 238 IYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292
+SFGT L ++ SG P L DR Q EL L
Sbjct: 201 KWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-----------HQLPAPKAAELANLI 249
Query: 293 SRCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIPH 332
+ C+ YEP RP+ ++++ L+ L VP H
Sbjct: 250 NNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH 289
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 58/266 (21%), Positives = 103/266 (38%), Gaps = 32/266 (12%)
Query: 76 VYKGKL----ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY G+ +N+ + A+K +R+ FL E + L + + L+G +
Sbjct: 37 VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96
Query: 131 RLL-VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
+ YM + L + + + L +A+ +EY + H DL A
Sbjct: 97 LPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAAR 153
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--------TPPEYLRTGRVTPESVIYS 240
+ DE +++ FGL ++ D + YS T E L+T R T +S ++S
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWS 213
Query: 241 FGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
FG LL +LL+ G HI P + + C + L ++ +C
Sbjct: 214 FGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD---------SLYQVMQQC 264
Query: 296 LQYEPRERPNPKSLVTALSPLQKETE 321
+ +P RP + LV + +
Sbjct: 265 WEADPAVRPTFRVLVGEVEQIVSALL 290
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 32/266 (12%)
Query: 76 VYKGKL----ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY G L + AVK NR+ + QFL E + + + +LLG C +
Sbjct: 41 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100
Query: 131 -RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
L+V YM + L + ETH + L +A+ ++Y SK H DL A
Sbjct: 101 SPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAAR 157
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--------TPPEYLRTGRVTPESVIYS 240
+ DE +++ FGL ++ D + YS + E L+T + T +S ++S
Sbjct: 158 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 217
Query: 241 FGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
FG LL +L++ G + + + + C + L + +C
Sbjct: 218 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVMLKC 268
Query: 296 LQYEPRERPNPKSLVTALSPLQKETE 321
+ RP+ LV+ +S +
Sbjct: 269 WHPKAEMRPSFSELVSRISAIFSTFI 294
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 53/280 (18%), Positives = 104/280 (37%), Gaps = 45/280 (16%)
Query: 76 VYKGKL----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + +L + ++AVK + + +A D +FL EA + + + + L+G
Sbjct: 39 VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98
Query: 130 ER------LLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
+ +++ +M + L + +R ++ +A +EY +S+
Sbjct: 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN- 157
Query: 180 ALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSY---STNLAF----TPPEYLRT 229
H DL A + ED ++ FGL SR Y E L
Sbjct: 158 -FIHRDLAARNCMLAEDMTVCVADFGL---SRKIYSGDYYRQGCASKLPVKWLALESLAD 213
Query: 230 GRVTPESVIYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
T S +++FG + ++++ G+ I + + + N C+E
Sbjct: 214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECME------- 266
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPS 324
E+ L +C +P++RP+ L L + V S
Sbjct: 267 --EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 55/271 (20%), Positives = 104/271 (38%), Gaps = 38/271 (14%)
Query: 76 VYKGKLEN------QRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VY+G + + R+A+K N A + +FL EA + + + + LLG +G
Sbjct: 41 VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100
Query: 129 DERLLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLH----LAQALEYCTSKGRA 180
L++ E M L +P+ L ++ +A + Y +
Sbjct: 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158
Query: 181 LYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPEYLRTGRVT 233
H DL A + ED ++ FG+ ++ + Y PE L+ G T
Sbjct: 159 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218
Query: 234 PESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288
S ++SFG +L ++ + + + L + + L D+C + L
Sbjct: 219 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 269
Query: 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKE 319
L C QY P+ RP+ +++++ +
Sbjct: 270 FELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 54/263 (20%), Positives = 96/263 (36%), Gaps = 29/263 (11%)
Query: 76 VYKGKL----ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V++G +A+K R+ FL+EA ++ Q + + L+G +
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VITENP 464
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
++ E L L + A + L+ AL Y SK H D+ A
Sbjct: 465 VWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARN 521
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGTL 244
+L + +L FGL + D Y + + PE + R T S ++ FG
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 581
Query: 245 LLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+ ++L P + + I + + +C L L ++C Y+
Sbjct: 582 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 632
Query: 300 PRERPNPKSLVTALSPLQKETEV 322
P RP L LS + +E ++
Sbjct: 633 PSRRPRFTELKAQLSTILEEEKL 655
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 50/292 (17%), Positives = 99/292 (33%), Gaps = 54/292 (18%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL---GCCCEGDER- 131
V+ GK ++ +AVK F + + E + Q R N+L +G
Sbjct: 53 VWMGKWRGEK-VAVKVFF---TTEEASWFRE-TEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 132 ---LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY------CTSKGRALY 182
L+ +Y N +L +L ++ + L++ L + T A+
Sbjct: 108 TQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 183 H-DLNAYRILFDEDGNPRLSTFGL----MKNSRDGKSYSTNLAFTP----PEYLRTGRVT 233
H DL + IL ++G ++ GL + ++ + T PE L +
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD-ESLN 223
Query: 234 PESV-------IYSFGTLLLDLLSGKHI--------PPSHALDLIRDRNLQMLTDSCLEG 278
+YSFG +L ++ P H L M C++
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283
Query: 279 Q--------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322
+D+ ++ +L + C + P R + L+ + + ++
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 61/264 (23%), Positives = 105/264 (39%), Gaps = 38/264 (14%)
Query: 76 VYKGKL----ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY G L + AVK NR+ + QFL E + + + +LLG C +
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 131 -RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
L+V YM + L + ETH + L +A+ +++ SK H DL A
Sbjct: 165 SPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAAR 221
Query: 189 RILFDEDGNPRLSTFGLMKNSRD------GKSYSTNLAF-----TPPEYLRTGRVTPESV 237
+ DE +++ FGL +RD ++ A E L+T + T +S
Sbjct: 222 NCMLDEKFTVKVADFGL---ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 238 IYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292
++SFG LL +L++ G + + + + C + L +
Sbjct: 279 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD---------PLYEVM 329
Query: 293 SRCLQYEPRERPNPKSLVTALSPL 316
+C + RP+ LV+ +S +
Sbjct: 330 LKCWHPKAEMRPSFSELVSRISAI 353
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 6e-14
Identities = 53/264 (20%), Positives = 97/264 (36%), Gaps = 31/264 (11%)
Query: 75 VVYKGKLENQRR----IAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
V++G + +A+K + +FL+EA ++ Q + + L+G
Sbjct: 30 DVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIG-VITE 87
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ ++ E L L + + A + L+ AL Y SK H D+ A
Sbjct: 88 NPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAA 144
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFG 242
+L + +L FGL + D Y + + PE + R T S ++ FG
Sbjct: 145 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 204
Query: 243 TLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
+ ++L P + + I + + +C L L ++C
Sbjct: 205 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWA 255
Query: 298 YEPRERPNPKSLVTALSPLQKETE 321
Y+P RP L LS + +E +
Sbjct: 256 YDPSRRPRFTELKAQLSTILEEEK 279
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 57/274 (20%), Positives = 97/274 (35%), Gaps = 35/274 (12%)
Query: 76 VYKGKLEN-----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + +AVK A P + +E + L + + GCC +
Sbjct: 47 VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106
Query: 130 ER--LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
LV EY+P +L +L H + A L + + + Y ++ H DL
Sbjct: 107 AASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLA 161
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIY 239
A +L D D ++ FGL K +G Y + PE L+ + S ++
Sbjct: 162 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVW 221
Query: 240 SFGTLLLDLLS--GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG----------TE 287
SFG L +LL+ P + +T L + G E
Sbjct: 222 SFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL--LERGERLPRPDKCPAE 279
Query: 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
+ L C + E RP ++L+ L + ++ +
Sbjct: 280 VYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 63/315 (20%), Positives = 116/315 (36%), Gaps = 44/315 (13%)
Query: 76 VYKGKL----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V G+L + + +A+K + R FL EA +GQ + + L G +
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTE-KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALY-H-DL 185
++V EYM N +L L H ++ + + ++ +A ++Y + G Y H DL
Sbjct: 120 PVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDL 173
Query: 186 NAYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVI 238
A IL + + ++S FGL + D + T PE + + T S +
Sbjct: 174 AARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 239 YSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
+S+G +L +++S P + + + C L +L
Sbjct: 234 WSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA---------ALYQLML 284
Query: 294 RCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTA 353
C Q + RP + +V+ L L + P + + +A S L
Sbjct: 285 DCWQKDRNNRPKFEQIVSILDKLIRN---PGSLKIITSAAARPSNLLLDQSNVDITTFRT 341
Query: 354 IHEILEKIS---YKD 365
+ L + K+
Sbjct: 342 TGDWLNGVWTAHCKE 356
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 47/291 (16%), Positives = 96/291 (32%), Gaps = 52/291 (17%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEAR--SVGQLRNNRLTNLLGCCCEGD---- 129
V++GK +AVK F+ + R + EA LR+ + + + +
Sbjct: 58 VWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY------CTSKGRALYH 183
+ LV++Y + +L +L + + +++ L A L + T A+ H
Sbjct: 114 QLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 184 -DLNAYRILFDEDGNPRLSTFGL----MKNSRDGKSYSTNLAFTP----PEYLRTGRVTP 234
DL + IL ++G ++ GL + + T PE L +
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD-DSINM 229
Query: 235 ESV-------IYSFGTLLLDLLSGKHI--------PPSHALDLIRDRNLQMLTDSCLEGQ 279
+ IY+ G + ++ I P + L +M C +
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 289
Query: 280 --------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322
+ + + ++ C R + LS L ++ +
Sbjct: 290 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 48/337 (14%), Positives = 82/337 (24%), Gaps = 80/337 (23%)
Query: 75 VVYKGK-LENQRRIAVK---RFNRMAWPDPRQFLEEARSVGQLRNNR------------- 117
+ E V R +Q EE + LR +
Sbjct: 93 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152
Query: 118 ---LTNLLGCCCEGDER-------------LLVAEYMPNETLAKHLFHW--ETHPMKWAM 159
L R L +T + L +
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212
Query: 160 RLRVVLHLAQALEYCTSKGRALYH-DL---NAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215
RL++ L + + L G L H L + I+ D+ G L+ F +
Sbjct: 213 RLQLTLQVIRLLASLHHYG--LVHTYLRPVD---IVLDQRGGVFLTGFEHLVRDGASAVS 267
Query: 216 STNLAFTPPEYL----------RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD 265
F PPE +T ++ G + + P+ +
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--LPNTDDAALGG 325
Query: 266 RNLQMLTDSCLEGQFTDDDGT--ELVRLASRCLQYEPRERPNP------------KSLVT 311
E F + L L+Y +R P ++ ++
Sbjct: 326 ----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375
Query: 312 ALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSR 348
A PL + P+ P S + EA +
Sbjct: 376 AALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAVTA 412
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 58/269 (21%), Positives = 102/269 (37%), Gaps = 38/269 (14%)
Query: 75 VVYKGKL----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
V G+L + +A+K + R FL EA +GQ + + L G G
Sbjct: 64 EVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALY-H-D 184
++V EYM N +L L TH ++ + + ++ + + Y + G Y H D
Sbjct: 123 RLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRD 176
Query: 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESV 237
L A +L D + ++S FGL + D +T T PE + + S
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASD 236
Query: 238 IYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292
++SFG ++ ++L+ P + + + C L +L
Sbjct: 237 VWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH---------ALHQLM 287
Query: 293 SRCLQYEPRERPNPKSLVTALSPLQKETE 321
C + +RP +V+ L L + E
Sbjct: 288 LDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 59/290 (20%), Positives = 112/290 (38%), Gaps = 38/290 (13%)
Query: 76 VYKGKL-----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L + + +A+K + FL EA +GQ ++ + L G +
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALYH-DL 185
+++ EYM N L K L ++++ + ++ +A ++Y + H DL
Sbjct: 119 KPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDL 173
Query: 186 NAYRILFDEDGNPRLSTFGL---MKNSRDGKSYSTNLAF----TPPEYLRTGRVTPESVI 238
A IL + + ++S FGL +++ + ++ T PE + + T S +
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 233
Query: 239 YSFGTLLLDLLSGKHIP-P----SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
+SFG ++ ++++ P + I D C + +L
Sbjct: 234 WSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS---------AIYQLMM 284
Query: 294 RCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLG 343
+C Q E RP +V+ L L + + L S+ S G
Sbjct: 285 QCWQQERARRPKFADIVSILDKLIRAPD-SLKTLADFDPRVSIRLPSTSG 333
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 50/276 (18%), Positives = 98/276 (35%), Gaps = 44/276 (15%)
Query: 76 VYKGKL----ENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V +G L ++AVK + + + + +FL EA + + + LLG C E
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109
Query: 130 -----ERLLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
+ +++ +M L + L+ ++ +A +EY +++
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-- 167
Query: 181 LYH-DLNAYRILFDEDGNPRLSTFGLMKNSRD--GKSY---STNLAF----TPPEYLRTG 230
H DL A + +D ++ FGL S+ Y E L
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGL---SKKIYSGDYYRQGRIAKMPVKWIAIESLADR 224
Query: 231 RVTPESVIYSFGTLLLDLLS-GK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285
T +S +++FG + ++ + G + D + + + CL+
Sbjct: 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD-------- 276
Query: 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
EL + C + +P +RP L L L +
Sbjct: 277 -ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 53/279 (18%), Positives = 97/279 (34%), Gaps = 41/279 (14%)
Query: 75 VVYKGKLENQR-----RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + + + +AVK+ R F E + L+++ + G C
Sbjct: 56 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115
Query: 130 ER--LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
R L+ EY+P +L +L + + L+ + + +EY +K H DL
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLA 172
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIY 239
IL + + ++ FGL K K Y PE L + + S ++
Sbjct: 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 232
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV----RLA--- 292
SFG +L +L + S + +R +GQ EL+ RL
Sbjct: 233 SFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRLPRPD 286
Query: 293 ----------SRCLQYEPRERPNPKSLVTALSPLQKETE 321
+ C +RP+ + L + ++ +
Sbjct: 287 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 41/276 (14%)
Query: 76 VYKGKLEN------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V+ + N + +AVK + F EA + L++ + G C +GD
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 90
Query: 130 ERLLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--SKGRALY- 182
++V EYM + + L H + + L L+Q L + + G Y
Sbjct: 91 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV-YL 149
Query: 183 ------H-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS--TNLAF----TPPEYLRT 229
H DL L + ++ FG+ ++ Y + PPE +
Sbjct: 150 ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 209
Query: 230 GRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
+ T ES ++SFG +L ++ + GK + + ++ I + C +
Sbjct: 210 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK------- 262
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320
E+ + C Q EP++R N K + L L K T
Sbjct: 263 --EVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 48/291 (16%), Positives = 102/291 (35%), Gaps = 39/291 (13%)
Query: 75 VVYKGKLENQRR-----IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
V+KG + + +K + + + ++G L + + LLG C G
Sbjct: 28 TVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCPG 86
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
LV +Y+P +L H+ + + L + +A+ + Y G + H +L A
Sbjct: 87 SSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAA 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSF 241
+L +++ FG+ + + E + G+ T +S ++S+
Sbjct: 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203
Query: 242 GTLLLDLLS-GKH----IPPSHALDLIRD--RNLQMLTDSCLEGQFTDDDGTELVRLASR 294
G + +L++ G + + DL+ R Q C ++ + +
Sbjct: 204 GVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP--QICTI---------DVYMVMVK 252
Query: 295 CLQYEPRERPNPKSLVTALSPLQKE----TEVPSHVLMGIPHSASVSPLSP 341
C + RP K L + + ++ + GI L+
Sbjct: 253 CWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTN 303
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 50/267 (18%), Positives = 98/267 (36%), Gaps = 35/267 (13%)
Query: 75 VVYKGKLENQRR-----IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG + +A+K P ++ L+EA + + N + LLG C
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
L+ + MP L ++ + L + +A+ + Y + L H DL A
Sbjct: 89 STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPEYLRTGRVTPESVIYSF 241
+L + +++ FGL K + + E + T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 242 GTLLLDLLS-GKH----IPPSHALDLIRD--RNLQMLTDSCLEGQFTDDDGTELVRLASR 294
G + +L++ G IP S ++ R Q C ++ + +
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP--PICTI---------DVYMIMRK 254
Query: 295 CLQYEPRERPNPKSLVTALSPLQKETE 321
C + RP + L+ S + ++ +
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 42/280 (15%), Positives = 70/280 (25%), Gaps = 49/280 (17%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLR---NNRLTNLLGCCCE 127
VV+ + +E A+K F A + E + +L +
Sbjct: 77 VVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 128 GD-----------------------ERLLVAEYMP--NETLAKHLFHWET--HPMKWAMR 160
D LL+ E L L
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 161 LRVVLHLAQALEYCTSKGRALYH-DL---NAYRILFDEDGNPRLSTFGL-MKNSRDGKSY 215
+ L + SKG L H N + DG L K G +
Sbjct: 197 HILTAQLIRLAANLQSKG--LVHGHFTPDN---LFIMPDGRLMLGDVSALWKVGTRGPAS 251
Query: 216 STNLAFTPPEYL--RTGRVTPESVIYSFGTLLLDLLSGK---HIPPSHALDLIRDRNLQM 270
S + + P E+L T T + G + + + + +L++
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
L + L R L ++ R R P +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 55/307 (17%), Positives = 112/307 (36%), Gaps = 40/307 (13%)
Query: 75 VVYKGKLENQRR-----IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG + +A+K P ++ L+EA + + N + LLG C
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLT 88
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
L+ + MP L ++ + L + +A+ + Y + L H DL A
Sbjct: 89 STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAA 145
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSF 241
+L + +++ FGL K + + + E + T +S ++S+
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 242 GTLLLDLLS-GKH----IPPSHALDLIRD--RNLQMLTDSCLEGQFTDDDGTELVRLASR 294
G + +L++ G IP S ++ R Q C ++ + +
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP--PICTI---------DVYMIMVK 254
Query: 295 CLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIPHSASVSPLSPLGEACSRRDLTAI 354
C + RP + L+ S + ++ + + I + SP ++ R L
Sbjct: 255 CWMIDADSRPKFRELIIEFSKMARDPQ----RYLVIQGDERMHLPSP-TDSNFYRALMDE 309
Query: 355 HEILEKI 361
++ + +
Sbjct: 310 EDMDDVV 316
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 55/264 (20%), Positives = 97/264 (36%), Gaps = 32/264 (12%)
Query: 75 VVYKGKLENQRR---IAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V KG + ++ +AVK + + L EA + QL N + ++G CE +
Sbjct: 32 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAE 90
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
+LV E L K+L K + +V ++ ++Y H DL A
Sbjct: 91 SWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLEESN--FVHRDLAAR 146
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIYSF 241
+L ++S FGL K R ++Y T+ + PE + + + +S ++SF
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206
Query: 242 GTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCL 296
G L+ + S P S ++ C E+ L + C
Sbjct: 207 GVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCW 257
Query: 297 QYEPRERPNPKSLVTALSPLQKET 320
Y+ RP ++ L +
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDV 281
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 52/264 (19%), Positives = 96/264 (36%), Gaps = 30/264 (11%)
Query: 75 VVYKGKLENQRR---IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V +G +++ +A+K + D + + EA+ + QL N + L+G C+ +
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 409
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+LV E L K L + + ++ ++ ++Y K H +L A
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARN 466
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFG 242
+L ++S FGL K SY T L + PE + + + S ++S+G
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 526
Query: 243 TLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
+ + LS P + I C EL L S C
Sbjct: 527 VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWI 577
Query: 298 YEPRERPNPKSLVTALSPLQKETE 321
Y+ +RP+ ++ +
Sbjct: 578 YKWEDRPDFLTVEQRMRACYYSLA 601
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 42/261 (16%), Positives = 78/261 (29%), Gaps = 63/261 (24%)
Query: 64 IVSEHGEKAPNVVYKG---KLENQRRIAVK--RFNRMAWPDPRQ-FLEEARSVGQLRNNR 117
++ HG P ++ L+ R++A+ + D Q L + ++
Sbjct: 35 LLIFHGGVPPLQFWQALDTALD--RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 118 LTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK 177
+ +L L+VAE++ +L + +T P +R + LA A +
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGA-IRAMQSLAAAADAAHRA 148
Query: 178 GRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPES 236
G + + R+ DG+ L+ M P+
Sbjct: 149 G--VALSIDHPSRVRVSIDGDVVLAYPATM-----------------------PDANPQD 183
Query: 237 VIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT---------- 286
I G L LL + P S L D G
Sbjct: 184 DIRGIGASLYALLVNR--WPLPEAG----------VRSGLAPAERDTAGQPIEPADIDRD 231
Query: 287 ---ELVRLASRCLQYEPRERP 304
++ +A+R +Q + R
Sbjct: 232 IPFQISAVAARSVQGDGGIRS 252
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 52/285 (18%), Positives = 99/285 (34%), Gaps = 52/285 (18%)
Query: 76 VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEA--RSVGQLRNNRLTNLLGCCCEGD---- 129
V++G + + +AVK F+ D + + E + LR+ + +
Sbjct: 24 VWRGSWQGEN-VAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY------CTSKGRALYH 183
+ L+ Y +L +L + + LR+VL +A L + T A+ H
Sbjct: 80 QLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 184 -DLNAYRILFDEDGNPRLSTFGL----MKNSRDGKSYSTNLAFTP----PEYLRTGRVTP 234
DL + IL ++G ++ GL +++ + T PE L +
Sbjct: 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD-ETIQV 195
Query: 235 ESV-------IYSFGTLLLDLLSGKHI--------PPSHALDLIRDRNLQMLTDSCLEGQ 279
+ I++FG +L ++ PP + + M C++ Q
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 280 --------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316
F+D T L +L C P R + L+ +
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 56/263 (21%), Positives = 100/263 (38%), Gaps = 29/263 (11%)
Query: 75 VVYKGKLENQR----RIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGD 129
VY+G N + +AVK + D ++ F+ EA + L + + L+G E +
Sbjct: 27 EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEE 85
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
++ E P L +L + + + L + +A+ Y S H D+
Sbjct: 86 PTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYLESIN--CVHRDIAVR 142
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-----FTPPEYLRTGRVTPESVIYSFGT 243
IL +L FGL + D Y ++ + PE + R T S ++ F
Sbjct: 143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 244 LLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+ ++LS P + ++ + D C L L +RC Y
Sbjct: 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP---------VLYTLMTRCWDY 253
Query: 299 EPRERPNPKSLVTALSPLQKETE 321
+P +RP LV +LS + + +
Sbjct: 254 DPSDRPRFTELVCSLSDVYQMEK 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 53/281 (18%), Positives = 96/281 (34%), Gaps = 45/281 (16%)
Query: 75 VVYKGKLE-----NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + + +AVK+ R F E + L+++ + G C
Sbjct: 25 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84
Query: 130 ER--LLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALYH-D 184
R L+ EY+P +L +L + H + L+ + + +EY +K H D
Sbjct: 85 RRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRD 139
Query: 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESV 237
L IL + + ++ FGL K K + PE L + + S
Sbjct: 140 LATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASD 199
Query: 238 IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV----RLA- 292
++SFG +L +L + S + +R +GQ EL+ RL
Sbjct: 200 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRLPR 253
Query: 293 ------------SRCLQYEPRERPNPKSLVTALSPLQKETE 321
+ C +RP+ + L + ++
Sbjct: 254 PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 52/274 (18%), Positives = 97/274 (35%), Gaps = 38/274 (13%)
Query: 76 VYKGKLENQR------RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VY+G++ ++AVK + D FL EA + + + + +G +
Sbjct: 46 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105
Query: 129 DERLLVAEYMPNETLAKHL-----FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
R ++ E M L L + + L V +A +Y H
Sbjct: 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 163
Query: 184 -DLNAYRILFDEDGNPRL---STFGLMKNSRDGKSYSTNLA------FTPPEYLRTGRVT 233
D+ A L G R+ FG+ ++ Y + PPE G T
Sbjct: 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 223
Query: 234 PESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288
++ +SFG LL ++ S G L+ + +C +
Sbjct: 224 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG---------PV 274
Query: 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322
R+ ++C Q++P +RPN ++ + ++ +V
Sbjct: 275 YRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 55/274 (20%), Positives = 99/274 (36%), Gaps = 38/274 (13%)
Query: 76 VYKGKLENQR------RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VY+G++ ++AVK + D FL EA + + + + +G +
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146
Query: 129 DERLLVAEYMPNETLAKHL---FHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALYH 183
R ++ E M L L + P AM L V +A +Y H
Sbjct: 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIH 204
Query: 184 -DLNAYRILFDEDGNPRL---STFGLMKNSRDGKSYSTNLA------FTPPEYLRTGRVT 233
D+ A L G R+ FG+ ++ Y + PPE G T
Sbjct: 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT 264
Query: 234 PESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288
++ +SFG LL ++ S G L+ + +C +
Sbjct: 265 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG---------PV 315
Query: 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322
R+ ++C Q++P +RPN ++ + ++ +V
Sbjct: 316 YRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 60/283 (21%), Positives = 100/283 (35%), Gaps = 42/283 (14%)
Query: 76 VYKGKLENQR------RIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V+ + N +AVK + + F EA + L++ + G C EG
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 130 ERLLVAEYMPNETLAKHL-------------FHWETHPMKWAMRLRVVLHLAQALEYCTS 176
L+V EYM + L + L P+ L V +A + Y
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176
Query: 177 KGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPEYLRT 229
H DL L + ++ FG+ ++ Y PPE +
Sbjct: 177 LH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY 234
Query: 230 GRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
+ T ES ++SFG +L ++ + GK + + A+D I +C
Sbjct: 235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPP------- 287
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHVL 327
E+ + C Q EP++R + K + L L + V VL
Sbjct: 288 --EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL 328
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 51/264 (19%), Positives = 95/264 (35%), Gaps = 30/264 (11%)
Query: 75 VVYKGKLENQRR---IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V +G +++ +A+K + D + + EA+ + QL N + L+G C+ +
Sbjct: 25 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEA 83
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+LV E L K L + + ++ ++ ++Y K H DL A
Sbjct: 84 LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARN 140
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIYSFG 242
+L ++S FGL K SY + + PE + + + S ++S+G
Sbjct: 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 200
Query: 243 TLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
+ + LS P + I C EL L S C
Sbjct: 201 VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWI 251
Query: 298 YEPRERPNPKSLVTALSPLQKETE 321
Y+ +RP+ ++ +
Sbjct: 252 YKWEDRPDFLTVEQRMRACYYSLA 275
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 45/249 (18%), Positives = 87/249 (34%), Gaps = 25/249 (10%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCC---CEGD 129
VYKG E +A + ++F EEA + L++ + +G
Sbjct: 42 VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101
Query: 130 ERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+ + LV E M + TL +L MK + + + L++ ++ + H DL
Sbjct: 102 KCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 188 YRILFD-EDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGTL 244
I G+ ++ GL R + + F PE +Y+FG
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMC 218
Query: 245 LLDLLSGKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
+L++ + ++ + + +T F E+ + C++
Sbjct: 219 MLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271
Query: 301 RERPNPKSL 309
ER + K L
Sbjct: 272 DERYSIKDL 280
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 53/261 (20%), Positives = 96/261 (36%), Gaps = 34/261 (13%)
Query: 75 VVYKGKL----ENQRRIAVK--RFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCE 127
VV +G+ +AVK + + ++ P+ F+ E ++ L + L L G
Sbjct: 33 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVL 91
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
+V E P +L L R + +A+ + Y SK H DL
Sbjct: 92 TPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLA 148
Query: 187 AYRILFDEDGNPRLSTFGLMKN-SRDGKSYSTN------LAFTPPEYLRTGRVTPESVIY 239
A +L ++ FGLM+ ++ Y A+ PE L+T + S +
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 240 SFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLT-DSCLEGQFTDDDGTELVRLAS 293
FG L ++ + P S L I ++ + C + ++ +
Sbjct: 209 MFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ---------DIYNVMV 259
Query: 294 RCLQYEPRERPNPKSLVTALS 314
+C ++P +RP +L L
Sbjct: 260 QCWAHKPEDRPTFVALRDFLL 280
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 60/282 (21%), Positives = 103/282 (36%), Gaps = 47/282 (16%)
Query: 76 VYKGKL--------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRN-NRLTNLLGCC 125
V + ++AVK A D + E + + + NLLG C
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 126 CEGDERLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLHL----AQAL 171
+ ++ EY L ++L + +H + + + ++ A+ +
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204
Query: 172 EYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPP 224
EY SK H DL A +L ED +++ FGL ++ Y +TN P
Sbjct: 205 EYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQ 279
E L T +S ++SFG LL ++ + G +P L+++ + +C
Sbjct: 263 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTN-- 320
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
EL + C P +RP K LV L + T
Sbjct: 321 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 33/194 (17%), Positives = 58/194 (29%), Gaps = 34/194 (17%)
Query: 132 LLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DL--- 185
L +T + L + RL++ L + + L G L H L
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPV 235
Query: 186 NAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYL-----------RTGRVTP 234
+ I+ D+ G L+ F + S + F PPE R +T
Sbjct: 236 D---IVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTF 292
Query: 235 ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR-LAS 293
++ G ++ + P I ++ + + VR L
Sbjct: 293 SFDAWALGLVIYWIWCAD--LP------ITKDAALGGSEWIFRS---CKNIPQPVRALLE 341
Query: 294 RCLQYEPRERPNPK 307
L+Y +R P
Sbjct: 342 GFLRYPKEDRLLPL 355
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 45/278 (16%)
Query: 76 VYKGKL---ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNN-RLTNLLGCCCEGDE 130
V K ++ + A+KR A D R F E + +L ++ + NLLG C
Sbjct: 41 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100
Query: 131 RLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLHL----AQALEYCTS 176
L EY P+ L L + + + +LH A+ ++Y +
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160
Query: 177 KGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPEYLRT 229
K H DL A IL E+ +++ FGL SR + Y T E L
Sbjct: 161 KQ--FIHRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWMAIESLNY 215
Query: 230 GRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
T S ++S+G LL +++S G + + + + +C +
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD------- 268
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322
E+ L +C + +P ERP+ ++ +L+ + +E +
Sbjct: 269 --EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 51/275 (18%), Positives = 97/275 (35%), Gaps = 45/275 (16%)
Query: 76 VYKGKLE-----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V + + ++AVK + +E + L + + G C E
Sbjct: 37 VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96
Query: 130 ER--LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
L+ E++P+ +L ++L + + +L+ + + + ++Y S+ H DL
Sbjct: 97 GNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLA 153
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRVTPESVIY 239
A +L + + ++ FGL K K Y + PE L + S ++
Sbjct: 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVW 213
Query: 240 SFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV----RLAS- 293
SFG L +LL+ AL L GQ T + RL
Sbjct: 214 SFGVTLHELLTYCDSDSSPMALFLKMIGPTH--------GQMTVTRLVNTLKEGKRLPCP 265
Query: 294 ------------RCLQYEPRERPNPKSLVTALSPL 316
+C +++P R + ++L+ L
Sbjct: 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 63/300 (21%), Positives = 103/300 (34%), Gaps = 49/300 (16%)
Query: 76 VYKGKL-----ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V + +AVK+ R F E + + L ++ + G
Sbjct: 39 VELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98
Query: 131 R--LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--SKG------RA 180
+ LV EY+P+ L L R R L ++ L Y + KG R
Sbjct: 99 QSLRLVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 181 LYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY---STNLAF----TPPEYLRTGRV 232
H DL A IL + + + +++ FGL K K Y PE L
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG------- 285
+ +S ++SFG +L +L + S + + +R + + ++G
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPP 267
Query: 286 ---TELVRLASRCLQYEPRERPNPKSLVTAL-----SPLQKETEVPSHVLMGIPHSASVS 337
E+ L C P++RP+ +L L ET + G HS S S
Sbjct: 268 ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 54/270 (20%), Positives = 95/270 (35%), Gaps = 42/270 (15%)
Query: 76 VYKGKLENQR------RIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L +A+K A R+ F EA +L++ + LLG +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 84
Query: 129 DERLLVAEYMPN----ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--SKGRALY 182
++ Y + E L H + ++ L + + G Y
Sbjct: 85 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME-Y 143
Query: 183 -------H-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA------FTPPEYLR 228
H DL +L + N ++S GL + Y + PE +
Sbjct: 144 LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM 203
Query: 229 TGRVTPESVIYSFGTLLLDLLSGKHIP-PSHA----LDLIRDRNLQMLTDSCLEGQFTDD 283
G+ + +S I+S+G +L ++ S P ++ +++IR+R + D C
Sbjct: 204 YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPA------ 257
Query: 284 DGTELVRLASRCLQYEPRERPNPKSLVTAL 313
+ L C P RP K + + L
Sbjct: 258 ---WVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 59/292 (20%), Positives = 108/292 (36%), Gaps = 47/292 (16%)
Query: 76 VYKGKL--------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNR-LTNLLGCC 125
V + + +AVK A D + E + + ++ + NLLG C
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110
Query: 126 CEGDERLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLHL----AQAL 171
+ ++ EY L ++L + + M + ++ A+ +
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 172 EYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPP 224
EY S+ H DL A +L E+ +++ FGL ++ + Y +TN P
Sbjct: 171 EYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQ 279
E L T +S ++SFG L+ ++ + G IP L+++ + +C
Sbjct: 229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTN-- 286
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLMGIP 331
EL + C P +RP K LV L + T ++ + P
Sbjct: 287 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQP 331
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 45/244 (18%), Positives = 92/244 (37%), Gaps = 19/244 (7%)
Query: 76 VYKGK-LENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
K E+ R+ +K +RM+ + + E + +++ + E
Sbjct: 40 AILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
+V +Y L K + + + L + + AL++ + + L+ D+ + I
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFL 158
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDL 248
+DG +L FG+ + + TP PE +S I++ G +L +L
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT---ELVRLASRCLQYEPRERPN 305
+ K A +++ L + G F +L L S+ + PR+RP+
Sbjct: 219 CTLK--HAFEA------GSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270
Query: 306 PKSL 309
S+
Sbjct: 271 VNSI 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 47/282 (16%)
Query: 76 VYKGKL--------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNR-LTNLLGCC 125
V + + +AVK A D + E + + ++ + NLLG C
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156
Query: 126 CEGDERLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLHL----AQAL 171
+ ++ EY L ++L + + M + ++ A+ +
Sbjct: 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216
Query: 172 EYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPP 224
EY S+ H DL A +L E+ +++ FGL ++ + Y +TN P
Sbjct: 217 EYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSCLEGQ 279
E L T +S ++SFG L+ ++ + G IP L+++ + +C
Sbjct: 275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTN-- 332
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
EL + C P +RP K LV L + T
Sbjct: 333 -------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 39/192 (20%), Positives = 75/192 (39%), Gaps = 16/192 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY + ++A+K ++F E + QL + + +++ E D
Sbjct: 26 TVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
LV EY+ TL++++ P+ + + +++ + H D+
Sbjct: 86 YYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQN 141
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF-TP----PEYLRTGRVTPESVIYSFGTL 244
IL D + ++ FG+ K + TN T PE + + IYS G +
Sbjct: 142 ILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIV 201
Query: 245 LLDLLSGKHIPP 256
L ++L G+ PP
Sbjct: 202 LYEMLVGE--PP 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 62/279 (22%), Positives = 104/279 (37%), Gaps = 52/279 (18%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
V K +AVK A + R L E + Q+ + + L G C +
Sbjct: 39 VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98
Query: 129 DERLLVAEYMPN------------------ETLAKHLFHWETHPMKWAMRLRVVLH---- 166
LL+ EY + HP + A+ + ++
Sbjct: 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF-- 221
++Q ++Y L H DL A IL E ++S FGL ++ + SY +
Sbjct: 159 ISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPV 216
Query: 222 --TPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDS 274
E L T +S ++SFG LL ++++ G + IPP +L++ + D+
Sbjct: 217 KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDN 276
Query: 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
C E E+ RL +C + EP +RP + L
Sbjct: 277 CSE---------EMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 52/245 (21%), Positives = 84/245 (34%), Gaps = 26/245 (10%)
Query: 76 VYKG-KLENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDER 131
V+K E+ R AVKR D + L E S ++ + L EG
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132
Query: 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
L E +L +H W + A + AL + S+G ++ D+ I
Sbjct: 133 YLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG-LVHLDVKPANIF 189
Query: 192 FDEDGNPRLSTFGLMKN-SRDGKSYSTNLAF--TP----PEYLRTGRVTPESVIYSFGTL 244
G +L FGL+ G P PE L+ + ++S G
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEV----QEGDPRYMAPELLQGSY-GTAADVFSLGLT 244
Query: 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
+L++ P Q L L +FT +EL + L+ +P+ R
Sbjct: 245 ILEVACNME-LPHGG------EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRA 297
Query: 305 NPKSL 309
++L
Sbjct: 298 TAEAL 302
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 51/260 (19%), Positives = 85/260 (32%), Gaps = 53/260 (20%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARS-VGQLRN-NRLTNL--LGCCCEGDE 130
+VY+G +N R +AVKR + A V LR + N+ C + +
Sbjct: 40 IVYRGMFDN-RDVAVKRILP-------ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 131 RL-LVAEYMPNE----TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-D 184
+ E K H P+ ++ L + S + H D
Sbjct: 92 FQYIAIELCAATLQEYVEQKDFAHLGLEPIT------LLQQTTSGLAHLHSLN--IVHRD 143
Query: 185 LNAYRILF---DEDGNPR--LSTFGLMKNSRDGKSYSTNLAF---TP----PEYLR---T 229
L + IL + G + +S FGL K G+ + + T PE L
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203
Query: 230 GRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
T I+S G + ++S P A L+ +L L +
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE-------KHE 256
Query: 285 GTELVRLASRCLQYEPRERP 304
L + + +P++RP
Sbjct: 257 DVIARELIEKMIAMDPQKRP 276
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 64/291 (21%), Positives = 103/291 (35%), Gaps = 50/291 (17%)
Query: 76 VYKGKLEN------QRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEG 128
V++ + +AVK A D + F EA + + N + LLG C G
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122
Query: 129 DERLLVAEYMPN------------ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT- 175
L+ EYM T+ + + + L A+ L
Sbjct: 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 176 -SKGRALY-------H-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF--- 221
+ G A Y H DL L E+ +++ FGL +N Y N A
Sbjct: 183 VAAGMA-YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR 241
Query: 222 -TPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKH----IPPSHALDLIRDRNLQMLTDSC 275
PPE + R T ES ++++G +L ++ S G + + +RD N+ ++C
Sbjct: 242 WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENC 301
Query: 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHV 326
EL L C P +RP+ S+ L + + E V
Sbjct: 302 PL---------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVGV 343
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 55/250 (22%), Positives = 100/250 (40%), Gaps = 20/250 (8%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
G+ A VY + + +A+++ N P + E + + +N + N L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
GDE +V EY+ +L + M V QALE+ S ++ D+ +
Sbjct: 89 GDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQV-IHRDIKS 144
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG+ +L+ FG +S + + TP PE + P+ I+S G
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 244 LLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+ ++++ G+ + P AL LI L + + + +RCL+ +
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP---EKLSA----IFRDFLNRCLEMD 257
Query: 300 PRERPNPKSL 309
+R + K L
Sbjct: 258 VEKRGSAKEL 267
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 2e-09
Identities = 77/518 (14%), Positives = 157/518 (30%), Gaps = 151/518 (29%)
Query: 34 EMSEV-----DGLPSFRE-F--------TLEQLKNATSGFAVENIVSEHGEKAPNVVYK- 78
E E D L F + F + K+ S +++I+ + + V
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHII-----MSKDAVSGT 64
Query: 79 ----GKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
L +++ V++F +FL Q + + +T + E +RL
Sbjct: 65 LRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY---IEQRDRL-- 119
Query: 135 AEYMPNETLAKHLFHWETHPM----KWAMRLR----VVLH---------LAQALEYCTSK 177
Y N+ AK+ P + + LR V++ +A L+ C S
Sbjct: 120 --YNDNQVFAKY-NVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA--LDVCLSY 174
Query: 178 GRALYHDLNAYRILFDEDGNPR-----LSTF--GLMKNSRDGKSYSTNLAFTPPE---YL 227
D + + +P L + N +S+N+ L
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 228 R---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-----LI--RDRNL------QML 271
R + ++ +LL++ + K +A + L+ R + +
Sbjct: 235 RRLLKSKPYENCLL-----VLLNVQNAKAW---NAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 272 TDSCLEGQ---FTDDDGTELVRLASRCLQYEPRERP------NPK--SLVTALSP----- 315
T L+ T D+ L+ + L P++ P NP+ S++
Sbjct: 287 THISLDHHSMTLTPDEVKSLL---LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343
Query: 316 ----LQKETEVPSHVLMGIPHSASVSPLSP-----LGEACS--RRDL---TAIHEIL-EK 360
+ + ++ +S++ L P + + S T + ++
Sbjct: 344 WDNWKHVNCDKLTTII-----ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD 398
Query: 361 ISYKDDEGVANEVHSMFSIIKNYCMALKYLLSIIYVLLSTCIFNWTYM--------QFQL 412
+ D V N++H + K + + S IY+ L + N +
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTISIPS-IYLELKVKLENEYALHRSIVDHYNIPK 457
Query: 413 CSCCMFCSL----QYFFLYSVQLFICSLVLCFSYANHL 446
QYF+ + + HL
Sbjct: 458 TFDSDDLIPPYLDQYFYSH------------IGH--HL 481
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 50/250 (20%), Positives = 95/250 (38%), Gaps = 20/250 (8%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
GE + +V + + R++AVK + E + ++ + +
Sbjct: 54 GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV 113
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
G+E ++ E++ L + + V + QAL Y ++G ++ D+ +
Sbjct: 114 GEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGV-IHRDIKS 169
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL DG +LS FG +L TP PE + E I+S G
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 244 LLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
++++++ G+ P A+ +RD L +S + + L R L +
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS---HKVSP----VLRDFLERMLVRD 282
Query: 300 PRERPNPKSL 309
P+ER + L
Sbjct: 283 PQERATAQEL 292
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 55/283 (19%), Positives = 97/283 (34%), Gaps = 48/283 (16%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRN-NRLTNLLGCCCE 127
V + + +AVK A + + E + + L N + NLLG C
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98
Query: 128 GDERLLVAEYMPN------------ETLAKHLFHWETHPMKWAMRLRVVLHL----AQAL 171
G L++ EY + + A+ L +L A+ +
Sbjct: 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 172 EYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPP 224
+ SK H DL A IL ++ FGL ++ ++ +Y N P
Sbjct: 159 AFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNLQMLTDSCLEG 278
E + T ES ++S+G L +L S P P + +I++ + +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPA- 275
Query: 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
E+ + C +P +RP K +V + E+
Sbjct: 276 --------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 54/283 (19%), Positives = 92/283 (32%), Gaps = 54/283 (19%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMA-WPDPRQFLEEAR---SVGQLRNNRLTNLLGCC 125
V + + ++AVK A + + E + +GQ N + NLLG C
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN--IVNLLGAC 119
Query: 126 CEGDERLLVAEYMPN------------ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY 173
G L++ EY F L +AQ + +
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 174 CTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRD---GKSY--STNLAF----TP 223
SK H D+ A +L ++ FGL +RD +Y N
Sbjct: 180 LASKN--CIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMNDSNYIVKGNARLPVKWMA 234
Query: 224 PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP----PSHA--LDLIRDRNLQMLTDSCLE 277
PE + T +S ++S+G LL ++ S P ++ L++D +
Sbjct: 235 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPK 294
Query: 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320
+ + C EP RP + + + L +E
Sbjct: 295 ---------NIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 52/272 (19%), Positives = 102/272 (37%), Gaps = 31/272 (11%)
Query: 76 VYKGK-LENQRRIAVKR---FNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VY+ L + +A+K+ F+ M ++E + QL + + E +E
Sbjct: 48 VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107
Query: 132 LLVAEYMPNETLAKHL--FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAY 188
+V E L++ + F + + + + L ALE+ S+ + H D+
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPA 165
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTL 244
+ G +L GL + + + +L TP PE + +S I+S G L
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF----TDDDGTELVRLASRCLQYEP 300
L ++ + + P + NL L + + +D EL +L + C+ +P
Sbjct: 226 LYEMAALQ--SPFYG----DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 279
Query: 301 RERPN-------PKSLVTALSPLQKETEVPSH 325
+RP+ K + + + H
Sbjct: 280 EKRPDVTYVYDVAKRMHACTASSLEHHH-HHH 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 53/290 (18%), Positives = 101/290 (34%), Gaps = 51/290 (17%)
Query: 75 VVYKGK-LENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VV++ K + A+K R + + E +++ +L + + E +
Sbjct: 20 VVFEAKNKVDDCNYAIKRIRLPNREL-AREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 132 L------------LVAEYMPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTSKG 178
+ + E L + T + ++ L + L +A+A+E+ SKG
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138
Query: 179 RALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRV-TP-- 234
L H DL I F D ++ FGL+ + T L P TG+V T
Sbjct: 139 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY 196
Query: 235 -------------ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
+ I+S G +L +LL P S ++ +R +F
Sbjct: 197 MSPEQIHGNSYSHKVDIFSLGLILFELL----YPFSTQMERVR------TLTDVRNLKFP 246
Query: 282 DDDGT---ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHVLM 328
+ L P ERP +++ + + ++ + P ++
Sbjct: 247 PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFEDLDFPGKTVL 294
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 54/282 (19%), Positives = 97/282 (34%), Gaps = 47/282 (16%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNN-RLTNLLGCCCE 127
V + R +AVK A + R + E + + + ++ + NLLG C +
Sbjct: 43 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102
Query: 128 GDE-RLLVAEYMPNETLAKHL----------FHWETHPMKWAMRLRVVLH----LAQALE 172
+++ E+ L+ +L K + L ++ +A+ +E
Sbjct: 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 162
Query: 173 YCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF----TPPE 225
+ S+ H DL A IL E ++ FGL ++ Y + PE
Sbjct: 163 FLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220
Query: 226 YLRTGRVTPESVIYSFGTLLLDLLSGKHIP------PSHALDLIRDRNLQMLTDSCLEGQ 279
+ T +S ++SFG LL ++ S P +++ D
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-- 278
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
E+ + C EP +RP LV L L +
Sbjct: 279 -------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 45/249 (18%), Positives = 83/249 (33%), Gaps = 30/249 (12%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
V++ K + + AVK+ + R EE + L + R+ L G EG +
Sbjct: 74 VHRMKDKQTGFQCAVKK---VRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIF 128
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E + +L + + + L + + LEY ++ L+ D+ A +L
Sbjct: 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLLSS 185
Query: 195 DGNP-RLSTFGLMKNSRDGKSYSTNLAF-----TP----PEYLRTGRVTPESVIYSFGTL 244
DG+ L FG + + L T PE + + I+S +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 245 LLDLLSGKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
+L +L+G H I ++ + + L+ EP
Sbjct: 246 MLHMLNGCHPWTQYFRGPLCLKIA-------SEPPPIREIPPSCAPLTAQAIQEGLRKEP 298
Query: 301 RERPNPKSL 309
R + L
Sbjct: 299 VHRASAMEL 307
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 45/194 (23%), Positives = 75/194 (38%), Gaps = 22/194 (11%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNL--LGCCCEGD 129
VY+ + +R +A+K + DP + EAR+ G+L+ + + G E D
Sbjct: 50 VYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG---EID 106
Query: 130 ERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
+L + + LA L P+ + +V + AL+ + G H D+
Sbjct: 107 GQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKP 162
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFG 242
IL D L FG+ + D K L + PE T + IY+
Sbjct: 163 ENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT 222
Query: 243 TLLLDLLSGKHIPP 256
+L + L+G PP
Sbjct: 223 CVLYECLTGS--PP 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 54/293 (18%), Positives = 97/293 (33%), Gaps = 49/293 (16%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-- 132
V K + + R A+K+ R L E + L + + E +
Sbjct: 22 VVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80
Query: 133 -----------LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRAL 181
+ EY N TL + + + R+ + +AL Y S+G +
Sbjct: 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-RLFRQILEALSYIHSQG--I 137
Query: 182 YH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--------------TP--- 223
H DL I DE N ++ FGL KN + T
Sbjct: 138 IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYV 197
Query: 224 -PEYLR-TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
E L TG + +YS G + +++ P S ++ + F
Sbjct: 198 ATEVLDGTGHYNEKIDMYSLGIIFFEMIY----PFSTGMERVNILKKLRSVSIEFPPDFD 253
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALS----PLQKETEVPSHVLMGI 330
D+ ++ + ++P +RP ++L L+ P++ + EV L +
Sbjct: 254 DNKMKVEKKIIRLLIDHDPNKRPGARTL---LNSGWLPVKHQDEVIKEALKSL 303
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 38/146 (26%), Positives = 61/146 (41%), Gaps = 19/146 (13%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFT 222
+ A++YC K + H DL A +L D D N +++ FG G +
Sbjct: 123 IVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 223 PPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280
PE + G+ PE ++S G +L L+SG +P +NL+ L + L G++
Sbjct: 181 APELFQ-GKKYDGPEVDVWSLGVILYTLVSG-SLP-------FDGQNLKELRERVLRGKY 231
Query: 281 TDDDG--TELVRLASRCLQYEPRERP 304
T+ L R L P +R
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNPIKRG 257
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 56/287 (19%), Positives = 97/287 (33%), Gaps = 51/287 (17%)
Query: 76 VYKGKL------ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNN-RLTNLLGCCCE 127
V ++AVK A + + E + + QL ++ + NLLG C
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120
Query: 128 GDERLLVAEYMPN-----------ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT- 175
L+ EY E ++ +E VL L +
Sbjct: 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 176 -SKGRALY-------H-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY--STNLAF--- 221
+KG + H DL A +L ++ FGL ++ +Y N
Sbjct: 181 VAKGME-FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK 239
Query: 222 -TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP------PSHALDLIRDRNLQMLTDS 274
PE L G T +S ++S+G LL ++ S P ++ LI++
Sbjct: 240 WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY 299
Query: 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321
E E+ + C ++ R+RP+ +L + L + E
Sbjct: 300 ATE---------EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 59/274 (21%), Positives = 97/274 (35%), Gaps = 50/274 (18%)
Query: 76 VYKGK-LENQRRIAVK----RFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLL--GCC 125
V+ + L + R +AVK R DP +F EA++ L + + + G
Sbjct: 28 VHLARDLRDHRDVAVKVLRADLAR----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83
Query: 126 CEGDERL--LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
L +V EY+ TL + PM + V+ QAL + G + H
Sbjct: 84 ETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG--IIH 139
Query: 184 -DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF---TP----PEYLRTGRVTPE 235
D+ I+ ++ FG+ + D + T A T PE R V
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 236 SVIYSFGTLLLDLLSG--------------KHI-----PPSHALDLIRDRNLQMLTDSCL 276
S +YS G +L ++L+G +H+ PPS + + +L + L
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL-SADLDAVVLKAL 258
Query: 277 EGQFTD--DDGTELVRLASRCLQYEPRERPNPKS 308
+ E+ R EP E P +
Sbjct: 259 AKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT 292
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 19/160 (11%)
Query: 161 LRVVLHLAQALEYCTSKGRALYH----DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS 216
LRV+ L AL+ C + + DL + D N +L FGL + S++
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 217 TNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272
TP PE + +S I+S G LL +L + PP A + + L
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTA------FSQKELA 225
Query: 273 DSCLEGQFT---DDDGTELVRLASRCLQYEPRERPNPKSL 309
EG+F EL + +R L + RP+ + +
Sbjct: 226 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 44/253 (17%), Positives = 91/253 (35%), Gaps = 33/253 (13%)
Query: 75 VVYKGKLENQRRIAVKR--FNRMAWPDPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDE 130
V++ E ++ A+K + E + +L+ ++++ L
Sbjct: 43 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+V E + L L ++ ++ +A+ G + H DL
Sbjct: 103 IYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPAN 157
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKS--YSTNLAFTP----PEYLR-----------TGRV 232
L DG +L FG+ + + + T PE ++ ++
Sbjct: 158 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 233 TPESVIYSFGTLLLDLLSGKHIPP-SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291
+P+S ++S G +L + GK P ++ I L + D E +F D +L +
Sbjct: 217 SPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQDV 272
Query: 292 ASRCLQYEPRERP 304
CL+ +P++R
Sbjct: 273 LKCCLKRDPKQRI 285
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 63/276 (22%), Positives = 100/276 (36%), Gaps = 49/276 (17%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFN-RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC 126
G A VV + ++A+KR N + L+E +++ Q + + +
Sbjct: 24 GSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83
Query: 127 EGDERLLVAEYMPN---ETLAKHLFHWETHPMKW------AMRLRVVLHLAQALEYCTSK 177
DE LV + + + KH+ H A LR VL + LEY
Sbjct: 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL---EGLEYLHKN 140
Query: 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVT---- 233
G+ ++ D+ A IL EDG+ +++ FG S LA R T
Sbjct: 141 GQ-IHRDVKAGNILLGEDGSVQIADFG----------VSAFLATGGDITRNKVRKTFVGT 189
Query: 234 -----PESV-----------IYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLTD 273
PE + I+SFG ++L +G PP L L + L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ + G ++ S CLQ +P +RP L
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 34/176 (19%), Positives = 61/176 (34%), Gaps = 17/176 (9%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
L+ E+ P L K L + + + LA AL YC + + H D+ +L
Sbjct: 91 LMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADALHYCHERK--VIHRDIKPENLL 146
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G +++ FG ++ + + L + PPE + + ++ G L + L
Sbjct: 147 MGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT--DDDGTELVRLASRCLQYEPRER 303
G PP + + L S+ L+Y P +R
Sbjct: 207 VGM--PPFD------SPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQR 254
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 46/271 (16%), Positives = 81/271 (29%), Gaps = 34/271 (12%)
Query: 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNL 121
IV K + E P + + ++ N
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 122 LGCCCEGDERLL---VAEYMPNETLAKHLFHWETH-PMKWAMRLRVVLHLAQALEYCTSK 177
+G ++ + E L + + + + L + + +A+A+E+ SK
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 178 GRALYHDL---NAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRV-T 233
G ++ DL N I F D ++ FGL+ + T L P TG+V T
Sbjct: 184 G-LMHRDLKPSN---IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 234 P---------------ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278
+ I+S G +L +LL + RNL+
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLF---- 295
Query: 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ + L P ERP +
Sbjct: 296 ---TQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 42/176 (23%), Positives = 66/176 (37%), Gaps = 17/176 (9%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
L+ EY P T+ + L + + LA AL YC SK + H D+ +L
Sbjct: 86 LILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHSKR--VIHRDIKPENLL 141
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G +++ FG ++ + L + PPE + + ++S G L + L
Sbjct: 142 LGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT--DDDGTELVRLASRCLQYEPRER 303
GK PP Q +FT D L SR L++ P +R
Sbjct: 202 VGK--PP------FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 249
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 50/282 (17%), Positives = 91/282 (32%), Gaps = 46/282 (16%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDER-- 131
VY+ + + + R A+KR R ++E + +L + + G E
Sbjct: 44 VYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103
Query: 132 ------LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-D 184
LL+ E + + P+ L++ +A+++ + + H D
Sbjct: 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD 163
Query: 185 LNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF------------TP----PEYLR 228
L +L G +L FG YS + TP PE +
Sbjct: 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 229 TGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT---- 281
+ + I++ G +L L +H P +R + G+++
Sbjct: 224 LYSNFPIGEKQDIWALGCILYLLCFRQH--PFEDGAKLR----------IVNGKYSIPPH 271
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVP 323
D T L LQ P ER + +V L + V
Sbjct: 272 DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 44/253 (17%), Positives = 91/253 (35%), Gaps = 33/253 (13%)
Query: 75 VVYKGKLENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDE 130
V++ E ++ A+K N + E + +L+ ++++ L
Sbjct: 71 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+V E + L L ++ ++ +A+ G + H DL
Sbjct: 131 IYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPAN 185
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKS--YSTNLAFTP----PEYLR-----------TGRV 232
L DG +L FG+ + + + PE ++ ++
Sbjct: 186 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI 244
Query: 233 TPESVIYSFGTLLLDLLSGKHIPP-SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291
+P+S ++S G +L + GK P ++ I L + D E +F D +L +
Sbjct: 245 SPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 292 ASRCLQYEPRERP 304
CL+ +P++R
Sbjct: 301 LKCCLKRDPKQRI 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 44/253 (17%), Positives = 91/253 (35%), Gaps = 33/253 (13%)
Query: 75 VVYKGKLENQRRIAVKR--FNRMAWPDPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDE 130
V++ E ++ A+K + E + +L+ ++++ L
Sbjct: 24 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYR 189
+V E + L L ++ ++ +A+ G + H DL
Sbjct: 84 IYMVMECGNID-LNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQHG--IVHSDLKPAN 138
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--TP----PEYLR-----------TGRV 232
L DG +L FG+ + + + T PE ++ ++
Sbjct: 139 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 197
Query: 233 TPESVIYSFGTLLLDLLSGKHIPP-SHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291
+P+S ++S G +L + GK P ++ I L + D E +F D +L +
Sbjct: 198 SPKSDVWSLGCILYYMTYGK--TPFQQIINQIS--KLHAIIDPNHEIEFPDIPEKDLQDV 253
Query: 292 ASRCLQYEPRERP 304
CL+ +P++R
Sbjct: 254 LKCCLKRDPKQRI 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 52/272 (19%), Positives = 87/272 (31%), Gaps = 56/272 (20%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARS-VGQLRNNRLT---NL--LGCCCEG 128
VV++G + + AVKR F + A + L N+ C
Sbjct: 31 VVFQGSFQGRPV-AVKRMLI-------DFCDIALMEIKLLT--ESDDHPNVIRYYCSETT 80
Query: 129 DERL-LVAEYMPNE----TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
D L + E +K++ K + ++ +A + + S + H
Sbjct: 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIH 138
Query: 184 -DLNAYRILFD-------------EDGNPRLSTFGLMKNSRDGKSYSTNLAFTP------ 223
DL IL E+ +S FGL K G+S P
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 224 --PEYLR-------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--LT 272
PE L R+T I+S G + +LS P R+ N+ +
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD--KYSRESNIIRGIFS 256
Query: 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
++ E L S+ + ++P +RP
Sbjct: 257 LDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 32/182 (17%), Positives = 66/182 (36%), Gaps = 18/182 (9%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
+ E+ TL + + + + L + + + ++Y SK L + DL I
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF 154
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLD 247
+ ++ FGL+ + ++ + + T PE + + E +Y+ G +L +
Sbjct: 155 LVDTKQVKIGDFGLVTSLKNDGKRTRSKG-TLRYMSPEQISSQDYGKEVDLYALGLILAE 213
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
LL D +G +D + L + L +P +RPN
Sbjct: 214 LLHVCD-TAFETSKFFTD---------LRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTS 263
Query: 308 SL 309
+
Sbjct: 264 EI 265
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 47/283 (16%), Positives = 90/283 (31%), Gaps = 41/283 (14%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDE 130
V + L + A+KR D + EA + + L+ C E
Sbjct: 45 VDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMR--LRVVLHLAQALEYCTSKGRALYH-DLNA 187
L+ + TL + + L ++L + + LE +KG H DL
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKP 162
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTG----------------R 231
IL ++G P L G M + S +
Sbjct: 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222
Query: 232 VTPESVIYSFGTLLLDLLSGKH-----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286
+ + ++S G +L ++ G+ ++ L L + +
Sbjct: 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH--------SS 274
Query: 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKET--EVPSHVL 327
L +L + + +P +RP+ L++ L LQ + + +L
Sbjct: 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQIL 317
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 46/251 (18%), Positives = 83/251 (33%), Gaps = 53/251 (21%)
Query: 75 VVYKGK--LENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDER 131
+Y N R + +K + + + E + + ++ + + + D
Sbjct: 95 WIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154
Query: 132 L-----LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL- 185
+V EY+ ++L + + A + +L + AL Y S G +Y+DL
Sbjct: 155 GDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHSIG-LVYNDLK 209
Query: 186 --NAYRILFDEDGNPRLSTFGLMKN-SRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFG 242
N I+ E+ +L G + + G Y T F PE +R T + IY+ G
Sbjct: 210 PEN---IMLTEEQ-LKLIDLGAVSRINSFGYLYGT-PGFQAPEIVR-TGPTVATDIYTVG 263
Query: 243 TLLLDLLSG---------KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
L L +P + D RL
Sbjct: 264 RTLAALTLDLPTRNGRYVDGLPEDDPVLKTYD---------------------SYGRLLR 302
Query: 294 RCLQYEPRERP 304
R + +PR+R
Sbjct: 303 RAIDPDPRQRF 313
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 29/266 (10%), Positives = 67/266 (25%), Gaps = 47/266 (17%)
Query: 75 VVYKGK------LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN---LLGCC 125
VY+ +N+++ +K +P +F + + +L+ +
Sbjct: 80 QVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136
Query: 126 CEGDERLLVAEYMPNETL---AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA-- 180
+ +LV E TL + M + + + + +E
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG 196
Query: 181 --------LYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEY-- 226
L + D L G S D K + FT +
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ---SIDMKLFPKGTIFTAKCETSGFQC 253
Query: 227 --LRTGRVTPESV-IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283
+ + + + + + +L G ++ +++ + + D
Sbjct: 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK-------VKNEGGECKPEGLFRRLPHLD 306
Query: 284 DGTELVRLASRCLQYEPRERPNPKSL 309
E L L
Sbjct: 307 MWNEFFH---VMLNIPDCHHLPSLDL 329
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 42/265 (15%), Positives = 78/265 (29%), Gaps = 43/265 (16%)
Query: 75 VVYKG-KLENQRRIAVKRFNRMAWPDP--RQFLEEARSVGQLRNNR-LTNLLGCCCEGDE 130
V+K K + A+KR + + L E + L + + E D
Sbjct: 26 SVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85
Query: 131 RLLVAEYMPNETLAKHL--FHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNA 187
L+ EY +LA + + K A ++L + + L Y S L H D+
Sbjct: 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKP 143
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLA-F--------------TP----PEYLR 228
I P ++ ++ + E L+
Sbjct: 144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ 203
Query: 229 -TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL---IRDRNLQMLTDSCLEGQFTDDD 284
P++ I++ ++ + P D IR L + +
Sbjct: 204 ENYTHLPKADIFALALTVVCAAGAE--PLPRNGDQWHEIRQGRL-----PRIPQVLSQ-- 254
Query: 285 GTELVRLASRCLQYEPRERPNPKSL 309
E L + +P RP+ +L
Sbjct: 255 --EFTELLKVMIHPDPERRPSAMAL 277
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 42/193 (21%), Positives = 66/193 (34%), Gaps = 24/193 (12%)
Query: 122 LGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSK 177
+ ++L + + M L HL + + A+ LE+ ++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEHMHNR 311
Query: 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVT 233
+Y DL IL DE G+ R+S GL + K ++ T PE L+ G
Sbjct: 312 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQKGVAY 368
Query: 234 PESVIY-SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ--FTDDDGTELVR 290
S + S G +L LL G P ++ + L D EL
Sbjct: 369 DSSADWFSLGCMLFKLLRGH--SPFRQHK---TKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 291 LASRCLQYEPRER 303
L LQ + R
Sbjct: 424 LLEGLLQRDVNRR 436
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 36/160 (22%), Positives = 58/160 (36%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
R++ + + Y + H DL +L +D N R+ FGL + K
Sbjct: 130 RIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE L G + ++S G +L LLSG PP + N +
Sbjct: 188 -KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC--PPFN------GANEYDILK 237
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
+G++T + +L+R + L Y P R
Sbjct: 238 KVEKGKYTFELPQWKKVSESAKDLIR---KMLTYVPSMRI 274
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 37/173 (21%), Positives = 61/173 (35%), Gaps = 41/173 (23%)
Query: 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFD-EDGN 197
E ++ F + A+++C S+G + H D+ IL D G
Sbjct: 137 GEGPSRCFFG----------------QVVAAIQHCHSRG--VVHRDIKDENILIDLRRGC 178
Query: 198 PRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKH 253
+L FG D Y+ ++PPE++ + + ++S G LL D++ G
Sbjct: 179 AKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237
Query: 254 IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEPRERP 304
P I LE + + L RCL +P RP
Sbjct: 238 --PFERDQEI------------LEAELHFPAHVSPDCCALIRRCLAPKPSSRP 276
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 35/214 (16%)
Query: 108 RSVGQLRNNRLTNLLGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLH 166
+ + + N+R L E + L LV M L H++H A R V +
Sbjct: 235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFY 291
Query: 167 LAQ---ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF-- 221
A+ LE + +Y DL IL D+ G+ R+S GL + +G++
Sbjct: 292 AAEICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG---RVG 347
Query: 222 TPPEYLRTGRVTPESVIY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNLQML 271
T Y+ PE V + G LL ++++G+ P + + +
Sbjct: 348 T-VGYM-----APEVVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRK--KKIKREEV 397
Query: 272 TDSCLEGQ--FTDDDGTELVRLASRCLQYEPRER 303
E +++ + L S+ L +P ER
Sbjct: 398 ERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 46/275 (16%), Positives = 76/275 (27%), Gaps = 29/275 (10%)
Query: 68 HGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPR--QFLEEARSVGQLRNNRLTNLLGC 124
G + V + + V+R N A + E + +
Sbjct: 35 KGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94
Query: 125 CCEGDERLLVAEYMPNETLAKHLFHWETHPMK---WAMRLRVVLHLAQALEYCTSKGRAL 181
+E +V +M + + M A L+ VL +AL+Y G
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHMGYV- 150
Query: 182 YH-DLNAYRILFDEDGNPRLSTFGL-------MKNSRDGKSYSTNLAFTP----PEYLRT 229
H + A IL DG LS + R + PE L+
Sbjct: 151 -HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 230 GRV--TPESVIYSFGTLLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283
+S IYS G +L +G +P + L + + L D+
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT 269
Query: 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318
S P P + + P +
Sbjct: 270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 30/160 (18%), Positives = 60/160 (37%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
++ + + Y + H DL +L ++D ++ FGL + K
Sbjct: 140 VIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE 197
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE LR + + ++S G +L LL+G PP + Q +
Sbjct: 198 -RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY--PP------FGGQTDQEILR 247
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
+G++T + +L++ + LQ++ + R
Sbjct: 248 KVEKGKYTFDSPEWKNVSEGAKDLIK---QMLQFDSQRRI 284
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 40/173 (23%), Positives = 65/173 (37%), Gaps = 41/173 (23%)
Query: 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRILFDED-GN 197
E LA+ F + +A+ +C + G + H D+ IL D + G
Sbjct: 147 QEELARSFFW----------------QVLEAVRHCHNCG--VLHRDIKDENILIDLNRGE 188
Query: 198 PRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKH 253
+L FG +D Y+ ++PPE++R R + ++S G LL D++ G
Sbjct: 189 LKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247
Query: 254 IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEPRERP 304
P + I + GQ +E L CL P +RP
Sbjct: 248 --PFEHDEEI------------IRGQVFFRQRVSSECQHLIRWCLALRPSDRP 286
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 36/148 (24%), Positives = 58/148 (39%), Gaps = 21/148 (14%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGL---MKNSRDGKSYSTNL--- 219
L LEY S+G + H D+ +L G ++S G+ + + T+
Sbjct: 118 LIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 220 AFTPPEYLRTGRV--TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277
AF PPE + I+S G L ++ +G P N+ L ++ +
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG-LYP-------FEGDNIYKLFENIGK 227
Query: 278 GQFT--DDDGTELVRLASRCLQYEPRER 303
G + D G L L L+YEP +R
Sbjct: 228 GSYAIPGDCGPPLSDLLKGMLEYEPAKR 255
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 29/160 (18%), Positives = 55/160 (34%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
++ + + Y + H D+ IL + N ++ FGL
Sbjct: 150 NIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE L+ + + ++S G ++ LL G PP +N Q +
Sbjct: 208 -RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY--PPFGG------QNDQDIIK 257
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
+G++ D+ EL++ L Y+ +R
Sbjct: 258 KVEKGKYYFDFNDWKNISDEAKELIK---LMLTYDYNKRC 294
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 46/250 (18%), Positives = 95/250 (38%), Gaps = 20/250 (8%)
Query: 69 GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127
GE + VYK E + +A+K+ + D ++ ++E + Q + + G +
Sbjct: 38 GEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+ +V EY +++ + + ++ + LEY + ++ D+ A
Sbjct: 96 NTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK-IHRDIKA 153
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGT 243
IL + +G+ +L+ FG+ D + + TP PE ++ + I+S G
Sbjct: 154 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGI 213
Query: 244 LLLDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+++ GK I P A+ +I ++D +CL
Sbjct: 214 TAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP---ELWSD----NFTDFVKQCLVKS 266
Query: 300 PRERPNPKSL 309
P +R L
Sbjct: 267 PEQRATATQL 276
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 28/138 (20%), Positives = 56/138 (40%), Gaps = 20/138 (14%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRL------RVVLHLAQALEYCTSKGRALYH-DL 185
++ EYM N+++ K ++ + + ++ + + Y ++ + + H D+
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE-KNICHRDV 178
Query: 186 ---NAYRILFDEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYL--RTGRVTPESVI 238
N IL D++G +LS FG + D K + F PPE+ + + I
Sbjct: 179 KPSN---ILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 239 YSFGTLLLDLLSGKHIPP 256
+S G L + P
Sbjct: 236 WSLGICLYVMFYNV--VP 251
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 34/179 (18%), Positives = 62/179 (34%), Gaps = 18/179 (10%)
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLNAYRIL 191
LV E N + ++L P + + + Y S G + H DL +L
Sbjct: 88 LVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLL 144
Query: 192 FDEDGNPRLSTFGL-MKNSRDGKSYSTN---LAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
+ N +++ FGL + + + T + PE ES ++S G +
Sbjct: 145 LTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYT 204
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT--DDDGTELVRLASRCLQYEPRERP 304
LL G+ PP ++ + + + E L + L+ P +R
Sbjct: 205 LLIGR--PPFD------TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRL 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 32/151 (21%), Positives = 54/151 (35%), Gaps = 17/151 (11%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGL-MKNSRDGKSYSTN---LAF 221
+ +Y + H DL + +ED ++ FGL K DG+ +
Sbjct: 124 IVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
PE L + E ++S G ++ LL GK PP L+ + +++
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFE------TSCLKETYLRIKKNEYS 233
Query: 282 --DDDGTELVRLASRCLQYEPRERPNPKSLV 310
L + LQ +P RP L+
Sbjct: 234 IPKHINPVAASLIQKMLQTDPTARPTINELL 264
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 32/151 (21%), Positives = 54/151 (35%), Gaps = 17/151 (11%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGL-MKNSRDGKSYST---NLAF 221
+ +Y + H DL + +ED ++ FGL K DG+ +
Sbjct: 150 IVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207
Query: 222 TPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
PE L + E ++S G ++ LL GK PP L+ + +++
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK--PPFE------TSCLKETYLRIKKNEYS 259
Query: 282 --DDDGTELVRLASRCLQYEPRERPNPKSLV 310
L + LQ +P RP L+
Sbjct: 260 IPKHINPVAASLIQKMLQTDPTARPTINELL 290
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 42/198 (21%), Positives = 74/198 (37%), Gaps = 28/198 (14%)
Query: 122 LGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEYCTSK 177
L E L LV M + H+++ + + R + + AQ LE+ +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLHQR 308
Query: 178 GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESV 237
+Y DL +L D+DGN R+S GL + G++ + A T P ++ PE +
Sbjct: 309 N-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT-PGFM-----APELL 361
Query: 238 IY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ--FTDDDG 285
+ + G L ++++ + P A + L LE + D
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR--GPFRARG--EKVENKELKQRVLEQAVTYPDKFS 417
Query: 286 TELVRLASRCLQYEPRER 303
LQ +P +R
Sbjct: 418 PASKDFCEALLQKDPEKR 435
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 35/165 (21%), Positives = 60/165 (36%), Gaps = 40/165 (24%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DL---NAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217
+++ L + + + H DL N IL D+D N +L+ FG G+
Sbjct: 128 KIMRALLEVICALHKLN--IVHRDLKPEN---ILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 218 NLAFTP----PEYLRTGRV------TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN 267
+ TP PE + E ++S G ++ LL+G PP R
Sbjct: 183 -VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--SPPFW------HRK 233
Query: 268 LQMLTDSCLEGQFT---------DDDGTELVRLASRCLQYEPRER 303
++ + G + D +LV R L +P++R
Sbjct: 234 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKR 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 55/245 (22%), Positives = 99/245 (40%), Gaps = 23/245 (9%)
Query: 75 VVYKGK-LENQRRIAVKRFN-RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
V+KG Q+ +A+K + A + +E + Q + +T G + +
Sbjct: 37 EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96
Query: 133 LVAEYMPNETLAKHLFHWETHPMKW-AMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
++ EY+ + L A LR +L + L+Y S+ + ++ D+ A +L
Sbjct: 97 IIMEYLGGGSAL-DLLEPGPLDETQIATILREIL---KGLDYLHSEKK-IHRDIKAANVL 151
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLD 247
E G +L+ FG+ D + TP PE ++ ++ I+S G ++
Sbjct: 152 LSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDS---CLEGQFTDDDGTELVRLASRCLQYEPRERP 304
L G+ PP L ++ L ++ + LEG ++ L CL EP RP
Sbjct: 212 LARGE--PPHSELHPMK--VLFLIPKNNPPTLEGNYSK----PLKEFVEACLNKEPSFRP 263
Query: 305 NPKSL 309
K L
Sbjct: 264 TAKEL 268
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 41/164 (25%), Positives = 61/164 (37%), Gaps = 34/164 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DL---NAYRILF-DEDGNP---RLSTFGLMKNSRDGK 213
V+ + + +EY ++G H DL N IL+ DE GNP R+ FG K R
Sbjct: 120 AVLFTITKTVEYLHAQGVV--HRDLKPSN---ILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 214 SYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ 269
+T PE L I+S G LL +L+G P D +
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG--YTPFANG---PDDTPE 229
Query: 270 MLTDSCLEGQFTDDDGT---------ELVRLASRCLQYEPRERP 304
+ G+F+ G +LV + L +P +R
Sbjct: 230 EILARIGSGKFSLSGGYWNSVSDTAKDLVS---KMLHVDPHQRL 270
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 41/160 (25%), Positives = 56/160 (35%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
R++ + A+ YC + H DL LF D +L FGL + GK T
Sbjct: 110 RIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
TP P+ L G PE +S G ++ LL G PP +
Sbjct: 168 -KVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGY--PPFS------APTDSEVML 217
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
EG FT L+R R L P++R
Sbjct: 218 KIREGTFTFPEKDWLNVSPQAESLIR---RLLTKSPKQRI 254
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 45/248 (18%), Positives = 86/248 (34%), Gaps = 23/248 (9%)
Query: 76 VYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VYK K E A K + + ++ E + + + LLG + ++
Sbjct: 35 VYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E+ P + + + V + +AL + SK ++ DL A +L
Sbjct: 95 IEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI-IHRDLKAGNVLMTL 152
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PE-----YLRTGRVTPESVIYSFGTLL 245
+G+ RL+ FG+ + + TP PE ++ ++ I+S G L
Sbjct: 153 EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 246 LDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+++ + + P L I + L +++ E L P
Sbjct: 213 IEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT---PSKWSV----EFRDFLKIALDKNPE 265
Query: 302 ERPNPKSL 309
RP+ L
Sbjct: 266 TRPSAAQL 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 31/159 (19%), Positives = 57/159 (35%), Gaps = 31/159 (19%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
++ + AL Y S+ + H DL ILF ++ FGL + + + +
Sbjct: 128 ELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE + VT + I+S G ++ LL+G P +L+ +
Sbjct: 186 AAG-TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC--LPFT------GTSLEEVQQ 235
Query: 274 SCLEGQFT--------DDDGTELVRLASRCLQYEPRERP 304
+ +L++ + L +P RP
Sbjct: 236 KATYKEPNYAVECRPLTPQAVDLLK---QMLTKDPERRP 271
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 19/145 (13%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFT 222
+ A++YC + H DL +L D N +++ FGL DG+ T + +
Sbjct: 120 ILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177
Query: 223 PPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280
PE + GR PE I+S G +L LL G +P D ++ L G F
Sbjct: 178 APEVIS-GRLYAGPEVDIWSCGVILYALLCG-TLP-------FDDEHVPTLFKKIRGGVF 228
Query: 281 T--DDDGTELVRLASRCLQYEPRER 303
+ + L LQ +P +R
Sbjct: 229 YIPEYLNRSVATLLMHMLQVDPLKR 253
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 39/165 (23%), Positives = 63/165 (38%), Gaps = 40/165 (24%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DL---NAYRILFDEDGNPRLSTFGLMKNSRDGKSYST 217
++ L +A+ + + + H DL N IL D++ RLS FG + G+
Sbjct: 204 SIMRSLLEAVSFLHANN--IVHRDLKPEN---ILLDDNMQIRLSDFGFSCHLEPGEKLRE 258
Query: 218 NLAFTP----PEYLRTGRV------TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN 267
L TP PE L+ E +++ G +L LL+G PP R
Sbjct: 259 -LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPP------FWHRR 309
Query: 268 LQMLTDSCLEGQFT---------DDDGTELVRLASRCLQYEPRER 303
++ +EGQ+ +L+ R LQ +P R
Sbjct: 310 QILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS---RLLQVDPEAR 351
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 36/163 (22%), Positives = 60/163 (36%), Gaps = 38/163 (23%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DL---NAYRILF---DEDGNPRLSTFGLMKNSRDGKS 214
R++ + + Y + H DL N IL ++D + ++ FGL +
Sbjct: 125 RIIKQVFSGITYMHKHN--IVHRDLKPEN---ILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 215 YSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM 270
T PE LR G + ++S G +L LLSG PP + +N
Sbjct: 180 MKD-RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT--PPFYG------KNEYD 229
Query: 271 LTDSCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
+ G++ DD +L+R + L + P R
Sbjct: 230 ILKRVETGKYAFDLPQWRTISDDAKDLIR---KMLTFHPSLRI 269
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 39/189 (20%), Positives = 73/189 (38%), Gaps = 38/189 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DL---NAYRILF---DEDGNPRLSTFGLMKNSRDGKS 214
++ + +A++Y S A H D+ N +L+ + +L+ FG K + S
Sbjct: 165 EIMKSIGEAIQYLHSINIA--HRDVKPEN---LLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 215 YSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM 270
+T +TP PE L + ++S G ++ LL G PP ++
Sbjct: 220 LTT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY--PPFYSNH--GLAISPG 274
Query: 271 LTDSCLEGQFT---------DDDGTELVRLASRCLQYEPRERPNPKSLVTALS-P-LQKE 319
+ GQ+ ++ L+R L+ EP +R ++ P + +
Sbjct: 275 MKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITE---FMNHPWIMQS 328
Query: 320 TEVPSHVLM 328
T+VP L
Sbjct: 329 TKVPQTPLH 337
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 35/160 (21%), Positives = 59/160 (36%), Gaps = 32/160 (20%)
Query: 162 RVVLHLAQALEYCTSKGRALYH-DLNAYRILF---DEDGNPRLSTFGLMKNSRDGKSYST 217
R++ + + Y + H DL IL ++D + ++ FGL +
Sbjct: 125 RIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 218 NLAFTP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD 273
T PE LR G + ++S G +L LLSG PP + +N +
Sbjct: 183 -RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG--TPPFY------GKNEYDILK 232
Query: 274 SCLEGQFT---------DDDGTELVRLASRCLQYEPRERP 304
G++ DD +L+R + L + P R
Sbjct: 233 RVETGKYAFDLPQWRTISDDAKDLIR---KMLTFHPSLRI 269
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 28/173 (16%)
Query: 102 QFLEEARSVGQLRNNR-LTNLLGCCCEGDERL-LVAEYMPNETLAKHLFHWETH-PMKWA 158
F EE R V + R +T L + + L LV EY L L + P + A
Sbjct: 107 CFREE-RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 159 MRLRVVLHLAQ---ALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL-MKNSRDGKS 214
+LA+ A++ G ++ D+ IL D G+ RL+ FG +K DG
Sbjct: 165 -----RFYLAEIVMAIDSVHRLG-YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 215 YSTNLAFTP----PEYLRTGRVTPESVIY-------SFGTLLLDLLSGKHIPP 256
S TP PE L+ P + Y + G ++ G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TP 269
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 19/142 (13%)
Query: 170 ALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFTPPE 225
A+EYC + H DL +L D++ N +++ FGL DG T + + PE
Sbjct: 120 AIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 226 YLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT-- 281
+ G+ PE ++S G +L +L G +P D + L +
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVG-RLP-------FDDEFIPNLFKKVNSCVYVMP 228
Query: 282 DDDGTELVRLASRCLQYEPRER 303
D L R + +P +R
Sbjct: 229 DFLSPGAQSLIRRMIVADPMQR 250
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 30/146 (20%), Positives = 56/146 (38%), Gaps = 16/146 (10%)
Query: 167 LAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP--- 223
L AL+Y ++ ++ D+ IL DE G+ ++ F + +T +A T
Sbjct: 124 LVMALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYM 181
Query: 224 -PEYLRTGRVTPESVI---YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG- 278
PE + + S +S G +LL G+ P H + + + +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR--RPYHIRS---STSSKEIVHTFETTV 236
Query: 279 -QFTDDDGTELVRLASRCLQYEPRER 303
+ E+V L + L+ P +R
Sbjct: 237 VTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 37/204 (18%), Positives = 67/204 (32%), Gaps = 26/204 (12%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC-------- 125
V + + ++A+K+ + P R+ + ++ N++
Sbjct: 29 YVLRWIHQDTGEQVAIKQCRQELSPKNRERWC--LEIQIMKKLNHPNVVSAREVPDGLQK 86
Query: 126 -CEGDERLLVAEYMPNETLAKHLF-HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
D LL EY L K+L +K ++ ++ AL Y + H
Sbjct: 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIH 144
Query: 184 -DLNAYRILFDEDGNPR---LSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPE 235
DL I+ + G K G+ + + T PE L + T
Sbjct: 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG-TLQYLAPELLEQKKYTVT 203
Query: 236 SVIYSFGTLLLDLLSGKHIPPSHA 259
+SFGTL + ++G P
Sbjct: 204 VDYWSFGTLAFECITGF--RPFLP 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 31/149 (20%), Positives = 52/149 (34%), Gaps = 22/149 (14%)
Query: 167 LAQALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN----LAF 221
L + +EY + + H D+ +L EDG+ +++ FG+ + + +N AF
Sbjct: 146 LIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAF 203
Query: 222 TPPEYLRTGRVT---PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278
PE L R +++ G L + G P D + L
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFG-QCP-------FMDERIMCLHSKIKSQ 255
Query: 279 QFT----DDDGTELVRLASRCLQYEPRER 303
D +L L +R L P R
Sbjct: 256 ALEFPDQPDIAEDLKDLITRMLDKNPESR 284
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 42/205 (20%)
Query: 118 LTNLLGCCCEGDERL-LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQ---ALEY 173
LT L + +RL V EY L HL R + A+ AL+Y
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALDY 263
Query: 174 CTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK-NSRDGKSYSTNLAF--TPPEYLRTG 230
S+ +Y DL ++ D+DG+ +++ FGL K +DG + T F T PEYL
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGT-PEYL--- 316
Query: 231 RVTPESVIY----------SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG-- 278
PE + G ++ +++ G+ P +++ + L + L
Sbjct: 317 --APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LP------FYNQDHEKLFELILMEEI 366
Query: 279 QFTDDDGTELVRLASRCLQYEPRER 303
+F G E L S L+ +P++R
Sbjct: 367 RFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 39/144 (27%), Positives = 58/144 (40%), Gaps = 23/144 (15%)
Query: 170 ALEYCTSKGRALYH-DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST-----NLAFTP 223
++YC + H DL +L D N +++ FGL DG+ T N A
Sbjct: 128 GVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA-- 183
Query: 224 PEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281
PE + GR PE I+S G +L LL G +P D ++ L +G F
Sbjct: 184 PEVIS-GRLYAGPEVDIWSSGVILYALLCG-TLP-------FDDDHVPTLFKKICDGIFY 234
Query: 282 --DDDGTELVRLASRCLQYEPRER 303
++ L LQ +P +R
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKR 258
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 48/253 (18%), Positives = 89/253 (35%), Gaps = 31/253 (12%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
+VY G+ L NQ RIA+K + EE L++ + LG E +
Sbjct: 37 IVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRL--RVVLHLAQALEYCTSKGRALYH-DLNAYRI 190
E +P +L+ L + P+K + + + L+Y H D+ +
Sbjct: 97 FMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV--HRDIKGDNV 153
Query: 191 LFD-EDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRV--TPESVIYSFGT 243
L + G ++S FG K + T PE + G + I+S G
Sbjct: 154 LINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQML-----TDSC--LEGQFTDDDGTELVRLASRCL 296
++++ +GK PP + L + + + + + +C
Sbjct: 214 TIIEMATGK--PPFYEL----GEPQAAMFKVGMFKVHPEIPESMS-AEAKAFIL---KCF 263
Query: 297 QYEPRERPNPKSL 309
+ +P +R L
Sbjct: 264 EPDPDKRACANDL 276
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 449 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.67 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.6 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.52 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.32 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.04 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.8 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.71 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.54 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.4 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.92 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.42 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.41 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.53 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.86 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.52 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-59 Score=454.93 Aligned_cols=247 Identities=16% Similarity=0.207 Sum_probs=210.6
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.++|+++++||+|+||+||+|++. +|+.||||+++...... .+.+.+|++++++++|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999964 59999999997654332 467999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
|||+||+|.++|...+...+++.+++.|+.||+.||+|||+++ |+||||||+|||++++|.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 9999999999997656667899999999999999999999999 999999999999999999999999999876543
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.......+......... ...+..+++++.+|
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-----PPVSLHYSYDLRSL 256 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----CCCCTTSCHHHHHH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----CCCCccCCHHHHHH
Confidence 235699999999999999999999999999999999999999987765544443332211 12345678899999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
|.+||++||++|||++++++
T Consensus 257 i~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=452.61 Aligned_cols=245 Identities=19% Similarity=0.251 Sum_probs=214.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
..|+++++||+|+||+||+|++. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45899999999999999999965 59999999998766566778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
+||+|.+++. .+.+++.+++.++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+|+..... ..
T Consensus 154 ~gg~L~~~l~---~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 154 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp TTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCcHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999999995 356999999999999999999999999 999999999999999999999999999876443 35
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..||+.|||||++.+..|+.++|||||||++|||++|+.||.+............... .....+..+++++.+||.+
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---CCCSCGGGSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CCCCccccCCHHHHHHHHH
Confidence 6799999999999999999999999999999999999999987654443332222111 1122345678899999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||++||++|||++|+++
T Consensus 307 ~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 307 LLVRDPAQRATAAELLK 323 (346)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999988
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-59 Score=448.17 Aligned_cols=254 Identities=24% Similarity=0.299 Sum_probs=215.4
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
+++.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|++.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45778899999999999999863 377899999987554446789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEec
Q 013126 134 VAEYMPNETLAKHLFHW-----------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLST 202 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~-----------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~D 202 (449)
|||||+||+|.++|+.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCccCHhhEEECCCCcEEECC
Confidence 99999999999999742 2357999999999999999999999998 99999999999999999999999
Q ss_pred cCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccc
Q 013126 203 FGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSC 275 (449)
Q Consensus 203 FGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (449)
||+++..... ....||+.|||||++.++.|+.++|||||||++|||+| |+.||.......+........
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~---- 247 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR---- 247 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC----
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----
Confidence 9999865432 22458999999999999999999999999999999999 899987755444433322211
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
....+..+++++.+|+.+||+.||++|||++++++.|+.+.+.
T Consensus 248 -~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 248 -VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1234566788999999999999999999999999999887654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=444.15 Aligned_cols=255 Identities=19% Similarity=0.273 Sum_probs=208.6
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+++++++.++||+|+||+||+|+++ ..||||+++...... .+.|.+|++++++++|||||+++|++.+ +.++|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 4567888999999999999999864 369999997544322 4679999999999999999999998864 5789999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
|||+||+|.+++.. ...++++.++..|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~-IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 111 QWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAKN-IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp ECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999974 4567999999999999999999999998 999999999999999999999999999865432
Q ss_pred ---CccccCccccccccccC---CCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-HHhhcccccccccccCCCCCchhH
Q 013126 213 ---KSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
....||+.|||||++.+ +.|+.++|||||||++|||+||+.||...... .+..........+. ....+.+++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~ 267 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD-LSKLYKNCP 267 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-STTSCTTSC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-cccccccch
Confidence 24579999999999964 35899999999999999999999999754322 22211111111111 123455778
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+++.+++.+||+.||++|||+.++++.|+.++.
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 899999999999999999999999999987754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-58 Score=445.80 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=214.4
Q ss_pred CcccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
++.++++++||+|+||+||+|.+. +++.||||+++..... ..++|.+|+.++++++|||||+++|++.+++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 456788999999999999999862 4678999999765433 367899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~ 197 (449)
++|||||++|+|.++|.... ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGC
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-CCCCCccccceEECCCCC
Confidence 99999999999999996421 246899999999999999999999999 999999999999999999
Q ss_pred eEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccccc
Q 013126 198 PRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (449)
Q Consensus 198 ~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (449)
+||+|||+++..... ....||+.|||||++.++.|+.++|||||||++|||+| |..||.+.....+.......
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~ 263 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 263 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999999864322 33568999999999999999999999999999999999 88888766544443332221
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
. ....++.+++++.+|+.+||+.||++|||+++|++.|+.+
T Consensus 264 ~-----~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 264 Q-----VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred C-----CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 1234567788999999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-58 Score=448.60 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=211.4
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
+++.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|++.+++.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677889999999999999864 478899999987554446789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEE
Q 013126 134 VAEYMPNETLAKHLFHWE-------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRL 200 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL 200 (449)
|||||+||+|.++++... ..++++.+++.|+.||+.||+|||+++ |+||||||+|||+++++.+||
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-FVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTTEEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecccccHhhEEECCCCcEEE
Confidence 999999999999997432 246999999999999999999999998 999999999999999999999
Q ss_pred eccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccc
Q 013126 201 STFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTD 273 (449)
Q Consensus 201 ~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 273 (449)
+|||+++..... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.......+.......
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g--- 276 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG--- 276 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT---
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence 999999865432 23468999999999999999999999999999999999 89998765444333222211
Q ss_pred cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.+...+..+++++.+|+.+||+.||++|||++++++.|+.+.+.
T Consensus 277 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 277 --RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11234566788999999999999999999999999999887643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=447.27 Aligned_cols=258 Identities=17% Similarity=0.122 Sum_probs=215.9
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
....|++.++||+|+||+||+|++. +|+.||||+++.... ..+|+.+++.++|||||++++++.+++.+|||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3456888999999999999999965 599999999976432 2479999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-CeEEeccCCcccCCCC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~--- 212 (449)
||+||+|.+++. +.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||+|+.....
T Consensus 131 y~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 131 LLEGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred ccCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999997 4467999999999999999999999999 99999999999999887 5999999999865432
Q ss_pred ------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 213 ------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 213 ------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.......+......... .....++.+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~s~ 284 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP---PIREIPPSCAP 284 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC---GGGGSCTTSCH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC---CchhcCccCCH
Confidence 224699999999999999999999999999999999999999976533322222211111 11234567888
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccccCCCCcc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVPSHV 326 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~ 326 (449)
++.++|.+||++||++|||+.|++++|.....+...-.++
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 9999999999999999999999999988776655443333
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-58 Score=441.19 Aligned_cols=242 Identities=17% Similarity=0.189 Sum_probs=213.1
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
++|++++.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999964 5999999999753 2344678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++||+|.+++. +.+.+++..++.++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~~~-IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999997 4568999999999999999999999999 999999999999999999999999999875432
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
.+..||+.|||||++.+..|+.++||||+||++|||+||+.||.......+........ ..++..+++++.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------~~~p~~~s~~~~ 262 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE------YDFPEKFFPKAR 262 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------CCCCTTCCHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------CCCCcccCHHHH
Confidence 34579999999999999999999999999999999999999998776555544433221 134556788999
Q ss_pred HHHHHhcccCCCCCCCHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLV 310 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil 310 (449)
+||.+||++||++|||++|++
T Consensus 263 dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHHccCCHhHCcChHHHc
Confidence 999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=453.77 Aligned_cols=245 Identities=19% Similarity=0.251 Sum_probs=214.7
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
..|+++++||+|+||+||+|++. +|+.||||+++.......+.+.+|+.+|+.++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 45899999999999999999965 59999999998776666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
+||+|.+++. .+.+++.+++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 231 ~gG~L~~~i~---~~~l~e~~~~~~~~qil~aL~ylH~~~-IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 231 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp TTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCCcHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999999995 356999999999999999999999999 999999999999999999999999999875433 35
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..||+.|||||++.+..|+.++|||||||++|||++|+.||.+............... .....+..+++++.+||.+
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCSCTTSSCHHHHHHHHH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CCCcccccCCHHHHHHHHH
Confidence 6799999999999999999999999999999999999999977654433332222211 1122345678899999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||++||++|||++|+++
T Consensus 384 ~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 384 LLVRDPAQRATAAELLK 400 (423)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999988
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=429.52 Aligned_cols=243 Identities=20% Similarity=0.256 Sum_probs=199.3
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
..+|++++.||+|+||+||+|+.. +|+.||||++++... ...+.+.+|++++++++|||||++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999954 599999999976432 2356799999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||+ +|+|.+++. +.+.+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~~-IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIV--QRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHH--HSCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9999 689999997 4578999999999999999999999999 999999999999999999999999999875543
Q ss_pred -CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....||+.|||||++.+..+ +.++||||+||++|+|+||+.||.......+........ ..++...++++.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~ 241 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------YTLPKFLSPGAAG 241 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------CCCCTTSCHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHH
Confidence 35679999999999998886 579999999999999999999998776555443332221 1234567889999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||++||++|||++|+++
T Consensus 242 li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 242 LIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHc
Confidence 999999999999999999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=428.53 Aligned_cols=243 Identities=19% Similarity=0.249 Sum_probs=200.8
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEee----CCeeEEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLLV 134 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 134 (449)
+++.++||+|+||+||+|.+. +++.||+|++...... ..+.|.+|++++++++|||||++++++.+ ++.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 456678999999999999965 4899999999754322 24679999999999999999999999875 3568999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccccCceeeC-CCCCeEEeccCCcccCCCC
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~ 212 (449)
||||+||+|.+++. +.+.+++..++.++.||+.||+|||+++ +|+||||||+|||++ ++|.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999999997 4568999999999999999999999975 399999999999998 4899999999999865543
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh-hHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ...+......... +...+...++++.
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~~ 260 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----PASFDKVAIPEVK 260 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----CGGGGGCCCHHHH
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC----CCCCCccCCHHHH
Confidence 34679999999999864 69999999999999999999999996532 2222222222111 1122334567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+||.+||++||++|||++++++
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=435.39 Aligned_cols=243 Identities=19% Similarity=0.213 Sum_probs=203.5
Q ss_pred cccccccccCCccceEEEEEEEc----CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
++|++++.||+|+||+||+|+.. +++.||||++++... .+..++.+|++++++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999852 478999999975331 123478899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
|||||+||+|.+++. +.+.+++.+++.++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999999999997 4568999999999999999999999999 999999999999999999999999999864332
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|||||++.+..|+.++||||+||++|||+||+.||.+.....+........ ...+..+++++.
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------~~~p~~~s~~~~ 254 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK------LGMPQFLSPEAQ 254 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTSCHHHH
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC------CCCCCcCCHHHH
Confidence 35679999999999999999999999999999999999999998766555444333221 133556788999
Q ss_pred HHHHHhcccCCCCCCCH-----HHHHH
Q 013126 290 RLASRCLQYEPRERPNP-----KSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~-----~eil~ 311 (449)
+|+.+||++||++|||+ +|+++
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 99999999999999985 57765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=432.58 Aligned_cols=257 Identities=22% Similarity=0.278 Sum_probs=213.3
Q ss_pred CCCcccccccccCCccceEEEEEEEcC------CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCC-CCcccceeeEeeC
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRN-NRLTNLLGCCCEG 128 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~~------~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~ 128 (449)
-..++|++.++||+|+||+||+|.+.+ ++.||||.++...... .+.|.+|+++|++++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 456789999999999999999999543 3589999997654332 4679999999999976 8999999999764
Q ss_pred -CeeEEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC
Q 013126 129 -DERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193 (449)
Q Consensus 129 -~~~~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~ 193 (449)
+.+++|||||+||+|.++|+... ...+++..+..++.||+.||+|||+++ ||||||||+|||++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-iiHRDLK~~NILl~ 219 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLS 219 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-eecCccCccceeeC
Confidence 56899999999999999997432 345899999999999999999999999 99999999999999
Q ss_pred CCCCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhH-HHhh
Q 013126 194 EDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALD-LIRD 265 (449)
Q Consensus 194 ~~~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~-~~~~ 265 (449)
+++.+||+|||+|+...... ...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... .+..
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998654432 3457899999999999999999999999999999998 89998764322 1111
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.... ..+...++.+++++.+++.+||+.||++|||+++++++|+.+.+.
T Consensus 300 ~i~~-----g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 300 RLKE-----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHH-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHc-----CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1111 112234556788999999999999999999999999999887543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-55 Score=421.41 Aligned_cols=251 Identities=16% Similarity=0.222 Sum_probs=196.6
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHH--HHHHHHHhccCCCCcccceeeEeeCC----eeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQF--LEEARSVGQLRNNRLTNLLGCCCEGD----ERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~--~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV 134 (449)
++.+.++||+|+||+||+|++ +|+.||||+++... .+.+ .+|+..+.+++|||||+++|++.+++ .+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 466778999999999999998 68999999996532 3334 45566667889999999999998764 57999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccccccccCceeeCCCCCeEEeccCCc
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK--------GRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
|||++||+|.++++ ..++++..+.+++.|++.||+|||++ + |+||||||+|||+++++.+||+|||++
T Consensus 80 ~Ey~~~gsL~~~l~---~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~-IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHH---HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC-EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-EeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999995 35799999999999999999999987 6 999999999999999999999999999
Q ss_pred ccCCCC--------CccccCccccccccccCC------CCCCCCceeeHhHHHHHHhcCCCCCCch--------------
Q 013126 207 KNSRDG--------KSYSTNLAFTPPEYLRTG------RVTPESVIYSFGTLLLDLLSGKHIPPSH-------------- 258 (449)
Q Consensus 207 ~~~~~~--------~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg~~p~~~~-------------- 258 (449)
+..... ....||+.|||||++.+. .++.++|||||||++|||+||.+|+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 865432 134689999999999764 3778999999999999999998765321
Q ss_pred -hhHHHhhcccccccccccCC-CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 259 -ALDLIRDRNLQMLTDSCLEG-QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 259 -~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
....+.........++..+. ....+.+..+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111111111111111111 11234567899999999999999999999999999887654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-54 Score=414.17 Aligned_cols=244 Identities=17% Similarity=0.241 Sum_probs=188.9
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCC--------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-------- 129 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------- 129 (449)
++|++++.||+|+||+||+|++. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 36889999999999999999964 5999999999754422 2467999999999999999999999987654
Q ss_pred ----eeEEEEeeCCCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccC
Q 013126 130 ----ERLLVAEYMPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (449)
Q Consensus 130 ----~~~lV~Ey~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFG 204 (449)
.+|+|||||+||+|.+++..... ...++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~-IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc-CccccCcHHHeEECCCCcEEEccCc
Confidence 37999999999999999974221 23456678999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCC----------------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc
Q 013126 205 LMKNSRDG----------------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268 (449)
Q Consensus 205 la~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 268 (449)
+|+..... ....||+.|||||++.+..|+.++|||||||++|||++ ||...........
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~-- 238 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT-- 238 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH--
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH--
Confidence 99865432 12469999999999999999999999999999999997 6654322111100
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....... +......++.+.+++.+||++||++|||+.++++
T Consensus 239 -~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 239 -DVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000000 0011233456789999999999999999999988
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=421.53 Aligned_cols=248 Identities=16% Similarity=0.258 Sum_probs=203.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeC------Ce
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG------DE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 130 (449)
++|++++.||+|+||+||+|++. +|+.||||+++...... .+.+.+|+++|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 36999999999999999999964 59999999997644322 45788999999999999999999987643 57
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
+|||||||+ |+|.+++. ..+++++..++.+++||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~-iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCc-CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999996 78999997 5678999999999999999999999999 9999999999999999999999999998643
Q ss_pred C--------CCccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccc------
Q 013126 211 D--------GKSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC------ 275 (449)
Q Consensus 211 ~--------~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 275 (449)
. .....||+.|||||++.+.. ++.++||||+||++|||++|++||.+................+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 2 13567999999999998754 69999999999999999999999987643332222111100000
Q ss_pred ------------cCC-------CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 276 ------------LEG-------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 276 ------------~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
... ...+..++++.+||.+||++||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 011245678999999999999999999999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=405.57 Aligned_cols=244 Identities=19% Similarity=0.262 Sum_probs=197.4
Q ss_pred cccccccccCCccceEEEEEEEc----CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 134 (449)
+.|+++++||+|+||+||+|+.+ +++.||||.+... ....++.+|+++|+.+ +||||+++++++.+++++|+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 35889999999999999999853 3688999998654 3467789999999998 699999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-CCeEEeccCCcccCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~- 212 (449)
|||++||+|.+++. .+++.+++.+++||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+...+.
T Consensus 99 mE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g-IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 99 MPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG-IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC-eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999983 4899999999999999999999999 9999999999999876 89999999999754322
Q ss_pred -------------------------------CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhh
Q 013126 213 -------------------------------KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHAL 260 (449)
Q Consensus 213 -------------------------------~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~ 260 (449)
....||+.|+|||++.+.. |+.++||||+||++|||+||+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1246899999999998764 89999999999999999999999854321
Q ss_pred HHHh-hcc-------------------c------------------cc-----------ccccccCCCCCchhHHHHHHH
Q 013126 261 DLIR-DRN-------------------L------------------QM-----------LTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 261 ~~~~-~~~-------------------~------------------~~-----------~~~~~~~~~~~~~~~~~l~~l 291 (449)
+... ... . .. ..............++++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 1000 000 0 00 000000011223567889999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+.+||+.||++|||++|+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=427.14 Aligned_cols=249 Identities=18% Similarity=0.159 Sum_probs=214.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
++|++++.||+|+||+||+|... +|+.||+|++......+.+.+.+|+++|+.++|||||++++++.+++.+|+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 56899999999999999999965 59999999997755445677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC--CCeEEeccCCcccCCCCC---
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED--GNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~--~~~kL~DFGla~~~~~~~--- 213 (449)
+||+|.+++.. ..+.+++.++..+++||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++......
T Consensus 237 ~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 237 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred CCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 99999999964 3467999999999999999999999999 9999999999999854 899999999999876553
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...||+.|||||++.+..|+.++||||+||++|||++|+.||.+................ ........+++++.+||.
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCSGGGTTSCHHHHHHHH
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--CCcccccCCCHHHHHHHH
Confidence 457999999999999999999999999999999999999999876554443332221111 111223456789999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~ 312 (449)
+||+.||++|||+.|++++
T Consensus 393 ~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999983
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=424.13 Aligned_cols=248 Identities=19% Similarity=0.171 Sum_probs=205.8
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHH---HHHHhccCCCCcccceeeEeeCCe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEE---ARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E---~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
..++|++++.||+|+||+||+|+.. +|+.||||++++.. ........+| +.+++.++|||||++++++.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 4678999999999999999999965 59999999996421 2223334444 667778899999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
+|+||||++||+|.++|. +.+.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+...
T Consensus 267 lylVmEy~~GGdL~~~l~--~~~~l~E~~a~~y~~qIl~aL~yLH~~g-IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999997 4567999999999999999999999999 9999999999999999999999999998765
Q ss_pred CC--CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 211 DG--KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 211 ~~--~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
.. .+..||+.|||||++.+ ..|+.++|+|||||++|||++|++||.......... ....+.. ....++..++++
T Consensus 344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~~~i~~--~~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--MAVELPDSFSPE 420 (689)
T ss_dssp SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HHHHHHH--CCCCCCTTSCHH
T ss_pred CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcC--CCCCCCccCCHH
Confidence 44 45689999999999975 569999999999999999999999997643211110 0011111 112345678899
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHHH
Q 013126 288 LVRLASRCLQYEPRERPN-----PKSLVT 311 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps-----~~eil~ 311 (449)
+.+||.+||++||++|++ ++++++
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 999999999999999998 688876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=376.58 Aligned_cols=247 Identities=20% Similarity=0.288 Sum_probs=213.2
Q ss_pred CCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.....|++++.||+|+||.||+|.+ .+|+.||||++...... ..+.+.+|+++++.++||||+++++++..++..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3456799999999999999999996 46999999999764322 24578899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||++||+|.+++.. .+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999973 467999999999999999999999999 999999999999999999999999999865543
Q ss_pred --CccccCccccccccccCCCCC-CCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVT-PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+..++ .++||||+||++|+|++|+.||................ ...+...++++.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~ 242 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK------YRIPFYMSTDCE 242 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTSCHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CCCCCCCCHHHH
Confidence 345789999999999888765 79999999999999999999998776555544333221 123445678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+++.+||+.||++|||+++++++
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999983
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=373.70 Aligned_cols=248 Identities=19% Similarity=0.250 Sum_probs=212.3
Q ss_pred CCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+....|++++.||+|+||+||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 3445789999999999999999995 459999999998766666788999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++||+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp ECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999999999953 46999999999999999999999999 999999999999999999999999998765543
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||............... .......+...++.+.++
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSCGGGSCHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCccccCHHHHHH
Confidence 2456899999999999999999999999999999999999998765332222111111 111122345677889999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+.+||+.||++|||++++++
T Consensus 250 i~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhh
Confidence 99999999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=371.02 Aligned_cols=261 Identities=19% Similarity=0.238 Sum_probs=219.9
Q ss_pred cccCHHHHHHhhCCCcc-------cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCC
Q 013126 45 REFTLEQLKNATSGFAV-------ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN 116 (449)
Q Consensus 45 ~~~~~~~l~~~~~~f~~-------~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hp 116 (449)
..++.++++.+++.... ++..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 56889999988876322 556678899999999999976 6999999999876666678899999999999999
Q ss_pred CcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC
Q 013126 117 RLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196 (449)
Q Consensus 117 nIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~ 196 (449)
||+++++++..++..++||||++|++|.+++. ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQG-VIHRDIKSDSILLTLDG 178 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCC
Confidence 99999999999999999999999999999984 467999999999999999999999999 99999999999999999
Q ss_pred CeEEeccCCcccCCCC----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc
Q 013126 197 NPRLSTFGLMKNSRDG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272 (449)
Q Consensus 197 ~~kL~DFGla~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 272 (449)
.+||+|||++...... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||................
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~- 257 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP- 257 (321)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-
T ss_pred cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-
Confidence 9999999998765433 34568999999999998889999999999999999999999987654333222211111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.+ ........++++.+++.+||+.||++|||++++++.
T Consensus 258 ~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 258 PP--KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CC--CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 111233567889999999999999999999999983
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=372.24 Aligned_cols=262 Identities=19% Similarity=0.290 Sum_probs=210.1
Q ss_pred hCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 56 TSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 56 ~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.-.+.+|++++.||+|+||+||+|++ +|+.||+|++....... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34567899999999999999999987 67899999997654332 3578999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 134 VAEYMPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~-iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||++++ |+||||||+||++++++.+||+|||+++....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999997321 1238999999999999999999999853 99999999999999999999999999975443
Q ss_pred C----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 212 G----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 212 ~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
. ....||+.|+|||++.+..++.++||||||+++|+|++|+.||............... ......+...+++
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 267 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----CKRLEIPRNLNPQ 267 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS----CCCCCCCTTSCHH
T ss_pred cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----CCCCCCCccCCHH
Confidence 3 3456899999999999999999999999999999999999998765443332221111 1122345567789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhcccccccCC
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 322 (449)
+.+++.+||+.||++|||++++++.|+.+.+...+
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998766443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=374.97 Aligned_cols=270 Identities=26% Similarity=0.429 Sum_probs=222.4
Q ss_pred cCHHHHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEe
Q 013126 47 FTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC 126 (449)
Q Consensus 47 ~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 126 (449)
++..++...++ .|++.+.||+|+||+||+|.+++++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 29 ~~~~~~~~~~~---~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 29 VPLVDLEEATN---NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp -CCSCCCCCCC---CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred ecHHHHHHHHh---ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 44444444444 456777789999999999998789999999998766555778999999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccC
Q 013126 127 EGDERLLVAEYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (449)
Q Consensus 127 ~~~~~~lV~Ey~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFG 204 (449)
+++..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC-eecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999986432 235899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-----------HHhhcc
Q 013126 205 LMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-----------LIRDRN 267 (449)
Q Consensus 205 la~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-----------~~~~~~ 267 (449)
+++..... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99764322 2335789999999999889999999999999999999999988643211 111122
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.....++......+...+..+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 22333333334456678899999999999999999999999999998876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=374.40 Aligned_cols=272 Identities=29% Similarity=0.482 Sum_probs=224.1
Q ss_pred CCCccccCHHHHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcc
Q 013126 41 LPSFREFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLT 119 (449)
Q Consensus 41 ~p~~~~~~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv 119 (449)
....+.++..++...+++|. +.+.||+|+||+||+|...+++.||||+++..... ....+.+|+++++.++||||+
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~---~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 90 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFS---NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 90 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSC---STTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBC
T ss_pred cCccceecHHHHHHHhhccc---cceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCcc
Confidence 34457899999988887655 56667999999999999878999999999765432 234799999999999999999
Q ss_pred cceeeEeeCCeeEEEEeeCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCccccccccCceeeCC
Q 013126 120 NLLGCCCEGDERLLVAEYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSK---GRALYHDLNAYRILFDE 194 (449)
Q Consensus 120 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---~~iiHrDlkp~NILl~~ 194 (449)
++++++.+++..++||||+++|+|.+++.... ..++++..+..++.|++.||+|||++ + ++||||||+|||+++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK-IIHRDVKAANILLDE 169 (326)
T ss_dssp CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC-EECCCCSGGGEEECT
T ss_pred ceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeCCCchhhEEECC
Confidence 99999999999999999999999999997532 33599999999999999999999999 8 999999999999999
Q ss_pred CCCeEEeccCCcccCCCC-----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-------
Q 013126 195 DGNPRLSTFGLMKNSRDG-----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL------- 262 (449)
Q Consensus 195 ~~~~kL~DFGla~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~------- 262 (449)
++.+||+|||+++..... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 999999999999865433 23458999999999988889999999999999999999999985321110
Q ss_pred ------HhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 263 ------IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 263 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
..........+.......+...++.+.+++.+||+.||++|||+++++++|+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 111122223333333445567788999999999999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=372.96 Aligned_cols=257 Identities=18% Similarity=0.250 Sum_probs=214.2
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.++|++.+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 356888999999999999999965 5899999998765544467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
++|++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 89 IKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMN-IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp CTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred cCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999999975 3567999999999999999999999999 9999999999999999999999999997654321
Q ss_pred --------------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCC
Q 013126 214 --------------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 214 --------------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (449)
...||+.|+|||++.+..++.++||||||+++|+|++|..|+............ .........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---~~~~~~~~~ 243 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---NVRGFLDRY 243 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---CHHHHHHHT
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---hhhcccccc
Confidence 346899999999999999999999999999999999999887543211111000 000011112
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.+..+++.+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 24455677999999999999999999999999998887553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=373.45 Aligned_cols=245 Identities=20% Similarity=0.247 Sum_probs=212.1
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.++|++++.||+|+||+||+|+.. +|+.||+|++++. .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467899999999999999999965 5999999999753 234467899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||++||+|.+++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999999997 4467999999999999999999999999 999999999999999999999999999864322
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....||+.|+|||++.+..++.++||||||+++|||++|+.||............... ...++...++++.+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~ 234 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKS 234 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHH
Confidence 3457899999999999989999999999999999999999999776544443332221 11234567789999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHHH
Q 013126 291 LASRCLQYEPRERP-----NPKSLVTA 312 (449)
Q Consensus 291 li~~cl~~dP~~Rp-----s~~eil~~ 312 (449)
+|.+||+.||++|| ++++++++
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999 89999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=366.22 Aligned_cols=258 Identities=17% Similarity=0.233 Sum_probs=213.4
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
..|++++.||+|+||+||+|.+. +++.||+|.+....... .+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 45889999999999999999965 58999999996544333 357899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++|++|.+++. ..+++++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDMR-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 9999999999997 3467999999999999999999999999 999999999999999999999999999865433
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||................... .....+...++.+.+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN-VTTDVRKDIPQSLSN 246 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC-HHHHSCTTSCHHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC-cchhcccCCCHHHHH
Confidence 23468999999999999899999999999999999999999997765443332222221111 111234456788999
Q ss_pred HHHHhcccCCCCCC-CHHHHHHHhcccccccC
Q 013126 291 LASRCLQYEPRERP-NPKSLVTALSPLQKETE 321 (449)
Q Consensus 291 li~~cl~~dP~~Rp-s~~eil~~L~~~~~~~~ 321 (449)
++.+||+.||++|| +++++.+.|+.+..+..
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 99999999999998 89999999988765543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=361.37 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=216.9
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+.++|++++.||+|+||+||+|.+.+++.||+|+++... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 346789999999999999999998888899999998654 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----- 212 (449)
+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 87 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp CTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCC-eecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999999964 4467999999999999999999999999 999999999999999999999999999865433
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||................ ....+...++++.++
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l 239 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-----RLYKPRLASTHVYQI 239 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----CCCCCTTSCHHHHHH
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-----cCCCCCcCCHHHHHH
Confidence 23446778999999998899999999999999999999 888887654444333222211 122234557889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+.+||+.||++|||+.++++.|+.+..
T Consensus 240 i~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 240 MNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 999999999999999999999988754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=359.19 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=215.3
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
-++|++++.||+|+||+||+|.+.++..||+|+++... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35789999999999999999998888899999997654 34678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----- 213 (449)
++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 86 SNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESHQ-FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp TTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTT-EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred CCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 99999999975 3456999999999999999999999999 9999999999999999999999999998665442
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...+|+.|+|||++.+..++.++||||||+++|+|++ |+.||................ ....+...++.+.+++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-----RLYRPHLASDTIYQIM 238 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----CCCCCTTSCHHHHHHH
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-----CCCCCCcChHHHHHHH
Confidence 2345678999999998889999999999999999999 888886554433332222111 1122344567899999
Q ss_pred HHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.+||+.||++|||+.++++.|+.+...
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 999999999999999999999988654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=374.23 Aligned_cols=246 Identities=17% Similarity=0.186 Sum_probs=209.5
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC------CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.|++++.||+|+||+||+|... +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4889999999999999999965 5899999999764322 25789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC----CeEEeccCCcccC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~----~~kL~DFGla~~~ 209 (449)
||||++||+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++ .+||+|||+++..
T Consensus 93 v~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 93 ILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999997 4568999999999999999999999999 99999999999998776 7999999999876
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~ 247 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD--FDEEFFSQTSE 247 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTSCH
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCchhccCCCH
Confidence 543 3456899999999999889999999999999999999999999776544433322221111 00111234567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
++.++|.+||..||++|||+.++++
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999999997
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=370.61 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=214.0
Q ss_pred CcccccccccCCccceEEEEEEEc----CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
...|++.+.||+|+||+||+|.+. .+..||||+++..... ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356899999999999999999964 3456999999764322 24679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||++|++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 128 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLG-YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999964 3467999999999999999999999999 9999999999999999999999999998765432
Q ss_pred -------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 214 -------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 214 -------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
...+|+.|+|||++.+..++.++||||||+++|+|++ |..||................ ....+..++
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 280 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-----RLPAPMGCP 280 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-----CCCCCTTCC
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-----CCCCCCCcC
Confidence 2234678999999998889999999999999999999 999887654444333222211 122345677
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
+++.+++.+||+.||++|||+.++++.|+.+....+
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 899999999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=373.13 Aligned_cols=247 Identities=18% Similarity=0.217 Sum_probs=208.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+.|++++.||+|+||+||+|... +|+.||+|+++...... .+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 35889999999999999999965 58999999997654322 4578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC---CCeEEeccCCcccCCCCC
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~ 213 (449)
|++||+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++......
T Consensus 109 ~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 109 LVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred cCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999999997 4567999999999999999999999999 9999999999999865 459999999998765442
Q ss_pred ---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 214 ---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.................. ........+++++.+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEWDTVTPEAKS 263 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTGGGGSCHHHHH
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--CCcccccCCCHHHHH
Confidence 357899999999999888999999999999999999999999765544333322221111 011112356788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||+.||++|||+.++++
T Consensus 264 li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHcCCChhhCcCHHHHhc
Confidence 999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=359.71 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=214.0
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+.++|++++.||+|+||+||+|.+.+++.||+|+++... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 345789999999999999999998888899999998654 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----- 212 (449)
+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 101 MANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp CTTCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred cCCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 999999999974 2457999999999999999999999999 999999999999999999999999999865433
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||................ ....+...++.+.++
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-----RLYRPHLASEKVYTI 253 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----CCCCCTTCCHHHHHH
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-----CCCCCCcCCHHHHHH
Confidence 23346788999999998889999999999999999998 998887654443333222221 112234556789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
+.+||+.||++|||++++++.|..+..+
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999887654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=375.13 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=212.9
Q ss_pred CcccccccccCCccceEEEEEEEc--------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEG 128 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~--------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 128 (449)
.++|++.+.||+|+||+||+|++. ++..||||+++..... ..+.+.+|+++++.+ +||||+++++++.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467899999999999999999852 3457999999765322 246799999999999 899999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC
Q 013126 129 DERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~ 194 (449)
+..|+||||++||+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVLVTE 238 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-eeccccchhhEEECC
Confidence 99999999999999999997532 235889999999999999999999999 999999999999999
Q ss_pred CCCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcc
Q 013126 195 DGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 267 (449)
Q Consensus 195 ~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 267 (449)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......+....
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~ 318 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999999865432 22345788999999998899999999999999999999 88888765433332221
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
... .....+..++.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 319 ~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 319 KEG-----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HTT-----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcC-----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111 11233456778999999999999999999999999999887543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=366.01 Aligned_cols=245 Identities=18% Similarity=0.223 Sum_probs=212.4
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
..++|++++.||+|+||+||+|+.. +|+.||+|++++. .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 3567899999999999999999965 5999999999753 22346778899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||++||+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 84 IMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp EECCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EEeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 999999999999997 4567999999999999999999999999 999999999999999999999999999876543
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
....||+.|+|||++.+..++.++||||||+++|||++|+.||................ ..++...++++.+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~li 234 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------LRFPPFFNEDVKDLL 234 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------CCCCTTSCHHHHHHH
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CCCCCCCCHHHHHHH
Confidence 35678999999999999899999999999999999999999997654443333222211 123456678999999
Q ss_pred HHhcccCCCCCC-----CHHHHHH
Q 013126 293 SRCLQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 293 ~~cl~~dP~~Rp-----s~~eil~ 311 (449)
.+||+.||++|| +++++++
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhccCHHHcCCCcCCCHHHHhc
Confidence 999999999999 8899986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=369.33 Aligned_cols=249 Identities=15% Similarity=0.183 Sum_probs=210.2
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.+.|++++.||+|+||+||+|.+. +++.||+|.++... .+.+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 357889999999999999999965 48899999997532 2356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC--CCCeEEeccCCcccCCCCC--
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE--DGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~~-- 213 (449)
++|++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g-ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 999999999964 3457999999999999999999999999 999999999999997 7899999999998765543
Q ss_pred -ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...||+.|+|||++.+..++.++||||||+++|+|++|..||................... ........++++.+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--DEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CHHHHTTSCHHHHHHH
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC--ChhhhccCCHHHHHHH
Confidence 3468999999999998889999999999999999999999997765444333322211110 0011234567899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~ 312 (449)
.+||+.||++|||+.+++++
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHS
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999983
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=375.18 Aligned_cols=245 Identities=19% Similarity=0.253 Sum_probs=207.7
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
+.++|++++.||+|+||+||+|+.. +++.||||++++. .....+.+.+|..+++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3567899999999999999999965 4899999999753 223456788999999988 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||++||+|.+++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ--KSRRFDEARARFYAAEIISALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999997 4467999999999999999999999999 999999999999999999999999999864322
Q ss_pred ----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
....||+.|+|||++.+..++.++|||||||++|||++|+.||................ ..++...++++
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~ 251 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE------VVYPTWLHEDA 251 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTSCHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHH
Confidence 34568999999999998889999999999999999999999998766554444333221 12345567889
Q ss_pred HHHHHHhcccCCCCCCCH------HHHHH
Q 013126 289 VRLASRCLQYEPRERPNP------KSLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~------~eil~ 311 (449)
.+++.+||++||++||++ +++++
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 999999999999999998 77776
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=370.71 Aligned_cols=255 Identities=15% Similarity=0.217 Sum_probs=204.4
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCC----eeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD----ERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV 134 (449)
..+|++++.||+|+||+||+|++. ++.||||+++... .....+.+|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357899999999999999999874 7899999996532 22345677999999999999999999998754 36999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCccccccccCceeeCCCCCeEEeccC
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK----------GRALYHDLNAYRILFDEDGNPRLSTFG 204 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------~~iiHrDlkp~NILl~~~~~~kL~DFG 204 (449)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||++ + |+||||||+|||+++++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~-ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-ISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE-EECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC-EEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999953 5699999999999999999999999 8 9999999999999999999999999
Q ss_pred CcccCCCC------CccccCccccccccccCC-----CCCCCCceeeHhHHHHHHhcCCCCCCchhh-------------
Q 013126 205 LMKNSRDG------KSYSTNLAFTPPEYLRTG-----RVTPESVIYSFGTLLLDLLSGKHIPPSHAL------------- 260 (449)
Q Consensus 205 la~~~~~~------~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~p~~~~~~------------- 260 (449)
+++..... ....||+.|+|||++.+. .++.++||||||+++|||+||+.||.....
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99764432 235689999999999863 467789999999999999999988754211
Q ss_pred ---HHHhhcccccccccccCCC-CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 261 ---DLIRDRNLQMLTDSCLEGQ-FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 261 ---~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
..+..........+..... .....++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111111111100 1224567799999999999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=380.35 Aligned_cols=248 Identities=17% Similarity=0.185 Sum_probs=209.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++|++++.||+|+||+||+|... +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 46889999999999999999964 5899999999764422 24568999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC---CCCCeEEeccCCcccCCCC-
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~- 212 (449)
|++||+|.+.+. ....+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++.....
T Consensus 91 ~~~gg~L~~~i~--~~~~~~e~~~~~i~~qil~aL~~lH~~g-ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIV--AREYYSEADASHCIQQILEAVLHCHQMG-VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999999997 4567999999999999999999999999 99999999999998 5688999999999776543
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+..++.++||||+||++|+|++|..||................... ........++++.
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~ 245 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF--PSPEWDTVTPEAK 245 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CTTTTTTSCHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--CccccccCCHHHH
Confidence 23578999999999998899999999999999999999999997765544443332221111 1122345678999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+++.+||+.||++|||+.+++++
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999983
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=365.14 Aligned_cols=246 Identities=16% Similarity=0.167 Sum_probs=208.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC------CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.|++.+.||+|+||+||+|... +|+.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5888999999999999999965 5899999999764322 35789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC----CeEEeccCCcccC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~----~~kL~DFGla~~~ 209 (449)
||||++|++|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||+++++ .+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 92 ILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCC-eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999997 4567999999999999999999999999 99999999999999887 7999999999876
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.................. .........++
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 246 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--FEDEYFSNTSA 246 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC--CCHHHHTTSCH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC--cCccccccCCH
Confidence 433 3456899999999999889999999999999999999999998765443332221111000 00011234567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+.+++.+||+.||++|||+.++++
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 8999999999999999999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=364.29 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=210.3
Q ss_pred cccccccccCCccceEEEEEEEcC-C-------CEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-Q-------RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~-------~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
++|++.+.||+|+||+||+|.+.. + ..||+|.+........+.+.+|++++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568899999999999999999543 4 57999999766555578899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC--------eEEecc
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--------PRLSTF 203 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~--------~kL~DF 203 (449)
++||||++|++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++. +||+||
T Consensus 88 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEENT-LIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhCC-eECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999999975 3345999999999999999999999999 999999999999998877 999999
Q ss_pred CCcccCCCCCccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCc
Q 013126 204 GLMKNSRDGKSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 204 Gla~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
|++..........+|+.|+|||++.+ ..++.++||||||+++|+|++|..|+............... ....+.
T Consensus 166 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~------~~~~~~ 239 (289)
T 4fvq_A 166 GISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------RHQLPA 239 (289)
T ss_dssp CSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------TCCCCC
T ss_pred cccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc------cCCCCC
Confidence 99987766666678999999999987 66899999999999999999976655433222111111111 112233
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
..++++.+++.+||+.||++|||++++++.|+.+....
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 44567999999999999999999999999999887543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=363.34 Aligned_cols=250 Identities=21% Similarity=0.274 Sum_probs=202.3
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.++|++++.||+|+||+||+|++.+++.||+|+++...... .+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46799999999999999999998889999999997643222 4678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++ ++|.+.+.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 100 FME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp CCS-EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CCC-CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 998 588888864 4456999999999999999999999999 999999999999999999999999999865432
Q ss_pred CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc-----------------
Q 013126 213 KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS----------------- 274 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----------------- 274 (449)
....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||..................+
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 33467999999999976 458999999999999999999999986543222111110000000
Q ss_pred -------ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 -------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.......+..++++.+++.+||+.||++|||++++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000012235678999999999999999999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=357.20 Aligned_cols=249 Identities=18% Similarity=0.245 Sum_probs=202.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++|++++.||+|+||+||+|.+. +++.||+|+++...... .+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 58999999997654332 4678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|+++ +|.+.+.. ..+.+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~-ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9985 66666653 4578999999999999999999999999 999999999999999999999999999865432
Q ss_pred CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCch-hhHHHhhcccccc--------------cc---
Q 013126 213 KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQML--------------TD--- 273 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~--------------~~--- 273 (449)
....+|+.|+|||++.+.. ++.++||||||+++|+|++|..|+... ............. .+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 3456799999999998766 899999999999999999998875432 2111111110000 00
Q ss_pred ------cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 ------SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
........+..++++.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00001122346788999999999999999999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=378.79 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=213.5
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+.++|++.+.||+|+||+||+|.+. +++.||||.++...... .+.|.+|++++++++||||+++++++..++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467889999999999999999976 58999999997543221 346889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC--
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-- 213 (449)
||++||+|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++......
T Consensus 192 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKC-CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp ECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999974 3456899999999999999999999999 9999999999999999999999999998654331
Q ss_pred ----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 214 ----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 214 ----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
...+++.|+|||++.++.++.++||||||+++|||+| |..|+............... .....+..+++++
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l 344 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-----GRLPCPELCPDAV 344 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-----CCCCCCTTCCHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHH
Confidence 1234678999999998889999999999999999998 88888765443332221111 1122345567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 289 VRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 345 ~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999887543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=382.70 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=216.2
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.++|++.+.||+|+||+||+|.++++..||||.++... ...+.|.+|++++++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45688899999999999999999888899999998654 45788999999999999999999999986 66789999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----C
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-----~ 213 (449)
++|+|.+++.......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 9999999997544457899999999999999999999999 999999999999999999999999999876532 2
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...+++.|+|||++.+..++.++||||||+++|||+| |+.||............... .....+..+++++.+++
T Consensus 344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~l~~li 418 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-----YRMPRPENCPEELYNIM 418 (454)
T ss_dssp SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-----CCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHH
Confidence 2345678999999998899999999999999999999 99888765443333222111 11223456778999999
Q ss_pred HHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.+||+.||++|||++++++.|+.+....
T Consensus 419 ~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 419 MRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999999999886543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=375.67 Aligned_cols=256 Identities=17% Similarity=0.170 Sum_probs=214.2
Q ss_pred HHHHhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEe
Q 013126 51 QLKNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCC 126 (449)
Q Consensus 51 ~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 126 (449)
.+.......++|++++.||+|+||+||+|+.. +++.||+|++++. .....+.+.+|+.+++.++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34445556778999999999999999999975 4899999999642 1223456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 127 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
+++..|+||||++||+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g-ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999953 46899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCC-----CccccCccccccccccCCC----CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccC
Q 013126 207 KNSRDG-----KSYSTNLAFTPPEYLRTGR----VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 207 ~~~~~~-----~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
+..... ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||................... .
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--~ 293 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--T 293 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--C
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc--c
Confidence 876543 2567999999999998665 8899999999999999999999998765544443333221111 1
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRE--RPNPKSLVTA 312 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~eil~~ 312 (449)
......+++++.+||.+||+.+|.+ ||++++++++
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1112356789999999999999988 9999999984
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=374.37 Aligned_cols=253 Identities=22% Similarity=0.288 Sum_probs=203.1
Q ss_pred cccccccccCCccceEEEEEEEc----CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
..|++.+.||+|+||+||+|++. ++..||||.++..... ..+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46788899999999999999864 4778999999765322 246799999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
|||++||+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 125 TEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMG-YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999974 3457999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||................ ....+...+.
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-----~~~~~~~~~~ 277 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-----RLPPPMDCPA 277 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-----ECCCCTTCBH
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----CCCCCccccH
Confidence 1234678999999998899999999999999999998 999887654443332222211 1122445678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++.+++.+||+.||++||++.++++.|+.+...
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999888654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=364.49 Aligned_cols=258 Identities=19% Similarity=0.299 Sum_probs=209.0
Q ss_pred cccccccccCCccceEEEEEEE-----cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-----~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 132 (449)
..|++++.||+|+||+||+|++ .+++.||||+++.......+.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5689999999999999999984 25889999999865544456799999999999999999999998654 5689
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 90 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEEECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEEEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 99999999999999975 3446999999999999999999999999 999999999999999999999999999865433
Q ss_pred C-------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc-----------ccccccc
Q 013126 213 K-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------LQMLTDS 274 (449)
Q Consensus 213 ~-------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-----------~~~~~~~ 274 (449)
. ...++..|+|||++.+..++.++||||||+++|+|+||..|+............ .......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence 2 234567799999999899999999999999999999999887654322111100 0000111
Q ss_pred ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
......+..+++++.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 112233556778999999999999999999999999999887654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=371.64 Aligned_cols=252 Identities=18% Similarity=0.131 Sum_probs=198.9
Q ss_pred CCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
...++|++++.||+|+||+||+++.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 34567999999999999999999975 589999999976543 3467899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC--eEEeccCCcccCCC--
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--PRLSTFGLMKNSRD-- 211 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~--~kL~DFGla~~~~~-- 211 (449)
||++||+|.+++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 96 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~ql~~~L~~LH~~~-ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 96 EYASGGELYERIC--NAGRFSEDEARFFFQQLLSGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 9999999999997 3457999999999999999999999999 999999999999987765 99999999874332
Q ss_pred -CCccccCccccccccccCCCCCCC-CceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 212 -GKSYSTNLAFTPPEYLRTGRVTPE-SVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 212 -~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
.....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||...............+.............++++.
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 252 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence 234578999999999988887655 999999999999999999987532211111111111111111111224678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+++.+||+.||++|||+.+++++
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 253 HLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHHhC
Confidence 99999999999999999999984
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=366.53 Aligned_cols=248 Identities=19% Similarity=0.182 Sum_probs=204.1
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+++|++++.||+|+||+||+|.+. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999965 5899999999654322 24678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++|++|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999996 5567999999999999999999999999 999999999999999999999999999754322
Q ss_pred --CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.............. ............++++.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---EKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH---TTCTTSTTGGGSCHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cccccCCccccCCHHHH
Confidence 24568999999999987775 7799999999999999999999865322111100000 00011111245678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+++.+||+.||++|||++++++.
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhhCcCHHHHhhC
Confidence 99999999999999999999984
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=368.42 Aligned_cols=246 Identities=16% Similarity=0.170 Sum_probs=213.2
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
..++|++++.||+|+||.||+|+.. +|+.||+|++++.. ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 4578999999999999999999965 59999999996532 2346789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||++||+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 9999999999999973 457999999999999999999999999 999999999999999999999999999876544
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
....||+.|+|||++.+..++.++||||||+++|||++|+.||................ ..++...++++.++|
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------VRFPSHFSSDLKDLL 269 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTCCHHHHHHH
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHHHH
Confidence 35678999999999999899999999999999999999999997765444433322211 123456778999999
Q ss_pred HHhcccCCCCCCC-----HHHHHHH
Q 013126 293 SRCLQYEPRERPN-----PKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rps-----~~eil~~ 312 (449)
.+||+.||++||+ +++++++
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhhcCHHhccCCccCCHHHHHhC
Confidence 9999999999998 8888863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=358.40 Aligned_cols=249 Identities=19% Similarity=0.267 Sum_probs=203.1
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|++++.||+|+||+||+|+..+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999987799999999965432 2246789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
++ ++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 82 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LD-QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CS-EEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 98 599998864 3467999999999999999999999999 999999999999999999999999998765432 2
Q ss_pred ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc--------------------
Q 013126 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT-------------------- 272 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------------------- 272 (449)
...+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.................
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 34679999999999764 489999999999999999999999876433222111110000
Q ss_pred ---ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 ---DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+..........++++.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000001122346788999999999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=380.05 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=213.8
Q ss_pred CCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCC-eeEEEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-ERLLVA 135 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~ 135 (449)
-+.++|++++.||+|+||.||+|.+. ++.||||+++... ..+.|.+|++++++++||||+++++++.+.+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 35678899999999999999999984 7899999998654 4678999999999999999999999987765 789999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-Cc
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KS 214 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~ 214 (449)
||+++|+|.+++.......+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++..... ..
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 345 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccC
Confidence 9999999999998655556899999999999999999999999 999999999999999999999999999865433 23
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..+++.|+|||++.+..++.++||||||+++|||+| |+.|+............... .....+..+++++.+++.
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~p~~~~~~l~~li~ 420 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----YKMDAPDGCPPAVYDVMK 420 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-----CCCCCCTTCCHHHHHHHH
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCcCCHHHHHHHH
Confidence 456789999999999999999999999999999998 99888654332222211111 112345567789999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcccccc
Q 013126 294 RCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
+||+.||++|||+.++++.|+.+...
T Consensus 421 ~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 421 NCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999887543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=367.09 Aligned_cols=263 Identities=23% Similarity=0.293 Sum_probs=217.7
Q ss_pred HHHhhCCCcccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceee
Q 013126 52 LKNATSGFAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGC 124 (449)
Q Consensus 52 l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~ 124 (449)
+....-..+.|++++.||+|+||.||+|++. +++.||+|.++...... .+.+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3444455678899999999999999999974 24889999997654222 4679999999999999999999999
Q ss_pred EeeCCeeEEEEeeCCCCCHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 013126 125 CCEGDERLLVAEYMPNETLAKHLFHWE----------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALY 182 (449)
Q Consensus 125 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiH 182 (449)
+.+++..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+|
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivH 197 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-FVH 197 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eec
Confidence 999999999999999999999997532 157899999999999999999999999 999
Q ss_pred cccccCceeeCCCCCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCC
Q 013126 183 HDLNAYRILFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIP 255 (449)
Q Consensus 183 rDlkp~NILl~~~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~ 255 (449)
|||||+||++++++.+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999999999999999998754322 23457889999999998889999999999999999999 88888
Q ss_pred CchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 256 PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
................ ....+...+.++.+++.+||+.||++|||+.++++.|+.+....
T Consensus 278 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGN-----ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTSCHHHHHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCChHHHHHHHhCCC-----cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 7654443332221111 11234566788999999999999999999999999999886543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=359.92 Aligned_cols=245 Identities=17% Similarity=0.193 Sum_probs=201.5
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--------------------------CHHHHHHHHHHHh
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--------------------------DPRQFLEEARSVG 111 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--------------------------~~~~~~~E~~~l~ 111 (449)
.++|++++.||+|+||+||+|... +++.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467899999999999999999964 5899999999654311 1356899999999
Q ss_pred ccCCCCcccceeeEee--CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCc
Q 013126 112 QLRNNRLTNLLGCCCE--GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189 (449)
Q Consensus 112 ~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~N 189 (449)
+++||||+++++++.+ .+..++||||+++++|.+++ ...++++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQK-IIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHH
Confidence 9999999999999987 56899999999999998876 4568999999999999999999999999 9999999999
Q ss_pred eeeCCCCCeEEeccCCcccCCCC----CccccCccccccccccCCC---CCCCCceeeHhHHHHHHhcCCCCCCchhhHH
Q 013126 190 ILFDEDGNPRLSTFGLMKNSRDG----KSYSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDL 262 (449)
Q Consensus 190 ILl~~~~~~kL~DFGla~~~~~~----~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~~ 262 (449)
|+++.++.+||+|||+++..... ....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 99999999999999999875543 2456899999999998765 4778999999999999999999997664443
Q ss_pred HhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 263 IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.......... ........++++.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 LHSKIKSQAL----EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHCCC----CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhcccC----CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3322211111 11122456788999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=366.96 Aligned_cols=247 Identities=17% Similarity=0.190 Sum_probs=205.1
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCC-----CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM-----AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.|++++.||+|+||+||+|... +++.||||+++.. .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 5899999999999999999965 5899999998532 222467899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC---eEEeccCCcccC
Q 013126 135 AEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKNS 209 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~---~kL~DFGla~~~ 209 (449)
|||++|++|.+.+... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN-IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999999999888643 2346899999999999999999999999 999999999999986554 999999999876
Q ss_pred CCC----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 210 RDG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 210 ~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ........ ........+
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-i~~~~~~~--~~~~~~~~s 260 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG-IIKGKYKM--NPRQWSHIS 260 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHH-HHHTCCCC--CHHHHTTSC
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHH-HHcCCCCC--CccccccCC
Confidence 543 23568999999999998889999999999999999999999997654322221 11110000 000113456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+++.+||+.||++|||+.++++
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 78999999999999999999999997
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=372.88 Aligned_cols=249 Identities=17% Similarity=0.253 Sum_probs=205.3
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
+.++|++++.||+|+||+||+|+.. +++.||+|++++... ...+.+.+|..+++++ +||||+++++++.+++..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4567999999999999999999965 488999999976432 2245688999999887 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~- 211 (449)
+||||++||+|.+++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 130 lV~E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999999997 4467999999999999999999999999 99999999999999999999999999985322
Q ss_pred ---CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh-----hcccccccccccCCCCCch
Q 013126 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR-----DRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 212 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 283 (449)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+... ...++..
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~ 284 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRS 284 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--CCCCCTT
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--ccCCCCc
Confidence 23467899999999999999999999999999999999999998532111000 0000111111 1234556
Q ss_pred hHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNP------KSLVT 311 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~------~eil~ 311 (449)
.++++.++|.+||+.||++||++ +++++
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 78899999999999999999986 56665
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=364.54 Aligned_cols=255 Identities=16% Similarity=0.133 Sum_probs=208.7
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
..|++++.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++..++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 4588899999999999999996 468999999997543 234688999999999 999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC-----eEEeccCCcccCCCC
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN-----PRLSTFGLMKNSRDG 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~-----~kL~DFGla~~~~~~ 212 (449)
+ +++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 87 L-GPSLEDLFDL-CDRTFSLKTVLMIAIQLISRMEYVHSKN-LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred C-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 9 8999999975 3568999999999999999999999999 999999999999998887 999999999864332
Q ss_pred -----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHH---hhcccccccccccCC
Q 013126 213 -----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI---RDRNLQMLTDSCLEG 278 (449)
Q Consensus 213 -----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~ 278 (449)
....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........ ......
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK-RATPIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH-HHSCHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh-ccCCHH
Confidence 245689999999999999999999999999999999999999875321111 11110000 000000
Q ss_pred CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
......+ ++.+++.+||+.||.+||+++++++.|+.+.....
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1122345 89999999999999999999999999988766543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=369.59 Aligned_cols=245 Identities=18% Similarity=0.243 Sum_probs=209.5
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
..++|++++.||+|+||+||+|+.. +|+.||+|++++.. ....+.+.+|..+++.+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4567889999999999999999975 58999999997532 23467788999999987 9999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~- 211 (449)
+||||++||+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 95 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999973 467999999999999999999999999 99999999999999999999999999986432
Q ss_pred ---CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 212 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
.....||+.|+|||++.+..++.++|+||||+++|||++|+.||.......+....... ...++...++++
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~ 245 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWLEKEA 245 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC------CCCCCcccCHHH
Confidence 23457899999999999989999999999999999999999999876544443332221 112345577899
Q ss_pred HHHHHHhcccCCCCCCCHH-HHHH
Q 013126 289 VRLASRCLQYEPRERPNPK-SLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~-eil~ 311 (449)
.+++.+||+.||++||++. ++++
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHHc
Confidence 9999999999999999997 6664
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=352.91 Aligned_cols=251 Identities=19% Similarity=0.260 Sum_probs=201.2
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCC----CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP----DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
++.+|++.+.||+|+||+||+|.+ +++.||+|+++..... ..+.+.+|+++++.++||||+++++++.+++..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 457789999999999999999997 4789999999764322 24679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccccCceeeCC--------CCCeEEecc
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG--RALYHDLNAYRILFDE--------DGNPRLSTF 203 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~iiHrDlkp~NILl~~--------~~~~kL~DF 203 (449)
||||++|++|.+++ ....+++..++.++.|++.||+|||+++ +++||||||+||+++. ++.+||+||
T Consensus 84 v~e~~~~~~L~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 84 VMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEECCTTEEHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEcCCCCCHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999998 4568999999999999999999999986 3779999999999986 778999999
Q ss_pred CCcccCCCC--CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCC
Q 013126 204 GLMKNSRDG--KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 204 Gla~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
|+++..... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||............... ......+
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~ 236 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN----KLALPIP 236 (271)
T ss_dssp CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS----CCCCCCC
T ss_pred CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC----CCCCCCC
Confidence 999765443 2456899999999999888999999999999999999999998765433332221111 1112334
Q ss_pred chhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
...++.+.+++.+||+.||++|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 56678899999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=371.08 Aligned_cols=248 Identities=17% Similarity=0.233 Sum_probs=207.5
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
++++|++++.||+|+||.||+|... +++.||+|+++.. .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4678999999999999999999965 4899999999642 23346789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||++||+|.+++. ....+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++.....
T Consensus 93 v~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999997 5668999999999999999999999999 999999999999999999999999999875443
Q ss_pred --CccccCccccccccccC---CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 213 --KSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ...+.. .....+...+++
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~-~~~~~~--~~~~~p~~~s~~ 246 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI-VHTFET--TVVTYPSAWSQE 246 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH-HHHHHH--CCCCCCTTSCHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH-HHHHhh--cccCCCCcCCHH
Confidence 35678999999999974 4589999999999999999999999864321111100 000000 112345567789
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHH
Q 013126 288 LVRLASRCLQYEPRERPN-PKSLVT 311 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps-~~eil~ 311 (449)
+.++|.+||+.||++||+ ++++++
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999999999999998 777765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=351.33 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=216.0
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+.++|++++.||+|+||.||+|.+.+++.||+|.++... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 446789999999999999999998888899999998654 3457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----- 212 (449)
+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 85 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp CTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999999975 3467899999999999999999999999 999999999999999999999999999865432
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....+++.|+|||++.+..++.++||||||+++|+|++ |+.|+................ ....+...++.+.++
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-----~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-----RLYKPRLASTHVYQI 237 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----CCCCCTTSCHHHHHH
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-----cCCCCccCcHHHHHH
Confidence 23456778999999998889999999999999999999 888887654433332222111 112234567789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+.+||+.||++|||+.++++.|+.+..
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999988754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=379.80 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=212.7
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.+.|++.+.||+|+||+||+|.++++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35688899999999999999998877889999998654 346789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----C
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-----~ 213 (449)
++|+|.+++.......+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++..... .
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 9999999997544467999999999999999999999999 999999999999999999999999999865432 1
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...+++.|+|||++.+..++.++||||||+++|||++ |+.|+............... .....+..+++.+.+++
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~l~~li 414 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPPECPESLHDLM 414 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHH
Confidence 2345788999999998899999999999999999999 88888765433333222111 11223456778999999
Q ss_pred HHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
.+||+.||++|||++++++.|+.+....+
T Consensus 415 ~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 415 CQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 99999999999999999999998876544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=355.98 Aligned_cols=270 Identities=29% Similarity=0.477 Sum_probs=221.7
Q ss_pred ccccCHHHHHHhhCCCccc---ccccccCCccceEEEEEEEcCCCEEEEEEecCCCC----CCHHHHHHHHHHHhccCCC
Q 013126 44 FREFTLEQLKNATSGFAVE---NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW----PDPRQFLEEARSVGQLRNN 116 (449)
Q Consensus 44 ~~~~~~~~l~~~~~~f~~~---~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~----~~~~~~~~E~~~l~~l~Hp 116 (449)
...|++.++..++++|+.. ...+.||+|+||+||+|.. +++.||+|++..... ...+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4789999999999999865 2236789999999999987 678999999975321 2256799999999999999
Q ss_pred CcccceeeEeeCCeeEEEEeeCCCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC
Q 013126 117 RLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (449)
Q Consensus 117 nIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~ 195 (449)
||+++++++.+++..++||||+++++|.+++... ...++++..++.++.|++.||+|||+++ ++||||||+||+++++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH-HIHRDIKSANILLDEA 169 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTT
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecCCCCHHHEEEcCC
Confidence 9999999999999999999999999999998743 2457999999999999999999999999 9999999999999999
Q ss_pred CCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH----Hhh
Q 013126 196 GNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL----IRD 265 (449)
Q Consensus 196 ~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~----~~~ 265 (449)
+.+||+|||+++..... ....||+.|+|||++.+ .++.++||||||+++|+|++|..|+....... +..
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH
Confidence 99999999998865432 23468999999999864 58999999999999999999999886532111 111
Q ss_pred c------ccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 266 R------NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 266 ~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
. ......+... ...+...++.+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 249 EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred Hhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 0 0111111111 2234567788999999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=367.86 Aligned_cols=245 Identities=20% Similarity=0.230 Sum_probs=208.1
Q ss_pred CCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
....|++++.||+|+||+||+|.+ .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 456799999999999999999996 46899999998642 12234679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+ +|+|.+++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIV--EKKRMTEDEGRRFFQQIICAIEYCHRHK-IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 689999887 3467999999999999999999999999 999999999999999999999999999865544
Q ss_pred --CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||............. .. ....+...++++.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~----~~--~~~~p~~~s~~~~ 236 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN----SC--VYVMPDFLSPGAQ 236 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC----SS--CCCCCTTSCHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH----cC--CCCCcccCCHHHH
Confidence 34568999999999988776 789999999999999999999987653322222111 11 1223556778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+++.+||+.||.+|||+++++++
T Consensus 237 ~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 237 SLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHHhC
Confidence 99999999999999999999973
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=367.02 Aligned_cols=252 Identities=17% Similarity=0.265 Sum_probs=206.4
Q ss_pred cccccccccCCccceEEEEEEEc-CCCE----EEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRR----IAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~----vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
++|++++.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56899999999999999999964 3443 8888886543 223467889999999999999999999986 567899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHG-MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHTT-CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhCC-CCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999974 3457899999999999999999999999 999999999999999999999999999875433
Q ss_pred -----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 213 -----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 213 -----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||............... .....+...+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 244 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-----ERLAQPQICTI 244 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-----CBCCCCTTBCT
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----CCCCCCCcCcH
Confidence 23456789999999998899999999999999999999 99998765433332221111 11122334556
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 789999999999999999999999999887654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=367.03 Aligned_cols=245 Identities=19% Similarity=0.252 Sum_probs=209.8
Q ss_pred CCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCC---CCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRM---AWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
..++|++++.||+|+||+||+|+... ++.||+|++++. .....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35678999999999999999999764 889999999753 223467789999999988 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~- 211 (449)
+||||++||+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999973 457999999999999999999999999 99999999999999999999999999986332
Q ss_pred ---CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 212 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.......+........ ..++...++++
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~ 248 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------VAYPKSMSKEA 248 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTSCHHH
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC------CCCCCCCCHHH
Confidence 234578999999999999999999999999999999999999998765544443332211 12355677899
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHH
Q 013126 289 VRLASRCLQYEPRERPN-----PKSLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps-----~~eil~ 311 (449)
.+++.+||+.||++||+ ++++++
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99999999999999995 577775
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=371.05 Aligned_cols=255 Identities=20% Similarity=0.313 Sum_probs=212.4
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
..|++++.||+|+||+||+|.+. +++.||||+++..... ...++.+|+.++++++||||+++++++.+++..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56889999999999999999943 3678999999754322 2457899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC---CeEEeccC
Q 013126 133 LVAEYMPNETLAKHLFHWET-----HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG---NPRLSTFG 204 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~---~~kL~DFG 204 (449)
+||||++||+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChhhEEEecCCCCceEEECCCc
Confidence 99999999999999975432 45899999999999999999999999 99999999999999555 59999999
Q ss_pred CcccC------CCCCccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccC
Q 013126 205 LMKNS------RDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 205 la~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
+++.. .......+|+.|+|||++.+..++.++|||||||++|||++ |..||................ .
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-----~ 304 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-----R 304 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-----C
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----C
Confidence 98743 22234567899999999998899999999999999999998 888887665444333222211 1
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
...+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 2234566788999999999999999999999999998876553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=383.57 Aligned_cols=254 Identities=20% Similarity=0.325 Sum_probs=217.0
Q ss_pred CcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
..+|++.+.||+|+||.||+|.+.. +..||||.++... ...++|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568889999999999999999765 8899999997654 3578899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 99999999998655677999999999999999999999999 9999999999999999999999999998754332
Q ss_pred -ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
...+++.|+|||++.+..++.++||||||+++|||+| |..|+.......+...... ......+..+++++.++
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----DYRMERPEGCPEKVYEL 451 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----TCCCCCCTTCCHHHHHH
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHH
Confidence 2335678999999998889999999999999999999 8888865443322221111 11223355677899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
+.+||+.||++|||+.++++.|+.+...
T Consensus 452 i~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999887543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=360.54 Aligned_cols=256 Identities=14% Similarity=0.157 Sum_probs=207.9
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCC--eeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD--ERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 135 (449)
..|++++.||+|+||+||+|.+.. ++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 468999999999999999999754 8999999997543 234678899999999999999999999998765 789999
Q ss_pred eeCCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee----CCCCCeEEeccCCcccCC
Q 013126 136 EYMPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla~~~~ 210 (449)
||++|++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+++...
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999999997532 234999999999999999999999999 9999999999999 778889999999998765
Q ss_pred CCC---ccccCcccccccccc--------CCCCCCCCceeeHhHHHHHHhcCCCCCCchhh----HHHhhccccccc---
Q 013126 211 DGK---SYSTNLAFTPPEYLR--------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNLQMLT--- 272 (449)
Q Consensus 211 ~~~---~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~----~~~~~~~~~~~~--- 272 (449)
... ...||+.|+|||++. +..++.++||||||+++|||++|+.||..... ...........+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 443 456899999999986 46789999999999999999999999853211 111111111100
Q ss_pred ----------------ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 273 ----------------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 273 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
............+..+.+++.+||+.||++|||++++++...+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 00111233456788999999999999999999999999976543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=369.51 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=215.7
Q ss_pred CcccccccccCCccceEEEEEEEc--------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEG 128 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~--------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 128 (449)
.+.|++.+.||+|+||+||+|++. ++..||+|+++..... ..+++.+|+++++++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357889999999999999999952 2357999999765322 246789999999999 999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC
Q 013126 129 DERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~ 194 (449)
+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||+++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTE 226 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCcceEEEcC
Confidence 99999999999999999997533 245999999999999999999999999 999999999999999
Q ss_pred CCCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcc
Q 013126 195 DGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 267 (449)
Q Consensus 195 ~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 267 (449)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..|+.......+....
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~ 306 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999865432 23346788999999999899999999999999999999 88888765544433322
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
.... ....+...++++.+++.+||+.||++|||++++++.|+.+.....
T Consensus 307 ~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 307 KEGH-----RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HTTC-----CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HcCC-----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2211 122345677899999999999999999999999999998876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=350.95 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=213.0
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 133 (449)
++++|++++.||+|+||+||+|++ +++.||+|+++...... .+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 567899999999999999999998 48899999998654322 45799999999999999999999999887 78899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
||||++||+|.+++.......+++..++.++.|++.||+|||+++ +++||||||+||++++++.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999998644457999999999999999999999964 399999999999999999999999988765332
Q ss_pred CccccCccccccccccCCCCCC---CCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTP---ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....+|+.|+|||++.+..++. ++||||||+++|||++|+.||................ .....+...++++.
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 241 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG----LRPTIPPGISPHVS 241 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC----CCCCCCTTCCHHHH
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC----CCCCCCCCCCHHHH
Confidence 3456899999999998766544 7999999999999999999987654433322222111 12234556778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 290 RLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+++.+||+.||++|||++++++.|+.+..
T Consensus 242 ~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 242 KLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999987753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=364.28 Aligned_cols=245 Identities=18% Similarity=0.262 Sum_probs=205.7
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
+..+|++++.||+|+||.||+|+.. +++.||+|++++..... .+.+.+|..+++++ +||||+++++++.+.+..|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3567899999999999999999965 48999999997654333 35688999999988 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~- 211 (449)
+||||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 87 lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999973 467999999999999999999999999 99999999999999999999999999985322
Q ss_pred ---CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh---------hHHHhhcccccccccccCCC
Q 013126 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA---------LDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 212 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~ 279 (449)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+..... .. ...
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~----~~--~~~ 237 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----EK--QIR 237 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH----HC--CCC
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH----cC--CCC
Confidence 234578999999999999899999999999999999999999985421 111111111 11 123
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNP------KSLVT 311 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~------~eil~ 311 (449)
++...+.++.+++.+||+.||++||++ .++++
T Consensus 238 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 238 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 455677899999999999999999996 56665
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=378.91 Aligned_cols=245 Identities=21% Similarity=0.251 Sum_probs=202.5
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
..++|++++.||+|+||.||+|... +|+.||||+++.. .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999964 5899999999753 22334678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
||||++||+|.+++. ....+++..++.++.||+.||+|||+ ++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 226 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~g-iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHHTC-CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhcCC-EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999999997 44679999999999999999999998 88 999999999999999999999999999764322
Q ss_pred ----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
....||+.|+|||++.+..++.++||||||+++|||++|+.||................ ..++...++++
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~ 376 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------IRFPRTLGPEA 376 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTSCHHH
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------CCCCccCCHHH
Confidence 34578999999999999999999999999999999999999997765544443332211 12345677899
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHH
Q 013126 289 VRLASRCLQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rp-----s~~eil~ 311 (449)
.++|.+||+.||++|| +++++++
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 9999999999999999 9999997
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=358.52 Aligned_cols=249 Identities=18% Similarity=0.255 Sum_probs=199.7
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhc--cCCCCcccceeeEeeC----CeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQ--LRNNRLTNLLGCCCEG----DERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~----~~~~l 133 (449)
++|++++.||+|+||+||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4688999999999999999998 6889999999653 35667777777776 7999999999987653 45899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--------SKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
||||+++|+|.+++ +...+++..++.++.|++.||+||| +++ |+||||||+|||++.++.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-IAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHH---TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE-EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ehhhccCCCHHHHH---hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-eecCCCChHhEEEcCCCCEEEeeCCC
Confidence 99999999999999 4567999999999999999999999 888 99999999999999999999999999
Q ss_pred cccCCCC--------CccccCccccccccccCC------CCCCCCceeeHhHHHHHHhcC----------CCCCCchh--
Q 013126 206 MKNSRDG--------KSYSTNLAFTPPEYLRTG------RVTPESVIYSFGTLLLDLLSG----------KHIPPSHA-- 259 (449)
Q Consensus 206 a~~~~~~--------~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg----------~~p~~~~~-- 259 (449)
++..... ....||+.|+|||++.+. .++.++||||||+++|||++| +.||....
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 8754332 223689999999999876 456799999999999999999 77764321
Q ss_pred ---hHHHhhccccccccc-ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 260 ---LDLIRDRNLQMLTDS-CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 260 ---~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
..............+ .+........++++.+++.+||+.||++|||+.++++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111111111111111 111112345778999999999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=370.87 Aligned_cols=250 Identities=18% Similarity=0.167 Sum_probs=210.6
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++.|++++.||+|+||+||+|... +|+.||+|++......+...+.+|+++++.++||||+++++++.+++..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 356899999999999999999965 5899999999765433456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC--CCCCeEEeccCCcccCCCCC--
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~-- 213 (449)
++||+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 130 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999999999864 3457999999999999999999999999 99999999999997 45789999999998765442
Q ss_pred -ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...||+.|+|||++.+..++.++|||||||++|+|++|..||................. ..........++++.++|
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCCSSTTTTSCHHHHHHH
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccccccCCHHHHHHH
Confidence 34689999999999988899999999999999999999999976543332222111110 111222345678999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~ 312 (449)
.+||+.||++|||+.+++++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999983
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=361.92 Aligned_cols=244 Identities=18% Similarity=0.239 Sum_probs=200.9
Q ss_pred CcccccccccCCccceEEEEEEE----cCCCEEEEEEecCCCC----CCHHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMAW----PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~----~~~~~vAiK~l~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
.++|++++.||+|+||.||+++. .+++.||+|++++... .....+.+|+.+++.++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45789999999999999999996 4689999999976431 234568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||++|++|.+++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE--REGIFMEDTACFYLAEISMALGHLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCC-EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999999997 3467899999999999999999999999 9999999999999999999999999987543
Q ss_pred CC----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 211 DG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 211 ~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|+.||................ ...+...+.
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------~~~p~~~~~ 246 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK------LNLPPYLTQ 246 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------CCCCTTSCH
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------CCCCCCCCH
Confidence 22 34568999999999998889999999999999999999999997665443333222211 123456678
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rp-----s~~eil~ 311 (449)
++.+++.+||+.||++|| ++.++++
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 999999999999999999 7788887
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=377.62 Aligned_cols=254 Identities=18% Similarity=0.165 Sum_probs=210.6
Q ss_pred hhCCCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 55 ATSGFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 55 ~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
..-..++|++++.||+|+||+||+|++.+ ++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 33445678899999999999999999765 8899999996421 1223458899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.|+||||++||+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 9999999999999999974 2567999999999999999999999999 9999999999999999999999999997654
Q ss_pred CCC-----ccccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCC
Q 013126 211 DGK-----SYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (449)
Q Consensus 211 ~~~-----~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (449)
... ...||+.|+|||++. +..++.++|||||||++|||++|+.||..................... ...
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~ 305 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF-PTQ 305 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC-CSS
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC-Ccc
Confidence 432 357899999999997 456899999999999999999999999876554444333221111111 112
Q ss_pred CchhHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 013126 281 TDDDGTELVRLASRCLQYEPRE--RPNPKSLVT 311 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~--Rps~~eil~ 311 (449)
....++++.+||.+||..+|++ ||+++++++
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 2357789999999999988888 999999997
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.15 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=192.0
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.++|++++.||+|+||+||+|... +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 356889999999999999999954 589999999976443 235789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 137 YMPNETLAKHLFHWE----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
|++ ++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 998 69999886432 246899999999999999999999999 999999999999999999999999999865432
Q ss_pred ----CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc--------------c
Q 013126 213 ----KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT--------------D 273 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------------~ 273 (449)
....+|+.|+|||++.+. .++.++||||||+++|+|++|+.||................. .
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 345689999999999764 589999999999999999999999876543322211110000 0
Q ss_pred --cc------------cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 --SC------------LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 --~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.. .........+.++.+++.+||+.||++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 000112245678999999999999999999999997
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=368.55 Aligned_cols=254 Identities=17% Similarity=0.176 Sum_probs=204.8
Q ss_pred CCcccccccccCCc--cceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEK--APNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G--~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
+-.+|++++.||+| +||+||+|++. +|+.||||+++...... .+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34578999999999 99999999975 59999999997643222 456888999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~- 211 (449)
+||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG-YVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999998655578999999999999999999999999 99999999999999999999999998754321
Q ss_pred ----------CCccccCccccccccccC--CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc------
Q 013126 212 ----------GKSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD------ 273 (449)
Q Consensus 212 ----------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------ 273 (449)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..................
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 123467899999999987 56999999999999999999999998653222111111100000
Q ss_pred ----------------------------------cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 274 ----------------------------------SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 274 ----------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.......+...++++.+|+.+||+.||++|||+++++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000011234456789999999999999999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=359.90 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=212.4
Q ss_pred CcccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
.+.|++.+.||+|+||.||+|.+. +++.||+|+++..... ..+.+.+|+++++.++||||+++++++.+++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 456889999999999999999852 3578999999764322 246789999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCc
Q 013126 132 LLVAEYMPNETLAKHLFHWET----------------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~N 189 (449)
++||||++|++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dikp~N 180 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-LVHRDLAARN 180 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-Ccccccchhe
Confidence 999999999999999975322 34889999999999999999999999 9999999999
Q ss_pred eeeCCCCCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHH
Q 013126 190 ILFDEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDL 262 (449)
Q Consensus 190 ILl~~~~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~ 262 (449)
|++++++.+||+|||+++...... ...+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+.......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998654332 2346788999999998889999999999999999999 988887654333
Q ss_pred HhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 263 IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
........ .....+...++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 261 ~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 261 LFNLLKTG-----HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHHHHHTT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhcC-----CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 32221111 1123345677899999999999999999999999999988754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=350.16 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=206.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCH-------HHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDP-------RQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~-------~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
++|++.+.||+|+||+||+|++. +++.||+|++........ +.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 56889999999999999999964 589999999976443321 67899999999999999999999987655
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccccccccCceeeCCCCC-----eEEeccCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGR-ALYHDLNAYRILFDEDGN-----PRLSTFGL 205 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~-iiHrDlkp~NILl~~~~~-----~kL~DFGl 205 (449)
++||||+++++|.+.+.. ....+++..++.++.|++.||+|||++++ ++||||||+||+++.++. +||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 799999999999998875 45679999999999999999999999854 999999999999988776 99999999
Q ss_pred cccCCCC-CccccCcccccccccc--CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCc
Q 013126 206 MKNSRDG-KSYSTNLAFTPPEYLR--TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 206 a~~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
++..... ....||+.|+|||++. ...++.++||||||+++|+|++|+.||........... ............+.
T Consensus 176 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~ 253 (287)
T 4f0f_A 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI--NMIREEGLRPTIPE 253 (287)
T ss_dssp CBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH--HHHHHSCCCCCCCT
T ss_pred cccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH--HHHhccCCCCCCCc
Confidence 9865543 3456899999999994 44578999999999999999999999865432221100 00111112223455
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
..++++.+++.+||+.||++|||++++++.|+.+
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 6778999999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=354.97 Aligned_cols=255 Identities=21% Similarity=0.326 Sum_probs=217.4
Q ss_pred CCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
..++|++.+.||+|+||+||+|.+.. ++.||+|.++... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34568899999999999999999765 8899999997543 346789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--- 213 (449)
|++|++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT-CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC-ccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 999999999998656677999999999999999999999999 9999999999999999999999999998765432
Q ss_pred --ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 214 --SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 214 --~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
...+|+.|+|||++.+..++.++||||||+++|+|++ |..|+............... .....+...++++.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-----YRMERPEGCPEKVYE 243 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----CCCCCCTTCCHHHHH
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-----CCCCCCCCCCHHHHH
Confidence 2345778999999998899999999999999999999 88888654433332222111 112334566789999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 291 LASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++.+||+.||++|||+.++++.|+.+..+
T Consensus 244 li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999887654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=365.15 Aligned_cols=259 Identities=20% Similarity=0.256 Sum_probs=211.7
Q ss_pred cccccccccCCccceEEEEEEE-----cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEe--eCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC--EGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-----~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~~ 132 (449)
..|++++.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4689999999999999999984 358899999998765444567999999999999999999999887 456689
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 103 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSRR-CVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEeecCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999999999974 2346999999999999999999999999 999999999999999999999999999865433
Q ss_pred C-------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc----------ccccccc
Q 013126 213 K-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL----------QMLTDSC 275 (449)
Q Consensus 213 ~-------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~ 275 (449)
. ...+|+.|+|||++.+..++.++||||||+++|+|++|+.|+............. .......
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 2 2346788999999998889999999999999999999999876544332211100 0011111
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.....+...++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus 261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 122345567789999999999999999999999999999886654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=361.90 Aligned_cols=257 Identities=18% Similarity=0.262 Sum_probs=198.2
Q ss_pred CcccccccccCCccceEEEEEEEcC-CC---EEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCee-
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN-QR---RIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER- 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~-~~---~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~- 131 (449)
..+|++++.||+|+||+||+|.+.. +. .||||+++.... ...+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3568889999999999999999543 32 799999976532 2356799999999999999999999999877655
Q ss_pred -----EEEEeeCCCCCHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEec
Q 013126 132 -----LLVAEYMPNETLAKHLFHWE----THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLST 202 (449)
Q Consensus 132 -----~lV~Ey~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~D 202 (449)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-FIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-cccCCCCcceEEEcCCCCEEEee
Confidence 99999999999999986432 226899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccc
Q 013126 203 FGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSC 275 (449)
Q Consensus 203 FGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (449)
||+++...... ...+++.|+|||++.+..++.++||||||+++|+|++ |..||................
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---- 256 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN---- 256 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC----
Confidence 99997654332 2345778999999998899999999999999999999 888886543333222221111
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
....+...++++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 257 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 257 -RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 122345667889999999999999999999999999998876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=351.93 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=214.1
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.+.|++++.||+|+||+||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 45788999999999999999998788899999997644 35678999999999999999999999986 45689999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-----
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK----- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~----- 213 (449)
++++|.+++.......+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 9999999996433347999999999999999999999999 9999999999999999999999999998765432
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...+++.|+|||++.+..++.++||||||+++|+|++ |+.|+............... .....+...++++.+++
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li 243 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-----YRMVRPDNCPEELYQLM 243 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTCCHHHHHHH
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-----cCCCCcccccHHHHHHH
Confidence 2345778999999988889999999999999999999 88888665433332222111 11223456678999999
Q ss_pred HHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.+||+.||++|||+.++++.|+.+....
T Consensus 244 ~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 244 RLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999886553
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=363.17 Aligned_cols=244 Identities=21% Similarity=0.249 Sum_probs=192.2
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.|++.+.||+|+||+||+|++. +++.||||+++... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 4788899999999999999976 48899999997643 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---CCCeEEeccCCcccCCCC---C
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSRDG---K 213 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~---~ 213 (449)
|++|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++..... .
T Consensus 132 ~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 132 GGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHENG-IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp SCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 999999997 4567999999999999999999999999 999999999999975 889999999999865443 3
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-HhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......... ..........+.++.+++
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY--YFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC--CCCTTTTTTSCHHHHHHH
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC--ccCCchhhhCCHHHHHHH
Confidence 4568999999999998889999999999999999999999986543332 1111111110 011122346678999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~ 311 (449)
.+||+.||++|||+.++++
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=369.35 Aligned_cols=257 Identities=22% Similarity=0.283 Sum_probs=209.2
Q ss_pred CCcccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhcc-CCCCcccceeeEeeCC
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 129 (449)
..++|++.+.||+|+||.||+|++. +++.||||+++...... .+.+.+|+++++++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4467889999999999999999842 35799999997643222 45799999999999 7899999999998765
Q ss_pred e-eEEEEeeCCCCCHHHHHhccCC--------------------------------------------------------
Q 013126 130 E-RLLVAEYMPNETLAKHLFHWET-------------------------------------------------------- 152 (449)
Q Consensus 130 ~-~~lV~Ey~~ggsL~~~l~~~~~-------------------------------------------------------- 152 (449)
. .++||||++||+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 4 8999999999999999975321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC------CccccC
Q 013126 153 --------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------KSYSTN 218 (449)
Q Consensus 153 --------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~------~~~~gt 218 (449)
..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ....+|
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 12889999999999999999999999 999999999999999999999999999865332 234568
Q ss_pred ccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcc
Q 013126 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297 (449)
Q Consensus 219 ~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (449)
+.|+|||++.+..++.++||||||+++|||+| |..||............... ......+...++++.+++.+||+
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHHHHHHcc
Confidence 89999999998899999999999999999998 99888654322111111111 11122345567889999999999
Q ss_pred cCCCCCCCHHHHHHHhcccccc
Q 013126 298 YEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 298 ~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.||++|||+.+++++|+.+...
T Consensus 335 ~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 335 GEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHH
T ss_pred CChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999887643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=350.58 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=207.9
Q ss_pred CCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.+++|++++.||+|+||+||+|.+.. ++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45679999999999999999999654 7899999985422 1235678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+++++|.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~-i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT-CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-EecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999973 467999999999999999999999999 999999999999999999999999988654433
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....+|+.|+|||++.+..++.++||||||+++|+|++|+.||............... ....+...++++.++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EFTFPDFVTEGARDL 237 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCCCTTSCHHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC------CCCCCCcCCHHHHHH
Confidence 3456899999999999888999999999999999999999998766544333322111 122345567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~ 312 (449)
+.+||+.||++|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhC
Confidence 999999999999999999983
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=375.52 Aligned_cols=246 Identities=18% Similarity=0.160 Sum_probs=209.0
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+.|++++.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 35889999999999999999965 58999999996543 234678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee---CCCCCeEEeccCCcccCCCC
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~ 212 (449)
||++||+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 106 e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999999999997 5678999999999999999999999999 9999999999999 46789999999999876554
Q ss_pred C---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 K---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
. ...||+.|+|||++.+ .++.++||||+|+++|+|++|..||................... ........++++.
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF--ELPQWKKVSESAK 259 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CSGGGGGSCHHHH
T ss_pred cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--CCcccccCCHHHH
Confidence 3 3468999999999975 79999999999999999999999998765443333222211111 1111235678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+||+.||++|||+.++++
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHCCCChhHCcCHHHHhh
Confidence 9999999999999999999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=354.21 Aligned_cols=254 Identities=19% Similarity=0.286 Sum_probs=203.3
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++++|++.+.||+|+||+||+|++ .++.||+|.+... ...+.+.+|++++++++||||+++++++. +..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 467789999999999999999997 4789999998643 34578999999999999999999999886 457999999
Q ss_pred CCCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCccccccccCceeeCCCCC-eEEeccCCcccCCCC
Q 013126 138 MPNETLAKHLFHWET-HPMKWAMRLRVVLHLAQALEYCTS---KGRALYHDLNAYRILFDEDGN-PRLSTFGLMKNSRDG 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~~~iiHrDlkp~NILl~~~~~-~kL~DFGla~~~~~~ 212 (449)
++|++|.+++..... ..+++..++.++.|++.||+|||+ ++ ++||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~-ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC-CCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC-eecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999974322 247889999999999999999999 77 999999999999998887 799999999765433
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHH--hhcccccccccccCCCCCchhHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLI--RDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ....... .........++.+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-----TRPPLIKNLPKPIE 234 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-----CCCCCBTTCCHHHH
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-----CCCCcccccCHHHH
Confidence 345689999999999988999999999999999999999999864321111 1000000 11223345678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhcccccccCC
Q 013126 290 RLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 322 (449)
+++.+||+.||++|||++++++.|+.+.+....
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 999999999999999999999999888765443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=355.11 Aligned_cols=261 Identities=18% Similarity=0.220 Sum_probs=207.0
Q ss_pred HhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCC
Q 013126 54 NATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129 (449)
Q Consensus 54 ~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 129 (449)
.....+.+|++++.||+|+||.||+|.+. +++.||+|+++.....+ .+.+.+|+.++++++||||+++++++..++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 34455788999999999999999999965 58999999997643333 367899999999999999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
..++||||++|++|.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAG-ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred eEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCc-CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999999999999999973 467999999999999999999999999 999999999999999999999999998765
Q ss_pred CCC-----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 210 RDG-----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 210 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||................... ...+...
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~ 261 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRP---STVRPGI 261 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCG---GGTSTTC
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCc---cccCCCC
Confidence 433 23468899999999998889999999999999999999999998765543332222211111 1234456
Q ss_pred HHHHHHHHHHhcccCCCCCC-CHHHHHHHhccccccc
Q 013126 285 GTELVRLASRCLQYEPRERP-NPKSLVTALSPLQKET 320 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rp-s~~eil~~L~~~~~~~ 320 (449)
++++.+++.+||+.||++|| +++++++.|+......
T Consensus 262 ~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 262 PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 77899999999999999999 9999999998775543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=353.78 Aligned_cols=253 Identities=20% Similarity=0.313 Sum_probs=197.5
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
..|++.+.||+|+||+||+|++. ..||+|+++...... .+.+.+|++++++++||||++++++. ..+..++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 45888999999999999999863 369999997654332 46799999999999999999999965 55678999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----- 212 (449)
++|++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 101 CEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp CCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred cCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999999964 4567999999999999999999999999 999999999999999999999999998754321
Q ss_pred -CccccCcccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-HhhcccccccccccCCCCCchhHHH
Q 013126 213 -KSYSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
....||+.|+|||++. +..++.++||||||+++|+|++|+.||....... ...........+ ........++++
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 257 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP-DLSKVRSNCPKR 257 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-CTTSSCTTSCHH
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-chhhccccCCHH
Confidence 2346899999999986 5568889999999999999999999986532221 111111111111 112234467789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 9999999999999999999999999988754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=358.82 Aligned_cols=244 Identities=17% Similarity=0.261 Sum_probs=196.8
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCC--------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD-------- 129 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------- 129 (449)
++|++++.||+|+||+||+|++. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46889999999999999999976 6999999999764433 3578999999999999999999999986643
Q ss_pred -------------------------------------------------eeEEEEeeCCCCCHHHHHhccCC-CCCCHHH
Q 013126 130 -------------------------------------------------ERLLVAEYMPNETLAKHLFHWET-HPMKWAM 159 (449)
Q Consensus 130 -------------------------------------------------~~~lV~Ey~~ggsL~~~l~~~~~-~~l~~~~ 159 (449)
..++||||++|++|.+++..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 37999999999999999974322 3355667
Q ss_pred HHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----------------CccccCccccc
Q 013126 160 RLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----------------KSYSTNLAFTP 223 (449)
Q Consensus 160 ~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----------------~~~~gt~~y~a 223 (449)
++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ....||+.|+|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHhCC-eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 8999999999999999999 999999999999999999999999999865543 23458999999
Q ss_pred cccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCC
Q 013126 224 PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303 (449)
Q Consensus 224 PE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 303 (449)
||++.+..++.++||||||+++|+|++|..|+..... .... ..... ........++++.+++.+||+.||++|
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-~~~~-~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-IITD-VRNLK-----FPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-HHHH-HHTTC-----CCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-HHHH-hhccC-----CCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999998999999999999999999999765432211 1111 00000 001112345678999999999999999
Q ss_pred CCHHHHHH
Q 013126 304 PNPKSLVT 311 (449)
Q Consensus 304 ps~~eil~ 311 (449)
||+.++++
T Consensus 318 ps~~~~l~ 325 (332)
T 3qd2_B 318 PEATDIIE 325 (332)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhh
Confidence 99999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.32 Aligned_cols=252 Identities=17% Similarity=0.227 Sum_probs=201.0
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCe----e
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE----R 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----~ 131 (449)
+.|++++.||+|+||+||+|++ .+++.||||+++.....+ .+.+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 4688999999999999999996 458999999998754444 3468899999999999999999999887654 4
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||++|++|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 92 ~lv~e~~~g~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 99999999999999997 3467999999999999999999999999 99999999999999999999999999976543
Q ss_pred C-------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 212 G-------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 212 ~-------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
. ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+ ........
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 246 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--PSARHEGL 246 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--HHHHSTTC
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--cccccCCC
Confidence 2 23458999999999998899999999999999999999999997664443322222111111 01112346
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHH-HHhccc
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLV-TALSPL 316 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil-~~L~~~ 316 (449)
++++.+++.+||+.||++||++.+++ +.+...
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 77899999999999999999666555 444443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.90 Aligned_cols=252 Identities=17% Similarity=0.247 Sum_probs=204.7
Q ss_pred cccccccccCCccceEEEEEEEc-CCC----EEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~----~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.+|++++.||+|+||+||+|++. +++ .||+|.++... ....+.+.+|+.++++++||||+++++++.+++ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 45889999999999999999954 344 36888886533 234678999999999999999999999998754 789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 9999999999999975 4567999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......+....... .....+...+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 246 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----ERLPQPPICTI 246 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----CCCCCCTTBCH
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-----CCCCCCccCCH
Confidence 2345779999999999999999999999999999999 99888765433332211111 11223455678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 899999999999999999999999999887654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=349.48 Aligned_cols=246 Identities=17% Similarity=0.181 Sum_probs=207.9
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+.|++.+.||+|+||+||+|.+.. +..||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 358899999999999999999654 7899999998766667889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee---CCCCCeEEeccCCcccCCCC---
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~--- 212 (449)
+|++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||++ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 89 TGGELFERVV--HKRVFRESDAARIMKDVLSAVAYCHKLN-VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred CCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 9999999987 3467999999999999999999999999 9999999999999 78899999999999865543
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
....+|+.|+|||++.+ .++.++||||||+++|+|++|+.||................... ........++++.+++
T Consensus 166 ~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 242 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF--PEKDWLNVSPQAESLI 242 (277)
T ss_dssp CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CHHHHTTSCHHHHHHH
T ss_pred hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--CchhhhcCCHHHHHHH
Confidence 34568999999999865 48999999999999999999999987654433332222111100 0000114567899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~ 311 (449)
.+||+.||++|||+.++++
T Consensus 243 ~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 243 RRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=367.36 Aligned_cols=250 Identities=19% Similarity=0.161 Sum_probs=203.0
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++..+...+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3333444667899999999999964 589999999987554456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee--CCCCCeEEeccCCcccCCCC--
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF--DEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl--~~~~~~kL~DFGla~~~~~~-- 212 (449)
|++|++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.....
T Consensus 167 ~~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 167 YVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp CCTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred CCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 9999999998864 3457999999999999999999999999 9999999999999 56788999999999876543
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....||+.|+|||++.+..++.++||||||+++|||++|+.||.................. .........++++.++
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~l 322 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--LEDEEFQDISEEAKEF 322 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--SCSGGGTTSCHHHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CChhhhccCCHHHHHH
Confidence 2346899999999999888999999999999999999999999765443332222211111 0111123567889999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+.+||+.||++|||+.++++
T Consensus 323 i~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 323 ISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHhc
Confidence 99999999999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=352.25 Aligned_cols=250 Identities=16% Similarity=0.192 Sum_probs=202.9
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC-----CCCHHHHHHHHHHHhccC---CCCcccceeeEeeCC-
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA-----WPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGD- 129 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~-----~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~- 129 (449)
++|++++.||+|+||+||+|++ .+++.||+|+++... ......+.+|+.+++.++ ||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 4688999999999999999995 458999999996422 122457788888887775 999999999998765
Q ss_pred ----eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 130 ----ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 130 ----~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
..++||||+. ++|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 5899999997 69999998655556999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc--------
Q 013126 206 MKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS-------- 274 (449)
Q Consensus 206 a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 274 (449)
++..... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence 9865543 34568999999999999999999999999999999999999997654433322211110000
Q ss_pred ------ccC-------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 ------CLE-------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 ------~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
... ....+..++++.+++.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000 0011345688999999999999999999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.72 Aligned_cols=242 Identities=20% Similarity=0.215 Sum_probs=198.9
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC---CCHHHHHHHHHH-HhccCCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW---PDPRQFLEEARS-VGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
..++|++++.||+|+||.||+|+.+ +++.||+|++++... ...+.+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3467899999999999999999975 488999999976432 224567778777 57789999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~- 211 (449)
+||||++||+|.+++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 116 lv~E~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999997 3467899999999999999999999999 99999999999999999999999999986322
Q ss_pred ---CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 212 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
.....||+.|+|||++.+..++.++|+|||||++|||++|..||............... ...++...+.++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~ 266 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNITNSA 266 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS------CCCCCSSSCHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------ccCCCCCCCHHH
Confidence 23567899999999999989999999999999999999999999876555444333222 112345677899
Q ss_pred HHHHHHhcccCCCCCCCHHH
Q 013126 289 VRLASRCLQYEPRERPNPKS 308 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~~e 308 (449)
.+++.+||+.||++||++.+
T Consensus 267 ~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHHHcccCHHhCCCCCC
Confidence 99999999999999999853
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=352.61 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=199.9
Q ss_pred CcccccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.+.|++.+.||+|+||+||+|.+.. +..||+|.++..... ..+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3578899999999999999999642 457999998764322 2467899999999999999999999984 567899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 93 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999999999974 3457999999999999999999999999 9999999999999999999999999998654432
Q ss_pred -----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 214 -----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 214 -----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...+|+.|+|||++.+..++.++||||||+++|||++ |..||............... .....+...+++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~ 245 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMPPNCPPT 245 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----CCCCCCTTCCHH
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-----CCCCCCCCCCHH
Confidence 2345678999999998889999999999999999997 88888654332222211111 112234567789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999988754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=357.18 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=212.0
Q ss_pred cccccccccCCccceEEEEEEE------cCCCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~------~~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 131 (449)
++|++.+.||+|+||+||+|++ .+++.||+|.++..... ..+.+.+|+.+++++ +||||+++++++.+++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5688999999999999999985 24689999999765432 246799999999999 999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWET----------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~ 195 (449)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||+++++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHG 181 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEETT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCccceEEEcCC
Confidence 999999999999999975332 25899999999999999999999999 9999999999999999
Q ss_pred CCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccc
Q 013126 196 GNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNL 268 (449)
Q Consensus 196 ~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 268 (449)
+.+||+|||+++...... ...+|+.|+|||++.+..++.++||||||+++|+|+| |+.|+.............
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 999999999998665432 2345788999999998899999999999999999999 888876543221111111
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.. ......+...++++.+++.+||+.||++|||+.++++.|+++..+
T Consensus 262 ~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 262 KE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 111223445678899999999999999999999999999887654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=355.89 Aligned_cols=246 Identities=17% Similarity=0.192 Sum_probs=208.4
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC------CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.|++.+.||+|+||.||+|... +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 5889999999999999999965 5899999999764322 35789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC----CeEEeccCCcccC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~----~~kL~DFGla~~~ 209 (449)
||||++|++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++ .+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~-ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 93 ILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999997 4567999999999999999999999999 99999999999999887 7999999999876
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.................. .........++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 247 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--FDEEFFSHTSE 247 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTCCH
T ss_pred CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc--cChhhhcccCH
Confidence 543 3456899999999999889999999999999999999999998765444333222111110 00011134567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 8999999999999999999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=348.74 Aligned_cols=247 Identities=19% Similarity=0.222 Sum_probs=208.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++|++++.||+|+||+||+|.+. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 56889999999999999999965 4899999999754322 24678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC---eEEeccCCcccCCCCC
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKNSRDGK 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~---~kL~DFGla~~~~~~~ 213 (449)
|++|++|.+.+. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++. +||+|||++.......
T Consensus 86 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 86 LVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred cCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 999999999887 3467999999999999999999999999 999999999999986655 9999999997765443
Q ss_pred ---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 214 ---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||................... ........++++.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY--PSPEWDTVTPEAKS 240 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTTTTTSCHHHHH
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC--CchhhcccCHHHHH
Confidence 3568999999999999899999999999999999999999987665444333322221111 11122456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||+.||++|||+.++++
T Consensus 241 li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcccChhhCCCHHHHhc
Confidence 999999999999999999997
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=374.44 Aligned_cols=246 Identities=20% Similarity=0.199 Sum_probs=206.8
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCC--CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM--AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
+.|++++.||+|+||+||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 36899999999999999999965 5899999999642 23346789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC---CCCCeEEeccCCcccCCCC-
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~- 212 (449)
|++|++|.+.+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999999999873 467999999999999999999999999 99999999999995 4567999999999865543
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....||+.|+|||++.+ .++.++||||+||++|+|++|+.||................... ........++++.+
T Consensus 179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--DLPQWRTISDDAKD 255 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS--CSGGGGGSCHHHHH
T ss_pred ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCcccCCCCHHHHH
Confidence 34568999999999975 59999999999999999999999997765444333222211110 11112356788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||+.||++|||+.++++
T Consensus 256 li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhc
Confidence 999999999999999999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.28 Aligned_cols=255 Identities=18% Similarity=0.299 Sum_probs=206.8
Q ss_pred ccccccccCCccceEEEEEEE-----cCCCEEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-----~~~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 132 (449)
.|++++.||+|+||.||+|++ .+++.||+|+++... ....+.+.+|+++++.++||||+++++++... +..+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 488999999999999999983 358899999997543 23467899999999999999999999999876 6689
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 102 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcCC-cccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 99999999999999964 4467999999999999999999999999 999999999999999999999999999876543
Q ss_pred C-------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh----------hcccccccccc
Q 013126 213 K-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNLQMLTDSC 275 (449)
Q Consensus 213 ~-------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~ 275 (449)
. ...+|..|+|||++.+..++.++||||||+++|+|++|..|+......... ...........
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 2 345678899999999888999999999999999999999875332111100 00000011111
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
.....+...++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 122345567789999999999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=362.42 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=208.7
Q ss_pred CCcccccccccCCccceEEEEEEEc------CCCEEEEEEecCCC-CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCC
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 129 (449)
..+.|++.+.||+|+||+||+|.+. +++.||+|+++... ....+.+.+|+.+++++ +||||+++++++..++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3467889999999999999999962 35689999997543 23357899999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWET---------------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~ 188 (449)
..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~ 201 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAAR 201 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-EEETTCSGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChh
Confidence 99999999999999999975322 24789999999999999999999999 999999999
Q ss_pred ceeeCCCCCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhH
Q 013126 189 RILFDEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALD 261 (449)
Q Consensus 189 NILl~~~~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~ 261 (449)
||+++.++.+||+|||++....... ...+|+.|+|||++.+..++.++||||||+++|+|+| |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 9999999999999999997544322 2346788999999998899999999999999999998 98888654322
Q ss_pred HHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 262 LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
......... ......+...++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 282 ~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 282 ANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111111111 111223445678899999999999999999999999999887654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=374.12 Aligned_cols=244 Identities=19% Similarity=0.268 Sum_probs=210.8
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
...|++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456889999999999999999975 69999999996432 23356799999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||++||+|.+++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999999997 5567999999999999999999999999 999999999999999999999999999876543
Q ss_pred -CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||................. ..+...++++.+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------~~p~~~s~~~~~ 245 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------YTPQYLNPSVIS 245 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC------CCCTTCCHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc------CCCccCCHHHHH
Confidence 34568999999999988775 6899999999999999999999987654444333222211 223456778999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||+.||++|||++++++
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCchhCcCHHHHHh
Confidence 999999999999999999997
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=355.74 Aligned_cols=239 Identities=20% Similarity=0.222 Sum_probs=197.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.|+++++||+|+||+||+|.+. +|+.||||++....... ...+.+|+..+.++ +||||+++++++.+++..++|||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e 137 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence 5889999999999999999976 69999999987644322 33456666666666 89999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---C
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---K 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---~ 213 (449)
|+ +++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 138 ~~-~~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 138 LC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQG-LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp CC-CCBHHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred cc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence 99 5799998875 3467999999999999999999999999 999999999999999999999999998876543 3
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh-hHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...||+.|+|||++.+ .++.++||||||+++|||++|..|+.... ...+..... ....+...++++.+++
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li 285 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL--------PPEFTAGLSSELRSVL 285 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCC--------CHHHHTTSCHHHHHHH
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCC--------CcccccCCCHHHHHHH
Confidence 4468999999999875 79999999999999999999977665432 222222111 1112234568899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~ 311 (449)
.+||+.||++|||++++++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 286 VMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHSCSSTTTSCCHHHHHT
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=375.92 Aligned_cols=246 Identities=15% Similarity=0.159 Sum_probs=204.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-------------CCHHHHHHHHHHHhccCCCCcccceeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-------------PDPRQFLEEARSVGQLRNNRLTNLLGCC 125 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 125 (449)
..|+++++||+|+||+||+|... +++.||+|+++.... ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 46889999999999999999965 489999999975431 2356799999999999999999999999
Q ss_pred eeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC---CeEEec
Q 013126 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG---NPRLST 202 (449)
Q Consensus 126 ~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~---~~kL~D 202 (449)
.+++..++||||++||+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQII--NRHKFDECDAANIMKQILSGICYLHKHN-IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999997 3467999999999999999999999999 99999999999999776 699999
Q ss_pred cCCcccCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCC
Q 013126 203 FGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 203 FGla~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (449)
||+++..... ....||+.|+|||++. +.++.++||||+|+++|+|++|..||.......+........... ...
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~ 269 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF--DFN 269 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--Ccc
Confidence 9999876544 3456899999999986 569999999999999999999999998765544433322211110 000
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....+++++.+++.+||+.||.+|||++++++
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11345688999999999999999999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=360.58 Aligned_cols=245 Identities=20% Similarity=0.229 Sum_probs=206.7
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.|++++.||+|+||+||+|+. .+++.||||++....... .+.+.+|++++++++||||+++++++..++..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 478889999999999999996 468999999997654332 3568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCccc
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS 216 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 216 (449)
|++ |+|.+.+.. ...++++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 135 ~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 211 (348)
T 1u5q_A 135 YCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 211 (348)
T ss_dssp CCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred cCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEeeccCceecCCCCccc
Confidence 998 688888754 3567999999999999999999999999 9999999999999999999999999998877777788
Q ss_pred cCcccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 217 TNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 217 gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
||+.|+|||++. +..++.++||||||+++|||++|+.||................ .....+...++.+.+++.
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPALQSGHWSEYFRNFVD 287 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----CCCCCCTTSCHHHHHHHH
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----CCCCCCCCCCHHHHHHHH
Confidence 999999999985 4668999999999999999999999986543322211111111 111223456778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~ 312 (449)
+||+.||++|||++++++.
T Consensus 288 ~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTC
T ss_pred HHcccChhhCcCHHHHhhC
Confidence 9999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=352.23 Aligned_cols=256 Identities=15% Similarity=0.138 Sum_probs=210.1
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|++++.||+|+||+||+|.. .+++.||+|+++... ..+.+.+|+.+++.+ +|+|++++++++.++...++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 4588999999999999999996 469999999986543 335688999999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC-----eEEeccCCcccCCCC
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN-----PRLSTFGLMKNSRDG 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~-----~kL~DFGla~~~~~~ 212 (449)
+ +++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+++.....
T Consensus 88 ~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 88 L-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred c-CCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9 8999999975 3457999999999999999999999999 999999999999987766 999999999865432
Q ss_pred -----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh---hHHHhhcccccccccccCC
Q 013126 213 -----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 213 -----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~ 278 (449)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ............... ...
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-PLR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-CHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-cHH
Confidence 23468999999999998889999999999999999999999986531 111111100000000 001
Q ss_pred CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
......++++.+++.+||+.||++|||++++++.|+.+.....
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 1123566789999999999999999999999999998876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=351.26 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=205.7
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC-CeeEEEEe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG-DERLLVAE 136 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E 136 (449)
+.++|++++.||+|+||+||+|+. +|+.||+|+++... ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 457799999999999999999987 57899999997543 467899999999999999999999997654 47899999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-Ccc
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~ 215 (449)
|+++++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++..... ...
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 999999999997543345899999999999999999999999 999999999999999999999999998765443 334
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
.+++.|+|||++.+..++.++||||||+++|+|++ |+.|+............... .....+...++.+.+++.+
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----YKMDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----CCCCCCTTCCHHHHHHHHH
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----CCCCCcccCCHHHHHHHHH
Confidence 57889999999998889999999999999999998 98888655433332221111 1123345677899999999
Q ss_pred hcccCCCCCCCHHHHHHHhcccccc
Q 013126 295 CLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
||+.||++|||+.++++.|+.+...
T Consensus 250 ~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCChhhCCCHHHHHHHHHHHHhh
Confidence 9999999999999999999887543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=357.15 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=206.9
Q ss_pred cccccccccCCccceEEEEEEEcC-----CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-----~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
..|++.+.||+|+||+||+|.+.. +..||+|.++..... ....+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 457788899999999999998643 235999999764422 24568999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 124 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999999975 4567999999999999999999999999 9999999999999999999999999998654331
Q ss_pred -------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 214 -------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 214 -------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
...+|+.|+|||++.+..++.++||||||+++|||++ |+.||................ ....+...+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 276 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-----RLPTPMDCP 276 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----CCCCCTTCB
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-----cCCCcccCC
Confidence 2234678999999998889999999999999999999 998886554333332221111 112244567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 88999999999999999999999999998876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=351.81 Aligned_cols=247 Identities=16% Similarity=0.198 Sum_probs=207.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+.|++++.||+|+||+||+|+.. +|+.||+|+++.......+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46889999999999999999965 58999999998765445567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee---CCCCCeEEeccCCcccCCCC--C
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG--K 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~--~ 213 (449)
+|++|.+++.. .+.+++..+..++.|++.||+|||+++ ++||||||+||++ ++++.+||+|||+++..... .
T Consensus 89 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 89 SGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENG-IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp CSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred CCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 99999999873 457999999999999999999999999 9999999999999 78899999999998765443 2
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||.................. .........++++.+++.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~li~ 243 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE--FESPFWDDISESAKDFIC 243 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC--CCTTTTTTSCHHHHHHHH
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCccccccCCHHHHHHHH
Confidence 345899999999999888999999999999999999999998765444333322221111 112234566789999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
+||+.||++|||+.++++
T Consensus 244 ~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 244 HLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHCSSTTTSCCHHHHHT
T ss_pred HHcCCChhHCcCHHHHhc
Confidence 999999999999999997
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.46 Aligned_cols=258 Identities=22% Similarity=0.308 Sum_probs=212.1
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEE--EEEEecCCC-CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRI--AVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~v--AiK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
++++|++.+.||+|+||.||+|++. ++..+ |+|.++... ....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 3467889999999999999999954 46644 999987533 23356799999999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCe
Q 013126 133 LVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP 198 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~ 198 (449)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCccceEEEcCCCeE
Confidence 9999999999999997422 247999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCC---CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccccccccc
Q 013126 199 RLSTFGLMKNSRD---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDS 274 (449)
Q Consensus 199 kL~DFGla~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 274 (449)
||+|||+++.... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||................
T Consensus 182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~--- 258 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--- 258 (327)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC---
T ss_pred EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC---
Confidence 9999999875332 223456789999999988889999999999999999998 999987665444433322211
Q ss_pred ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
....+...++++.+++.+||+.||++|||++++++.|+.+.....
T Consensus 259 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 259 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 122345667899999999999999999999999999998876544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=347.41 Aligned_cols=247 Identities=19% Similarity=0.241 Sum_probs=211.1
Q ss_pred hCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 56 TSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 56 ~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
.-..++|++++.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 345577999999999999999999965 48899999996421 23356799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHERK-VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999999974 457999999999999999999999999 99999999999999999999999999876543
Q ss_pred C--CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 212 G--KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 212 ~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
. ....|++.|+|||++.+..++.++||||||+++|+|++|+.||............... ....+...+.++.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 240 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DLKFPPFLSDGSK 240 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------CCCCCTTSCHHHH
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc------ccCCCCcCCHHHH
Confidence 3 3456899999999999888999999999999999999999998765433332222111 1123456678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+||+.||++|||++++++
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhcCHhhCCCHHHHhh
Confidence 9999999999999999999997
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=346.53 Aligned_cols=242 Identities=17% Similarity=0.198 Sum_probs=205.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
++|++++.||+|+||+||+|.+. +++.||+|+++...... ..++.+|+..+..+ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 45889999999999999999975 59999999998654333 56788999999999 9999999999999999999999
Q ss_pred eeCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC------------------
Q 013126 136 EYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED------------------ 195 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~------------------ 195 (449)
||++|++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS-LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEC--------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC-EeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999997532 267999999999999999999999999 9999999999999844
Q ss_pred -CCeEEeccCCcccCCCCCccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhh-HHHhhccccccc
Q 013126 196 -GNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQMLT 272 (449)
Q Consensus 196 -~~~kL~DFGla~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~ 272 (449)
..+||+|||.+..........+|+.|+|||++.+. .++.++||||||+++|+|++|.+++..... ..+....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----- 244 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR----- 244 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTC-----
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCC-----
Confidence 47999999999988777777899999999999876 567899999999999999999976654321 1122111
Q ss_pred ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....+...++++.+++.+||+.||++|||+.++++
T Consensus 245 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 245 ----LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 12234566788999999999999999999999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=367.91 Aligned_cols=248 Identities=14% Similarity=0.132 Sum_probs=195.1
Q ss_pred Ccccccc-cccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhc-cCCCCcccceeeEee----CCee
Q 013126 59 FAVENIV-SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQ-LRNNRLTNLLGCCCE----GDER 131 (449)
Q Consensus 59 f~~~~~l-~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~----~~~~ 131 (449)
+++|+++ +.||+|+||+||+|.+. +|+.||||+++. ...+.+|++++.+ .+||||+++++++.. .+.+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4557776 57999999999999965 589999999963 3567889998755 489999999999876 5678
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---CCCeEEeccCCccc
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKN 208 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~ 208 (449)
|+||||++||+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 99999999999999998544557999999999999999999999999 999999999999997 78899999999987
Q ss_pred CCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc--ccCCCCCch
Q 013126 209 SRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS--CLEGQFTDD 283 (449)
Q Consensus 209 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 283 (449)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...............+... .........
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 5543 34567999999999998899999999999999999999999986542211000000000000 011112245
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+++++.++|.+||+.||++|||+.+++++
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 67899999999999999999999999984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=381.00 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=216.3
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.+.|++.+.||+|+||+||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45688899999999999999998877889999998654 346789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----C
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-----~ 213 (449)
++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence 9999999997544467999999999999999999999999 999999999999999999999999999875532 2
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...++..|+|||++.+..++.++||||||+++|||++ |+.||.......+....... .....+..+++++.++|
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~l~~li 497 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPPECPESLHDLM 497 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTCCHHHHHHH
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHH
Confidence 3345788999999998899999999999999999999 88888765433333222111 11223456778899999
Q ss_pred HHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
.+||+.||++|||++++++.|+.+.....
T Consensus 498 ~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 498 CQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 99999999999999999999998875543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=353.16 Aligned_cols=261 Identities=18% Similarity=0.227 Sum_probs=205.6
Q ss_pred CCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
..+.+|++++.||+|+||.||+|.. .+|+.||+|+++.....+ .+.+.+|+.++++++||||+++++++..++..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 4556799999999999999999996 468999999997643333 457889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 133 LVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998642 3567999999999999999999999999 9999999999999999999999999987654
Q ss_pred CC----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH--HHhhcccccccccccCCCCCchh
Q 013126 211 DG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD--LIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 211 ~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
.. ....+++.|+|||++.+..++.++||||||+++|+|++|+.||...... ........ ...........
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 263 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ----CDYPPLPSDHY 263 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT----TCSCCCCTTTS
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc----ccCCCCccccc
Confidence 33 2346889999999999888999999999999999999999998654221 11111111 11111122456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccCC
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 322 (449)
++++.+++.+||+.||++|||+.++++.|+.+......
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 78899999999999999999999999999998776543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=372.38 Aligned_cols=248 Identities=18% Similarity=0.242 Sum_probs=185.7
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeC-----Cee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 131 (449)
++|++++.||+|+||+||+|.+. +++.||||++...... ..+++.+|+++++.++||||+++++++... +..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 46899999999999999999965 5899999999764322 246789999999999999999999998543 568
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
|+||||+. ++|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~-iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSAG-ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEeccc-cchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99999985 89999997 5677999999999999999999999999 99999999999999999999999999986532
Q ss_pred C-------------------------------CccccCcccccccccc-CCCCCCCCceeeHhHHHHHHhc---------
Q 013126 212 G-------------------------------KSYSTNLAFTPPEYLR-TGRVTPESVIYSFGTLLLDLLS--------- 250 (449)
Q Consensus 212 ~-------------------------------~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~ellt--------- 250 (449)
. ....||+.|+|||++. +..++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 1 2345799999999864 5569999999999999999999
Q ss_pred --CCCCCCchhh---------------------HHHhh----------------------cccccccc--cccCCCCCch
Q 013126 251 --GKHIPPSHAL---------------------DLIRD----------------------RNLQMLTD--SCLEGQFTDD 283 (449)
Q Consensus 251 --g~~p~~~~~~---------------------~~~~~----------------------~~~~~~~~--~~~~~~~~~~ 283 (449)
|+++|++... +.+.. ........ ........+.
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 5555544321 00000 00000000 0000011234
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.++++.+||.+||+.||++|||++++++
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 5788999999999999999999999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=357.79 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=209.7
Q ss_pred cccccccCCccceEEEEEEEc-----CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeC--CeeEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-----NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG--DERLL 133 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-----~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 133 (449)
|++++.||+|+||+||++.+. +++.||||+++..... ..+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999988642 5889999999865322 246789999999999999999999999884 67899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||+++++|.+++. ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 113 v~e~~~~~~L~~~l~---~~~~~~~~~~~i~~~l~~~l~~LH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHh---hCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 999999999999995 345999999999999999999999999 9999999999999999999999999998765432
Q ss_pred -------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh----------ccccccccccc
Q 013126 214 -------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD----------RNLQMLTDSCL 276 (449)
Q Consensus 214 -------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~----------~~~~~~~~~~~ 276 (449)
...+|+.|+|||++.+..++.++||||||+++|+|++|+.|+.......... ...........
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 3346788999999998889999999999999999999998876543221110 00111111112
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
....+..+++++.+++.+||+.||++|||++++++.|+.+....
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 22345567789999999999999999999999999998886554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=350.60 Aligned_cols=247 Identities=18% Similarity=0.287 Sum_probs=208.0
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEee-----------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----------- 127 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----------- 127 (449)
.+|++++.||+|+||.||+|.+. +++.||+|.++... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 35788899999999999999975 69999999997543 467899999999999999999998864
Q ss_pred -----CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEec
Q 013126 128 -----GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLST 202 (449)
Q Consensus 128 -----~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~D 202 (449)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCHHHEEEcCCCCEEECc
Confidence 445899999999999999997655678999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCC
Q 013126 203 FGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 203 FGla~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (449)
||+++..... ....+|+.|+|||++.+..++.++||||||+++|+|++|..|+..... ... ... ...
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~----~~~----~~~ 235 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFT----DLR----DGI 235 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHH----HHH----TTC
T ss_pred chhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHH----Hhh----ccc
Confidence 9998876543 345689999999999988899999999999999999999987643211 111 111 112
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
.+...+..+.+++.+||+.||++|||+.++++.|+.+.+..+
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 234556789999999999999999999999999988876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=349.89 Aligned_cols=256 Identities=20% Similarity=0.248 Sum_probs=213.3
Q ss_pred ccccccc-ccCCccceEEEEEEEc---CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVS-EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~-~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
..|.+++ .||+|+||+||+|.+. +++.||+|+++..... ..+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4567777 8999999999999853 5788999999865322 256799999999999999999999999 55679999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCC-EeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999964 4467999999999999999999999999 9999999999999999999999999998764332
Q ss_pred ------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...+|+.|+|||++.+..++.++||||||+++|+|++ |+.||............... .....+...++
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~ 240 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECPPECPP 240 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-----CCCCCCTTCCH
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-----CcCCCCCCcCH
Confidence 2345788999999988889999999999999999998 99988765433332221111 11233456778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccccCCC
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEVP 323 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~ 323 (449)
++.+++.+||+.||++|||+.++++.|+.+..+...+
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 9999999999999999999999999999987665443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=357.00 Aligned_cols=250 Identities=19% Similarity=0.288 Sum_probs=198.7
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++.|++++.||+|+||+||+|... +++.||+|+++...... ...+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 357899999999999999999975 58999999997543222 2346689999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++ |+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQK-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 998 699998875 4567999999999999999999999999 999999999999999999999999998765432
Q ss_pred CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccc---cC-----------
Q 013126 213 KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC---LE----------- 277 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~----------- 277 (449)
....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||..................+. ..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 23467999999999976 4589999999999999999999999976543332221111100000 00
Q ss_pred ----------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 278 ----------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 278 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....+..++++.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0011235678999999999999999999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=370.25 Aligned_cols=255 Identities=19% Similarity=0.159 Sum_probs=208.8
Q ss_pred HHhhCCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeC
Q 013126 53 KNATSGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG 128 (449)
Q Consensus 53 ~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 128 (449)
.+..-..++|++++.||+|+||+||+|+.. +|+.||+|++++.. ....+.+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 334445677889999999999999999975 59999999996421 11234588999999999999999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
+..|+||||++||+|.+++.+ ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~g-iiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAEIVMAIDSVHRLG-YVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HSSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccCHHHeeecCCCCEEEeechhhee
Confidence 999999999999999999974 2357999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCC-----ccccCcccccccccc-------CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccccc
Q 013126 209 SRDGK-----SYSTNLAFTPPEYLR-------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL 276 (449)
Q Consensus 209 ~~~~~-----~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (449)
..... ...||+.|+|||++. +..++.++|||||||++|||++|+.||................... .
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-~ 290 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL-S 290 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-C
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc-C
Confidence 65432 347899999999997 3568999999999999999999999998765444433332211100 0
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRER---PNPKSLVT 311 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~eil~ 311 (449)
....+...++++.++|.+||. +|.+| |+++++++
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111234577899999999999 99998 58999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=361.97 Aligned_cols=257 Identities=15% Similarity=0.159 Sum_probs=204.6
Q ss_pred cccccccccCCccceEEEEEEEcC------CCEEEEEEecCCCCCC-----------HHHHHHHHHHHhccCCCCcccce
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWPD-----------PRQFLEEARSVGQLRNNRLTNLL 122 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~------~~~vAiK~l~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~l~ 122 (449)
..|++++.||+|+||+||+|.+.+ ++.||||++....... ...+.+|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 478899999999999999999754 4789999987543110 12344566677788899999999
Q ss_pred eeEeeC----CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC--CCC
Q 013126 123 GCCCEG----DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDG 196 (449)
Q Consensus 123 ~~~~~~----~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~--~~~ 196 (449)
+++... ...++||||+ |++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++ .++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~-iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHE-YVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEESSCTT
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eEEecCCHHHEEEecCCCC
Confidence 998875 4589999999 9999999975 4467999999999999999999999999 99999999999999 889
Q ss_pred CeEEeccCCcccCCCC-----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh-
Q 013126 197 NPRLSTFGLMKNSRDG-----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR- 264 (449)
Q Consensus 197 ~~kL~DFGla~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~- 264 (449)
.+||+|||+++..... ....||+.|+|||++.+..++.++||||||+++|||+||+.||.........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999764322 2234899999999999888999999999999999999999998753211110
Q ss_pred -------hcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccCC
Q 013126 265 -------DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322 (449)
Q Consensus 265 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 322 (449)
......+.+.... ....++++.+++.+||+.||++||+++++++.|+.+......
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 0111111122111 234567899999999999999999999999999888765443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=361.67 Aligned_cols=247 Identities=18% Similarity=0.260 Sum_probs=197.1
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCC------e
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 130 (449)
..|++++.||+|+||+||+|.+. +|+.||||++....... .+++.+|+++++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 46889999999999999999964 59999999996543222 467889999999999999999999998763 4
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 69999999 7999999953 57999999999999999999999999 9999999999999999999999999998765
Q ss_pred CC-CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc------------------
Q 013126 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM------------------ 270 (449)
Q Consensus 211 ~~-~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~------------------ 270 (449)
.. ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.............
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 43 44678999999999987 67999999999999999999999998764332211111000
Q ss_pred -----ccc--cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 -----LTD--SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 -----~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
... ...........++++.+|+.+||+.||++|||++++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 00001123456788999999999999999999999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=356.89 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=213.1
Q ss_pred CcccccccccCCccceEEEEEEEc--------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEG 128 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~--------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 128 (449)
.++|++.+.||+|+||+||+|++. +++.||+|+++..... ..+.+.+|+++++++ +||||+++++++.++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367889999999999999999863 4678999999764322 245789999999999 899999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC
Q 013126 129 DERLLVAEYMPNETLAKHLFHWET--------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~ 194 (449)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVLVTE 192 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCccceEEEcC
Confidence 999999999999999999975321 24899999999999999999999999 999999999999999
Q ss_pred CCCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcc
Q 013126 195 DGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 267 (449)
Q Consensus 195 ~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 267 (449)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+............
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 272 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence 999999999999865543 22345788999999988889999999999999999999 88888765444333222
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.... ....+...+.++.+++.+||+.||++|||+.++++.|+.+....
T Consensus 273 ~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 273 KEGH-----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcCC-----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111 12234566788999999999999999999999999999887653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=359.82 Aligned_cols=248 Identities=20% Similarity=0.152 Sum_probs=200.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCC-----CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM-----AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.|++++.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 106 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence 5888999999999999999964 5889999998643 223457899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 013126 135 AEYMPNETLAKHLFHWE--------------------------------------THPMKWAMRLRVVLHLAQALEYCTS 176 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi~~aL~yLH~ 176 (449)
|||++||+|.+++.... ...+++..++.++.|++.||+|||+
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 186 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999985210 1223577888999999999999999
Q ss_pred CCCccccccccCceeeCCCC--CeEEeccCCcccCCC--------CCccccCccccccccccC--CCCCCCCceeeHhHH
Q 013126 177 KGRALYHDLNAYRILFDEDG--NPRLSTFGLMKNSRD--------GKSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTL 244 (449)
Q Consensus 177 ~~~iiHrDlkp~NILl~~~~--~~kL~DFGla~~~~~--------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvi 244 (449)
++ |+||||||+||+++.++ .+||+|||+++.... .....||+.|+|||++.+ ..++.++||||||++
T Consensus 187 ~~-ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 187 QG-ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp TT-EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred CC-ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99 99999999999998776 899999999975422 134568999999999975 568999999999999
Q ss_pred HHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 245 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+|+|++|+.||................... ........++++.+++.+||+.||++|||+.++++
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCF--ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCT--TSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhccccc--CCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999987654433332222211110 11112245788999999999999999999999998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.78 Aligned_cols=249 Identities=17% Similarity=0.209 Sum_probs=190.7
Q ss_pred hhCCCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 55 ATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 55 ~~~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
....+.+|++.+.||+|+||.||+|+. .+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 345667899999999999999999996 468999999996432 2235789999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||+++++|.+++.. ...++++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHG-ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999999974 3467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CC----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 211 DG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 211 ~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
.. ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.............. . ....+...+.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~--~~~~~~~~~~ 237 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----A--DYEMPSFLSI 237 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----S--CCCCCTTSCH
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----c--ccCCccccCH
Confidence 32 235689999999999988899999999999999999999999875432222111111 0 1123445678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+++.+||+.||++|||++++++
T Consensus 238 ~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 238 EAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhc
Confidence 8999999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.79 Aligned_cols=246 Identities=16% Similarity=0.179 Sum_probs=203.2
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 5888999999999999999964 58999999997644 334688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee---CCCCCeEEeccCCcccCCCC-
Q 013126 139 PNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 139 ~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~- 212 (449)
++++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC-EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 999999998642 3467999999999999999999999999 9999999999999 45688999999999765433
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....+|+.|+|||++. +.++.++||||||+++|+|++|+.||................... .......++++.+
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 257 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY---AVECRPLTPQAVD 257 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---CC--CCCCHHHHH
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc---ccccCcCCHHHHH
Confidence 3456899999999985 568999999999999999999999998765544433322211111 1112235678999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||+.||++|||+.++++
T Consensus 258 li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 258 LLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999997
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.88 Aligned_cols=246 Identities=18% Similarity=0.169 Sum_probs=198.3
Q ss_pred ccccc-cccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIV-SEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l-~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|+++ +.||+|+||+||+|.. .+++.||||+++.......+.+.+|+++++++ +||||+++++++.+++..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 47775 6789999999999995 46899999999876656678899999999985 799999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC---eEEeccCCcccCCCC--
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~---~kL~DFGla~~~~~~-- 212 (449)
++|++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+++.....
T Consensus 93 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 93 MRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKG-IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred CCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999974 467999999999999999999999999 999999999999998766 999999998754321
Q ss_pred ---------CccccCccccccccccC-----CCCCCCCceeeHhHHHHHHhcCCCCCCchhh---------------HHH
Q 013126 213 ---------KSYSTNLAFTPPEYLRT-----GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL---------------DLI 263 (449)
Q Consensus 213 ---------~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~---------------~~~ 263 (449)
....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ..+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 12348999999999975 4589999999999999999999999865321 011
Q ss_pred hhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 264 RDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.......... .........++++.+++.+||+.||++|||+.++++
T Consensus 250 ~~~i~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 250 FESIQEGKYE--FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHCCCC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhccCcc--cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1111000000 000001235678999999999999999999999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=357.99 Aligned_cols=245 Identities=20% Similarity=0.289 Sum_probs=200.4
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCC--CCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRN--NRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~ 135 (449)
..|++++.||+|+||+||++...+++.||||+++...... .+.+.+|+.+++.++| |||+++++++.+++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 5689999999999999999998889999999997644322 3678999999999987 99999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
|+ .+++|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 89 e~-~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 EC-GNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp CC-CSEEHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred eC-CCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 95 5789999997 4568999999999999999999999999 99999999999997 678999999999865433
Q ss_pred ---CccccCccccccccccC-----------CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCC
Q 013126 213 ---KSYSTNLAFTPPEYLRT-----------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (449)
....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... .....+.....
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~ 240 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAIIDPNHEI 240 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---HHHHHCTTSCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH---HHHHhcCCccc
Confidence 23468999999999865 56889999999999999999999998653221111 11111222223
Q ss_pred CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
..+...+.++.+++.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 3445556789999999999999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=347.99 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=206.3
Q ss_pred ccccccccCCccceEEEEEEEcC-CC---EEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCee-EEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-QR---RIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER-LLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~~---~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~-~lV 134 (449)
.|++.+.||+|+||+||+|.+.+ ++ .||+|.++..... ..+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35566889999999999998533 33 7999999764322 246789999999999999999999999876655 999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||+.+++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK-FVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999975 4567899999999999999999999999 999999999999999999999999999754322
Q ss_pred ------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch-hhHHHhhcccccccccccCCCCCchhH
Q 013126 213 ------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 ------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
....+++.|+|||.+.+..++.++||||||+++|+|++|..|+... ............ .....+...+
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 254 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-----RRLPQPEYCP 254 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-----CCCCCCTTCC
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-----CCCCCCccch
Confidence 2345688999999999889999999999999999999976665432 211111111111 1122344567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
+.+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 889999999999999999999999999998876643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=351.52 Aligned_cols=249 Identities=20% Similarity=0.224 Sum_probs=200.7
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++|++++.||+|+||+||+|.+. +|+.||+|++....... .+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56889999999999999999975 48999999997654322 4568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|+++++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 83 YCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKHN-CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp CCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 999999999886 5567999999999999999999999999 999999999999999999999999999875533
Q ss_pred CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc--------------------c
Q 013126 213 KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM--------------------L 271 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------------------~ 271 (449)
....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||............... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 23468899999999976 56899999999999999999999998765332211110000 0
Q ss_pred cccccCCC-----CCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 272 TDSCLEGQ-----FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 272 ~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..+..... ..+..++++.+++.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000 01345678999999999999999999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=356.78 Aligned_cols=252 Identities=17% Similarity=0.253 Sum_probs=204.8
Q ss_pred cccccccccCCccceEEEEEEEc-CCCE----EEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRR----IAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~----vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.+|++++.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++..++ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56889999999999999999954 3443 5788776543 334678999999999999999999999998754 789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCC-CcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 9999999999999975 4567999999999999999999999999 9999999999999999999999999998654321
Q ss_pred ------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...+|+.|+|||++.+..++.++||||||+++|+|++ |..||............... .....+...+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 246 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----ERLPQPPICTI 246 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----CCCCCCTTBCH
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----CCCCCCccCCH
Confidence 2345778999999999999999999999999999999 99888765433332221111 11223455678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999887654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=379.68 Aligned_cols=252 Identities=18% Similarity=0.253 Sum_probs=211.3
Q ss_pred CCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
-..++|++++.||+|+||.||+|+.. +|+.||+|++.+. .....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34567889999999999999999965 5999999999652 2234567899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||++||+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g-IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999998544556999999999999999999999999 999999999999999999999999999876544
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...............+.. ....++...++++.
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERFSPQAR 417 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCTTSCHHHH
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCccCCHHHH
Confidence 2457899999999999888999999999999999999999998764211000000011111 11234566788999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHH
Q 013126 290 RLASRCLQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rp-----s~~eil~ 311 (449)
++|.+||+.||++|| +++++++
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 999999999999999 7888886
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.26 Aligned_cols=256 Identities=24% Similarity=0.293 Sum_probs=205.8
Q ss_pred CCcccccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEe-eCCee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCC-EGDER 131 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 131 (449)
+...|++.+.||+|+||+||+|.+.+ +..+|+|.++..... ..+.+.+|+.++++++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34568899999999999999999532 236899999764322 2467899999999999999999999864 45678
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999974 4567899999999999999999999999 99999999999999999999999999976543
Q ss_pred C--------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCC-CCchhhHHHhhcccccccccccCCCCCc
Q 013126 212 G--------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI-PPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 212 ~--------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
. ....+|+.|+|||.+.+..++.++||||||+++|+|++|..| +............... .....+.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 255 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-----RRLLQPE 255 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT-----CCCCCCT
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC-----CCCCCCc
Confidence 2 234567889999999988999999999999999999995544 4332222111111111 1112234
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
..+..+.+++.+||+.||++|||++++++.|+.+....
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 56678999999999999999999999999998886643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=355.06 Aligned_cols=250 Identities=19% Similarity=0.196 Sum_probs=209.1
Q ss_pred CHHHHHHhhCCC-cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--------CHHHHHHHHHHHhccCCCC
Q 013126 48 TLEQLKNATSGF-AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--------DPRQFLEEARSVGQLRNNR 117 (449)
Q Consensus 48 ~~~~l~~~~~~f-~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--------~~~~~~~E~~~l~~l~Hpn 117 (449)
.++.+......| ..|++++.||+|+||+||+|.+. +++.||||+++..... ..+.+.+|+.++++++|||
T Consensus 11 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (335)
T 3dls_A 11 ELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90 (335)
T ss_dssp ECCHHHHHTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTT
T ss_pred cccccccCCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCC
Confidence 334444444433 46899999999999999999954 5899999999765321 2346788999999999999
Q ss_pred cccceeeEeeCCeeEEEEeeCCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC
Q 013126 118 LTNLLGCCCEGDERLLVAEYMPNE-TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG 196 (449)
Q Consensus 118 Iv~l~~~~~~~~~~~lV~Ey~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~ 196 (449)
|+++++++.+.+..++||||+.+| +|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 91 Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLKD-IIHRDIKDENIVIAEDF 167 (335)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTS
T ss_pred EeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eEEeccCHHHEEEcCCC
Confidence 999999999999999999999766 9999997 5567999999999999999999999999 99999999999999999
Q ss_pred CeEEeccCCcccCCCCC---ccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc
Q 013126 197 NPRLSTFGLMKNSRDGK---SYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT 272 (449)
Q Consensus 197 ~~kL~DFGla~~~~~~~---~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 272 (449)
.+||+|||+++...... ...||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... ...
T Consensus 168 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~--- 238 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVE--- 238 (335)
T ss_dssp CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTT---
T ss_pred cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHh---
Confidence 99999999998765443 3568999999999988776 7899999999999999999999865211 000
Q ss_pred ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 273 DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
. ....+...++++.+++.+||+.||++|||+.++++.
T Consensus 239 -~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 -A--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -T--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -h--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011233467889999999999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=353.72 Aligned_cols=245 Identities=16% Similarity=0.142 Sum_probs=209.0
Q ss_pred CCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
....|++.+.||+|+||.||++.+.+ ++.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34678999999999999999999754 8899999997643222 4678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+++++|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 119 v~e~~~~~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999999987 3467999999999999999999999999 999999999999999999999999999865432
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||............... ....+...++++.
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 269 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EYSIPKHINPVAA 269 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCCCTTSCHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC------CCCCCccCCHHHH
Confidence 2356899999999999888999999999999999999999998765433322211111 1123445667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+||+.||++|||++++++
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999997
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=364.46 Aligned_cols=248 Identities=21% Similarity=0.297 Sum_probs=192.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccC-CCCcccceeeEeeCC--eeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLR-NNRLTNLLGCCCEGD--ERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~~l 133 (449)
.+|++++.||+|+||+||+|.+. +|+.||||++...... ..+.+.+|+.+++.+. ||||+++++++...+ ..|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 46889999999999999999964 5899999999654322 2456889999999997 999999999997654 6899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC--
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD-- 211 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~-- 211 (449)
||||++ ++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 v~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG-LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999998 699999853 57999999999999999999999999 99999999999999999999999999976432
Q ss_pred -----------------------CCccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc
Q 013126 212 -----------------------GKSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN 267 (449)
Q Consensus 212 -----------------------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 267 (449)
.....||+.|+|||++.+ ..++.++||||+||++|||++|++||.+..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 123468999999999987 56899999999999999999999999765433222211
Q ss_pred cccccccc-----------------------------cC------------CCCCchhHHHHHHHHHHhcccCCCCCCCH
Q 013126 268 LQMLTDSC-----------------------------LE------------GQFTDDDGTELVRLASRCLQYEPRERPNP 306 (449)
Q Consensus 268 ~~~~~~~~-----------------------------~~------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (449)
......+. .. .......++++.+|+.+||+.||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 11000000 00 00112456789999999999999999999
Q ss_pred HHHHHH
Q 013126 307 KSLVTA 312 (449)
Q Consensus 307 ~eil~~ 312 (449)
++++++
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=352.78 Aligned_cols=254 Identities=17% Similarity=0.252 Sum_probs=201.2
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc--CCCCcccceeeEeeC----CeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL--RNNRLTNLLGCCCEG----DERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~~~~~~~----~~~~l 133 (449)
++|++++.||+|+||.||+|++. ++.||||++... ....+.+|.+++..+ +||||+++++++... +..++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 36889999999999999999974 899999998643 245566677776665 899999999999887 78999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccccccccCceeeCCCCCeEEeccCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK--------GRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
||||+++|+|.+++. ...+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 113 v~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 113 ITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EECCCTTCBHHHHHH---HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC-EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeccCCCcHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC-EEecccchHHEEECCCCCEEEEeCCC
Confidence 999999999999995 34799999999999999999999998 8 99999999999999999999999999
Q ss_pred cccCCCCC--------ccccCccccccccccCCCCCCC------CceeeHhHHHHHHhcC----------CCCCCch---
Q 013126 206 MKNSRDGK--------SYSTNLAFTPPEYLRTGRVTPE------SVIYSFGTLLLDLLSG----------KHIPPSH--- 258 (449)
Q Consensus 206 a~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvil~elltg----------~~p~~~~--- 258 (449)
++...... ...||+.|+|||++.+...+.+ +||||||+++|||+|| +.|+...
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 97654332 3468999999999987766665 9999999999999999 5554321
Q ss_pred --hhHHHhhccccccccccc-CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 259 --ALDLIRDRNLQMLTDSCL-EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 259 --~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
...............+.. .......+++++.+++.+||+.||++|||+.++++.|+.+....+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 111111111111111111 011123678889999999999999999999999999998876543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=353.68 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=210.4
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
+.|++.+.||+|+||.||+|.+. +++.||+|.++..... ....+.+|+++++.++||||+++++++.+++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 46888999999999999999854 3688999999754322 2456899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccC
Q 013126 133 LVAEYMPNETLAKHLFHWE--------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFG 204 (449)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-CccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999999997422 246789999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccC
Q 013126 205 LMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 205 la~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
+++..... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..|+.................
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 258 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL----- 258 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-----
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-----
Confidence 98754332 22345788999999998889999999999999999999 7788766544333322221111
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
...+...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 12345667889999999999999999999999999987644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=356.97 Aligned_cols=240 Identities=18% Similarity=0.234 Sum_probs=180.9
Q ss_pred cccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEeeCCCCCH
Q 013126 66 SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPNETL 143 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 143 (449)
+.||+|+||+||+|.+. +++.||||++... ....+.+|+.+++.++ ||||+++++++.+++..++||||++||+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67899999999999975 5899999999653 3567889999999997 99999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC---CeEEeccCCcccCCCC----Cccc
Q 013126 144 AKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG---NPRLSTFGLMKNSRDG----KSYS 216 (449)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~---~~kL~DFGla~~~~~~----~~~~ 216 (449)
.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++..... ....
T Consensus 94 ~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 94 FERIK--KKKHFSETEASYIMRKLVSAVSHMHDVG-VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp HHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 99997 4568999999999999999999999999 99999999999998665 7999999999865443 2446
Q ss_pred cCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh---ccccccccccc--CCCCCchhHHHHHHH
Q 013126 217 TNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD---RNLQMLTDSCL--EGQFTDDDGTELVRL 291 (449)
Q Consensus 217 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~l~~l 291 (449)
+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .....+..... ........++++.++
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence 7899999999998899999999999999999999999987542211000 00011111100 001112457889999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+.+||+.||++|||++++++
T Consensus 251 i~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 251 IQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHCCCChhHCCCHHHHhc
Confidence 99999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=359.06 Aligned_cols=244 Identities=19% Similarity=0.245 Sum_probs=201.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+.|++++.||+|+||+||+|... +|+.||+|+++.... ...+|++++.++ +||||+++++++.+++..|+||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 45899999999999999999965 589999999976542 245788888888 799999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC----CCeEEeccCCcccCCCC-
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED----GNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~----~~~kL~DFGla~~~~~~- 212 (449)
++||+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++.....
T Consensus 98 ~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~g-ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 98 MKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999997 5567999999999999999999999999 9999999999998533 34999999999865433
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch---hhHHHhhcccccccccccCCCCCchhHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH---ALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
....+|+.|+|||++.+..++.++||||||+++|+|++|..||... ....+......... ......+...++
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~ 252 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF--SLSGGYWNSVSD 252 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC--CCCSTTTTTSCH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc--ccCccccccCCH
Confidence 2456799999999998888999999999999999999999998642 12222211111111 111223456778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
++.+++.+||+.||++|||+.+++++
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=358.42 Aligned_cols=255 Identities=18% Similarity=0.162 Sum_probs=199.7
Q ss_pred cccccccccCCccceEEEEEEEc----CCCEEEEEEecCCCCC-----------CHHHHHHHHHHHhccCCCCcccceee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWP-----------DPRQFLEEARSVGQLRNNRLTNLLGC 124 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~l~~~ 124 (449)
++|++++.||+|+||+||+|.+. ++..+|+|++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56899999999999999999964 5788999999765321 12346788899999999999999999
Q ss_pred Eee----CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC--Ce
Q 013126 125 CCE----GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG--NP 198 (449)
Q Consensus 125 ~~~----~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~--~~ 198 (449)
+.. ....++||||+ |++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHENE-YVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCcCHHHEEEccCCCCcE
Confidence 988 67899999999 9999999974 348999999999999999999999999 99999999999999877 99
Q ss_pred EEeccCCcccCCCC-----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-----
Q 013126 199 RLSTFGLMKNSRDG-----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL----- 262 (449)
Q Consensus 199 kL~DFGla~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~----- 262 (449)
||+|||+++..... ....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999999765322 23468999999999998889999999999999999999999985421111
Q ss_pred HhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 263 IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
......................++++.+++.+||+.||++|||++++++.|+.+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111100000112566789999999999999999999999999988654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=355.43 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=196.7
Q ss_pred CCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
..+++|++++.||+|+||+||+|.+. +++.||||+++...... .+.+.+|++++++++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44678999999999999999999964 58999999997644322 4568899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-----CCCCeEEeccCCccc
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-----EDGNPRLSTFGLMKN 208 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-----~~~~~kL~DFGla~~ 208 (449)
||||++ |+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++.
T Consensus 111 v~e~~~-~~L~~~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSRR-CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEECCS-EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEecCC-CCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999998 69999997 4567999999999999999999999999 99999999999994 455699999999976
Q ss_pred CCCC----CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccc--------
Q 013126 209 SRDG----KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC-------- 275 (449)
Q Consensus 209 ~~~~----~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 275 (449)
.... ....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||..................+.
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 5432 3345799999999998754 89999999999999999999999876543322211111100000
Q ss_pred ----cCCC------------CCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 276 ----LEGQ------------FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 276 ----~~~~------------~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .....++++.+++.+||+.||++|||++++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 01124678999999999999999999999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=356.67 Aligned_cols=248 Identities=19% Similarity=0.179 Sum_probs=201.4
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-----CCCcccceeeEeeCCeeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-----NNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~~~~~~~~~~~lV 134 (449)
.|+++++||+|+||+||+|++. +++.||||+++... ...+.+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv 114 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence 5788899999999999999964 58999999997422 22456788999999996 99999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC--------------------
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-------------------- 194 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-------------------- 194 (449)
|||+ +++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS-LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCcccEEEccccccccccchhccccccccc
Confidence 9999 899999998655567999999999999999999999999 999999999999975
Q ss_pred -----CCCeEEeccCCcccCCCC-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc
Q 013126 195 -----DGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268 (449)
Q Consensus 195 -----~~~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 268 (449)
++.+||+|||+++..... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 272 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 789999999999865543 45678999999999999999999999999999999999999986543222111000
Q ss_pred c---ccc-----------------ccccCCCCC--------------------chhHHHHHHHHHHhcccCCCCCCCHHH
Q 013126 269 Q---MLT-----------------DSCLEGQFT--------------------DDDGTELVRLASRCLQYEPRERPNPKS 308 (449)
Q Consensus 269 ~---~~~-----------------~~~~~~~~~--------------------~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (449)
. ..+ ........+ ...++.+.+++.+||+.||++|||+++
T Consensus 273 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~e 352 (360)
T 3llt_A 273 SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352 (360)
T ss_dssp HHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHH
Confidence 0 000 000000000 001267889999999999999999999
Q ss_pred HHH
Q 013126 309 LVT 311 (449)
Q Consensus 309 il~ 311 (449)
+++
T Consensus 353 lL~ 355 (360)
T 3llt_A 353 LLK 355 (360)
T ss_dssp HTT
T ss_pred Hhc
Confidence 987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=344.82 Aligned_cols=245 Identities=16% Similarity=0.141 Sum_probs=209.0
Q ss_pred CcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
...|++.+.||+|+||.||+|.+.+ ++.||+|++....... .+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4578899999999999999999754 8899999997643222 45788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||+++++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999999999887 3467999999999999999999999999 999999999999999999999999999865432
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....+|+.|+|||++.+..++.++||||||+++|+|++|+.||............... ....+...++.+.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 244 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EYSIPKHINPVAAS 244 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------CCCCCTTSCHHHHH
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc------cCCCccccCHHHHH
Confidence 2356899999999999888999999999999999999999998765443322211111 11234456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~~ 312 (449)
++.+||+.||++|||++++++.
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHcccChhhCcCHHHHhhC
Confidence 9999999999999999999973
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.15 Aligned_cols=252 Identities=18% Similarity=0.294 Sum_probs=203.0
Q ss_pred CCCcccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
..+++|++++.||+|+||+||+|++.. |+.||+|++....... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 356789999999999999999999754 8999999987654332 3568899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+++++|.+++. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 102 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHCC-EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999999988876 5567999999999999999999999999 999999999999999999999999999765432
Q ss_pred ---CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc--------------------
Q 013126 213 ---KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL-------------------- 268 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~-------------------- 268 (449)
....+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.............
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 345689999999999875 68999999999999999999999987653222111100
Q ss_pred ccccccccC-----CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 QMLTDSCLE-----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 ~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.....+... ....+..++++.+++.+||+.||++|||++++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 0011245788999999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=344.10 Aligned_cols=246 Identities=16% Similarity=0.201 Sum_probs=204.9
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC------CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.|++++.||+|+||+||+|... +++.||+|.++..... ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 5889999999999999999976 5899999999754322 35789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC----CeEEeccCCcccC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~----~~kL~DFGla~~~ 209 (449)
||||+++++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++ .+||+|||++...
T Consensus 86 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLA--EKESLTEDEATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999997 3467999999999999999999999999 99999999999999877 7999999999876
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.................. .........++
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 240 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD--FDEEYFSNTSE 240 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCHHHHTTCCH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC--CcchhcccCCH
Confidence 543 2346899999999999888999999999999999999999998765443332221111100 00011234567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHh
Confidence 8999999999999999999999997
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=350.01 Aligned_cols=257 Identities=18% Similarity=0.228 Sum_probs=206.2
Q ss_pred CcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEee----CCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~l 133 (449)
-..|++++.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35789999999999999999996 4699999999876544446779999999999999999999999873 347899
Q ss_pred EEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 134 VAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
||||+++++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-YAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999998743 3567999999999999999999999999 99999999999999999999999999876542
Q ss_pred C-------------CccccCccccccccccCCC---CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccc
Q 013126 212 G-------------KSYSTNLAFTPPEYLRTGR---VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC 275 (449)
Q Consensus 212 ~-------------~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 275 (449)
. ....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ..........
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~ 263 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVALAVQNQ 263 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHHHHHCC
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhHHhhcc
Confidence 1 1234689999999997654 7899999999999999999999885321100 0000000001
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.........++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 11122345678899999999999999999999999999887643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=346.82 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=208.6
Q ss_pred Cccccccc-ccCCccceEEEEEEEc---CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 59 FAVENIVS-EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 59 f~~~~~l~-~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
...|++.+ .||+|+||+||+|.+. +++.||||+++...... .+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35678887 8999999999999642 36889999997654333 46799999999999999999999999 667889
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+++++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 94 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHH--hCcCCCHHHHHHHHHHHHHHHHHHHhCC-eEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 9999999999999997 4567999999999999999999999999 999999999999999999999999999876543
Q ss_pred C-------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 213 K-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 213 ~-------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
. ...+++.|+|||++.+..++.++||||||+++|+|++ |+.||............... .....+...
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~ 245 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----ERMGCPAGC 245 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTC
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCC
Confidence 2 2235688999999988889999999999999999999 99988765443333222111 112334567
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 78999999999999999999999999999887654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=360.67 Aligned_cols=245 Identities=20% Similarity=0.285 Sum_probs=199.9
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccC--CCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~ 135 (449)
..|++++.||+|+||+||+|...+++.||||++...... ..+.+.+|+.++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999877999999999764432 2467899999999996 599999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
| +.+++|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHH--HCSSCCHHHHHHHHHHHHHHHHHHHTTT-CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 56799999997 4457899999999999999999999999 99999999999996 589999999999865433
Q ss_pred ---CccccCccccccccccC-----------CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCC
Q 013126 213 ---KSYSTNLAFTPPEYLRT-----------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (449)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+..+....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---~~~~~~~~~~~ 287 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAIIDPNHEI 287 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHCTTSCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH---HHHHhCccccC
Confidence 24568999999999865 35889999999999999999999998653211100 11111111222
Q ss_pred CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
..+...+.++.+++.+||+.||++|||+.+++++
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 3344456789999999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=359.34 Aligned_cols=256 Identities=15% Similarity=0.139 Sum_probs=207.0
Q ss_pred cccccccccCCccceEEEEEEEcC---------CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCccc----------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN---------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTN---------- 120 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~---------~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~---------- 120 (449)
..|++++.||+|+||+||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578999999999999999999653 789999999753 46889999999999999887
Q ss_pred -----ceeeEee-CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC
Q 013126 121 -----LLGCCCE-GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (449)
Q Consensus 121 -----l~~~~~~-~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~ 194 (449)
+++++.. ++..++||||+ +++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE-YVHGNVTAENIFVDP 194 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCCGGGEEEET
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCHHHEEEcC
Confidence 5677766 67899999999 899999998543578999999999999999999999999 999999999999999
Q ss_pred CC--CeEEeccCCcccCCCC-----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh--
Q 013126 195 DG--NPRLSTFGLMKNSRDG-----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-- 259 (449)
Q Consensus 195 ~~--~~kL~DFGla~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~-- 259 (449)
++ .+||+|||+++..... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999754322 23468999999999998899999999999999999999999987542
Q ss_pred hHHHhhccc--cccccccc-CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccCC
Q 013126 260 LDLIRDRNL--QMLTDSCL-EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322 (449)
Q Consensus 260 ~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 322 (449)
...+..... ........ ........++++.+++.+||+.||++|||++++++.|+.+......
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 111111110 00000000 0111124568899999999999999999999999999998766543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=359.99 Aligned_cols=251 Identities=19% Similarity=0.221 Sum_probs=205.7
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
-++|++++.||+|+||+||+|.+. +++.||+|+++...... .+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356899999999999999999975 58999999997653222 4678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeCCCCCeEEeccCCcccCC--CCC
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR--DGK 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~--~~~ 213 (449)
|++|++|.+++.. ...+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+|||++.... ...
T Consensus 112 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 112 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC-CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCC-EEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999999999973 45799999999999999999999996 8 9999999999999999999999999986532 223
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc-------------------------
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL------------------------- 268 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~------------------------- 268 (449)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 4578999999999999899999999999999999999999986543332211100
Q ss_pred -------------ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 269 -------------QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 269 -------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
................+.++.+++.+||+.||++|||+++++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000011111123457789999999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=371.48 Aligned_cols=246 Identities=16% Similarity=0.178 Sum_probs=203.1
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.|++++.||+|+||+||+|+.. +++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 5899999999999999999975 58999999997643 23357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---CCCeEEeccCCcccCCCC--
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~-- 212 (449)
++||+|.+.+. ....+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 118 ~~~g~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 118 YKGGELFDEII--HRMKFNEVDAAVIIKQVLSGVTYLHKHN-IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp CCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 99999999887 4467999999999999999999999999 999999999999975 455999999999875543
Q ss_pred -CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....||+.|+|||++. +.++.++||||+||++|+|++|..||.......+........... ........++++.++
T Consensus 195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--DSPEWKNVSEGAKDL 271 (494)
T ss_dssp BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CSGGGTTSCHHHHHH
T ss_pred ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CchhcccCCHHHHHH
Confidence 3456899999999986 569999999999999999999999998765544433322221111 111123567889999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~ 312 (449)
+.+||+.||++|||+.+++++
T Consensus 272 i~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHCCCChhhCccHHHHhcC
Confidence 999999999999999999963
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.25 Aligned_cols=252 Identities=22% Similarity=0.267 Sum_probs=206.1
Q ss_pred CcccccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.++|++.+.||+|+||+||+|.+.+ +..||+|.++..... ..+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578899999999999999998543 346999999765322 35679999999999999999999999865 56789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 90 IMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESIN-CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999999975 3456999999999999999999999999 999999999999999999999999999865443
Q ss_pred ----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
....+++.|+|||++.+..++.++||||||+++|+|++ |+.||............... .....+...++.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 242 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-----DRLPKPDLCPPV 242 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-----CCCCCCTTCCHH
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-----CCCCCCCCCCHH
Confidence 23446788999999988889999999999999999998 99988643322222111111 111224456788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999987654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=366.66 Aligned_cols=248 Identities=18% Similarity=0.220 Sum_probs=195.1
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeC-----Cee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 131 (449)
+.|++++.||+|+||+||+|.+. +++.||||+++..... ..+++.+|+++++.++||||+++++++... +..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 46889999999999999999965 4889999999764322 246789999999999999999999999876 568
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
|+||||++ ++|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHESG-IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999997 69999997 5577999999999999999999999999 99999999999999999999999999986543
Q ss_pred C--------------------------CccccCccccccccc-cCCCCCCCCceeeHhHHHHHHhcCCCCC---------
Q 013126 212 G--------------------------KSYSTNLAFTPPEYL-RTGRVTPESVIYSFGTLLLDLLSGKHIP--------- 255 (449)
Q Consensus 212 ~--------------------------~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltg~~p~--------- 255 (449)
. ....||+.|+|||++ .+..++.++||||+||++|||++|..|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2 345689999999986 4556999999999999999999854333
Q ss_pred --Cchh------------------hHHHh---------------h---cccccccccccC-CC-----CCchhHHHHHHH
Q 013126 256 --PSHA------------------LDLIR---------------D---RNLQMLTDSCLE-GQ-----FTDDDGTELVRL 291 (449)
Q Consensus 256 --~~~~------------------~~~~~---------------~---~~~~~~~~~~~~-~~-----~~~~~~~~l~~l 291 (449)
++.. .+.+. . ............ .. ..+..++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 2211 00000 0 000000000000 00 013467889999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 013126 292 ASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~ 311 (449)
+.+||+.||++|||++++++
T Consensus 342 l~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=349.14 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=201.6
Q ss_pred CcccccccccCCccceEEEEEEEc----CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCC---
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD--- 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 129 (449)
.+.|++.+.||+|+||+||+|... +++.||+|.++...... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 356889999999999999999854 24589999997654322 457899999999999999999999998765
Q ss_pred --eeEEEEeeCCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEecc
Q 013126 130 --ERLLVAEYMPNETLAKHLFHW----ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (449)
Q Consensus 130 --~~~lV~Ey~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DF 203 (449)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-FLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-CCCCCCSGGGEEECTTSCEEECSC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCcEEEeec
Confidence 359999999999999998531 3467999999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccccccccccc
Q 013126 204 GLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCL 276 (449)
Q Consensus 204 Gla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (449)
|+++..... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..|+................
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 266 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH----- 266 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-----
Confidence 999765432 23346788999999998889999999999999999999 777776543333222221111
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
....+...++++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1223456678899999999999999999999999999887654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=358.15 Aligned_cols=256 Identities=19% Similarity=0.267 Sum_probs=209.4
Q ss_pred CCcccccccccCCccceEEEEEEEcC-C-----CEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeCC
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN-Q-----RRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~-~-----~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 129 (449)
..+.|++.+.||+|+||+||+|.+.. + +.||+|.++..... ..+.+.+|+.+++.+ +||||+++++++.+++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34678899999999999999999643 3 47999999765422 246789999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWE------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN 197 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~ 197 (449)
..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-CIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGCEEEGGGE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-cccCCcccceEEECCCCe
Confidence 9999999999999999997532 346899999999999999999999999 999999999999999999
Q ss_pred eEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhccccc
Q 013126 198 PRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQM 270 (449)
Q Consensus 198 ~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 270 (449)
+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|+|+| |..|+...............
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 999999999754332 22345788999999998889999999999999999999 88887654222111111111
Q ss_pred ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 271 LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
......+...++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 283 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 283 ----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 11112234456789999999999999999999999999987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=352.33 Aligned_cols=249 Identities=15% Similarity=0.157 Sum_probs=205.8
Q ss_pred ccccc-cccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEE
Q 013126 61 VENIV-SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 61 ~~~~l-~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.|.+. +.||+|+||+||+|... +++.||+|+++.... .....+.+|+.+++.++ ||||+++++++.+.+..++||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 35666 78999999999999965 489999999976432 23578999999999994 699999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---CCCeEEeccCCcccCCCC
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~ 212 (449)
||++||+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g-ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN-IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999999999987545578999999999999999999999999 999999999999997 789999999999876543
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||.................. .........++.+.
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD--YSEETFSSVSQLAT 265 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTTTTTSCHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc--cCchhhcccCHHHH
Confidence 3456899999999999899999999999999999999999998765444332222111111 11222345678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+++.+||+.||++|||+++++++
T Consensus 266 ~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcCCChhhCcCHHHHhCC
Confidence 99999999999999999999873
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=370.89 Aligned_cols=248 Identities=16% Similarity=0.213 Sum_probs=194.7
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeC------C
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------D 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 129 (449)
..+|++++.||+|+||+||+|.+. +++.||||++..... ...+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 356889999999999999999965 589999999975422 2256788999999999999999999999755 3
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
.+|+||||++ ++|.+.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~-~~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~-iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCS-EEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCC-CCHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 5799999998 45777764 24899999999999999999999999 999999999999999999999999999876
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc------------
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS------------ 274 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------------ 274 (449)
... ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+................+
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 543 34678999999999999999999999999999999999999997653322111111100000
Q ss_pred ------cc--C-----CCCC-----------chhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 275 ------CL--E-----GQFT-----------DDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 275 ------~~--~-----~~~~-----------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.. . ..++ ...++++.+|+.+||+.||++|||+++++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 0000 0126789999999999999999999999983
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=353.47 Aligned_cols=252 Identities=19% Similarity=0.216 Sum_probs=198.4
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-----HHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-----PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
....|++++.||+|+||.||+|.+. +|+.||+|+++...... .+.+.+|+++++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3467889999999999999999964 58999999997533211 34688999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||++ ++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFME-TDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCS-EEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCC-CCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCC-EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999998 489988864 3457899999999999999999999999 99999999999999999999999999986543
Q ss_pred C----CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccc-----------
Q 013126 212 G----KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC----------- 275 (449)
Q Consensus 212 ~----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 275 (449)
. ....+|+.|+|||++.+. .++.++||||||+++|+|++|.+|+..................+.
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2 245689999999999764 489999999999999999999988876543322221111100000
Q ss_pred ---cCCC--------CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 276 ---LEGQ--------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 276 ---~~~~--------~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.... .....+.++.+++.+||+.||++|||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 013456789999999999999999999999983
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=344.69 Aligned_cols=243 Identities=18% Similarity=0.268 Sum_probs=208.2
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.|++++.||+|+||.||+|... +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 4788999999999999999964 589999999976543 34678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
+|++|.+++. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 103 ~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 103 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp TTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9999999994 567999999999999999999999999 999999999999999999999999999765443 24
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..+|+.|+|||++.+..++.++||||||+++|+|++|+.|+............... .....+...+..+.+++.+
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-----NPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----CCCCCCSSCCHHHHHHHHH
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-----CCCCCccccCHHHHHHHHH
Confidence 56889999999999888999999999999999999999998654333222111111 1123345667889999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~ 312 (449)
||+.||++|||+.++++.
T Consensus 254 ~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HCCSSGGGSCCHHHHTTC
T ss_pred HcCCChhhCcCHHHHhhC
Confidence 999999999999999984
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=350.55 Aligned_cols=251 Identities=18% Similarity=0.230 Sum_probs=200.3
Q ss_pred CCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEee-------
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE------- 127 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------- 127 (449)
..++|++++.||+|+||+||+|+. .+|+.||+|++...... ....+.+|+++++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 356799999999999999999997 46899999998654322 25678899999999999999999999987
Q ss_pred -CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 128 -GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 128 -~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
.+..++||||++ ++|.+.+.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccC-CCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 346899999998 578777764 3467999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCC--------CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc---c
Q 013126 207 KNSRDG--------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD---S 274 (449)
Q Consensus 207 ~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~ 274 (449)
+..... ....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.................. .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 765421 234578999999999764 5899999999999999999999998765433222111110000 0
Q ss_pred ccCC--------------CCCc---------hhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 CLEG--------------QFTD---------DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 ~~~~--------------~~~~---------~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .... ..++++.+++.+||+.||++|||++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 0000 01467899999999999999999999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=347.84 Aligned_cols=247 Identities=18% Similarity=0.215 Sum_probs=202.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
..|++++.||+|+||+||+|.+. +++.||+|++........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 46889999999999999999975 48999999998766666789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC----CCCc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR----DGKS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~----~~~~ 214 (449)
++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.... ....
T Consensus 99 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 99 PGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSKR-IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp TTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred CCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 99999998864 3467999999999999999999999999 9999999999999999999999999875321 2234
Q ss_pred cccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 215 YSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 215 ~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
..||+.|+|||++. +..++.++||||||+++|+|++|+.|+................. .....+...+.++.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---PTLLTPSKWSVEFR 253 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCSSGGGSCHHHH
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC---cccCCccccCHHHH
Confidence 56899999999983 56689999999999999999999999876433322221111111 11122345678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+||+.||++|||+.++++
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHcccChhhCCCHHHHhc
Confidence 9999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.53 Aligned_cols=258 Identities=19% Similarity=0.297 Sum_probs=210.1
Q ss_pred CcccccccccCCccceEEEEEEE-----cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCC--ee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-----ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD--ER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-----~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~ 131 (449)
-..|++++.||+|+||.||+|++ .+++.||+|+++.......+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999984 358899999998765444678999999999999999999999987654 78
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-EeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999975 3456999999999999999999999999 99999999999999999999999999987654
Q ss_pred CC-------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhh---c--------ccccccc
Q 013126 212 GK-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRD---R--------NLQMLTD 273 (449)
Q Consensus 212 ~~-------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~---~--------~~~~~~~ 273 (449)
.. ...++..|+|||++.+..++.++||||||+++|+|+||..|+.......... . .......
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 32 2345678999999998889999999999999999999998765432111110 0 0001111
Q ss_pred cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
.......+..+++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111122345677899999999999999999999999999988754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=359.31 Aligned_cols=255 Identities=24% Similarity=0.301 Sum_probs=198.6
Q ss_pred cccccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEee-CCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~l 133 (449)
..|++.+.||+|+||+||+|.+.+ +..||+|.++..... ..+++.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457788899999999999999532 246899998754322 25679999999999999999999998754 567899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC-EecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999974 4456899999999999999999999999 999999999999999999999999999754332
Q ss_pred -------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 213 -------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 213 -------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
....+|+.|+|||++.+..++.++||||||+++|||+| |.+|+............... .....+..+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-----~~~~~p~~~ 321 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-----RRLLQPEYC 321 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT-----CCCCCCTTC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC-----CCCCCCCCC
Confidence 22345778999999998899999999999999999999 45555433221111111111 111224456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 7889999999999999999999999999998876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=383.48 Aligned_cols=245 Identities=19% Similarity=0.249 Sum_probs=211.7
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
..++|++++.||+|+||.||+|+.. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4677999999999999999999965 4889999999753 223457788999999998 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC-
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD- 211 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~- 211 (449)
+||||++||+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g-IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTS-EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999974 467999999999999999999999999 99999999999999999999999999986332
Q ss_pred ---CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 212 ---GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 212 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.......+........ ..++...++++
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~ 569 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------VAYPKSMSKEA 569 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC------CCCCTTSCHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC------CCCCccCCHHH
Confidence 234678999999999999999999999999999999999999998776555544433321 23456778899
Q ss_pred HHHHHHhcccCCCCCCCH-----HHHHH
Q 013126 289 VRLASRCLQYEPRERPNP-----KSLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps~-----~eil~ 311 (449)
.+||.+||++||++||++ +++++
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 999999999999999997 67765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=341.14 Aligned_cols=246 Identities=19% Similarity=0.184 Sum_probs=204.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|++++.||+|+||.||+|... +++.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46889999999999999999975 5899999999754332 357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----- 212 (449)
+++++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999986 4567999999999999999999999999 999999999999999999999999998754321
Q ss_pred -CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.............. ............++.+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---EKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH---TTCTTSTTGGGSCHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh---hcccccCchhhcCHHHHH
Confidence 34568999999999987775 7799999999999999999999865422111000000 000011112356788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||+.||++|||++++++
T Consensus 241 li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHCCCCchhCCCHHHHhc
Confidence 999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=373.50 Aligned_cols=248 Identities=18% Similarity=0.251 Sum_probs=209.7
Q ss_pred CCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
-..+.|++++.||+|+||.||+|+.. +|+.||+|++++.. ....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45577889999999999999999975 59999999996532 234577899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 133 LVAEYMPNETLAKHLFHWE--THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
+||||++||+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC-CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999997432 457999999999999999999999999 9999999999999999999999999998765
Q ss_pred CC----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh----HHHhhcccccccccccCCCCCc
Q 013126 211 DG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 211 ~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...... . ...++.
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~----~--~~~~p~ 414 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE----Q--AVTYPD 414 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH----C--CCCCCT
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh----c--ccCCCc
Confidence 43 234789999999999998999999999999999999999999976421 122221111 1 123456
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 013126 283 DDGTELVRLASRCLQYEPRERPNP-----KSLVT 311 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~-----~eil~ 311 (449)
..++++.+++.+||+.||++||++ +++++
T Consensus 415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 678899999999999999999965 66765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=351.77 Aligned_cols=257 Identities=22% Similarity=0.289 Sum_probs=209.0
Q ss_pred CCcccccccccCCccceEEEEEEE------cCCCEEEEEEecCCCCCC-HHHHHHHHHHHhcc-CCCCcccceeeEeeCC
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~------~~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 129 (449)
..++|++.+.||+|+||+||+|.+ .+++.||||+++...... .+.+.+|+++++++ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 346788999999999999999984 246899999997654322 45789999999999 7899999999988755
Q ss_pred -eeEEEEeeCCCCCHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC
Q 013126 130 -ERLLVAEYMPNETLAKHLFHWET--------------HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (449)
Q Consensus 130 -~~~lV~Ey~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~ 194 (449)
..++||||++|++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSE 183 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-cccccCccceEEECC
Confidence 58999999999999999975321 12889999999999999999999999 999999999999999
Q ss_pred CCCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcc
Q 013126 195 DGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRN 267 (449)
Q Consensus 195 ~~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 267 (449)
++.+||+|||+++...... ...+|+.|+|||++.+..++.++||||||+++|+|+| |..|+............
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 9999999999998654332 2346789999999998899999999999999999998 88888654321111111
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
... ......+...++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 264 ~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 264 LKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcc----CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 110 011123445678899999999999999999999999999887654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=344.06 Aligned_cols=255 Identities=17% Similarity=0.219 Sum_probs=208.9
Q ss_pred CCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEee--CCee
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCE--GDER 131 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 131 (449)
...++|++++.||+|+||+||+|... +++.||+|.+....... .+.+.+|++++++++||||+++++++.. ++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34568999999999999999999975 58999999997654322 4578999999999999999999998854 5689
Q ss_pred EEEEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----ccccccccCceeeCCCCCeEEeccCC
Q 013126 132 LLVAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGR----ALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~----iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
++||||++|++|.+++... ....+++..++.++.|++.||+|||+++. ++||||||+||++++++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999743 24569999999999999999999999763 99999999999999999999999999
Q ss_pred cccCCCCC----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCC
Q 013126 206 MKNSRDGK----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 206 a~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
++...... ...+|+.|+|||++.+..++.++||||||+++|+|++|+.|+................ ....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-----~~~~~ 237 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-----FRRIP 237 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----CCCCC
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-----cccCC
Confidence 98765442 3468899999999998889999999999999999999999987654433332221111 11234
Q ss_pred chhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 282 DDDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
...++++.+++.+||+.||++|||+.++++.+...
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 46678899999999999999999999999965443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=377.74 Aligned_cols=250 Identities=20% Similarity=0.255 Sum_probs=206.8
Q ss_pred cccc-ccCCccceEEEEEEEc---CCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 63 NIVS-EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 63 ~~l~-~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.+.+ +||+|+||.||+|.+. ++..||||+++.... ...+++.+|++++++++||||+++++++.. +..++||||
T Consensus 338 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~ 416 (613)
T 2ozo_A 338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 416 (613)
T ss_dssp EEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred eEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEe
Confidence 3444 7899999999999864 466799999987543 346889999999999999999999999976 568999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
++||+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 417 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 417 AGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN-FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp CTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred CCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999999999964 3567999999999999999999999999 9999999999999999999999999998754332
Q ss_pred ---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 214 ---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||.......+....... .....+..+++++.
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-----~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECPPECPPELY 569 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-----CCCCCCTTCCHHHH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCcCCHHHH
Confidence 1234578999999998899999999999999999998 99998765443333222111 11234556788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 290 RLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
+++.+||+.||++||++.++++.|+.+....
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999998876543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.40 Aligned_cols=246 Identities=19% Similarity=0.183 Sum_probs=202.8
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC----CCCHHHHHHHHHHHhccCCCCcccceeeEe--eCCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA----WPDPRQFLEEARSVGQLRNNRLTNLLGCCC--EGDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~ 131 (449)
...|++++.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 357889999999999999999964 58999999997532 233577999999999999999999999984 45678
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||++++ |.+++.......+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG-IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999865 778777655678999999999999999999999999 99999999999999999999999999986543
Q ss_pred C------CccccCccccccccccCCC--CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCch
Q 013126 212 G------KSYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 212 ~------~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (449)
. ....+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||............... ....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------~~~~~~~ 235 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------SYAIPGD 235 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------CCCCCSS
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC------CCCCCCc
Confidence 2 2345899999999997644 477999999999999999999999765444333222111 1123456
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.++.+.+++.+||+.||++|||+++++++
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 67889999999999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=339.92 Aligned_cols=245 Identities=19% Similarity=0.253 Sum_probs=202.0
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
...|++.+.||+|+||.||+|.+. +|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 457889999999999999999975 5899999999643 223456899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHC-SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999999999974 457899999999999999999999999 999999999999999999999999999876543
Q ss_pred -CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....+|+.|+|||++.+..+ +.++||||||+++|+|++|+.||................ ...+...+.++.+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV------FYIPEYLNRSVAT 240 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTSCHHHHH
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------ccCchhcCHHHHH
Confidence 23467899999999987765 689999999999999999999987654443332221111 1234456678999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~~ 312 (449)
++.+||+.||++|||+.+++++
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999983
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.21 Aligned_cols=249 Identities=17% Similarity=0.224 Sum_probs=202.6
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++++.....||+|+||.||+|.+. +++.||+|.++.......+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 344455557799999999999964 5889999999876655577899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-CCCeEEeccCCcccCCCC---
Q 013126 138 MPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~--- 212 (449)
+++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||+++. ++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC-EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 99999999997532 235678899999999999999999999 999999999999987 899999999999865432
Q ss_pred -CccccCccccccccccCCC--CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||............. .........+...++++.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---GMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---HHHCCCCCCCTTSCHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---ccccccccccccCCHHHH
Confidence 3456899999999997654 7899999999999999999999986432111110000 000111234556778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+||+.||++|||+.++++
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.30 Aligned_cols=259 Identities=14% Similarity=0.156 Sum_probs=209.2
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCC--eeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGD--ERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 135 (449)
..|++.+.||+|+||+||+|.+.. |+.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 468999999999999999999754 8999999997543 234678899999999999999999999998765 789999
Q ss_pred eeCCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee----CCCCCeEEeccCCcccCC
Q 013126 136 EYMPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl----~~~~~~kL~DFGla~~~~ 210 (449)
||++||+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC-EEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999999997532 234999999999999999999999999 9999999999999 777889999999998765
Q ss_pred CCC---ccccCccccccccccC--------CCCCCCCceeeHhHHHHHHhcCCCCCCchh----hHHHhhccccccc---
Q 013126 211 DGK---SYSTNLAFTPPEYLRT--------GRVTPESVIYSFGTLLLDLLSGKHIPPSHA----LDLIRDRNLQMLT--- 272 (449)
Q Consensus 211 ~~~---~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvil~elltg~~p~~~~~----~~~~~~~~~~~~~--- 272 (449)
... ...||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ............+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 442 4568999999999865 457889999999999999999999885321 1111111111000
Q ss_pred ----------------ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 273 ----------------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 273 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
............+..+.+++.+||+.||++|||++++++.++.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00011223456788999999999999999999999999988776543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.99 Aligned_cols=251 Identities=19% Similarity=0.248 Sum_probs=205.0
Q ss_pred CCcccccccccCCccceEEEEEEE----cCCCEEEEEEecCCC----CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeC
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKL----ENQRRIAVKRFNRMA----WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEG 128 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~----~~~~~vAiK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 128 (449)
+...|++++.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++++.+ +||||+++++++..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 346799999999999999999997 368999999997532 22356678899999999 699999999999999
Q ss_pred CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999974 457999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCC-----CccccCccccccccccCC--CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCC
Q 013126 209 SRDG-----KSYSTNLAFTPPEYLRTG--RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT 281 (449)
Q Consensus 209 ~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (449)
.... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||................... ....+
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYP 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--CCCCC
Confidence 5432 234689999999999863 47899999999999999999999986432111100011111111 12345
Q ss_pred chhHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 013126 282 DDDGTELVRLASRCLQYEPRERP-----NPKSLVTAL 313 (449)
Q Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~~L 313 (449)
...+..+.+++.+||+.||++|| ++++++++.
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 56778899999999999999999 999999854
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=351.09 Aligned_cols=256 Identities=20% Similarity=0.249 Sum_probs=198.0
Q ss_pred CCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHH--HhccCCCCcccceeeEee-----CC
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARS--VGQLRNNRLTNLLGCCCE-----GD 129 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~-----~~ 129 (449)
-+.++|++++.||+|+||+||+|+. +++.||||+++.. ....+..|.++ ++.++||||+++++.+.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 4567899999999999999999987 6899999999643 24455555555 445899999999986543 23
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccccccccCceeeCCCCCeEE
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK---------GRALYHDLNAYRILFDEDGNPRL 200 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~~iiHrDlkp~NILl~~~~~~kL 200 (449)
..++||||+++|+|.+++.. ...++..+..++.||+.||+|||++ + |+||||||+|||+++++.+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~-ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA-ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC-EECSSCSGGGEEECTTSCEEE
T ss_pred eEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccc-eeecccccceEEEcCCCcEEE
Confidence 57899999999999999953 4558999999999999999999999 8 999999999999999999999
Q ss_pred eccCCcccCCCC------------CccccCccccccccccC-------CCCCCCCceeeHhHHHHHHhcCCCCCCchhh-
Q 013126 201 STFGLMKNSRDG------------KSYSTNLAFTPPEYLRT-------GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL- 260 (449)
Q Consensus 201 ~DFGla~~~~~~------------~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~elltg~~p~~~~~~- 260 (449)
+|||+++..... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 999999765422 13458999999999986 3567899999999999999999766532210
Q ss_pred H-----------------HHhhcccccccccccCCC--CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 261 D-----------------LIRDRNLQMLTDSCLEGQ--FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 261 ~-----------------~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
. ............+..... .....++++.+++.+||+.||++|||++++++.|+.+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 0 000000000001111111 12346778999999999999999999999999998876544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=350.08 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=207.9
Q ss_pred cccccccccCCccceEEEEEEE------cCCCEEEEEEecCCCC-CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL------ENQRRIAVKRFNRMAW-PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~------~~~~~vAiK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 132 (449)
..|++++.||+|+||+||+|++ .+++.||||.+..... ....++.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 5688999999999999999983 2477899999975432 22457899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---CCCeEEeccC
Q 013126 133 LVAEYMPNETLAKHLFHWET-----HPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFG 204 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~~~~kL~DFG 204 (449)
+||||++|++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++. +..+||+|||
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-eecCcCCHhHEEEecCCCcceEEECccc
Confidence 99999999999999975332 45899999999999999999999999 999999999999994 4569999999
Q ss_pred CcccCCC------CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccC
Q 013126 205 LMKNSRD------GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 205 la~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
+++.... .....+|+.|+|||++.+..++.++||||||+++|+|+| |..|+................ .
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----~ 263 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-----R 263 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-----C
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-----C
Confidence 9874322 223457889999999988889999999999999999998 888887654433332221111 1
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
...+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1234456788999999999999999999999999998876543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.52 Aligned_cols=246 Identities=16% Similarity=0.199 Sum_probs=202.6
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.+.|++++.||+|+||.||+|.+. +|+.||+|.++... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 356889999999999999999975 48999999997643 457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .
T Consensus 106 ~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 106 CGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMR-KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp CTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBC
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccC
Confidence 999999999864 3567999999999999999999999999 999999999999999999999999999765433 2
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...+|+.|+|||++.+..++.++||||||+++|+|++|+.||............... .......+...+..+.+++.
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN---PPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSSGGGSCHHHHHHHH
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC---CCcccCCcccCCHHHHHHHH
Confidence 456889999999999888999999999999999999999998654322211111000 00111123445788999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
+||+.||++|||+.++++
T Consensus 261 ~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHTCSCTTTSCCHHHHTT
T ss_pred HHccCChhhCcCHHHHHh
Confidence 999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=342.38 Aligned_cols=253 Identities=15% Similarity=0.165 Sum_probs=206.7
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeE-eeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC-CEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~Ey 137 (449)
++|++++.||+|+||+||+|++ .+++.||+|++.... ..+.+.+|+.+++.++|++++..++.+ ..++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4688899999999999999996 469999999987644 235789999999999998876666555 566788999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC---CCCCeEEeccCCcccCCCC--
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~-- 212 (449)
+ +++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++ +++.+||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9 8999999964 3567999999999999999999999999 99999999999994 8899999999999865432
Q ss_pred ---------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh-------HHHhhccccccccccc
Q 013126 213 ---------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-------DLIRDRNLQMLTDSCL 276 (449)
Q Consensus 213 ---------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~ 276 (449)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..+........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 238 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----- 238 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-----
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-----
Confidence 344689999999999998999999999999999999999999865211 11111111100
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccCC
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETEV 322 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 322 (449)
........++++.+++.+||+.||++|||++++++.|+.+......
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0011234567899999999999999999999999999988766543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=364.33 Aligned_cols=242 Identities=15% Similarity=0.195 Sum_probs=192.0
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--------CCHHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--------PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
+.|++++.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++. .+.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 45888999999999999999965 489999999965321 11235889999999999999999999975 456
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC---CCeEEeccCCcc
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMK 207 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla~ 207 (449)
.++||||+++|+|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 214 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 899999999999999887 5678999999999999999999999999 9999999999999754 459999999998
Q ss_pred cCCCC---CccccCccccccccccC---CCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-----HHhhccccccccccc
Q 013126 208 NSRDG---KSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-----LIRDRNLQMLTDSCL 276 (449)
Q Consensus 208 ~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~ 276 (449)
..... ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .+........
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~----- 365 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI----- 365 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC-----
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC-----
Confidence 76543 34568999999999864 56888999999999999999999998653211 1111111000
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.......++.+.+++.+||+.||++|||++++++
T Consensus 366 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 366 -PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0111245678999999999999999999999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=365.05 Aligned_cols=239 Identities=15% Similarity=0.121 Sum_probs=191.1
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC---CCCHHHHHHHH---HHHhccCCCCcccce-------eeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA---WPDPRQFLEEA---RSVGQLRNNRLTNLL-------GCC 125 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~---~~~~~~~~~E~---~~l~~l~HpnIv~l~-------~~~ 125 (449)
+.|++.+.||+|+||+||+|++ .+|+.||||+++... ....+.+.+|+ +++++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 6688999999999999999995 569999999997532 22357799999 555666899999998 665
Q ss_pred eeCC-----------------eeEEEEeeCCCCCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q 013126 126 CEGD-----------------ERLLVAEYMPNETLAKHLFHWET-----HPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183 (449)
Q Consensus 126 ~~~~-----------------~~~lV~Ey~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHr 183 (449)
.+++ ..++||||+ +|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHr 230 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-LVHT 230 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-EECS
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-eecC
Confidence 5543 278999999 5899999974311 12335888899999999999999999 9999
Q ss_pred ccccCceeeCCCCCeEEeccCCcccCCCC-CccccCccccccccccCC-----------CCCCCCceeeHhHHHHHHhcC
Q 013126 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTG-----------RVTPESVIYSFGTLLLDLLSG 251 (449)
Q Consensus 184 Dlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvil~elltg 251 (449)
||||+|||++.++.+||+|||+++..... ....| +.|+|||++.+. .++.++||||||+++|||++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 99999999999999999999999875543 23456 999999999887 799999999999999999999
Q ss_pred CCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 252 KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 252 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.||......... ..+.. .....++++.+++.+||+.||++|||+.++++
T Consensus 310 ~~Pf~~~~~~~~~----~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 310 DLPITKDAALGGS----EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp SCCC------CCS----GGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred CCCCcccccccch----hhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9998654322111 11111 12456678999999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=339.77 Aligned_cols=246 Identities=19% Similarity=0.235 Sum_probs=200.9
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEee----CCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~ 131 (449)
-..|++.+.||+|+||+||+|.+. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345788889999999999999964 4889999999754322 24678999999999999999999999875 3568
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccccCceeeC-CCCCeEEeccCCcccC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFD-EDGNPRLSTFGLMKNS 209 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~ 209 (449)
++||||+++++|.+++. ....+++..++.++.|++.||+|||+++ +++||||||+||+++ +++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEecCCCCHHHHHH--HccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999999997 3467999999999999999999999975 499999999999998 7899999999999765
Q ss_pred CCC--CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh-HHHhhcccccccccccCCCCCchhHH
Q 013126 210 RDG--KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 210 ~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
... ....||+.|+|||++. +.++.++||||||+++|+|++|+.||..... ............. ...+...++
T Consensus 183 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 257 (290)
T 1t4h_A 183 RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----ASFDKVAIP 257 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----GGGGGCCCH
T ss_pred cccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----cccCCCCCH
Confidence 544 2456899999999886 4589999999999999999999999865322 2221111111111 112233457
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+++.+||+.||++|||++++++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCCCHHHHhh
Confidence 8999999999999999999999998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.75 Aligned_cols=249 Identities=13% Similarity=0.059 Sum_probs=186.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhcc--CCCCcccce-------eeEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQL--RNNRLTNLL-------GCCC 126 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l--~HpnIv~l~-------~~~~ 126 (449)
..|++++.||+|+||+||+|.+. +|+.||||+++...... .+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35889999999999999999965 58999999998755322 35577885544444 699988755 4444
Q ss_pred eC-----------------CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCcccc
Q 013126 127 EG-----------------DERLLVAEYMPNETLAKHLFHWETHPMKWAMR------LRVVLHLAQALEYCTSKGRALYH 183 (449)
Q Consensus 127 ~~-----------------~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~yLH~~~~iiHr 183 (449)
.. ...++||||++ |+|.+++... +..+++..+ ..++.||+.||+|||+++ |+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-LVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-EEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-CccC
Confidence 33 33799999999 8999999753 234455555 678899999999999999 9999
Q ss_pred ccccCceeeCCCCCeEEeccCCcccCCCCC-ccccCccccccccccC--CCCCCCCceeeHhHHHHHHhcCCCCCCchhh
Q 013126 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDGK-SYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL 260 (449)
Q Consensus 184 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~-~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~ 260 (449)
||||+|||++.++.+||+|||+++...... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998776554 5667899999999987 6699999999999999999999999876532
Q ss_pred HHHhhccc---ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 261 DLIRDRNL---QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 261 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
........ ................++++.+++.+||+.||++|||+.++++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 21111000 0011111111223467889999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=351.72 Aligned_cols=247 Identities=12% Similarity=0.137 Sum_probs=205.4
Q ss_pred CcccccccccCCccceEEEEEE------EcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC---CCCcccceeeEeeCC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGK------LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGD 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~------~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~ 129 (449)
-..|++.+.||+|+||+||+|. ..+++.||+|+++.. ...++.+|+++++.++ |+||+++++++..++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3568899999999999999993 445899999999753 4677888888888886 999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-----------C
Q 013126 130 ERLLVAEYMPNETLAKHLFHW---ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-----------D 195 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-----------~ 195 (449)
..++||||++||+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++. +
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~-ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-IIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECGGGTCC------C
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-eecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999999742 2467999999999999999999999999 999999999999998 8
Q ss_pred CCeEEeccCCcccCC---CC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc
Q 013126 196 GNPRLSTFGLMKNSR---DG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ 269 (449)
Q Consensus 196 ~~~kL~DFGla~~~~---~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 269 (449)
+.+||+|||+++... .. ....||+.|+|||++.+..++.++|||||||++|||+||+.||.........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----- 294 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----- 294 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----
Confidence 999999999996532 21 3456899999999999989999999999999999999999988543211100
Q ss_pred cccccccCCCCCchhHHHHHHHHHHhcccCCCCC-CCHHHHHHHhcccccc
Q 013126 270 MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER-PNPKSLVTALSPLQKE 319 (449)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~eil~~L~~~~~~ 319 (449)
...... ....++.+.+++.+||+.+|.+| |+++++.+.|+.+...
T Consensus 295 --~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 --PEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --ECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --echhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 111111 11346788999999999999999 6888999888887654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=347.78 Aligned_cols=247 Identities=18% Similarity=0.229 Sum_probs=194.1
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEe------------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCC------------ 126 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------------ 126 (449)
+.|++++.||+|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 468899999999999999999764 8999999997654344577899999999999999999999873
Q ss_pred --eCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-CCCCeEEecc
Q 013126 127 --EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTF 203 (449)
Q Consensus 127 --~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-~~~~~kL~DF 203 (449)
+.+..++||||++ |+|.+++ ..+++++..++.++.|++.||+|||+++ ++||||||+||+++ +++.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVL---EQGPLLEEHARLFMYQLLRGLKYIHSAN-VLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccC-CCHHHHh---hcCCccHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999998 6999999 4567999999999999999999999999 99999999999997 5679999999
Q ss_pred CCcccCCCC-------CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc--
Q 013126 204 GLMKNSRDG-------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD-- 273 (449)
Q Consensus 204 Gla~~~~~~-------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-- 273 (449)
|+++..... ....+|..|+|||++.+ ..++.++||||||+++|+|++|+.||..................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999865422 23456889999999865 56899999999999999999999998765332221111110000
Q ss_pred ---------------------c-ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 ---------------------S-CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ---------------------~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+ .......+..+.++.+++.+||+.||++|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 0000112346788999999999999999999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.59 Aligned_cols=247 Identities=19% Similarity=0.200 Sum_probs=204.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--------HHHHHHHHHHHhcc-CCCCcccceeeEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--------PRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--------~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 129 (449)
..|++.+.||+|+||.||+|.+. +|+.||||+++...... .+.+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 45888899999999999999975 69999999997654221 34678999999999 8999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
..++||||++|++|.+++. ....+++..+..++.||+.||.|||++| ++||||||+||++++++.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g-i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLT--EKVALSEKETRSIMRSLLEAVSFLHANN-IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999999997 3467999999999999999999999999 999999999999999999999999998876
Q ss_pred CCC---CccccCccccccccccC------CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCC
Q 013126 210 RDG---KSYSTNLAFTPPEYLRT------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (449)
... ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................... ...
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~ 328 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS--SPE 328 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--HHH
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--Ccc
Confidence 543 34568999999999863 3588999999999999999999999876543322221111111000 000
Q ss_pred CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....+..+.+++.+||+.||++|||+.++++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1245678999999999999999999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=344.86 Aligned_cols=253 Identities=19% Similarity=0.288 Sum_probs=189.4
Q ss_pred CCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
+.++|++++.||+|+||+||+|.. .+++.||||.+.... ....+++.+|+.++++++||||+++++++..++..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 346788999999999999999995 468999999987543 233567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 136 EYMPNETLAKHLFHW------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
||++|++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||++...
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-QIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999998631 2456899999999999999999999999 999999999999999999999999998765
Q ss_pred CCC---------CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc----cccccccc
Q 013126 210 RDG---------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN----LQMLTDSC 275 (449)
Q Consensus 210 ~~~---------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~----~~~~~~~~ 275 (449)
... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||............ ........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence 432 23468899999999976 46899999999999999999999998654322211111 11111111
Q ss_pred cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.........++++.+++.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ---CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 112233456788999999999999999999999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.44 Aligned_cols=247 Identities=18% Similarity=0.235 Sum_probs=184.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeC------Ce
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 130 (449)
..|++++.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 46889999999999999999954 5899999999764322 246788999999999999999999998754 56
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||+ +++|.+++. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 79999999 689999884 467999999999999999999999999 9999999999999999999999999998755
Q ss_pred CC-CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc----------------
Q 013126 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT---------------- 272 (449)
Q Consensus 211 ~~-~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---------------- 272 (449)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...............
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 43 44678999999999987 5689999999999999999999999876533221111110000
Q ss_pred ---cccc---CC---CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 ---DSCL---EG---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ---~~~~---~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .. ......++++.+|+.+||+.||++|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000 00 011234678999999999999999999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=339.62 Aligned_cols=252 Identities=15% Similarity=0.157 Sum_probs=203.4
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeE-eeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCC-CEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~Ey 137 (449)
+.|++++.||+|+||+||+|.+ .+++.||||++..... .+.+.+|+++++.++|++++..++.+ ..++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4588889999999999999996 4589999998765432 34688999999999988877766655 667788999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee---CCCCCeEEeccCCcccCCCC--
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~-- 212 (449)
+ +++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9 8999999864 3567999999999999999999999999 9999999999999 78899999999999865432
Q ss_pred ---------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-------HHhhccccccccccc
Q 013126 213 ---------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-------LIRDRNLQMLTDSCL 276 (449)
Q Consensus 213 ---------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~ 276 (449)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ......... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~ 238 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-----P 238 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----C
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----h
Confidence 2346899999999999989999999999999999999999998653111 111110000 0
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
........++++.+++.+||+.||++|||++++++.|+.+.....
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 001123456789999999999999999999999999998876654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=342.95 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=200.7
Q ss_pred CcccccccccCCccceEEEEEEEcC--CC--EEEEEEecCCCCC---CHHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN--QR--RIAVKRFNRMAWP---DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~--~~--~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
..+|++++.||+|+||+||+|++.. ++ .||+|+++..... ..+.+.+|++++++++||||+++++++..++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3578999999999999999998532 33 6899999764322 2467899999999999999999999998755 8
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeEecccCCCHHHHHHh-ccCCcCHHHHHHHHHHHHHHHHHHHhCC-cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999975 2456899999999999999999999999 99999999999999999999999999987654
Q ss_pred CC-------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCch
Q 013126 212 GK-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 212 ~~-------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (449)
.. ...+|+.|+|||++.+..++.++||||||+++|+|++ |+.||................ .....+..
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 249 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG----ERLPRPED 249 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC----CCCCCCTT
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC----CCCCCCcC
Confidence 32 2346778999999988889999999999999999999 998887654443332221111 11223446
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
.++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 678999999999999999999999999999887643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=348.67 Aligned_cols=252 Identities=18% Similarity=0.201 Sum_probs=191.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEe--------eCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCC--------EGD 129 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~--------~~~ 129 (449)
.+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 36889999999999999999965 58999999986654444567899999999996 999999999984 334
Q ss_pred eeEEEEeeCCCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccccCceeeCCCCCeEEeccCCcc
Q 013126 130 ERLLVAEYMPNETLAKHLFHW-ETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
..++||||+. |+|.+++... ....+++..++.++.||+.||+|||+++ +++||||||+|||+++++.+||+|||+++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 5899999996 7999988642 3567999999999999999999999974 39999999999999999999999999998
Q ss_pred cCCCCC----------------ccccCccccccccc---cCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc
Q 013126 208 NSRDGK----------------SYSTNLAFTPPEYL---RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268 (449)
Q Consensus 208 ~~~~~~----------------~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 268 (449)
...... ...+|+.|+|||++ .+..++.++||||||+++|+|++|+.||.............
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 266 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY 266 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------C
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCcc
Confidence 654321 33478999999998 55668999999999999999999999986543322221111
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
........+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 267 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 267 --------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11122334456899999999999999999999999998887654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=343.74 Aligned_cols=244 Identities=16% Similarity=0.207 Sum_probs=199.5
Q ss_pred CcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEee--CCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCE--GDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~~lV 134 (449)
-++|++++.||+|+||+||+|.. .+++.||+|+++. ...+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36789999999999999999996 4589999999974 34678999999999997 9999999999988 5678999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-CeEEeccCCcccCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~- 212 (449)
|||+++++|.+++. .+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999884 3889999999999999999999999 99999999999999776 8999999999865443
Q ss_pred --CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhH--HH----------------hhcc----
Q 013126 213 --KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALD--LI----------------RDRN---- 267 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~--~~----------------~~~~---- 267 (449)
....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .+ ....
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 34568899999999987 56899999999999999999999998432110 00 0000
Q ss_pred ----------cccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 268 ----------LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 268 ----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.................++++.+++.+||+.||++|||++++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000001111122336789999999999999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=360.80 Aligned_cols=248 Identities=17% Similarity=0.219 Sum_probs=201.9
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc------CCCCcccceeeEeeCCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL------RNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~~~~~~~~~l 133 (449)
+|++++.||+|+||+||+|.+. +++.||||+++... ...+.+.+|+++++.+ +|+||+++++++...+..++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 5889999999999999999965 48999999997532 2245678898888887 56799999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC--eEEeccCCcccCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN--PRLSTFGLMKNSRD 211 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~--~kL~DFGla~~~~~ 211 (449)
||||+. ++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT-EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 999996 79999998655567999999999999999999999999 999999999999999887 99999999976554
Q ss_pred C-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc-----------------cc
Q 013126 212 G-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML-----------------TD 273 (449)
Q Consensus 212 ~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-----------------~~ 273 (449)
. ....+|+.|+|||++.+..++.++|||||||++|||++|.+||................ .+
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~ 334 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS 334 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBC
T ss_pred cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccC
Confidence 3 35678999999999999999999999999999999999999987653322111000000 00
Q ss_pred -------------------------------cccC-----CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 -------------------------------SCLE-----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 -------------------------------~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .......++++.+||.+||+.||++|||++++++
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 335 SKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp TTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 0000 0011123577999999999999999999999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=345.14 Aligned_cols=248 Identities=13% Similarity=0.182 Sum_probs=200.7
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEee------CC
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCE------GD 129 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~------~~ 129 (449)
....|++++.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3456788899999999999999964 58999999997543 3457899999999999 89999999999987 46
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
..++||||+++++|.+++.......+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 7899999999999999998655568999999999999999999999999 999999999999999999999999998765
Q ss_pred CCC----CccccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCC
Q 013126 210 RDG----KSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQF 280 (449)
Q Consensus 210 ~~~----~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (449)
... ....||+.|+|||++. +..++.++||||||+++|+|++|+.||............. ........
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~ 255 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP----RNPAPRLK 255 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----HSCCCCCS
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh----cCccccCC
Confidence 432 3456899999999997 4568999999999999999999999986543222211111 11111122
Q ss_pred CchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 281 TDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....+..+.+++.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 3456788999999999999999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=352.35 Aligned_cols=246 Identities=15% Similarity=0.218 Sum_probs=192.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCC------e
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 130 (449)
..|++++.||+|+||+||+|... +++.||||++....... .+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 56889999999999999999965 58999999997643222 456889999999999999999999997665 6
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||++ ++|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC-eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 899999998 68888885 35899999999999999999999999 9999999999999999999999999998655
Q ss_pred CC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccc------------
Q 013126 211 DG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSC------------ 275 (449)
Q Consensus 211 ~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------ 275 (449)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+.
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 43 345689999999999998899999999999999999999999876543222111111100000
Q ss_pred ---------------------cCCC---CCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 276 ---------------------LEGQ---FTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 276 ---------------------~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .....+.++.+|+.+||+.||++|||++++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000 00123678999999999999999999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=341.14 Aligned_cols=249 Identities=17% Similarity=0.154 Sum_probs=207.1
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC---------CHHHHHHHHHHHhccC-CCCcccceeeEe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---------DPRQFLEEARSVGQLR-NNRLTNLLGCCC 126 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~---------~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 126 (449)
-++.|++++.||+|+||.||+|... +|+.||||+++..... ..+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4567899999999999999999975 5899999999764321 1346889999999995 999999999999
Q ss_pred eCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 127 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
.++..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999973 467999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCC---CccccCcccccccccc------CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccC
Q 013126 207 KNSRDG---KSYSTNLAFTPPEYLR------TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 207 ~~~~~~---~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
...... ....+|+.|+|||++. ...++.++||||||+++|+|++|+.|+.................. ..
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~ 249 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--FG 249 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CC
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc--cC
Confidence 875543 2356899999999985 446889999999999999999999998765443332222111111 11
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.......+.++.+++.+||+.||++|||+.++++
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1112356788999999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.00 Aligned_cols=255 Identities=18% Similarity=0.263 Sum_probs=204.2
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.++.|++.+.||+|+||+||+|.+.+ .+|+|+++.... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 46778999999999999999999754 499999975432 23456889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC----
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD---- 211 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~---- 211 (449)
||++|++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++ ++.+||+|||+++....
T Consensus 109 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKG-ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp BCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred ecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999999964 3457999999999999999999999999 99999999999998 67999999999765421
Q ss_pred -----CCccccCccccccccccC---------CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccC
Q 013126 212 -----GKSYSTNLAFTPPEYLRT---------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 212 -----~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..................
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 261 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP---- 261 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC----
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC----
Confidence 123457899999999874 34788999999999999999999998765544333222221111
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccccC
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKETE 321 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 321 (449)
.......+.++.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11122455679999999999999999999999999999876643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=349.37 Aligned_cols=252 Identities=16% Similarity=0.221 Sum_probs=203.7
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhc--cCCCCcccceeeEeeCC----eeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQ--LRNNRLTNLLGCCCEGD----ERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~----~~~lV 134 (449)
.|++.+.||+|+||+||+|++ +++.||||+++.. ..+.+.+|+++++. ++||||+++++++...+ ..++|
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 578889999999999999998 5899999999643 35678899999887 79999999999998876 78999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT--------SKGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
|||+++|+|.+++.. ..+++..++.++.|++.||+||| +++ ++||||||+||++++++.+||+|||++
T Consensus 119 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp ECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC-eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999999999953 57999999999999999999999 788 999999999999999999999999999
Q ss_pred ccCCCC--------CccccCccccccccccCC------CCCCCCceeeHhHHHHHHhcC----------CCCCCchh---
Q 013126 207 KNSRDG--------KSYSTNLAFTPPEYLRTG------RVTPESVIYSFGTLLLDLLSG----------KHIPPSHA--- 259 (449)
Q Consensus 207 ~~~~~~--------~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg----------~~p~~~~~--- 259 (449)
+..... ....||+.|+|||++.+. .++.++||||||+++|||++| ..||....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 764432 234689999999999765 234789999999999999999 56664321
Q ss_pred --hHHHhhcccccccccccCC-CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 260 --LDLIRDRNLQMLTDSCLEG-QFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 260 --~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
...+..........+.... ......+..+.+++.+||+.||++|||+.++++.|+.+.++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 1122211111111111110 112356788999999999999999999999999999886653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=351.08 Aligned_cols=251 Identities=18% Similarity=0.193 Sum_probs=206.2
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC-----------------HHHHHHHHHHHhccCCCCcccc
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD-----------------PRQFLEEARSVGQLRNNRLTNL 121 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~-----------------~~~~~~E~~~l~~l~HpnIv~l 121 (449)
..+|++++.||+|+||.||+|.. +++.||+|.+....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35789999999999999999999 89999999996432111 1789999999999999999999
Q ss_pred eeeEeeCCeeEEEEeeCCCCCHHHH------HhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCC
Q 013126 122 LGCCCEGDERLLVAEYMPNETLAKH------LFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDE 194 (449)
Q Consensus 122 ~~~~~~~~~~~lV~Ey~~ggsL~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~ 194 (449)
++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||+|||+ ++ ++||||||+||+++.
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDK 187 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC-EECCCCCGGGEEECT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC-EeecCCChHhEEEcC
Confidence 9999999999999999999999998 654336789999999999999999999999 88 999999999999999
Q ss_pred CCCeEEeccCCcccCCCC--CccccCccccccccccCC-CCCC-CCceeeHhHHHHHHhcCCCCCCchhh-HHHhhcccc
Q 013126 195 DGNPRLSTFGLMKNSRDG--KSYSTNLAFTPPEYLRTG-RVTP-ESVIYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNLQ 269 (449)
Q Consensus 195 ~~~~kL~DFGla~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvil~elltg~~p~~~~~~-~~~~~~~~~ 269 (449)
++.+||+|||++...... ....+|+.|+|||++.+. .++. ++||||||+++|+|++|+.||..... .........
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 999999999999875443 345689999999999887 5666 99999999999999999999875433 222211111
Q ss_pred ccccccc-C------------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 MLTDSCL-E------------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 ~~~~~~~-~------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....... . .......+.++.+++.+||+.||++|||+.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1000000 0 0011456789999999999999999999999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.62 Aligned_cols=246 Identities=19% Similarity=0.216 Sum_probs=189.5
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.++|++++.||+|+||+||+|... +|+.||+|+++...... .+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467899999999999999999964 68999999997643222 223445555688889999999999999999999999
Q ss_pred eeCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 136 EYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
||++ |+|.+++.. .....+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC-CCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-eecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 9998 588887753 2457899999999999999999999998 8 999999999999999999999999999765443
Q ss_pred ---CccccCccccccccc----cCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh--HHHhhcccccccccccCCCCCch
Q 013126 213 ---KSYSTNLAFTPPEYL----RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 283 (449)
....||+.|+|||++ .+..++.++||||||+++|+|++|+.||..... ......... .........
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 238 (290)
T 3fme_A 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-----PSPQLPADK 238 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-----CCCCCCTTT
T ss_pred ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-----CCCCccccc
Confidence 234689999999996 455689999999999999999999999864221 111111111 111122345
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.++++.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 6788999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=362.68 Aligned_cols=249 Identities=14% Similarity=0.176 Sum_probs=199.8
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccC--------CCCcccceeeEe----
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR--------NNRLTNLLGCCC---- 126 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~l~~~~~---- 126 (449)
..|++++.||+|+||+||+|+.. +++.||||+++... ...+.+.+|+++++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 46899999999999999999964 58899999997432 23467889999999996 788999999987
Q ss_pred eCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeCCCC---------
Q 013126 127 EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDG--------- 196 (449)
Q Consensus 127 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~~~~--------- 196 (449)
.+...++||||+ +++|.+.+.......+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g-ivHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHeeEeccchhhhhhhhh
Confidence 456799999999 56777777654557799999999999999999999998 8 99999999999999775
Q ss_pred ----------------------------------------CeEEeccCCcccCCCC-CccccCccccccccccCCCCCCC
Q 013126 197 ----------------------------------------NPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPE 235 (449)
Q Consensus 197 ----------------------------------------~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~ 235 (449)
.+||+|||+++..... ....||+.|+|||++.+..++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 273 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcH
Confidence 7999999999865543 34578999999999999899999
Q ss_pred CceeeHhHHHHHHhcCCCCCCchhhH-------HHhh--cccccc------------------------cccc-------
Q 013126 236 SVIYSFGTLLLDLLSGKHIPPSHALD-------LIRD--RNLQML------------------------TDSC------- 275 (449)
Q Consensus 236 sDvwSlGvil~elltg~~p~~~~~~~-------~~~~--~~~~~~------------------------~~~~------- 275 (449)
+|||||||++|||++|+.||...... .... ...... ....
T Consensus 274 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (397)
T 1wak_A 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353 (397)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHH
T ss_pred HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHh
Confidence 99999999999999999998643210 0000 000000 0000
Q ss_pred --cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 276 --LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 276 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.....+...+.++.+|+.+||+.||++|||++++++
T Consensus 354 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001224456788999999999999999999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=353.67 Aligned_cols=246 Identities=19% Similarity=0.234 Sum_probs=197.0
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC----------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG---------- 128 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---------- 128 (449)
..|++++.||+|+||+||+|.+ .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 4688999999999999999996 4699999999975432 234799999999999999999998543
Q ss_pred ----------------------------CeeEEEEeeCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 013126 129 ----------------------------DERLLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKG 178 (449)
Q Consensus 129 ----------------------------~~~~lV~Ey~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ 178 (449)
...++||||++ ++|.+.+.. .....+++..++.++.||+.||+|||+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 34889999998 688877753 24678999999999999999999999999
Q ss_pred CccccccccCceeeC-CCCCeEEeccCCcccCCCC---CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCC
Q 013126 179 RALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKH 253 (449)
Q Consensus 179 ~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~ 253 (449)
|+||||||+|||++ +++.+||+|||+++..... ....+|+.|+|||++.+.. ++.++||||+||++|||++|+.
T Consensus 162 -i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 162 -ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp -EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 99999999999998 6899999999999865433 3456899999999998754 8999999999999999999999
Q ss_pred CCCchhhHHHhhcccccc-----------------------cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 013126 254 IPPSHALDLIRDRNLQML-----------------------TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (449)
Q Consensus 254 p~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil 310 (449)
||................ .........+...++++.+++.+||+.||++|||+.+++
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 987653322211111100 000001113345678899999999999999999999999
Q ss_pred H
Q 013126 311 T 311 (449)
Q Consensus 311 ~ 311 (449)
+
T Consensus 321 ~ 321 (383)
T 3eb0_A 321 A 321 (383)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=343.14 Aligned_cols=250 Identities=20% Similarity=0.247 Sum_probs=203.0
Q ss_pred cccccccccCCccceEEEEEEE--cCCCEEEEEEecCCCC--CCHHHHHHHHHHHhcc---CCCCcccceeeEe-----e
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL--ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQL---RNNRLTNLLGCCC-----E 127 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~--~~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~-----~ 127 (449)
..|++++.||+|+||+||+|.+ .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 5688999999999999999997 3588999999965322 2234677888888777 8999999999987 4
Q ss_pred CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 128 ~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
....++||||++ |+|.+++.......+++..++.++.|++.||+|||++| ++||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g-i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 567899999998 69999998655567999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc------------
Q 013126 208 NSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT------------ 272 (449)
Q Consensus 208 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~------------ 272 (449)
..... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.................
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 65433 345679999999999988899999999999999999999999876533222111110000
Q ss_pred ---------ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 ---------DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
............++.+.+++.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000001223456788999999999999999999999996
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=376.61 Aligned_cols=244 Identities=21% Similarity=0.258 Sum_probs=203.6
Q ss_pred cccCCccceEEEEEEEc---CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
++||+|+||+||+|.+. +++.||||+++..... ..+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 36899999999999753 3678999999764322 25789999999999999999999999864 568999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-------
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------- 213 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~------- 213 (449)
|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 454 g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~-iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999997 4567999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......+........ ....+..+++++.+++
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-----~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-----RMGCPAGCPREMYDLM 605 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----CCCCCTTCCHHHHHHH
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCCHHHHHHH
Confidence 2235688999999998899999999999999999998 999987655444333222211 1233556778999999
Q ss_pred HHhcccCCCCCCCHHHHHHHhccccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
.+||+.||++|||+.++++.|+.+..
T Consensus 606 ~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999987653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.61 Aligned_cols=246 Identities=19% Similarity=0.270 Sum_probs=199.1
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeC-----CeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~l 133 (449)
.|++++.||+|+||+||+|.+. +++.||||++....... .+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 6889999999999999999965 58899999997543222 36789999999999999999999999765 36899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||++ ++|.+++. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 108 v~e~~~-~~L~~~l~---~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 108 VQDLME-TDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEECCS-EEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEcccC-cCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999997 69999985 356999999999999999999999999 999999999999999999999999999865432
Q ss_pred ------CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc-----------
Q 013126 213 ------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS----------- 274 (449)
Q Consensus 213 ------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 274 (449)
....||+.|+|||++.+. .++.++||||||+++|+|++|+.||..................+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 234689999999987654 48999999999999999999999987543222211111000000
Q ss_pred --------cc-C-----CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 --------CL-E-----GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 --------~~-~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.. . ....+..++++.+++.+||+.||++|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0 0112345678999999999999999999999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=344.15 Aligned_cols=249 Identities=17% Similarity=0.184 Sum_probs=204.1
Q ss_pred cccccccccCCccceEEEEEEE-c-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC------cccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-E-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR------LTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~~ 131 (449)
+.|++++.||+|+||+||+|.+ . +++.||+|+++... ...+.+.+|+++++.++|+| ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4689999999999999999986 3 58899999997532 22467889999999997765 99999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-----------------
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE----------------- 194 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~----------------- 194 (449)
++||||+ +++|.+++......++++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK-LTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9999999 799999998655567999999999999999999999999 999999999999987
Q ss_pred --CCCeEEeccCCcccCCCC-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc---c
Q 013126 195 --DGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---L 268 (449)
Q Consensus 195 --~~~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~---~ 268 (449)
++.+||+|||+++..... ....||+.|+|||++.+..++.++||||||+++|||++|..||............ .
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 250 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 678999999999875543 4457899999999999889999999999999999999999998764332211100 0
Q ss_pred ccccc-----------------------------------cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 QMLTD-----------------------------------SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 ~~~~~-----------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...+. ...........++++.+++.+||+.||++|||+.++++
T Consensus 251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 00000 00001123456788999999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=337.44 Aligned_cols=246 Identities=19% Similarity=0.190 Sum_probs=204.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
..|++++.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 46889999999999999999975 58999999996533 2346789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC---CCeEEeccCCcccCCCCC
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED---GNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~ 213 (449)
|+++++|.+.+.. ...+++..++.++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999999998873 457999999999999999999999999 9999999999999754 469999999988655432
Q ss_pred ---ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 214 ---SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 214 ---~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
...+|+.|+|||++.+ .++.++||||||+++|+|++|+.||................... ........++++.+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--DLPQWRTISDDAKD 255 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CSGGGTTSCHHHHH
T ss_pred ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CchhhhhcCHHHHH
Confidence 3457899999999875 58999999999999999999999987654443332221111100 00111345678999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||+.||++|||+.++++
T Consensus 256 li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcccChhhCcCHHHHhc
Confidence 999999999999999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.89 Aligned_cols=257 Identities=15% Similarity=0.205 Sum_probs=198.0
Q ss_pred HHHHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC-----------HHHHHHHHHHHhccCCCC
Q 013126 49 LEQLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD-----------PRQFLEEARSVGQLRNNR 117 (449)
Q Consensus 49 ~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~-----------~~~~~~E~~~l~~l~Hpn 117 (449)
..++....+ .|++++.||+|+||.||+|...+|+.||||++....... .+.+.+|++++++++|||
T Consensus 14 ~~~~~~~~~---~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 14 IAELHAMQS---PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHTTC---SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHhcc---ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 445555554 467788889999999999998789999999996533221 267999999999999999
Q ss_pred cccceeeEeeC-----CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee
Q 013126 118 LTNLLGCCCEG-----DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (449)
Q Consensus 118 Iv~l~~~~~~~-----~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl 192 (449)
|+++++++... ...++||||++ |+|.+.+.. ....+++..++.++.||+.||+|||+++ |+||||||+||++
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAG-VVHRDLHPGNILL 167 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCc-CEecCCChHHEEE
Confidence 99999998543 36899999998 688888864 4457999999999999999999999999 9999999999999
Q ss_pred CCCCCeEEeccCCcccCCCC---CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc
Q 013126 193 DEDGNPRLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL 268 (449)
Q Consensus 193 ~~~~~~kL~DFGla~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 268 (449)
+.++.+||+|||+++..... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.............
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999754433 34568899999999987 668999999999999999999999987653322221111
Q ss_pred cccc-----------------------ccccC---CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 QMLT-----------------------DSCLE---GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 ~~~~-----------------------~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... ..... ....+..++.+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1000 00000 0112344678999999999999999999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.49 Aligned_cols=247 Identities=15% Similarity=0.221 Sum_probs=198.8
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeC-----CeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 132 (449)
++|++++.||+|+||+||+|.+. +|+.||||+++..... ....+.+|+++++.++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 46889999999999999999965 5899999999754322 245688999999999999999999988764 6789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
+||||+. ++|.+++.. ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 91 lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN-VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 9999997 699999853 57999999999999999999999999 999999999999999999999999999865422
Q ss_pred --------------CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc-----
Q 013126 213 --------------KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT----- 272 (449)
Q Consensus 213 --------------~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----- 272 (449)
....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 12357899999998865 6689999999999999999999999876543221111000000
Q ss_pred ---------------cccc------CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 ---------------DSCL------EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ---------------~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .....+..++++.+++.+||+.||++|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 00012356788999999999999999999999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=346.89 Aligned_cols=242 Identities=16% Similarity=0.198 Sum_probs=196.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--------CCHHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--------PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
++|++++.||+|+||.||+|.+. +++.||||++..... .....+.+|++++++++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 36889999999999999999965 489999999975321 11345889999999999999999999987654
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC---eEEeccCCcc
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGLMK 207 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~---~kL~DFGla~ 207 (449)
.++||||+++++|.+++. ....+++..++.++.||+.||+|||+++ ++||||||+||+++.++. +||+|||+++
T Consensus 89 ~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 899999999999999997 5578999999999999999999999999 999999999999987654 9999999998
Q ss_pred cCCCCC---ccccCcccccccccc---CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-----HHhhccccccccccc
Q 013126 208 NSRDGK---SYSTNLAFTPPEYLR---TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-----LIRDRNLQMLTDSCL 276 (449)
Q Consensus 208 ~~~~~~---~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~ 276 (449)
...... ...||+.|+|||++. +..++.++||||||+++|+|++|..||...... .+........
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 240 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI----- 240 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC-----
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC-----
Confidence 766542 346899999999974 456899999999999999999999998653211 1111111000
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.......++++.+++.+||+.||++|||+.++++
T Consensus 241 -~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 241 -PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0011345678999999999999999999999996
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=344.62 Aligned_cols=247 Identities=14% Similarity=0.160 Sum_probs=176.0
Q ss_pred ccccccc-cCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEee----CCeeEEE
Q 013126 61 VENIVSE-HGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLLV 134 (449)
Q Consensus 61 ~~~~l~~-lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 134 (449)
+|+++++ ||+|+||+||+|.+. +|+.||||++... .....+....++.++||||+++++++.. +...++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 5778664 899999999999976 5999999999642 2222233344666799999999999976 4558999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---CCCeEEeccCCcccCCC
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~~~~ 211 (449)
|||++||+|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||+++. ++.+||+|||+++....
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 99999999999998655567999999999999999999999999 999999999999986 45599999999986554
Q ss_pred C--CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc--ccCCCCCchhHHH
Q 013126 212 G--KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS--CLEGQFTDDDGTE 287 (449)
Q Consensus 212 ~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 287 (449)
. ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||................... ..........+++
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED 263 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHH
T ss_pred cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHH
Confidence 3 34567999999999988889999999999999999999999986654333221111111111 1111222456789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+.+++.+||+.||++|||+++++++
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 264 AKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999999983
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.90 Aligned_cols=246 Identities=17% Similarity=0.232 Sum_probs=197.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCee-----
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER----- 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~----- 131 (449)
..|++++.||+|+||+||+|.+. +|+.||||++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 36788899999999999999965 58999999997654332 46788999999999999999999999887665
Q ss_pred -EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 132 -LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 132 -~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
++||||+. ++|.+.+. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG-VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999998 78888773 35999999999999999999999999 9999999999999999999999999998655
Q ss_pred CC-CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccc----------------
Q 013126 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT---------------- 272 (449)
Q Consensus 211 ~~-~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---------------- 272 (449)
.. ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 43 34578999999999987 6789999999999999999999999976533222111110000
Q ss_pred ---ccccC---C---CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 273 ---DSCLE---G---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 273 ---~~~~~---~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..... . ...+..++++.+++.+||+.||++|||+.++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000 0 012345688999999999999999999999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=350.78 Aligned_cols=246 Identities=20% Similarity=0.258 Sum_probs=194.9
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCe------eEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE------RLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~~l 133 (449)
..|++++.||+|+||+||+|++.++..||+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46889999999999999999987766799999865332 22379999999999999999999965443 789
Q ss_pred EEeeCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-CCCCeEEeccCCcccCC
Q 013126 134 VAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~ 210 (449)
||||+++ ++.+.+.. .....+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 116 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999985 44444331 13578999999999999999999999999 99999999999999 79999999999998654
Q ss_pred CC---CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc----------------
Q 013126 211 DG---KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM---------------- 270 (449)
Q Consensus 211 ~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---------------- 270 (449)
.. ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.............
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 33 346789999999999765 4899999999999999999999999765332211111100
Q ss_pred -------ccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 -------LTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 -------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.........++...++++.+|+.+||+.||++|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000001123346789999999999999999999999997
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=355.15 Aligned_cols=245 Identities=23% Similarity=0.255 Sum_probs=194.3
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC------CeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~l 133 (449)
.|++++.||+|+||+||+|++. +|+.||||++.... ....+|+++++.++||||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5888999999999999999975 59999999996543 2234799999999999999999998542 23679
Q ss_pred EEeeCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-CCeEEeccCCcccCC
Q 013126 134 VAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-GNPRLSTFGLMKNSR 210 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~ 210 (449)
||||++ ++|.+.+.. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 131 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 999998 577766643 24578999999999999999999999999 9999999999999955 668999999998654
Q ss_pred CC---CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccc----------------
Q 013126 211 DG---KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQM---------------- 270 (449)
Q Consensus 211 ~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---------------- 270 (449)
.. ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 33 345789999999999765 6899999999999999999999999765322111111100
Q ss_pred --ccccc-----cCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 271 --LTDSC-----LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 271 --~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..-+. +...++...++++.+|+.+||+.||++|||+.++++
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000 000123345788999999999999999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.30 Aligned_cols=250 Identities=20% Similarity=0.224 Sum_probs=188.7
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCe-------
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE------- 130 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------- 130 (449)
++.|++++.||+|+||+||+|++. +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 356788889999999999999975 58999999986543 234567888999999999999999999976443
Q ss_pred eEEEEeeCCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccccccccCceeeCC-CCCeEEeccCC
Q 013126 131 RLLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCT--SKGRALYHDLNAYRILFDE-DGNPRLSTFGL 205 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH--~~~~iiHrDlkp~NILl~~-~~~~kL~DFGl 205 (449)
.++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| +++ |+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-CBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC-eecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 7899999985 55544432 14567899999999999999999999 898 999999999999996 89999999999
Q ss_pred cccCCCC---CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc--------
Q 013126 206 MKNSRDG---KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD-------- 273 (449)
Q Consensus 206 a~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 273 (449)
++..... ....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..................
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 9876543 2456899999999997655 899999999999999999999998765433222211110000
Q ss_pred ------------------cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 ------------------SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...........++++.+++.+||+.||++|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00001122346789999999999999999999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=335.73 Aligned_cols=244 Identities=19% Similarity=0.269 Sum_probs=194.4
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEee-----------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE----------- 127 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----------- 127 (449)
++|++++.||+|+||+||+|+.. +++.||||.++... ...+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 35888999999999999999964 68999999996422 234678999999999999999999998865
Q ss_pred --CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 128 --GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 128 --~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
.+..++||||++|++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQG-IIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCC-eecccCCHHhEEEcCCCCEEEeeCcc
Confidence 4568999999999999999975 3456788999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCC------------------CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchh-hHHHhh
Q 013126 206 MKNSRDG------------------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHA-LDLIRD 265 (449)
Q Consensus 206 a~~~~~~------------------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~-~~~~~~ 265 (449)
++..... ....||+.|+|||++.+. .++.++||||||+++|+|++ |+.... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 8765321 234578999999999865 68999999999999999998 343221 111111
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... .........+...++.+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 240 KLRS--VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHS--TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccc--cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111 0111222345566778999999999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=341.21 Aligned_cols=250 Identities=18% Similarity=0.214 Sum_probs=182.7
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHH-HHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEAR-SVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.++|++++.||+|+||.||+|... +|+.||||+++..... ...++.+|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999975 5899999999764322 2345666666 778889999999999999999999999
Q ss_pred eeCCCCCHHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 136 EYMPNETLAKHLFH---WETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 136 Ey~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
||++ ++|.+++.. .....+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS-CCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC-EeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9998 588887752 1357899999999999999999999998 8 99999999999999999999999999976544
Q ss_pred C---CccccCccccccccc----cCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-HhhcccccccccccCCCCCch
Q 013126 212 G---KSYSTNLAFTPPEYL----RTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 212 ~---~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 283 (449)
. ....||+.|+|||++ .+..++.++||||||+++|+|++|+.||....... ........ ..+.........
T Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 257 (327)
T 3aln_A 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEERE 257 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-CCCCCCCCSSCC
T ss_pred ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-CCCCCCCccccc
Confidence 3 233689999999999 45668999999999999999999999987532111 11111111 111111122345
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.++++.+++.+||+.||++|||+.++++
T Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 6789999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=355.71 Aligned_cols=249 Identities=17% Similarity=0.195 Sum_probs=204.5
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC-CCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN-NRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+.|++++.||+|+||.||+|.+ .+++.||||+++.... .+++.+|+++++.++| ++|..+..++...+..++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4688999999999999999996 4599999999875432 3468899999999987 5666677777788889999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee---CCCCCeEEeccCCcccCCCCC-
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF---DEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~- 213 (449)
+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 85 ~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~g-IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9 8999999964 3567999999999999999999999999 9999999999999 588999999999998654332
Q ss_pred ----------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhh-------HHHhhccccccccccc
Q 013126 214 ----------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHAL-------DLIRDRNLQMLTDSCL 276 (449)
Q Consensus 214 ----------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~ 276 (449)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+..........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--- 238 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE--- 238 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH---
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH---
Confidence 45689999999999999999999999999999999999999865321 1111111111110
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
.....++.++.+++.+||+.||++||++.++++.|+.+..
T Consensus 239 --~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 --ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp --HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred --HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1113456789999999999999999999999999887744
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.70 Aligned_cols=249 Identities=18% Similarity=0.222 Sum_probs=200.2
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-----------CCCcccceeeEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-----------NNRLTNLLGCCCE 127 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~ 127 (449)
..|++++.||+|+||+||+|++ .+++.||||+++... ...+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 4689999999999999999996 458999999997432 23467889999999886 8999999999987
Q ss_pred CC----eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeC------CCC
Q 013126 128 GD----ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFD------EDG 196 (449)
Q Consensus 128 ~~----~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~------~~~ 196 (449)
.+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ + |+||||||+|||++ ..+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~-ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECSCCSGGGEEEEEEETTTTEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC-EEecCCChHHeEEeccCCCcCcc
Confidence 54 789999999 89999999865567799999999999999999999998 9 99999999999994 445
Q ss_pred CeEEeccCCcccCCCC-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh------hccc-
Q 013126 197 NPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR------DRNL- 268 (449)
Q Consensus 197 ~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~------~~~~- 268 (449)
.+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||......... ....
T Consensus 176 ~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 7999999999876543 3457899999999999989999999999999999999999998643211000 0000
Q ss_pred --cccc--------------------cc-------------ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 --QMLT--------------------DS-------------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 --~~~~--------------------~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...+ .. ......+...++++.++|.+||+.||++|||++++++
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 0000 00 0011234567889999999999999999999999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.49 Aligned_cols=252 Identities=16% Similarity=0.236 Sum_probs=184.3
Q ss_pred ccccc-ccCCccceEEEEEEEc---CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEee--CCeeEEEE
Q 013126 62 ENIVS-EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLLVA 135 (449)
Q Consensus 62 ~~~l~-~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 135 (449)
|++.+ +||+|+||+||+|++. +++.||||+++... ....+.+|+.++++++||||+++++++.. +...++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 55544 6999999999999964 47899999997543 34678999999999999999999999954 67899999
Q ss_pred eeCCCCCHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee----CCCCCeEEeccC
Q 013126 136 EYMPNETLAKHLFHW-------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF----DEDGNPRLSTFG 204 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl----~~~~~~kL~DFG 204 (449)
||++ ++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-EeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 9997 6888887532 1235999999999999999999999999 9999999999999 677899999999
Q ss_pred CcccCCCC-------CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHh---------hcc
Q 013126 205 LMKNSRDG-------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIR---------DRN 267 (449)
Q Consensus 205 la~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~---------~~~ 267 (449)
+++..... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....+... ...
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99865432 235689999999999874 4899999999999999999999998643221000 000
Q ss_pred cc-----------cc-------------cccccC--------CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcc
Q 013126 268 LQ-----------ML-------------TDSCLE--------GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 268 ~~-----------~~-------------~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 315 (449)
.. .+ ...... .......++++.+||.+||+.||++|||++++++ +.
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~--hp 335 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ--DP 335 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT--SG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--Ch
Confidence 00 00 000000 0001112567899999999999999999999998 44
Q ss_pred cccc
Q 013126 316 LQKE 319 (449)
Q Consensus 316 ~~~~ 319 (449)
+...
T Consensus 336 ~f~~ 339 (405)
T 3rgf_A 336 YFLE 339 (405)
T ss_dssp GGTS
T ss_pred hhcc
Confidence 4443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.41 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=207.9
Q ss_pred CcccccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
...|++.+.||+|+||+||+|.+.. +..||+|.++...... .+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 4568899999999999999999642 4679999987643222 467999999999999999999999985 467899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 468 v~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 468 IMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999999999974 3457999999999999999999999999 9999999999999999999999999998765432
Q ss_pred -----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 214 -----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 214 -----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...+|+.|+|||++.+..++.++||||||+++|||++ |..||............... .....+..+++.
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~ 620 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMPPNCPPT 620 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-----CCCCCCTTCCHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-----CCCCCCccccHH
Confidence 2345688999999998899999999999999999997 88888765433332222111 112234567789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999987753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=335.95 Aligned_cols=246 Identities=19% Similarity=0.275 Sum_probs=198.7
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCC--CHHHHHHHHHHHhccC--CCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV 134 (449)
-..|++++.||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 3568899999999999999999878999999999754332 2467899999999997 49999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|| +.+++|.+++. ....+++..++.++.|++.||+|||+++ ++||||||+||++++ +.+||+|||+++.....
T Consensus 107 ~e-~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 107 ME-CGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EC-CCSEEHHHHHH--HCSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred Ee-cCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 99 55799999997 4567899999999999999999999999 999999999999964 89999999999865433
Q ss_pred ----CccccCccccccccccC-----------CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccC
Q 013126 213 ----KSYSTNLAFTPPEYLRT-----------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (449)
....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... ..........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~ 258 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAIIDPNHE 258 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---HHHHHCTTSC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH---HHHHHhcccc
Confidence 23468999999999875 46888999999999999999999998653221111 0111111122
Q ss_pred CCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
...+...+.++.+++.+||+.||++|||+.++++.
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 23344556789999999999999999999999983
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=337.88 Aligned_cols=246 Identities=17% Similarity=0.222 Sum_probs=197.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCe------
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE------ 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------ 130 (449)
..|.+.+.||+|+||+||+|.+. +|+.||||++....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 45788899999999999999965 58999999997644322 4578899999999999999999999987654
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||++ ++|.+++. ..+++..++.++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG-VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999998 68888763 35999999999999999999999999 9999999999999999999999999998654
Q ss_pred CC-CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-------------------
Q 013126 211 DG-KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------- 269 (449)
Q Consensus 211 ~~-~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------------- 269 (449)
.. ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||..............
T Consensus 178 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 43 34568999999999987 5689999999999999999999999875432221111100
Q ss_pred ----ccccc--ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 ----MLTDS--CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 ----~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..... .......+..++++.+++.+||+.||++|||++++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0011223456789999999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=344.34 Aligned_cols=197 Identities=17% Similarity=0.149 Sum_probs=171.0
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CC-----CcccceeeEeeCCeeE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NN-----RLTNLLGCCCEGDERL 132 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~~~~~~~~~~~ 132 (449)
++|++++.||+|+||+||+|.+. +++.||||+++... ...+++.+|+.+++.++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 56889999999999999999965 58899999997432 22456788999998885 45 4999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCccccccccCceeeC--CCCCeEEeccCCccc
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS--KGRALYHDLNAYRILFD--EDGNPRLSTFGLMKN 208 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~~~iiHrDlkp~NILl~--~~~~~kL~DFGla~~ 208 (449)
+||||++ ++|.+++.......+++..++.++.|++.||.|||+ .+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~-ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC-EECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC-EEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 9999997 599999986555679999999999999999999994 57 99999999999995 578899999999987
Q ss_pred CCCC-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh
Q 013126 209 SRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA 259 (449)
Q Consensus 209 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~ 259 (449)
.... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 211 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6543 45678999999999999899999999999999999999999987643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.37 Aligned_cols=249 Identities=15% Similarity=0.147 Sum_probs=201.1
Q ss_pred cccccccccCCccceEEEEEEEc-CC-CEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC------cccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQ-RRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR------LTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~-~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~~ 131 (449)
+.|++++.||+|+||+||+|... ++ +.||+|+++... ...+.+.+|+.+++.++|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 46889999999999999999964 34 689999997532 23467889999999998766 89999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee-------------------
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF------------------- 192 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl------------------- 192 (449)
++||||+ +++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ-LTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEecccccccccccccccccc
Confidence 9999999 577777777545567999999999999999999999999 9999999999999
Q ss_pred CCCCCeEEeccCCcccCCCC-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcc---c
Q 013126 193 DEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRN---L 268 (449)
Q Consensus 193 ~~~~~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~---~ 268 (449)
+.++.+||+|||+++..... ....||+.|+|||++.+..++.++||||||+++|||++|+.||............ .
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 56789999999999865543 4567899999999999889999999999999999999999998764322211100 0
Q ss_pred ccccc----------------------------------c-ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 QMLTD----------------------------------S-CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 ~~~~~----------------------------------~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
...+. + ..........+.++.+++.+||+.||++|||+.++++
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0 0001112345678999999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=340.67 Aligned_cols=238 Identities=19% Similarity=0.284 Sum_probs=202.3
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC------CHHHHHHHHHHHhccC--CCCcccceeeEeeCC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLR--NNRLTNLLGCCCEGD 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~ 129 (449)
.+.|++++.||+|+||+||+|.+. +++.||||+++..... ..+.+.+|+.++++++ ||||+++++++..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 456889999999999999999964 5899999999764322 2346778999999996 599999999999999
Q ss_pred eeEEEEeeCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-CCCCeEEeccCCcc
Q 013126 130 ERLLVAEYMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLMK 207 (449)
Q Consensus 130 ~~~lV~Ey~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~ 207 (449)
..++|||++.+ ++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++ +++.+||+|||+++
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999986 899999973 467999999999999999999999999 99999999999999 78999999999998
Q ss_pred cCCCC--CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 208 NSRDG--KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 208 ~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
..... ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .... ....+...
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~----------~~~~~~~~ 266 (320)
T 3a99_A 199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRG----------QVFFRQRV 266 (320)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHC----------CCCCSSCC
T ss_pred ccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hhcc----------cccccccC
Confidence 76543 34568999999999987765 7789999999999999999999875421 1111 01223456
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
++++.+++.+||+.||++|||++++++
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 788999999999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.23 Aligned_cols=238 Identities=21% Similarity=0.310 Sum_probs=195.7
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCC------CHHHHHHHHHHHhcc----CCCCcccceeeEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP------DPRQFLEEARSVGQL----RNNRLTNLLGCCCEG 128 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~------~~~~~~~E~~~l~~l----~HpnIv~l~~~~~~~ 128 (449)
++|++.+.||+|+||.||+|.+ .+++.||+|+++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 4588899999999999999995 45899999999764322 223466899999999 899999999999999
Q ss_pred CeeEEEEee-CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC-CCCCeEEeccCCc
Q 013126 129 DERLLVAEY-MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD-EDGNPRLSTFGLM 206 (449)
Q Consensus 129 ~~~~lV~Ey-~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~-~~~~~kL~DFGla 206 (449)
+..++|||| +.+++|.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+||+++ +++.+||+|||++
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRG-VVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT-EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999 789999999974 457999999999999999999999999 99999999999999 8899999999999
Q ss_pred ccCCCC--CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCch
Q 013126 207 KNSRDG--KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 207 ~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (449)
+..... ....+|+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... .... ....+..
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~----------~~~~~~~ 255 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--ILEA----------ELHFPAH 255 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HHHT----------CCCCCTT
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hhhh----------ccCCccc
Confidence 876543 34568999999999987766 4589999999999999999999865421 1111 1123455
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.+.++.+++.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 67889999999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.01 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=183.8
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-H-HHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-P-RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~-~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.+++|++++.||+|+||.||+|.+. +|+.||||++....... . +.+.++..+++.++||||+++++++.+++..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 4567899999999999999999975 58999999997654222 2 2344455678888999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK-GRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
|||+ ++.+..+... ....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC-CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC-EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9999 5666655543 457899999999999999999999995 8 999999999999999999999999998765433
Q ss_pred --CccccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-HHhhcccccccccccCCCCCchh
Q 013126 213 --KSYSTNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
....+|+.|+|||++. +..++.++||||||+++|+|++|+.||...... ............ ........
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 256 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP---LLPGHMGF 256 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC---CCCSSSCC
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC---CCCccCCC
Confidence 2346899999999995 456889999999999999999999998652211 111111111110 01112346
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
++++.+++.+||+.||++|||++++++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 788999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=346.62 Aligned_cols=242 Identities=19% Similarity=0.125 Sum_probs=186.7
Q ss_pred cccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 62 ENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 3445678999999998776667999999998653 246788999999987 89999999999999999999999996
Q ss_pred CCHHHHHhccCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC-------------CCeEEec
Q 013126 141 ETLAKHLFHWETHP-----MKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED-------------GNPRLST 202 (449)
Q Consensus 141 gsL~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~-------------~~~kL~D 202 (449)
|+|.+++....... .++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 69999997422111 123345789999999999999999 9999999999999754 4799999
Q ss_pred cCCcccCCCCC--------ccccCccccccccccC-------CCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHH--Hh
Q 013126 203 FGLMKNSRDGK--------SYSTNLAFTPPEYLRT-------GRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDL--IR 264 (449)
Q Consensus 203 FGla~~~~~~~--------~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~--~~ 264 (449)
||+++...... ...||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....... +.
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~ 251 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHH
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHh
Confidence 99998765432 3468999999999976 568999999999999999999 888886542221 11
Q ss_pred hcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 265 DRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..... .+..........++++.+++.+||+.||++|||+.++++
T Consensus 252 ~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 252 RGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11110 011111223457789999999999999999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=325.81 Aligned_cols=232 Identities=16% Similarity=0.149 Sum_probs=187.1
Q ss_pred cccccccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
..|++++.||+|+||.||+|.+.. ++.||||+++.....+ .+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 358899999999999999999754 8999999998765433 367999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCcc
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 215 (449)
||++|++|.+++. .+ ....++..++.|++.||+|||++| |+||||||+|||++++|.+||+++|
T Consensus 111 e~~~g~~L~~~l~---~~-~~~~~~~~i~~ql~~aL~~lH~~g-ivH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVAD---TS-PSPVGAIRAMQSLAAAADAAHRAG-VALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHT---TC-CCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHh---cC-CChHHHHHHHHHHHHHHHHHHHCC-CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999999999994 23 355678899999999999999999 9999999999999999999998554
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc-cccCCCCCchhHHHHHHHHHH
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD-SCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 294 (449)
|++ .++.++||||||+++|||+||+.||.................. ..........+++++.+++.+
T Consensus 175 -----~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 242 (286)
T 3uqc_A 175 -----TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242 (286)
T ss_dssp -----CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHH
T ss_pred -----ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHH
Confidence 333 3788999999999999999999998764321100000000000 000011234567889999999
Q ss_pred hcccCCCCCCCHHHHHHHhccccccc
Q 013126 295 CLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
||+.||++| |+.++++.|+......
T Consensus 243 ~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 243 SVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HcccCCccC-CHHHHHHHHHHHhccC
Confidence 999999999 9999999998876543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=343.51 Aligned_cols=243 Identities=16% Similarity=0.115 Sum_probs=189.3
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
..|++.+.||+|+||+||.....+++.||||++.... ...+.+|+++++.+ +||||+++++++.+.+..|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 3577788889999999765555678999999996533 23467899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-----CCCeEEeccCCcccCCCC-
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-----DGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-----~~~~kL~DFGla~~~~~~- 212 (449)
+ |+|.+++.. .....++..+..++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 101 A-ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLN-IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp S-EEHHHHHHS-SSCCCCSSCHHHHHHHHHHHHHHHHHTT-CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred C-CCHHHHHHh-cCCCccchhHHHHHHHHHHHHHHHHHCc-CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 7 699999975 3344555667899999999999999999 999999999999953 235889999999865432
Q ss_pred ------CccccCccccccccccC---CCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCc
Q 013126 213 ------KSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 213 ------~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
....||+.|+|||++.+ ..++.++|||||||++|||++ |..||............... ... ......
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~--~~~~~~ 254 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC-SLD--CLHPEK 254 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC-CCT--TSCTTC
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC-Ccc--ccCccc
Confidence 23568999999999974 557889999999999999999 77777544322222111110 000 111234
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
..+..+.+++.+||+.||++|||+.++++
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 55677899999999999999999999996
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.27 Aligned_cols=252 Identities=17% Similarity=0.196 Sum_probs=197.4
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEee------CC
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCE------GD 129 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~ 129 (449)
.+..|++++.||+|+||+||+|.+. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.. ++
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3467999999999999999999964 5899999999764322 24678999999999999999999998765 67
Q ss_pred eeEEEEeeCCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCC---eEEeccCC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWE-THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGN---PRLSTFGL 205 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~---~kL~DFGl 205 (449)
..++||||++||+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g-IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT-BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 7899999999999999997532 236899999999999999999999999 999999999999997765 99999999
Q ss_pred cccCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-Hhh-------------ccc
Q 013126 206 MKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-IRD-------------RNL 268 (449)
Q Consensus 206 a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-~~~-------------~~~ 268 (449)
+...... ....||+.|+|||++.+..++.++||||||+++|+|++|..||....... +.. ...
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 9876543 34568999999999999999999999999999999999999986531111 000 000
Q ss_pred cc---cc-ccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 013126 269 QM---LT-DSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310 (449)
Q Consensus 269 ~~---~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil 310 (449)
.. .. ............++.+.+++.+||+.||++|||+.+++
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00 00 00111234456789999999999999999999997743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=320.33 Aligned_cols=227 Identities=15% Similarity=0.150 Sum_probs=184.0
Q ss_pred cccccc-cccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHH-hccCCCCcccceeeEee----CCeeE
Q 013126 60 AVENIV-SEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSV-GQLRNNRLTNLLGCCCE----GDERL 132 (449)
Q Consensus 60 ~~~~~l-~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~~~~~ 132 (449)
.+|+++ +.||+|+||.||+|... +++.||+|+++. ...+.+|+.++ +..+||||+++++++.. .+..+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 457777 66999999999999964 589999999963 35788999988 55699999999999987 67799
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---CCCeEEeccCCcccC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNS 209 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~~ 209 (449)
+||||++|++|.+++.......+++..++.++.|++.||+|||+++ ++||||||+||+++. ++.+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 9999999999999998655568999999999999999999999999 999999999999997 788999999998653
Q ss_pred CCCCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCC----chhH
Q 013126 210 RDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFT----DDDG 285 (449)
Q Consensus 210 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 285 (449)
. +..++.++||||||+++|+|++|+.||..................... ..+ ...+
T Consensus 171 ~------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 230 (299)
T 3m2w_A 171 T------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--EFPNPEWSEVS 230 (299)
T ss_dssp T------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC--SSCHHHHTTSC
T ss_pred c------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc--cCCchhcccCC
Confidence 2 245788999999999999999999998765433222222111111111 111 3467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
+++.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 231 EEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 889999999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=359.59 Aligned_cols=239 Identities=19% Similarity=0.240 Sum_probs=195.8
Q ss_pred cccccccccCCccceEEEEEEEc--CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCe-----e
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE--NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE-----R 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~--~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----~ 131 (449)
..|++++.||+|+||+||+|.+. +++.||||++...... ..+.+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 56889999999999999999975 5899999998754322 24578999999999999999999999988765 7
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
|+||||++|++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++++ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~g-iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIG-LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC-CeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 99999999999998774 27999999999999999999999999 9999999999999975 899999999998877
Q ss_pred CCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 212 GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 212 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
.....||+.|+|||++.++ ++.++||||||+++|+|++|..|+..... .... ........++.+.++
T Consensus 234 ~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~--------~~~~----~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 234 FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV--------DGLP----EDDPVLKTYDSYGRL 300 (681)
T ss_dssp CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC--------SSCC----TTCHHHHHCHHHHHH
T ss_pred CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc--------cccc----ccccccccCHHHHHH
Confidence 7777899999999999765 48899999999999999999877653211 0110 011111234689999
Q ss_pred HHHhcccCCCCCC-CHHHHHHHhcccc
Q 013126 292 ASRCLQYEPRERP-NPKSLVTALSPLQ 317 (449)
Q Consensus 292 i~~cl~~dP~~Rp-s~~eil~~L~~~~ 317 (449)
+.+||+.||++|| +++++.+.|..+.
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 9999999999998 5666666665543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.88 Aligned_cols=241 Identities=13% Similarity=0.083 Sum_probs=187.5
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCC--------CCHHHHHHHHHHHhccC---------CCCcccc
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW--------PDPRQFLEEARSVGQLR---------NNRLTNL 121 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~--------~~~~~~~~E~~~l~~l~---------HpnIv~l 121 (449)
.++|++++.||+|+||+||+|++ +|+.||||+++.... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688999999999999999998 789999999976432 22478999999999986 5555555
Q ss_pred eee-----------------Eee-------------CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHH
Q 013126 122 LGC-----------------CCE-------------GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQAL 171 (449)
Q Consensus 122 ~~~-----------------~~~-------------~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL 171 (449)
.++ +.+ ++..++||||+++|++.+.+. +..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHHH
Confidence 554 433 678999999999998777773 36789999999999999999
Q ss_pred HHHH-hCCCccccccccCceeeCCCC--------------------CeEEeccCCcccCCCCCccccCccccccccccCC
Q 013126 172 EYCT-SKGRALYHDLNAYRILFDEDG--------------------NPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTG 230 (449)
Q Consensus 172 ~yLH-~~~~iiHrDlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~gt~~y~aPE~~~~~ 230 (449)
+||| +++ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.+.
T Consensus 175 ~~lH~~~~-ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 175 AVAEASLR-FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHHHC-CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCCC
T ss_pred HHHHHhCC-EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcCC
Confidence 9999 898 99999999999999887 8999999999876543 45799999999999876
Q ss_pred CCCCCCceeeHhHH-HHHHhcCCCCCCchhh-HHHhhcccccc-cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHH
Q 013126 231 RVTPESVIYSFGTL-LLDLLSGKHIPPSHAL-DLIRDRNLQML-TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307 (449)
Q Consensus 231 ~~~~~sDvwSlGvi-l~elltg~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 307 (449)
. +.++||||+|++ .+++++|..|+....+ ........... .............++++.+||.+||++| |++
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 6 889999998777 7888999988754321 11111111010 0111111123457899999999999977 999
Q ss_pred HHH-H
Q 013126 308 SLV-T 311 (449)
Q Consensus 308 eil-~ 311 (449)
+++ +
T Consensus 327 e~l~~ 331 (336)
T 2vuw_A 327 DLLCQ 331 (336)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 998 6
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=330.82 Aligned_cols=240 Identities=15% Similarity=0.099 Sum_probs=183.5
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC---CHHHHHHHHHHHhccCC-CCcccce-----------
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP---DPRQFLEEARSVGQLRN-NRLTNLL----------- 122 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~~E~~~l~~l~H-pnIv~l~----------- 122 (449)
...+++.+.||+|+||+||+|.+. +|+.||||+++..... ..+.+.+|+.+++.++| +|.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 344667788999999999999954 5999999999843322 25789999999999987 3221111
Q ss_pred ----------eeEee-----CCeeEEEEeeCCCCCHHHHHh-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 013126 123 ----------GCCCE-----GDERLLVAEYMPNETLAKHLF-----HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALY 182 (449)
Q Consensus 123 ----------~~~~~-----~~~~~lV~Ey~~ggsL~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiH 182 (449)
.++.. ....+++|+++ +++|.+++. ......+++..++.++.|++.||+|||+++ |+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-iiH 234 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-LVH 234 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-EEC
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccc
Confidence 11111 12357777776 589999884 223456788899999999999999999999 999
Q ss_pred cccccCceeeCCCCCeEEeccCCcccCCCC-CccccCccccccccc----------cCCCCCCCCceeeHhHHHHHHhcC
Q 013126 183 HDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSYSTNLAFTPPEYL----------RTGRVTPESVIYSFGTLLLDLLSG 251 (449)
Q Consensus 183 rDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvil~elltg 251 (449)
|||||+|||++.++.+||+|||+++..... ....| +.|+|||++ .+..++.++|||||||++|||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999998865543 33456 999999999 555688999999999999999999
Q ss_pred CCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 252 KHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 252 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+.||.......... .... .....++++.+++.+||+.||++|||+.++++
T Consensus 314 ~~Pf~~~~~~~~~~----~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 314 DLPNTDDAALGGSE----WIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SCCCCTTGGGSCSG----GGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcchhhhHH----HHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99987653222111 1111 11245678999999999999999999877764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=297.82 Aligned_cols=179 Identities=13% Similarity=0.098 Sum_probs=129.9
Q ss_pred ccCCccceEEEEEE-EcCCCEEEEEEecCCCCC----------CHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeEEE
Q 013126 67 EHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWP----------DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 67 ~lG~G~~g~Vy~~~-~~~~~~vAiK~l~~~~~~----------~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 134 (449)
..+.|+.|.+..++ .-.|+.+|+|.+.+.... +.++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777777666 335889999999764321 124699999999999 799999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||++|++|.++|. ..++++.. +|+.||+.||+|+|++| ||||||||+|||++++|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~G-IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQG-FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHTT-CEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHCC-ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999997 55677754 58999999999999999 999999999999999999999999999876543
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCC
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK 252 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~ 252 (449)
....||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus 395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 23568999999999975 5677899999999988887664
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=256.46 Aligned_cols=177 Identities=12% Similarity=0.106 Sum_probs=144.9
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCC--------HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPD--------PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.+.||+|+||+||+|.. .++.+|+|+........ .+++.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 34679999999999954 57899999876533222 2358999999999999999977777778888899999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|++|++|.+++.. +..++.|++.||+|||+++ |+||||||+|||+++ .+||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g-IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND-VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT-EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc-CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999852 5689999999999999999 999999999999998 9999999999987653
Q ss_pred -------CccccCccccccccccC--CCCCCCCceeeHhHHHHHHhcCCCCC
Q 013126 213 -------KSYSTNLAFTPPEYLRT--GRVTPESVIYSFGTLLLDLLSGKHIP 255 (449)
Q Consensus 213 -------~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~ 255 (449)
....||+.|||||++.+ ..|+..+|+||..+-..+-+.++.++
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 24568999999999987 56888999999998888877766543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-26 Score=217.66 Aligned_cols=155 Identities=15% Similarity=0.088 Sum_probs=123.3
Q ss_pred HHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCC------------------CHHHHHHHHHHHhc
Q 013126 51 QLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP------------------DPRQFLEEARSVGQ 112 (449)
Q Consensus 51 ~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~------------------~~~~~~~E~~~l~~ 112 (449)
.+....++-..|++.+.||+|+||.||+|.+.+|+.||+|.++..... ....+.+|++++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 334444444556666999999999999999967999999999753211 13468899999999
Q ss_pred cCCCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee
Q 013126 113 LRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (449)
Q Consensus 113 l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl 192 (449)
++ | +++.+++.. +..++||||++|++|.+ +. . .....++.|++.||.|||+++ |+||||||+|||+
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--~------~~~~~i~~qi~~~l~~lH~~g-iiHrDlkp~NILl 226 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--V------ENPDEVLDMILEEVAKFYHRG-IVHGDLSQYNVLV 226 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--C------SCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEE
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--h------hhHHHHHHHHHHHHHHHHHCC-CEeCCCCHHHEEE
Confidence 99 5 677776544 56799999999999988 42 1 234579999999999999999 9999999999999
Q ss_pred CCCCCeEEeccCCcccCCCCCccccCccccccccccC
Q 013126 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRT 229 (449)
Q Consensus 193 ~~~~~~kL~DFGla~~~~~~~~~~gt~~y~aPE~~~~ 229 (449)
+ ++.+||+|||+++. +..++|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~---------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE---------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------CCCCCHHHHHHH
Confidence 9 99999999999864 344789998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.3e-22 Score=185.56 Aligned_cols=150 Identities=13% Similarity=0.080 Sum_probs=115.8
Q ss_pred CHHHHHHhhCCCcccccccccCCccceEEEEEEE-cCCCE--EEEEEecCCCCCC------------------------H
Q 013126 48 TLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRR--IAVKRFNRMAWPD------------------------P 100 (449)
Q Consensus 48 ~~~~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~--vAiK~l~~~~~~~------------------------~ 100 (449)
+...+....++-..|++.+.||+|+||.||+|.+ .+|+. ||||+++...... .
T Consensus 35 ~~~~l~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (258)
T 1zth_A 35 TLKTLYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVF 114 (258)
T ss_dssp HHHHHHHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHH
T ss_pred HHHHHHHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHH
Confidence 3444455555555678889999999999999997 67888 9999976532110 1
Q ss_pred HHHHHHHHHHhccCCCCc--ccceeeEeeCCeeEEEEeeCCC-C----CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 013126 101 RQFLEEARSVGQLRNNRL--TNLLGCCCEGDERLLVAEYMPN-E----TLAKHLFHWETHPMKWAMRLRVVLHLAQALEY 173 (449)
Q Consensus 101 ~~~~~E~~~l~~l~HpnI--v~l~~~~~~~~~~~lV~Ey~~g-g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~y 173 (449)
..+.+|+.+++++.|+++ +.+++. +..++||||+.+ | +|.+.... .++..+..++.|++.||.|
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~ 185 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKR 185 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHH
Confidence 368899999999998865 333332 356899999942 3 77776532 2345678899999999999
Q ss_pred HH-hCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 174 CT-SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 174 LH-~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
|| +.+ |+||||||+|||+++ .++|+|||++...
T Consensus 186 lH~~~g-ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 186 LYQEAE-LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHTSC-EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHCC-EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99 898 999999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-19 Score=177.62 Aligned_cols=148 Identities=13% Similarity=0.082 Sum_probs=106.5
Q ss_pred HHHHhhCCCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCC--------------CCHHHH--------HHHHH
Q 013126 51 QLKNATSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW--------------PDPRQF--------LEEAR 108 (449)
Q Consensus 51 ~l~~~~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~--------------~~~~~~--------~~E~~ 108 (449)
.+....+.=..|++.++||.|++|.||+|...+|+.||||+++.... ...... .+|..
T Consensus 86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 44555555567999999999999999999988899999999864211 011122 34555
Q ss_pred HHhccCCCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccC
Q 013126 109 SVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188 (449)
Q Consensus 109 ~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~ 188 (449)
.|.++.+.++.-..-+.. ...+|||||++|++|.+... . .....++.|++.+|.+||++| ||||||||.
T Consensus 166 nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~g-IVHrDLKp~ 234 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHG-LIHGDFNEF 234 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTT-EECSCCSTT
T ss_pred HHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCC-CcCCCCCHH
Confidence 666664444322211111 22379999999988865432 1 234568899999999999999 999999999
Q ss_pred ceeeCCCC----------CeEEeccCCcccC
Q 013126 189 RILFDEDG----------NPRLSTFGLMKNS 209 (449)
Q Consensus 189 NILl~~~~----------~~kL~DFGla~~~ 209 (449)
|||++++| .+.|+||+-+...
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99998776 3899999977654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=9.7e-14 Score=130.44 Aligned_cols=138 Identities=12% Similarity=0.001 Sum_probs=110.9
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.|++....|.|+.+.||++... ++.+++|............+.+|+++++.+. +.+++++++++...+..|+||||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 3566777788899999999853 6899999987532233456889999999994 6788999999999899999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS------------------------------------------- 176 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~------------------------------------------- 176 (449)
|.+|.+.+. +......++.+++.+|+.||+
T Consensus 94 G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 94 GVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999987641 112234678899999999998
Q ss_pred ----------------CCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 177 ----------------KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 177 ----------------~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
.. ++|+|++|.||++++++.+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~-l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELV-FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEE-EECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCce-EECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 33 8999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.4e-12 Score=119.22 Aligned_cols=127 Identities=13% Similarity=0.085 Sum_probs=97.6
Q ss_pred CCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC--cccceeeEeeCCeeEEEEeeCCCCCHHHH
Q 013126 69 GEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTNLLGCCCEGDERLLVAEYMPNETLAKH 146 (449)
Q Consensus 69 G~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~ 146 (449)
+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +++++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 466679999998766788999998654 2356789999999996544 566888888888899999999998884
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 013126 147 LFHWETHPMKWAMRLRVVLHLAQALEYCTSKG------------------------------------------------ 178 (449)
Q Consensus 147 l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------------------------ 178 (449)
. .. .+ ...++.+++..|+.||+..
T Consensus 104 ~---~~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 S---SH--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp T---SC--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred c---Cc--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 2 11 11 2356777788888888642
Q ss_pred ---------CccccccccCceeeCCCCCeEEeccCCccc
Q 013126 179 ---------RALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 179 ---------~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
.++|+|++|.||++++++.+.|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 089999999999998776677999998643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.5e-11 Score=121.02 Aligned_cols=159 Identities=14% Similarity=0.169 Sum_probs=114.5
Q ss_pred cccCHHHHHHh----hCCCcccccccccCCccceEEEEEEEcCCCEEEEEEec--CCCC-CCHHHHHHHHHHHhccC--C
Q 013126 45 REFTLEQLKNA----TSGFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFN--RMAW-PDPRQFLEEARSVGQLR--N 115 (449)
Q Consensus 45 ~~~~~~~l~~~----~~~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~--~~~~-~~~~~~~~E~~~l~~l~--H 115 (449)
..++...+... ...+....-++.++.|.++.||+.... +..+++|+.. .... .....+.+|+.+++.+. +
T Consensus 19 ~~ld~~~l~~~l~~~~~~~~~~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~ 97 (359)
T 3dxp_A 19 QRFDTEALEAWMRQHVEGFAGPLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTD 97 (359)
T ss_dssp -CCCHHHHHHHHHHHSTTCCCCCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSS
T ss_pred cCCCHHHHHHHHHHhCCCCCCCceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCC
Confidence 34555444433 223333445678899999999999864 4688999876 3321 22456889999999997 4
Q ss_pred CCcccceeeEeeC---CeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------
Q 013126 116 NRLTNLLGCCCEG---DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK--------------- 177 (449)
Q Consensus 116 pnIv~l~~~~~~~---~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------------- 177 (449)
.++++++.++.+. +..++||||++|.++.+.. ...++......++.++++.|+.||+.
T Consensus 98 vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~ 173 (359)
T 3dxp_A 98 VPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGN 173 (359)
T ss_dssp SCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSC
T ss_pred CCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCC
Confidence 5688899888776 4589999999988775422 23477888899999999999999972
Q ss_pred ------------------------------------------CCccccccccCceeeCCCCC--eEEeccCCccc
Q 013126 178 ------------------------------------------GRALYHDLNAYRILFDEDGN--PRLSTFGLMKN 208 (449)
Q Consensus 178 ------------------------------------------~~iiHrDlkp~NILl~~~~~--~kL~DFGla~~ 208 (449)
..++|+|++|.||+++.++. +.|+||+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 174 YFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred chHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 12899999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-11 Score=118.55 Aligned_cols=184 Identities=13% Similarity=0.110 Sum_probs=123.6
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCC--cccceeeEeeCC---eeEEEEeeC
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNR--LTNLLGCCCEGD---ERLLVAEYM 138 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~Ey~ 138 (449)
++.++.|..+.||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++.....++ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4567899999999863 46899986532 22467899999999884 433 445554443333 358999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK----------------------------------------- 177 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------------------------------------- 177 (449)
+|.+|.+... ..++..++..++.+++..|+.||+.
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988875432 2467777888888888888888861
Q ss_pred ----------------CCccccccccCceeeCC--CCCeEEeccCCcccCCCCCccccCccc---cccccccC-------
Q 013126 178 ----------------GRALYHDLNAYRILFDE--DGNPRLSTFGLMKNSRDGKSYSTNLAF---TPPEYLRT------- 229 (449)
Q Consensus 178 ----------------~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~gt~~y---~aPE~~~~------- 229 (449)
..++|+|++|.||++++ ++.+.|+||+.+..............+ ..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 01699999999999997 556889999988754332211111111 22222110
Q ss_pred -------CCCCCCCceeeHhHHHHHHhcCCCCCCch
Q 013126 230 -------GRVTPESVIYSFGTLLLDLLSGKHIPPSH 258 (449)
Q Consensus 230 -------~~~~~~sDvwSlGvil~elltg~~p~~~~ 258 (449)
.......+.|++|.++|.+.+|..++...
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~ 290 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEE 290 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHH
Confidence 00112257899999999999998665443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=8e-08 Score=92.19 Aligned_cols=134 Identities=13% Similarity=0.062 Sum_probs=94.2
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCC---CcccceeeEe-eCCeeEEEEeeCCC
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN---RLTNLLGCCC-EGDERLLVAEYMPN 140 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lV~Ey~~g 140 (449)
++.++.|....||+. ++.+++|+.... .....+.+|+++|+.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456688888899988 567889985321 1246789999999999753 3666676664 34567899999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG------------------------------------------ 178 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------------------ 178 (449)
.+|.+... ..++......++.+++..|+.||+..
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88876322 12345555555566666655555421
Q ss_pred -----------------CccccccccCceeeCC---CCC-eEEeccCCccc
Q 013126 179 -----------------RALYHDLNAYRILFDE---DGN-PRLSTFGLMKN 208 (449)
Q Consensus 179 -----------------~iiHrDlkp~NILl~~---~~~-~kL~DFGla~~ 208 (449)
.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1589999999999997 455 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=2.2e-07 Score=87.02 Aligned_cols=130 Identities=16% Similarity=0.057 Sum_probs=93.7
Q ss_pred Cccce-EEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEeeCCCCCHHHH
Q 013126 70 EKAPN-VVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMPNETLAKH 146 (449)
Q Consensus 70 ~G~~g-~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~ 146 (449)
.|..| .||+.... ++..+.+|.-... ....+.+|...|+.+. +-.+.++++++.+++..++|||+++|.++.+.
T Consensus 34 ~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 34 VGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp CSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred CCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 34443 68988754 4678999987542 2457889999999884 44578889999999999999999999888776
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 013126 147 LFHWETHPMKWAMRLRVVLHLAQALEYCTSKG------------------------------------------------ 178 (449)
Q Consensus 147 l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------------------------ 178 (449)
... .......+..+++..|+-||+..
T Consensus 111 ~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 111 LEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred ccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 531 11223344555555555555310
Q ss_pred ---------CccccccccCceeeCCCCCeEEeccCCccc
Q 013126 179 ---------RALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 179 ---------~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
-++|+|+.|.||++++++.+-|+||+.+..
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999887778999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.3e-07 Score=92.64 Aligned_cols=80 Identities=5% Similarity=-0.048 Sum_probs=57.5
Q ss_pred cccc-CCccceEEEEEEEc-------CCCEEEEEEecCCC---CCCHHHHHHHHHHHhccC-C--CCcccceeeEeeC--
Q 013126 65 VSEH-GEKAPNVVYKGKLE-------NQRRIAVKRFNRMA---WPDPRQFLEEARSVGQLR-N--NRLTNLLGCCCEG-- 128 (449)
Q Consensus 65 l~~l-G~G~~g~Vy~~~~~-------~~~~vAiK~l~~~~---~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~-- 128 (449)
++.+ +.|..+.+|+.... +++.+++|...... ......+.+|+.+++.+. + ..+.+++.+..++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4566 78989999998764 26789999875432 112246788999999884 3 3577888877655
Q ss_pred -CeeEEEEeeCCCCCHH
Q 013126 129 -DERLLVAEYMPNETLA 144 (449)
Q Consensus 129 -~~~~lV~Ey~~ggsL~ 144 (449)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3578999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.1e-06 Score=85.17 Aligned_cols=76 Identities=13% Similarity=0.076 Sum_probs=51.9
Q ss_pred cccccCCccceEEEEEEEc-CCCEEEEEEecCCCC-------CCHHHHHHHHHHHhccCC--C-CcccceeeEeeCCeeE
Q 013126 64 IVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW-------PDPRQFLEEARSVGQLRN--N-RLTNLLGCCCEGDERL 132 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~-------~~~~~~~~E~~~l~~l~H--p-nIv~l~~~~~~~~~~~ 132 (449)
-++.+|.|..+.||++... +++.+++|....... ...+++..|+++++.+.. | .+++++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3567899999999999754 478999998653211 124567889999988842 3 34456544 445678
Q ss_pred EEEeeCCCC
Q 013126 133 LVAEYMPNE 141 (449)
Q Consensus 133 lV~Ey~~gg 141 (449)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.32 E-value=5.9e-06 Score=79.78 Aligned_cols=138 Identities=11% Similarity=0.123 Sum_probs=81.0
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC--CCccccee------eEeeCCeeEEEEe
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN--NRLTNLLG------CCCEGDERLLVAE 136 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~------~~~~~~~~~lV~E 136 (449)
++.++.|..+.||+....+| .+++|+... ...+...|..+++.+.. -++++++. +...++..+++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566678899999987554 599999875 23455566666666632 23344443 1234667899999
Q ss_pred eCCCCCHH--------------HHHhcc-CCC--C---------CCHHHH------------------------------
Q 013126 137 YMPNETLA--------------KHLFHW-ETH--P---------MKWAMR------------------------------ 160 (449)
Q Consensus 137 y~~ggsL~--------------~~l~~~-~~~--~---------l~~~~~------------------------------ 160 (449)
|++|.++. ..++.. ... + -.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986532 111110 100 0 112110
Q ss_pred -HHHHHHHHHHHHHHHh-------------CCCccccccccCceeeCCCCCeEEeccCCccc
Q 013126 161 -LRVVLHLAQALEYCTS-------------KGRALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 161 -~~i~~qi~~aL~yLH~-------------~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
..+..++..++++|+. .. ++|+|++|.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPN-LCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCC-EECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCc-eecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223345666652 34 99999999999998888999999997643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.7e-05 Score=74.93 Aligned_cols=76 Identities=21% Similarity=0.234 Sum_probs=57.4
Q ss_pred ccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC---CCcccceeeEeeCCeeEEEEeeCC
Q 013126 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN---NRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.-++.+|.|..+.||+.+..+|+.|.+|+...........|.+|+..|+.+.. -.+++++++. .-++||||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence 34677899999999999998999999999766554445678899999999843 2345555442 3478999998
Q ss_pred CCC
Q 013126 140 NET 142 (449)
Q Consensus 140 ggs 142 (449)
++.
T Consensus 94 ~~~ 96 (288)
T 3f7w_A 94 ERP 96 (288)
T ss_dssp CCC
T ss_pred ccC
Confidence 754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.1e-05 Score=75.33 Aligned_cols=75 Identities=15% Similarity=0.068 Sum_probs=61.1
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC---CCCcccceeeEeeCCeeEEEEeeCCCC
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR---NNRLTNLLGCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~gg 141 (449)
++.++.|..+.+|+... +++.+++|+.... ....+.+|+..|+.+. ...+++++++....+..++||||++|.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45679999999999986 4678999987642 3567899999999984 367888999888888899999999987
Q ss_pred CH
Q 013126 142 TL 143 (449)
Q Consensus 142 sL 143 (449)
++
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.92 E-value=8e-05 Score=71.32 Aligned_cols=159 Identities=13% Similarity=0.130 Sum_probs=92.1
Q ss_pred cccCHHHHHHhhCCCccc--ccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC--ccc
Q 013126 45 REFTLEQLKNATSGFAVE--NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR--LTN 120 (449)
Q Consensus 45 ~~~~~~~l~~~~~~f~~~--~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~ 120 (449)
..++.+++......|... .-++.++.|....+|+....+| .+++|...... ..+.+..|+.+++.+...+ +.+
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 346677777777666542 2356678888899999987555 68899987531 2345667888888774322 344
Q ss_pred ceee------EeeCCeeEEEEeeCCCCCHHH--------------HHhcc-CC--CC----CC---HHHHHH--------
Q 013126 121 LLGC------CCEGDERLLVAEYMPNETLAK--------------HLFHW-ET--HP----MK---WAMRLR-------- 162 (449)
Q Consensus 121 l~~~------~~~~~~~~lV~Ey~~ggsL~~--------------~l~~~-~~--~~----l~---~~~~~~-------- 162 (449)
++.. ....+..+++|+|++|.++.. .++.. .. .+ .. |.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 4321 123456789999999865311 01110 00 00 11 111000
Q ss_pred ----HHHHHHHHHHHHHh-------CCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 163 ----VVLHLAQALEYCTS-------KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 163 ----i~~qi~~aL~yLH~-------~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
+...+...++.++. .+ ++|+|++|.||++++++.+.++||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~-liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAG-VIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEE-EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcc-cCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113344555542 24 8999999999999987666899998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.89 E-value=7.7e-05 Score=74.50 Aligned_cols=74 Identities=14% Similarity=0.168 Sum_probs=46.6
Q ss_pred cccccCCccceEEEEEEEcCCCEEEEEEecCC------C---CCCHHHHHHHHHHHh-ccCCCCcccceeeEeeCCeeEE
Q 013126 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFNRM------A---WPDPRQFLEEARSVG-QLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~------~---~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~l 133 (449)
-++.+|.|..+.||++.. +++.++||..... . ......+..|+..+. ......+++++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356779999999999964 4678999943211 0 012233444443332 22335677777765 567799
Q ss_pred EEeeC-CC
Q 013126 134 VAEYM-PN 140 (449)
Q Consensus 134 V~Ey~-~g 140 (449)
||||+ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 86
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00023 Score=68.29 Aligned_cols=97 Identities=19% Similarity=0.160 Sum_probs=62.4
Q ss_pred ccccCHHHHHHhhCCCccc--ccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCC--Ccc
Q 013126 44 FREFTLEQLKNATSGFAVE--NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNN--RLT 119 (449)
Q Consensus 44 ~~~~~~~~l~~~~~~f~~~--~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv 119 (449)
....+.+++......+... .-+..++ |....||+....+|+.+++|..+... ...+.+..|..+++.+... .++
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence 3456666666665444321 1234556 88889999887667789999987432 2456778899888888432 244
Q ss_pred cceee-----EeeCCeeEEEEeeCCCCC
Q 013126 120 NLLGC-----CCEGDERLLVAEYMPNET 142 (449)
Q Consensus 120 ~l~~~-----~~~~~~~~lV~Ey~~ggs 142 (449)
+++.. ...++..+++|||++|.+
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCC
Confidence 44443 223456688999999754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00018 Score=64.33 Aligned_cols=141 Identities=12% Similarity=0.035 Sum_probs=94.7
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCccccCc
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCT-SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNL 219 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~gt~ 219 (449)
-||.+.|.. .+.+++++++|.++.|.+.+|.-+- .+. -..+=+.|..|++..+|.+...+ +.+ .....
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s--------~~~~~ 101 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AAD--------DAGEP 101 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-ccc--------ccccc
Confidence 479998875 5789999999999999999987762 222 12233457999999999987763 111 11234
Q ss_pred cccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHHhccc-
Q 013126 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY- 298 (449)
Q Consensus 220 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~- 298 (449)
.+.|||... ...+.+.=|||||+++|..+--..|... ...+++.+.+||..|...
T Consensus 102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e-----------------------E~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE-----------------------ERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE-----------------------EECCCHHHHHHHHHHTTCC
T ss_pred CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc-----------------------chhhCHHHHHHHHHHHhcc
Confidence 577888773 3456788899999999999876544321 234567788999888765
Q ss_pred ------------------------CCCCCCCHHHHHHHhccc
Q 013126 299 ------------------------EPRERPNPKSLVTALSPL 316 (449)
Q Consensus 299 ------------------------dP~~Rps~~eil~~L~~~ 316 (449)
.+..|++.++|++.-+.-
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence 245788999998865443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00011 Score=69.80 Aligned_cols=71 Identities=13% Similarity=0.155 Sum_probs=46.0
Q ss_pred ccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCc-ccceeeEeeCCeeEEEEeeC-CCCC
Q 013126 65 VSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYM-PNET 142 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~-~ggs 142 (449)
++.++.|..+.+|+. +.+++|+....... .....+|+.+++.+...++ .++++. +.+.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567788999999999 46899988653211 1223568888888753333 455554 333457899999 7655
Q ss_pred H
Q 013126 143 L 143 (449)
Q Consensus 143 L 143 (449)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.0002 Score=68.96 Aligned_cols=138 Identities=9% Similarity=-0.003 Sum_probs=73.5
Q ss_pred cccCCccceE-EEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC--CCcccceeeEeeCCeeEEEEeeCCCCC
Q 013126 66 SEHGEKAPNV-VYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN--NRLTNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 66 ~~lG~G~~g~-Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
+.++.|+... +|+....+++.+++|....... +.+..|+.+++.+.. -.+.+++.+....+ +++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4455555544 6677654467788887544321 334567777777642 23566676643333 78999998777
Q ss_pred HHHHHhcc---------------------CC---CCCCHHHHH-------HH-------------HHHHHHHHHHH----
Q 013126 143 LAKHLFHW---------------------ET---HPMKWAMRL-------RV-------------VLHLAQALEYC---- 174 (449)
Q Consensus 143 L~~~l~~~---------------------~~---~~l~~~~~~-------~i-------------~~qi~~aL~yL---- 174 (449)
+.+.+... .. ..++..... .+ ...+...++.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 75443210 00 011111100 00 00111122222
Q ss_pred --HhCCCccccccccCceeeCCC----CCeEEeccCCcccC
Q 013126 175 --TSKGRALYHDLNAYRILFDED----GNPRLSTFGLMKNS 209 (449)
Q Consensus 175 --H~~~~iiHrDlkp~NILl~~~----~~~kL~DFGla~~~ 209 (449)
+... ++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 179 ~~~~~~-lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMV-FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCE-EECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCe-eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1234 9999999999999874 67999999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.0002 Score=70.42 Aligned_cols=138 Identities=14% Similarity=0.199 Sum_probs=83.1
Q ss_pred ccccCCccceEEEEEEEc--------CCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEE
Q 013126 65 VSEHGEKAPNVVYKGKLE--------NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~--------~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 135 (449)
++.+..|-...+|+.... +++.+.+|+.... ........+|.++++.+. +.-..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356677888999999864 2478999996332 234567779999999884 3333566666543 3999
Q ss_pred eeCCCCCHHHH--------------Hhcc--C----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 013126 136 EYMPNETLAKH--------------LFHW--E----THPMK--WAMRLRVVLHLAQ-------------------ALEYC 174 (449)
Q Consensus 136 Ey~~ggsL~~~--------------l~~~--~----~~~l~--~~~~~~i~~qi~~-------------------aL~yL 174 (449)
||++|.+|... +.+- . ..... +.+..++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655311 1100 0 11122 3455555544422 22333
Q ss_pred H----hCC---CccccccccCceeeCCC----CCeEEeccCCcc
Q 013126 175 T----SKG---RALYHDLNAYRILFDED----GNPRLSTFGLMK 207 (449)
Q Consensus 175 H----~~~---~iiHrDlkp~NILl~~~----~~~kL~DFGla~ 207 (449)
. ..+ -++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 211 18999999999999876 789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00023 Score=71.29 Aligned_cols=73 Identities=16% Similarity=0.303 Sum_probs=51.8
Q ss_pred ccccCCccceEEEEEEEcC--------CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCc-ccceeeEeeCCeeEEEE
Q 013126 65 VSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVA 135 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~--------~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~ 135 (449)
++.++.|....||+....+ ++.+++|+.... ...+.+.+|..+++.+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567889899999998653 578999998432 122567789999999854444 566665532 3899
Q ss_pred eeCCCCCH
Q 013126 136 EYMPNETL 143 (449)
Q Consensus 136 Ey~~ggsL 143 (449)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0014 Score=63.38 Aligned_cols=68 Identities=7% Similarity=0.020 Sum_probs=44.5
Q ss_pred CCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC---CCcccceee------EeeCCeeEEEEeeCC
Q 013126 69 GEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN---NRLTNLLGC------CCEGDERLLVAEYMP 139 (449)
Q Consensus 69 G~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~------~~~~~~~~lV~Ey~~ 139 (449)
|.|....||+....+| .+++|+...... .+|+..++.|.. |++++++.. ...++..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444789999987666 899998765432 355666665531 224454432 233567899999999
Q ss_pred CCCH
Q 013126 140 NETL 143 (449)
Q Consensus 140 ggsL 143 (449)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0021 Score=64.83 Aligned_cols=74 Identities=14% Similarity=0.082 Sum_probs=48.7
Q ss_pred ccccCCccceEEEEEEEcC-CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCc-ccceeeEeeCCeeEEEEeeCCCCC
Q 013126 65 VSEHGEKAPNVVYKGKLEN-QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL-TNLLGCCCEGDERLLVAEYMPNET 142 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~ggs 142 (449)
++.|+.|-...+|+....+ ++.+++|+...... ..-+-.+|..+++.+...++ +++++.+. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567888899999998755 47899998754321 11122589999999865444 56777663 2 35999999755
Q ss_pred H
Q 013126 143 L 143 (449)
Q Consensus 143 L 143 (449)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00036 Score=68.28 Aligned_cols=74 Identities=12% Similarity=0.179 Sum_probs=45.8
Q ss_pred ccccCCccceEEEEEEEcC---------CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC-cccceeeEeeCCeeEEE
Q 013126 65 VSEHGEKAPNVVYKGKLEN---------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLV 134 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~---------~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV 134 (449)
++.++.|....+|+....+ ++.+++|+...... ...+..+|..+++.+...+ +.++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888899999998643 26899998754321 1112467888888885434 44666544 2 3789
Q ss_pred EeeCCCCCH
Q 013126 135 AEYMPNETL 143 (449)
Q Consensus 135 ~Ey~~ggsL 143 (449)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999997543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.011 Score=58.85 Aligned_cols=75 Identities=16% Similarity=0.111 Sum_probs=50.5
Q ss_pred cccccCCccceEEEEEEEcC--------CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC-cccceeeEeeCCeeEEE
Q 013126 64 IVSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLV 134 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~~--------~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV 134 (449)
-++.+..|-...+|+....+ ++.+++|+...... ..-+-.+|..+++.+...+ ..++++.+ . -++|
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 35677789999999998753 58899999754321 1123457888888885333 45566533 2 2789
Q ss_pred EeeCCCCCH
Q 013126 135 AEYMPNETL 143 (449)
Q Consensus 135 ~Ey~~ggsL 143 (449)
|||++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.41 E-value=0.15 Score=50.18 Aligned_cols=29 Identities=21% Similarity=0.134 Sum_probs=24.1
Q ss_pred ccccccccCceee------CCCCCeEEeccCCccc
Q 013126 180 ALYHDLNAYRILF------DEDGNPRLSTFGLMKN 208 (449)
Q Consensus 180 iiHrDlkp~NILl------~~~~~~kL~DFGla~~ 208 (449)
++|+|+.+.||++ ++++.++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999987643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.53 E-value=0.068 Score=53.77 Aligned_cols=62 Identities=5% Similarity=-0.034 Sum_probs=19.6
Q ss_pred ccccccCCccceEEEEEEEcC-CCEEEE------EEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEee
Q 013126 63 NIVSEHGEKAPNVVYKGKLEN-QRRIAV------KRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCE 127 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~~-~~~vAi------K~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 127 (449)
.+.+++| ||.||+|.+.. ..+||+ |..+.... .....+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 5567777 99999999754 468888 76654322 223568899999999999999999887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.86 E-value=2.6 Score=37.47 Aligned_cols=83 Identities=13% Similarity=0.142 Sum_probs=58.6
Q ss_pred CCCCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCccccccccCceee
Q 013126 114 RNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALE-YCTSKGRALYHDLNAYRILF 192 (449)
Q Consensus 114 ~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~-yLH~~~~iiHrDlkp~NILl 192 (449)
.||+. -..+-.+++.+.+.++.-+++.=...+ ..++...+++++.+|+.... +++. -+|--|.|+||++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~---r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSAR---RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSS---SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhC---ceeEEEeCceEEE
Confidence 57777 445556677777777765443323344 24778889988888877555 4433 5677899999999
Q ss_pred CCCCCeEEeccCCc
Q 013126 193 DEDGNPRLSTFGLM 206 (449)
Q Consensus 193 ~~~~~~kL~DFGla 206 (449)
+.++.+++.-.|+-
T Consensus 118 ~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 118 NRALEPFFLHVGVK 131 (219)
T ss_dssp CTTCCEEESCCEET
T ss_pred eCCCcEEEEEcCCc
Confidence 99999999977753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.52 E-value=2.5 Score=37.39 Aligned_cols=114 Identities=15% Similarity=0.169 Sum_probs=73.1
Q ss_pred CCCCcccceeeEeeCCeeEEEEeeCCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceee
Q 013126 114 RNNRLTNLLGCCCEGDERLLVAEYMPNE-TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192 (449)
Q Consensus 114 ~HpnIv~l~~~~~~~~~~~lV~Ey~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl 192 (449)
.||+.+.. .+-.+.+.+.+.++.-+++ ++.. + ..++...+++++.+|+....+++. -+|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecceEEE
Confidence 57888866 5666667666666654422 2222 3 357788899999999887744433 4677899999999
Q ss_pred CCCCCeEEeccCCcccCCCCCccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCC
Q 013126 193 DEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP 255 (449)
Q Consensus 193 ~~~~~~kL~DFGla~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~ 255 (449)
+.++.+++.--|+... ++|.-+ +...=.-.+=+++..+++++..|
T Consensus 113 ~~~~~p~i~~RGik~~-------------l~P~~~-----~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV-------------VDPLPV-----SEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp CTTSCEEESCCEETTT-------------BSCCCC-----CHHHHHHHHHHHHHHHHCTTCCH
T ss_pred cCCCCEEEEEccCccC-------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999987665322 222211 11111124557788888887654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 449 | ||||
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-32 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-22 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-21 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-15 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-13 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-06 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-41
Identities = 52/249 (20%), Positives = 105/249 (42%), Gaps = 12/249 (4%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
+V+ G N+ ++A+K A + F+EEA + +L + +L L G C E LV
Sbjct: 20 LVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
E+M + L+ + + L + L + + + Y ++ DL A L E
Sbjct: 79 FEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGE 136
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ ++S FG+ + D + S+ + + PE R + +S ++SFG L+ ++
Sbjct: 137 NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
S IP + + + + T + ++ + C + P +RP L
Sbjct: 197 SEGKIPYEN----RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252
Query: 310 VTALSPLQK 318
+ L+ + +
Sbjct: 253 LRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-40
Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 12/244 (4%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VV GK Q +A+K + + +F+EEA+ + L + +L L G C + ++
Sbjct: 19 VVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
EYM N L +L H + L + + +A+EY SK L+ DL A L ++
Sbjct: 78 TEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF-LHRDLAARNCLVND 135
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
G ++S FGL + D + S+ + ++PPE L + + +S I++FG L+ ++
Sbjct: 136 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
S +P + L ++ + C + ERP K L
Sbjct: 196 SLGKMPYER----FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
Query: 310 VTAL 313
++ +
Sbjct: 252 LSNI 255
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-40
Identities = 59/257 (22%), Positives = 107/257 (41%), Gaps = 22/257 (8%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
V+ G ++AVK + + P FL EA + QL++ RL L + + ++
Sbjct: 28 EVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
EYM N +L L + L + +A+ + + + ++ DL A IL +
Sbjct: 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY-IHRDLRAANILVSD 144
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + + +T PE + G T +S ++SFG LL +++
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 250 SGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
+ IP + + + D+C E EL +L C + P +RP
Sbjct: 205 THGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRP 255
Query: 305 NPKSLVTALSPLQKETE 321
L + L TE
Sbjct: 256 TFDYLRSVLEDFFTATE 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-39
Identities = 60/256 (23%), Positives = 103/256 (40%), Gaps = 12/256 (4%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
V+ G R+A+K P FL+EA+ + +LR+ +L L E + +V
Sbjct: 32 EVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
EYM +L L ++ + + +A + Y ++ DL A IL E
Sbjct: 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-VHRDLRAANILVGE 148
Query: 195 DGNPRLSTFGLMKNSRDGKSYSTN-----LAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
+ +++ FGL + D + + + +T PE GR T +S ++SFG LL +L
Sbjct: 149 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ +P + +R + + + L L +C + EP ERP + L
Sbjct: 209 TKGRVPYPG----MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264
Query: 310 VTALSPLQKETEVPSH 325
L TE
Sbjct: 265 QAFLEDYFTSTEPQYQ 280
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 4e-39
Identities = 54/258 (20%), Positives = 109/258 (42%), Gaps = 12/258 (4%)
Query: 75 VVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VY+G + +AVK + +FL+EA + ++++ L LLG C +
Sbjct: 32 EVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
+ E+M L +L + + L + ++ A+EY K ++ DL A L
Sbjct: 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-IHRDLAARNCLVG 149
Query: 194 EDGNPRLSTFGLMKNSRDGKSYST-----NLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
E+ +++ FGL + + + +T PE L + + +S +++FG LL ++
Sbjct: 150 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKS 308
+ P +DL + L + + + ++ L C Q+ P +RP+
Sbjct: 210 ATYGM-SPYPGIDL---SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 265
Query: 309 LVTALSPLQKETEVPSHV 326
+ A + +E+ + V
Sbjct: 266 IHQAFETMFQESSISDEV 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-39
Identities = 62/251 (24%), Positives = 100/251 (39%), Gaps = 20/251 (7%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL-L 133
V G ++AVK A + FL EA + QLR++ L LLG E L +
Sbjct: 22 DVMLGDYRG-NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
V EYM +L +L + L+ L + +A+EY ++ DL A +L
Sbjct: 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-VHRDLAARNVLVS 137
Query: 194 EDGNPRLSTFGLMKN-SRDGKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK 252
ED ++S FGL K S + + +T PE LR + + +S ++SFG LL ++ S
Sbjct: 138 EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197
Query: 253 HIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
+P + + D C + + C + RP+
Sbjct: 198 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMRPSFL 248
Query: 308 SLVTALSPLQK 318
L L ++
Sbjct: 249 QLREQLEHIKT 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (347), Expect = 5e-38
Identities = 59/292 (20%), Positives = 112/292 (38%), Gaps = 26/292 (8%)
Query: 47 FTLEQLKNATSGFAVENIVSEH------GEKAPNVVYKGKL----ENQRRIAVKRFNRMA 96
FT E A FA E +S G V G L + + +A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 97 WPDP-RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPM 155
R FL EA +GQ + + +L G + +++ E+M N +L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 156 KWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY 215
+ ++ +A ++Y ++ DL A IL + + ++S FGL + D S
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNY-VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 216 STN---------LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDR 266
T + +T PE ++ + T S ++S+G ++ +++S P + ++
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD----MTNQ 240
Query: 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318
++ + D + L +L C Q + RP +V L + +
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 9e-38
Identities = 51/258 (19%), Positives = 102/258 (39%), Gaps = 20/258 (7%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134
VYKGK + + + F E + + R+ + +G + +V
Sbjct: 23 TVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 81
Query: 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194
++ +L HL ET + + + AQ ++Y +K ++ DL + I E
Sbjct: 82 TQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSI-IHRDLKSNNIFLHE 139
Query: 195 DGNPRLSTFGL--MKNSRDGKSYSTNLAFTP----PEYLRT---GRVTPESVIYSFGTLL 245
D ++ FGL +K+ G L+ + PE +R + +S +Y+FG +L
Sbjct: 140 DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 246 LDLLSGK----HIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
+L++G+ +I + + R S + + RL + CL+ +
Sbjct: 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK----AMKRLMAECLKKKRD 255
Query: 302 ERPNPKSLVTALSPLQKE 319
ERP ++ ++ L +
Sbjct: 256 ERPLFPQILASIELLARS 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-36
Identities = 55/272 (20%), Positives = 100/272 (36%), Gaps = 25/272 (9%)
Query: 45 REFTLEQLKNATSGFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDP--- 100
R++ LE + I G+ VY + +++ +A+K +
Sbjct: 1 RQWALEDFE----------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 50
Query: 101 RQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMR 160
Q E LR+ + L G + L+ EY P T+ + L
Sbjct: 51 HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRT 108
Query: 161 LRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-- 218
+ LA AL YC SK ++ D+ +L G +++ FG ++ + +
Sbjct: 109 ATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 167
Query: 219 LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278
L + PPE + + ++S G L + L GK ++ R + +E
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEF 221
Query: 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLV 310
F D L SR L++ P +RP + ++
Sbjct: 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 6e-35
Identities = 48/243 (19%), Positives = 85/243 (34%), Gaps = 14/243 (5%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
VY + + N +A+K+ + + ++E R + +LR+ GC
Sbjct: 30 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
LV EY H P++ V Q L Y S ++ D+ A I
Sbjct: 90 AWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNM-IHRDVKAGNI 146
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRT---GRVTPESVIYSFGTLLLD 247
L E G +L FG S+ + PE + G+ + ++S G ++
Sbjct: 147 LLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
L K + Q + + G +++ CLQ P++RP +
Sbjct: 207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE----YFRNFVDSCLQKIPQDRPTSE 262
Query: 308 SLV 310
L+
Sbjct: 263 VLL 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 9e-35
Identities = 55/268 (20%), Positives = 100/268 (37%), Gaps = 30/268 (11%)
Query: 75 VVYKGKLENQ---RRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V KG + + + +AVK A + L EA + QL N + ++G C E +
Sbjct: 22 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 80
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
+LV E L K+L + +K + +V ++ ++Y ++ DL A
Sbjct: 81 SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF-VHRDLAARN 137
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFG 242
+L ++S FGL K R ++Y + + PE + + + +S ++SFG
Sbjct: 138 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 197
Query: 243 TLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
L+ + S P S ++ C E+ L + C
Sbjct: 198 VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR---------EMYDLMNLCWT 248
Query: 298 YEPRERPNPKSLVTALSPLQKETEVPSH 325
Y+ RP ++ L + H
Sbjct: 249 YDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-34
Identities = 52/277 (18%), Positives = 98/277 (35%), Gaps = 44/277 (15%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
VV+K + +A K + P Q + E + + + + + G E
Sbjct: 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
+ E+M +L + L + + + +V + + + L Y K + ++ D+ IL
Sbjct: 81 ICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS 250
+ G +L FG+ D + S ++ PE L+ + +S I+S G L+++
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 251 GKH-IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT----------------------- 286
G++ IPP A +L Q+ D+ G
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 287 --------------ELVRLASRCLQYEPRERPNPKSL 309
E ++CL P ER + K L
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-34
Identities = 57/265 (21%), Positives = 107/265 (40%), Gaps = 36/265 (13%)
Query: 75 VVYKGKL------ENQRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCE 127
+VY+G E + R+A+K N A R +FL EA + + + + LLG +
Sbjct: 35 MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94
Query: 128 GDERLLVAEYMPNETLAKHLFHW--------ETHPMKWAMRLRVVLHLAQALEYCTSKGR 179
G L++ E M L +L P + +++ +A + Y +
Sbjct: 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF 154
Query: 180 ALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVT 233
++ DL A + ED ++ FG+ ++ + Y + + PE L+ G T
Sbjct: 155 -VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 213
Query: 234 PESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288
S ++SFG +L ++ + P L + + L D+C + L
Sbjct: 214 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPD---------ML 264
Query: 289 VRLASRCLQYEPRERPNPKSLVTAL 313
L C QY P+ RP+ +++++
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-34
Identities = 47/255 (18%), Positives = 88/255 (34%), Gaps = 28/255 (10%)
Query: 75 VVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
K + + + + K + M + + + E + +L++ + +
Sbjct: 19 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78
Query: 132 LL--VAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH---- 183
L V EY LA + E + LRV+ L AL+ C + +
Sbjct: 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIY 239
DL + D N +L FGL + S++ TP PE + +S I+
Sbjct: 139 DLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIW 198
Query: 240 SFGTLLLDLLSGKH----IPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRC 295
S G LL +L + IR+ + + + EL + +R
Sbjct: 199 SLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD---------ELNEIITRM 249
Query: 296 LQYEPRERPNPKSLV 310
L + RP+ + ++
Sbjct: 250 LNLKDYHRPSVEEIL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 5e-34
Identities = 61/284 (21%), Positives = 105/284 (36%), Gaps = 50/284 (17%)
Query: 75 VVYKGKL------ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCE 127
V++ + E +AVK A D F EA + + N + LLG C
Sbjct: 28 RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87
Query: 128 GDERLLVAEYMPNETLAKHLFHWETH----------------------PMKWAMRLRVVL 165
G L+ EYM L + L H P+ A +L +
Sbjct: 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 147
Query: 166 HLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------L 219
+A + Y + + ++ DL L E+ +++ FGL +N Y + +
Sbjct: 148 QVAAGMAYLSERKF-VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 206
Query: 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDS 274
+ PPE + R T ES ++++G +L ++ S P + +RD N+ ++
Sbjct: 207 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN 266
Query: 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318
C EL L C P +RP+ S+ L + +
Sbjct: 267 CPL---------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 7e-34
Identities = 45/256 (17%), Positives = 88/256 (34%), Gaps = 15/256 (5%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL 122
I+ E G+ A VYK + E A K + + + ++ E + + + LL
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 123 GCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALY 182
+ ++ E+ + + E P+ + V AL Y ++
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK-IIH 133
Query: 183 HDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST----NLAFTPPEYLRT-----GRVT 233
DL A ILF DG+ +L+ FG+ + + PE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 234 PESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293
++ ++S G L+++ + PP H L+ + L++ +
Sbjct: 194 YKADVWSLGITLIEMAEIE--PPHHELNPM-RVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250
Query: 294 RCLQYEPRERPNPKSL 309
+CL+ R L
Sbjct: 251 KCLEKNVDARWTTSQL 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 8e-34
Identities = 63/262 (24%), Positives = 112/262 (42%), Gaps = 26/262 (9%)
Query: 75 VVYKGKLENQRR----IAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
VY G L + AVK NR+ + QFL E + + + +LLG C +
Sbjct: 42 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101
Query: 130 ER-LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
L+V YM + L ++ ETH + L +A+ +++ SK ++ DL A
Sbjct: 102 GSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF-VHRDLAAR 159
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTN--------LAFTPPEYLRTGRVTPESVIYS 240
+ DE +++ FGL ++ D + S + + + E L+T + T +S ++S
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ---FTDDDGTELVRLASRCLQ 297
FG LL +L++ P D N +T L+G+ + L + +C
Sbjct: 220 FGVLLWELMTRGAPPYP-------DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWH 272
Query: 298 YEPRERPNPKSLVTALSPLQKE 319
+ RP+ LV+ +S +
Sbjct: 273 PKAEMRPSFSELVSRISAIFST 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-33
Identities = 60/272 (22%), Positives = 110/272 (40%), Gaps = 15/272 (5%)
Query: 46 EFTLEQLKNATSGFAVEN---IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPR 101
E LE+L++ S + + G+ A VY + + +A+++ N P
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 102 QFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRL 161
+ E + + +N + N L GDE +V EY+ +L + M
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIA 119
Query: 162 RVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF 221
V QALE+ S ++ D+ + IL DG+ +L+ FG +S + +
Sbjct: 120 AVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 222 TP----PEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE 277
TP PE + P+ I+S G + ++++ G+ PP + +R + T+ E
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--PPYLNENPLRALY-LIATNGTPE 235
Query: 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
Q + +RCL + +R + K L
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-33
Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 28/255 (10%)
Query: 75 VVYKGKL---ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V +G + Q +A+K + D + + EA+ + QL N + L+G C + +
Sbjct: 24 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 82
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
+LV E L K L + + ++ ++ ++Y K ++ DL A +
Sbjct: 83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF-VHRDLAARNV 140
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSFGT 243
L ++S FGL K SY T L + PE + + + S ++S+G
Sbjct: 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200
Query: 244 LLLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+ + LS P + I C EL L S C Y
Sbjct: 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------ELYALMSDCWIY 251
Query: 299 EPRERPNPKSLVTAL 313
+ +RP+ ++ +
Sbjct: 252 KWEDRPDFLTVEQRM 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-32
Identities = 53/274 (19%), Positives = 99/274 (36%), Gaps = 39/274 (14%)
Query: 75 VVYKGKLENQRR------IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNR-LTNLLGCCC 126
V + +AVK A R+ + E + + QL ++ + NLLG C
Sbjct: 52 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111
Query: 127 EGDERLLVAEYMPNETLAKHLF---------------------HWETHPMKWAMRLRVVL 165
L+ EY L +L + + + + L
Sbjct: 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171
Query: 166 HLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------L 219
+A+ +E+ K ++ DL A +L ++ FGL ++ +Y +
Sbjct: 172 QVAKGMEFLEFKS-CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230
Query: 220 AFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQ 279
+ PE L G T +S ++S+G LL ++ S P + D N L + +
Sbjct: 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP---GIPVDANFYKLIQNGFKMD 287
Query: 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTAL 313
E+ + C ++ R+RP+ +L + L
Sbjct: 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-32
Identities = 55/267 (20%), Positives = 103/267 (38%), Gaps = 27/267 (10%)
Query: 75 VVYKGKLEN---QRRIAVKRFNRMAWPDP-RQFLEEARSVGQLRNNR-LTNLLGCCCEGD 129
V K +++ + A+KR A D R F E + +L ++ + NLLG C
Sbjct: 25 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84
Query: 130 ERLLVAEYMPNETLAKHL--------------FHWETHPMKWAMRLRVVLHLAQALEYCT 175
L EY P+ L L + + L +A+ ++Y +
Sbjct: 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144
Query: 176 SKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGRV 232
K ++ DL A IL E+ +++ FGL + + + + E L
Sbjct: 145 QKQF-IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY 203
Query: 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292
T S ++S+G LL +++S P + L + + E+ L
Sbjct: 204 TTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAELYEKLPQGYRLEKPLNCDDEVYDLM 259
Query: 293 SRCLQYEPRERPNPKSLVTALSPLQKE 319
+C + +P ERP+ ++ +L+ + +E
Sbjct: 260 RQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-32
Identities = 44/259 (16%), Positives = 97/259 (37%), Gaps = 19/259 (7%)
Query: 75 VVYKGKL-----ENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG + + +A+K P ++ L+EA + + N + LLG C
Sbjct: 24 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
+L+ + MP L + + L + +A+ + Y + ++ DL A
Sbjct: 84 TVQLIT-QLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL-VHRDLAAR 140
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESVIYSFG 242
+L + +++ FGL K + + + E + T +S ++S+G
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 200
Query: 243 TLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRE 302
+ +L++ P D I + + + ++ + +C +
Sbjct: 201 VTVWELMTFGSKPY----DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 303 RPNPKSLVTALSPLQKETE 321
RP + L+ S + ++ +
Sbjct: 257 RPKFRELIIEFSKMARDPQ 275
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 7e-32
Identities = 51/260 (19%), Positives = 102/260 (39%), Gaps = 19/260 (7%)
Query: 75 VVYKGKLEN-----QRRIAVKRFNRMAWPDPR-QFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYKG L+ + +A+K R FL EA +GQ ++ + L G +
Sbjct: 22 EVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
+++ EYM N + + ++ +A ++Y + + DL A
Sbjct: 82 KPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV-HRDLAAR 139
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYSF 241
IL + + ++S FGL + D + + +T PE + + T S ++SF
Sbjct: 140 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 199
Query: 242 GTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
G ++ ++++ P + + + + D + + +L +C Q E
Sbjct: 200 GIVMWEVMTYGERPYWE----LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERA 255
Query: 302 ERPNPKSLVTALSPLQKETE 321
RP +V+ L L + +
Sbjct: 256 RRPKFADIVSILDKLIRAPD 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 122 bits (307), Expect = 7e-32
Identities = 54/290 (18%), Positives = 98/290 (33%), Gaps = 21/290 (7%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VV++ A K D +E +++ LR+ L NL + +E ++
Sbjct: 41 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF- 192
+ E+M L + + E + M + + + + L + ++ DL I+F
Sbjct: 101 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFT 158
Query: 193 -DEDGNPRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+L FGL + +S F PE V + ++S G L L
Sbjct: 159 TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKS 308
LSG P + D ++ + + L +P R
Sbjct: 219 LSGL--SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 309 L-----VTALSPLQKETEVPSHVLMGIPHS------ASVSPLSPLGEACS 347
+T + +++++PS I S A PL PLG +
Sbjct: 277 ALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISN 326
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-31
Identities = 53/276 (19%), Positives = 96/276 (34%), Gaps = 34/276 (12%)
Query: 75 VVYKGKL------ENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNR-LTNLLGCCC 126
V + + +AVK A R+ + E + + L N+ + NLLG C
Sbjct: 38 KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97
Query: 127 EGDERLLVAEYMPNETLAKHLFHW----------------ETHPMKWAMRLRVVLHLAQA 170
G L++ EY L L + + L +A+
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 171 LEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPP 224
+ + SK ++ DL A IL ++ FGL ++ ++ +Y + + P
Sbjct: 158 MAFLASKNC-IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
E + T ES ++S+G L +L S P + D + +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---MPVDSKFYKMIKEGFRMLSPEHA 273
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320
E+ + C +P +RP K +V + E+
Sbjct: 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 2e-31
Identities = 46/247 (18%), Positives = 92/247 (37%), Gaps = 17/247 (6%)
Query: 75 VVYKGKL-ENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VYKG E +A ++ + ++F EEA + L++ + +
Sbjct: 24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 132 ----LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH-DLN 186
+LV E M + TL +L MK + + + L++ ++ + H DL
Sbjct: 84 KKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 141
Query: 187 AYRILF-DEDGNPRLSTFGLMKNSRDGKSYST--NLAFTPPEYLRTGRVTPESVIYSFGT 243
I G+ ++ GL R + + F PE + +Y+FG
Sbjct: 142 CDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGM 200
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRER 303
+L++ + ++ P S + + + +T F E+ + C++ ER
Sbjct: 201 CMLEMATSEY-PYSECQN--AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257
Query: 304 PNPKSLV 310
+ K L+
Sbjct: 258 YSIKDLL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-30
Identities = 52/263 (19%), Positives = 99/263 (37%), Gaps = 27/263 (10%)
Query: 75 VVYKGKLENQRR----IAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGD 129
V++G + +A+K R+ FL+EA ++ Q + + L+G E +
Sbjct: 22 DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 80
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
++ E L + + + A + L+ AL Y SK ++ D+ A
Sbjct: 81 PVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF-VHRDIAARN 138
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEY-----LRTGRVTPESVIYSFGTL 244
+L + +L FGL + D Y + P ++ + R T S ++ FG
Sbjct: 139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198
Query: 245 LLDLLSGKHIP-----PSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
+ ++L P + + I + + +C L L ++C Y+
Sbjct: 199 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP---------TLYSLMTKCWAYD 249
Query: 300 PRERPNPKSLVTALSPLQKETEV 322
P RP L LS + +E +
Sbjct: 250 PSRRPRFTELKAQLSTILEEEKA 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-30
Identities = 43/288 (14%), Positives = 90/288 (31%), Gaps = 50/288 (17%)
Query: 75 VVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEA--RSVGQLRNNRLTNLLGCCCEGD--- 129
V++GK +AVK F+ + R + EA LR+ + + + +
Sbjct: 18 EVWRGKWRG-EEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73
Query: 130 -ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH----- 183
+ LV++Y + +L +L + + +++ L A L + +
Sbjct: 74 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130
Query: 184 --DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSY----STNLAFTP----PEYLRT---- 229
DL + IL ++G ++ GL + T PE L
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 230 --GRVTPESVIYSFGTLLLDLLSGKHIPPSHAL----------------DLIRDRNLQML 271
+ IY+ G + ++ I H ++ + Q L
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 272 TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319
+ + + + ++ C R + LS L ++
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-30
Identities = 50/257 (19%), Positives = 90/257 (35%), Gaps = 20/257 (7%)
Query: 75 VVYKGKLE----NQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCE 127
VV +G+ + +AVK P F+ E ++ L + L L G
Sbjct: 23 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+ +V E P +L R + +A+ + Y SK ++ DL A
Sbjct: 83 PPMK-MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-IHRDLAA 139
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN-------LAFTPPEYLRTGRVTPESVIYS 240
+L ++ FGLM+ + A+ PE L+T + S +
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
FG L ++ + P L + L + +D ++ + +C ++P
Sbjct: 200 FGVTLWEMFTYGQEPWI---GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKP 256
Query: 301 RERPNPKSLVTALSPLQ 317
+RP +L L Q
Sbjct: 257 EDRPTFVALRDFLLEAQ 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (293), Expect = 7e-30
Identities = 45/241 (18%), Positives = 81/241 (33%), Gaps = 10/241 (4%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
VV++ R K N D E + QL + +L NL + E +L
Sbjct: 44 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103
Query: 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193
+ E++ L + E + M A + + + L++ ++ D+ I+ +
Sbjct: 104 ILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHEHSI-VHLDIKPENIMCE 161
Query: 194 --EDGNPRLSTFGLMKNSRDGKS---YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDL 248
+ + ++ FGL + + F PE + V + +++ G L L
Sbjct: 162 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 249 LSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKS 308
LSG P D + D + E LQ EPR+R
Sbjct: 222 LSGL--SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279
Query: 309 L 309
Sbjct: 280 A 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-29
Identities = 46/244 (18%), Positives = 76/244 (31%), Gaps = 15/244 (6%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
V + +AVK + D P +E L + + G EG+ +
Sbjct: 20 EVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
L EY L + M R L + Y G + D+ +L
Sbjct: 80 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGI-THRDIKPENLLL 136
Query: 193 DEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPEYLRTGRVTPESV-IYSFGTLL 245
DE N ++S FGL R L + PE L+ E V ++S G +L
Sbjct: 137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 196
Query: 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
+L+G+ + + + + D L+ + L P R
Sbjct: 197 TAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARIT 253
Query: 306 PKSL 309
+
Sbjct: 254 IPDI 257
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 9e-29
Identities = 38/252 (15%), Positives = 92/252 (36%), Gaps = 11/252 (4%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLL 122
I + G +V++ +++ K ++ D +E + R+ + +L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 123 GCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALY 182
+E +++ E++ + + + + + + V + +AL++ S +
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHSHNIG-H 125
Query: 183 HDLNAYRILFDEDGNPR--LSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGRVTPESV 237
D+ I++ + + FG + + G ++ + PE + V+ +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 238 IYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQ 297
++S GTL+ LLSG P A + M + + + + E + R L
Sbjct: 186 MWSLGTLVYVLLSGI--NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243
Query: 298 YEPRERPNPKSL 309
E + R
Sbjct: 244 KERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (282), Expect = 1e-28
Identities = 41/242 (16%), Positives = 78/242 (32%), Gaps = 11/242 (4%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ-FLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
V + Q+ +A+K + A E + ++++ + L G
Sbjct: 24 EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA--LYHDLNAYRI 190
L+ + + L + E R++ + A++Y G N
Sbjct: 84 LIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRVTPESVIYSFGTLLLD 247
DED +S FGL K G ST + PE L + +S G +
Sbjct: 142 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201
Query: 248 LLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPK 307
LL G PP + + + + + + + DD ++ +P +R +
Sbjct: 202 LLCGY--PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259
Query: 308 SL 309
Sbjct: 260 QA 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-28
Identities = 41/253 (16%), Positives = 81/253 (32%), Gaps = 19/253 (7%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V + L R A+K + E + +L + L + ++
Sbjct: 23 TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
Y N L K++ + ALEY K ++ DL I
Sbjct: 83 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENI 139
Query: 191 LFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTL 244
L +ED + +++ FG K S+ + PE L S +++ G +
Sbjct: 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 199
Query: 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
+ L++G + LI + +++ E F + + L + L + +R
Sbjct: 200 IYQLVAGLPPFRAGNEYLIFQKIIKL------EYDFPEKFFPKARDLVEKLLVLDATKRL 253
Query: 305 NPKSLVTALSPLQ 317
+ +
Sbjct: 254 GCEEMEGYGPLKA 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (277), Expect = 3e-28
Identities = 49/245 (20%), Positives = 86/245 (35%), Gaps = 20/245 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTNLLGCCCE--- 127
V+ + L R +AVK DP +F EA++ L + + +
Sbjct: 22 EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81
Query: 128 -GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLN 186
G +V EY+ TL + PM + V+ QAL + G ++ D+
Sbjct: 82 AGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG-IIHRDVK 138
Query: 187 AYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNL-------AFTPPEYLRTGRVTPESVIY 239
I+ ++ FG+ + D + T + PE R V S +Y
Sbjct: 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 198
Query: 240 SFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYE 299
S G +L ++L+G+ PP + + D + +L + + L
Sbjct: 199 SLGCVLYEVLTGE--PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256
Query: 300 PRERP 304
P R
Sbjct: 257 PENRY 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-27
Identities = 54/271 (19%), Positives = 95/271 (35%), Gaps = 33/271 (12%)
Query: 75 VVYKG------KLENQRRIAVKRFNR-MAWPDPRQFLEEARSVGQLRN-NRLTNLLGCCC 126
V + K R +AVK + R + E + + + + + NLLG C
Sbjct: 28 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87
Query: 127 E-GDERLLVAEYMPNETLAKHLFHWETH--------------PMKWAMRLRVVLHLAQAL 171
+ G +++ E+ L+ +L + + +A+ +
Sbjct: 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 147
Query: 172 EYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPPE 225
E+ S+ ++ DL A IL E ++ FGL ++ Y L + PE
Sbjct: 148 EFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206
Query: 226 YLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285
+ T +S ++SFG LL ++ S P + D + D
Sbjct: 207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDEEFCRRLKEGTRMRAPDYTT 263
Query: 286 TELVRLASRCLQYEPRERPNPKSLVTALSPL 316
E+ + C EP +RP LV L L
Sbjct: 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 107 bits (269), Expect = 1e-26
Identities = 47/240 (19%), Positives = 80/240 (33%), Gaps = 16/240 (6%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---RQFLEEARSVGQLRNNRLTN---LLGCCCE 127
VY + + + A+K ++ L E + + +
Sbjct: 19 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
D+ + + M L HL A + LE+ ++ +Y DL
Sbjct: 79 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFV-VYRDLKP 135
Query: 188 YRILFDEDGNPRLSTFGLMKNSRDGKSYSTN--LAFTPPEYLRTGR-VTPESVIYSFGTL 244
IL DE G+ R+S GL + K +++ + PE L+ G + +S G +
Sbjct: 136 ANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 245 LLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERP 304
L LL G H + + LT + + D EL L LQ + R
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV---ELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 105 bits (264), Expect = 2e-26
Identities = 45/255 (17%), Positives = 82/255 (32%), Gaps = 25/255 (9%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP---------RQFLEEARSVGQLRNNRLT-NLLG 123
VV + + AVK + L+E + ++ + L
Sbjct: 18 VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77
Query: 124 CCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYH 183
LV + M L +L E + +++ L + + +
Sbjct: 78 TYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKLNIV-HR 134
Query: 184 DLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYST---NLAFTPPEYLRTGRV------TP 234
DL IL D+D N +L+ FG G+ ++ PE +
Sbjct: 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 235 ESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294
E ++S G ++ LL+G PP + + M + DD + L SR
Sbjct: 195 EVDMWSTGVIMYTLLAGS--PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 295 CLQYEPRERPNPKSL 309
L +P++R +
Sbjct: 253 FLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 2e-26
Identities = 43/237 (18%), Positives = 86/237 (36%), Gaps = 18/237 (7%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ---FLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V+ + N R A+K + +Q +E + + + + + G + +
Sbjct: 19 RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 78
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
++ +Y+ L ++ + + ALEY SK +Y DL I
Sbjct: 79 IFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENI 135
Query: 191 LFDEDGNPRLSTFGLMKNSRD-GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
L D++G+ +++ FG K D + + PE + T +SFG L+ ++L
Sbjct: 136 LLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT--ELVRLASRCLQYEPRERP 304
+G D N + L + ++ L SR + + +R
Sbjct: 196 AGYTPFY--------DSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRL 244
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 3e-26
Identities = 46/242 (19%), Positives = 84/242 (34%), Gaps = 22/242 (9%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDP----RQFLEEARSVGQLRNNRLTNLLGCCCEGD 129
V+ + + + A+K + +E+ + LT++ +
Sbjct: 17 KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76
Query: 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
V EY+ L H+ H + + L++ SKG +Y DL
Sbjct: 77 NLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKGI-VYRDLKLDN 133
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT----PPEYLRTGRVTPESVIYSFGTLL 245
IL D+DG+ +++ FG+ K + G + + T PE L + +SFG LL
Sbjct: 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 193
Query: 246 LDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEPRER 303
++L G+ ++ + L S E L + EP +R
Sbjct: 194 YEMLIGQSPFH--------GQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245
Query: 304 PN 305
Sbjct: 246 LG 247
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 3e-25
Identities = 54/272 (19%), Positives = 94/272 (34%), Gaps = 35/272 (12%)
Query: 75 VVYKGKL--------ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNR-LTNLLGC 124
V + ++AVK A D + E + + ++ + NLLG
Sbjct: 28 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87
Query: 125 CCEGDERLLVAEYMPNETLAKHLFHWETHP--------------MKWAMRLRVVLHLAQA 170
C + ++ EY L ++L + + +A+
Sbjct: 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 147
Query: 171 LEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN------LAFTPP 224
+EY SK ++ DL A +L ED +++ FGL ++ Y + + P
Sbjct: 148 MEYLASKKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206
Query: 225 EYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284
E L T +S ++SFG LL ++ + P + L L +
Sbjct: 207 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFKLLKEGHRMDKPSNC 262
Query: 285 GTELVRLASRCLQYEPRERPNPKSLVTALSPL 316
EL + C P +RP K LV L +
Sbjct: 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 8e-25
Identities = 38/249 (15%), Positives = 77/249 (30%), Gaps = 19/249 (7%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ------FLEEARSVGQLRNNRLTNLLGCCCE 127
VV K + + A K + R+ E + ++++ + L
Sbjct: 25 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84
Query: 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNA 187
+ +L+ E + L E + + + + Y S A + DL
Sbjct: 85 KTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHSLQIA-HFDLKP 141
Query: 188 YRILFDEDGNPR----LSTFGLMKNSRDGKSYSTNL---AFTPPEYLRTGRVTPESVIYS 240
I+ + P+ + FGL G + F PE + + E+ ++S
Sbjct: 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201
Query: 241 FGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEP 300
G + LLSG + + E ++ + R L +P
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANVSAV--NYEFEDEYFSNTSALAKDFIRRLLVKDP 259
Query: 301 RERPNPKSL 309
++R +
Sbjct: 260 KKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 2e-24
Identities = 50/248 (20%), Positives = 93/248 (37%), Gaps = 27/248 (10%)
Query: 75 VVYKGK-LENQRRIAVKRFNR------MAWPDPRQFLEEARSVGQLRNN--RLTNLLGCC 125
VY G + + +A+K + P+ + E + ++ + + LL
Sbjct: 19 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78
Query: 126 CEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL 185
D +L+ E E ++ + + +A+ +C + G L+ D+
Sbjct: 79 ERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGV-LHRDI 136
Query: 186 NAYRILFDED-GNPRLSTFGLMKNSRDG--KSYSTNLAFTPPEYLRTGRVTPESV-IYSF 241
IL D + G +L FG +D + ++PPE++R R S ++S
Sbjct: 137 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196
Query: 242 GTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPR 301
G LL D++ G P H ++IR + F +E L CL P
Sbjct: 197 GILLYDMVCGDI-PFEHDEEIIRGQVF-----------FRQRVSSECQHLIRWCLALRPS 244
Query: 302 ERPNPKSL 309
+RP + +
Sbjct: 245 DRPTFEEI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 97.6 bits (242), Expect = 2e-23
Identities = 40/284 (14%), Positives = 81/284 (28%), Gaps = 32/284 (11%)
Query: 63 NIVSEH-------GEKAPNVVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR 114
N+V H GE + V+++G L N +++A+K R + D Q +E R+ L
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA 58
Query: 115 N-NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEY 173
+ N+ EG +LV + + L + ++
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLE--DLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 174 CTSKGRALYHDLNAYRILFDE-----DGNPRLSTFGLMKNSRDGKSYSTN---------- 218
K +Y D+ L + FG++K RD +
Sbjct: 117 IHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 219 -LAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLT--DSC 275
+ + + + G + + L G + + ++ S
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 276 LEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319
+ E + P+ L S + +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.6 bits (242), Expect = 2e-23
Identities = 38/264 (14%), Positives = 79/264 (29%), Gaps = 24/264 (9%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN-NRLTNLLGCCCEGDERL 132
+Y G + +A+K Q E++ ++ + + C EGD +
Sbjct: 22 DIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79
Query: 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILF 192
+V E + LF++ + L + + +EY SK ++ D+ L
Sbjct: 80 MVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF-IHRDVKPDNFLM 136
Query: 193 DEDGNPRL---STFGLMKNSRDGKSYSTN-----------LAFTPPEYLRTGRVTPESVI 238
L FGL K RD +++ + + +
Sbjct: 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL 196
Query: 239 YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD--SCLEGQFTDDDGTELVRLASRCL 296
S G +L+ G R + ++ S +E + C
Sbjct: 197 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCR 256
Query: 297 QYEPRERPNPKSLVTAL-SPLQKE 319
++P+ L + ++
Sbjct: 257 SLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 3e-23
Identities = 39/271 (14%), Positives = 94/271 (34%), Gaps = 37/271 (13%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERL 132
+V N+ R+A+K+ + ++ L E + + + R+ + +
Sbjct: 23 MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82
Query: 133 LVAEYMPNETLAKHLFHW-ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
+ Y+ + L+ +T + + + + L+Y S L+ DL +L
Sbjct: 83 MKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV-LHRDLKPSNLL 141
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYST-------NLAFTPPEYLRTGRVTPESV-IYSFGT 243
+ + ++ FGL + + ++ + PE + + +S+ I+S G
Sbjct: 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE-------------------------G 278
+L ++LS + I P + L +L E
Sbjct: 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 261
Query: 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ + ++ + L + L + P +R +
Sbjct: 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 5e-23
Identities = 46/268 (17%), Positives = 82/268 (30%), Gaps = 36/268 (13%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPD-----PRQFLEEARSVGQLRNNRLTNLLGCCCEG 128
VYK + + +A+K+ + R L E + + +L + + LL
Sbjct: 13 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
LV ++M + + + + + +L Q LEY + DL
Sbjct: 73 SNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL-HRDLKPN 129
Query: 189 RILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT-----PPEYLRTGRVTPESVIYSFGT 243
+L DE+G +L+ FGL K+ T+ T P +++ G
Sbjct: 130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189
Query: 244 LLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE----------------------GQFT 281
+L +LL P + R + L E
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249
Query: 282 DDDGTELVRLASRCLQYEPRERPNPKSL 309
G +L+ L + P R
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.0 bits (235), Expect = 1e-22
Identities = 44/276 (15%), Positives = 95/276 (34%), Gaps = 33/276 (11%)
Query: 64 IVSEHGEKAPNVVYKGKLENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTNL 121
+ + GE VVYK + A+K+ + P + E + +L+++ + L
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 122 LGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRAL 181
+LV E++ + L ++ +L L + YC + L
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR-VL 122
Query: 182 YHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP-----PEYLRTGRVTPES 236
+ DL +L + +G +++ FGL + T+ T + + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 237 VIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG------------------ 278
I+S G + ++++G + P + R ++L +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 279 -----QFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
F + L S+ L+ +P +R K
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 3e-22
Identities = 39/249 (15%), Positives = 77/249 (30%), Gaps = 20/249 (8%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCC----CEG 128
V + Q + A+K D + E + + ++
Sbjct: 27 KVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81
Query: 129 DERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188
L+V E + L + ++ + +A++Y S A + D+
Sbjct: 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA-HRDVKPE 140
Query: 189 RILFD---EDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGRVTPESVIYSFG 242
+L+ + +L+ FG K + S +T + PE L + ++S G
Sbjct: 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 200
Query: 243 TLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG--TELVRLASRCLQYEP 300
++ LL G S+ I + E + E+ L L+ EP
Sbjct: 201 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 260
Query: 301 RERPNPKSL 309
+R
Sbjct: 261 TQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 5e-22
Identities = 48/242 (19%), Positives = 87/242 (35%), Gaps = 17/242 (7%)
Query: 75 VVYKGK-LENQRRIAVKRFNR---MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V + R A+K + +A + + E+R + R+ LT L D
Sbjct: 20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
V EY L HL + A + ALEY S+ +Y D+ +
Sbjct: 80 LCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLHSRDV-VYRDIKLENL 136
Query: 191 LFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTP----PEYLRTGRVTPESVIYSFGTLLL 246
+ D+DG+ +++ FGL K + TP PE L + G ++
Sbjct: 137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196
Query: 247 DLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNP 306
+++ G+ + + + + L E +F E L + L+ +P++R
Sbjct: 197 EMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
Query: 307 KS 308
Sbjct: 251 GP 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 1e-21
Identities = 53/272 (19%), Positives = 89/272 (32%), Gaps = 43/272 (15%)
Query: 75 VVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER-- 131
VVY+ KL ++ +A+K+ + D R E + + +L + + L E+
Sbjct: 35 VVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90
Query: 132 ----LLVAEYMPNETLAKHLFHWETH-PMKWAMRLRVVLHLAQALEYCTSKGRALYH-DL 185
LV +Y+P + + + L ++L Y S G + H D+
Sbjct: 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDI 148
Query: 186 NAYRILFDEDGNP-RLSTFGLMKNSRDGKSYSTNLAFT----PPEYLRTGRVTPESVIYS 240
+L D D +L FG K G+ + + P T ++S
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWS 208
Query: 241 FGTLLLDLLSGKHI----PPSHALDLI-------------------RDRNLQMLTDSCLE 277
G +L +LL G+ I L I + +
Sbjct: 209 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT 268
Query: 278 GQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
F E + L SR L+Y P R P
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 3e-21
Identities = 52/266 (19%), Positives = 99/266 (37%), Gaps = 33/266 (12%)
Query: 75 VVYKGK-LENQRRIAVK--RFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
VVYK + +A+K R + P + E + +L + + LL ++
Sbjct: 17 VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76
Query: 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
LV E++ ++ L K + + + + L Q L +C S R L+ DL +L
Sbjct: 77 YLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLL 134
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT-----PPEYLRTGRVTPESVIYSFGTLLL 246
+ +G +L+ FGL + T+ T P L + I+S G +
Sbjct: 135 INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFA 194
Query: 247 DLLSGKHI-PPSHALDLIRD--RNLQMLTDSCLEGQFTDDD------------------- 284
++++ + + P +D + R L + G + D
Sbjct: 195 EMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254
Query: 285 -GTELVRLASRCLQYEPRERPNPKSL 309
+ L S+ L Y+P +R + K+
Sbjct: 255 LDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 6e-21
Identities = 36/267 (13%), Positives = 82/267 (30%), Gaps = 33/267 (12%)
Query: 75 VVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
V ++A+K+ R + ++ E R + +R+ + LL +
Sbjct: 33 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92
Query: 132 LLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189
++ + + +V + + L Y + G + DL
Sbjct: 93 DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII-HRDLKPGN 151
Query: 190 ILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAF--TPPEYLRTGRVTPESVIYSFGTLLLD 247
+ +ED ++ FGL + + + + P L R T I+S G ++ +
Sbjct: 152 LAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211
Query: 248 LLSGKHI-------------------PPSHALDLIRDRNLQMLTDSCLE------GQFTD 282
+++GK + PP+ + ++ + E
Sbjct: 212 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 271
Query: 283 DDGTELVRLASRCLQYEPRERPNPKSL 309
+ V L + L + +R
Sbjct: 272 NASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 8e-21
Identities = 47/281 (16%), Positives = 88/281 (31%), Gaps = 36/281 (12%)
Query: 64 IVSEHGEKAPNVVYKGK--LENQRRIAVKRFNRMAWPD--PRQFLEEA---RSVGQLRNN 116
V+E GE A V+K + R +A+KR + P + E R + +
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 117 RLTNLLGCCCEGDERLLVAEYMPNETLA----KHLFHWETHPMKWAMRLRVVLHLAQALE 172
+ L C + E + +L + ++ L + L+
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 173 YCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRT 229
+ S ++ DL IL G +L+ FGL + + ++ L + PE L
Sbjct: 131 FLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 230 GRVTPESVIYSFGTLLLDLLSGKHI---------------------PPSHALDLIRDRNL 268
++S G + ++ K + D+ R
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ +F D L +CL + P +R + S
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 87.2 bits (215), Expect = 2e-19
Identities = 43/236 (18%), Positives = 78/236 (33%), Gaps = 14/236 (5%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQ---FLEEARSVGQLRNNRLTNLLGCCCEGDE 130
V K E+ A+K ++ +Q L E R + + L L +
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
+V EY+ + HL + EY S +Y DL +
Sbjct: 116 LYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENL 172
Query: 191 LFDEDGNPRLSTFGLMKNSRD-GKSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLL 249
L D+ G +++ FG K + + PE + + ++ G L+ ++
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 250 SGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPN 305
+G PP A I+ + +F ++L L LQ + +R
Sbjct: 233 AGY--PPFFADQPIQ----IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFG 282
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 3e-19
Identities = 40/267 (14%), Positives = 78/267 (29%), Gaps = 35/267 (13%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131
V+K K E +A+KR + P L E + +L++ + L +
Sbjct: 17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76
Query: 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRIL 191
LV E+ + F + + + L + L +C S+ L+ DL +L
Sbjct: 77 TLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV-LHRDLKPQNLL 133
Query: 192 FDEDGNPRLSTFGLMKNSRDGKSYSTNLAFT-----PPEYLRTGRVTPESVIYSFGTLLL 246
+ +G +L+ FGL + + T P + ++S G +
Sbjct: 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 247 DLLSGKHIP------------------------PSHALDLIRDRNLQMLTDSCLEGQFTD 282
+L + L + M +
Sbjct: 194 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP 253
Query: 283 DDGTELVRLASRCLQYEPRERPNPKSL 309
L L+ P +R + +
Sbjct: 254 KLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (208), Expect = 1e-18
Identities = 47/292 (16%), Positives = 94/292 (32%), Gaps = 49/292 (16%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFN--RMAWPDPRQFLEEARSVGQLRNNRLTN 120
+++ G+ V+K + + +++A+K+ P L E + + L++ + N
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 121 LLGCCCEGDER--------LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALE 172
L+ C LV ++ ++ + RV+ L L
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLNGLY 131
Query: 173 YCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN--------LAFTPP 224
Y L+ D+ A +L DG +L+ FGL + K+ N L + PP
Sbjct: 132 YIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 225 EYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283
E L R P ++ G ++ ++ + I + Q+ E D
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 284 DGT--------------------------ELVRLASRCLQYEPRERPNPKSL 309
+ + L + L +P +R +
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 6e-17
Identities = 43/246 (17%), Positives = 79/246 (32%), Gaps = 21/246 (8%)
Query: 75 VVYKGKL----ENQRRIAVKRFNRMAWPD----PRQFLEEARSVGQLRNNRLTNLLGCCC 126
V+ + + + A+K + E + + +R + L
Sbjct: 39 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98
Query: 127 EGDERLLVA-EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDL 185
+ + +L + +Y+ L HL E V + ALE+ G +Y D+
Sbjct: 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--YVGEIVLALEHLHKLG-IIYRDI 155
Query: 186 NAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTNLAFTPPEYLRT-------GRVTPESVI 238
IL D +G+ L+ FGL K ++ EY+
Sbjct: 156 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 215
Query: 239 YSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQY 298
+S G L+ +LL+G P + E + + L R L
Sbjct: 216 WSLGVLMYELLTGA--SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 299 EPRERP 304
+P++R
Sbjct: 274 DPKKRL 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.7 bits (185), Expect = 1e-15
Identities = 41/278 (14%), Positives = 83/278 (29%), Gaps = 33/278 (11%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTN 120
+S G A V + R+AVK+ +R + ++ E R + +++ +
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 121 LLGCCCEGDERLLVAEYMPNETLAKHLFH--WETHPMKWAMRLRVVLHLAQALEYCTSKG 178
LL + L + + + ++ + + L+Y S
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 179 RALYHDLNAYRILFDEDGNPRLSTFGL--MKNSRDGKSYSTNLAFTPPEYLRTGRVTPES 236
+ DL + +ED ++ FGL + +T P L
Sbjct: 142 II-HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 237 VIYSFGTLLLDLLSGKH-------------------IPPSHALDLIRDRNLQMLTDSCLE 277
I+S G ++ +LL+G+ P + L I + + S +
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 278 ------GQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
V L + L + +R
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 73.0 bits (178), Expect = 8e-15
Identities = 39/276 (14%), Positives = 88/276 (31%), Gaps = 50/276 (18%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERL 132
V++ + N ++ VK + ++ E + + LR + L + R
Sbjct: 50 EVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106
Query: 133 --LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRI 190
LV E++ N + + + + +AL+YC S G + D+ + +
Sbjct: 107 PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIM-HRDVKPHNV 160
Query: 191 LFDEDGNP-RLSTFGLMKNSRDGKSYS----TNLAFTPPEYLRTGRVTPESVIYSFGTLL 245
+ D + RL +GL + G+ Y+ + P + ++S G +L
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 246 LDLLSGKH--------------------------------IPPSHALDLIRDRNLQMLTD 273
++ K I + I R+ + +
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 274 SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ + E + + L+Y+ + R +
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.3 bits (168), Expect = 1e-13
Identities = 39/299 (13%), Positives = 84/299 (28%), Gaps = 65/299 (21%)
Query: 75 VVYKGK-LENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133
V+ K + N +A+K R +E + + ++ + T +LL
Sbjct: 28 TVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86
Query: 134 VAEYMPNETLAKHLFHWETHPMKW--------------AMRLRVVLHLAQALEYCTSKGR 179
+ +E ++ L L+Y +
Sbjct: 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 146
Query: 180 ALYHDLNAYRILFDEDGNP------RLSTFGLMKNSRDGKSYS-TNLAFTPPEYLRTGRV 232
++ D+ +L + +P +++ G + + S + PE L
Sbjct: 147 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPW 206
Query: 233 TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG-------------- 278
+ I+S L+ +L++G + + + L G
Sbjct: 207 GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR 266
Query: 279 ----------------------------QFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+F+ D+ E+ S LQ +PR+R + L
Sbjct: 267 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.9 bits (162), Expect = 1e-12
Identities = 39/294 (13%), Positives = 88/294 (29%), Gaps = 54/294 (18%)
Query: 64 IVSEHGEKAPNVVYKGK-LENQRRIAVKRFNR--MAWPDPRQFLEEARSVGQLRNNRLTN 120
+ G A +V R +A+K+ +R ++ E + + + + +
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 121 LLGCCC------EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYC 174
LL E + LV E M + ++ + +++
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIKHL 135
Query: 175 TSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYSTN---LAFTPPEYLRTGR 231
S G ++ DL I+ D ++ FGL + + + + PE +
Sbjct: 136 HSAGI-IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 232 VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLE-------------- 277
I+S G ++ +++ K + P ++ ++ L C E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 278 ----------------------GQFTDDDGTELVRLASRCLQYEPRERPNPKSL 309
+ ++ L S+ L +P +R +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 45.2 bits (106), Expect = 3e-06
Identities = 17/147 (11%), Positives = 37/147 (25%), Gaps = 25/147 (17%)
Query: 75 VVYKGKLENQRRIAVKRFN----------RMAWPDPRQFLEEARSVGQLRNNRLTNLLGC 124
V+ E VK F A + L L G
Sbjct: 15 AVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 74
Query: 125 CC----EGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRA 180
+ ++ E + E + ++ V+ + + + +
Sbjct: 75 AVPKVYAWEGNAVLMELI---------DAKELYRVRVENPDEVLDMILEEVAKFYHR-GI 124
Query: 181 LYHDLNAYRILFDEDGNPRLSTFGLMK 207
++ DL+ Y +L + + F
Sbjct: 125 VHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 449 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.71 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.19 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=423.30 Aligned_cols=243 Identities=21% Similarity=0.293 Sum_probs=213.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
++|++++.||+|+||+||+|++. +++.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56899999999999999999975 5899999998642 2334678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--C
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--K 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--~ 213 (449)
||++||+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 86 Ey~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~~~-ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp ECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred eecCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 9999999999997 4467999999999999999999999999 999999999999999999999999999876544 3
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............... ....++..++++.+++.
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EFTFPDFVTEGARDLIS 236 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------CCCCCTTSCHHHHHHHH
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------CCCCCccCCHHHHHHHH
Confidence 457899999999999999999999999999999999999999876554444332221 12345567889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
+||+.||++|||++|+++
T Consensus 237 ~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHccCCHhHCcCHHHHHc
Confidence 999999999999999987
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=428.32 Aligned_cols=245 Identities=20% Similarity=0.257 Sum_probs=212.2
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
..|+++++||+|+||+||+|.+ .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++.+|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 3589999999999999999995 459999999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Cc
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KS 214 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~ 214 (449)
+||+|.+++. .+.+++.+++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++..... ..
T Consensus 100 ~gg~L~~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~-iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 100 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp TTCBHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCcHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9999999885 357999999999999999999999999 999999999999999999999999999875433 34
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
..||+.|+|||++.+..++.++||||+||++|+|+||+.||............... .......+..+++++.++|.+
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSSGGGSCHHHHHHHHH
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---CCCCCCCcccCCHHHHHHHHH
Confidence 56899999999999999999999999999999999999999765433222211111 111123345678899999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 013126 295 CLQYEPRERPNPKSLVT 311 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~ 311 (449)
||+.||++|||++|+++
T Consensus 253 ~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HTCSSTTTSCCHHHHTT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-56 Score=427.61 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=217.5
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.++|++.++||+|+||+||+|.+. +|+.||||+++.+. ...++|.+|++++++++|||||+++|++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457889999999999999999975 48899999997654 4578899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK---- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---- 213 (449)
+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC-cccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 99999999998666778999999999999999999999999 9999999999999999999999999998765442
Q ss_pred -ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch-hhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
...||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....+...... ......+..+++++.+|
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~l~~l 248 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----DYRMERPEGCPEKVYEL 248 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----TCCCCCCTTCCHHHHHH
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-----CCCCCCCccchHHHHHH
Confidence 234688999999999999999999999999999999987765433 22222221111 12233456678899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
+.+||+.||++|||++++++.|+.+.++
T Consensus 249 i~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999877543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=423.60 Aligned_cols=256 Identities=20% Similarity=0.274 Sum_probs=207.3
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
..++|++.+.||+|+||+||+|+++ ..||||+++.... ...+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 3467889999999999999999863 4699999975432 235789999999999999999999998754 5689999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++||+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 83 Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~-ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp ECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred ecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999974 4467999999999999999999999999 999999999999999999999999999765432
Q ss_pred ---CccccCccccccccccCC---CCCCCCceeeHhHHHHHHhcCCCCCCchhhH-HHhhcccccccccccCCCCCchhH
Q 013126 213 ---KSYSTNLAFTPPEYLRTG---RVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
....||+.|||||++.+. .|+.++|||||||++|||+||+.||...... .+..........+. ....+.+++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~ 239 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-LSKVRSNCP 239 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-GGGSCTTCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-chhccccch
Confidence 245689999999999643 4899999999999999999999998754222 11111111111111 112345677
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
+++.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 8999999999999999999999999999887653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-56 Score=419.73 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=205.9
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
++|+++++||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5688999999999999999998888899999997644 456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----Cc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----KS 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-----~~ 214 (449)
+|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 84 ~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~-iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 84 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccc-eeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999999864 4567899999999999999999999999 999999999999999999999999999865433 23
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCC-CCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI-PPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..||+.|+|||++.+..++.++|||||||++|||+|+..| +.......+....... .....+...++++.+++.
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-----~~~~~p~~~~~~l~~li~ 236 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRLASTHVYQIMN 236 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-----CCCCCCTTSCHHHHHHHH
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-----CCCCCccccCHHHHHHHH
Confidence 4578999999999999999999999999999999996544 4443333232222111 112234556789999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcccc
Q 013126 294 RCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
+||+.||++|||++++++.|+++.
T Consensus 237 ~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 237 HCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=424.48 Aligned_cols=246 Identities=19% Similarity=0.184 Sum_probs=204.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|++++.||+|+||+||+|++. +|+.||||+++..... ..+++.+|++++++++||||+++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46899999999999999999965 5999999999764422 346799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----- 212 (449)
++||+|.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~-IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC-CccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999999996 5678999999999999999999999999 999999999999999999999999999865322
Q ss_pred -CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 -KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....||+.|||||++.+..+ +.++||||+||++|||+||+.||.............. ...........+++++.+
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---EKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH---TTCTTSTTGGGSCHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh---cCCCCCCccccCCHHHHH
Confidence 34579999999999988776 6789999999999999999999865422111111100 111111223456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
|+.+||+.||++|||++++++
T Consensus 239 li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-56 Score=429.04 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=211.6
Q ss_pred cCHHHHHHhhCCC------cccccccccCCccceEEEEEEEcC-C---CEEEEEEecCCCCC-CHHHHHHHHHHHhccCC
Q 013126 47 FTLEQLKNATSGF------AVENIVSEHGEKAPNVVYKGKLEN-Q---RRIAVKRFNRMAWP-DPRQFLEEARSVGQLRN 115 (449)
Q Consensus 47 ~~~~~l~~~~~~f------~~~~~l~~lG~G~~g~Vy~~~~~~-~---~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~H 115 (449)
++++++.+++++| +.|++.+.||+|+||+||+|++.. + ..||||.+...... ..++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4555566665444 567888999999999999999643 3 35899998764432 24679999999999999
Q ss_pred CCcccceeeEeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC
Q 013126 116 NRLTNLLGCCCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (449)
Q Consensus 116 pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~ 195 (449)
||||+++|++.+++..++||||++||+|.+++.. ..+.+++.+++.++.||+.||+|||+++ |+||||||+|||++++
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHrDlKp~NILl~~~ 164 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMN-YVHRDLAARNILVNSN 164 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC-CccCccccceEEECCC
Confidence 9999999999999999999999999999998874 4567999999999999999999999999 9999999999999999
Q ss_pred CCeEEeccCCcccCCCCC---------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhh
Q 013126 196 GNPRLSTFGLMKNSRDGK---------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRD 265 (449)
Q Consensus 196 ~~~kL~DFGla~~~~~~~---------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~ 265 (449)
+.+||+|||+++...... ...+|+.|+|||++.++.++.++|||||||++|||+| |+.||.......+..
T Consensus 165 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~ 244 (299)
T d1jpaa_ 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244 (299)
T ss_dssp CCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999998654331 1346889999999999999999999999999999998 788887655444433
Q ss_pred cccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 266 RNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
..... .....+..+++++.+++.+||+.||++|||++++++.|+++.+
T Consensus 245 ~i~~~-----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 245 AIEQD-----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHTT-----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcC-----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 22221 1122345677899999999999999999999999999988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=422.20 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=213.4
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
+.++|+++++||+|+||+||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 346788999999999999999999888899999997644 456789999999999999999999998754 567999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----- 212 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----- 212 (449)
+++|+|.+++......++++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~-ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999999887545557999999999999999999999999 999999999999999999999999999876543
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCc-hhhHHHhhcccccccccccCCCCCchhHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPS-HALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRL 291 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (449)
....||+.|+|||++.++.++.++|||||||++|||+||..|+.. ............. .....+..+++++.++
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-----~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-----YRMVRPDNCPEELYQL 242 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTCCHHHHHH
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----CCCCCcccChHHHHHH
Confidence 234678999999999988999999999999999999997665543 3222222221111 1223355677899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 292 ASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 292 i~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+.+||+.||++|||++++++.|+++..
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999999999987653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=425.68 Aligned_cols=246 Identities=16% Similarity=0.197 Sum_probs=210.2
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.|+++++||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 5899999999999999999964 589999999987665567889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----Ccc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----KSY 215 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~~~ 215 (449)
||+|.+++.+ ..+++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 93 ~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~~-ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 93 GGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp TEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 9999998864 3467999999999999999999999999 999999999999999999999999999764332 356
Q ss_pred ccCcccccccccc-----CCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 216 STNLAFTPPEYLR-----TGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 216 ~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
.||+.|+|||++. +..|+.++|||||||++|||+||+.||................. .....+...++++.+
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP---PTLAQPSRWSSNFKD 247 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC---CCCSSGGGSCHHHHH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---CCCCccccCCHHHHH
Confidence 7999999999984 45589999999999999999999999876543332222211111 112234567889999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 013126 291 LASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~eil~ 311 (449)
|+.+||+.||++|||++|+++
T Consensus 248 li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=418.71 Aligned_cols=248 Identities=17% Similarity=0.231 Sum_probs=201.5
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEee--CCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCE--GDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 133 (449)
.++|++++.||+|+||+||+|+.. +|+.||+|.++...... .+.+.+|++++++++|||||++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 467999999999999999999964 58999999997654332 4568999999999999999999999865 456899
Q ss_pred EEeeCCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC----CccccccccCceeeCCCCCeEEeccCCcc
Q 013126 134 VAEYMPNETLAKHLFHW--ETHPMKWAMRLRVVLHLAQALEYCTSKG----RALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~----~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
||||++||+|.+++.+. .+..+++..++.++.||+.||+|||+++ +|+||||||+|||+++++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998642 3568999999999999999999999854 39999999999999999999999999998
Q ss_pred cCCCC----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCch
Q 013126 208 NSRDG----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDD 283 (449)
Q Consensus 208 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (449)
..... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.......+........ ....+..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-----~~~~~~~ 237 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-----FRRIPYR 237 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----CCCCCTT
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-----CCCCCcc
Confidence 76543 34578999999999999999999999999999999999999998765554433322211 1233456
Q ss_pred hHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 284 DGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 284 ~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.++++.+++.+||+.||++|||++|+++
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 7789999999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=429.77 Aligned_cols=249 Identities=19% Similarity=0.233 Sum_probs=205.3
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|+++++||+|+||+||+|++. +|+.||+|+++...... .+++.+|+++|++++|||||++++++.+++.+|+||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46889999999999999999964 58999999997654333 56799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCCeEEeccCCcccCCC--CCc
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD--GKS 214 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~--~~~ 214 (449)
++||+|.+++. +.+.+++..++.++.|++.||.|||+ ++ |+||||||+|||++++|.+||+|||+|+...+ ...
T Consensus 86 ~~gg~L~~~l~--~~~~l~~~~~~~~~~qil~aL~yLH~~~~-IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 86 MDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp CTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHHHC-CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred CCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC-EEccccCHHHeeECCCCCEEEeeCCCccccCCCcccc
Confidence 99999999997 44679999999999999999999997 48 99999999999999999999999999986432 345
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-------------------------
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ------------------------- 269 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~------------------------- 269 (449)
..||+.|+|||++.+..|+.++||||+||++|||++|+.||..............
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 6899999999999999999999999999999999999999865422211000000
Q ss_pred -------------cccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 -------------MLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 -------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
......+........+.++.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000000111234678999999999999999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=408.43 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=215.4
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
++|+++++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|++.+++.+++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5678999999999999999999888899999998754 356789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----Cc
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----KS 214 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-----~~ 214 (449)
+|+|.+++.. ....+++..+.+++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++..... ..
T Consensus 83 ~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~-iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 83 NGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp TEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT-BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred CCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcC-cccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9999999765 4567899999999999999999999999 999999999999999999999999999765433 23
Q ss_pred cccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 215 YSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 215 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
..+|+.|+|||++.+..++.++||||||+++|||+| |+.||.......+....... .....+...++++.+++.
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-----~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----CCCCCCTTCCHHHHHHHH
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-----CCCCCcccccHHHHHHHH
Confidence 457899999999999999999999999999999998 78888766555444333221 112335567789999999
Q ss_pred HhcccCCCCCCCHHHHHHHhcc
Q 013126 294 RCLQYEPRERPNPKSLVTALSP 315 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~L~~ 315 (449)
+||+.||++|||++++++.|.+
T Consensus 236 ~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999998854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-55 Score=421.18 Aligned_cols=246 Identities=17% Similarity=0.213 Sum_probs=197.6
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.|++++.||+|+||+||+|++. +|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4889999999999999999965 5899999999764432 3456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC---CCCCeEEeccCCcccCCCC---
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~--- 212 (449)
+||+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++.....
T Consensus 90 ~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 90 SGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhce-eeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 9999999997 5678999999999999999999999999 99999999999995 5789999999999876544
Q ss_pred CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 213 KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+................ ......+.+++++.+++
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FDSPYWDDISDSAKDFI 244 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC--CCTTTTTTSCHHHHHHH
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--CCCccccCCCHHHHHHH
Confidence 3456999999999999999999999999999999999999999876554444333322111 12233456788999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~ 311 (449)
.+||++||++|||++|+++
T Consensus 245 ~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHH
T ss_pred HHHccCCHhHCcCHHHHhc
Confidence 9999999999999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-55 Score=421.87 Aligned_cols=244 Identities=20% Similarity=0.222 Sum_probs=209.5
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
.|+++++||+|+||+||+|+.. +|+.||||+++.....+ .+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3888999999999999999964 58999999997654333 3568999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCCccc
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGKSYS 216 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 216 (449)
||+||+|..++. .+.++++..++.++.||+.||.|||++| |+||||||+|||+++++.+||+|||+++.........
T Consensus 96 ~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~-iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (309)
T d1u5ra_ 96 YCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 172 (309)
T ss_dssp CCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred ecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeccCCCcceEEECCCCCEEEeecccccccCCCCccc
Confidence 999999987765 4578999999999999999999999999 9999999999999999999999999999888777889
Q ss_pred cCccccccccccC---CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 217 TNLAFTPPEYLRT---GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 217 gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
||+.|||||++.+ +.|+.++|||||||++|||++|+.||.+.............. .....+...++++.+|+.
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----CCCCSCTTSCHHHHHHHH
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----CCCCCCCCCCHHHHHHHH
Confidence 9999999999864 458999999999999999999999987654333222221111 111223456789999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~ 311 (449)
+||+.||++|||++++++
T Consensus 249 ~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHTCSSGGGSCCHHHHTT
T ss_pred HHCcCChhHCcCHHHHHh
Confidence 999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=418.84 Aligned_cols=243 Identities=17% Similarity=0.185 Sum_probs=210.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
++|++++.||+|+||+||+|++. +|+.||||++++. .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999964 5999999999642 2334678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC---
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~--- 212 (449)
||++||+|.+++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhcccc-EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999987 4568999999999999999999999999 999999999999999999999999999875432
Q ss_pred ---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 ---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.......+........ ..++...++++.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~ 238 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE------YDFPEKFFPKAR 238 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC------CCCCTTCCHHHH
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC------CCCCccCCHHHH
Confidence 23569999999999999999999999999999999999999998765544443332211 124556778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+||.+||+.||++|||++|+++
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHHHccCCHhHCcCHHHHcC
Confidence 9999999999999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=413.00 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=211.5
Q ss_pred CcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
+++|++.++||+|+||+||+|++++++.||||+++... .+.+.|.+|+.++++++|||||+++|++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 46799999999999999999999888889999997654 45688999999999999999999999985 45689999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-----C
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-----K 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-----~ 213 (449)
++|+|..++.......+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~-ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh-eecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 9999999987655567999999999999999999999999 999999999999999999999999999865433 2
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch-hhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...||+.|+|||++.++.++.++||||||+++|||+||+.|+... ....+....... .....+..+++++.+++
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPPECPESLHDLM 247 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTSCHHHHHHH
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----CCCCCCcccCHHHHHHH
Confidence 345789999999999999999999999999999999977665433 222222221111 11234566788999999
Q ss_pred HHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.+||+.||++|||++++++.|+++....
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999999998877544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-54 Score=423.97 Aligned_cols=250 Identities=18% Similarity=0.167 Sum_probs=214.8
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++.|++++.||+|+||+||+|... +|+.||||+++.....+.+.+.+|++++++++|||||++++++.+++.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999964 5999999999765544456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC--CCCCeEEeccCCcccCCCCC--
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~-- 213 (449)
++||+|.+.+.. ...++++.+++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+++......
T Consensus 108 ~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~-iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 108 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 999999998763 3457999999999999999999999999 99999999999998 67899999999998876543
Q ss_pred -ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...||+.|+|||++.+..++.++|||||||++|+|+||+.||.+............... .........+++++.+||
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCCSSTTTTSCHHHHHHH
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCcccccCCCHHHHHHH
Confidence 35689999999999999999999999999999999999999987654443332222111 112233456788999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~ 312 (449)
.+||+.||++|||++|++++
T Consensus 264 ~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999883
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-54 Score=406.98 Aligned_cols=243 Identities=19% Similarity=0.249 Sum_probs=200.5
Q ss_pred cccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC--CHHHHHHHHHHHhccCCCCcccceeeEee----CCeeEEE
Q 013126 62 ENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP--DPRQFLEEARSVGQLRNNRLTNLLGCCCE----GDERLLV 134 (449)
Q Consensus 62 ~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 134 (449)
|++.++||+|+||+||+|.+. +++.||+|.+...... ..+.+.+|++++++++|||||++++++.+ +..+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 466678999999999999965 5889999999754322 24679999999999999999999999875 3468999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccccCceeeC-CCCCeEEeccCCcccCCCC
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKG-RALYHDLNAYRILFD-EDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~ 212 (449)
|||++||+|.+++. +...+++..++.++.||+.||+|||+++ +|+||||||+|||++ +++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EeCCCCCcHHHHHh--ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999997 4467999999999999999999999975 399999999999997 5799999999999875543
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchh-hHHHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHA-LDLIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ...+.......... ...+...++++.
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----ASFDKVAIPEVK 243 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----GGGGGCCCHHHH
T ss_pred ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC----cccCccCCHHHH
Confidence 34679999999999864 69999999999999999999999986532 22222222221111 122334567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 013126 290 RLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+||+.||++|||++|+++
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCCHhHCcCHHHHhC
Confidence 9999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-54 Score=422.02 Aligned_cols=249 Identities=18% Similarity=0.160 Sum_probs=213.1
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeC
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
++|++++.||+|+||+||+|+.. +|+.||||++......+.+.+.+|++++++++|||||++++++.+++.+|+||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46899999999999999999964 59999999998765445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC--CCCCeEEeccCCcccCCCCC---
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD--EDGNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~--- 213 (449)
+||+|.+++.+ ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 106 ~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~-iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 106 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred CCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcC-CeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999999964 4467999999999999999999999999 99999999999996 46889999999998766543
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...||+.|||||++.+..++.++|||||||++|+|++|+.||.+................ ........+++++.+||.
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--SCCGGGGGCCHHHHHHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CCcccccCCCHHHHHHHH
Confidence 457899999999999999999999999999999999999999776544433322221111 111223456789999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 013126 294 RCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rps~~eil~~ 312 (449)
+||+.||++|||+++++++
T Consensus 262 ~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999983
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=409.62 Aligned_cols=243 Identities=21% Similarity=0.266 Sum_probs=202.1
Q ss_pred cccCCccceEEEEEEEcC---CCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEeeCCC
Q 013126 66 SEHGEKAPNVVYKGKLEN---QRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEYMPN 140 (449)
Q Consensus 66 ~~lG~G~~g~Vy~~~~~~---~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 140 (449)
++||+|+||+||+|.+++ ++.||||+++...... .++|.+|++++++++|||||+++|++.. +..++||||++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 468999999999998643 5689999997644322 4679999999999999999999999864 567899999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-------
Q 013126 141 ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK------- 213 (449)
Q Consensus 141 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~------- 213 (449)
|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~~-iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhCC-cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999997 5577999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.....+....... .....+..+++++.+++
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-----~~~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----ERMGCPAGCPREMYDLM 243 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTCCHHHHHHH
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCcccCHHHHHHH
Confidence 2457899999999999999999999999999999998 88888765444333222111 12234566788999999
Q ss_pred HHhcccCCCCCCCHHHHHHHhcccc
Q 013126 293 SRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
.+||+.||++|||++++++.|+...
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 9999999999999999999887653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=410.03 Aligned_cols=249 Identities=21% Similarity=0.256 Sum_probs=207.2
Q ss_pred cccccc-ccCCccceEEEEEEEc---CCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEE
Q 013126 61 VENIVS-EHGEKAPNVVYKGKLE---NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 61 ~~~~l~-~lG~G~~g~Vy~~~~~---~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 135 (449)
.+.+.+ +||+|+||+||+|.++ ++..||||+++..... ..++|.+|++++++++|||||+++|++.. +.+|+||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 344555 4899999999999853 3557999999765432 25679999999999999999999999865 5689999
Q ss_pred eeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC--
Q 013126 136 EYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 136 Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-- 213 (449)
||++||+|.+++.. .+..+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 88 E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~-iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 88 EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp ECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999999999864 4567999999999999999999999999 9999999999999999999999999998754432
Q ss_pred -----ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 214 -----SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 214 -----~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
...||+.|+|||++.++.++.++|||||||++|||+| |+.||.......+....... .....++.++++
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-----~~~~~p~~~~~~ 240 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----KRMECPPECPPE 240 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-----CCCCCCTTCCHH
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCcCCHH
Confidence 3457899999999998999999999999999999998 89888765433332222111 122345677889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
+.+++.+||+.||++|||+.++++.|+...
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999887654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=415.61 Aligned_cols=244 Identities=19% Similarity=0.237 Sum_probs=214.1
Q ss_pred CcccccccccCCccceEEEEEEE-cCCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.++|++++.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46799999999999999999996 46999999999753 233467899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||++||+|.+++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~~-iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhhcC-ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999997 4567999999999999999999999999 999999999999999999999999999865432
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....||+.|+|||++.+..|+.++||||+||++|||++|++||.+.....+........ ..++...++++.+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~d 234 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------IRFPRTLSPEAKS 234 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTSCHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC------CCCCccCCHHHHH
Confidence 34678999999999999999999999999999999999999998876655544333221 2345667889999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHH
Q 013126 291 LASRCLQYEPRERPN-----PKSLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps-----~~eil~ 311 (449)
||.+||++||++|++ ++++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHhhccCCchhhcccccccHHHHHc
Confidence 999999999999995 788886
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-54 Score=408.81 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=204.2
Q ss_pred ccccccccCCccceEEEEEEEcC-C----CEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLEN-Q----RRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~-~----~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.|++.+.||+|+||+||+|.+++ + ..||||+++...... .++|.+|++++++++|||||+++|++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 45666778999999999999654 2 479999997644322 45799999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC-
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK- 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~- 213 (449)
|||+.++++.+.+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 88 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~-iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 88 TEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccc-cccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999998864 4568999999999999999999999999 9999999999999999999999999998654321
Q ss_pred ------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCch-hhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...||+.|+|||++.++.++.++|||||||++|||++|..|+... ....+...... ......+..++.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-----~~~~~~~~~~~~ 240 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-----GFRLPTPMDCPS 240 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----TCCCCCCTTCBH
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc-----cCCCCCchhhHH
Confidence 235789999999999999999999999999999999976665433 22222221111 112234556778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999999999999887653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=408.80 Aligned_cols=246 Identities=15% Similarity=0.161 Sum_probs=209.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC------CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW------PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.|++++.||+|+||+||+|++. +|+.||||++++... ...+.+.+|++++++++|||||++++++.+++..|+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4899999999999999999964 599999999965322 125789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC----CeEEeccCCcccC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG----NPRLSTFGLMKNS 209 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~----~~kL~DFGla~~~ 209 (449)
||||++||+|.+++.. .+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 91 v~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~-ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhcc-eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999973 467999999999999999999999999 99999999999999776 4999999999876
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
... ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+................ .....+...++
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~ 245 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--FEDEYFSNTSA 245 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--CCHHHHTTSCH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCchhcCCCCH
Confidence 543 3456899999999999989999999999999999999999999876544433322221111 01111235677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
++.+||.+||+.||++|||++++++
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=416.73 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=206.6
Q ss_pred CCcccccccccCCccceEEEEEEEcC-C-----CEEEEEEecCCC-CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCC
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN-Q-----RRIAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGD 129 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~-~-----~~vAiK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 129 (449)
+.++|++.+.||+|+||+||+|++.. + ..||+|.+.... ......+.+|+.+++++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34678899999999999999999643 2 369999997543 23356799999999998 8999999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHhccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWE---------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAY 188 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~---------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~ 188 (449)
..++||||++||+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-IiHRDlKp~ 193 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAAR 193 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-EEETTCSGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCchh
Confidence 9999999999999999997532 135899999999999999999999999 999999999
Q ss_pred ceeeCCCCCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhH
Q 013126 189 RILFDEDGNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALD 261 (449)
Q Consensus 189 NILl~~~~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~ 261 (449)
|||++.++.+||+|||+|+...... ...||+.|||||++.++.++.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999997654332 3456899999999999999999999999999999998 88888654322
Q ss_pred HHhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 013126 262 LIRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALS 314 (449)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 314 (449)
....... ........+..+++++.+||.+||+.||++|||+++++++|.
T Consensus 274 ~~~~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHH----hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2111111 111122345567889999999999999999999999999884
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-53 Score=410.80 Aligned_cols=245 Identities=18% Similarity=0.221 Sum_probs=214.4
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.++|++++.||+|+||+||+|++. +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 357999999999999999999964 5999999999642 234467899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-C
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-K 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~ 213 (449)
|||++||+|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+++..... .
T Consensus 83 mE~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~-iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 83 MDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp ECCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred eeecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccCc-EEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence 99999999999987 5677899999999999999999999999 999999999999999999999999999886554 4
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...||+.|+|||++.+..|+.++||||+||++|||+||+.||................ ...++..++++.+++.
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------LRFPPFFNEDVKDLLS 233 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------CCCCTTSCHHHHHHHH
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC------CCCCCCCCHHHHHHHH
Confidence 5679999999999999999999999999999999999999998765554444332221 2335567789999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 013126 294 RCLQYEPRERP-----NPKSLVTA 312 (449)
Q Consensus 294 ~cl~~dP~~Rp-----s~~eil~~ 312 (449)
+||++||.+|+ |+++++++
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccchhhHHHHHcC
Confidence 99999999996 89999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=401.02 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=205.1
Q ss_pred CCcccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEee-CCeeEEEEe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLLVAE 136 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 136 (449)
+.+++++++.||+|+||+||+|++ +|+.||||+++.. ...+.|.+|++++++++||||++++|++.+ .+.+++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 356788999999999999999998 5789999999754 345789999999999999999999999865 456899999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-Ccc
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-KSY 215 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~~~ 215 (449)
|+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~-ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc-eeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 999999999997544456899999999999999999999998 999999999999999999999999999875543 345
Q ss_pred ccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHHH
Q 013126 216 STNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLASR 294 (449)
Q Consensus 216 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (449)
.+|+.|+|||++.++.++.++||||||+++|||+| |++|+.......+....... .....+...++++.+++.+
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----YKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----CCCCCCTTCCHHHHHHHHH
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----CCCCCCccCCHHHHHHHHH
Confidence 67899999999999999999999999999999998 56666554433333322221 1233455677899999999
Q ss_pred hcccCCCCCCCHHHHHHHhcccc
Q 013126 295 CLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 295 cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
||+.||++|||+.++++.|+.+.
T Consensus 236 cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.9e-53 Score=401.40 Aligned_cols=253 Identities=17% Similarity=0.212 Sum_probs=208.0
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCC----ee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGD----ER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~ 131 (449)
++|++++.||+|+||+||+|++. +|+.||||+++.....+ .+.+.+|+++++.++||||+++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 45899999999999999999964 69999999998765444 346899999999999999999999998754 37
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
|+||||++|++|.+++. ..+++++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+++|||.++....
T Consensus 87 ~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~-iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCccccCcccccCccccceeehhhhhhhhcc
Confidence 99999999999999887 4567999999999999999999999999 99999999999999999999999998875432
Q ss_pred C-------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchh
Q 013126 212 G-------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDD 284 (449)
Q Consensus 212 ~-------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (449)
. ....||+.|+|||++.+..++.++||||+||++|||+||+.||.................. ......+.+
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 241 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI--PPSARHEGL 241 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--CGGGTSSSC
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC--CCchhccCC
Confidence 2 2456899999999999989999999999999999999999999876544433322222111 112234567
Q ss_pred HHHHHHHHHHhcccCCCCCC-CHHHHHHHhcccc
Q 013126 285 GTELVRLASRCLQYEPRERP-NPKSLVTALSPLQ 317 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rp-s~~eil~~L~~~~ 317 (449)
++++.+++.+||++||++|| |++++++.|.++.
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 78999999999999999998 8999998887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-52 Score=397.22 Aligned_cols=248 Identities=18% Similarity=0.169 Sum_probs=210.8
Q ss_pred CcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC---------HHHHHHHHHHHhccC-CCCcccceeeEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD---------PRQFLEEARSVGQLR-NNRLTNLLGCCCE 127 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~---------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 127 (449)
+++|++++.||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46799999999999999999996 468999999997644322 235889999999997 9999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 128 ~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
++.+|+||||++||+|.+++. ..+++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999997 4568999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCC---CccccCccccccccccC------CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCC
Q 013126 208 NSRDG---KSYSTNLAFTPPEYLRT------GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEG 278 (449)
Q Consensus 208 ~~~~~---~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (449)
..... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.................. ...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~--~~~ 236 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--FGS 236 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC--CCC
Confidence 76543 34568999999999863 34788999999999999999999999876554443332222111 112
Q ss_pred CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 279 QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 279 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.....+++++.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 233467889999999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-52 Score=410.77 Aligned_cols=244 Identities=16% Similarity=0.174 Sum_probs=213.5
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
.++|++++.||+|+||+||+|++. +|+.||||++++. .....+.+.+|+++|+.++|||||++++++.+.+..++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 467999999999999999999964 5999999998642 233467899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-C
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-K 213 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~ 213 (449)
|||+.||+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..... .
T Consensus 120 ~e~~~~g~l~~~l~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~-iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EECCTTCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cccccccchhhhHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 99999999999997 4467999999999999999999999999 999999999999999999999999999876644 4
Q ss_pred ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHHH
Q 013126 214 SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLAS 293 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (449)
...||+.|||||++.+..++.++|||||||++|||+||+.||.+.............. ...+..+++++.++|.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------VRFPSHFSSDLKDLLR 270 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCTTCCHHHHHHHH
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC------CCCCccCCHHHHHHHH
Confidence 5679999999999999999999999999999999999999998765544443332221 1234567789999999
Q ss_pred HhcccCCCCCC-----CHHHHHH
Q 013126 294 RCLQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 294 ~cl~~dP~~Rp-----s~~eil~ 311 (449)
+||+.||.+|+ |++++++
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhhhCHHhccccccccHHHHHc
Confidence 99999999994 8999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=399.35 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=202.4
Q ss_pred CcccccccccCCccceEEEEEEEcC----CCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
.++|++.+.||+|+||+||+|++.. +..||||.++...... .+.|.+|++++++++||||++++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4578999999999999999998643 3568999986544322 467999999999999999999999985 567899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC-
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~- 212 (449)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ ++||||||+||++++++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~-iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccC-eeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999998764 5568999999999999999999999999 999999999999999999999999999865433
Q ss_pred ----CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHHH
Q 013126 213 ----KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTE 287 (449)
Q Consensus 213 ----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (449)
....||+.|+|||++.+..++.++|||||||++|||+| |.+|+.......+....... .....++.++++
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----ERLPMPPNCPPT 237 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----CCCCCCTTCCHH
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHH
Confidence 23457899999999999999999999999999999998 78777655443333222211 112345677889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 288 LVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 288 l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
+.+||.+||+.||++|||++++++.|+.+..
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=406.82 Aligned_cols=249 Identities=15% Similarity=0.190 Sum_probs=211.0
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
|++|++++.||+|+||+||+|.+. +|+.||||+++... .+...+.+|+++|+.++|||||++++++.+++.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 678999999999999999999965 58999999997643 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC--CCCeEEeccCCcccCCCCC--
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE--DGNPRLSTFGLMKNSRDGK-- 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~~-- 213 (449)
|+||+|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~-iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC-CCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 999999999964 3347999999999999999999999999 999999999999984 4579999999998765543
Q ss_pred -ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHHHH
Q 013126 214 -SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVRLA 292 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (449)
...+|+.|+|||.+.+..++.++||||+||++|+|++|+.||.................. ........+++++.+|+
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCHHHHTTSCHHHHHHH
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CChhhccCCCHHHHHHH
Confidence 346899999999999999999999999999999999999999876555444333221111 00111224677899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 013126 293 SRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 293 ~~cl~~dP~~Rps~~eil~~ 312 (449)
.+||+.||++|||++|++++
T Consensus 239 ~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999973
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=398.16 Aligned_cols=252 Identities=20% Similarity=0.262 Sum_probs=201.8
Q ss_pred CCcccccccccCCccceEEEEEEEcC--C--CEEEEEEecCCCCCC---HHHHHHHHHHHhccCCCCcccceeeEeeCCe
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN--Q--RRIAVKRFNRMAWPD---PRQFLEEARSVGQLRNNRLTNLLGCCCEGDE 130 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~--~--~~vAiK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 130 (449)
+..+|+++++||+|+||+||+|+++. + ..||||++++..... .++|.+|++++++++||||++++|++.+ +.
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 34679999999999999999998532 2 378999997643222 4679999999999999999999999965 56
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~-iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp CEEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred hheeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhCC-EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 7899999999999998875 3457999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCC-------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCc
Q 013126 211 DGK-------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 211 ~~~-------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
... ...++..|+|||++.+..++.++||||||+++|||+| |+.||................ .....++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~----~~~~~~~ 238 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG----ERLPRPE 238 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC----CCCCCCT
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC----CCCCCcc
Confidence 432 2346789999999999999999999999999999998 899887665554433322221 1223345
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccc
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALSPL 316 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~ 316 (449)
.+++++.+++.+||+.||++|||++++++.|.+.
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 6778999999999999999999999999988764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=404.24 Aligned_cols=247 Identities=15% Similarity=0.137 Sum_probs=201.5
Q ss_pred cccccccc-cCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhcc-CCCCcccceeeEee----CCeeE
Q 013126 60 AVENIVSE-HGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQL-RNNRLTNLLGCCCE----GDERL 132 (449)
Q Consensus 60 ~~~~~l~~-lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~~~~ 132 (449)
++|+++++ ||+|+||+||+|++ .+++.||||+++. .+.+.+|++++.++ +|||||++++++.+ +..+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 46888875 99999999999996 4699999999963 35788999987655 89999999999876 46789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC---CCCeEEeccCCcccC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE---DGNPRLSTFGLMKNS 209 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~---~~~~kL~DFGla~~~ 209 (449)
+|||||+||+|.+++.......+++.+++.++.||+.||+|||+++ |+||||||+|||+++ ++.+||+|||+++..
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~-iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC-Cccccccccccccccccccccccccccceeeec
Confidence 9999999999999998544567999999999999999999999999 999999999999985 567999999999865
Q ss_pred CCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccccc--CCCCCchh
Q 013126 210 RDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCL--EGQFTDDD 284 (449)
Q Consensus 210 ~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 284 (449)
... ....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.............+..... +......+
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 543 3457899999999999989999999999999999999999999765332222211111111111 11112346
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 285 GTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
++++.+||.+||+.||++|||+.+++++
T Consensus 245 s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 7889999999999999999999999883
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=402.87 Aligned_cols=251 Identities=18% Similarity=0.245 Sum_probs=206.1
Q ss_pred cccccccccCCccceEEEEEEEc-CCC----EEEEEEecCCC-CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQR----RIAVKRFNRMA-WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~----~vAiK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 133 (449)
++|++++.||+|+||+||+|.+. +|+ .||+|.++... ....++|.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999964 344 58999987543 33467899999999999999999999999764 5678
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK 213 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 213 (449)
++||+.+|+|.+.+.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~-iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcC-cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 8999999999998875 5678999999999999999999999999 9999999999999999999999999998754332
Q ss_pred ------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhcccccccccccCCCCCchhHH
Q 013126 214 ------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGT 286 (449)
Q Consensus 214 ------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (449)
...||+.|+|||++.++.++.++|||||||++|||+| |.+|+.......+....... .....++.+++
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-----~~~~~p~~~~~ 240 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----ERLPQPPICTI 240 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-----CCCCCCTTBCH
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----CCCCCCcccCH
Confidence 2357899999999999999999999999999999999 67776654333332221111 11234556788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 287 ELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 287 ~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
++.+++.+||+.||++|||++++++.|..+.+
T Consensus 241 ~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999887654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-52 Score=400.35 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=210.6
Q ss_pred CcccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
.++|+++++||+|+||+||+|+++ +++.||||+++.....+ .++|.+|++++++++||||+++++++.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 356889999999999999999964 35789999997644332 46799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCc
Q 013126 132 LLVAEYMPNETLAKHLFHWE----------------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYR 189 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~N 189 (449)
+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~-ivHrDlKp~N 170 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-FVHRDLATRN 170 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-eEeeEEcccc
Confidence 99999999999999996421 235889999999999999999999999 9999999999
Q ss_pred eeeCCCCCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCC-CCCchhhHH
Q 013126 190 ILFDEDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH-IPPSHALDL 262 (449)
Q Consensus 190 ILl~~~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~-p~~~~~~~~ 262 (449)
||++.++.+||+|||+++...+. ....+|+.|+|||.+.+..++.++|||||||++|||++|.. |+.......
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 99999999999999999754332 23457889999999999999999999999999999999964 555444333
Q ss_pred HhhcccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 263 IRDRNLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
+........ ....+..+++++.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 251 ~~~~v~~~~-----~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 VIYYVRDGN-----ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHcCC-----CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 332222111 12345567789999999999999999999999999998763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=398.55 Aligned_cols=257 Identities=22% Similarity=0.277 Sum_probs=212.3
Q ss_pred CCcccccccccCCccceEEEEEEEc-CCC--EEEEEEecCCC-CCCHHHHHHHHHHHhcc-CCCCcccceeeEeeCCeeE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLE-NQR--RIAVKRFNRMA-WPDPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDERL 132 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~--~vAiK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 132 (449)
+|+++++.+.||+|+||+||+|+++ +|. .||||.++... ....+.|.+|+++++++ +|||||+++|++.+++..+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 5678889999999999999999964 344 57888886543 33456899999999999 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCe
Q 013126 133 LVAEYMPNETLAKHLFHW--------------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNP 198 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~ 198 (449)
+||||++||+|.++++.. ....+++..+..++.||+.||.|+|+++ |+||||||+|||+++++.+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-ccccccccceEEEcCCCce
Confidence 999999999999999742 2367999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCC-CCCchhhHHHhhccccccccc
Q 013126 199 RLSTFGLMKNSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH-IPPSHALDLIRDRNLQMLTDS 274 (449)
Q Consensus 199 kL~DFGla~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~ 274 (449)
||+|||+++..... ....||..|+|||.+.++.++.++|||||||++|||++|.. |+.......+.......
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~---- 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---- 242 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT----
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc----
Confidence 99999999765433 24468999999999999999999999999999999999865 45544444433322221
Q ss_pred ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 275 CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
.....+..+++++.+||.+||+.||++|||++++++.|+++..+.
T Consensus 243 -~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 122345677889999999999999999999999999999887654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=403.00 Aligned_cols=243 Identities=19% Similarity=0.258 Sum_probs=209.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCC---CCCCHHHHHHHHHHHh-ccCCCCcccceeeEeeCCeeEEE
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRM---AWPDPRQFLEEARSVG-QLRNNRLTNLLGCCCEGDERLLV 134 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~---~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lV 134 (449)
++|++++.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46889999999999999999965 5999999999653 2344567788888765 68999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
|||++||+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~~-iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999999997 4567899999999999999999999999 999999999999999999999999999864432
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTELVR 290 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (449)
....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.....+....... ....+..+++++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~~~p~~~s~~~~d 232 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------NPFYPRWLEKEAKD 232 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCCCTTSCHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCCCccCCHHHHH
Confidence 3457899999999999999999999999999999999999999876655544433222 12335567889999
Q ss_pred HHHHhcccCCCCCCCHH-HHHH
Q 013126 291 LASRCLQYEPRERPNPK-SLVT 311 (449)
Q Consensus 291 li~~cl~~dP~~Rps~~-eil~ 311 (449)
|+.+||++||++|||+. ++++
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHhcccCCCCCcCHHHHHHh
Confidence 99999999999999995 6765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.6e-52 Score=408.42 Aligned_cols=247 Identities=19% Similarity=0.173 Sum_probs=203.5
Q ss_pred CcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCC---CCCHHHHHHH---HHHHhccCCCCcccceeeEeeCCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMA---WPDPRQFLEE---ARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~~E---~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
.++|++++.||+|+||+||+|++. +|+.||||++.+.. ......+.+| +++++.++|||||++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 467899999999999999999965 59999999986421 1223344444 6777788899999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRD 211 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 211 (449)
|+||||++||+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++++|.+||+|||+++....
T Consensus 83 ~ivmE~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~-iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHH--hcccccHHHHHHHHHHHHHHHHHHHHCC-ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999997 4567899999999999999999999999 99999999999999999999999999987654
Q ss_pred C--CccccCccccccccccC-CCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhHHHH
Q 013126 212 G--KSYSTNLAFTPPEYLRT-GRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDGTEL 288 (449)
Q Consensus 212 ~--~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (449)
. ....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||........... ...... .....+..+++++
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~~--~~~~~~~~~s~~~ 236 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLT--MAVELPDSFSPEL 236 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-HHHSSS--CCCCCCSSSCHHH
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccc--CCCCCCCCCCHHH
Confidence 4 34679999999999975 4589999999999999999999999975432211110 001111 1123455678899
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHH
Q 013126 289 VRLASRCLQYEPRERPN-----PKSLVT 311 (449)
Q Consensus 289 ~~li~~cl~~dP~~Rps-----~~eil~ 311 (449)
.+||.+||++||++||| ++++++
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 99999999999999999 688886
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-52 Score=398.00 Aligned_cols=245 Identities=20% Similarity=0.217 Sum_probs=196.3
Q ss_pred cccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC-----HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 64 IVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD-----PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 64 ~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
.++.||+|+||+||+|++. +|+.||||+++...... .+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4577899999999999964 59999999997543221 35689999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
+.|+++..... .+..+++..+..+++||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~-iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc-eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 99887776654 5677999999999999999999999999 999999999999999999999999999765543 2
Q ss_pred ccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc--------------cccCC
Q 013126 214 SYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD--------------SCLEG 278 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~ 278 (449)
...||+.|+|||++.+. .++.++||||+||++|||+||.+||.................. .....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 45689999999998755 5899999999999999999999998765433222111110000 00000
Q ss_pred --------CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 279 --------QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 279 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
......++++.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 011245678999999999999999999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-52 Score=398.23 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=198.6
Q ss_pred CCcccccccccCCccceEEEEEEEcC------CCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeC-
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN------QRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEG- 128 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~------~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~- 128 (449)
+.++|+++++||+|+||+||+|.+.. ++.||||+++..... ..+.+.+|...+.++ +|+||+.+++++.+.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 44679999999999999999999532 468999999764432 245688898888887 689999999998765
Q ss_pred CeeEEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC
Q 013126 129 DERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE 194 (449)
Q Consensus 129 ~~~~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~ 194 (449)
+..++||||++||+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSE 169 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-CcCCcCCccceeECC
Confidence 46899999999999999997432 235889999999999999999999999 999999999999999
Q ss_pred CCCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCC-CCCchhhHHHhhcc
Q 013126 195 DGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKH-IPPSHALDLIRDRN 267 (449)
Q Consensus 195 ~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~ 267 (449)
++.+||+|||+++..... ....||+.|+|||++.++.++.++|||||||++|||+||.. ||............
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999864432 23468999999999999999999999999999999999865 55433211111111
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 268 LQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
.. .......++..++++.+++.+||+.||++|||+++++++|+.+.+
T Consensus 250 ~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 250 LK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HH----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hh----cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 111123455677899999999999999999999999999988754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=388.86 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=201.6
Q ss_pred cccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++|+++++||+|+||+||+|++ .+|+.||||+++.... ...+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999996 4599999999975432 235789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG---- 212 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~---- 212 (449)
|+.+ ++.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~-IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC-EEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 9974 5555555445678999999999999999999999999 999999999999999999999999999865433
Q ss_pred CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc-----------c---ccccc--
Q 013126 213 KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ-----------M---LTDSC-- 275 (449)
Q Consensus 213 ~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-----------~---~~~~~-- 275 (449)
....||+.|+|||++.... ++.++||||+||++|+|++|+.||.............. . .....
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 2457899999999987766 57899999999999999999999876532221111000 0 00000
Q ss_pred cCCC-------CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 276 LEGQ-------FTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 276 ~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.... .....++++.+|+.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 012456789999999999999999999999983
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=391.55 Aligned_cols=254 Identities=21% Similarity=0.283 Sum_probs=208.1
Q ss_pred CCcccccccccCCccceEEEEEEEcC--------CCEEEEEEecCCCCCC-HHHHHHHHHHHhcc-CCCCcccceeeEee
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWPD-PRQFLEEARSVGQL-RNNRLTNLLGCCCE 127 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~~~--------~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 127 (449)
+.++|++++.||+|+||.||+|+..+ +..||||+++...... ..++.+|...+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34679999999999999999998532 2479999997655322 46788999999998 89999999999999
Q ss_pred CCeeEEEEeeCCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC
Q 013126 128 GDERLLVAEYMPNETLAKHLFHWE--------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD 193 (449)
Q Consensus 128 ~~~~~lV~Ey~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~ 193 (449)
++..++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVT 169 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEC
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-EEeeeecccceeec
Confidence 999999999999999999997432 245899999999999999999999999 99999999999999
Q ss_pred CCCCeEEeccCCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhc-CCCCCCchhhHHHhhc
Q 013126 194 EDGNPRLSTFGLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLS-GKHIPPSHALDLIRDR 266 (449)
Q Consensus 194 ~~~~~kL~DFGla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 266 (449)
.++.+||+|||+++..... ....+|+.|+|||.+.++.|+.++||||||+++|||++ |.+||.......+...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 9999999999998854432 23567899999999999999999999999999999998 5777765544443322
Q ss_pred ccccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 267 NLQMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
... ......+...++++.+|+.+||+.||++|||+.++++.|+++.
T Consensus 250 i~~-----~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 250 LKE-----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHT-----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHc-----CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 211 1122345567789999999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=389.41 Aligned_cols=248 Identities=24% Similarity=0.306 Sum_probs=202.6
Q ss_pred ccccCCccceEEEEEEEcC----CCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEee-CCeeEEEEeeC
Q 013126 65 VSEHGEKAPNVVYKGKLEN----QRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCE-GDERLLVAEYM 138 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~----~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~ 138 (449)
-+.||+|+||+||+|++.+ ...||||+++..... ..++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 3568999999999999643 236899999753322 24679999999999999999999999876 46899999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC------
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG------ 212 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~------ 212 (449)
++|+|.+++.. ....+++..++.++.|++.||.|+|+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~-iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccC-cccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 99999998874 4556788899999999999999999999 999999999999999999999999999865432
Q ss_pred --CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhH-HHhhcccccccccccCCCCCchhHHHHH
Q 013126 213 --KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALD-LIRDRNLQMLTDSCLEGQFTDDDGTELV 289 (449)
Q Consensus 213 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (449)
....||+.|+|||.+.++.++.++||||||+++|||+||+.||...... .+.... ... .+...+..+++++.
T Consensus 190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i----~~g-~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQG-RRLLQPEYCPDPLY 264 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH----HTT-CCCCCCTTCCHHHH
T ss_pred ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcC-CCCCCcccCcHHHH
Confidence 1245789999999999999999999999999999999988877654211 111111 111 11233456678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 290 RLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 290 ~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
+++.+||+.||++|||+.|+++.|+.+...
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999888654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-50 Score=385.47 Aligned_cols=249 Identities=18% Similarity=0.243 Sum_probs=203.7
Q ss_pred cccccccccCCccceEEEEEEEcCCCEEEEEEecCCC--CCCHHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMA--WPDPRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAEY 137 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 137 (449)
++|+++++||+|+||+||+|++++|+.||||+++... ....+++.+|+.++++++||||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5789999999999999999999889999999997643 22357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC----C
Q 013126 138 MPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG----K 213 (449)
Q Consensus 138 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----~ 213 (449)
+.++.+..+.. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+...... .
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~-IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCc-EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 98777766665 5678999999999999999999999999 999999999999999999999999999765433 3
Q ss_pred ccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc--------------cc-------
Q 013126 214 SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ--------------ML------- 271 (449)
Q Consensus 214 ~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~--------------~~------- 271 (449)
...+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.............. ..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 446889999999997654 79999999999999999999999875432221111000 00
Q ss_pred --cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 272 --TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 272 --~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.............++++.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111223456788999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=391.77 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=209.6
Q ss_pred cccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCC-CHHHHHHHHHHHhcc-CCCCcccceeeEeeCCee
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWP-DPRQFLEEARSVGQL-RNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 131 (449)
++|++.+.||+|+||.||+|++. +++.||||+++..... ....|.+|+.+++++ +|||||+++|++.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57889999999999999999852 3678999999865432 245799999999999 699999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCC
Q 013126 132 LLVAEYMPNETLAKHLFHWE----------------THPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDED 195 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~ 195 (449)
++||||++||+|.+++.... ...+++..++.++.||+.||+|||+++ ++||||||+||+++.+
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHG 181 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEETT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccccccccccccc
Confidence 99999999999999997532 236899999999999999999999999 9999999999999999
Q ss_pred CCeEEeccCCcccCCCCC------ccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCC-CCchhhHHHhhccc
Q 013126 196 GNPRLSTFGLMKNSRDGK------SYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHI-PPSHALDLIRDRNL 268 (449)
Q Consensus 196 ~~~kL~DFGla~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p-~~~~~~~~~~~~~~ 268 (449)
+.+|++|||+++...... ...||+.|+|||++.++.++.++||||||+++|||+|++.| +...........
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~-- 259 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK-- 259 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH--
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH--
Confidence 999999999998755432 34678999999999999999999999999999999995544 433322111111
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccccc
Q 013126 269 QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKE 319 (449)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~ 319 (449)
+.........+...++++.+||.+||+.||++|||++++++.|++...+
T Consensus 260 --~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 260 --MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp --HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1111112233456678999999999999999999999999999876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=386.95 Aligned_cols=237 Identities=20% Similarity=0.290 Sum_probs=201.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCC------CHHHHHHHHHHHhccC--CCCcccceeeEeeCCe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWP------DPRQFLEEARSVGQLR--NNRLTNLLGCCCEGDE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~ 130 (449)
++|++.+.||+|+||+||+|+.. +|+.||||++++.... ...++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 36889999999999999999964 6999999999753322 1245779999999996 8999999999999999
Q ss_pred eEEEEeeCCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-CCCeEEeccCCccc
Q 013126 131 RLLVAEYMPN-ETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-DGNPRLSTFGLMKN 208 (449)
Q Consensus 131 ~~lV~Ey~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~ 208 (449)
.++||||+.+ +++.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~~-iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 68888887 4567999999999999999999999999 999999999999985 57899999999986
Q ss_pred CCCC--CccccCccccccccccCCCC-CCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCchhH
Q 013126 209 SRDG--KSYSTNLAFTPPEYLRTGRV-TPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTDDDG 285 (449)
Q Consensus 209 ~~~~--~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (449)
.... ....||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... .+... ...++..++
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~~~----------~~~~~~~~s 228 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG----------QVFFRQRVS 228 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHHHC----------CCCCSSCCC
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HHhhc----------ccCCCCCCC
Confidence 5543 45679999999999987775 667999999999999999999987642 11111 112345677
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 286 TELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 286 ~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
+++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 89999999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=387.29 Aligned_cols=251 Identities=20% Similarity=0.229 Sum_probs=200.5
Q ss_pred cccccccccCCccceEEEEEEE-cC-CCEEEEEEecCCC--CCCHHHHHHHHHHHhcc---CCCCcccceeeEee-----
Q 013126 60 AVENIVSEHGEKAPNVVYKGKL-EN-QRRIAVKRFNRMA--WPDPRQFLEEARSVGQL---RNNRLTNLLGCCCE----- 127 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~-~~-~~~vAiK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~----- 127 (449)
++|+++++||+|+||+||+|++ .+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 5799999999999999999996 34 6679999996532 22244677888887776 79999999999863
Q ss_pred CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 128 GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 128 ~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
....+++|||++++++..... .....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC-EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 346899999999876654443 25677999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc-------------
Q 013126 208 NSRDG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML------------- 271 (449)
Q Consensus 208 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------------- 271 (449)
..... ....||+.|+|||++.+..|+.++||||+||++|||++|+.||................
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence 65433 35678999999999999999999999999999999999999997654332211111000
Q ss_pred --------cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 272 --------TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 272 --------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.............++.+.+|+.+||++||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000112234567889999999999999999999999983
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=387.10 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=210.3
Q ss_pred CcccccccccCCccceEEEEEEEc------CCCEEEEEEecCCCCCC-HHHHHHHHHHHhccCCCCcccceeeEeeCCee
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE------NQRRIAVKRFNRMAWPD-PRQFLEEARSVGQLRNNRLTNLLGCCCEGDER 131 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~------~~~~vAiK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 131 (449)
.+++++.++||+|+||+||+|.+. +++.||||+++...... ...|.+|++++++++||||++++|++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467889999999999999999863 25789999997543222 34689999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEecc
Q 013126 132 LLVAEYMPNETLAKHLFHW--------ETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTF 203 (449)
Q Consensus 132 ~lV~Ey~~ggsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DF 203 (449)
++||||+++|+|.+++... ....+++..+..++.|+++||.|||+++ |+||||||+|||+++++++||+||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCSGGGEEECTTCCEEECCT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC-eeeceEcCCceeecCCceEEEeec
Confidence 9999999999999998642 1245789999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCC------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCC-CCCCchhhHHHhhccccccccccc
Q 013126 204 GLMKNSRDG------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGK-HIPPSHALDLIRDRNLQMLTDSCL 276 (449)
Q Consensus 204 Gla~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 276 (449)
|+++..... ....+|+.|+|||.+.++.++.++||||||+++|||+||. .|+................
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~----- 252 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----- 252 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-----
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-----
Confidence 999865432 2335789999999999999999999999999999999996 5555444333332222111
Q ss_pred CCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhcccc
Q 013126 277 EGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQ 317 (449)
Q Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~ 317 (449)
....+..+++.+.+++.+||+.||++|||++++++.|++..
T Consensus 253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 12234567789999999999999999999999999987763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=385.65 Aligned_cols=252 Identities=16% Similarity=0.232 Sum_probs=196.0
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHH--HHHHHhccCCCCcccceeeEeeCC----eeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLE--EARSVGQLRNNRLTNLLGCCCEGD----ERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~--E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV 134 (449)
++.+.++||+|+||+||+|++ +|+.||||+++.. ..+.+.+ |+..+++++||||+++++++.+++ .+++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 466778899999999999997 6789999999643 2344444 555566789999999999998754 57999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCccccccccCceeeCCCCCeEEeccCCc
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS--------KGRALYHDLNAYRILFDEDGNPRLSTFGLM 206 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------~~~iiHrDlkp~NILl~~~~~~kL~DFGla 206 (449)
|||+++|+|.+++++ .++++..++.++.|++.||+|+|+ ++ |+||||||+|||+++++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~-IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC-eeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999963 479999999999999999999997 46 999999999999999999999999999
Q ss_pred ccCCCC--------CccccCccccccccccCCC------CCCCCceeeHhHHHHHHhcCCCCCCch--------------
Q 013126 207 KNSRDG--------KSYSTNLAFTPPEYLRTGR------VTPESVIYSFGTLLLDLLSGKHIPPSH-------------- 258 (449)
Q Consensus 207 ~~~~~~--------~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg~~p~~~~-------------- 258 (449)
+..... ....||+.|+|||++.+.. ++.++|||||||++|||+||..|+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 865332 2356899999999987542 677999999999999999998765321
Q ss_pred -hhHHHhhcccccccccccCCC-CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 259 -ALDLIRDRNLQMLTDSCLEGQ-FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 259 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
..............++..... ...+.+..+.+++.+||+.||++|||+.|+++.|+++..+.
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 111111111111111111111 12345567999999999999999999999999999887553
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=386.34 Aligned_cols=247 Identities=18% Similarity=0.244 Sum_probs=196.2
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCC------e
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGD------E 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 130 (449)
+.|+++++||+|+||+||+|.+. +|+.||||+++...... .+.+.+|+++|++++|||||++++++...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 46899999999999999999964 59999999997644322 457899999999999999999999998765 4
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
+|+||||+ +.+|...+. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||+++...
T Consensus 98 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~-IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhCC-CcccccCcchhhcccccccccccccceeccC
Confidence 69999999 578888774 467999999999999999999999999 9999999999999999999999999998766
Q ss_pred CC-CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc--------------------
Q 013126 211 DG-KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL-------------------- 268 (449)
Q Consensus 211 ~~-~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~-------------------- 268 (449)
.. ....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.............
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 54 456789999999999765 47899999999999999999999986543221111000
Q ss_pred ------ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 269 ------QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 269 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
....... ........++++.+||.+||+.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 253 NYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccCCcccccc-hHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 011234556889999999999999999999999983
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=375.89 Aligned_cols=252 Identities=17% Similarity=0.205 Sum_probs=197.0
Q ss_pred CCCcccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCC--CCHHHHHHHHHHHhccCCCCcccceeeEee------
Q 013126 57 SGFAVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAW--PDPRQFLEEARSVGQLRNNRLTNLLGCCCE------ 127 (449)
Q Consensus 57 ~~f~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 127 (449)
+..+.|+++++||+|+||+||+|++. +|+.||||++..... ...+++.+|+++|++++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 34578999999999999999999964 699999999865432 235789999999999999999999999865
Q ss_pred --CCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCC
Q 013126 128 --GDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGL 205 (449)
Q Consensus 128 --~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGl 205 (449)
++..++||||+.++++..... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~-ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCC-EEecCcCchheeecCCCcEEeeecce
Confidence 346899999998776665443 5678999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCC--------CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccc---
Q 013126 206 MKNSRDG--------KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTD--- 273 (449)
Q Consensus 206 a~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--- 273 (449)
++..... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9754422 234689999999999765 5899999999999999999999998754332221111110000
Q ss_pred ccc--------------CCCCCc---------hhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 274 SCL--------------EGQFTD---------DDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 274 ~~~--------------~~~~~~---------~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
... ...... ..++++.+||.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 000000 12457789999999999999999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=368.40 Aligned_cols=249 Identities=17% Similarity=0.215 Sum_probs=204.6
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeCCeeEEEEe
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEGDERLLVAE 136 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 136 (449)
++|+++++||+|+||+||+|++. +++.||||+++...... .+++.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999964 58999999997654322 5789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCCC---
Q 013126 137 YMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDGK--- 213 (449)
Q Consensus 137 y~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--- 213 (449)
++.|++|..++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~-IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCC-EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999999988876 6678899999999999999999999999 9999999999999999999999999998765432
Q ss_pred -ccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCch-hhHHHhhccc----------------------
Q 013126 214 -SYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNL---------------------- 268 (449)
Q Consensus 214 -~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~---------------------- 268 (449)
...+++.|+|||++.+.. ++.++||||+||++|||++|+.||... ..........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 345678999999998765 689999999999999999999886432 1111110000
Q ss_pred -ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 -QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
................++++.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000111223456788999999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=379.22 Aligned_cols=248 Identities=18% Similarity=0.241 Sum_probs=194.2
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCC-CHHHHHHHHHHHhccCCCCcccceeeEeeCC----eeEEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWP-DPRQFLEEARSVGQLRNNRLTNLLGCCCEGD----ERLLV 134 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV 134 (449)
.|+++++||+|+||+||+|.+ .+|+.||||++++.... ..+++.+|+++|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 489999999999999999996 46999999999764422 2457899999999999999999999997653 23455
Q ss_pred EeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC--
Q 013126 135 AEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG-- 212 (449)
Q Consensus 135 ~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-- 212 (449)
++|+.||+|.+++. .+.+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 89 ~~~~~~g~L~~~l~---~~~l~~~~i~~i~~qil~al~yLH~~~-iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 56677899999995 347999999999999999999999999 999999999999999999999999999764432
Q ss_pred -----CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc---------------
Q 013126 213 -----KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML--------------- 271 (449)
Q Consensus 213 -----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------------- 271 (449)
....||+.|+|||++... .++.++||||+||++|+|++|+.||................
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 334689999999998554 57889999999999999999999987543221111110000
Q ss_pred --------cc--cccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013126 272 --------TD--SCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVTA 312 (449)
Q Consensus 272 --------~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 312 (449)
.. ........+..++++.+|+.+||+.||++|||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000001123456789999999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=376.04 Aligned_cols=246 Identities=21% Similarity=0.225 Sum_probs=194.1
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcccceeeEeeC------CeeEE
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLTNLLGCCCEG------DERLL 133 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~l 133 (449)
.|+.++.||+|+||+||+|++. +|+.||||+++.... ...+|+++|++++||||+++++++... .++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778889999999999999975 599999999976432 234799999999999999999998543 35789
Q ss_pred EEeeCCCCCHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-CeEEeccCCcccCCC
Q 013126 134 VAEYMPNETLAKHLF-HWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRD 211 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~ 211 (449)
||||++++.+..... ......+++.+++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC-CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 999998654333322 124668999999999999999999999999 99999999999999775 899999999987654
Q ss_pred C---CccccCccccccccccCC-CCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccc-------------------
Q 013126 212 G---KSYSTNLAFTPPEYLRTG-RVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNL------------------- 268 (449)
Q Consensus 212 ~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~------------------- 268 (449)
. ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.............
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 3 345789999999988754 58999999999999999999999987553322111110
Q ss_pred ----ccccccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 269 ----QMLTDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 269 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
................++++.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000011123356788999999999999999999999997
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-47 Score=371.91 Aligned_cols=245 Identities=16% Similarity=0.221 Sum_probs=198.3
Q ss_pred CCcccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEeeC--CeeEE
Q 013126 58 GFAVENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEG--DERLL 133 (449)
Q Consensus 58 ~f~~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~l 133 (449)
+.++|+++++||+|+||+||+|++ .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 456899999999999999999996 45999999999753 4678999999999995 99999999998754 56899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCC-CeEEeccCCcccCCCC
Q 013126 134 VAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDG-NPRLSTFGLMKNSRDG 212 (449)
Q Consensus 134 V~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~ 212 (449)
||||+++++|.+.. +.+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++.....
T Consensus 110 v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g-IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc-cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999987654 46999999999999999999999999 99999999999998655 6999999999876543
Q ss_pred ---CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHH------------------hhcccc-
Q 013126 213 ---KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLI------------------RDRNLQ- 269 (449)
Q Consensus 213 ---~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~------------------~~~~~~- 269 (449)
....+|+.|+|||.+.+.. ++.++||||+||++|+|++|+.||........ ......
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 3456899999999988755 79999999999999999999998854311100 000000
Q ss_pred --c---c--------cccccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 270 --M---L--------TDSCLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 270 --~---~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
. . .............++++.+||.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 0001111122346788999999999999999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=378.70 Aligned_cols=247 Identities=16% Similarity=0.199 Sum_probs=196.1
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeC-----CeeE
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG-----DERL 132 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 132 (449)
+|+++++||+|+||+||+|++ .+|+.||||+++...... .+++.+|+++|++++|||||++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 589999999999999999996 469999999998654322 45788999999999999999999998643 3446
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCCCC
Q 013126 133 LVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSRDG 212 (449)
Q Consensus 133 lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 212 (449)
++|+|+.||+|.+++. .+.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++......
T Consensus 99 ~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~g-iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp EEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred EEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCC-CcccccCCccccccccccccccccchhcccCcc
Confidence 6778888999999994 467999999999999999999999999 999999999999999999999999998765443
Q ss_pred -CccccCccccccccccCCC-CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhccccccccc----------------
Q 013126 213 -KSYSTNLAFTPPEYLRTGR-VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDS---------------- 274 (449)
Q Consensus 213 -~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------- 274 (449)
....||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.................
T Consensus 175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 4566889999999987655 6889999999999999999999987653322221111100000
Q ss_pred ------ccCC---CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 275 ------CLEG---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 275 ------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... ......++++.+||.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 001245678999999999999999999999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=376.34 Aligned_cols=248 Identities=19% Similarity=0.237 Sum_probs=204.5
Q ss_pred CcccccccccCCccceEEEEEEEc----CCCEEEEEEecCCC----CCCHHHHHHHHHHHhccCC-CCcccceeeEeeCC
Q 013126 59 FAVENIVSEHGEKAPNVVYKGKLE----NQRRIAVKRFNRMA----WPDPRQFLEEARSVGQLRN-NRLTNLLGCCCEGD 129 (449)
Q Consensus 59 f~~~~~l~~lG~G~~g~Vy~~~~~----~~~~vAiK~l~~~~----~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~ 129 (449)
.++|++++.||+|+||+||+|+.. +|+.||||.+++.. ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 467999999999999999999852 47899999996532 2335678899999999977 89999999999999
Q ss_pred eeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccC
Q 013126 130 ERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNS 209 (449)
Q Consensus 130 ~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 209 (449)
..+++|||+.||+|.+++. ..+.+++..+..++.||+.||+|+|+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~~~-ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhcCC-EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999997 4457789999999999999999999999 999999999999999999999999999765
Q ss_pred CCC-----CccccCccccccccccCCC--CCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccccccccCCCCCc
Q 013126 210 RDG-----KSYSTNLAFTPPEYLRTGR--VTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQMLTDSCLEGQFTD 282 (449)
Q Consensus 210 ~~~-----~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (449)
... ....|++.|+|||.+.+.. ++.++|||||||+||+|++|+.||................... ....+.
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~~~ 257 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQ 257 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCCCT
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC--CCCCcc
Confidence 432 2456899999999997654 7889999999999999999999986643222211111111111 123355
Q ss_pred hhHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 013126 283 DDGTELVRLASRCLQYEPRERP-----NPKSLVT 311 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~ 311 (449)
..++++.+++.+||++||++|| |++|+++
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 6788999999999999999998 4788886
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-47 Score=365.97 Aligned_cols=253 Identities=15% Similarity=0.128 Sum_probs=198.9
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcc-cceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT-NLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~ 138 (449)
.|+++++||+|+||+||+|++. +|+.||||++..... .+++.+|+++++.++|+|++ .+.+++.+++..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 5889999999999999999964 589999999876432 34688999999999877655 5556667788899999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeC---CCCCeEEeccCCcccCCCC---
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFD---EDGNPRLSTFGLMKNSRDG--- 212 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~---~~~~~kL~DFGla~~~~~~--- 212 (449)
. ++|.+.+.. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.....
T Consensus 86 ~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 G-PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp C-CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred C-Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 5 667666653 5678999999999999999999999999 99999999999986 3557999999999865432
Q ss_pred --------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccc--cccccccCCCCCc
Q 013126 213 --------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQ--MLTDSCLEGQFTD 282 (449)
Q Consensus 213 --------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 282 (449)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.............. .............
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence 234689999999999999999999999999999999999999865432221111100 0000000111234
Q ss_pred hhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccc
Q 013126 283 DDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQK 318 (449)
Q Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~ 318 (449)
.+|+++.+++.+||+.||++||+++++.+.|+.+..
T Consensus 243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 567889999999999999999999999888877644
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.8e-47 Score=363.61 Aligned_cols=254 Identities=16% Similarity=0.143 Sum_probs=206.0
Q ss_pred ccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC-CCcccceeeEeeCCeeEEEEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN-NRLTNLLGCCCEGDERLLVAEYM 138 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~ 138 (449)
.|++++.||+|+||+||+|++. +|+.||||+++... +.+.+.+|+++++.++| +|++.+++++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 5889999999999999999965 58999999986543 23467889999999976 89999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCC-----CCCeEEeccCCcccCCCC-
Q 013126 139 PNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDE-----DGNPRLSTFGLMKNSRDG- 212 (449)
Q Consensus 139 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~-----~~~~kL~DFGla~~~~~~- 212 (449)
+++|.+++.. ....+++.++..++.|++.||+|||++| |+||||||+|||++. ++.+||+|||+++.....
T Consensus 84 -~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~g-iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 -GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp -CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred -CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCC-ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 6899998864 4567999999999999999999999999 999999999999974 578999999999864321
Q ss_pred ----------CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH---HhhcccccccccccCCC
Q 013126 213 ----------KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL---IRDRNLQMLTDSCLEGQ 279 (449)
Q Consensus 213 ----------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 279 (449)
....||+.|||||++.+..++.++||||||+++|||+||+.||....... ........ ........
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~-~~~~~~~~ 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQSTPLRE 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-HHHSCHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-cCCCChHH
Confidence 23468999999999999999999999999999999999999986432111 10000000 00011111
Q ss_pred CCchhHHHHHHHHHHhcccCCCCCCCHHHHHHHhccccccc
Q 013126 280 FTDDDGTELVRLASRCLQYEPRERPNPKSLVTALSPLQKET 320 (449)
Q Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~~~~~~ 320 (449)
....+|+++.+++..|++.+|++||+++.+.+.|+++....
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 23456678999999999999999999999998888765443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=369.77 Aligned_cols=246 Identities=16% Similarity=0.211 Sum_probs=189.5
Q ss_pred cccccccccCCccceEEEEEEEc-CCCEEEEEEecCCCCCC--HHHHHHHHHHHhccCCCCcccceeeEeeC------Ce
Q 013126 60 AVENIVSEHGEKAPNVVYKGKLE-NQRRIAVKRFNRMAWPD--PRQFLEEARSVGQLRNNRLTNLLGCCCEG------DE 130 (449)
Q Consensus 60 ~~~~~l~~lG~G~~g~Vy~~~~~-~~~~vAiK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 130 (449)
..|+++++||+|+||+||+|.+. +|+.||||+++...... .+++.+|+.++++++||||+++++++... +.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 46999999999999999999965 59999999997654322 35688999999999999999999999643 67
Q ss_pred eEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccCCcccCC
Q 013126 131 RLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFGLMKNSR 210 (449)
Q Consensus 131 ~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 210 (449)
+|+||||+.++ +.+.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g-iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc-cccccCCccccccccccceeeechhhhhccc
Confidence 89999999755 444443 46899999999999999999999999 9999999999999999999999999987655
Q ss_pred CC---CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHHHhhcccccc----------------
Q 013126 211 DG---KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDLIRDRNLQML---------------- 271 (449)
Q Consensus 211 ~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---------------- 271 (449)
.. ....+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+..............
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 43 34568999999999999999999999999999999999999986543222111110000
Q ss_pred -----------------cccccCC---CCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 272 -----------------TDSCLEG---QFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 272 -----------------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
....... ......++++.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 001235678999999999999999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-41 Score=329.97 Aligned_cols=249 Identities=17% Similarity=0.213 Sum_probs=190.0
Q ss_pred ccccccccCCccceEEEEEEE-cCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-----------CCCcccceeeEeeC
Q 013126 61 VENIVSEHGEKAPNVVYKGKL-ENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-----------NNRLTNLLGCCCEG 128 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~-~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~~ 128 (449)
+|+++++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 499999999999999999996 469999999997543 12467888999998885 57899999987653
Q ss_pred --CeeEEEEeeCCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccCceeeCCCCC------e
Q 013126 129 --DERLLVAEYMPNE-TLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTS-KGRALYHDLNAYRILFDEDGN------P 198 (449)
Q Consensus 129 --~~~~lV~Ey~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~iiHrDlkp~NILl~~~~~------~ 198 (449)
...+++|+++.++ +............+++..++.++.||+.||+|||+ .| |+||||||+|||++.++. +
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~-IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECSCCSGGGEEEEEEETTTTEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC-cccccCChhHeeeeccCccccccee
Confidence 4566666666544 33444444466788999999999999999999998 77 999999999999986553 9
Q ss_pred EEeccCCcccCCCC-CccccCccccccccccCCCCCCCCceeeHhHHHHHHhcCCCCCCchhhHH-------H-------
Q 013126 199 RLSTFGLMKNSRDG-KSYSTNLAFTPPEYLRTGRVTPESVIYSFGTLLLDLLSGKHIPPSHALDL-------I------- 263 (449)
Q Consensus 199 kL~DFGla~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-------~------- 263 (449)
+++|||.+...... ....||+.|+|||++.+..++.++||||+||++++|++|+.||....... +
T Consensus 172 kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~l 251 (362)
T d1q8ya_ 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251 (362)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred eEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHh
Confidence 99999998865543 45678999999999999999999999999999999999999975321100 0
Q ss_pred --------hhcc-----------ccccccc---------ccCCCCCchhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013126 264 --------RDRN-----------LQMLTDS---------CLEGQFTDDDGTELVRLASRCLQYEPRERPNPKSLVT 311 (449)
Q Consensus 264 --------~~~~-----------~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 311 (449)
.... ....... ..........++++.+|+.+||+.||.+|||++|+++
T Consensus 252 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 0000000 0011233456789999999999999999999999997
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.6e-25 Score=199.52 Aligned_cols=163 Identities=16% Similarity=0.138 Sum_probs=121.2
Q ss_pred ccccccCCccceEEEEEEEcCCCEEEEEEecCCCCC-----C-------------HHHHHHHHHHHhccCCCCcccceee
Q 013126 63 NIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWP-----D-------------PRQFLEEARSVGQLRNNRLTNLLGC 124 (449)
Q Consensus 63 ~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~-----~-------------~~~~~~E~~~l~~l~HpnIv~l~~~ 124 (449)
.+-++||+|+||+||+|.+.+|+.||||+++..... . .....+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356788999999999999888999999998642111 0 1234578899999999999988765
Q ss_pred EeeCCeeEEEEeeCCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccCceeeCCCCCeEEeccC
Q 013126 125 CCEGDERLLVAEYMPNETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSKGRALYHDLNAYRILFDEDGNPRLSTFG 204 (449)
Q Consensus 125 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~iiHrDlkp~NILl~~~~~~kL~DFG 204 (449)
. ..+++|||+++..+.+ ++...+..++.|++.+|+|||+++ |+||||||+|||+++++ ++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g-iiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG-IVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEEETTE-EEECCCT
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC-EEEccCChhheeeeCCC-EEEEECC
Confidence 3 2379999999765432 334456789999999999999999 99999999999999654 8999999
Q ss_pred CcccCCCCCccccCccccc------cccccCCCCCCCCceeeHhHHH
Q 013126 205 LMKNSRDGKSYSTNLAFTP------PEYLRTGRVTPESVIYSFGTLL 245 (449)
Q Consensus 205 la~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwSlGvil 245 (449)
+|......... .|.. .+.+ ...|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~~----~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWR----EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHH----HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcH----HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99775533211 1111 1112 35688999999976433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.71 E-value=3.1e-08 Score=90.20 Aligned_cols=140 Identities=11% Similarity=0.006 Sum_probs=96.9
Q ss_pred ccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccC-CCCcccceeeEeeCCeeEEEEeeCC
Q 013126 61 VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLR-NNRLTNLLGCCCEGDERLLVAEYMP 139 (449)
Q Consensus 61 ~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 139 (449)
.++.++..+.++.+.||+... +++.+.+|+...........+.+|...++.+. +-.+.+++.+...++..++||++++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 345565555556678998875 46678899887655445556788999988874 4457888888888899999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 013126 140 NETLAKHLFHWETHPMKWAMRLRVVLHLAQALEYCTSK------------------------------------------ 177 (449)
Q Consensus 140 ggsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~------------------------------------------ 177 (449)
|.++.+.... . . ....++.+++..++.||+.
T Consensus 94 G~~~~~~~~~---~-~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 94 GVLCSEEYED---E-Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SEEHHHHTTT---C-S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred cccccccccc---c-c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 9888654421 0 1 1122334444444444421
Q ss_pred ---------------C-CccccccccCceeeCCCCCeEEeccCCccc
Q 013126 178 ---------------G-RALYHDLNAYRILFDEDGNPRLSTFGLMKN 208 (449)
Q Consensus 178 ---------------~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 208 (449)
. -++|+|+.|.||++++++.+-|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0 168999999999999877677999987643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=2.3e-05 Score=70.13 Aligned_cols=73 Identities=16% Similarity=0.141 Sum_probs=54.2
Q ss_pred CCcc-ceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCC--CCcccceeeEeeCCeeEEEEeeCCCCCHH
Q 013126 69 GEKA-PNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRN--NRLTNLLGCCCEGDERLLVAEYMPNETLA 144 (449)
Q Consensus 69 G~G~-~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 144 (449)
..|. .+.||+...+++..+.+|.-.... ...+.+|+..++.+.. -.+.+++.+..+++..++||++++|.++.
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3443 367999998778889999876543 3346778888887743 34677888888888899999999986653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=7.6e-06 Score=78.79 Aligned_cols=76 Identities=12% Similarity=0.069 Sum_probs=50.8
Q ss_pred ccccCCccceEEEEEEEcC-CCEEEEEEecC------CC-CCCHHHHHHHHHHHhccC-C--CCcccceeeEeeCCeeEE
Q 013126 65 VSEHGEKAPNVVYKGKLEN-QRRIAVKRFNR------MA-WPDPRQFLEEARSVGQLR-N--NRLTNLLGCCCEGDERLL 133 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~-~~~vAiK~l~~------~~-~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~~~~~l 133 (449)
.+.+|.|....||+....+ ++.+++|.-.. .. .....+...|++.|+.+. + ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998544 78899996532 11 123456667888888773 3 345666654 4556689
Q ss_pred EEeeCCCCC
Q 013126 134 VAEYMPNET 142 (449)
Q Consensus 134 V~Ey~~ggs 142 (449)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.48 E-value=0.00022 Score=66.30 Aligned_cols=95 Identities=20% Similarity=0.215 Sum_probs=60.3
Q ss_pred ccccCHHHHHHhhCCCc---ccccccccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCcc-
Q 013126 44 FREFTLEQLKNATSGFA---VENIVSEHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRLT- 119 (449)
Q Consensus 44 ~~~~~~~~l~~~~~~f~---~~~~l~~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv- 119 (449)
+..++.+.+..+..++. +.++. .|+ +--..||+++.++|+.|++|+.+.... ..+++..|...+..|...++.
T Consensus 5 f~~L~pd~i~~al~~~g~~~~~~~~-~L~-s~EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv 81 (325)
T d1zyla1 5 FQTLHPDTIMDALFEHGIRVDSGLT-PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPV 81 (325)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCE-EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSB
T ss_pred ccccCHHHHHHHHHHcCCCCCcCcc-ccc-cccceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCC
Confidence 45566666665554332 11222 232 334689999988899999999876543 457788899988888533321
Q ss_pred -cce-----eeEeeCCeeEEEEeeCCCC
Q 013126 120 -NLL-----GCCCEGDERLLVAEYMPNE 141 (449)
Q Consensus 120 -~l~-----~~~~~~~~~~lV~Ey~~gg 141 (449)
... ..+..++..+.++++++|.
T Consensus 82 ~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 82 AAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred CCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 111 2234456788999999864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.21 E-value=0.00088 Score=63.81 Aligned_cols=73 Identities=15% Similarity=0.253 Sum_probs=51.9
Q ss_pred ccccCCccceEEEEEEEcC--------CCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCC-cccceeeEeeCCeeEEEE
Q 013126 65 VSEHGEKAPNVVYKGKLEN--------QRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNR-LTNLLGCCCEGDERLLVA 135 (449)
Q Consensus 65 l~~lG~G~~g~Vy~~~~~~--------~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~ 135 (449)
+++|+.|-...+|+....+ .+.|.+++.-. ........+|..+++.+.-.+ ..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4678889999999998643 35677777642 233456678999999885334 4577777643 6899
Q ss_pred eeCCCCCH
Q 013126 136 EYMPNETL 143 (449)
Q Consensus 136 Ey~~ggsL 143 (449)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.19 E-value=0.0009 Score=61.46 Aligned_cols=158 Identities=13% Similarity=0.068 Sum_probs=86.6
Q ss_pred ccCHHHHHHhhCCCccccccc--ccCCccceEEEEEEEcCCCEEEEEEecCCCCCCHHHHHHHHHHHhccCCCCc--ccc
Q 013126 46 EFTLEQLKNATSGFAVENIVS--EHGEKAPNVVYKGKLENQRRIAVKRFNRMAWPDPRQFLEEARSVGQLRNNRL--TNL 121 (449)
Q Consensus 46 ~~~~~~l~~~~~~f~~~~~l~--~lG~G~~g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~~E~~~l~~l~HpnI--v~l 121 (449)
.++.+++.....+|+.-++.+ .|..|--.+.|+.+.++| .+++|+..... +.++...|++++..+.+.++ ...
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 356788888888776544443 455777788999987655 58999986532 23455667777777743322 221
Q ss_pred e------eeEeeCCeeEEEEeeCCCCCHHH--------------HHhcc-C--C----CCCC------------------
Q 013126 122 L------GCCCEGDERLLVAEYMPNETLAK--------------HLFHW-E--T----HPMK------------------ 156 (449)
Q Consensus 122 ~------~~~~~~~~~~lV~Ey~~ggsL~~--------------~l~~~-~--~----~~l~------------------ 156 (449)
. .+....+....++.+..|..... .++.. . . ....
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 1 11223445667777776532211 00000 0 0 0000
Q ss_pred HHHHHHHHHHHHHHHHHHHh----CCCccccccccCceeeCCCCCeEEeccCCcc
Q 013126 157 WAMRLRVVLHLAQALEYCTS----KGRALYHDLNAYRILFDEDGNPRLSTFGLMK 207 (449)
Q Consensus 157 ~~~~~~i~~qi~~aL~yLH~----~~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 207 (449)
.......+......+.-.+. .| +||+|+.++||+++++...-+.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~g-iIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAG-VIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEE-EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccc-cccCCcchhhhhcccccceeEecccccc
Confidence 00111122222222333222 34 9999999999999988877899999764
|